PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Godlee, F				Godlee, F			The BMJ is evolving - We want it to be a great magazine as well as a great journal	BRITISH MEDICAL JOURNAL			English	Editorial Material												fgodlee@hmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					1	2		10.1136/bmj.332.7532.1	http://dx.doi.org/10.1136/bmj.332.7532.1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399707	Green Published			2022-12-28	WOS:000234684200001
J	Kravitz, RL; Chang, S				Kravitz, RL; Chang, S			Promise and perils for patients and physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA; Calif Healthcare Fdn, Chron Care Dis Program, Oakland, CA USA	University of California System; University of California Davis	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA.		Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X				Alexander GC, 2005, ARCH INTERN MED, V165, P633, DOI 10.1001/archinte.165.6.633; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Shrank WH, 2005, AM J MANAG CARE, V11, P180; Shrank WH, 2005, AM J MANAG CARE, V11, P16; WOLF R, 2005, USA TODAY       1004, pA3	5	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2735	2739		10.1056/NEJMp058248	http://dx.doi.org/10.1056/NEJMp058248			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382057				2022-12-28	WOS:000234246700002
J	Alder, MN; Rogozin, IB; Iyer, LM; Glazko, GV; Cooper, MD; Pancer, Z				Alder, MN; Rogozin, IB; Iyer, LM; Glazko, GV; Cooper, MD; Pancer, Z			Diversity and function of adaptive immune receptors in a jawless vertebrate	SCIENCE			English	Article							AMINO-ACID SITES; VARIABLE LYMPHOCYTE RECEPTORS; SOMATIC DIVERSIFICATION; CRYSTAL-STRUCTURE; PROTEIN; SELECTION; COMPLEX; GENE; SUBSTITUTION; INHIBITION	Instead of the immunoglobulin-type antigen receptors of jawed vertebrates, jawless fish have variable lymphocyte receptors (VLRs), which consist of leucine-rich repeat (LRR) modules. Somatic diversification of the VLR gene is shown here to occur through a multistep assembly of LRR modules randomly selected from a large bank of flanking cassettes. The predicted concave surface of the VLR is lined with hypervariable positively selected residues, and computational analysis suggests a repertoire of about 1014 unique receptors. Lamprey immunized with anthrax spores responded with the production of soluble antigen-specific VLRs. These findings reveal that two strikingly different modes of antigen recognition through rearranged lymphocyte receptors have evolved in the jawless and jawed vertebrates.	Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Pathol, Birmingham, AL 35294 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stowers Institute for Medical Research	Pancer, Z (corresponding author), Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, 600 E Lombard St, Baltimore, MD 21202 USA.	pancer@comb.umbi.umd.edu	Iyer, Lakshminarayan M./H-2996-2019	Rogozin, Igor/0000-0003-0802-4851; Alder, Matthew/0000-0003-2879-6576	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; GOJOBORI T, 1986, MOL BIOL EVOL, V3, P156; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kreitman M, 1999, CURR OPIN GENET DEV, V9, P637, DOI 10.1016/S0959-437X(99)00034-9; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Nielsen R, 1998, GENETICS, V148, P929; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Papadopoulos NG, 1997, CLIN RHEUMATOL, V16, P162, DOI 10.1007/BF02247845; Rogozin IB, 2001, HUM MUTAT, V17, P83, DOI 10.1002/1098-1004(200102)17:2<83::AID-HUMU1>3.0.CO;2-E; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tang H, 1999, GENETICS, V153, P485; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Yang ZH, 2000, GENETICS, V155, P431; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	23	234	255	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1970	1973		10.1126/science.1119420	http://dx.doi.org/10.1126/science.1119420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373579				2022-12-28	WOS:000234275400047
J	Jermiin, LS; Poladian, L; Charleston, MA				Jermiin, LS; Poladian, L; Charleston, MA			Evolution - Is the "Big Bang" in animal evolution real?	SCIENCE			English	Editorial Material							SEQUENCE; HETEROGENEITY; MODEL		Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Jermiin, LS (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	lars.jermiin@usyd.edu.au	Charleston, Michael A/O-4903-2017; Jermiin, Lars Sommer/C-2458-2009; Jermiin, Lars Sommer/AAQ-7033-2020	Charleston, Michael A/0000-0001-8385-341X; Jermiin, Lars Sommer/0000-0002-9619-3809; Jermiin, Lars Sommer/0000-0002-9619-3809; Poladian, Leon/0000-0001-7110-0031				Briggs DEG, 2005, PALEOBIOLOGY, V31, P94, DOI 10.1666/0094-8373(2005)031[0094:WSSSGA]2.0.CO;2; DARWIN C, 1888, ORIGIN SPECIES MEANS, P313; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gould S. J., 1989, WONDERFUL LIFE BURGE; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Jayaswal V, 2005, EVOL BIOINFORM, V1, P62; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Lockhart P, 2006, MOL BIOL EVOL, V23, P40, DOI 10.1093/molbev/msj005; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Valentine JW, 1999, DEVELOPMENT, V126, P851; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	18	20	21	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1910	1911		10.1126/science.1122440	http://dx.doi.org/10.1126/science.1122440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373562				2022-12-28	WOS:000234275400027
J	Marris, E				Marris, E			Merck opts for shake-up to clear drug pipeline	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1076	1077		10.1038/4381076a	http://dx.doi.org/10.1038/4381076a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371975				2022-12-28	WOS:000234111500015
J	Yealy, DM; Auble, TE; Stone, RA; Lave, JR; Meehan, TP; Graff, LG; Fine, JM; Obrosky, DS; Mor, MK; Whittle, J; Fine, MJ				Yealy, DM; Auble, TE; Stone, RA; Lave, JR; Meehan, TP; Graff, LG; Fine, JM; Obrosky, DS; Mor, MK; Whittle, J; Fine, MJ			Effect of increasing the intensity of implementing pneumonia guidelines - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LOW-RISK PATIENTS; QUALITY-OF-CARE; ANTIMICROBIAL THERAPY; INITIAL MANAGEMENT; ELDERLY-PATIENTS; OUTCOMES; SEVERITY; ADULTS	Background: Despite the development of evidence-based pneumonia guidelines, limited data exist on the most effective means to implement guideline recommendations into clinical practice. Objective: To compare the effectiveness and safety of 3 guideline implementation strategies. Design: Cluster-randomized, controlled trial. Setting: 32 emergency departments in Pennsylvania and Connecticut. Patients: 3219 patients with a clinical and radiographic diagnosis of pneumonia. Interventions: The authors implemented a project-developed guideline for the initial site of treatment based on the Pneumonia Severity Index and performance of evidence-based processes of care at the emergency department level. Guideline implementation strategies were defined as low (n = 8), moderate (n = 12), and high intensity (n = 12). Measurements: Effectiveness outcomes were the rate at which low-risk patients were treated on an outpatient basis and the performance of recommended processes of care. Safety outcomes included death, subsequent hospitalization for outpatients, and medical complications for inpatients. Results: More low-risk patients (n = 1901) were treated as outpatients in the moderate-intensity and high-intensity groups in the low-intensity group (high-intensity group, 61.9%; moderate-intensity group, 61.0%; low-intensity group, 37.5%; P = 0.004). More outpatients (n = 1125) in the high-intensity group received all 4 recommended processes of care (high-intensity group, 60.9%; moderate-intensity group, 28.3%; low-intensity group, 25.3%; P < 0.001); more inpatients (n = 2076) in the high-intensity group received all 4 recommended processes of care (high-intensity group, 44.3%; moderate-intensity group, 30.1 %; low-intensity group, 23.0%; P < 0.001). No statistically significant differences in safety outcomes were observed across interventions. Limitations: Twenty percent of eligible patients were not enrolled, and data on effectiveness outcomes were not collected before the trial. Conclusions: Both moderate-intensity and high-intensity guideline implementation strategies safely increased the proportion of low-risk patients with pneumonia who were treated as outpatients. The high-intensity strategy was most effective for increasing the performance of the recommended processes of care for outpatients and inpatients.	Vet Adm Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Qualidigm, Middletown, CT USA; Yale Univ, Sch Med, New Haven, CT USA; New Britain Gen Hosp, New Britain, CT USA; Norwalk Hosp, Norwalk, CT 06856 USA; Univ Connecticut, Storrs, CT 06269 USA; Clement J Zablocki Vet Adm Med Ctr, Milwaukee, WI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University of Connecticut; Medical College of Wisconsin	Fine, MJ (corresponding author), Vet Adm Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 151-C-U,Univ Dr C,Bldg 21,1AI02, Pittsburgh, PA 15240 USA.	Michael.Fine@va.gov		Whittle, Jeff/0000-0002-9544-838X	AHRQ HHS [R01 HS10049] Funding Source: Medline; NIAID NIH HHS [K24 AI001769] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001769] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atlas SJ, 1998, ARCH INTERN MED, V158, P1350, DOI 10.1001/archinte.158.12.1350; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; BROWNE WJ, 2003, ESTIMATION MLWIN VER; Carratala J, 2005, ANN INTERN MED, V142, P165, DOI 10.7326/0003-4819-142-3-200502010-00006; Chu LA, 2003, ARCH INTERN MED, V163, P326, DOI 10.1001/archinte.163.3.326; Coley CM, 1996, ARCH INTERN MED, V156, P1565, DOI 10.1001/archinte.156.14.1565; *CTR MED MED SERV, 2005, NAT PNEUM MED QUAL I; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Fine MJ, 1997, ARCH INTERN MED, V157, P36, DOI 10.1001/archinte.157.1.36; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Halm EA, 2002, NEW ENGL J MED, V347, P2039, DOI 10.1056/NEJMcp020499; Halm EA, 2004, CHEST, V126, P100, DOI 10.1378/chest.126.1.100; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; *JOINT COMM ACCR H, 2005, OV COMM ACQ PNEUM CA; Lave JR, 1999, SEM RESP CRIT CARE M, V20, P189, DOI 10.1055/s-2007-1021315; Levin KP, 2001, J GEN INTERN MED, V16, P590, DOI 10.1046/j.1525-1497.2001.016009590.x; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McGarvey R N, 1993, QRB Qual Rev Bull, V19, P124; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; Murrey K O, 1992, QRB Qual Rev Bull, V18, P423; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; OBRIEN MAT, 2000, COCHRANE DB SYST REV; RICE N, 2001, WILEY SER PROB STAT, P27; Suchyta MR, 2001, AM J MED, V110, P306, DOI 10.1016/S0002-9343(00)00719-1; Yealy DM, 2004, ANN EMERG MED, V43, P770, DOI 10.1016/j.annemergmed.2003.09.013	35	152	153	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					881	894		10.7326/0003-4819-143-12-200512200-00006	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365469				2022-12-28	WOS:000234077400004
J	Golding, I; Paulsson, J; Zawilski, SM; Cox, EC				Golding, I; Paulsson, J; Zawilski, SM; Cox, EC			Real-time kinetics of gene activity in individual bacteria	CELL			English	Article							RNA-POLYMERASE MOLECULES; ESCHERICHIA-COLI; MESSENGER-RNA; TRANSCRIPTION ELONGATION; TRYPTOPHAN OPERON; STOCHASTIC-MODEL; LACTOSE OPERON; SINGLE-CELL; EXPRESSION; PROTEIN	Protein levels have been shown to vary substantially between individual cells in clonal populations. In prokaryotes, the contribution to such fluctuations from the inherent randomness of gene expression has largely been attributed to having just a few transcripts of the corresponding mRNAs. By contrast, eukaryotic studies tend to emphasize chromatin remodeling and burst-like transcription. Here, we study single-cell transcription in Escherichia coli by measuring mRNA levels in individual living cells. The results directly demonstrate transcriptional bursting, similar to that indirectly inferred foreukaryotes. We also measure mRNA partitioning at cell division and correlate mRNA and protein levels in single cells. Partitioning is approximately binomial, and mRNA protein correlations are weaker earlier in the cell cycle, where cell division has recently randomized the relative concentrations. Our methods further extend protein-based approaches by counting the integer-valued number of transcript with single-molecule resolution. This greatly facilitates kinetic interpretations in terms of the integer-valued random processes that produce the fluctuations.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Princeton University; University of Cambridge	Golding, I (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	igolding@princeton.edu; ecox@princeton.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001506] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 001506] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2004, HDB STOCHASTIC METHO; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BAKER RF, 1968, P NATL ACAD SCI USA, V60, P313, DOI 10.1073/pnas.60.1.313; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Beckwith J. R., 1970, LACTOSE OPERON; BENZER S, 1953, BIOCHIM BIOPHYS ACTA, V11, P383, DOI 10.1016/0006-3002(53)90057-2; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BREMER H, 1995, BBA-GENE STRUCT EXPR, V1262, P15, DOI 10.1016/0167-4781(95)00042-F; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CONTESSE G, 1969, B SOC CHIM BIOL, V51, P1445; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [10.1063/1.1750549, DOI 10.1063/1.1750549]; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; Hendrix R. W, 1983, LAMBDA, VII; IMAMOTO F, 1968, P NATL ACAD SCI USA, V60, P305, DOI 10.1073/pnas.60.1.305; Johansson HE, 1998, P NATL ACAD SCI USA, V95, P9244, DOI 10.1073/pnas.95.16.9244; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Li Y, 2004, J MOL BIOL, V339, P31, DOI 10.1016/j.jmb.2004.03.041; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathews C.K., 2000, BIOCHEMISTRY; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RIGNEY DR, 1979, J THEOR BIOL, V79, P247, DOI 10.1016/0022-5193(79)90250-9; RIGNEY DR, 1979, J THEOR BIOL, V76, P453, DOI 10.1016/0022-5193(79)90013-4; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; TAPASWI PK, 1987, SANKHYA SER B, V49, P51; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tolker-Nielsen T, 1998, MOL MICROBIOL, V27, P1099, DOI 10.1046/j.1365-2958.1998.00760.x; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Van Kampen NG, 1992, STOCHASTIC PROCESSES; YANOFSKY C, 1966, J MOL BIOL, V21, P313, DOI 10.1016/0022-2836(66)90102-1	59	1027	1042	5	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1025	1036		10.1016/j.cell.2005.09.031	http://dx.doi.org/10.1016/j.cell.2005.09.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360033	Bronze			2022-12-28	WOS:000234177200012
J	Hill, R; Song, YR; Cardiff, RD; Van Dyke, T				Hill, R; Song, YR; Cardiff, RD; Van Dyke, T			Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis	CELL			English	Article							GENETIC ALTERATIONS; TUMOR-SUPPRESSOR; MICRODISSECTED STROMA; TARGETED DISRUPTION; UROGENITAL SINUS; G(1) CONTROL; CELLS; CARCINOGENESIS; FIBROBLASTS; MUTATIONS	Our understanding of cancer has largely come from the analysis of aberrations within the tumor cell population. Yet it is increasingly clear that the tumor microenvironment can significantly influence tumorigenesis. For example, the mesenchyme can support the growth of tumorigenic epithelium. However, whether fibroblasts are subject to genetic/epigenetic changes as a result of selective pressures conferred by oncogenic stress in the epithelium has not been experimentally assessed. Recent analyses of some human carcinomas have shown tumor-suppressor gene mutations within the stroma, suggesting that the interplay among multiple cell types can select for aberrations nonautonomously during tumor progression. We demonstrate that this indeed occurs in a mouse model of prostate cancer where epithelial cell cycle disruption via cell-specific inhibition of pRb function induces a paracrine p53 response that suppresses fibroblast proliferation in associated stroma. This interaction imposes strong selective pressure yielding a highly proliferative mesenchyme that has undergone p53 loss.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis	Hill, R (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	tvdlab@med.unc.edu	Song, Yurong/GRX-9328-2022; Hill, Reginald/D-2270-2016		NCI NIH HHS [R01-CA046283, U01-CA84294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084294, R01CA046283] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Cunha GR, 1996, ACTA ANAT, V155, P63; CUNHA GR, 1980, ENDOCRINOLOGY, V107, P1767, DOI 10.1210/endo-107-6-1767; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; DAMERON KM, 1994, COLD SPRING HARB SYM, V59, P483, DOI 10.1101/SQB.1994.059.01.053; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gatalica Z, 2001, PATHOL RES PRACT, V197, P183, DOI 10.1078/0344-0338-00031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ittmann M, 1996, CANCER RES, V56, P2143; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kleihues P, 1997, AM J PATHOL, V150, P1; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Matsumoto N, 2003, BRIT J CANCER, V89, P707, DOI 10.1038/sj.bjc.6601141; McCarthy RP, 2004, AM J PATHOL, V165, P1395, DOI 10.1016/S0002-9440(10)63397-4; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Moinfar F, 2000, CANCER RES, V60, P2562; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; SAKAKURA T, 1991, INT REV CYTOL, V125, P165, DOI 10.1016/S0074-7696(08)61219-X; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wernert N, 2001, ANTICANCER RES, V21, P2259; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Yu EY, 1997, PROSTATE CANCER P D, V1, P39, DOI 10.1038/sj.pcan.4500205	50	263	278	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1001	1011		10.1016/j.cell.2005.09.030	http://dx.doi.org/10.1016/j.cell.2005.09.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360031	Bronze, Green Submitted			2022-12-28	WOS:000234177200010
J	Pirisi, A				Pirisi, A			Profile - Marlon Shirley - Paralympic star	LANCET			English	Biographical-Item												apirisi@interlynx.net						SHIRLEY M, PUBLICATION LIST	1	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S12	S12		10.1016/S0140-6736(05)67825-7	http://dx.doi.org/10.1016/S0140-6736(05)67825-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360729				2022-12-28	WOS:000234374400008
J	Goldstein, JL; DeBose-Boyd, RA; Brown, MS				Goldstein, JL; DeBose-Boyd, RA; Brown, MS			Protein sensors for membrane sterols	CELL			English	Review							ELEMENT-BINDING PROTEINS; HMG-COA REDUCTASE; CLEAVAGE-ACTIVATING PROTEIN; FATTY-ACID SYNTHESIS; RETICULUM-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; COENZYME-A REDUCTASE; ENDOPLASMIC-RETICULUM; SENSING DOMAIN; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE	Cholesterol is an essential component of animal cell membranes, and its concentration is tightly controlled by a feedback system that operates at transcriptional and post-transcriptional levels. Here, we discuss recent advances that explain how cells employ an ensemble of membrane-embedded proteins to monitor sterol concentrations and adjust sterol synthesis and uptake.	Univ Texas, Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas	Goldstein, JL (corresponding author), Univ Texas, Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, K01HL070441] Funding Source: NIH RePORTER; NHLBI NIH HHS [K01-HL70441, P01-HL20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BROWN MS, 1975, J BIOL CHEM, V250, P4025; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; LISCUM L, 1985, J BIOL CHEM, V260, P522; LUONG A, 2000, THESIS U TEXAS SW ME, P1; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Peng Y, 1997, GENOMICS, V43, P278, DOI 10.1006/geno.1997.4821; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2000, J BIOL CHEM, V275, P29881, DOI 10.1074/jbc.M005439200; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	74	1188	1232	3	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					35	46		10.1016/j.cell.2005.12.022	http://dx.doi.org/10.1016/j.cell.2005.12.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413480	Bronze			2022-12-28	WOS:000234969600008
J	Luo, GM; Malkova, S; Yoon, J; Schultz, DG; Lin, BH; Meron, M; Benjamin, I; Vanysek, P; Schlossman, ML				Luo, GM; Malkova, S; Yoon, J; Schultz, DG; Lin, BH; Meron, M; Benjamin, I; Vanysek, P; Schlossman, ML			Ion distributions near a liquid-liquid interface	SCIENCE			English	Article							RAY STANDING WAVES; DOUBLE-LAYER; X-RAY; ELECTROLYTE-SOLUTIONS; CAPACITANCE; ADSORPTION; DYNAMICS	Mean field theories of ion distributions, such as the Gouy-Chapman theory that describes the distribution near a charged planar surface, ignore the molecular-scale structure in the liquid solution. The predictions of the Gouy-Chapman theory vary substantially from our x-ray reflectivity measurements of the interface between two electrolyte solutions. Molecular dynamics simulations, which include the liquid structure, were used to calculate the potential of mean force on a single ion. We used this potential of mean force in a generalized Poisson-Boltzmann equation to predict the full ion distributions. These distributions agree with our measurements without any adjustable parameters.	Univ Illinois, Dept Phys, Chicago, IL 60607 USA; Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; No Illinois Univ, Dept Chem & Biochem, De Kalb, IL 60115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of California System; University of California Santa Cruz; Northern Illinois University	Schlossman, ML (corresponding author), Univ Illinois, Dept Phys, Chicago, IL 60607 USA.	schloss@uic.edu	Vanysek, Petr/A-1949-2016	Vanysek, Petr/0000-0002-5458-393X				Andresen K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.248103; BEDZYK MJ, 1990, SCIENCE, V248, P52, DOI 10.1126/science.2321026; BENJAMIN I, 1993, SCIENCE, V261, P1558, DOI 10.1126/science.261.5128.1558; BLOCH JM, 1988, PHYS REV LETT, V61, P2941, DOI 10.1103/PhysRevLett.61.2941; BURLEY DM, 1972, MOL PHYS, V23, P867, DOI 10.1080/00268977200100871; Chapman DL, 1913, PHILOS MAG, V25, P475, DOI 10.1080/14786440408634187; Daikhin LI, 2001, J ELECTROANAL CHEM, V500, P461, DOI 10.1016/S0022-0728(00)00484-8; Daikhin LI, 2000, J ELECTROANAL CHEM, V483, P68, DOI 10.1016/S0022-0728(00)00054-1; Das R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188103; Fenter P, 2000, J COLLOID INTERF SCI, V225, P154, DOI 10.1006/jcis.2000.6756; GAVACH C, 1977, J ELECTROANAL CHEM, V83, P225, DOI 10.1016/0368-1874(77)80378-X; Girault H. H., 1993, MOD ASPECT ELECTROC, V25, P1; Gouy, 1909, CR HEBD ACAD SCI, V149, P654; Kirkwood JG, 1934, J CHEM PHYS, V2, DOI 10.1063/1.1749393; KRUMGALZ BS, 1982, J CHEM SOC FARAD T 1, V78, P437, DOI 10.1039/f19827800437; LEVEILLER F, 1991, SCIENCE, V252, P1532, DOI 10.1126/science.252.5012.1532; LEVINE S, 1981, J ELECTROANAL CHEM, V123, P105, DOI 10.1016/S0022-0728(81)80046-0; Mecke KR, 1999, PHYS REV E, V59, P6766, DOI 10.1103/PhysRevE.59.6766; Mitrinovic DM, 2000, PHYS REV LETT, V85, P582, DOI 10.1103/PhysRevLett.85.582; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; PEREIRA CM, 1994, J CHEM SOC FARADAY T, V90, P143, DOI 10.1039/ft9949000143; REID JD, 1983, J ELECTROANAL CHEM, V147, P71, DOI 10.1016/S0022-0728(83)80057-6; SAMEC Z, 1985, J ELECTROANAL CHEM, V187, P31, DOI 10.1016/0368-1874(85)85573-8; Schmickler W., 1996, INTERFACIAL ELECTROC; Stern O, 1924, Z ELKTROCHEM ANGEW P, V30, P508; Vaknin D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.178102	27	215	220	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					216	218		10.1126/science.1120392	http://dx.doi.org/10.1126/science.1120392			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410522				2022-12-28	WOS:000234722200038
J	Genta, MS; Gabay, C				Genta, MS; Gabay, C			Milwaukee shoulder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland	University of Geneva	Genta, MS (corresponding author), Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					E2	E2		10.1056/NEJMicm050094	http://dx.doi.org/10.1056/NEJMicm050094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407503				2022-12-28	WOS:000234528600011
J	Hou, FF; Zhang, X; Zhang, GH; Xie, D; Chen, PY; Zhang, WR; Jiang, JP; Liang, M; Wang, GB; Liu, ZR; Geng, RW				Hou, FF; Zhang, X; Zhang, GH; Xie, D; Chen, PY; Zhang, WR; Jiang, JP; Liang, M; Wang, GB; Liu, ZR; Geng, RW			Efficacy and safety of benazepril for advanced chronic renal insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING ENZYME-INHIBITION; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE CONTROL; SERUM CREATININE; CHRONIC NEPHROPATHIES; CHINESE PATIENTS; PROGRESSION; DISEASE; TRIAL; EQUATIONS	BACKGROUND: Angiotensin-converting-enzyme inhibitors provide renal protection in patients with mild-to-moderate renal insufficiency (serum creatinine level, 3.0 mg per deciliter or less). We assessed the efficacy and safety of benazepril in patients without diabetes who had advanced renal insufficiency. METHODS: We enrolled 422 patients in a randomized, double-blind study. After an eight-week run-in period, 104 patients with serum creatinine levels of 1.5 to 3.0 mg per deciliter (group 1) received 20 mg of benazepril per day, whereas 224 patients with serum creatinine levels of 3.1 to 5.0 mg per deciliter (group 2) were randomly assigned to receive 20 mg of benazepril per day (112 patients) or placebo (112 patients) and then followed for a mean of 3.4 years. All patients received conventional antihypertensive therapy. The primary outcome was the composite of a doubling of the serum creatinine level, end-stage renal disease, or death. Secondary end points included changes in the level of proteinuria and the rate of progression of renal disease. RESULTS: Of 102 patients in group 1, 22 (22 percent) reached the primary end point, as compared with 44 of 108 patients given benazepril in group 2 (41 percent) and 65 of 107 patients given placebo in group 2 (60 percent). As compared with placebo, benazepril was associated with a 43 percent reduction in the risk of the primary end point in group 2 (P=0.005). This benefit did not appear to be attributable to blood-pressure control. Benazepril therapy was associated with a 52 percent reduction in the level of proteinuria and a reduction of 23 percent in the rate of decline in renal function. The overall incidence of major adverse events in the benazepril and placebo subgroups of group 2 was similar. CONCLUSIONS: Benazepril conferred substantial renal benefits in patients without diabetes who had advanced renal insufficiency.	So Med Univ, Nanfang Hosp, Div Renal, Guangzhou, Peoples R China	Southern Medical University - China	Hou, FF (corresponding author), So Med Univ, Nanfang Hosp, Div Renal, 1838 N Guangzhou Ave, Guangzhou, Peoples R China.	ffhou@public.guangzhou.gd.cn						Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Hou Fan-Fan, 2005, Zhonghua Yi Xue Za Zhi, V85, P458; Ihle BU, 1996, AM J KIDNEY DIS, V27, P489, DOI 10.1016/S0272-6386(96)90158-4; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 1998, PRIMER KIDNEY DIS, P20; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MITCH WE, 1976, LANCET, V2, P1326; Moser M, 1997, J AM COLL CARDIOL, V29, P1414, DOI 10.1016/S0735-1097(97)00096-X; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; REAMS GP, 1988, AM J KIDNEY DIS, V11, P499, DOI 10.1016/S0272-6386(88)80086-6; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2001, J AM SOC NEPHROL, V12, P2832, DOI 10.1681/ASN.V12122832; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2096; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Tomlinson B, 2004, CLIN THER, V26, P1292, DOI 10.1016/S0149-2918(04)80145-0; Zhang Guo-hua, 2005, Zhonghua Nei Ke Za Zhi, V44, P592; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012; 2001, CHIN J NEPHROL, V17, P77	24	477	537	46	609	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					131	140		10.1056/NEJMoa053107	http://dx.doi.org/10.1056/NEJMoa053107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407508	Bronze			2022-12-28	WOS:000234528600005
J	Svenningsson, P; Chergui, K; Rachleff, I; Flajolet, M; Zhang, XQ; El Yacoubi, M; Vaugeois, JM; Nomikos, GG; Greengard, P				Svenningsson, P; Chergui, K; Rachleff, I; Flajolet, M; Zhang, XQ; El Yacoubi, M; Vaugeois, JM; Nomikos, GG; Greengard, P			Alterations in 5-HT1B receptor function by p11 in depression-like states	SCIENCE			English	Article							EXPRESSION; DISORDERS; PROTEINS; CHANNEL; MICE	The pathophysiology of depression remains enigmatic, although abnormalities in serotonin signaling have been implicated. We have found that the serotonin 113 receptor [5-hydroxytryptamine (5-HT1B) receptor] interacts with p11. p11 increases localization of 5-HT1B receptors at the cell surface. p11 is increased in rodent brains by antidepressants or electroconvulsive therapy, but decreased in an animal model of depression and in brain tissue from depressed patients. Overexpression of p11 increases 5-HT1B receptor function in cells and recapitulates certain behaviors seen after antidepressant treatment in mice. p11 knockout mice exhibit a depression-like phenotype and have reduced responsiveness to 5-HT1B receptor agonists and reduced behavioral reactions to an antidepressant.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; European Inst Peptide Res, IFRMP 23, Fac Med & Pharm, CNRS FRE2735,Unite Neuropsychopharmacol Expt, F-76183 Rouen, France; Eli Lilly & Co, Lilly Corp Ctr, Neurosci Discovery Res, Indianapolis, IN 46285 USA	Rockefeller University; Karolinska Institutet; Eli Lilly	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	greengard@rockefeller.edu	Svenningsson, Per JL/K-5210-2014	Vaugeois, Jean-Marie/0000-0001-8296-672X; EL YACOUBI, Malika/0000-0002-1010-9179; Chergui, Karima/0000-0001-5702-0422	NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; Moret C, 2000, EUR J PHARMACOL, V404, P1, DOI 10.1016/S0014-2999(00)00581-1; Morikawa H, 2000, MOL PHARMACOL, V58, P1271, DOI 10.1124/mol.58.6.1271; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SCHLICKER E, 1992, BRIT J PHARMACOL, V105, P732, DOI 10.1111/j.1476-5381.1992.tb09047.x; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162	16	431	448	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					77	80		10.1126/science.1117571	http://dx.doi.org/10.1126/science.1117571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400147				2022-12-28	WOS:000234546300036
J	Bienko, M; Green, CM; Crosetto, N; Rudolf, F; Zapart, G; Coull, B; Kannouche, P; Wider, G; Peter, M; Lehmann, AR; Hofmann, K; Dikic, I				Bienko, M; Green, CM; Crosetto, N; Rudolf, F; Zapart, G; Coull, B; Kannouche, P; Wider, G; Peter, M; Lehmann, AR; Hofmann, K; Dikic, I			Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis	SCIENCE			English	Article							DNA-POLYMERASES; PCNA; ETA; LOCALIZATION; COMPONENTS; SWITCH; DAMAGE; CELLS; IOTA; SUMO	Translesion synthesis (TLS) is the major pathway by which mammalian cells replicate across DNA lesions. Upon DNA damage, ubiquitination of proliferating cell nuclear antigen (PCNA) induces bypass of the lesion by directing the replication machinery into the TLS pathway. Yet, how this modification is recognized and interpreted in the cell remains unclear. Here we describe the identification of two ubiquitin (Ub)-binding domains (UBM and UBZ), which are evolutionarily conserved in all Y-family TLS polymerases (pols). These domains are required for binding of pol eta and pol iota to ubiquitin, their accumulation in replication factories, and their interaction with monoubiquitinated PCNA. Moreover, the UBZ domain of poll) is essential to efficiently restore a normal response to ultraviolet irradiation in xeroderma pigmentosum variant (XP-V) fibroblasts. Our results indicate that Ub-binding domains of Y-family polymerases play crucial regulatory roles in TLS.	Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Univ Sussex, Brighton BN1 9RQ, E Sussex, England; ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Miltenyi Biotec GmbH, Bioinformat Grp, D-50829 Cologne, Germany	Goethe University Frankfurt; University of Sussex; Swiss Federal Institutes of Technology Domain; ETH Zurich; Miltenyi Biotec	Dikic, I (corresponding author), Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Bienko, Magda/AAM-8867-2020; Green, Catherine/B-4235-2009; Green, Catherine/D-7528-2014; Hofmann, Kay/D-6714-2011; Dikic, Ivan/O-4650-2015	Bienko, Magda/0000-0002-6499-9082; Hofmann, Kay/0000-0002-2289-9083; Dikic, Ivan/0000-0001-8156-9511; Wider, Gerhard/0000-0001-9366-7645; Coull, Barry/0000-0001-5438-7085; Green, Catherine/0000-0002-7068-7106				Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HOELLER D, IN PRESS NAT CELL BI; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche P, 2003, EMBO J, V22, P1223, DOI 10.1093/emboj/7595006; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lehmann A, 2003, CURR BIOL, V13, pR585, DOI 10.1016/S0960-9822(03)00518-9; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	18	557	568	7	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1821	1824		10.1126/science.1120615	http://dx.doi.org/10.1126/science.1120615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357261				2022-12-28	WOS:000234093600048
J	Moumen, A; Masterson, P; O'Connor, MJ; Jackson, SP				Moumen, A; Masterson, P; O'Connor, MJ; Jackson, SP			hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage	CELL			English	Article							NUCLEAR RIBONUCLEOPROTEIN-K; CELL-CYCLE CHECKPOINTS; BOX-BINDING-PROTEIN; SINGLE-STRANDED-DNA; ATAXIA-TELANGIECTASIA; GEL-ELECTROPHORESIS; GENE-EXPRESSION; IN-VIVO; CANCER; RNA	In response to DNA damage, mammalian cells trigger the p53-dependent transcriptional induction of factors that regulate DNA repair, cell-cycle progression, or cell survival. Through differential proteomics, we identify heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR. Induction of hnRNP K ensues through the inhibition of its ubiquitin-dependent proteasomal degradation mediated by the ubiquitin E3 ligase HDM2/MDM2. Strikingly, hnRNP K depletion abrogates transcriptional induction of p53 target genes and causes defects in DNA-damage induced cell-cycle-checkpoint arrests. Furthermore, in response to DNA damage, p53 and hnRNP K are recruited to the promoters of p53-responsive genes in a mutually dependent manner. These findings establish hnRNP K as a new HDM2 target and show that, by serving as a cofactor for p53, hnRNP K plays key roles in coordinating transcriptional responses to DNA damage.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England	University of Cambridge; University of Cambridge; AstraZeneca	Moumen, A (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	mjoconnor@kudospharma.co.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Elkon R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r43; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farmer G, 1996, MOL CELL BIOL, V16, P4295; GAILLARD C, 1994, NUCLEIC ACIDS RES, V22, P4183, DOI 10.1093/nar/22.20.4183; Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ichikawa M, 2000, MUTAT RES-DNA REPAIR, V459, P285, DOI 10.1016/S0921-8777(00)00005-7; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee MH, 1996, J BIOL CHEM, V271, P3420; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LUNA RMD, 1995, NATURE, V378, P203; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Perry ME, 2004, MOL CANCER RES, V2, P9; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Prives C, 1999, J PATHOL, V187, P112; Ramos YFM, 2001, CANCER RES, V61, P1839; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shiloh Y, 2004, SEMIN CANCER BIOL, V14, P295, DOI 10.1016/j.semcancer.2004.04.009; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Urbani A, 2005, PROTEOMICS, V5, P796, DOI 10.1002/pmic.200401147; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	56	249	263	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1065	1078		10.1016/j.cell.2005.09.032	http://dx.doi.org/10.1016/j.cell.2005.09.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360036	Bronze			2022-12-28	WOS:000234177200015
J	Steele, FR				Steele, FR			Big pharma's commedia	CELL			English	Editorial Material							LESSONS; VIOXX	Despite continuing financial success, many big pharmaceutical companies are facing an uncertain future. Merging basic and clinical research in a determined effort to fully elucidate the molecular mechanisms of disease and thus to develop effective drugs with fewer side effects is the tough journey ahead that big pharma needs to pursue to ensure a brighter future.	MIT, Broad Inst, Cambridge, MA 02141 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Steele, FR (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	fsteele@broad.mit.edu						Angell M., 2004, TRUTH DRUG CO; BERENSON A, 2005, NY TIMES        1129; Chin-Dusting J, 2005, NAT REV DRUG DISCOV, V4, P891, DOI 10.1038/nrd1879; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Frazier KC, 2005, NEW ENGL J MED, V353, P1420; Krimsky S., 2004, SCI PRIVATE INTEREST; *PHRMA, 2004, RESP M ANG BOOK; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; 2001, RX R D MYTHS CASE DR	9	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					971	973		10.1016/j.cell.2005.11.033	http://dx.doi.org/10.1016/j.cell.2005.11.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360023	Bronze			2022-12-28	WOS:000234177200002
J	Larkin, M				Larkin, M			Feature - Can nutrition improve athletic performance?	LANCET			English	Article												Mleditor@aol.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S27	S28		10.1016/S0140-6736(05)67835-X	http://dx.doi.org/10.1016/S0140-6736(05)67835-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360739				2022-12-28	WOS:000234374400018
J	Surov, A; Kornhuber, ME				Surov, A; Kornhuber, ME			A spinal foreign body	LANCET			English	Editorial Material									Univ Halle Wittenberg, Dept Radiol, D-06097 Halle Saale, Germany; Univ Halle Wittenberg, Neurol Hosp, D-06097 Halle Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Surov, A (corresponding author), Univ Halle Wittenberg, Dept Radiol, Ernst Grube Str 40, D-06097 Halle Saale, Germany.	alex.surow@medizin.uni-halle.de		Surov, Alexey/0000-0002-9273-3943					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2122	2122		10.1016/S0140-6736(05)67891-9	http://dx.doi.org/10.1016/S0140-6736(05)67891-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360790				2022-12-28	WOS:000234146000028
J	Duncan, S				Duncan, S			The nursing profession's coming of age - Contribution of "maxi" nurses is exaggerated	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Hope Hosp, Salford M6 8HD, Lancs, England		Duncan, S (corresponding author), Hope Hosp, Salford M6 8HD, Lancs, England.	susan@susanduncan.co.uk						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51-b	http://dx.doi.org/10.1136/bmj.332.7532.51-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399749	Green Published			2022-12-28	WOS:000234684200031
J	Armstrong, DK; Bundy, B; Wenzel, L; Huang, HQ; Baergen, R; Lele, S; Copeland, LJ; Walker, JL; Burger, RA				Armstrong, DK; Bundy, B; Wenzel, L; Huang, HQ; Baergen, R; Lele, S; Copeland, LJ; Walker, JL; Burger, RA		Gynecologic Oncology Grp	Intraperitoneal cisplatin and paclitaxel in ovarian cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE-III OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; THERAPY; CHEMOTHERAPY; CARBOPLATIN; CARCINOMA; TRIAL; CYCLOPHOSPHAMIDE; INTERGROUP	BACKGROUND: Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology Group conducted a randomized, phase 3 trial that compared intravenous paclitaxel plus cisplatin with intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel in patients with stage III ovarian cancer. METHODS: We randomly assigned patients with stage III ovarian carcinoma or primary peritoneal carcinoma with no residual mass greater than 1.0 cm to receive 135 mg of intravenous paclitaxel per square meter of body-surface area over a 24-hour period followed by either 75 mg of intravenous cisplatin per square meter on day 2 (intravenous-therapy group) or 100 mg of intraperitoneal cisplatin per square meter on day 2 and 60 mg of intraperitoneal paclitaxel per square meter on day 8 (intraperitoneal-therapy group). Treatment was given every three weeks for six cycles. Quality of life was assessed. RESULTS: Of 429 patients who underwent randomization, 415 were eligible. Grade 3 and 4 pain, fatigue, and hematologic, gastrointestinal, metabolic, and neurologic toxic effects were more common in the intraperitoneal-therapy group than in the intravenous-therapy group (P lessthan/equal 0.001). Only 42 percent of the patients in the intraperitoneal-therapy group completed six cycles of the assigned therapy, but the median duration of progression-free survival in the intravenous-therapy and intraperitoneal-therapy groups was 18.3 and 23.8 months, respectively (P=0.05 by the log-rank test). The median duration of overall survival in the intravenous-therapy and intraperitoneal-therapy groups was 49.7 and 65.6 months, respectively (P=0.03 by the log-rank test). Quality of life was significantly worse in the intraperitoneal-therapy group before cycle 4 and three to six weeks after treatment but not one year after treatment. CONCLUSIONS: As compared with intravenous paclitaxel plus cisplatin, intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel improves survival in patients with optimally debulked stage III ovarian cancer.	Gynecol Oncol Grp, Adm Off, Stat & Data Ctr, Philadelphia, PA 19103 USA; Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Univ Calif Irvine, Div Gynecol Oncol, Irvine, CA USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, New York, NY USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Oklahoma, Oklahoma City, OK USA	Johns Hopkins University; Johns Hopkins Medicine; Roswell Park Cancer Institute; University of California System; University of California Irvine; Cornell University; NewYork-Presbyterian Hospital; University System of Ohio; Ohio State University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Armstrong, DK (corresponding author), Gynecol Oncol Grp, Adm Off, Stat & Data Ctr, 4 Penn Ctr,1600 JFK Blvd,Ste 1020, Philadelphia, PA 19103 USA.				NATIONAL CANCER INSTITUTE [U10CA027469, U10CA037517] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37517, CA 27469] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Alberts DS, 2002, J CLIN ONCOL, V20, P3944, DOI 10.1200/JCO.2002.20.19.3944; Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; COX DR, 1972, J R STAT SOC B, V34, P187; FRANCIS P, 1995, J CLIN ONCOL, V13, P2961, DOI 10.1200/JCO.1995.13.12.2961; Fujiwara K, 2003, GYNECOL ONCOL, V91, P662, DOI 10.1016/j.ygyno.2003.09.006; Fujiwara K, 2003, GYNECOL ONCOL, V90, P637, DOI 10.1016/S0090-8258(03)00377-9; Greer BE, 2005, GYNECOL ONCOL, V99, P71, DOI 10.1016/j.ygyno.2005.05.012; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Jemal A, 2005, CA-CANCER J CLIN, V55, P259; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; MCGUIRE WP, 1995, J CLIN ONCOL, V13, P1589, DOI 10.1200/JCO.1995.13.7.1589; McGuire WP, 2001, J CLIN ONCOL, V19, P921, DOI 10.1200/JCO.2001.19.4.921; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 1999, ANN ONCOL, V10, P59, DOI 10.1023/A:1008363519331; Rothenberg ML, 2003, J CLIN ONCOL, V21, P1313, DOI 10.1200/JCO.2003.07.031; SCHNEIDER JG, 1994, OBSTET GYN CLIN N AM, V21, P195; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Thigpen T, 2004, NEW ENGL J MED, V351, P2544, DOI 10.1056/NEJMe048292; Walker JL, 2006, GYNECOL ONCOL, V100, P27, DOI 10.1016/j.ygyno.2005.11.013; Wenzel LB, 2005, J CLIN ONCOL, V23, p754S; WENZEL LB, 2004, P AN M AM SOC CLIN, V23, P454	28	1999	2078	1	135	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					34	43		10.1056/NEJMoa052985	http://dx.doi.org/10.1056/NEJMoa052985			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394300	Bronze			2022-12-28	WOS:000234358600006
J	Scavini, M; Pontiroli, AE; Folli, F				Scavini, M; Pontiroli, AE; Folli, F			Asymptomatic hyperinsulinemic hypoglycemia after gastric banding	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									San Raffaele Sci Inst, I-20132 Milan, Italy; Univ Milan, I-20100 Milan, Italy; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; University of Texas System; University of Texas Health San Antonio	Scavini, M (corresponding author), San Raffaele Sci Inst, I-20132 Milan, Italy.	folli@uthscsa.edu	pontiroli, antonio e/AAI-5575-2020; folli, franco/J-2795-2018; Scavini, Marina/AAN-1892-2020	folli, franco/0000-0001-9824-5222; Scavini, Marina/0000-0002-7983-6905				DeMaria EJ, 2005, SURG CLIN N AM, V85, P773, DOI 10.1016/j.suc.2005.04.008; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; Service GJ, 2005, NEW ENGL J MED, V353, P249, DOI 10.1056/NEJMoa043690	5	42	44	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2822	2823		10.1056/NEJMc052356	http://dx.doi.org/10.1056/NEJMc052356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382076				2022-12-28	WOS:000234246700035
J	Lill, MM; Willkinson, TJ				Lill, MM; Willkinson, TJ			Judging a book by its cover: descriptive survey of patients' preferences for doctors' appearance and mode of address	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE COATS; ATTITUDES; ATTIRE; DRESS	Objective To document patients' preferred dress styles of their doctors and modes of address. Design Descriptive survey. Setting Inpatients and outpatients at a tertiary level hospital, New Zealand. Participants 202 inpatients and 249 outpatients, mean age 55.9 (SD 19.3) years. Main outcome measures Ranking of patients' opinions of photographs showing doctors wearing different dress styles. A five point Likert scale was used to measure patient comfort with particular items of appearance. Results Patients preferred doctors to wear semiformal attire, but the addition of a smiling face was even better. The next most preferred styles were semiformal without a smile, followed by white coat, formal suit,jeans, and casual dress. Patients were more comfortable with conservative items of clothing, such as long sleeves, covered shoes, and dress trousers or skirts than with less conservative items such as facial piercing, short tops, and earrings on men. Many less conservative items Such as jeans were still acceptable to most patients. Most patients preferred to be called by their first name, to be introduced to a doctor by full name mid title, and to see the doctor's name badge worn at the breast pocket. Older patients had more conservative preferences. Conclusions Patients prefer doctors to wear semiformal dress and are most comfortable with conservative items; many less conservative items were, however, acceptable. A smile made a big difference.	Univ Otago, Christchurch Sch Med & Hlth, Dunedin, New Zealand	University of Otago	Willkinson, TJ (corresponding author), Princess Margaret Hosp, POB 800, Christchurch 2, New Zealand.	tim.wilkinson@chmeds.ac.nz	Wilkinson, Tim/C-5515-2008	Wilkinson, Tim/0000-0002-4080-4164				Baevsky RH, 1998, ACAD EMERG MED, V5, P82, DOI 10.1111/j.1553-2712.1998.tb02583.x; BLONDELL RD, 1987, AM J DIS CHILD, V141, P830, DOI 10.1001/archpedi.1987.04460080016010; Friis R, 1988, Fam Pract Res J, V8, P24; GJERDINGEN DK, 1987, ARCH INTERN MED, V147, P1209, DOI 10.1001/archinte.147.7.1209; Gooden BR, 2001, MED J AUSTRALIA, V175, P219, DOI 10.5694/j.1326-5377.2001.tb143103.x; Harnett PR, 2001, MED J AUSTRALIA, V174, P343, DOI 10.5694/j.1326-5377.2001.tb143310.x; HENNESSY N, 1993, ANAESTHESIA, V48, P219, DOI 10.1111/j.1365-2044.1993.tb06905.x; MCKINSTRY B, 1991, BRIT J GEN PRACT, V41, P275; SHORT D, 1993, BRIT J HOSP MED, V50, P270; WONG D, 1991, BRIT MED J, V303, P1602, DOI 10.1136/bmj.303.6817.1602	10	88	91	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1524	1527		10.1136/bmj.331.7531.1524	http://dx.doi.org/10.1136/bmj.331.7531.1524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373739	Green Published, Bronze			2022-12-28	WOS:000234351300019
J	Adams, WW; Baughman, RH				Adams, WW; Baughman, RH			Richard E. Smalley (1943-2005) - Retrospective	SCIENCE			English	Biographical-Item									Rice Univ, Ctr Nanoscale Sci & Technol, Houston, TX 77251 USA; Univ Texas, Nanotech Inst, Richardson, TX 75080 USA	Rice University; University of Texas System; University of Texas Dallas	Adams, WW (corresponding author), Rice Univ, Ctr Nanoscale Sci & Technol, Houston, TX 77251 USA.	wade.adams@rice.edu; ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018; Adams, Wade/A-7305-2010	Baughman, Ray/0000-0001-5845-5137; 					0	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2005	310	5756					1916	1916		10.1126/science.1122120	http://dx.doi.org/10.1126/science.1122120			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373566				2022-12-28	WOS:000234275400031
J	Whitehead, GG; Makino, S; Lien, CL; Keating, MT				Whitehead, GG; Makino, S; Lien, CL; Keating, MT			fgf20 is essential for initiating zebrafish fin regeneration	SCIENCE			English	Article							CELL-PROLIFERATION; DIFFERENTIATION; INDUCTION	Epimorphic regeneration requires the presence or creation of pluripotent cells capable of reproducing lost organs. Zebrafish fin regeneration is mediated by the creation of blastema cells. Here, we characterize the devoid of blastema (dob) mutant that fails fin regeneration during initial steps, forms abnormai regeneration epithelium, and does not form blastema. This mutation has no impact on embryonic survival. Dob results from an fgf20a null mutation, Y148S. Fgf20a is expressed during initiation of fin regeneration at the epithelial-mesenchymal boundary and later overlaps with the blastema marker msxb. Thus, fgf20a has a regeneration-specific requirement, initiating fin regeneration, and controlling blastema formation.	Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol,Dept Cell Biol,Howard Hughes Med Ins, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Keating, MT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol,Dept Cell Biol,Howard Hughes Med Ins, Boston, MA 02115 USA.	mark.keating@novartis.com			NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; JOHNSON SL, 1995, GENETICS, V141, P1583; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Makino S, 2005, P NATL ACAD SCI USA, V102, P14599, DOI 10.1073/pnas.0507408102; Nechiporuk A, 2003, DEV BIOL, V258, P291, DOI 10.1016/S0012-1606(03)00129-5; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Ohmachi S, 2003, J NEUROSCI RES, V72, P436, DOI 10.1002/jnr.10592; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857	17	218	223	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1957	1960		10.1126/science.1117637	http://dx.doi.org/10.1126/science.1117637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373575				2022-12-28	WOS:000234275400043
J	Leibfried, A; To, JPC; Busch, W; Stehling, S; Kehle, A; Demar, M; Kieber, JJ; Lohmann, JU				Leibfried, A; To, JPC; Busch, W; Stehling, S; Kehle, A; Demar, M; Kieber, JJ; Lohmann, JU			WUSCHEL controls meristem function by direct regulation of cytokinin-inducible response regulators	NATURE			English	Article							ARABIDOPSIS SHOOT MERISTEM; STEM-CELL FATE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CLAVATA1; THALIANA; CLV3; ENCODES; KINASE; FAMILY	Plants continuously maintain pools of totipotent stem cells in their apical meristems from which elaborate root and shoot systems are produced. In Arabidopsis thaliana, stem cell fate in the shoot apical meristem is controlled by a regulatory network that includes the CLAVATA (CLV) ligand - receptor system and the homeodomain protein WUSCHEL (WUS)(1,2). Phytohormones such as auxin and cytokinin are also important for meristem regulation(3). Here we show a mechanistic link between the CLV/WUS network and hormonal control. WUS, a positive regulator of stem cells, directly represses the transcription of several two-component ARABIDOPSIS RESPONSE REGULATOR genes (ARR5, ARR6, ARR7 and ARR15), which act in the negative-feedback loop of cytokinin signalling(4,5). These data indicate that ARR genes might negatively influence meristem size and that their repression by WUS might be necessary for proper meristem function. Consistent with this hypothesis is our observation that a mutant ARR7 allele, which mimics the active, phosphorylated form, causes the formation of aberrant shoot apical meristems. Conversely, a loss-of-function mutation in a maize ARR homologue was recently shown to cause enlarged meristems(6).	Ag Lohmann, Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill	Lohmann, JU (corresponding author), Ag Lohmann, Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	jlohmann@tuebingen.mpg.de	Kieber, Joseph/GLN-6328-2022; Lohmann, Jan/T-3776-2019; Busch, Wolfgang/B-8593-2008; Ding, Cheng-Qiang/B-6287-2011	Kieber, Joseph/0000-0002-5766-812X; Lohmann, Jan/0000-0003-3667-187X; Busch, Wolfgang/0000-0003-2042-7290; Leibfried, Andrea/0000-0001-7713-024X; To, Jennifer/0000-0001-6149-9835	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064425] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064425-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Laux T, 1996, DEVELOPMENT, V122, P87; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Leyser O, 2003, TRENDS PLANT SCI, V8, P541, DOI 10.1016/j.tplants.2003.09.008; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; WU Z, 2004, 1 J HOPK U DEPT BIOS	30	582	641	12	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1172	1175		10.1038/nature04270	http://dx.doi.org/10.1038/nature04270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372013				2022-12-28	WOS:000234111500054
J	DeSalvo, KB				DeSalvo, KB			Letter from New Orleans	ANNALS OF INTERNAL MEDICINE			English	Article									Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University	DeSalvo, KB (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave,SL 16, New Orleans, LA 70112 USA.	karen.desalvo@gmail.com							0	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					905	906		10.7326/0003-4819-143-12-200512200-00008	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365471				2022-12-28	WOS:000234077400006
J	Lee, CC; Sui, GD; Elizarov, A; Shu, CYJ; Shin, YS; Dooley, AN; Huang, J; Daridon, A; Wyatt, P; Stout, D; Kolb, HC; Witte, ON; Satyamurthy, N; Heath, JR; Phelps, ME; Quake, SR; Tseng, HR				Lee, CC; Sui, GD; Elizarov, A; Shu, CYJ; Shin, YS; Dooley, AN; Huang, J; Daridon, A; Wyatt, P; Stout, D; Kolb, HC; Witte, ON; Satyamurthy, N; Heath, JR; Phelps, ME; Quake, SR; Tseng, HR			Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics	SCIENCE			English	Article							CHEMISTRY; DEVICE	Microreactor technology has shown potential for optimizing synthetic efficiency, particularly in preparing sensitive compounds. We achieved the synthesis of an [F-18]fluoride-radiolabeled molecular imaging probe, 2-deoxy-2-[F-18]fluoro-D-glucose ([F-18]FDG), in an integrated microfluidic device. Five sequential processes-[F-18]fluoride concentration, water evaporation, radiofluorination, solvent exchange, and hydrolytic deprotection-proceeded with high radiochemical yield and purity and with shorter synthesis time relative to conventional automated synthesis. Multiple doses of [F-18[FDG for positron emission tomography imaging studies in mice were prepared. These results, which constitute a proof of principle for automated multistep syntheses at the nanogram to microgram scale, could be generalized to a range of radiolabeled substrates.	Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mass Spect Facil, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Fluidigm Corp, San Francisco, CA 94080 USA; Siemens Med Solut USA Inc, Culver City, CA 90230 USA; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; California Institute of Technology; California Institute of Technology; Siemens AG; Stanford University	Quake, SR (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	quake@stanford.edu; hrtseng@mednet.ucla.edu	Kolb, Hartmuth C/P-4309-2018; Tseng, Hsian-Rong/G-2222-2010	Shin, Young Shik/0000-0002-1097-9035; Tseng, Hsian-Rong/0000-0003-0942-5905	NIGMS NIH HHS [5T32-GM07616] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chan EM, 2003, NANO LETT, V3, P199, DOI 10.1021/nl0259481; Chou HP, 2001, BIOMED MICRODEVICES, V3, P323, DOI 10.1023/A:1012412916446; de Mello A, 2002, LAB CHIP, V2, p7N, DOI 10.1039/b200736n; Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; HAMACHER K, 1986, J NUCL MED, V27, P235; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Kawaguchi T, 2005, ANGEW CHEM INT EDIT, V44, P2413, DOI 10.1002/anie.200462466; Kikutani Y, 2004, MACROMOL RAPID COMM, V25, P158, DOI 10.1002/marc.200300192; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; PADGETT HC, 1989, APPL RADIAT ISOTOPES, V40, P433, DOI 10.1016/0883-2889(89)90213-X; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; SATYAMURTHY N, 2004, PET MOL IMAGING ITS, P217; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Watts P, 2003, CURR OPIN CHEM BIOL, V7, P380, DOI 10.1016/S1367-5931(03)00050-4; Worz O, 2001, CHEM ENG SCI, V56, P1029, DOI 10.1016/S0009-2509(00)00318-3	18	412	450	8	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1793	1796		10.1126/science.1118919	http://dx.doi.org/10.1126/science.1118919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357255				2022-12-28	WOS:000234093600040
J	Kanneganti, TD; Ozoren, N; Body-Malapel, M; Amer, A; Park, JH; Franchi, L; Whitfield, J; Barchet, W; Colonna, M; Vandenabeele, P; Bertin, J; Coyle, A; Grant, EP; Akira, S; Nunez, G				Kanneganti, TD; Ozoren, N; Body-Malapel, M; Amer, A; Park, JH; Franchi, L; Whitfield, J; Barchet, W; Colonna, M; Vandenabeele, P; Bertin, J; Coyle, A; Grant, EP; Akira, S; Nunez, G			Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3	NATURE			English	Article							TOLL-LIKE RECEPTORS; CUTTING EDGE; INTERLEUKIN-1-BETA; CELLS; INFLAMMASOME; SECRETION; IMIQUIMOD; DISEASE; INNATE; RECOGNITION	Missense mutations in the CIAS1 gene cause three autoinflammatory disorders: familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multiple-system inflammatory disease(1). Cryopyrin (also called Nalp3), the product of CIAS1, is a member of the NOD-LRR protein family that has been linked to the activation of intracellular host defence signalling pathways(2,3). Cryopyrin forms a multi-protein complex termed 'the inflammasome', which contains the apoptosis-associated speck-like protein (ASC) and caspase-1, and promotes caspase-1 activation and processing of pro-interleukin (IL)-1 beta (ref. 4). Here we show the effect of cryopyrin deficiency on inflammasome function and immune responses. Cryopyrin and ASC are essential for caspase-1 activation and IL-1 beta and IL-18 production in response to bacterial RNA and the imidazoquinoline compounds R837 and R848. In contrast, secretion of tumour-necrosis factor-alpha and IL-6, as well as activation of NF-kappa B and mitogen-activated protein kinases (MAPKs) were unaffected by cryopyrin deficiency. Furthermore, we show that Toll-like receptors and cryopyrin control the secretion of IL-1 beta and IL-18 through different intracellular pathways. These results reveal a critical role for cryopyrin in host defence through bacterial RNA-mediated activation of caspase-1, and provide insights regarding the pathogenesis of autoinflammatory syndromes.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Ghent, Dept Mol Biomed Res, B-9052 Zwijnaarde, Belgium; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	University of Michigan System; University of Michigan; Washington University (WUSTL); Ghent University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Osaka University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@med.umich.edu	Vandenabeele, Peter/AAD-5793-2022; Akira, Shizuo/C-3134-2009; Grant, Ethan/GQP-2720-2022; Ozoren, Nesrin/AAS-3279-2020; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Nuñez, Gabriel/A-7160-2014; Amer, Amal/E-2643-2011; Vandenabeele, Peter/C-8597-2009; Body-Malapel, Mathilde/K-9981-2018	Vandenabeele, Peter/0000-0002-6669-8822; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Body-Malapel, Mathilde/0000-0003-3392-4229; Barchet, Winfried/0000-0002-6745-6606; Colonna, Marco/0000-0001-5222-4987; OZOREN, NESRIN/0000-0002-8580-618X				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Athman R, 2004, CURR OPIN MICROBIOL, V7, P25, DOI 10.1016/j.mib.2003.12.013; Craft N, 2005, J IMMUNOL, V175, P1983, DOI 10.4049/jimmunol.175.3.1983; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dockrell DH, 2001, J ANTIMICROB CHEMOTH, V48, P751, DOI 10.1093/jac/48.6.751; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; HARRISON CJ, 1988, ANTIVIR RES, V10, P209, DOI 10.1016/0166-3542(88)90032-0; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Janssen R, 2004, ARTHRITIS RHEUM, V50, P3329, DOI 10.1002/art.20494; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marks R, 2001, J AM ACAD DERMATOL, V44, P807, DOI 10.1067/mjd.2001.113689; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; OZOREN N, UNPUB J IMMUNOL; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; TOMAI MA, 1995, ANTIVIR RES, V28, P253, DOI 10.1016/0166-3542(95)00054-P	27	862	900	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					233	236		10.1038/nature04517	http://dx.doi.org/10.1038/nature04517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407888	Green Published, Bronze			2022-12-28	WOS:000235839500051
J	Stingl, J; Eirew, P; Ricketson, I; Shackleton, M; Vaillant, F; Choi, D; Li, HYI; Eaves, CJ				Stingl, J; Eirew, P; Ricketson, I; Shackleton, M; Vaillant, F; Choi, D; Li, HYI; Eaves, CJ			Purification and unique properties of mammary epithelial stem cells	NATURE			English	Article							IDENTIFICATION; GLAND; PROGENITORS; ENRICHMENT	Elucidation of the cellular and molecular mechanisms that maintain mammary epithelial tissue integrity is of broad interest and paramount to the design of more effective treatments for breast cancer(1). Evidence from both in vitro and in vivo experiments suggests that mammary cell differentiation is a hierarchical process originating in an uncommitted stem cell with self-renewal potential(2-4). However, analysis of the properties and regulation of mammary stem cells has been limited by a lack of methods for their prospective isolation. Here we report the use of multiparameter cell sorting and limiting dilution transplant analysis to demonstrate the purification of a rare subset of adult mouse mammary cells that are able individually to regenerate an entire mammary gland within 6 weeks in vivo while simultaneously executing up to ten symmetrical self-renewal divisions. These mammary stem cells are phenotypically distinct from and give rise to mammary epithelial progenitor cells that produce adherent colonies in vitro. The mammary stem cells are also a rapidly cycling population in the normal adult and have molecular features indicative of a basal position in the mammary epithelium.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; StemCell Technol Inc, Vancouver, BC V5Z 1B3, Canada; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, WEHI Biotechnol Ctr, Parkville, Vic 3050, Australia; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; STEMCELL Technologies Canada Inc.; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of British Columbia; University of British Columbia; University of British Columbia	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca						Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bhattacharya S, 2003, INVEST OPHTH VIS SCI, V44, P2764, DOI 10.1167/iovs.02-0899; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Sakakura T., 1987, The mammary gland. Development, regulation, and function., P37; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; STINGL J, 2005, METHODS MOL BIOL BAS, P249; SZILVASSY SJ, 2002, METHODS MOL MED HEMA, P167; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Uchida N, 2004, BLOOD, V103, P4487, DOI 10.1182/blood-2003-11-3989; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Young SR, 2000, AM J HUM GENET, V67, P74; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	29	1175	1238	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					993	997		10.1038/nature04496	http://dx.doi.org/10.1038/nature04496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16395311				2022-12-28	WOS:000235486100051
J	Aaskov, J; Buzacott, K; Thu, HM; Lowry, K; Holmes, EC				Aaskov, J; Buzacott, K; Thu, HM; Lowry, K; Holmes, EC			Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes	SCIENCE			English	Article							SELECTION; GENETICS; HOST	In 2001, dengue virus type 1 (DENV-1) populations in humans and mosquitoes from Myanmar acquired a stop-codon mutation in the surface envelope (E) protein gene. Within a year, this stop-codon strain had spread to all individuals sampled. The presence of truncated E protein species within individual vital populations, along with a general relaxation in selective constraint, indicated that the stop-codon strain represents a defective lineage of DENV-1. We propose that such tong-term transmission of defective RNA viruses in nature was achieved through complementation by coinfection of host cells with functional viruses.	Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia; Dept Med Res, Yangon 11191, Myanmar; Australian Army Malaria Inst, Brisbane, Qld 4051, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute	Holmes, EC (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	ech15@psu.edu	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Lowry, Kym/AAK-2711-2021	Holmes, Edward/0000-0001-9596-3552; Lowry, Kym/0000-0002-9666-149X				Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Craig S, 2003, J VIROL, V77, P4463, DOI 10.1128/JVI.77.7.4463-4467.2003; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Froissart R, 2004, GENETICS, V168, P9, DOI 10.1534/genetics.104.030205; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; KASSANIS B, 1960, NATURE, V336, P435; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lopez-Ferber M, 2003, P ROY SOC B-BIOL SCI, V270, P2249, DOI 10.1098/rspb.2003.2498; Maddison D. R., 2000, MACCLADE ANAL PHYLOG; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Novella IS, 2004, J VIROL, V78, P5799, DOI 10.1128/JVI.78.11.5799-5804.2004; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STRAUSS EG, 1988, VIROLOGY, V164, P265, DOI 10.1016/0042-6822(88)90644-7; Swofford D.L., 2003, PAUP VERSION 40 B10; Taylor DR, 1998, AM NAT, V151, P343, DOI 10.1086/286123; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549	20	191	193	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					236	238		10.1126/science.1115030	http://dx.doi.org/10.1126/science.1115030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410525				2022-12-28	WOS:000234722200044
J	Alto, NM; Shao, F; Lazar, CS; Brost, RL; Chua, G; Mattoo, S; McMahon, SA; Ghosh, P; Hughes, TR; Boone, C; Dixon, JE				Alto, NM; Shao, F; Lazar, CS; Brost, RL; Chua, G; Mattoo, S; McMahon, SA; Ghosh, P; Hughes, TR; Boone, C; Dixon, JE			Identification of a bacterial type III effector family with G protein mimicry functions	CELL			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ACTIN STRESS FIBERS; GENOME-WIDE ANALYSIS; SALMONELLA-TYPHIMURIUM; FOCAL ADHESIONS; RHO; EXPRESSION; INTEGRITY; CYTOSKELETON; PATHWAYS	Many bacterial pathogens use the type III secretion system to inject "effector" proteins into host cells. Here, we report the identification of a 24 member effector protein family found in pathogens including Salmonella, Shigella, and entero pathogenic E. coli. Members of this family subvert host cell function by mimicking the signaling properties of Ras-like GTPases. The effector IpgB2 stimulates cellular responses analogous to GTP-active RhoA, whereas IpgB1 and Map function as the active forms of Rac1 and Cdc42, respectively. These effectors do not bind guanine nucleotides or have sequences corresponding the conserved GTPase domain, suggesting that they are functional but not structural mimics. However, several of these effectors harbor intracellular targeting sequences that contribute to their signaling specificities. The activities of IpgB2, IpgB1, and Map are dependent on an invariant WxxxE motif found in numerous effectors leading to the speculation that they all function by a similar molecular mechanism.	Univ Calif San Diego, Dept Pharmacol Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institute of Biological Sciences, Beijing; University of Toronto; University of Toronto; University of St Andrews	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol Cellular & Mol Med, La Jolla, CA 92093 USA.	jedixon@ucsd.edu	Mattoo, Seema/ABD-5624-2021	Mattoo, Seema/0000-0003-3260-0046				Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217	36	220	230	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					133	145		10.1016/j.cell.2005.10.031	http://dx.doi.org/10.1016/j.cell.2005.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413487	Bronze			2022-12-28	WOS:000234969600015
J	Coyne, CB; Bergelson, JM				Coyne, CB; Bergelson, JM			Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions	CELL			English	Article							DECAY-ACCELERATING FACTOR; TYROSINE KINASE; ADENOVIRUS RECEPTOR; ACTIN CYTOSKELETON; ADHESION MOLECULE; DYNAMIN; PHOSPHORYLATION; PROTEIN; INTERNALIZATION; INHIBITION	Group B coxsackieviruses (CVBs) must cross the epithelium as they initiate infection, but the mechanism by which this occurs remains uncertain. The coxsackievirus and adenovirus receptor (CAR) is a component of the tight junction and is inaccessible to virus approaching from the apical surface. Many CVBs also interact with the GPI-anchored protein decay-accelerating factor (DAF). Here, we report that virus attachment to DAF on the apical cell surface activates Abl kinase, triggering Rac-dependent actin rearrangements that permit virus movement to the tight junction. Within the junction, interaction with CAR promotes conformational changes in the virus capsid that are essential for virus entry and release of viral RNA. Interaction with DAF also activates Fyn kinase, an event that is required for the phosphorylation of caveolin and transport of virus into the cell within caveolar vesicles. CVBs thus exploit DAF-mediated signaling pathways to surmount the epithelial barrier.	Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Bergelson, JM (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.	bergelson@email.chop.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI07324, R01AI5228] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bergelson Jeffrey M., 2002, P107; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen YZ, 1999, EXP CELL RES, V246, P83, DOI 10.1006/excr.1998.4301; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Milstone AM, 2005, J VIROL, V79, P655, DOI 10.1128/JVI.79.1.655-660.2005; Nusrat A, 2000, J CELL SCI, V113, P1771; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Pallansch MA, 2001, ENTEROVIRUSES POLIOV; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; REAGAN KJ, 1984, J VIROL, V49, P635, DOI 10.1128/JVI.49.3.635-640.1984; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; Rueckert R., 1996, FIELDS VIROLOGY, P609; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Shieh JTC, 2002, J VIROL, V76, P9474, DOI 10.1128/JVI.76.18.9474-9480.2002; Skorski T, 1998, BLOOD, V91, P406, DOI 10.1182/blood.V91.2.406.406_406_418; STUTTS MJ, 1981, TOXICOL APPL PHARM, V60, P91, DOI 10.1016/0041-008X(81)90139-3; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tosteson MT, 1997, J VIROL, V71, P507, DOI 10.1128/JVI.71.1.507-511.1997; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	55	403	425	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					119	131		10.1016/j.cell.2005.10.035	http://dx.doi.org/10.1016/j.cell.2005.10.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413486	Bronze			2022-12-28	WOS:000234969600014
J	Komeili, A; Li, Z; Newman, DK; Jensen, GJ				Komeili, A; Li, Z; Newman, DK; Jensen, GJ			Magnetosomes are cell membrane invaginations organized by the actin-like protein MamK	SCIENCE			English	Article							CRYOELECTRON TOMOGRAPHY; SEGREGATION; BACTERIA; GRYPHISWALDENSE; CYTOSKELETON; FILAMENTS; REVEALS; GENE	Magnetosomes are membranous bacterial organelles sharing many features of eukaryotic organelles. Using electron cryotomography, we found that magnetosomes are invaginations of the cell membrane flanked by a network of cytoskeletal filaments. The filaments appeared to be composed of MamK, a homolog of the bacterial actin-like protein MreB, which formed filaments in vivo. In a mamK deletion strain, the magnetosome-associated cytoskeleton was absent and individual magnetosomes were no longer organized into chains. Thus, it seems that prokaryotes can use cytoskeletal filaments to position organelles within the cell.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Mail Code 3102, Berkeley, CA 94720 USA.	komeili@nature.berkeley.edu			NIGMS NIH HHS [P01 GM66521] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066521] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; FUERST JA, 2005, ANN REV MICROBIOL ON; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Kurner J, 2004, EXP CELL RES, V301, P38, DOI 10.1016/j.yexcr.2004.08.005; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; OFER S, 1984, BIOPHYS J, V46, P57, DOI 10.1016/S0006-3495(84)83998-3; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	22	477	506	0	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					242	245		10.1126/science.1123231	http://dx.doi.org/10.1126/science.1123231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16373532				2022-12-28	WOS:000234722200046
J	Asphaug, E; Agnor, CB; Williams, Q				Asphaug, E; Agnor, CB; Williams, Q			Hit-and-run planetary collisions	NATURE			English	Article							SPACE-TELESCOPE IMAGES; TIDAL DISRUPTION; ASTEROIDS; PLANETESIMALS; EVOLUTION; IMPACTS; DENSITY; HISTORY; LIQUIDS; ORIGIN	Terrestrial planet formation is believed to have concluded in our Solar System with about 10 million to 100 million years of giant impacts, where hundreds of Moon- to Mars-sized planetary embryos acquired random velocities through gravitational encounters and resonances with one another and with Jupiter. This led to planet-crossing orbits and collisions that produced the four terrestrial planets, the Moon and asteroids. But here we show that colliding planets do not simply merge, as is commonly assumed. In many cases, the smaller planet escapes from the collision highly deformed, spun up, depressurized from equilibrium, stripped of its outer layers, and sometimes pulled apart into a chain of diverse objects. Remnants of these '\hit-and-run' collisions are predicted to be common among remnant planet-forming populations, and thus to be relevant to asteroid formation and meteorite petrogenesis.	Univ Calif Santa Cruz, Dept Earth Sci, Inst Geophys & Planetary Phys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Asphaug, E (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Inst Geophys & Planetary Phys, 1156 High St, Santa Cruz, CA 95064 USA.	asphaug@pmc.ucsc.edu	Asphaug, Erik/AAC-9455-2020					Abe Y., 2000, ORIGIN EARTH MOON, P413; Agnor C, 2004, ASTROPHYS J, V613, pL157, DOI 10.1086/425158; Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Asphaug E, 2002, ASTEROIDS, P463; ASPHAUG E, 2005, LUN PLAN SCI C, V36; BENZ W, 1990, NATO ADV SCI I C-MAT, V302, P269; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; BOSS AP, 1991, ICARUS, V92, P165, DOI 10.1016/0019-1035(91)90042-R; Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Burbine TH, 1996, METORIT PLANET SCI, V31, P607, DOI 10.1111/j.1945-5100.1996.tb02033.x; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; DAVIS DR, 1985, ICARUS, V62, P30, DOI 10.1016/0019-1035(85)90170-8; Dixon JE, 1995, J PETROL, V36, P1607; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; GRADY DE, 1980, INT J ROCK MECH MIN, V17, P147, DOI 10.1016/0148-9062(80)91361-3; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Haack H, 1996, GEOCHIM COSMOCHIM AC, V60, P2609, DOI 10.1016/0016-7037(96)00110-X; JEANS JH, 1919, PROBLEMS COSMOGONY S; JEFFREYS H, 1947, MON NOT R ASTRON SOC, V107, P260, DOI 10.1093/mnras/107.3.260; Keil K, 1997, METEORIT PLANET SCI, V32, P349, DOI 10.1111/j.1945-5100.1997.tb01278.x; Kokubo E, 2002, ASTROPHYS J, V581, P666, DOI 10.1086/344105; McCoy TJ, 1997, GEOCHIM COSMOCHIM AC, V61, P623, DOI 10.1016/S0016-7037(96)00359-6; MCKINNON WB, 1995, GEOPHYS RES LETT, V22, P1829, DOI 10.1029/95GL01422; Mei S, 2002, EARTH PLANET SC LETT, V201, P491, DOI 10.1016/S0012-821X(02)00745-8; MIZUNO H, 1985, ICARUS, V63, P109, DOI 10.1016/0019-1035(85)90023-5; Ochs FA, 1999, SCIENCE, V283, P1314, DOI 10.1126/science.283.5406.1314; Ostro SJ, 2000, SCIENCE, V288, P836, DOI 10.1126/science.288.5467.836; Pierazzo E, 2000, METEORIT PLANET SCI, V35, P117, DOI 10.1111/j.1945-5100.2000.tb01979.x; Rettig TW, 1996, J GEOPHYS RES-PLANET, V101, P9271, DOI 10.1029/96JE00520; RIVERS ML, 1987, J GEOPHYS RES-SOLID, V92, P9247, DOI 10.1029/JB092iB09p09247; Rivkin AS, 2000, ICARUS, V145, P351, DOI 10.1006/icar.2000.6354; SRIDHAR S, 1992, ICARUS, V95, P86, DOI 10.1016/0019-1035(92)90193-B; Tackley PJ, 2001, J GEOPHYS RES-PLANET, V106, P32971, DOI 10.1029/2000JE001411; Walzer U, 2004, TECTONOPHYSICS, V384, P55, DOI 10.1016/j.tecto.2004.02.012; Weidenschilling SJ, 1997, ICARUS, V128, P429, DOI 10.1006/icar.1997.5747; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; WETHERILL GW, 1992, ICARUS, V100, P307, DOI 10.1016/0019-1035(92)90103-E; Wilson L, 1999, METEORIT PLANET SCI, V34, P541, DOI 10.1111/j.1945-5100.1999.tb01362.x; WILSON L, 1980, J VOLCANOL GEOTH RES, V8, P297, DOI 10.1016/0377-0273(80)90110-9	44	214	214	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					155	160		10.1038/nature04311	http://dx.doi.org/10.1038/nature04311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407944				2022-12-28	WOS:000234538400030
J	Bisset, DL				Bisset, DL			The nursing profession's coming of age - The end of medicine as a profession	BRITISH MEDICAL JOURNAL			English	Letter									Royal Bolton Hosp, Bolton BL4 OJR, England	Royal Bolton Hospital	Bisset, DL (corresponding author), Royal Bolton Hosp, Bolton BL4 OJR, England.	david.bisset@rbh.nhs.uk						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51	http://dx.doi.org/10.1136/bmj.332.7532.51			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399751	Green Published			2022-12-28	WOS:000234684200029
J	Nadkarni, VM; Larkin, GL; Peberdy, MA; Carey, SM; Kaye, W; Mancini, ME; Nichol, G; Lane-Truitt, T; Potts, J; Ornato, JP; Berg, RA				Nadkarni, VM; Larkin, GL; Peberdy, MA; Carey, SM; Kaye, W; Mancini, ME; Nichol, G; Lane-Truitt, T; Potts, J; Ornato, JP; Berg, RA		Natl Registry Cardiopulmonary Res	First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC CARDIOPULMONARY-RESUSCITATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE-PROFESSIONALS; MEDICAL EMERGENCY TEAM; ADVANCED LIFE-SUPPORT; UTSTEIN-STYLE; RECOMMENDED GUIDELINES; CARDIORESPIRATORY ARREST; STROKE-FOUNDATION; SOUTHERN-AFRICA	Context Cardiac arrests in adults are often due to ventricular fibrillation (VF) or pulse-less ventricular tachycardia (VT), which are associated with better outcomes than asystole or pulseless electrical activity (PEA). Cardiac arrests in children are typically asystole or PEA. Objective To test the hypothesis that children have relatively fewer in-hospital cardiac arrests associated with VF or pulseless VT compared with adults and, therefore, worse survival outcomes. Design, Setting, and Patients A prospective observational study from a multicenter registry (National Registry of Cardiopulmonary, Resuscitation) of cardiac arrests in 253 US and Canadian hospitals between January 1, 2000, and March 30, 2004. A total of 36 902 adults (>= 18 years) and 880 children (<18 years) with pulseless cardiac arrests requiring chest compressions, defibrillation, or both were assessed. Cardiac arrests occurring in the delivery department, neonatal intensive care unit, and in the out-of-hospital setting were excluded. Main Outcome Measure Survival to hospital discharge. Results The rate of survival to hospital discharge following pulseless cardiac arrest was higher in children than adults (27% [236/880] vs 18% [6485/36902]; adjusted odds ratio [OR], 2.29; 95% confidence interval [CI], 1.95-2.68). Of these survivors, 65% (154/236) of children and 73% (4737/6485) of adults had good neurological outcome. The prevalence of VF or pulseless VT as the first documented pulseless rhythm was 14% (120/880) in children and 23% (8361/36902) in adults (OR, 0.54; 95% Cl, 0.44-0.65; P<.001). The prevalence of asystole was 40% (350) in children and 35% (13 024) in adults (OR, 1.20; 95% Cl, 1.10-1.40; P=.006), whereas the prevalence of PEA was 24% (213) in children and 32% (11963) in adults (OR, 0.67; 95% Cl, 0.57-0.78; P<.001). After adjustment for differences in preexisting conditions, interventions in place at time of arrest, witnessed and/or monitored status, time to defibrillation of VF or pulseless VT, intensive care unit location of arrest, and duration of cardiopulmonary resuscitation, only first documented pulseless arrest rhythm remained significantly associated with differential survival to discharge (24% [135/ 563] in children vs 11% [2719/24 987] in adults with asystole and PEA; adjusted OR, 233; 95% Cl, 2.23-3.32). Conclusions In this multicenter registry of in-hospital cardiac arrest, the first documented pulseless arrest rhythm was typically asystole or PEA in both children and adults. Because of better survival after asystole and PEA, children had better outcomes than adults despite fewer cardiac arrests due to VF or pulseless VT.	Univ Penn, Sch Med, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Crit Care, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Emergency Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Publ Hlth, Dallas, TX 75235 USA; Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA; Digital Innovat Inc, Forest Hill, MD USA; Brown Univ, Sch Med, Dept Surg, Providence, RI 02912 USA; Brown Univ, Sch Med, Dept Med, Providence, RI 02912 USA; Univ Texas, Undergrad Nursing Programs, Arlington, TX 76019 USA; Univ Texas, Dept Nursing Educ, Arlington, TX 76019 USA; Univ Washington, Harbowview Prehosp Res & Training Ctr, Seattle, WA 98195 USA; Amer Heart Assoc, Emergency Cardiovasc Care, Dallas, TX USA; Univ Arizona, Sch Med, Tucson, AZ USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University; Virginia Commonwealth University; Brown University; Brown University; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Washington; University of Washington Seattle; University of Arizona	Nadkarni, VM (corresponding author), Univ Penn, Sch Med, Dept Anesthesia, 34th St & Civ Ctr Blvd,S Tower,Room 7C-08, Philadelphia, PA 19104 USA.	nadkarni@email.chop.edu	Nichol, Graham/Z-4996-2019					*AM HEART ASS COLL, 2000, CIRCULATION S, V102, P142; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Danciu SC, 2004, RESUSCITATION, V62, P35, DOI 10.1016/j.resuscitation.2004.01.035; *EUR RES COUNC, 2000, RESUSCITATION, V46, P301; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; HERLITZ J, 1995, ANN EMERG MED, V25, P58, DOI 10.1016/S0196-0644(95)70356-X; Herlitz J, 2000, J INTERN MED, V248, P53, DOI 10.1046/j.1365-2796.2000.00702.x; Herlitz J, 2001, RESUSCITATION, V48, P125, DOI 10.1016/S0300-9572(00)00249-5; Huang CH, 2002, RESUSCITATION, V53, P265, DOI 10.1016/S0300-9572(02)00024-2; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Lopez-Herce J, 2005, RESUSCITATION, V64, P79, DOI 10.1016/j.resuscitation.2004.07.010; Lopez-Herce J, 2004, RESUSCITATION, V63, P311, DOI 10.1016/j.resuscitation.2004.06.008; *NAT REG CARD RES, WELC NAT REG CARDIOP; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Perondi MBM, 2004, NEW ENGL J MED, V350, P1722, DOI 10.1056/NEJMoa032440; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Salamonson Y, 2001, RESUSCITATION, V49, P135, DOI 10.1016/S0300-9572(00)00353-1; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; The American Heart Assocation in collaboration with the International Liaison Committee on Resuscitation, 2000, CIRCULATION, V102, P1136; van Walraven C, 2001, JAMA-J AM MED ASSOC, V285, P1602, DOI 10.1001/jama.285.12.1602; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157; Zafari AM, 2004, J AM COLL CARDIOL, V44, P846, DOI 10.1016/j.jacc.2004.04.054; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	29	809	861	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					50	57		10.1001/jama.295.1.50	http://dx.doi.org/10.1001/jama.295.1.50			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391216	Bronze			2022-12-28	WOS:000234381100020
J	McCollom, TM; Hynek, BM				McCollom, TM; Hynek, BM			A volcanic environment for bedrock diagenesis at Meridiani Planum on Mars	NATURE			English	Article							TERRA-MERIDIANI; HEMATITE; CHEMISTRY; JAROSITE; REGION; CRATER; ROCKS; SOILS; WATER	Exposed bedrocks at Meridiani Planum on Mars display chemical and mineralogical evidence suggesting interaction with liquid water(1-6). On the basis of morphological observations as well as high abundances of haematite and sulphate minerals, the rocks have been interpreted as sediments that were deposited in a shallow body of briny water with subsequent evaporation leaving behind the sulphate minerals(1,2). The iron-sulphur mineralization at Meridiani has also been inferred to be analogous to that produced during oxidative weathering of metal sulphide minerals, such as occurs at acid mine drainage sites(7). Neither of these interpretations, however, is consistent with the chemical composition of the rocks. Here we propose an alternative model for diagenesis of Meridiani bedrock that involves deposition of volcanic ash followed by reaction with condensed sulphur dioxide- and water-bearing vapours emitted from fumaroles. This scenario does not require prolonged interaction with a standing body of surface water and may have occurred at high temperatures. Consequently, the model invokes an environment considerably less favourable for biological activity on Mars than previously proposed interpretations.	Univ Colorado, Ctr Astrobiol, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McCollom, TM (corresponding author), Univ Colorado, Ctr Astrobiol, Campus Box 392, Boulder, CO 80309 USA.	mccollom@lasp.colorado.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Coradossi N, 1996, B VOLCANOL, V58, P310, DOI 10.1007/s004450050142; CROWN DA, 1993, J GEOPHYS RES-PLANET, V98, P3431, DOI 10.1029/92JE02804; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Glamoclija M, 2004, GEOMICROBIOL J, V21, P529, DOI 10.1080/01490450490888235; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; LAUL JC, 1986, GEOCHIM COSMOCHIM AC, V50, P909, DOI 10.1016/0016-7037(86)90373-X; Lodders K, 1998, METEORIT PLANET SCI, V33, pA183, DOI 10.1111/j.1945-5100.1998.tb01331.x; Madden MEE, 2004, NATURE, V431, P821, DOI 10.1038/nature02971; Owen T., 1992, COMPOSITION EARLY HI, P818; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Ross CS, 1961, GEOLOGICAL SURVEY PR, V366, P1; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Villemant B, 1999, EARTH PLANET SC LETT, V168, P271, DOI 10.1016/S0012-821X(99)00058-8; WAHRENBERGER CM, 1997, THESIS SWISS FEDERAL; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113; Wohletz K.H., 1979, MODEL PYROCLASTIC SU, V180, P177, DOI DOI 10.1130/SPE180-P177	28	121	121	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1129	1131		10.1038/nature04390	http://dx.doi.org/10.1038/nature04390			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372002				2022-12-28	WOS:000234111500043
J	Meibom, KL; Blokesch, M; Dolganov, NA; Wu, CY; Schoolnik, GK				Meibom, KL; Blokesch, M; Dolganov, NA; Wu, CY; Schoolnik, GK			Chitin induces natural competence in Vibrio cholerae	SCIENCE			English	Article							GENETIC-TRANSFORMATION; HAEMOPHILUS-INFLUENZAE; DNA; EXPRESSION; IDENTIFICATION; POPULATION; INDUCTION; VIRULENCE; LYSIS	The mosaic-structured Vibrio cholerae genome points to the importance of horizontal gene transfer (HGT) in the evolution of this human pathogen. We showed that V. cholerae can acquire new genetic material by natural transformation during growth on chitin, a biopolymer that is abundant in aquatic habitats (e.g., from crustacean exoskeletons), where it lives as an autochthonous microbe. Transformation competence was found to require a type IV pilus assembly complex, a putative DNA binding protein, and three convergent regulatory cascades, which are activated by chitin, increasing cell density, and nutrient limitation, a decline in growth rate, or stress.	Stanford Univ, Div Infect Dis & Geog Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Stanford Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University	Meibom, KL (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	kmeibom@necker.fr; schoolni@cmgm.stanford.edu	Blokesch, Melanie/A-4057-2013	Blokesch, Melanie/0000-0002-7024-1489; Meibom, Karin/0000-0002-2612-6424	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053706] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053706] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; HAHN J, 1993, MOL MICROBIOL, V10, P99, DOI 10.1111/j.1365-2958.1993.tb00907.x; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; PALMEN R, 1995, CURR MICROBIOL, V30, P7, DOI 10.1007/BF00294516; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Silva AJ, 2004, J BACTERIOL, V186, P6374, DOI 10.1128/JB.186.19.6374-6382.2004; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; ZULTY JJ, 1995, P NATL ACAD SCI USA, V92, P3616, DOI 10.1073/pnas.92.8.3616	20	440	463	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1824	1827		10.1126/science.1120096	http://dx.doi.org/10.1126/science.1120096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357262				2022-12-28	WOS:000234093600049
J	Vassylyev, DG; Artsimovitch, I				Vassylyev, DG; Artsimovitch, I			Tracking RNA polymerase, one step at a time	CELL			English	Editorial Material							STRUCTURAL BASIS; TRANSCRIPTION; MECHANISM; TRANSLOCATION; ELONGATION; NTP	Although the structural analysis of transcription has attained atomic resolution, techniques to manipulate single molecules involved in transcription have lagged behind. A recent paper in Nature by Abbondanzieri et al. (2005) closes this gap. This study finds that individual molecules of bacterial RNA polymerase move in single base-pair steps and concludes that RNA polymerase acts as a Brownian ratchet that is driven forward by the binding of incoming nucleoside triphosphates.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham	Vassylyev, DG (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu	Artsimovitch, Irina/L-3467-2019; Vassylyev, Dmitry/A-9005-2008					Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; VASSYLYEV DG, 2005, NAT STRUCT MOL BIOL; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	10	12	12	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					977	979		10.1016/j.cell.2005.11.030	http://dx.doi.org/10.1016/j.cell.2005.11.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360025	Bronze			2022-12-28	WOS:000234177200004
J	Manjra, S				Manjra, S			Essay - Manufacturing categories - the case of disabled athletes	LANCET			English	Article											Manjra, S (corresponding author), 9 Woodside Court, ZA-7700 Rondebosch, South Africa.	shuaib.manjra@za.bp.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S8	S9		10.1016/S0140-6736(05)67823-3	http://dx.doi.org/10.1016/S0140-6736(05)67823-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360765	Bronze			2022-12-28	WOS:000234374400006
J	McConnell, J; Horton, R				McConnell, J; Horton, R			Preparing for pandemic influenza	LANCET			English	Editorial Material									Lancet Infect Dis, London NW1 7BY, England; Lancet, London NW1 7BY, England		McConnell, J (corresponding author), Lancet Infect Dis, London NW1 7BY, England.			McConnell, John/0000-0002-9928-6568				Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; *WHO, 2005, CUM NUMB CONF HUM CA; 1933, LANCET, V2, P83	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2072	2072		10.1016/S0140-6736(05)67869-5	http://dx.doi.org/10.1016/S0140-6736(05)67869-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360775	Green Published, Bronze			2022-12-28	WOS:000234146000008
J	Nishikiori, N; Abe, T; Costa, DGM; Dharmaratne, SD; Kunii, O; Moji, K				Nishikiori, N; Abe, T; Costa, DGM; Dharmaratne, SD; Kunii, O; Moji, K			Timing of mortality among internally displaced persons due to the tsunami in Sri Lanka: cross sectional household survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the distribution of mortality among internally displaced persons during two and a half months after the Indian Ocean tsunami, 2004. Design Cross sectional household survey with retrospective cohort analysis of mortality. Setting Camps for internally displaced persons due to the tsunami in an eastern coastal district of Sri Lanka. Participants 3533 people from 859 households accommodated in 13 camps. Main outcome measures All cause death and number of missing people. Results 446 deaths and 11 missing people were reported after the 2004 tsunami, of which most (99%) occurred on the day of the tsunami or within three days thereafter. No deaths were reported for the two and a half month period starting one week after the tsunami. Conclusions Most mortality after the 2004 tsunami occurred within the first few days of the disaster and was low in the study area.	Nagasaki Univ, Inst Trop Med, Res Ctr Trop Infect Dis, Nagasaki 8528523, Japan; Univ Peradeniya, Fac Med, Dept Community Med, Postgrad Inst Med, Kandy, Sri Lanka	Nagasaki University; University of Peradeniya	Nishikiori, N (corresponding author), Nagasaki Univ, Inst Trop Med, Res Ctr Trop Infect Dis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	nobu@net.nagasaki-u.ac.jp		Nishikiori, Nobuyuki/0000-0003-0962-8868				Chan CC, 2003, ANN EPIDEMIOL, V13, P502, DOI 10.1016/S1047-2797(03)00040-1; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Kysely J, 2004, INT J BIOMETEOROL, V49, P91, DOI 10.1007/s00484-004-0218-2; The Sphere Project, 2004, HUM CHART MIN STAND; *WHO, WHO APP US 66 MILL P	5	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2006	332	7537					334	335		10.1136/bmj.38693.465023.7C	http://dx.doi.org/10.1136/bmj.38693.465023.7C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012YI	16399768	Green Published, Bronze			2022-12-28	WOS:000235376400017
J	Zwierlein, MW; Schirotzek, A; Schunck, CH; Ketterle, W				Zwierlein, MW; Schirotzek, A; Schunck, CH; Ketterle, W			Fermionic superfluidity with imbalanced spin populations	SCIENCE			English	Article							SUPERCONDUCTIVITY; GAS; CONDENSATION; MOLECULES; FIELD	We established superfluidity in a two-state mixture of ultracold fermionic atoms with imbalanced state populations. This study relates to the long-standing debate about the nature of the superfluid state in Fermi systems. Indicators for superfluidity were condensates of fermion pairs and vortices in rotating clouds. For strong interactions, near a Feshbach resonance, superfluidity was observe for a broad range of population imbalances. We mapped out the superfluid regime as a function of interaction strength and population imbalance and characterized the quantum phase transition to the normal state, known as the Pauli limit of superfluidity.	MIT, MIT Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zwierlein, MW (corresponding author), MIT, MIT Harvard Ctr Ultracold Atoms, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zwierlei@mit.edu	Schunck, Christian H/A-3625-2010	Schunck, Christian H/0000-0002-7917-8180; /0000-0001-8120-8548				Abo-Shaeer JR, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.070409; [Anonymous], 1975, METHOD QUANTUM FIELD; Bedaque PF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247002; BERTSCH G, 1999, INT WORKSH EFF FIELD; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.187004; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; Carlson J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060401; Casalbuoni R, 2004, REV MOD PHYS, V76, P263, DOI 10.1103/RevModPhys.76.263; Castorina P, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.025601; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Cohen TD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.120403; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; FULDE P, 1964, PHYS REV           A, V135, P550; Guery-Odelin D, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.033607; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; KAGAN Y, 1997, PHYS REV A, V55, P18; Kinast J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150402; LARKIN AI, 1965, ZH EKSP TEOR FIZ, V20, P762; Leggett A. J., 1980, Modern Trends in the Theory of Condensed Matter. Proceedings of the XVIth Karpacz Winter School of Theoretical Physics, P13; Liu WV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047002; Menotti C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.250402; Mizushima T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.060404; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; PAO CH, PREPRINT; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; Partridge GB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020404; Powell S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024534; Radovan HA, 2003, NATURE, V425, P51, DOI 10.1038/nature01842; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; SARMA G, 1963, J PHYS CHEM SOLIDS, V24, P1029, DOI 10.1016/0022-3697(63)90007-6; Sedrakian A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013613; SHEEHY DE, PREPRINT; SON DT, PREPRINT; Viverit L, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053605; Vollhardt D., 1990, SUPERFLUID PHASES HE, V3; Yang K., PREPRINT; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250401	41	773	781	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2006	311	5760					492	496		10.1126/science.1122318	http://dx.doi.org/10.1126/science.1122318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16373535	Green Submitted			2022-12-28	WOS:000235071400038
J	Car, J				Car, J			BMJ learning - Urinary tract infections in women: diagnosis and management in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE URETHRAL SYNDROME; RISK-FACTORS; INTERSTITIAL CYSTITIS; TELEPHONE MANAGEMENT; GENERAL-PRACTICE; CONTROLLED-TRIAL; BACTERIURIA; THERAPY; CULTURE; TESTS		Univ London Imperial Coll Sci & Technol, Dept Primary Care & Social Med, London W6 8RP, England	Imperial College London	Car, J (corresponding author), Univ London Imperial Coll Sci & Technol, Dept Primary Care & Social Med, London W6 8RP, England.	josip.car@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X				Baerheim A, 1999, SCAND J PRIM HEALTH, V17, P170, DOI 10.1080/028134399750002593; BAILEY BL, 1995, J FAM PRACTICE, V40, P45; Barry HC, 2001, J FAM PRACTICE, V50, P589; Bennett MH, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005005.pub2, 10.1002/14651858.CD004818.pub2, 10.1002/14651858.CD004739.pub2, 10.1002/14651858.CD005277.pub2, 10.1002/14651858.CD004712.pub2, 10.1002/14651858.CD004954.pub2]; Bent S, 2002, AM J MED, V113, p20S; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; BRUMFITT W, 1991, BRIT MED J, V130, P1; Car J, 2003, BRIT MED J, V327, P1204, DOI 10.1136/bmj.327.7425.1204; Davey P, 2000, BRIT J GEN PRACT, V50, P143; Delzell JE, 2000, AM FAM PHYSICIAN, V61, P713; Fahey T, 2003, FAM PRACT, V20, P1, DOI 10.1093/fampra/20.1.1; Fenwick EAL, 2000, BRIT J GEN PRACT, V50, P635; Fihn SD, 2003, NEW ENGL J MED, V349, P259, DOI 10.1056/NEJMcp030027; FIHN SD, 1985, JAMA-J AM MED ASSOC, V254, P240, DOI 10.1001/jama.254.2.240; Fihn SD, 1998, ARCH INTERN MED, V158, P281, DOI 10.1001/archinte.158.3.281; FOWLER JE, 1981, NEW ENGL J MED, V304, P462, DOI 10.1056/NEJM198102193040805; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; HAMILTONMILLER JMT, 1994, J ANTIMICROB CHEMOTH, V33, P63, DOI 10.1093/jac/33.suppl_A.63; Hanno PM, 1999, J UROLOGY, V161, P553, DOI 10.1016/S0022-5347(01)61948-7; Hooton TM, 2003, INFECT DIS CLIN N AM, V17, P303, DOI 10.1016/S0891-5520(03)00004-7; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hummers-Pradier E, 2005, FAM PRACT, V22, P71, DOI 10.1093/fampra/cmh720; HURLBUT TA, 1991, AM J CLIN PATHOL, V96, P582, DOI 10.1093/ajcp/96.5.582; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; KUNIN CM, 1993, ANN INTERN MED, V119, P454, DOI 10.7326/0003-4819-119-6-199309150-00002; LEIBOVICI L, 1991, Q J MED, V78, P43; Lifshitz E, 2000, ARCH INTERN MED, V160, P2537, DOI 10.1001/archinte.160.16.2537; MacLean AB, 2001, INT J ANTIMICROB AG, V17, P273, DOI 10.1016/S0924-8579(00)00354-X; Malterud K, 1999, SCAND J PRIM HEALTH, V17, P49; McIsaac WJ, 2002, ARCH INTERN MED, V162, P600, DOI 10.1001/archinte.162.5.600; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Nicolle LE, 2002, AM J MED, V113, p35S; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; Robinson D, 2004, BJOG-INT J OBSTET GY, V111, P10, DOI 10.1111/j.1471-0528.2004.00459.x; RONALD AR, 1976, JAMA-J AM MED ASSOC, V235, P1854, DOI 10.1001/jama.235.17.1854; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Semeniuk H, 1999, J CLIN MICROBIOL, V37, P3051, DOI 10.1128/JCM.37.9.3051-3052.1999; STAMM WE, 1980, NEW ENGL J MED, V303, P409, DOI 10.1056/NEJM198008213030801; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; Stapleton A, 2002, AM J MED, V113, p80S; STROM BL, 1987, ANN INTERN MED, V107, P816, DOI 10.7326/0003-4819-107-6-816; Ueda T, 2003, INT J UROL, V10, pS39, DOI 10.1046/j.1442-2042.10.s1.14.x; Vinson DR, 2004, ARCH INTERN MED, V164, P1026, DOI 10.1001/archinte.164.9.1026; Vogel T, 2004, CAN MED ASSOC J, V170, P469; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; WINKENS RAG, 1995, FAM PRACT, V12, P290, DOI 10.1093/fampra/12.3.290; WONG ES, 1985, ANN INTERN MED, V102, P302, DOI 10.7326/0003-4819-102-3-302; 1998, DRUG THER B, V36, P30	53	57	63	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					94	97		10.1136/bmj.332.7533.94	http://dx.doi.org/10.1136/bmj.332.7533.94			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410583	Green Published			2022-12-28	WOS:000234777000022
J	Hayward, RD; Koronakis, V				Hayward, RD; Koronakis, V			Pathogens reWritE Rho's rules	CELL			English	Editorial Material							BACTERIAL; GTPASES	Many bacterial pathogens use a specialized "type III" secretion system to deliver virulence effector proteins into host mammalian cells. In this issue of Cell, Alto et al. (2006) describe a new family of effectors that share a WxxxE sequence motif. These effectors directly stimulate host signaling pathways by mimicking activated Ras-like cellular GTPases.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Koronakis, V (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	vk103@mole.bio.cam.ac.uk		Hayward, Richard David/0000-0002-1710-2172; Koronakis, Vassilis/0000-0002-1353-1092				ALTO NM, 2006, CELL; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000	10	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					15	17		10.1016/j.cell.2005.12.024	http://dx.doi.org/10.1016/j.cell.2005.12.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413475	Bronze			2022-12-28	WOS:000234969600003
J	Keppler, F; Hamilton, JTG; Brass, M; Rockmann, T				Keppler, F; Hamilton, JTG; Brass, M; Rockmann, T			Methane emissions from terrestrial plants under aerobic conditions	NATURE			English	Article							ATMOSPHERIC METHANE; ECOSYSTEM; BUDGET	Methane is an important greenhouse gas and its atmospheric concentration has almost tripled since pre-industrial times(1,2). It plays a central role in atmospheric oxidation chemistry and affects stratospheric ozone and water vapour levels. Most of the methane from natural sources in Earth's atmosphere is thought to originate from biological processes in anoxic environments(2). Here we demonstrate using stable carbon isotopes that methane is readily formed in situ in terrestrial plants under oxic conditions by a hitherto unrecognized process. Significant methane emissions from both intact plants and detached leaves were observed during incubation experiments in the laboratory and in the field. If our measurements are typical for short-lived biomass and scaled on a global basis, we estimate a methane source strength of 62 - 236 Tg yr(-1) for living plants and 1 - 7 Tg yr(-1) for plant litter (1 Tg = 10(12) g). We suggest that this newly identified source may have important implications for the global methane budget and may call for a reconsideration of the role of natural methane sources in past climate change.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; Dept Agr & Rural Dev No Ireland, Agr Food & Environm Sci Div, Belfast BT9 5PX, Antrim, North Ireland; Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TA Utrecht, Netherlands	Max Planck Society; Utrecht University	Keppler, F (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	frank.keppler@mpi-hd.mpg.de	Keppler, Frank/F-4401-2012; Röckmann, Thomas/F-4479-2015	Keppler, Frank/0000-0003-2766-8812; Röckmann, Thomas/0000-0002-6688-8968				BARTLETT KB, 1993, CHEMOSPHERE, V26, P261, DOI 10.1016/0045-6535(93)90427-7; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; FAO, 2001, 140 FAO UN; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Gogoi N, 2005, CHEMOSPHERE, V59, P1677, DOI 10.1016/j.chemosphere.2004.11.047; Hamilton JTG, 2003, SCIENCE, V301, P206, DOI 10.1126/science.1085036; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P8981, DOI 10.1029/1999JD901149; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P17243, DOI 10.1029/2000JD900193; Keppler F, 2004, BIOGEOSCIENCES, V1, P123, DOI 10.5194/bg-1-123-2004; Keppler F, 2005, ATMOS CHEM PHYS, V5, P2403, DOI 10.5194/acp-5-2403-2005; Lassey KR, 2000, GLOBAL BIOGEOCHEM CY, V14, P41, DOI 10.1029/1999GB900094; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; LOWE DC, 1994, J GEOPHYS RES-ATMOS, V99, P16913, DOI 10.1029/94JD00908; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Sass RL, 2002, P NATL ACAD SCI USA, V99, P11993, DOI 10.1073/pnas.202483599; SAUGIER B, 2001, GLOBAL TERRESTRIAL P, P541; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164	23	617	711	13	336	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					187	191		10.1038/nature04420	http://dx.doi.org/10.1038/nature04420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407949				2022-12-28	WOS:000234538400036
J	Sakamaki, T; Suzuki, A; Ohtani, E				Sakamaki, T; Suzuki, A; Ohtani, E			Stability of hydrous melt at the base of the Earth's upper mantle	NATURE			English	Article							HIGH-PRESSURE; OLIVINE FLOTATION; PERIDOTITE MELT; ELASTIC-MODULI; 25 GPA; DENSITY; LIQUID; H2O; TEMPERATURE; DIAMOND	Seismological observations have revealed the existence of low-velocity and high-attenuation zones above the discontinuity at 410 km depth, at the base of the Earth's upper mantle(1,2). It has been suggested that a small amount of melt could be responsible for such anomalies(3-5). The density of silicate melt under dry conditions has been measured at high pressure(4,6-13) and found to be denser than the surrounding solid, thereby allowing the melt to remain at depth. But no experimental investigation of the density of hydrous melt has yet been carried out. Here we present data constraining the density of hydrous basaltic melt under pressure to examine the stability of melt above the 410-km discontinuity. We infer that hydrous magma formed by partial melting above the 410-km discontinuity may indeed be gravitationally stable, thereby supporting the idea that low-velocity or high-attentuation regions just above the mantle transition zone may result from the presence of melt.	Tohoku Univ, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Suzuki, A (corresponding author), Tohoku Univ, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan.	a-suzuki@mail.tains.tohoku.ac.jp	Sakamaki, Tatsuya/U-5880-2019; Ohtani, Eiji/AAD-8011-2019; SUZUKI, Akio/AAP-1125-2020; Sakamaki, Tatsuya/D-1082-2014	SUZUKI, Akio/0000-0002-7093-6897; Sakamaki, Tatsuya/0000-0002-1158-844X; Ohtani, Eiji/0000-0001-8631-0736				Agee CB, 1998, PHYS EARTH PLANET IN, V107, P63, DOI 10.1016/S0031-9201(97)00124-6; AGEE CB, 1993, EARTH PLANET SC LETT, V114, P315, DOI 10.1016/0012-821X(93)90033-6; AGEE CB, 1988, J GEOPHYS RES-SOLID, V93, P3437, DOI 10.1029/JB093iB04p03437; BELONOSHKO A, 1991, GEOCHIM COSMOCHIM AC, V55, P381, DOI 10.1016/0016-7037(91)90425-5; BURNHAM CW, 1971, AM J SCI, V270, P54, DOI 10.2475/ajs.270.1.54; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; ITO E, 1987, NATURE, V328, P514, DOI 10.1038/328514a0; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Kawamoto T, 2004, PHYS EARTH PLANET IN, V143, P387, DOI 10.1016/j.pepi.2003.06.003; LANGE RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2931, DOI 10.1016/0016-7037(87)90368-1; Litasov K, 2003, PHYS CHEM MINER, V30, P147, DOI 10.1007/s00269-003-0301-y; Litasov K, 2002, PHYS EARTH PLANET IN, V134, P105, DOI 10.1016/S0031-9201(02)00152-8; MCSKIMIN HJ, 1972, J APPL PHYS, V43, P2944, DOI 10.1063/1.1661636; Ochs FA, 1997, CONTRIB MINERAL PETR, V129, P155, DOI 10.1007/s004100050329; Ochs FA, 1999, SCIENCE, V283, P1314, DOI 10.1126/science.283.5406.1314; Ohtani E, 2004, PHYS EARTH PLANET IN, V143, P255, DOI 10.1016/j.pepi.2003.09.015; OHTANI E, 1993, P JPN ACAD B-PHYS, V69, P23, DOI 10.2183/pjab.69.23; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; REVENAUGH J, 1994, NATURE, V369, P474, DOI 10.1038/369474a0; RIGDEN SM, 1984, SCIENCE, V226, P1071, DOI 10.1126/science.226.4678.1071; Song TRA, 2004, NATURE, V427, P530, DOI 10.1038/nature02231; Suzuki A, 2003, PHYS CHEM MINER, V30, P449, DOI 10.1007/s00269-003-0322-6; SUZUKI A, 1995, SCIENCE, V269, P216, DOI 10.1126/science.269.5221.216; Suzuki A, 1998, PHYS EARTH PLANET IN, V107, P53, DOI 10.1016/S0031-9201(97)00123-4; VINET P, 1989, J PHYS-CONDENS MAT, V1, P1941, DOI 10.1088/0953-8984/1/11/002; Wallace PJ, 1998, GEOPHYS RES LETT, V25, P3639, DOI 10.1029/98GL02805; ZHANG JZ, 1994, J GEOPHYS RES-SOL EA, V99, P17729, DOI 10.1029/94JB01406; Zouboulis ES, 1998, PHYS REV B, V57, P2889, DOI 10.1103/PhysRevB.57.2889	28	138	151	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					192	194		10.1038/nature04352	http://dx.doi.org/10.1038/nature04352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407950				2022-12-28	WOS:000234538400037
J	Magennis, S				Magennis, S			The nursing profession's coming of age - Doctors can use their skills to the maximum	BRITISH MEDICAL JOURNAL			English	Letter									Idle Med Ctr, Bradford BD10 8RU, W Yorkshire, England		Magennis, S (corresponding author), Idle Med Ctr, Bradford BD10 8RU, W Yorkshire, England.	sandra.magennis@bradford.nhs.nk						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					52	52		10.1136/bmj.332.7532.52-b	http://dx.doi.org/10.1136/bmj.332.7532.52-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399755	Green Published			2022-12-28	WOS:000234684200038
J	Stucki, M; Clapperton, JA; Mohammad, D; Yaffe, MB; Smerdon, SJ; Jackson, SP				Stucki, M; Clapperton, JA; Mohammad, D; Yaffe, MB; Smerdon, SJ; Jackson, SP			MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks	CELL			English	Article							IONIZING-RADIATION; BRCT REPEATS; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; GENOMIC INSTABILITY; DAMAGE CHECKPOINT; EARLY PARTICIPANT; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FOCUS FORMATION	Histone variant H2AX phosphorylation in response to DNA damage is the major signal for recruitment of DNA-damage-response proteins to regions of damaged chromatin. Loss of H2AX causes radiosensitivity, genome instability, and DNA double-strand-break repair defects, yet the mechanisms underlying these phenotypes remain obscure. Here, we demonstrate that mammalian MDC1/NFBD1 directly binds to phospho-H2AX (gamma H2AX) by specifically interacting with the phosphoepitope at the gamma H2AX carboxyl terminus. Moreover, through a combination of biochemical, cell-biological, and X-ray crystallographic approaches, we reveal the molecular details of the MDC1/NFBD1-gammaH2AX complex. These data provide compelling evidence that the MDC1/NFBD1 BRCT repeat domain is the major mediator of gamma H2AX recognition following DNA damage. We further show that MDC1/NFBD1-gamma H2AX complex formation regulates H2AX phosphorylation and is required for normal radioresistance and efficient accumulation of DNA-damage-response proteins on damaged chromatin. Thus, binding of MDCl/NFBD1 to gamma H2AX plays a central role in the mammalian response to DNA damage.	Univ Cambridge, Wellcome Trust Canc Res UK Gordon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Natl Inst Med Res, MRC, Div Prot Struct, London NW7 1AA, England; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	University of Cambridge; University of Cambridge; MRC National Institute for Medical Research; Massachusetts Institute of Technology (MIT)	Smerdon, SJ (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gordon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ssmerdo@nimr.mrc.ac.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Stucki, Manuel/H-4739-2017	Jackson, Stephen Philip/0000-0001-9317-7937; Smerdon, Stephen/0000-0001-5688-8465	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mochan TA, 2003, CANCER RES, V63, P8586; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	51	789	821	1	41	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1213	1226		10.1016/j.cell.2005.09.038	http://dx.doi.org/10.1016/j.cell.2005.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377563	Bronze			2022-12-28	WOS:000234584500011
J	Crumplin, MKH; Pearce, R				Crumplin, MKH; Pearce, R			Beatty's box	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Surgeons England, London WC2A 3PE, England; Hollywood Specialist Ctr, Nedlands, WA 6009, Australia	Royal College of Surgeons of England	Crumplin, MKH (corresponding author), Royal Coll Surgeons England, London WC2A 3PE, England.	mickcrumplin@doctors.org.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1531	1532		10.1136/bmj.331.7531.1531	http://dx.doi.org/10.1136/bmj.331.7531.1531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373741	Green Published, Bronze			2022-12-28	WOS:000234351300022
J	Fogelman, I; Blake, GM				Fogelman, I; Blake, GM			Bone densitometry: an update	LANCET			English	Editorial Material							FRACTURE RISK; POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURES; MINERAL DENSITY; REDUCTION; TRIAL; BMD		Guys Kings & St Thomas Sch Med, London SE1 9RT, England	University of London; King's College London	Fogelman, I (corresponding author), Guys Kings & St Thomas Sch Med, London SE1 9RT, England.	ignac.fogelman@kcl.ac.uk						Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; De Laet C, 2005, OSTEOPOROSIS INT, V16, P313, DOI 10.1007/s00198-004-1689-z; Eastell R, 2003, J BONE MINER RES, V18, P1051, DOI 10.1359/jbmr.2003.18.6.1051; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Genant HK, 1996, J BONE MINER RES, V11, P707; Gluer CC, 1999, J BONE MINER RES, V14, P1952, DOI 10.1359/jbmr.1999.14.11.1952; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Lu Y, 2001, J BONE MINER RES, V16, P901, DOI 10.1359/jbmr.2001.16.5.901; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; National Osteoporosis Society, 2004, POS STAT US PER XRAY; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Royal College of Physicians, 1999, OST CLIN GUID PREV T; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; *UK NAT I HLTH CLI, 2005, OST SEC PREV; World Health Organization, 1994, WHO TECHN REP SER, V843	20	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2068	2070		10.1016/S0140-6736(05)67867-1	http://dx.doi.org/10.1016/S0140-6736(05)67867-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360773				2022-12-28	WOS:000234146000006
J	Martinez-Patino, MJ				Martinez-Patino, MJ			Personal Account - A woman tried and tested	LANCET			English	Editorial Material									Univ Vigo, Fac Educ & Sports Sci, Vigo 36002, Pontevedra, Spain	Universidade de Vigo	Martinez-Patino, MJ (corresponding author), Univ Vigo, Fac Educ & Sports Sci, Vigo 36002, Pontevedra, Spain.	mjpatino@uvigo.es	MARTINEZ-PATIÑO, MARIA JOSE/K-7359-2014	MARTINEZ-PATIÑO, MARIA JOSE/0000-0003-2721-9240					0	47	48	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S38	S38		10.1016/S0140-6736(05)67841-5	http://dx.doi.org/10.1016/S0140-6736(05)67841-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360746				2022-12-28	WOS:000234374400024
J	Short, SE; Short, MW				Short, SE; Short, MW			Essay - Role of the coach in the coach-athlete relationship	LANCET			English	Article									Univ N Dakota, Dept Phys Educ & Exercise Sci, Grand Forks, ND 58202 USA; Univ N Dakota, Dept Phys & Educ, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Short, SE (corresponding author), Univ N Dakota, Dept Phys Educ & Exercise Sci, Grand Forks, ND 58202 USA.	Sandra_short@und.nodak.edu							0	18	19	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S29	S30		10.1016/S0140-6736(05)67836-1	http://dx.doi.org/10.1016/S0140-6736(05)67836-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360740				2022-12-28	WOS:000234374400019
J	Smith, GCS; Wood, AM; Pell, JP; Dobbie, R				Smith, GCS; Wood, AM; Pell, JP; Dobbie, R			Sudden infant death syndrome and complications in other pregnancies	LANCET			English	Article							SYNDROME SIDS BABIES; RECURRENCE RISK; BIRTH-WEIGHT; SCOTLAND; AGE	Background The likelihood of recurrence of sudden infant death syndrome (SIDS) is an issue of biological, clinical, and legal interest. Obstetric complications are associated with an increased risk of SIDS and are likely to recur in subsequent pregnancies. We postulated that women whose infants died from SIDS would be more likely to have had obstetric complications in their other pregnancies. Methods We linked national UK databases of maternity-hospital discharges, perinatal deaths, and death certifications. We studied 258 096 women who had consecutive births in Scotland between 1985 and 2001. Findings Women who had an infant who died from SIDS were at increased risk in their next pregnancy of delivering an infant small for gestational age (odds ratio 2.27, 95% CI 1.54-3.34, p<0.0001) and of preterm birth (2.53, 1.82-3.53, p<0.0001). The risk of SIDS was higher for the children of women whose previous infant had been small for gestational age (1.87, 1.19-2.94, p=0.007) or preterm (1.93, 1.24-3.00, p=0.004). Multivariate analysis showed that all associations were explained by common maternal risk factors for SIDS and obstetric complications and by the likelihood of recurrence of fetal growth restriction and preterm birth. Interpretation Women whose infants die from SIDS are more likely to have complications in their other pregnancies. Recurrence of pregnancy complications predisposing to SIDS could partly explain why some women have recurrent SIDS.	Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CBR 2SW, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Robinson Way, Cambridge CBR 2SW, England.	gcss2@cam.ac.uk	Wood, Angela/GZA-5762-2022; Smith, Gordon/A-8070-2008	Wood, Angela/0000-0002-7937-304X; Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				BEAL SM, 1988, ARCH DIS CHILD, V63, P924, DOI 10.1136/adc.63.8.924; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; CAMPBELL S, 1993, ULTRASOUND OBST GYN, P1431; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; COLE S, 1980, 8 STUD GROUP ROYAL C, P39; *CROWN OFF, 1998, DEATH PROC FISC; EVANS E, 1990, CLIN APPL ULTRASONIC; GUNTHEROTH WG, 1990, J PEDIATR-US, V116, P520, DOI 10.1016/S0022-3476(05)81596-3; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; IRGENS LM, 1984, J PEDIATR-US, V104, P349, DOI 10.1016/S0022-3476(84)81093-8; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; *NHS SCOTL INF STA, 2001, SCOTT PER INF MORT R; OYEN N, 1995, AM J EPIDEMIOL, V142, P84, DOI 10.1093/oxfordjournals.aje.a117549; Oyen N, 1997, PAEDIATR PERINAT EP, V11, P84, DOI 10.1046/j.1365-3016.11.s1.17.x; Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Smith GCS, 2004, NEW ENGL J MED, V351, P978, DOI 10.1056/NEJMoa040963; Smith GCS, 2003, PEDIATRICS, V111, P1367, DOI 10.1542/peds.111.6.1367; SPIERS PS, 1983, GROWTH, V47, P104; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; VANBELLE G, 1988, SUDDEN INFANT DEATH, P203; Watkins SJ, 2000, BRIT MED J, V320, P2, DOI 10.1136/bmj.320.7226.2	25	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2107	2111		10.1016/S0140-6736(05)67888-9	http://dx.doi.org/10.1016/S0140-6736(05)67888-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360787				2022-12-28	WOS:000234146000025
J	Showalter, MR; Lissauer, JJ				Showalter, MR; Lissauer, JJ			The second ring-moon system of Uranus: Discovery and dynamics	SCIENCE			English	Article							F-RING; SATURNS; SATELLITES; PHOTOMETRY; ORBITS; MODEL	Deep exposures of Uranus taken with the Hubble Space Telescope reveal two small moons and two faint rings. All of them orbit outside of Uranus's previously known (main) ring system but are interior to the large, classical moons. The outer new moon, U XXVI Mab, orbits at roughly twice the radius of the main rings and shares its orbit with a dust ring. The second moon, U XXVII Cupid, orbits just interior to the satellite Belinda. A second ring falls between the orbits of Portia and Rosalind, in a region with no known source bodies. Collectively, these constitute a densely packed, rapidly varying, and possibly unstable dynamical system.	SETI Inst, Mountain View, CA 94043 USA; NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Showalter, MR (corresponding author), SETI Inst, 515 N Whisman Rd, Mountain View, CA 94043 USA.	mshowalter@seti.org						Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; BROADFOOT AL, 1986, SCIENCE, V233, P74, DOI 10.1126/science.233.4759.74; Burns JA, 2004, CAMB PLANET, P241; Burns JA, 2001, ASTR AST LI, P641; COLWELL JE, 1992, J GEOPHYS RES-PLANET, V97, P10227, DOI 10.1029/92JE00788; COLWELL JE, 1990, ICARUS, V86, P530, DOI 10.1016/0019-1035(90)90232-X; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; Duncan MJ, 1997, ICARUS, V125, P1, DOI 10.1006/icar.1996.5568; Jacobson RA, 1998, ASTRON J, V115, P1195, DOI 10.1086/300263; Karkoschka E, 2001, ICARUS, V151, P51, DOI 10.1006/icar.2001.6596; Karkoschka E, 2001, ICARUS, V151, P69, DOI 10.1006/icar.2001.6597; Lissauer JJ, 2000, ICARUS, V146, P12, DOI 10.1006/icar.2000.6386; MEYER J, COMMUNICATION; OWEN WM, 1987, ASTRON J, V93, P1268, DOI 10.1086/114409; Poulet F, 2000, ICARUS, V144, P135, DOI 10.1006/icar.1999.6267; SHOWALTER MR, 1993, ICARUS, V103, P124, DOI 10.1006/icar.1993.1062; Showalter MR, 1998, SCIENCE, V282, P1099, DOI 10.1126/science.282.5391.1099; SHOWALTER MR, 2003, 8209 IAU; SHOWALTER MR, 2003, 8194 IAU; SMITH BA, 1986, SCIENCE, V233, P43, DOI 10.1126/science.233.4759.43; Throop HB, 1998, ICARUS, V131, P152, DOI 10.1006/icar.1997.5851	21	62	62	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2006	311	5763					973	977		10.1126/science.1122882	http://dx.doi.org/10.1126/science.1122882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014CS	16373533				2022-12-28	WOS:000235456900037
J	Lee, CY; Robinson, KJ; Doe, CQ				Lee, CY; Robinson, KJ; Doe, CQ			lgl, pins and aPKC regulate neuroblast self-renewal versus differentiation	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA NEUROBLASTS; POLARITY; LOCALIZATION; PROLIFERATION; LINEAGES; REVEALS; COMPLEX; GROWTH	How a cell chooses to proliferate or to differentiate is an important issue in stem cell and cancer biology. Drosophila neuroblasts undergo self-renewal with every cell division, producing another neuroblast and a differentiating daughter cell, but the mechanisms controlling the self-renewal/differentiation decision are poorly understood. Here we tested whether cell polarity genes, known to regulate embryonic neuroblast asymmetric cell division(1), also regulate neuroblast self-renewal. Clonal analysis in larval brains showed that pins mutant neuroblasts rapidly fail to self-renew, whereas lethal giant larvae (lgl) mutant neuroblasts generate multiple neuroblasts. Notably, lgl pins double mutant neuroblasts all divide symmetrically to self-renew, filling the brain with neuroblasts at the expense of neurons. The lgl pins neuroblasts show ectopic cortical localization of atypical protein kinase C ( aPKC), and a decrease in aPKC expression reduces neuroblast numbers, suggesting that aPKC promotes neuroblast self-renewal. In support of this hypothesis, neuroblast-specific overexpression of membrane-targeted aPKC, but not a kinase-dead version, induces ectopic neuroblast self-renewal. We conclude that cortical aPKC kinase activity is a potent inducer of neuroblast self-renewal.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoregon.edu						Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BUENZOW DE, 1995, DEV BIOL, V170, P338, DOI 10.1006/dbio.1995.1219; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; DATTA S, 1995, DEVELOPMENT, V121, P1173; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Freeman MR, 2001, DEVELOPMENT, V128, P4103; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	27	246	256	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					594	598		10.1038/nature04299	http://dx.doi.org/10.1038/nature04299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16357871				2022-12-28	WOS:000235033900042
J	Ozbay, E				Ozbay, E			Plasmonics: Merging photonics and electronics at nanoscale dimensions	SCIENCE			English	Review							ENHANCED TRANSMISSION; OPTICAL-TRANSMISSION; SUBWAVELENGTH; LIGHT; POLARITONS; RADIATION		Bilkent Univ, Nanotechnol Res Ctr, TR-06800 Ankara, Turkey	Ihsan Dogramaci Bilkent University	Ozbay, E (corresponding author), Bilkent Univ, Nanotechnol Res Ctr, TR-06800 Ankara, Turkey.	ozbay@bilkent.edu.tr	Ozbay, Ekmel/B-9495-2008					Akarca-Biyikli SS, 2004, APPL PHYS LETT, V85, P1098, DOI 10.1063/1.1783013; Barnes WL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107401; BERUETE M, 2004, OPT LETT, V12, P3629; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Caglayan H, 2005, OPT EXPRESS, V13, P1666, DOI 10.1364/OPEX.13.001666; Cao H, 2004, OPT EXPRESS, V12, P1004, DOI 10.1364/OPEX.12.001004; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Hashizume J, 2004, OPT EXPRESS, V12, P6391, DOI 10.1364/OPEX.12.006391; Hibbins AP, 2005, SCIENCE, V308, P670, DOI 10.1126/science.1109043; Kik PG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045418; Kobrinsky M. J., 2004, Intel Technology Journal; Krenn JR, 2004, PHILOS T ROY SOC A, V362, P739, DOI 10.1098/rsta.2003.1344; Lezec HJ, 2002, SCIENCE, V297, P820, DOI 10.1126/science.1071895; Lezec HJ, 2004, OPT EXPRESS, V12, P3629, DOI 10.1364/OPEX.12.003629; Liu C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895481; LUOA X, 2001, APPL PHYS LETT, V84, P4780; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Nezhad MP, 2004, OPT EXPRESS, V12, P4072, DOI 10.1364/OPEX.12.004072; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Rivas JG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.256804; Thio T, 2001, OPT LETT, V26, P1972, DOI 10.1364/OL.26.001972; Vuckovic J, 2000, IEEE J QUANTUM ELECT, V36, P1131, DOI 10.1109/3.880653; Wedge S, 2004, APPL PHYS LETT, V85, P182, DOI 10.1063/1.1772516	25	3764	3870	51	1691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					189	193		10.1126/science.1114849	http://dx.doi.org/10.1126/science.1114849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410515	Green Submitted			2022-12-28	WOS:000234722200030
J	Tian, G; Xiang, S; Noiva, R; Lennarz, WJ; Schindelin, H				Tian, G; Xiang, S; Noiva, R; Lennarz, WJ; Schindelin, H			The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites	CELL			English	Article							THIOREDOXIN-LIKE DOMAINS; ESCHERICHIA-COLI THIOREDOXIN; ENDOPLASMIC-RETICULUM; BOND FORMATION; FOLDING CATALYST; FUNCTIONAL-PROPERTIES; PEPTIDE-BINDING; BOVINE LIVER; ERO1P; DSBA	Protein disulfide isomerase plays a key role in catalyzing the folding of secretory proteins. It features two catalytically inactive thioredoxin domains inserted between two catalytically active thioredoxin domains and an acidic C-terminal tail. The crystal structure of yeast PDI reveals that the four thioredoxin domains are arranged in the shape of a twisted "U" with the active sites facing each other across the long sides of the "U." The inside surface of the "U" is enriched in hydrophobic residues, thereby facilitating interactions with misfolded proteins. The domain arrangement, active site location, and surface features strikingly resemble the Escherichia coli DsbC and DsbG protein disulfide isomerases. Biochemical studies demonstrate that all domains of PDI, including the C-terminal tail, are required for full catalytic activity. The structure defines a framework for rationalizing the differences between the two active sites and their respective roles in catalyzing the formation and rearrangement of disulfide bonds.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Struct Biol, Stony Brook, NY 11794 USA; Univ S Dakota, Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; Univ Wurzburg, Inst Biol Struct, D-97078 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of South Dakota; University of Wurzburg; University of Wurzburg	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	hermann.schindelin@sunysb.edu	Schindelin, Hermann/Q-2697-2019; Xiang, Song/AAF-6422-2019; Tian, Geng/G-7374-2011	Xiang, Song/0000-0001-9314-4684; 	NIDDK NIH HHS [DK54835] Funding Source: Medline; NIGMS NIH HHS [GM73421, GM33184] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033184, F33GM073421] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; DeLano W.L, PYMOL MOL GRAPHICS S; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1994, J BIOL CHEM, V269, P30946; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Natsuka S, 2001, J BIOCHEM-TOKYO, V130, P731, DOI 10.1093/oxfordjournals.jbchem.a003042; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Ohringer SL, 1996, ACTA CRYSTALLOGR D, V52, P224, DOI 10.1107/S0907444995011486; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Solovyov A, 2004, PROTEIN SCI, V13, P1902, DOI 10.1110/ps.04716104; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang XQ, 1999, ACTA CRYSTALLOGR D, V55, P1958, DOI 10.1107/S0907444999011762; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xiao RY, 2004, J BIOL CHEM, V279, P49780, DOI 10.1074/jbc.M409210200; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; Zheng J, 2001, J BIOL CHEM, V276, P15747, DOI 10.1074/jbc.M011444200	54	292	301	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					61	73		10.1016/j.cell.2005.10.044	http://dx.doi.org/10.1016/j.cell.2005.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413482	Bronze			2022-12-28	WOS:000234969600010
J	Ciruna, B; Jenny, A; Lee, D; Mlodzik, M; Schier, AF				Ciruna, B; Jenny, A; Lee, D; Mlodzik, M; Schier, AF			Planar cell polarity signalling couples cell division and morphogenesis during neurulation	NATURE			English	Article							NEURAL-TUBE DEFECTS; CONVERGENT EXTENSION; LOOP-TAIL; ZEBRAFISH GASTRULATION; FLOOR PLATE; MOUSE; MOVEMENTS; STRABISMUS; ORIENTATION; MIGRATION	Environmental and genetic aberrations lead to neural tube closure defects (NTDs) in 1 out of every 1,000 births(1). Mouse and frog models for these birth defects have indicated that Van Gogh-like 2 (Vangl2, also known as Strabismus) and other components of planar cell polarity (PCP) signalling might control neurulation by promoting the convergence of neural progenitors to the midline(2-8). Here we show a novel role for PCP signalling during neurulation in zebrafish. We demonstrate that non-canonical Wnt/PCP signalling polarizes neural progenitors along the anteroposterior axis. This polarity is transiently lost during cell division in the neural keel but is re-established as daughter cells reintegrate into the neuroepithelium. Loss of zebrafish Vangl2 ( in trilobite mutants) abolishes the polarization of neural keel cells, disrupts re-intercalation of daughter cells into the neuroepithelium, and results in ectopic neural progenitor accumulations and NTDs. Remarkably, blocking cell division leads to rescue of trilobite neural tube morphogenesis despite persistent defects in convergence and extension. These results reveal a function for PCP signalling in coupling cell division and morphogenesis at neurulation and indicate a previously unrecognized mechanism that might underlie NTDs.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Mt Sinai Sch Med, Brookdale Dept Mol Cellular & Dev Biol, New York, NY 10029 USA	New York University; New York University; Icahn School of Medicine at Mount Sinai	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev Biol, Toronto Med Discovery Tower, Toronto, ON M5G 1L7, Canada.	ciruna@sickkids.ca; schier@fas.harvard.edu		Schier, Alexander Franz/0000-0001-7645-5325	NIGMS NIH HHS [R01 GM056211] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Concha ML, 1998, DEVELOPMENT, V125, P983; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Thisse C, 1999, DEVELOPMENT, V126, P229; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581	30	301	311	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					220	224		10.1038/nature04375	http://dx.doi.org/10.1038/nature04375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407953	Green Accepted			2022-12-28	WOS:000234538400044
J	Davies, M				Davies, M			The nursing profession's coming of age - A team effort required?	BRITISH MEDICAL JOURNAL			English	Letter												mark.davies@nglam-tr.wales.nhs.uk		Davies, Mark/0000-0001-9315-9130				Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					52	52		10.1136/bmj.332.7532.52-c	http://dx.doi.org/10.1136/bmj.332.7532.52-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399754	Green Published			2022-12-28	WOS:000234684200039
J	Gartley, C				Gartley, C			Life with incontinence	LANCET			English	Editorial Material									Simon Fdn Continence, Wilmette, IL 60091 USA		Gartley, C (corresponding author), Simon Fdn Continence, POB 815, Wilmette, IL 60091 USA.	cbgartley@simonfoundation.org							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					68	68		10.1016/S0140-6736(06)67926-9	http://dx.doi.org/10.1016/S0140-6736(06)67926-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399155				2022-12-28	WOS:000234443100032
J	Healy, D; Jones, RR; Holdsworth, RE				Healy, D; Jones, RR; Holdsworth, RE			Three-dimensional brittle shear fracturing by tensile crack interaction	NATURE			English	Article							STRAIN FIELDS; DEFORMATION; GROWTH; FAULTS; ROCKS; SLIP	Faults in brittle rock are shear fractures formed through the interaction and coalescence of many tensile microcracks(1-3). The geometry of these microcracks and their surrounding elastic stress fields control the orientation of the final shear fracture surfaces(3,4). The classic Coulomb - Mohr failure criterion(5) predicts the development of two conjugate ( bimodal) shear planes that are inclined at an acute angle to the axis of maximum compressive stress. This criterion, however, is incapable of explaining the three-dimensional polymodal fault patterns that are widely observed in rocks(6-9). Here we show that the elastic stress around tensile microcracks in three dimensions promotes a mutual interaction that produces brittle shear planes oriented obliquely to the remote principal stresses, and can therefore account for observed polymodal fault patterns. Our microcrack interaction model is based on the three-dimensional solution of Eshelby(10,11), unlike previous models(4,12) that employed two-dimensional approximations. Our model predicts that shear fractures formed by the coalescence of interacting mode I cracks will be inclined at a maximum of 268 to the axes of remote maximum and intermediate compression. An improved understanding of brittle shear failure in three dimensions has important implications for earthquake seismology and rock-mass stability, as well as fluid migration in fractured rocks(13).	Univ Liverpool, Dept Earth & Ocean Sci, Rock Deformat Lab, Liverpool L69 3GP, Merseyside, England; e Sci Res Inst, Durham, England; Univ Durham, Dept Earth Sci, Reactivat Res Grp, Durham DH1 3LE, England	University of Liverpool; Durham University; Durham University	Healy, D (corresponding author), Univ Liverpool, Dept Earth & Ocean Sci, Rock Deformat Lab, Liverpool L69 3GP, Merseyside, England.	dhealy@liverpool.ac.uk	Healy, David/G-2005-2010; Healy, David/A-5305-2009; Holdsworth, Robert E/C-2381-2008	Holdsworth, Robert/0000-0002-3467-835X				Anderson E. M., 1942, DYNAMICS FAULTING DY; AYDIN A, 1982, GEOLOGY, V10, P107, DOI 10.1130/0091-7613(1982)10<107:NAOOFS>2.0.CO;2; Beacom LE, 1999, GEOL MAG, V136, P301, DOI 10.1017/S0016756899002605; COX SJD, 1988, J STRUCT GEOL, V10, P413, DOI 10.1016/0191-8141(88)90019-3; Crider JG, 2001, J STRUCT GEOL, V23, P1997, DOI 10.1016/S0191-8141(01)00047-5; De Paola N, 2005, J GEOL SOC LONDON, V162, P471, DOI 10.1144/0016-764904-043; Dewey JF, 1998, GEOL SOC SPEC PUBL, V135, P1, DOI 10.1144/GSL.SP.1998.135.01.01; DU Y, 1991, INT J NUMER ANAL MET, V15, P205, DOI 10.1002/nag.1610150305; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396; Glover PWJ, 2000, EARTH PLANET SC LETT, V183, P201, DOI 10.1016/S0012-821X(00)00267-3; JAEGER J, 1979, FUNDAMENTALS ROCK ME, pCH4; Jones RR, 2005, J STRUCT GEOL, V27, P1190, DOI 10.1016/j.jsg.2005.04.001; Ju JW, 2001, INT J SOLIDS STRUCT, V38, P183, DOI 10.1016/S0020-7683(00)00023-8; Lockner D., 1992, FAULT MECH TRANSPORT, V51, P3, DOI DOI 10.1016/S0074-6142(08)62813-2; Mccaffrey KJW, 2005, J GEOL SOC LONDON, V162, P927, DOI 10.1144/0016-764905-017; MOORE DE, 1995, J STRUCT GEOL, V17, P95, DOI 10.1016/0191-8141(94)E0018-T; Morris A, 1996, GEOLOGY, V24, P275, DOI 10.1130/0091-7613(1996)024<0275:STAAFR>2.3.CO;2; PATERSON MS, 1978, EXPT ROCK DEFORMATIO, pCH3; PENG S, 1972, INT J ROCK MECH MIN, V9, P37, DOI 10.1016/0148-9062(72)90050-2; PETIT JP, 1988, TECTONICS, V7, P1243, DOI 10.1029/TC007i006p01243; Pollard D.D., 1987, FRACTURE MECH ROCK, P277, DOI B978-0-12-066233-1.50013-2; RECHES Z, 1983, TECTONOPHYSICS, V95, P133, DOI 10.1016/0040-1951(83)90264-0; RECHES Z, 1978, TECTONOPHYSICS, V47, P109, DOI 10.1016/0040-1951(78)90154-3; RECHES Z, 1983, TECTONOPHYSICS, V95, P111, DOI 10.1016/0040-1951(83)90263-9; RECHES Z, 1994, J GEOPHYS RES-SOL EA, V99, P18159, DOI 10.1029/94JB00115; SCHOLZ C, 2002, MECH EARTHQUAKES FAU, pCH1; Sternlof KR, 2004, AAPG BULL, V88, P1315, DOI 10.1306/03280403103	28	149	153	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					64	67		10.1038/nature04346	http://dx.doi.org/10.1038/nature04346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397496				2022-12-28	WOS:000234378700034
J	Vesikari, T; Matson, DO; Dennehy, P; Van Damme, P; Santosham, M; Rodriguez, Z; Dallas, MJ; Heyse, JF; Goveia, MG; Black, SB; Shinefield, HR; Christie, CDC; Ylitalo, S; Itzler, RF; Coia, ML; Onorato, MT; Adeyi, BA; Marshall, GS; Gothefors, L; Campens, D; Karvonen, A; Watt, JP; O'Brien, KL; DiNubile, MJ; Clark, HF; Boslego, JW; Offit, PA; Heaton, PM				Vesikari, T; Matson, DO; Dennehy, P; Van Damme, P; Santosham, M; Rodriguez, Z; Dallas, MJ; Heyse, JF; Goveia, MG; Black, SB; Shinefield, HR; Christie, CDC; Ylitalo, S; Itzler, RF; Coia, ML; Onorato, MT; Adeyi, BA; Marshall, GS; Gothefors, L; Campens, D; Karvonen, A; Watt, JP; O'Brien, KL; DiNubile, MJ; Clark, HF; Boslego, JW; Offit, PA; Heaton, PM		REST Study Team	Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTUSSUSCEPTION; INFECTION; PROTECTION; GASTROENTERITIS; IMPLEMENTATION; ASSOCIATION; INFANTS; DISEASE; DEATHS; FUTURE	BACKGROUND: Rotavirus is a leading cause of childhood gastroenteritis and death worldwide. METHODS: We studied healthy infants approximately 6 to 12 weeks old who were randomly assigned to receive three oral doses of live pentavalent human-bovine (WC3 strain) reassortant rotavirus vaccine containing human serotypes G1, G2, G3, G4, and P[8] or placebo at 4-to-10-week intervals in a blinded fashion. Active surveillance was used to identify subjects with serious adverse and other events. RESULTS: The 34,035 infants in the vaccine group and 34,003 in the placebo group were monitored for serious adverse events. Intussusception occurred in 12 vaccine recipients and 15 placebo recipients within one year after the first dose including six vaccine recipients and five placebo recipients within 42 days after any dose (relative risk, 1.6; 95 percent confidence interval, 0.4 to 6.4). The vaccine reduced hospitalizations and emergency department visits related to G1-G4 rotavirus gastroenteritis occurring 14 or more days after the third dose by 94.5 percent (95 percent confidence interval, 91.2 to 96.6 percent). In a nested substudy, efficacy against any G1-G4 rotavirus gastroenteritis through the first full rotavirus season after vaccination was 74.0 percent (95 percent confidence interval, 66.8 to 79.9 percent); efficacy against severe gastroenteritis was 98.0 percent (95 percent confidence interval, 88.3 to 100 percent). The vaccine reduced clinic visits for G1-G4 rotavirus gastroenteritis by 86.0 percent (95 percent confidence interval, 73.9 to 92.5 percent). CONCLUSIONS: This vaccine was efficacious in preventing rotavirus gastroenteritis, decreasing severe disease and health care contacts. The risk of intussusception was similar in vaccine and placebo recipients.	Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; Eastern Virginia Med Sch, Ctr Pediat Res, Norfolk, VA 23501 USA; Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI USA; Univ Antwerp, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA; Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; Merck Res Labs, West Point, PA 19486 USA; Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; Inst Vaccine & Pharmacol Res San Francisco, San Francisco, CA USA; Univ W Indies, Dept Pediat, Kingston 7, Jamaica; Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA; Umea Univ, Dept Clin Sci Pediat, Umea, Sweden; Sanofi Pasteur Merck, Sharp & Dohme, Lyon, France; Childrens Hosp, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Tampere University; Eastern Virginia Medical School; Lifespan Health Rhode Island; Rhode Island Hospital; University of Antwerp; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Merck & Company; Kaiser Permanente; University West Indies Mona Jamaica; University of Louisville; Umea University; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Heaton, PM (corresponding author), Merck Res Labs, POB 4,UNC-151, West Point, PA 19486 USA.	penny_heaton@merck.com	Dennehy, Penelope/CAF-1123-2022; van damme, pierre/I-4846-2013	Dennehy, Penelope/0000-0002-2259-5370; van damme, pierre/0000-0002-8642-1249; O'Brien, Katherine/0000-0002-0164-4030; Christie, Celia DC/0000-0002-8981-3934				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Chang EJ, 2002, PEDIATR INFECT DIS J, V21, P97, DOI 10.1097/00006454-200202000-00003; Clark HF, 2004, PEDIATR ANN, V33, P537; Clark HF, 2004, J PEDIATR-US, V144, P184, DOI 10.1016/j.jpeds.2003.10.054; Coffin SE, 1997, J VIROL, V71, P7851, DOI 10.1128/JVI.71.10.7851-7856.1997; DiStefano DJ, 2005, J CLIN MICROBIOL, V43, P5876, DOI 10.1128/JCM.43.12.5876-5880.2005; DOLAN KT, 1985, J CLIN MICROBIOL, V21, P753, DOI 10.1128/JCM.21.5.753-758.1985; DUFFY LC, 1986, AM J PUBLIC HEALTH, V76, P259, DOI 10.2105/AJPH.76.3.259; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; GILCHRIST MJR, 1987, DIAGN MICR INFEC DIS, V8, P221, DOI 10.1016/0732-8893(87)90053-8; Glass RI, 2004, LANCET, V363, P1547, DOI 10.1016/S0140-6736(04)16155-2; Haber P, 2004, PEDIATRICS, V113, pE353, DOI 10.1542/peds.113.4.e353; Heaton PM, 2005, J INFECT DIS, V192, pS17, DOI 10.1086/431500; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; Jennison C, 2000, GROUP SEQUENTIAL MET; Joensuu J, 1998, PEDIATR INFECT DIS J, V17, P334, DOI 10.1097/00006454-199804000-00013; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; LEBARON CW, 1990, JAMA-J AM MED ASSOC, V264, P983, DOI 10.1001/jama.264.8.983; Moulton LH, 1998, J INFECT DIS, V178, P1562, DOI 10.1086/314504; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; ORYAN ML, 1994, J INFECT DIS, V169, P504, DOI 10.1093/infdis/169.3.504; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Rennels MB, 1996, PEDIATRICS, V97, P7; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; RODRIGUEZ WJ, 1978, LANCET, V2, P37; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 1999, ACTA PAEDIATR, V88, P24, DOI 10.1111/j.1651-2227.1999.tb14322.x; VESIKARI T, 2004, 22 ANN M EUR SOC PED, P26; Ward RL, 1997, J INFECT DIS, V176, P570, DOI 10.1086/514076; Withdrawal of rotavirus vaccine, 1999, MMWR-MORBID MORTAL W, V48, P1007; 1997, MMWR MORB MORTAL WKL, V46, P1092	37	1389	1464	2	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					23	33		10.1056/NEJMoa052664	http://dx.doi.org/10.1056/NEJMoa052664			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394299				2022-12-28	WOS:000234358600005
J	Chen, CJ; Yang, HI; Su, J; Jen, CL; You, SL; Lu, SN; Huang, GT; Iloeje, UH				Chen, CJ; Yang, HI; Su, J; Jen, CL; You, SL; Lu, SN; Huang, GT; Iloeje, UH		REVEAL-HBV Study Grp	Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E-ANTIGEN; HBV-DNA; AMINOTRANSFERASE LEVELS; INFECTION; ETIOLOGY; EFFICACY; THERAPY	Context Serum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy of antiviral treatment in individuals with chronic hepatitis B. Objective To evaluate the relationship between serum HBV DNA level and risk of hepatocellular carcinoma. Design, Setting, and Participants Prospective cohort study of 3653 participants (aged 30-65 years), who were seropositive for the hepatitis B surface antigen and seronegative for antibodies against the hepatitis C virus, recruited to a community-based cancer screening program in Taiwan between 1991 and 1992. Main Outcome Measure Incidence of hepatocellular carcinoma during follow-up examination and by data linkage with the national cancer registry and the death certification systems. Results There were 164 incident cases of hepatocellular carcinoma and 346 deaths during a mean follow-up of 11.4 years and 41779 person-years of follow-up. The incidence of hepatocellular carcinoma increased with serum HBV DNA level at study entry, in a dose-response relationship ranging from 108 per 100 000 person-years for an HBV DNA level of less than 300 copies/mL to 1152 per 100000 person-years for an HBV DNA level of 1 million copies/mL or greater. The corresponding cumulative incidence rates of hepatocellular carcinoma were 1.3% and 14.9%, respectively. The biological gradient of hepatocellular carcinoma by serum HBV DNA levels remained significant (P<.001) after adjustment for sex, age, cigarette smoking, alcohol consumption, serostatus for the hepatitis Be antigen (HBeAg), serum alanine aminotransferase level, and liver cirrhosis at study entry. The dose-response relationship was most prominent for participants who were seronegative for HBeAg with normal serum alanine aminotransferase levels and no liver cirrhosis at study entry. Participants with persistent elevation of serum HBV DNA level during follow-up had the highest hepatocellular carcinoma risk. Conclusion Elevated serum HBV DNA level (>= 10 000 copies/mL) is a strong risk predictor of hepatocellular carcinoma independent of HBeAg, serum alanine aminotransferase level, and liver cirrhosis.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10018, Taiwan; Bristol Myers Squibb Co, Global Epidemiol & Outcomes Res, Wallingford, CT 06492 USA; Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol, Kaohsiung, Taiwan	National Taiwan University; Bristol-Myers Squibb; Chang Gung Memorial Hospital	Chen, CJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Room 1547,1,Jen Ai Rd Sec 1, Taipei 10018, Taiwan.	cjchen@ha.mc.ntu.edu.tw	Yang, Hwai-I/A-9470-2008; Ibrahim, Essam Hassan/G-1960-2018; ting, huang/V-6326-2017; Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Yang, Hwai-I/0000-0002-3433-942X; Ibrahim, Essam Hassan/0000-0003-0130-2257; Huang, Guan-Tarn/0000-0001-7004-826X				AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Alberti A, 2003, HEPATOLOGY, V38, P18, DOI 10.1053/jhep.2003.50280; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BRESLOW N, 1974, ANN STAT, V2, P437, DOI 10.1214/aos/1176342705; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chen CJ, 2002, NEW ENGL J MED, V347, P1722; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Geier A, 2003, HEPATOLOGY, V37, P712, DOI 10.1053/jhep.2003.50099; LEE PI, 1990, HEPATOLOGY, V12, P657, DOI 10.1002/hep.1840120406; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Lok ASF, 2003, HEPATOLOGY, V37, P713, DOI 10.1053/jhep.2003.50111; MCMAHON BJ, 1997, VIRAL HEPATITIS, P315; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; PENA E, 1993, J STAT PLAN INFER, V37, P192; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; You SL, 2004, ANN MED, V36, P215, DOI 10.1080/07853890310021580; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043	22	2279	2452	1	201	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					65	73		10.1001/jama.295.1.65	http://dx.doi.org/10.1001/jama.295.1.65			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391218	Bronze			2022-12-28	WOS:000234381100022
J	Elliott, RA; Majumdar, SR; Gillick, MR; Soumerai, SB				Elliott, RA; Majumdar, SR; Gillick, MR; Soumerai, SB			Benefits and consequences for the poor and the disabled	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Manchester, Manchester, Lancs, England; Univ Alberta, Edmonton, AB, Canada; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA	University of Manchester; University of Alberta; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Elliott, RA (corresponding author), Univ Manchester, Manchester, Lancs, England.		Elliott, Rachel/P-5894-2018	Elliott, Rachel/0000-0002-3650-0168				Bambauer KZ, 2005, PSYCHIAT SERV, V56, P1143, DOI 10.1176/appi.ps.56.9.1143; Centers for Medicare and Medicaid Services, MED DUALL EL POP 200; *EMLIB, 2005, WHO MOD FORM; *KAIS COMM MED UN, 2004, MED BEN ONL DAT BEN; Soumerai SB, 2004, HEALTH AFFAIR, V23, P135, DOI 10.1377/hlthaff.23.1.135	5	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2739	2741		10.1056/NEJMp058242	http://dx.doi.org/10.1056/NEJMp058242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	997LK	16382058	Green Published			2022-12-28	WOS:000234246700003
J	Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA				Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA			Epidemiology and prognosis of coma in daytime television dramas	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOAP-OPERA; VEGETATIVE STATE; HEAD-INJURY; BREAST-CANCER; BRAIN-INJURY; EDUCATION; ATTITUDES; BEHAVIOR; PROGRAM; AIDS	Objective To determine how soap operas Portray, and possibly misrepresent, the likelihood of recovery for patients in coma. Design Retrospective cohort study Setting Nine soap operas in the United States reviewed between 1 January 1995 and 15 May 2005. Subjects 64 characters who experienced a period of unconsciousness lasting at least 24 hours. Their final status at the end of the follow-up period was compared with pooled data from a meta-analysis. Results Comas lasted a median of 13 days (interquartile range 7-25 days). Fifty seven (89%) patients recovered fully, five (8%) died, and two (3%) remained in a vegetative state. Mortality for non-traumatic and traumatic coma was significantly lower than would be predicted from the meta-analysis data (non-traumatic 4% v 53%; traumatic 6% v 67%; Fisher's exact test both P < 0.001). On the day that patients regained consciousness, most (49/57; 86%) had no evidence of limited function, cognitive deficit, or residual disability needing rehabilitation. Compared with meta-analysis data, patients in this sample had a much better than expected chance of returning to normal function (non-traumatic 91% v 1%; traumatic 89% 7%; both P < 0.001). Conclusions The portrayal of coma in soap operas is overly optimistic. Although these programmes are presented as fiction, they may contribute to unrealistic expectations of recovery.	Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Div Geriatr Med, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Casarett, D (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, 9 E,3900 Woodland Ave, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X				Ang I, 1991, DESPERATELY SEEKING; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BANJA JD, 1990, PHYS MED REHABIL, V4, P579; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; Borrayo EA, 2004, PREV MED, V39, P99, DOI 10.1016/j.ypmed.2004.03.024; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Brodie M, 2001, HEALTH AFFAIR, V20, P192, DOI 10.1377/hlthaff.20.1.192; Campbell MK, 2004, J NUTR EDUC BEHAV, V36, P58, DOI 10.1016/S1499-4046(06)60134-6; *COUNC SCI AFF COU, 1990, JAMA-J AM MED ASSOC, P426; Cranford R E, 1991, Law Med Health Care, V19, P13; Crayford T, 1997, BRIT MED J, V315, P1649, DOI 10.1136/bmj.315.7123.1649; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hamel Mary Beth, 1995, JAMA (Journal of the American Medical Association), V273, P1842, DOI 10.1001/jama.273.23.1842; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Howe A, 2002, J PUBLIC HEALTH MED, V24, P299, DOI 10.1093/pubmed/24.4.299; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jibaja ML, 2000, J CANCER EDUC, V15, P237; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kennedy MG, 2004, J COMMUN, V54, P287, DOI 10.1093/joc/54.2.287; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; *MULT SOC TASK FOR, 1995, NEW ENGL J MED, V330, P1572; *NIELS MED RES, 2000, REP TEL; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shapiro D, 2003, AIDS CARE, V15, P303, DOI 10.1080/0954012031000105360; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Walker WC, 1996, BRAIN INJURY, V10, P65	38	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1537	1539		10.1136/bmj.331.7531.1537	http://dx.doi.org/10.1136/bmj.331.7531.1537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373744	Bronze, Green Published			2022-12-28	WOS:000234351300025
J	Jackson, RB; Jobbagy, EG; Avissar, R; Roy, SB; Barrett, DJ; Cook, CW; Farley, KA; le Maitre, DC; McCarl, BA; Murray, BC				Jackson, RB; Jobbagy, EG; Avissar, R; Roy, SB; Barrett, DJ; Cook, CW; Farley, KA; le Maitre, DC; McCarl, BA; Murray, BC			Trading water for carbon with biological sequestration	SCIENCE			English	Article							GREENHOUSE-GAS MITIGATION; REGIONAL CLIMATE; US AGRICULTURE; LAND-USE; AFFORESTATION; VEGETATION; IMPACTS; TREES; GROUNDWATER; GRASSLAND	Carbon sequestration strategies highlight tree plantations without considering their full environmental consequences. We combined field research, synthesis of more than 600 observations, and climate and economic modeling to document substantial losses in stream flow, and increased soil salinization and acidification, with afforestation. Plantations decreased stream flow by 227 millimeters per year globally (52%), with 13% of streams drying completely for at least 1 year. Regional modeling of U.S. plantation scenarios suggests that climate feedbacks, are unlikely to offset such water losses and could exacerbate them. Plantations can help control groundwater recharge and upwelling but reduce stream flow and salinize and acidify some soils.	Duke Univ, Nicholas Sch Environm & Earth Sci, Dept Biol, Durham, NC 27708 USA; Duke Univ, Ctr Global Change, Durham, NC 27708 USA; Univ Nacl San Luis, IMASL, Grp Estudios Ambientales, RA-5700 San Luis, Argentina; Consejo Nacl Invest Cient & Tecn, RA-5700 San Luis, Argentina; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; CSIRO Land & Water, Canberra, ACT 2601, Australia; CSIR, ZA-7599 Stellenbosch, South Africa; Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA; Res Triangle Inst, Ctr Regulatory Econ & Policy Res, Res Triangle Pk, NC 27709 USA	Duke University; Duke University; Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Council for Scientific & Industrial Research (CSIR) - South Africa; Texas A&M University System; Texas A&M University College Station; Research Triangle Institute	Jackson, RB (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Dept Biol, Durham, NC 27708 USA.	jackson@duke.edu	Jobbágy, Esteban Gabriel/A-6293-2010; McCarl, Bruce A/E-9445-2011; Barrett, Damian J/C-7972-2009; Le Maitre, David/M-8791-2015	Jobbágy, Esteban Gabriel/0000-0002-4214-6011; Barrett, Damian J/0000-0002-8215-4892; Le Maitre, David/0000-0003-1037-6637; Baidya Roy, Somnath/0000-0002-7677-4972; Jackson, Robert/0000-0001-8846-7147				Adams DM, 1996, PNWRP495 USDA FOR SE; Cannell MGR, 1999, NEW FOREST, V17, P239, DOI 10.1023/A:1006551018221; Cotton WR, 2003, METEOROL ATMOS PHYS, V82, P5, DOI 10.1007/s00703-001-0584-9; DICKINSON RE, 1992, GEOPHYS RES LETT, V19, P1947, DOI 10.1029/92GL01905; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; George RJ, 1999, AGR WATER MANAGE, V39, P91, DOI 10.1016/S0378-3774(98)00073-0; Heuperman A, 1999, AGR WATER MANAGE, V39, P153, DOI 10.1016/S0378-3774(98)00076-6; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jobbagy EG, 2004, GLOBAL CHANGE BIOL, V10, P1299, DOI 10.1111/j.1365-2486.2004.00806.x; Le Maitre DC, 1999, WATER SA, V25, P137; McCarl BA, 2001, SCIENCE, V294, P2481, DOI 10.1126/science.1064193; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pattanayak SK, 2005, CLIMATIC CHANGE, V71, P341, DOI 10.1007/s10584-005-5925-0; Pearce A. J., 1979, J HYDROLOGY NZ, V18, P73; PIELKE RA, 1990, LANDSCAPE ECOL, V4, P133, DOI 10.1007/BF00132857; Plantinga AJ, 2003, LAND ECON, V79, P74, DOI 10.2307/3147106; Roy SB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000266; Sapanov MK, 2000, EURASIAN SOIL SCI+, V33, P1157; Scott DF, 1997, J HYDROL, V199, P360, DOI 10.1016/S0022-1694(96)03336-7; VITOUSEK PM, 1991, J ENVIRON QUAL, V20, P348, DOI 10.2134/jeq1991.00472425002000020003x; Walker GR, 2002, HYDROGEOL J, V10, P68, DOI 10.1007/s10040-001-0181-5; Wright JA, 2000, J FOREST, V98, P20; Xue YK, 1996, J GEOPHYS RES-ATMOS, V101, P7419, DOI 10.1029/95JD02169; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	28	835	897	32	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1944	1947		10.1126/science.1119282	http://dx.doi.org/10.1126/science.1119282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373572				2022-12-28	WOS:000234275400039
J	Papadakis, MA; Teherani, A; Banach, MA; Knettler, TR; Rattner, SL; Stern, DT; Veloski, JJ; Hodgson, CS				Papadakis, MA; Teherani, A; Banach, MA; Knettler, TR; Rattner, SL; Stern, DT; Veloski, JJ; Hodgson, CS			Disciplinary action by medical boards and prior behavior in medical school	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNPROFESSIONAL BEHAVIOR; MEASURING PROFESSIONALISM; STUDENTS; PERFORMANCE; COMPETENCE; EDUCATION	Background: Evidence supporting professionalism as a critical measure of competence in medical education is limited. In this case-control study, we investigated the association of disciplinary action against practicing physicians with prior unprofessional behavior in medical school. We also examined the specific types of behavior that are most predictive of disciplinary action against practicing physicians with unprofessional behavior in medical school. Methods: The study included 235 graduates of three medical schools who were disciplined by one of 40 state medical boards between 1990 and 2003 (case physicians). The 469 control physicians were matched with the case physicians according to medical school and graduation year. Predictor variables from medical school included the presence or absence of narratives describing unprofessional behavior, grades, standardized-test scores, and demographic characteristics. Narratives were assigned an overall rating for unprofessional behavior. Those that met the threshold for unprofessional behavior were further classified among eight types of behavior and assigned a severity rating (moderate to severe). Results: Disciplinary action by a medical board was strongly associated with prior unprofessional behavior in medical school (odds ratio, 3.0; 95 percent confidence interval, 1.9 to 4.8), for a population attributable risk of disciplinary action of 26 percent. The types of unprofessional behavior most strongly linked with disciplinary action were severe irresponsibility (odds ratio, 8.5; 95 percent confidence interval, 1.8 to 40.1) and severely diminished capacity for self-improvement (odds ratio, 3.1; 95 percent confidence interval, 1.2 to 8.2). Disciplinary action by a medical board was also associated with low scores on the Medical College Admission Test and poor grades in the first two years of medical school (1 percent and 7 percent population attributable risk, respectively), but the association with these variables was less strong than that with unprofessional behavior. Conclusions: In this case-control study, disciplinary action among practicing physicians by medical boards was strongly associated with unprofessional behavior in medical school. Students with the strongest association were those who were described as irresponsible or as having diminished ability to improve their behavior. Professionalism should have a central role in medical academics and throughout one's medical career.	Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; Federat State Med Boards, Dallas, TX USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Colorado, Denver, CO 80202 USA; Hlth Sci Ctr, Denver, CO USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Jefferson University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Colorado System; University of Colorado Denver	Papadakis, MA (corresponding author), Univ Calif San Francisco, Sch Med, S-245,Box 0454, San Francisco, CA 94143 USA.	papadakm@medsch.ucsf.edu	Stern, David/E-8678-2016	Stern, David/0000-0001-9278-7303				*ACCR COUNC GRAD E, OUTC PROJ GEN COMP; *AM MED ASS, 2004, AM MED ASS PHYS MAST; Anderson MB, 1999, ACAD MED, V74, P13; Arnold L, 2002, ACAD MED, V77, P502, DOI 10.1097/00001888-200206000-00006; Arnold L, 2005, MEASURING MED PROFES, P24; Bransford J. D., 2000, PRINC STAND SCH MATH, P51; Brufee K. A., 1999, COLLABORATIVE LEARNI; Cohen JJ, 1999, ACAD MED, V74, P1010, DOI 10.1097/00001888-199909000-00014; Cruess SR, 1997, BRIT MED J, V315, P1674, DOI 10.1136/bmj.315.7123.1674; Cruess SR, 2004, TEACH LEARN MED, V16, P74, DOI 10.1207/s15328015tlm1601_15; Dannefer EF, 2005, MED EDUC, V39, P713, DOI 10.1111/j.1365-2929.2005.02193.x; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Eva KW, 2004, ACAD MED, V79, pS40, DOI 10.1097/00001888-200410001-00012; *FED STAT MED BOAR, DOCINFO PREM PHYS DI; *FED STAT MED BOAR, 2004, SUMM 2003 BOARD ACT; Ginsburg S, 2000, ACAD MED, V75, pS6, DOI 10.1097/00001888-200010001-00003; Glick TH, 2005, ACAD MED, V80, P147, DOI 10.1097/00001888-200502000-00008; HOJAT M, 1985, J MED EDUC, V60, P911; HOSMER DW, 1989, APPL LOGISTIC REGRES, P187; Kohatsu ND, 2004, ARCH INTERN MED, V164, P653, DOI 10.1001/archinte.164.6.653; Morrison J, 1998, JAMA-J AM MED ASSOC, V279, P1889, DOI 10.1001/jama.279.23.1889; *NAT RES COUNC, 2000, PEOPL LEARN, P49; Papadakis MA, 1999, ACAD MED, V74, P980, DOI 10.1097/00001888-199909000-00009; Papadakis MA, 2001, ACAD MED, V76, P1100, DOI 10.1097/00001888-200111000-00010; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stern DT, 2005, MED EDUC, V39, P75, DOI 10.1111/j.1365-2929.2004.02035.x; Teherani A, 2005, ACAD MED, V80, pS17, DOI 10.1097/00001888-200510001-00008; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014	31	481	487	2	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2673	2682		10.1056/NEJMsa052596	http://dx.doi.org/10.1056/NEJMsa052596			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	995IQ	16371633				2022-12-28	WOS:000234094400008
J	van Oort, BEH; Tyler, NJC; Gerkema, MP; Folkow, L; Blix, AS; Stokkan, KA				van Oort, BEH; Tyler, NJC; Gerkema, MP; Folkow, L; Blix, AS; Stokkan, KA			Circadian organization in reindeer	NATURE			English	Editorial Material							MELATONIN		Univ Tromso, Dept Arctic Biol, N-9037 Tromso, Norway; Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; Univ Tromso, Ctr Sami Studies, N-9037 Tromso, Norway; Univ Groningen, Dept Chronobiol, NL-9750 AA Haren, Netherlands	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Groningen	van Oort, BEH (corresponding author), Univ Tromso, Dept Arctic Biol, N-9037 Tromso, Norway.	karlarne@fagmed.uit.no	van Oort, Bob/J-8617-2016; gerkema, menno/GLN-3200-2022; Jansen, Heiko T./A-5770-2008	van Oort, Bob/0000-0001-9508-1162; Jansen, Heiko T./0000-0003-0178-396X				Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; De Mairan J., 1729, HIST ACAD ROY SCI, P35; Gerkema M. P., 2002, P207; HAU M, 1995, PHYSIOL BEHAV, V58, P89, DOI 10.1016/0031-9384(95)00002-Z; Hut RA, 2002, J COMP PHYSIOL B, V172, P59; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; STOKKAN KA, 1994, CAN J ZOOL, V72, P904, DOI 10.1139/z94-123; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264	9	123	126	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1095	1096		10.1038/4381095a	http://dx.doi.org/10.1038/4381095a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371996				2022-12-28	WOS:000234111500033
J	Pain, MT; Pain, MA				Pain, MT; Pain, MA			Essay - Risk taking in sport	LANCET			English	Article									Loughborough Univ Technol, Sch Sport & Exercise Sci, Loughborough LE11 3TU, Leics, England	Loughborough University	Pain, MT (corresponding author), Loughborough Univ Technol, Sch Sport & Exercise Sci, Loughborough LE11 3TU, Leics, England.	m.t.g.pain@lboro.ac.uk						BREASHEARS D, 2003, HIGH EXPOSURE; WICKWIRE J, 1999, ADDICTED DANGER AFFI	2	54	55	2	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S33	S34		10.1016/S0140-6736(05)67838-5	http://dx.doi.org/10.1016/S0140-6736(05)67838-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360743				2022-12-28	WOS:000234374400021
J	Pincock, S				Pincock, S			Feature - Gene doping	LANCET			English	Article											Pincock, S (corresponding author), 105 Red Sq, London N16 9AG, England.	stephenpincock@blueyonder.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	6	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S18	S19		10.1016/S0140-6736(05)67829-4	http://dx.doi.org/10.1016/S0140-6736(05)67829-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360733				2022-12-28	WOS:000234374400012
J	Kaaret, P; Simet, MG; Lang, CC				Kaaret, P; Simet, MG; Lang, CC			The orbital period of the ultraluminous X-ray source in M82	SCIENCE			English	Article							BLACK-HOLES; STAR-CLUSTERS; EVOLUTION		Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	University of Iowa	Kaaret, P (corresponding author), Univ Iowa, Dept Phys & Astron, Van Allen Hall, Iowa City, IA 52242 USA.	philip-kaaret@uiowa.edu	Simet, Melanie/A-3415-2016	Simet, Melanie/0000-0001-8823-8926				Boyd PT, 2001, ASTROPHYS J, V555, P822, DOI 10.1086/321511; BRADT HV, 1993, ASTRON ASTROPHYS SUP, V97, P355; Colbert EJM, 1999, ASTROPHYS J, V519, P89, DOI 10.1086/307356; Corbet RHD, 2003, ASTROPHYS J, V595, P1086, DOI 10.1086/377469; ELSNER RF, 1980, ASTROPHYS J, V239, P335, DOI 10.1086/158115; Frank J., 1992, ACCRETION POWER ASTR, V2nd edn.; HORNE JH, 1986, ASTROPHYS J, V302, P757, DOI 10.1086/164037; Kaaret P, 2004, MON NOT R ASTRON SOC, V348, pL28, DOI 10.1111/j.1365-2966.2004.07516.x; Kaaret P, 2001, MON NOT R ASTRON SOC, V321, pL29, DOI 10.1046/j.1365-8711.2001.04064.x; Li XD, 2004, ASTROPHYS J, V616, pL119, DOI 10.1086/426669; McCrady N, 2003, ASTROPHYS J, V596, P240, DOI 10.1086/377631; Portegies Zwart S, 2004, MON NOT R ASTRON SOC, V355, P413, DOI 10.1111/j.1365-2966.2004.08327.x; Ptak A, 1999, ASTROPHYS J, V517, pL85, DOI 10.1086/312032; SMITH DM, 2002, ASTROPHYS J, V578, pL132; Strohmayer TE, 2003, ASTROPHYS J, V586, pL61, DOI 10.1086/374732; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	16	28	28	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					491	491		10.1126/science.1121067	http://dx.doi.org/10.1126/science.1121067			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16400109	Green Submitted			2022-12-28	WOS:000235071400037
J	Legood, R; Gray, A; Wolstenholme, J; Moss, S				Legood, R; Gray, A; Wolstenholme, J; Moss, S			Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CERVICAL-CANCER; STRATEGIES; TRIAGE	Objectives To predict the incremental lifetime effects, costs, and cost effectiveness of using human papillomavirus testing to triage women with borderline or mildly dyskaryotic cervical smear results for immediate colposcopy. Design Modelling study. Setting Three centres participating in NHS pilot studies, United Kingdom. Population Women aged 25-64 with borderline or mildly dyskaryotic cervical smear results. Interventions Screening using conventional cytology, liquid based cytology, and four strategies with different age cut-off points and follow-up times that used combined liquid based cytology and human papillomavirus testing (adjunctive human papillornavirus testing). Results The model predicts that compared with using conventional cytology without testing for human papillornavirus, testing for the virus in conjunction with liquid based cytology for women (aged 35 or more) with borderline or mildly dyskaryotic cervical smear results would cost 735 pound (E5528; $6474) per life year saved. Extending adjunctive human papillomavirus testing in combination with liquid based cytology to include women aged between 25 and 34 costs an additional 4233 pound per life year saved. Human papillornavirus testing is likely to reduce lifetime repeat smears by 52-86% but increase lifetime colposcopies by 64-138%. Conclusions Testing for human papillomavirus to manage all women with borderline or mildly dyskaryotic cervical smear results is likely to be cost effective. The predicted increase in lifetime colposcopies, however, deserves careful, consideration.	Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England	University of Oxford; University of London; Institute of Cancer Research - UK	Legood, R (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England.	rosa.legood@dphpc.ox.ac.uk	Legood, Rosa/GQZ-9121-2022	Legood, Rosa/0000-0003-2761-5227; Wolstenholme, Jane/0000-0001-7493-1850				ABRYN M, 2004, JNCI-J NATL CANCER I, V96, P280; *AG NAT ACCR EV SA, 2002, MAN PAT ABN SMEAR SE, P1; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; *DEP HLTH, 2003, STAT B DEP HLTH; DICKSON RJ, 1980, PRACTITIONER, V224, P899; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; *GB HM TREAS, 2003, GREEN BOOK APPR EV C; *GOV ACT DEP, 2003, LIF TABL FEM ENGL WA; KARNON J, HLTH EC, V12, P837; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; *LBC HPV CERV SCRE, IN PRESS BMJ; Moss S, 2006, BRIT MED J, V332, P83, DOI 10.1136/bmj.38701.440961.7C; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT AUD OFF, 1998, PERF NHS CERV SCREEN; Netten A., 2001, UNIT COSTS HLTH SOCI; NOORANI HZ, 2004, 40 CAN COORD OFF HLT; Payne N, 2000, Health Technol Assess, V4, P1; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Quinn M, 2001, CANC TRENDS ENGLAND; Sherlaw-Johnson C, 2004, BRIT J CANCER, V91, P84, DOI 10.1038/sj.bjc.6601884; *W MIDL CANC INT U, 2003, INV CERV CANC REL SU; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; WRIGHT TC, 2004, JAMA-J AM MED ASSOC, V287, P2120	27	44	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					79	83		10.1136/bmj.38698.458866.7C	http://dx.doi.org/10.1136/bmj.38698.458866.7C			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16399769	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000234777000017
J	Janjusevic, R; Abramovitch, RB; Martin, GB; Stebbins, CE				Janjusevic, R; Abramovitch, RB; Martin, GB; Stebbins, CE			A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase	SCIENCE			English	Article							PTO-MEDIATED RESISTANCE; III SECRETION; U-BOX; EFFECTOR; DISEASE; DELIVERY; AVRPTOB; SCF	The Pseudomonas syringae protein AvrPtoB is translocated into plant cells, where it inhibits immunity-associated programmed cell. death (PCD). The structure of a C-terminal domain of AvrPtoB that is essential for anti-PCD activity reveals an unexpected homology to the U-box and RING-finger components of eukaryotic E3 ubiquitin ligases, and we show that AvrPtoB has ubiquitin ligase activity. Mutation of conserved residues involved in the binding of E2 ubiquitin-conjugating enzymes abolishes this activity in vitro, as well as anti-PCD activity in tomato leaves, which dramatically decreases virulence. These results show that Pseudomonas syringae uses a mimic of host E3 ubiquitin ligases to inactivate plant defenses.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Rockefeller University; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu; stebbins@rockefeller.edu	Abramovitch, Robert/O-6798-2019; Abramovitch, Robert B/A-5324-2013; Stebbins, Erec/N-2565-2018; Martin, Gregory B/F-6262-2011	Abramovitch, Robert/0000-0002-4119-4169; Stebbins, Erec/0000-0001-6229-5308; Martin, Gregory B/0000-0003-0044-6830				Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cornelis GR, 2000, PHILOS T R SOC B, V355, P681, DOI 10.1098/rstb.2000.0608; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Estelle M, 2001, CURR OPIN PLANT BIOL, V4, P254, DOI 10.1016/S1369-5266(00)00169-2; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Imai N, 2003, J VIROL, V77, P923, DOI 10.1128/JVI.77.2.923-930.2003; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Tzfira T, 2004, NATURE, V431, P87, DOI 10.1038/nature02857; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zaharik ML, 2002, INT J MED MICROBIOL, V291, P593, DOI 10.1078/1438-4221-00179; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	263	279	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					222	226		10.1126/science.1120131	http://dx.doi.org/10.1126/science.1120131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16373536				2022-12-28	WOS:000234722200040
J	Lee, HX; Ambrosio, AL; Reversade, B; De Robertis, EM				Lee, HX; Ambrosio, AL; Reversade, B; De Robertis, EM			Embryonic dorsal-ventral signaling: Secreted Frizzled-related proteins as inhibitors of tolloid proteinases	CELL			English	Article							NEGATIVE FEEDBACK REGULATOR; PATTERN-FORMATION; ZEBRAFISH; CHORDIN; FAMILY; METALLOPROTEASE; ANTAGONIST; ACTIVATION; BINDING; DOMAIN	Here we report an unexpected role for the secreted Frizzled-related protein (sFRP) Sizzled/Ogon as an inhibitor of the extracellular proteolytic reaction that controls BMP signaling during Xenopus gastrulation. Microinjection experiments suggest that the Frizzled domain of Sizzled regulates the activity of Xolloid-related (Xlr), a metalloproteinase that degrades Chordin, through the following molecular pathway: Szl Xlr I Chd d BMP -> P-Smad1 -> Szl. In biochemical assays, the Xlr proteinase has similar affinities for its endogenous substrate Chordin and for its competitive inhibitor Sizzled, which is resistant to enzyme digestion. Extracellular levels of Sizzled and Chordin in the gastrula embryo and enzyme reaction constants were all in the 10(-8) M range, consistent with a physiological role in the regulation of dorsal-ventral patterning. Sizzled is also a natural inhibitor of BMP1, a Tolloid metalloproteinase of medical interest. Furthermore, mouse sFRP2 inhibited Xlr, suggesting a wider role for this molecular mechanism.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		Lee, Hojoon/0000-0001-6214-629X; REVERSADE, Bruno/0000-0002-4070-7997	NICHD NIH HHS [R37 HD021502, R37 HD021502-19, R37 HD21502-19] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; BYERS PH, 2001, METABOLIC MOL BASES, P5241; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dixon M., 1979, ENZYMES, Vthird; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Hammerschmidt M, 2002, RES PRO CEL, V40, P72; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Miller-Bertaglio V, 1999, DEV BIOL, V214, P72, DOI 10.1006/dbio.1999.9384; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Povelones M, 2005, EMBO J, V24, P3493, DOI 10.1038/sj.emboj.7600817; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rehn M, 1998, TRENDS BIOCHEM SCI, V23, P415, DOI 10.1016/S0968-0004(98)01290-0; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Salic AN, 1997, DEVELOPMENT, V124, P4739; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; STOCKER W, 1995, PROTEIN SCI, V4, P823; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506	42	177	193	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					147	159		10.1016/j.cell.2005.12.018	http://dx.doi.org/10.1016/j.cell.2005.12.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413488	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000234969600016
J	Li, G; Luo, ZX				Li, G; Luo, ZX			A Cretaceous symmetrodont therian with some monotreme-like postcranial features	NATURE			English	Article							MAMMALIAN EVOLUTION; MESOZOIC MAMMALS; SKELETON; CHINA	A new spalacotheriid mammal preserved with a complete postcranium and a partial skull has been discovered from the Yixian Formation(1-3) of Liaoning, China. Spalacotheroid symmetrodonts(4-11) are relatives to modern therians ( combined group of marsupials and placentals) and are characterized by many skeletal apomorphies of therians. But unlike the closely related spalacotheroids and living therians, this new mammal revealed some surprisingly convergent features to monotremes in the lumbar vertebrae, pelvis and hindlimb(12,13). These peculiar features may have developed as functional convergence to locomotory features of monotremes, or the presence of lumbar ribs in this newly discovered mammal and their absence in its close relatives might be due to evolutionary developmental homoplasy. Analysis including this new taxon suggests that spalacotheroids evolved earlier in Eurasia and then dispersed to North America, in concordance with prevailing geodispersal patterns of several common mammalian groups during the Early Cretaceous period.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Nanjing Univ, Dept Earth Sci, Nanjing 200017, Peoples R China; Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China	Nanjing University; Chinese Academy of Sciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021					Averianov AO, 2003, CRETACEOUS RES, V24, P171, DOI 10.1016/S0195-6671(03)00037-5; CIFELLI CL, 1999, GEODIVERSITAS, V21, P167; Clemens William A., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V77, P175; Gambaryan Petr P., 2002, Russian Journal of Theriology, V1, P1; Gill P, 2004, J VERTEBR PALEONTOL, V24, P748, DOI 10.1671/0272-4634(2004)024[0748:ANSFTE]2.0.CO;2; Hu YM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)475[0001:ANSSFT]2.0.CO;2; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Ji Q., 2004, MESOZOIC JEHOL BIOTA; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Lieberman BS, 2003, ANNU REV ECOL EVOL S, V34, P51, DOI 10.1146/annurev.ecolsys.34.121101.153549; Luo Zhe-Xi, 2005, Journal of Mammalian Evolution, V12, P337, DOI 10.1007/s10914-005-6958-x; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; PRIDMORE PA, 1985, J ZOOL, V205, P53; Reilly SM, 2003, SCIENCE, V299, P400, DOI 10.1126/science.1074905; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; SUES HD, 1983, THESIS HARVARD U; Tsubamoto T, 2004, ACTA PALAEONTOL POL, V49, P329; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; 陈丕基, 2004, [中国科学. D辑, 地球科学, Science in China], V34, P883	30	77	86	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					195	200		10.1038/nature04168	http://dx.doi.org/10.1038/nature04168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407951				2022-12-28	WOS:000234538400038
J	Gulbis, AAS; Elliot, JL; Person, MJ; Adams, ER; Babcock, BA; Emilio, M; Gangestad, JW; Kern, SD; Kramer, EA; Osip, DJ; Pasachoff, JM; Souza, SP; Tuvikene, T				Gulbis, AAS; Elliot, JL; Person, MJ; Adams, ER; Babcock, BA; Emilio, M; Gangestad, JW; Kern, SD; Kramer, EA; Osip, DJ; Pasachoff, JM; Souza, SP; Tuvikene, T			Charon's radius and atmospheric constraints from observations of a stellar occultation	NATURE			English	Article							PLUTOS ATMOSPHERE; MASS-RATIO; WATER ICE; ORIGIN	The physical characteristics of Pluto and its moon, Charon, provide insight into the evolution of the outer Solar System. Although previous measurements have constrained the masses of these bodies(1,2), their radii and densities have remained uncertain. The observation of a stellar occultation by Charon in 1980 established a lower limit on its radius of 600 km (ref. 3) ( later refined to 601.5 km; ref. 4) and suggested a possible atmosphere(4). Subsequent, mutual event modelling yielded a range of 600 650-km (ref. 5), corresponding to a density of 1.56 +/- 0.22 g cm(-3) (refs 2, 5). Here we report multiple-station observations of a stellar occultation by Charon. From these data, we find a mean radius of 606 +/- 8 km, a bulk density of 1.72 +/- 0.15 g cm(-3), and rock-mass fraction 0.63 +/- 0.05. We do not detect a significant atmosphere and place 3 sigma upper limits on atmospheric number densities for candidate gases. These results seem to be consistent with collisional formation for the Pluto - Charon system in which the precursor objects may have been differentiated(6), and they leave open the possibility of atmospheric retention by the largest objects in the outer Solar System.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; Lowell Observ, Flagstaff, AZ 86001 USA; Williams Coll, Dept Phys, Williamstown, MA 01267 USA; Williams Coll, Dept Astron, Williamstown, MA 01267 USA; Univ catolica Norte, Inst Astron, Antofagasta, Chile; Univ Estadual Ponta Grossa, Dept Geociencia, Ponta Grossa, Parana, Brazil; Carnegie Observ, Las Campanas Observ, La Serena, Chile; Vrije Univ Brussels, Brussels, Belgium	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Williams College; Williams College; Universidad Catolica del Norte; Universidade Estadual de Ponta Grossa; Carnegie Institution for Science; Vrije Universiteit Brussel	Gulbis, AAS (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	gulbis@mit.edu	Souza, Steven P/T-4303-2018; Emilio, Marcelo/C-4118-2011	Emilio, Marcelo/0000-0001-5589-9015; Tuvikene, Taavi/0000-0001-7501-5352; Adams, Elisabeth/0000-0002-9131-5969; Sickafoose, Amanda/0000-0002-9468-7477				BARTHOLDI P, 1972, ASTRON J, V77, P60, DOI 10.1086/111245; BROADFOOT AL, 1976, GEOPHYS RES LETT, V3, P577, DOI 10.1029/GL003i010p00577; BROWN ME, 2005, 8577 IAU; Buie MW, 2000, ICARUS, V148, P324, DOI 10.1006/icar.2000.6509; BUIE MW, 1987, NATURE, V329, P522, DOI 10.1038/329522a0; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; ELLIOT JL, 1991, ICARUS, V89, P244, DOI 10.1016/0019-1035(91)90176-T; Elliot JL, 2003, ASTRON J, V126, P1041, DOI 10.1086/375546; Elliot JL, 2003, NATURE, V424, P165, DOI 10.1038/nature01762; FRENCH RG, 1976, ASTRON J, V81, P445, DOI 10.1086/111905; MARCIALIS RL, 1987, SCIENCE, V237, P1349, DOI 10.1126/science.237.4820.1349; McDonald SW, 2000, ASTRON J, V120, P1599, DOI 10.1086/301543; McKinnon W. B., 1997, PLUTO CHARON, P295; MCKINNON WB, 1989, ASTROPHYS J, V344, pL41, DOI 10.1086/185526; Null GW, 1996, ASTRON J, V111, P1368, DOI 10.1086/117883; Olkin CB, 2003, ICARUS, V164, P254, DOI 10.1016/S0019-1035(03)00136-2; Pasachoff JM, 2005, ASTRON J, V129, P1718, DOI 10.1086/427963; ROUSH TL, 1994, ICARUS, V108, P243, DOI 10.1006/icar.1994.1059; Spencer JR, 2005, ICARUS, V176, P283, DOI 10.1016/j.icarus.2005.01.019; STERN SA, 1984, ICARUS, V57, P231, DOI 10.1016/0019-1035(84)90068-X; THOLEN DJ, 1997, PLUTO CHARON, P193; TRAFTON L, 1988, ICARUS, V74, P108, DOI 10.1016/0019-1035(88)90033-4; TRUJILLO CA, 2005, B AM ASTRON SOC, V37; *USNO, 2003, ASTR ALM YEAR 2005; Walker A. R, 1980, MNRAS, V192, P47; West C.J., 1933, INT CRITICAL TABLES; Yelle R.V., 1997, PLUTO CHARON PART 4, P347; YELLE RV, 1989, NATURE, V339, P288, DOI 10.1038/339288a0	28	47	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2006	439	7072					48	51		10.1038/nature04276	http://dx.doi.org/10.1038/nature04276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397492				2022-12-28	WOS:000234378700030
J	Lipner, RS; Bylsma, WH; Arnold, GK; Fortna, GS; Tooker, J; Cassel, CK				Lipner, RS; Bylsma, WH; Arnold, GK; Fortna, GS; Tooker, J; Cassel, CK			Who is maintaining certification in internal medicine - And why? A national survey 10 years after initial certification	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; QUALITY; RECERTIFICATION	Background: The American Board of Medical Specialties (ABMS) adopted a framework, called Maintenance of Certification (MOC), for all certifying boards to evaluate physicians' competence throughout their careers, with the goal of improving the quality of health care. The MOC participation rates of the American Board of Internal Medicine (ABIM) show that 23% of general internists and 14% of subspecialists choose not to renew their respective certificates. Objective: To study U.S. internists' perceptions about the forces driving them to maintain certification. Design: Mail survey. Setting: A nationally representative sample of certified internists in the United States. Participants: Physicians originally certified in internal medicine, a subspecialty, or an area of added qualifications in 1990, 1991, or 1992. Results: The overall rate of response to the survey was 51%. Although 91% of all participants are still working in internal medicine or its subspecialties, this percentage is notably lower among general internists (79%). Of those still working in the field of internal medicine or its subspecialties, approximately half report being required to maintain their specialty certificate by at least 1 employer, but only approximately one third of those who completed or enrolled in MOC report this requirement as a reason for participating. Those who completed or enrolled in MOC do so more for positive professional reasons than for monetary benefits or professional advancement. The most common reasons for not participating are the perceptions that it takes too much time, is too expensive, and is not required for employment. Limitations: Respondents were volunteers from an early cohort of diplomates entering the program, and those with less positive attitudes may have responded at higher rates. Results are based on self-reported data, and misconceptions about program requirements may have led to some inaccurate responses. Conclusions: The relatively large percentage of general internists who left internal medicine mostly to work in another medical field explains why rates of MOC participation for general internists seem lower than those for subspecialists (77% vs. 86%). Although positive professional reasons clearly have a compelling internal influence on program participation, it is less clear whether employers' requirements are an equally compelling external influence. Although half of all respondents report that MOC is required by 1 of their employers, only one third of those who participate in the program describe it as a reason for participating.	Amer Board Internal Med, Philadelphia, PA 19106 USA; Amer Coll Physicians, Philadelphia, PA USA	American Board of Internal Medicine; American College of Physicians	Lipner, RS (corresponding author), Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.							*ACCR COUNC GRAD M, GEN COMP; Accreditation Council for Graduate Medical Education, OUTC PROJ; American Board of Medical Specialties, MAINT CERT; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; GLASSOCK RJ, 1991, ANN INTERN MED, V114, P59, DOI 10.7326/0003-4819-114-1-59; HINTZE JL, 2000, PASS 2000 USERS GUID, P249; Institute of Medicine, 2001, CROSSING QUALITY CHA; KOHN KT, 1999, ERR IS HUM BUILD SAF; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; NORCINI JJ, 1985, ANN INTERN MED, V102, P385, DOI 10.7326/0003-4819-102-3-385; Weinberger SE, 2005, ANN INTERN MED, V142, P302, DOI 10.7326/0003-4819-142-4-200502150-00014	13	85	85	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					29	36		10.7326/0003-4819-144-1-200601030-00007	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389252				2022-12-28	WOS:000234474200004
J	Goodman, NW				Goodman, NW			From Shakespeare to Star Trek and beyond: a Medline search for literary and other allusions in biomedical titles	BRITISH MEDICAL JOURNAL			English	Article								Objectives To document biomedical paper titles containing literary and other allusions. Design Retrospective survey. Setting Medline (1951 to mid-2005) through Dialog Datastar. Main outcome measure Allusions to Shakespeare, Hans Christian Andersen, proverbs, the Bible, Lewis Carroll, and movie titles, corrected and scaled for five year periods 1950-4 to 2000-4. Results More than 1400 Shakespearean allusions exist, a third of them to "What's in a name" and another third to Hamlet-mostly to "To be or not to be." The trend of increasing use of allusive titles, identified from Shakespeare and Andersen, is paralleled by allusions to Carroll and proverbs; the trend of biblical allusions is also upward but is more erratic. Trends for newer allusions are also upwards, including the previously surveyed "paradigm shift." Allusive titles are likely to be to editorial or comment rather than to original research. Conclusions The similar trends are presumably a mark of a particular learnt author behaviour. Newer allusions may be becoming more popular than older ones. Allusive titles can be unhelpful to reviewers and researchers, and many are now cliches. Whether they attract readers or citations is unknown, but better ways of gaining attention exist.	Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Goodman, NW (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.	Nev.W.Goodman@bris.ac.uk	pan, lin/AAP-3557-2021					Atkin PA, 2002, BRIT MED J, V325, P1450, DOI 10.1136/bmj.325.7378.1450; DEBAKEY S, 1983, INT J CARDIOL, V2, P401, DOI 10.1016/0167-5273(83)90012-8; MITCHELL JRA, 1982, BRIT MED J, V285, P1140, DOI 10.1136/bmj.285.6349.1140; NONINO F, 2002, BMJ	4	7	8	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1540	1542		10.1136/bmj.331.7531.1540	http://dx.doi.org/10.1136/bmj.331.7531.1540			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	998WT	16373745	Green Published, Bronze			2022-12-28	WOS:000234351300026
J	Kutz, I				Kutz, I			Revisiting the lot of the first incestuous family: the biblical origins of shifting the blame on to female family members	BRITISH MEDICAL JOURNAL			English	Article							ABUSE		Meir Hosp, Consultat Liaison Unit, IL-44281 Kefar Sava, Israel; Shalvatah Psychiat Ctr, IL-44281 Kefar Sava, Israel	Tel Aviv University; Sackler Faculty of Medicine	Kutz, I (corresponding author), Meir Hosp, Consultat Liaison Unit, IL-44281 Kefar Sava, Israel.	ikutz@013.net.il						[Anonymous], 2000, FATHER DAUGHTER INCE; BENTOVIM A, 1987, BRIT MED J, V295, P1453, DOI 10.1136/bmj.295.6611.1453; Carlstedt A, 2001, ARCH SEX BEHAV, V30, P483, DOI 10.1023/A:1010287100679; DEMAUSE L, 1991, Journal of Psychohistory, V19, P123; FRIEDMAN RICHARD ELLIOTT, 1987, WHO WROTE BIBLE; RUSSEL DEH, 1999, SECRET TRAUMA INCEST; Sariola H, 1996, CHILD ABUSE NEGLECT, V20, P843, DOI 10.1016/0145-2134(96)00072-5	7	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1507	1508		10.1136/bmj.331.7531.1507	http://dx.doi.org/10.1136/bmj.331.7531.1507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373732	Green Published, Bronze			2022-12-28	WOS:000234351300012
J	Carvalho, J; Farkas, A				Carvalho, J; Farkas, A			Essay - Rehabilitation through sport - pilot project with amputees in Angola	LANCET			English	Article									Int Paralymp Comm, D-53113 Bonn, Germany; Univ Lisbon, Fac Human Kinet, P-1699 Lisbon, Portugal	Universidade de Lisboa	Farkas, A (corresponding author), Int Paralymp Comm, Adenauerallee 212-214, D-53113 Bonn, Germany.	Amy.farkas@paralympic.org							0	1	1	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S5	S6		10.1016/S0140-6736(05)67821-X	http://dx.doi.org/10.1016/S0140-6736(05)67821-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999FO	16360754				2022-12-28	WOS:000234374400004
J	Lellouch, E				Lellouch, E			Titan's zoo of clouds	SCIENCE			English	Editorial Material							HAZE		Observ Paris, F-92195 Meudon, France	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Lellouch, E (corresponding author), Observ Paris, F-92195 Meudon, France.	emmanuel.lellouch@obspm.fr						Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Hauglustaine DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003957; Lorenz RD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021415; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Rannou P, 2002, NATURE, V418, P853, DOI 10.1038/nature00961; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; Samuelson RE, 1997, PLANET SPACE SCI, V45, P941, DOI 10.1016/S0032-0633(97)00088-3; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126	14	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					186	187		10.1126/science.1122628	http://dx.doi.org/10.1126/science.1122628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410513				2022-12-28	WOS:000234722200028
J	Perrin, G; Woillez, J; Lai, O; Guerin, J; Kotani, T; Wizinowich, PL; Le Mignant, D; Hrynevych, M; Gathright, J; Lena, P; Chaffee, F; Vergnole, S; Delage, L; Reynaud, F; Adamson, AJ; Berthod, C; Brient, B; Collin, C; Cretenet, J; Dauny, F; Deleglise, C; Fedou, P; Goeltzenlichter, T; Guyon, O; Hulin, R; Marlot, C; Marteaud, M; Melse, BT; Nishikawa, J; Reess, JM; Ridgway, ST; Rigaut, F; Roth, K; Tokunaga, AT; Ziegler, D				Perrin, G; Woillez, J; Lai, O; Guerin, J; Kotani, T; Wizinowich, PL; Le Mignant, D; Hrynevych, M; Gathright, J; Lena, P; Chaffee, F; Vergnole, S; Delage, L; Reynaud, F; Adamson, AJ; Berthod, C; Brient, B; Collin, C; Cretenet, J; Dauny, F; Deleglise, C; Fedou, P; Goeltzenlichter, T; Guyon, O; Hulin, R; Marlot, C; Marteaud, M; Melse, BT; Nishikawa, J; Reess, JM; Ridgway, ST; Rigaut, F; Roth, K; Tokunaga, AT; Ziegler, D			Interferometric coupling of the Keck telescopes with single-mode fibers	SCIENCE			English	Article									Observ Paris, UMR 8109, LESIA, F-92190 Meudon, France; WM Keck Observ, Kamuela, HI 96743 USA; Canada France Hawaii Telescope Corp, Kamuela, HI 96743 USA; IRCOM, UMR 6615, F-87060 Limoges, France; United Kingdom Infrared Telescope, Hilo, HI 96720 USA; Inst Natl Sci Univers, Tech Div, F-92195 Meudon, France; Observ Paris, UMR 8111, F-92190 Meudon, France; Subaru Telescope, Hilo, HI 96720 USA; Natl Astron Observ Japan, Tokyo 1818588, Japan; Natl Opt Astron Observ, Tucson, AZ 85719 USA; Gemini Observ, Hilo, HI 96720 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Canada France Hawaii Telescope; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Optical Astronomy Observatory; University of Hawaii System	Perrin, G (corresponding author), Observ Paris, UMR 8109, LESIA, F-92190 Meudon, France.	guy.perrin@obspm.fr	Léna, Pierre/AAD-1909-2021; Guyon, Olivier/N-4719-2019; Rigaut, Francois/R-6116-2019; Lai, Olivier/R-1257-2017	Guyon, Olivier/0000-0002-1097-9908; Rigaut, Francois/0000-0003-3490-7121; adamson, andrew/0000-0003-1120-5178; Tokunaga, Alan/0000-0001-8136-9704; Vergnole, Sebastien/0000-0002-6150-1920; Lai, Olivier/0000-0001-5656-7346; Delage, Laurent/0000-0002-1476-9764; Perrin, Guy/0000-0003-0680-0167; LE MIGNANT, David/0000-0002-5339-5515				Colavita MM, 2004, P SOC PHOTO-OPT INS, V5491, P454, DOI 10.1117/12.552149; Froehly C, 1981, SCI IMPORTANCE HIGH, P285; Kotani T, 2005, APPL OPTICS, V44, P5029, DOI 10.1364/AO.44.005029; Mariotti JM, 1996, ASTRON ASTROPHYS SUP, V116, P381, DOI 10.1051/aas:1996121; MILLANGABET R, COMMUNICATION; Wizinowich P, 2000, PUBL ASTRON SOC PAC, V112, P315, DOI 10.1086/316543	6	41	41	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					194	194		10.1126/science.1120249	http://dx.doi.org/10.1126/science.1120249			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410516				2022-12-28	WOS:000234722200031
J	Relman, DA				Relman, DA			Bioterrorism - Preparing to fight the next war	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.			Relman, David A./0000-0001-8331-1354				Hirschberg R, 2004, NEW ENGL J MED, V350, P2119, DOI 10.1056/NEJMp048123; Petro James B, 2003, Biosecur Bioterror, V1, P161, DOI 10.1089/153871303769201815; Petro JB, 2003, SCIENCE, V302, P1898, DOI 10.1126/science.1092493; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061	5	21	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					113	115		10.1056/NEJMp058078	http://dx.doi.org/10.1056/NEJMp058078			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	001JE	16407505				2022-12-28	WOS:000234528600002
J	Chakraborty, A				Chakraborty, A			The nursing profession's coming of age - My experience of nurse practitioners	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												anjan@blueyonder.co.uk						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51-d	http://dx.doi.org/10.1136/bmj.332.7532.51-d			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399747	Green Published			2022-12-28	WOS:000234684200033
J	Coull, RS				Coull, RS			The nursing profession's coming of age - The death of nursing, the dumbing down of medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												locum@coull.net						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51-a	http://dx.doi.org/10.1136/bmj.332.7532.51-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399750	Green Published			2022-12-28	WOS:000234684200030
J	Geddes, J				Geddes, J			Commentary: Bipolar disorder-services need to catch up with rapidly developing evidence base	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEEKLY SYMPTOMATIC STATUS; NATURAL-HISTORY; LITHIUM		Univ Oxford, Warneford Hosp, Oxford OX10 0RU, England	University of Oxford	Geddes, J (corresponding author), Univ Oxford, Warneford Hosp, Oxford OX10 0RU, England.	john.geddes@psych.ox.ac.uk		Geddes, John/0000-0002-5281-5960				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Clement S, 2003, BRIT J PSYCHIAT, V182, P148, DOI 10.1192/bjp.182.2.148; Geddes John, 2005, Clin Evid, P1158; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Gijsman HJ, 2004, AM J PSYCHIAT, V161, P1537, DOI 10.1176/appi.ajp.161.9.1537; Goodwin GM, 2003, J PSYCHOPHARMACOL, V17, P149, DOI 10.1177/0269881103017002003; Johnston SG, 2006, BMJ-BRIT MED J, V332, P30, DOI 10.1136/bmj.332.7532.30; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Morriss R, 2002, BRIT MED J, V324, P61, DOI 10.1136/bmj.324.7329.61; *NAT COLL CTR MENT, BIP DIS MAN BIP DIS; Simon GE, 2005, PSYCHOL MED, V35, P13, DOI 10.1017/S0033291704002624	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					32	33		10.1136/bmj.332.7532.32	http://dx.doi.org/10.1136/bmj.332.7532.32			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399735	Green Published			2022-12-28	WOS:000234684200019
J	Goadsby, PJ				Goadsby, PJ			Recent advances in the diagnosis and management of migraine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BRAIN-STEM ACTIVATION; FAMILIAL HEMIPLEGIC MIGRAINE; EXTRACEREBRAL CIRCULATION; HEADACHE; PAIN; TOPIRAMATE; PREVENTION; RELEASE; HUMANS		UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Goadsby, PJ (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Goadsby, Peter J/B-2267-2009; Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Davies GM, 2000, CEPHALALGIA, V20, P554, DOI 10.1046/j.1468-2982.2000.00082.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Denuelle M, 2004, CEPHALALGIA, V24, P782; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Ferrari MD, 2002, CEPHALALGIA, V22, P633, DOI 10.1046/j.1468-2982.2002.00404.x; Goadsby P, 2004, BMJ-BRIT MED J, V329, P469, DOI 10.1136/bmj.329.7464.469; Goadsby PJ, 2000, PROG NEUROBIOL, V62, P509, DOI 10.1016/S0301-0082(00)00010-1; Goadsby PJ, 2002, J NEUROL NEUROSUR PS, V72, P2; GOADSBY PJ, 1991, HEADACHE, V31, P365, DOI 10.1111/j.1526-4610.1991.hed3106365.x; GOADSBY PJ, 1988, ANN NEUROL, V23, P193, DOI 10.1002/ana.410230214; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; GOADSBY PJ, HORIZONS MED, V17; Goadsby PJ, 2005, CHRONIC DAILY HEADAC; Lance J., 1981, PHYSL APPROACH CLIN; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; LIPTON RB, 2004, J HEADACHE PAIN, V5, P123, DOI DOI 10.1007/S10194-004-0080-Y; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; MATHARU MS, IN PRESS ANN NEUROL; May A, 1999, ANN NEUROL, V46, P791, DOI 10.1002/1531-8249(199911)46:5<791::AID-ANA18>3.0.CO;2-8; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; May A, 1999, CEPHALALGIA, V19, P464; May A, 2001, J CEREBR BLOOD F MET, V21, P1171, DOI 10.1097/00004647-200110000-00005; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Silberstein SD, 2004, ARCH NEUROL-CHICAGO, V61, P490, DOI 10.1001/archneur.61.4.490; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2002, CEPHALALGIA, V22, P491, DOI 10.1046/j.1468-2982.2002.00386.x; Tepper SJ, 2004, HEADACHE, V44, P856, DOI 10.1111/j.1526-4610.2004.04167.x; Tfelt-Hansen P, 1998, CEPHALALGIA, V18, P532, DOI 10.1046/j.1468-2982.1998.1808532.x; Tfelt-Hansen P, 2000, DRUGS, V60, P1259, DOI 10.2165/00003495-200060060-00003; Tfelt-Hansen P, 2000, BRAIN, V123, P9, DOI 10.1093/brain/123.1.9; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658	38	36	49	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					25	29		10.1136/bmj.332.7532.25	http://dx.doi.org/10.1136/bmj.332.7532.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399733	Green Published			2022-12-28	WOS:000234684200017
J	Huang, XC; McCoy, AB; Bowman, JM; Johnson, LM; Savage, C; Dong, F; Nesbitt, DJ				Huang, XC; McCoy, AB; Bowman, JM; Johnson, LM; Savage, C; Dong, F; Nesbitt, DJ			Quantum deconstruction of the infrared spectrum of CH5+	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACE; PROTONATED METHANE; GAS-PHASE; DYNAMICS; IONS; ENERGETICS; CHEMISTRY; CLUSTER; STORY	We present two quantum calculations of the infrared spectrum of protonated methane (CH5+) using fult-dimensional, ab initio-based potential energy and dipole moment surfaces. The calculated spectra compare well with a tow-resolution experimental spectrum except below 1000 cm(-1), where the experimental spectrum shows no absorption. The present calculations find substantial absorption features below 1000 cm(-1), in qualitative agreement with earlier classical calculations of the spectrum. The major spectral. bands are analyzed in terms of the molecular motions. of particular interest is an intense feature at 200 cm(-1), which is due to an isomerization mode that connects two equivalent minima. Very recent high-resolution jet-cooled spectra in the CH stretch region (2825 to 3050 cm(-1)) are also reported, and assignments of the band origins are made, based on the present quantum calculations.	Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Emory Univ, Cherry L Emerson Ctr Sci Comp, Atlanta, GA 30322 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University System of Ohio; Ohio State University; Emory University; Emory University	McCoy, AB (corresponding author), Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA.	mccoy@chemistry.ohio-state.edu; jmbowma@emory.edu; djn@jila.colorado.edu	HUANG, XINCHUAN/A-3266-2013	HUANG, XINCHUAN/0000-0003-2458-5050				Asvany O, 2005, SCIENCE, V309, P1219, DOI 10.1126/science.1113729; BOO DW, 1995, SCIENCE, V269, P57, DOI 10.1126/science.269.5220.57; Bowman JM, 2003, INT REV PHYS CHEM, V22, P533, DOI 10.1080/0144235031000124163; Brown A, 2004, J CHEM PHYS, V121, P4105, DOI 10.1063/1.1775767; Brown A, 2003, J CHEM PHYS, V119, P8790, DOI 10.1063/1.1622379; Bunker PR, 2004, J MOL STRUCT, V695, P253, DOI 10.1016/j.molstruc.2003.12.020; Deskevich MP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940613; Dong F, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1924699; Hammer NI, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1927522; HIRAOKA K, 1989, CHEM PHYS LETT, V161, P111, DOI 10.1016/0009-2614(89)85040-7; HIRAOKA K, 1975, J AM CHEM SOC, V97, P4179, DOI 10.1021/ja00848a005; HUANG X, UNPUB; JIN Z, IN PRESS J PHYS CH A; KOMORNICKI A, 1987, J CHEM PHYS, V86, P5625, DOI 10.1063/1.452539; Marx D, 1996, SCIENCE, V271, P179, DOI 10.1126/science.271.5246.179; MARX D, 1995, NATURE, V375, P216, DOI 10.1038/375216a0; Marx D, 1997, Z PHYS D ATOM MOL CL, V41, P253, DOI 10.1007/s004600050320; McCoy AB, 2004, J PHYS CHEM A, V108, P4991, DOI 10.1021/jp0487096; Muller H, 1997, J CHEM PHYS, V106, P1863, DOI 10.1063/1.473340; Olah GA, 1997, ACCOUNTS CHEM RES, V30, P245, DOI 10.1021/ar960103f; Savage C., 2005, 60 INT S MOL SPECTR; SAYKALLY RJ, 1988, SCIENCE, V239, P157, DOI 10.1126/science.239.4836.157; SCHLEYER PV, 1992, J COMPUT CHEM, V13, P997, DOI 10.1002/jcc.540130810; Schreiner PR, 2000, ANGEW CHEM INT EDIT, V39, P3239, DOI 10.1002/1521-3773(20000915)39:18<3239::AID-ANIE3239>3.3.CO;2-F; SCHREINER PR, 1993, J CHEM PHYS, V99, P3716, DOI 10.1063/1.466147; Tal'roze V. L., 1952, DOKL AKAD NAUK SSSR, V86, P909; Thompson KC, 2005, J AM CHEM SOC, V127, P4954, DOI 10.1021/ja0482280; TSE JS, 1995, PHYS REV LETT, V74, P876, DOI 10.1103/PhysRevLett.74.876; White ET, 1999, SCIENCE, V284, P135, DOI 10.1126/science.284.5411.135	29	95	95	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					60	63		10.1126/science.1121166	http://dx.doi.org/10.1126/science.1121166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400143	Green Published			2022-12-28	WOS:000234546300031
J	Kossinets, G; Watts, DJ				Kossinets, G; Watts, DJ			Empirical analysis of an evolving social network	SCIENCE			English	Article								Social networks evolve over time, driven by the shared activities and affiliations of their members, by similarity of individuals' attributes, and by the closure of short network cycles. We analyzed a dynamic social network comprising 43,553 students, faculty, and staff at a large university, in which interactions between individuals are inferred from time-stamped e-mail headers recorded over one academic year and are matched with affiliations and attributes. We found that network evolution is dominated by a combination of effects arising from network topology itself and the organizational. structure in which the network is embedded. In the absence of global perturbations, average network properties appear to approach an equilibrium state, whereas individual properties are unstable.	Columbia Univ, Dept Sociol, New York, NY 10027 USA; Columbia Univ, Inst Social & Econ Res & Policy, New York, NY 10027 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Columbia University; Columbia University; The Santa Fe Institute	Kossinets, G (corresponding author), Columbia Univ, Dept Sociol, 420 W 118th St,MC 3355, New York, NY 10027 USA.	gk297@columbia.edu; djw24@columbia.edu	Watts, Duncan J/J-6483-2012					Baym NK, 2004, NEW MEDIA SOC, V6, P299, DOI 10.1177/1461444804041438; Blau P. M., 1984, CROSSCUTTING SOCIAL; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Coleman J., 1988, SOCIOL THEOR, V6, P52, DOI DOI 10.2307/201913; Cortes C, 2003, J COMPUT GRAPH STAT, V12, P950, DOI 10.1198/1061860032742; DAVIS JA, 1963, AM J SOCIOL, V68, P444, DOI 10.1086/223401; Dodds PS, 2003, P NATL ACAD SCI USA, V100, P12516, DOI 10.1073/pnas.1534702100; Doreian P., 1997, EVOLUTION SOCIAL NET; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HALLINAN MT, 1980, SOC FORCES, V59, P225, DOI 10.2307/2577842; HAMMER M, 1980, SOC NETWORKS, V2, P165, DOI 10.1016/0378-8733(79)90005-4; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Louch H, 2000, SOC NETWORKS, V22, P45, DOI 10.1016/S0378-8733(00)00015-0; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newcomb T.M, 1961, ACQUAINTANCE PROCESS; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; RAPOPORT ANATOL, 1953, BULL MATH BIOPHYS, V15, P523, DOI 10.1007/BF02476440; Valente T, 1995, NETWORK MODELS DIFFU; Wasserman, 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; WELLMAN B, 2003, INTERNET EVERYDAY LI	26	862	909	17	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					88	90		10.1126/science.1116869	http://dx.doi.org/10.1126/science.1116869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400149				2022-12-28	WOS:000234546300039
J	Dyhrman, ST; Chappell, PD; Haley, ST; Moffett, JW; Orchard, ED; Waterbury, JB; Webb, EA				Dyhrman, ST; Chappell, PD; Haley, ST; Moffett, JW; Orchard, ED; Waterbury, JB; Webb, EA			Phosphonate utilization by the globally important marine diazotroph Trichodesmium	NATURE			English	Article							FIXATION	The factors that control the growth and nitrogen fixation rates of marine diazotrophs such as Trichodesmium have been intensively studied because of the role that these processes have in the global cycling of carbon and nitrogen, and in the sequestration of carbon to the deep sea. Because the phosphate concentrations of many ocean gyres are low(1), the bioavailability of the larger, chemically heterogeneous pool of dissolved organic phosphorus could markedly influence Trichodesmium physiology. Here we describe the induction, by phosphorus stress, of genes from the Trichodesmium erythraeum IMS101 genome that are predicted to encode proteins associated with the high-affinity transport and hydrolysis of phosphonate compounds by a carbon - phosphorus lyase pathway. We show the importance of these genes through expression analyses with T. erythraeum from the Sargasso Sea. Phosphonates are known to be present in oligotrophic marine systems, but have not previously been considered to be bioavailable to marine diazotrophs. The apparent absence of genes encoding a carbon phosphorus lyase pathway in the other marine cyanobacterial genomes suggests that, relative to other phytoplankton, Trichodesmium is uniquely adapted for scavenging phosphorus from organic sources. This adaptation may help to explain the prevalence of Trichodesmium in low phosphate, oligotrophic systems.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Webb, EA (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ewebb@whoi.edu	Chappell, Phoebe Dreux/AAC-8771-2022; Chappell, P. Dreux/B-9339-2016	Chappell, Phoebe Dreux/0000-0001-5212-6228; Chappell, P. Dreux/0000-0001-5212-6228; Webb, Eric/0000-0003-4085-7730				Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, 10.1029/2003EO180001]; ARMSTRONG FA, 1966, NATURE, V211, P481, DOI 10.1038/211481a0; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Dyhrman ST, 2002, LIMNOL OCEANOGR, V47, P1832, DOI 10.4319/lo.2002.47.6.1832; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Karl D. M., 2002, BIOGEOCHEMISTRY MARI, P249, DOI DOI 10.1016/B978-012323841-2/50008-7]; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Lundgren P, 2005, APPL ENVIRON MICROB, V71, P190, DOI 10.1128/AEM.71.1.190-196.2005; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Paytan A, 2003, MAR CHEM, V82, P55, DOI 10.1016/S0304-4203(03)00052-5; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Stihl A, 2001, J PHYCOL, V37, P310, DOI 10.1046/j.1529-8817.2001.037002310.x; Wanner Barry L., 1994, Biodegradation, V5, P175, DOI 10.1007/BF00696458; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	24	400	434	14	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					68	71		10.1038/nature04203	http://dx.doi.org/10.1038/nature04203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397497				2022-12-28	WOS:000234378700035
J	Gore, J; Bryant, Z; Stone, MD; Nollmann, MN; Cozzarelli, NR; Bustamante, C				Gore, J; Bryant, Z; Stone, MD; Nollmann, MN; Cozzarelli, NR; Bustamante, C			Mechanochemical analysis of DNA gyrase using rotor bead tracking	NATURE			English	Article							C-TERMINAL DOMAIN; MYOSIN-V MOTOR; TOPOISOMERASES; MECHANISM; ELASTICITY; BINDING; MOLECULES; TRANSPORT; SUBSTEPS; PROTEIN	DNA gyrase is a molecular machine that uses the energy of ATP hydrolysis to introduce essential negative supercoils into DNA(1-3). The directionality of supercoiling is ensured by chiral wrapping of the DNA(4,5) around a specialized domain(6-9) of the enzyme before strand passage. Here we observe the activity of gyrase in real time by tracking the rotation of a submicrometre bead attached to the side of a stretched DNA molecule(10). In the presence of gyrase and ATP, we observe bursts of rotation corresponding to the processive, stepwise introduction of negative supercoils in strict multiples of two(11). Changes in DNA tension have no detectable effect on supercoiling velocity, but the enzyme becomes markedly less processive as tension is increased over a range of only a few tenths of piconewtons. This behaviour is quantitatively explained by a simple mechanochemical model in which processivity depends on a kinetic competition between dissociation and rapid, tension-sensitive DNA wrapping. In a high-resolution variant of our assay, we directly detect rotational pauses corresponding to two kinetic substeps: an ATP-independent step at the end of the reaction cycle, and an ATP-binding step in the middle of the cycle, subsequent to DNA wrapping.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Howard Hughes Med Inst, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ncozzare@berkeley.edu; carlos@alice.berkeley.edu		Nollmann, Marcelo/0000-0003-3339-2349; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071552, R37GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071552, R37 GM032543] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bates A. D., 2005, DNA TOPOLOGY; Block SM, 1998, J CELL BIOL, V140, P1281, DOI 10.1083/jcb.140.6.1281; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; PATO ML, 1990, P NATL ACAD SCI USA, V87, P8716, DOI 10.1073/pnas.87.22.8716; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	29	155	159	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					100	104		10.1038/nature04319	http://dx.doi.org/10.1038/nature04319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397501	Green Accepted			2022-12-28	WOS:000234378700042
J	Fargnoli, MC; Frascione, P				Fargnoli, MC; Frascione, P			Acanthosis nigricans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Aquila, I-67100 Laquila, Italy	University of L'Aquila	Fargnoli, MC (corresponding author), Univ Aquila, I-67100 Laquila, Italy.			Frascione, Pasquale/0000-0002-5592-8485; Fargnoli, Maria Concetta/0000-0002-7249-2556					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2797	2797		10.1056/NEJMicm050300	http://dx.doi.org/10.1056/NEJMicm050300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382066				2022-12-28	WOS:000234246700011
J	Zarin, DA; Tse, T; Ide, NC				Zarin, DA; Tse, T; Ide, NC			Trial registration at ClinicalTrials.Gov between May and October 2005	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGISTERING CLINICAL-TRIALS; MEDICAL LANGUAGE SYSTEM; INTERNATIONAL COMMITTEE; JOURNAL EDITORS; STATEMENT	Background Clinical trial registration allows interested parties to obtain information about ongoing and completed trials, but there are few data indicating the quality of the information provided during the registration process. We used information in the publicly available ClinicalTrials.gov database to describe patterns of trial registration before and after the implementation by journal editors of a new policy requiring registration as a prerequisite for publication. Methods We reviewed ClinicalTrials.gov records to determine patterns of completion of the "Intervention Name'' and "Primary Outcome Measure'' data fields for trials registered on May 20 and October 11, 2005, and for trials registered during the interval between these two dates, inclusively. Results During the interval studied, the number of registrations in ClinicalTrials.gov increased by 73 percent from 13,153 to 22,714. The percentage of interventional trials registered by industry with nonspecific Intervention Name entries (attributable to four drug companies) decreased from 10 percent to 2 percent; all other industry and nonindustry records contained specific entries in this field. Of the 2670 studies registered by industry between the two dates, 76 percent provided information in the Primary Outcome Measure field, although these entries varied markedly in their degree of specificity. In the remaining 24 percent of the records, this field was blank. Conclusions During the summer of 2005, there were large increases in the number of clinical trial registrations. Overall, the data contained in records were more complete in October than they were in May, but there still is room for substantial improvement.	NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bldg 38A,8600 Rockville Pike, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	Intramural NIH HHS [Z99 LM999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*AMA, 2004, AMA REC DHHS EST REG; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; *CLIN TRIALS, 2005, DAT EL DEF; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin Kay, 2004, Clin Trials, V1, P417, DOI 10.1191/1740774504cn039oa; *EFPIA, 2005, JOINT POS DISCL CLIN; Evans T, 2004, LANCET, V363, P1413, DOI 10.1016/S0140-6736(04)16136-9; *FDAMA, 2005, FDAMA SECT 113 STAT; FISHER CB, 2005, CLIN TRIALS REGISTRI; GILLEN JE, 2004, MEDINFO, V11, P1466; *HLTH IMS, 2005, IMS NAT SAL PERSP; *INT C HARM TECHN, 1995, ICH HARM TRIP GUID E; Kennedy D, 2004, SCIENCE, V306, P1649, DOI 10.1126/science.1107657; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; McCray AT, 2000, J AM MED INFORM ASSN, V7, P313, DOI 10.1136/jamia.2000.0070313; MCCRAY AT, 2004, MEDINFO, V11, P1152; *MED PROD OUTS, 2005, TOP 30 GLOB MED DEV; *PHRMA CLIN TRIAL, 2005, PHARM RES MAN AM; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Steinbrook R, 2004, NEW ENGL J MED, V351, P1820, DOI 10.1056/NEJMp048264; 2004, WASHINGTON POST 0630, pA20; 2004, NY TIMES        0606, P12	24	219	219	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2779	2787		10.1056/NEJMsa053234	http://dx.doi.org/10.1056/NEJMsa053234			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382064	Green Accepted			2022-12-28	WOS:000234246700009
J	Rapezzi, C; Ferrari, R; Branzi, A				Rapezzi, C; Ferrari, R; Branzi, A			White coats and fingerprints: diagnostic reasoning in medicine and investigative methods of fictional detectives	BRITISH MEDICAL JOURNAL			English	Article									Univ Bologna, Inst Cardiol, I-40126 Bologna, Italy; Univ Ferrara, I-44100 Ferrara, Italy; Salvatore Maugeri Fdn IRCCS, Cardiovasc Res Ctr, Pavia, Italy	University of Bologna; University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS	Rapezzi, C (corresponding author), Policlin S Orsola Malpighi, Ist Cardiol, Via Massarenti 9, I-40138 Bologna, Italy.	crapezzi@orsola-malpighi.med.unibo.it	FERRARI, ROBERTO/ABD-5169-2020	Ferrari, Roberto/0000-0003-2046-9175; Rapezzi, Claudio/0000-0002-9198-2657				Chandler Raymond, 1972, SIMPLE ART MURDER; Christie A., 1934, MURDER ORIENT EXPRES; CONAN DA, 1891, STRAND MAGAZINE  OCT; CONAN DA, 2002, STRAND MAGAZINE  AUG; CONAN DA, 1891, STRAND MAGAZINE  SEP; CONAN DA, 1892, STRAND MAGAZINE  DEC; CONAN DA, 1887, BEETONS CHRISTMAS AN; CONAN DA, 1891, STRAND MAGAZINE  JUL; DOYLE AC, 1890, SIGN 4; Eco U., 1983, SIGN 3 DUPIN HOLMES; HARTSHORNE C, 1966, COLLECTED PAPERS CS; PESCHEL RE, 1989, J ROY SOC MED, V82, P33, DOI 10.1177/014107688908200114; POE EA, 1841, GRAHAMS LADYS GE APR; Popper K., 1959, LOGIC SCI DISCOVERY; Ramanan SV, 2001, ARCH INTERN MED, V161, P701, DOI 10.1001/archinte.161.5.701; Rapezzi Claudio, 2003, Ital Heart J Suppl, V4, P415; SIMENOU G, 1933, MONSIEUR GALLEI DECE; STOUT R, 1944, NERO WOLFE OMNIBUS; Trousseau A., 1872, LECT CLIN MED DELIVE; WOODFIELD WR, 1991, COLUMBO MURDER ROCK	20	22	24	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1491	1494		10.1136/bmj.331.7531.1491	http://dx.doi.org/10.1136/bmj.331.7531.1491			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373725	Green Published, Bronze			2022-12-28	WOS:000234351300006
J	Spence, SA				Spence, SA			Patients bearing gifts: are there strings attached?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIANS ACCEPT GIFTS; MOUTH		Univ Sheffield, Div Genome Med, Sheffield S5 7JT, S Yorkshire, England	University of Sheffield	Spence, SA (corresponding author), Univ Sheffield, Div Genome Med, Sheffield S5 7JT, S Yorkshire, England.	s.a.spence@sheffield.ac.uk	Spence, Sean A/A-6218-2008					Andereck W, 2001, WESTERN J MED, V175, P76, DOI 10.1136/ewjm.175.2.76; [Anonymous], 2005, OXFORD ENGLISH DICT; Berrios GE, 2002, HIST PSYCHIATR, V13, P381, DOI 10.1177/0957154X0201305202; Capozzi JD, 2004, J BONE JOINT SURG AM, V86A, P2339, DOI 10.2106/00004623-200410000-00032; Cheung S. T., 2003, Nutrition and Health (Bicester), V17, P65; DREW J, 1983, SOC SCI MED, V17, P399, DOI 10.1016/0277-9536(83)90343-X; *GEN MED COUNC, 2001, GOOD MED PRACT, P17; Hundert EM, 1998, HARVARD REV PSYCHIAT, V6, P114, DOI 10.3109/10673229809000319; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; KELLEHEAR A, 1988, OMEGA, V19, P275; Kline Nancy E, 2002, J Pediatr Oncol Nurs, V19, P1, DOI 10.1053/jpon.2002.31349; LEVENE MI, 1980, BRIT MED J, V281, P1685, DOI 10.1136/bmj.281.6256.1685; Lyckholm LJ, 1998, JAMA-J AM MED ASSOC, V280, P1944, DOI 10.1001/jama.280.22.1944; MAIN TF, 1957, BRIT J MED PSYCHOL, V30, P129, DOI 10.1111/j.2044-8341.1957.tb01193.x; Nadelson C, 2002, THEOR MED BIOETH, V23, P191, DOI 10.1023/A:1020899425668; Nelson RM, 1999, PEDIATRICS, V104, P334; Nisselle P, 2000, Aust Fam Physician, V29, P541; Rycroft C., 1972, CRITICAL DICT PSYCHO, P100; Smolar AL, 2002, AM J PSYCHOTHER, V56, P27, DOI 10.1176/appi.psychotherapy.2002.56.1.27; STEIN H, 1965, AM J PSYCHOTHER, V19, P480, DOI 10.1176/appi.psychotherapy.1965.19.3.480; Weijer C, 2001, WESTERN J MED, V175, P77, DOI 10.1136/ewjm.175.2.77	21	15	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1527	1529		10.1136/bmj.331.7531.1527	http://dx.doi.org/10.1136/bmj.331.7531.1527			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373740	Bronze, Green Published			2022-12-28	WOS:000234351300020
J	Brown, WM; Cronk, L; Grochow, K; Jacobson, A; Liu, CK; Popovic, Z; Trivers, R				Brown, WM; Cronk, L; Grochow, K; Jacobson, A; Liu, CK; Popovic, Z; Trivers, R			RETRACTED: Dance reveals symmetry especially in young men (Retracted article. See vol. 504, pg. 470, 2013)	NATURE			English	Article; Retracted Publication							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; ATTRACTIVENESS; PERFORMANCE; SUCCESS	Dance is believed to be important in the courtship of a variety of species, including humans, but nothing is known about what dance reveals about the underlying phenotypic - or genotypic quality of the dancer(1-6). One measure of quality in evolutionary studies is the degree of bodily symmetry ( fluctuating asymmetry, FA), because it measures developmental stability(7,8). Does dance quality reveal FA to the observer and is the effect stronger for male dancers than female? To answer these questions, we chose a population that has been measured twice for FA since 1996 (ref. 9) in a society ( Jamaican) in which dancing is important in the lives of both sexes. Motion-capture cameras created controlled stimuli ( in the form of videos) that isolated dance movements from all other aspects of visual appearance ( including FA), and the same population evaluated these videos for dancing ability. Here we report that there are strong positive associations between symmetry and dancing ability, and these associations were stronger in men than in women. In addition, women rate dances by symmetrical men relatively more positively than do men, and more-symmetrical men value symmetry in women dancers more than do less-symmetrical men. In summary, dance in Jamaica seems to show evidence of sexual selection and to reveal important information about the dancer.	Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08901 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Rutgers State University New Brunswick; University of Washington; University of Washington Seattle	Brown, WM (corresponding author), Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, 131 George St, New Brunswick, NJ 08901 USA.	wmbrown@rci.rutgers.edu	Brown, William/AAE-6557-2019; Brown, William M/B-5665-2008	Brown, William/0000-0001-6875-4296; Brown, William M/0000-0001-6875-4296				Bronseth T, 1997, CAN J ZOOL, V75, P589, DOI 10.1139/z97-073; Darwin C., 1871, P475; GANGESTAD SW, 1994, ETHOL SOCIOBIOL, V15, P73, DOI 10.1016/0162-3095(94)90018-3; Garland T, 2005, EVOLUTION, V59, P1851, DOI 10.1111/j.0014-3820.2005.tb01832.x; Grammer K, 2003, EVOLUTIONARY AESTHETICS, P295; GUMMER DL, 1995, CAN J ZOOL, V73, P990, DOI 10.1139/z95-116; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hanna JL., 1988, DANCE SEX GENDER SIG; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Josefsson T, 1996, COMPUT METH PROG BIO, V49, P119, DOI 10.1016/0169-2607(96)01715-4; Kellner JR, 2003, AM NAT, V161, P931, DOI 10.1086/375177; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Manning JT, 1998, INT J SPORTS MED, V19, P205, DOI 10.1055/s-2007-971905; Martin J, 2001, PHYSIOL BIOCHEM ZOOL, V74, P619, DOI 10.1086/322925; Moller A.P., 1997, DEV STABILITY EVOLUT; Moller AP, 1999, APPL ANIM BEHAV SCI, V62, P57, DOI 10.1016/S0168-1591(98)00213-5; MOODIE GEE, 1977, CAN J ZOOL, V55, P398, DOI 10.1139/z77-054; Nagata N, 2004, LECT NOTES COMPUT SC, V3333, P39; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Polak M., 2003, CAUSES CONSEQUENCES; Rintamaki PT, 1997, ANIM BEHAV, V54, P265, DOI 10.1006/anbe.1996.0434; Singer F, 2000, BEHAVIOUR, V137, P93, DOI 10.1163/156853900501890; Swaddle JP, 1997, BEHAV ECOL, V8, P601, DOI 10.1093/beheco/8.6.601; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Trivers R, 1999, HUM BIOL, V71, P417; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; VANVALEN L, 1962, EVOLUTION, V16, P125; Waddington C., 1957, STRATEGY GENES	30	109	111	0	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1148	1150		10.1038/nature04344	http://dx.doi.org/10.1038/nature04344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372008				2022-12-28	WOS:000234111500049
J	Karadottir, R; Cavelier, P; Bergersen, LH; Attwell, D				Karadottir, R; Cavelier, P; Bergersen, LH; Attwell, D			NMDA receptors are expressed in oligodendrocytes and activated in ischaemia	NATURE			English	Article							WHITE-MATTER INJURY; CA1 PYRAMIDAL CELLS; PRECURSOR CELLS; GLIAL-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; AXONAL INJURY; GLUTAMATE; VULNERABILITY; MECHANISMS; CHANNELS	Glutamate-mediated damage to oligodendrocytes contributes to mental or physical impairment in periventricular leukomalacia (pre- or perinatal white matter injury leading to cerebral palsy), spinal cord injury, multiple sclerosis and stroke(1-4). Unlike neurons(5), white matter oligodendrocytes reportedly lack NMDA (N-methyl-D- aspartate) receptors(6,7). It is believed that glutamate damages oligodendrocytes, especially their precursor cells, by acting on calcium-permeable AMPA (alpha-amino-3-hydroxy-5-methyl- 4-isoxazole propionic acid)/kainate receptors alone(1-4) or by reversing cystine - glutamate exchange and depriving cells of antioxidant protection(8). Here we show that precursor, immature and mature oligodendrocytes in the white matter of the cerebellum and corpus callosum exhibit NMDA-evoked currents, mediated by receptors that are blocked only weakly by Mg(2+) and that may contain NR1, NR2C and NR3 NMDA receptor subunits. NMDA receptors are present in the myelinating processes of oligodendrocytes, where the small intracellular space could lead to a large rise in intracellular ion concentration in response to NMDA receptor activation. Simulating ischaemia led to development of an inward current in oligodendrocytes, which was partly mediated by NMDA receptors. These results point to NMDA receptors of unusual subunit composition as a potential therapeutic target for preventing white matter damage in a variety of diseases.	UCL, Dept Physiol, London WC1E 6BT, England; Univ Oslo, Dept Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of London; University College London; University of Oslo; University of Oslo	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	D.Attwell@ucl.ac.uk	Messier, Claude/A-2322-2008; Attwell, David/ABE-6750-2020	Messier, Claude/0000-0002-4791-1763; Bergersen, Linda Hildegard/0000-0002-9964-9744; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	Wellcome Trust [075232, 017948, 065424] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agrawal SK, 1997, J NEUROSCI, V17, P1055; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Back SA, 2001, J NEUROSCI, V21, P1302; BERGER T, 1992, J NEUROSCI RES, V31, P21, DOI 10.1002/jnr.490310104; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; BORGES K, 1995, J NEUROSCI RES, V42, P579, DOI 10.1002/jnr.490420416; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Follett PL, 2000, J NEUROSCI, V20, P9235; Kirson ED, 1999, J PHYSIOL-LONDON, V521, P99, DOI 10.1111/j.1469-7793.1999.00099.x; Kuner T, 1996, J NEUROSCI, V16, P3549; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; OKA A, 1993, J NEUROSCI, V13, P1441; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wallstrom E, 1996, J NEUROL SCI, V137, P89, DOI 10.1016/0022-510X(95)00339-4; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Ziak D, 1998, PHYSIOL RES, V47, P365	28	539	563	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1162	1166		10.1038/nature04302	http://dx.doi.org/10.1038/nature04302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372011	Green Accepted			2022-12-28	WOS:000234111500052
J	Oganov, AR; Martonak, R; Laio, A; Raiteri, P; Parrinello, M				Oganov, AR; Martonak, R; Laio, A; Raiteri, P; Parrinello, M			Anisotropy of Earth's D '' layer and stacking faults in the MgSiO3 post-perovskite phase	NATURE			English	Article							AUGMENTED-WAVE METHOD; CORE-MANTLE BOUNDARY; LOWERMOST MANTLE; AZIMUTHAL ANISOTROPY; SEISMIC ANISOTROPY; MOLECULAR-DYNAMICS; TRANSITION; ELASTICITY	The post-perovskite phase of (Mg, Fe) SiO3 is believed to be the main mineral phase of the Earth's lowermost mantle (the D '' layer). Its properties explain(1-6) numerous geophysical observations associated with this layer - for example, the D '' discontinuity(7), its topography(8) and seismic anisotropy within the layer(9). Here we use a novel simulation technique, first-principles metadynamics, to identify a family of low-energy polytypic stacking-fault structures intermediate between the perovskite and post-perovskite phases. Metadynamics trajectories identify plane sliding involving the formation of stacking faults as the most favourable pathway for the phase transition, and as a likely mechanism for plastic deformation of perovskite and post-perovskite. In particular, the predicted slip planes are {010} for perovskite ( consistent with experiment(10,11)) and {110} for postperovskite ( in contrast to the previously expected {010} slip planes(1-4)). Dominant slip planes define the lattice preferred orientation and elastic anisotropy of the texture. The {110} slip planes in post-perovskite require a much smaller degree of lattice preferred orientation to explain geophysical observations of shear-wave anisotropy in the D '' layer.	ETH, Dept Mat, Crystallog Lab, CH-8093 Zurich, Switzerland; ETH, Dept Chem & Appl Sci, CH-6900 Lugano, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Oganov, AR (corresponding author), ETH, Dept Mat, Crystallog Lab, HCI G 515,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	a.oganov@mat.ethz.ch	Martoňák, Roman/T-5223-2018; Oganov, Artem R./O-8234-2019; Laio, Alessandro/K-2117-2012; Raiteri, Paolo/E-1465-2011; Oganov, Artem R/A-1213-2008; Oganov, Artem R./AAA-1478-2021	Martoňák, Roman/0000-0002-4013-9117; Oganov, Artem R./0000-0001-7082-9728; Laio, Alessandro/0000-0001-9164-7907; Raiteri, Paolo/0000-0003-0692-0505; Oganov, Artem R/0000-0001-7082-9728; 				BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cordier P, 2004, NATURE, V428, P837, DOI 10.1038/nature02472; Garnero EJ, 2004, SCIENCE, V306, P259, DOI 10.1126/science.1103411; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Iitaka T, 2004, NATURE, V430, P442, DOI 10.1038/nature02702; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LAY T, 1983, GEOPHYS RES LETT, V10, P63, DOI 10.1029/GL010i001p00063; LEGRAND B, 1984, PHILOS MAG B, V49, P171, DOI 10.1080/13642818408227636; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Martonak R, 2005, Z KRISTALLOGR, V220, P489, DOI 10.1524/zkri.220.5.489.65078; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nakagawa T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020648; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Oganov AR, 2000, PHYS EARTH PLANET IN, V122, P277, DOI 10.1016/S0031-9201(00)00197-7; Ono S, 2005, EARTH PLANET SC LETT, V236, P914, DOI 10.1016/j.epsl.2005.06.001; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Smith W, 2005, Z KRISTALLOGR, V220, P563, DOI 10.1524/zkri.220.5.563.65076; Tsuchiya T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020278; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; VINET P, 1989, J PHYS-CONDENS MAT, V1, P1941, DOI 10.1088/0953-8984/1/11/002; Wookey J, 2005, GEOPHYS J INT, V161, P829, DOI 10.1111/j.1365-246X.2005.02623.x	27	181	186	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1142	1144		10.1038/nature04439	http://dx.doi.org/10.1038/nature04439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372006	Green Submitted			2022-12-28	WOS:000234111500047
J	Ryan, ET; Felsenstein, D; Aquino, SL; Branda, JA; Morgan, JG; Phillips, J; Branda, JA				Ryan, ET; Felsenstein, D; Aquino, SL; Branda, JA; Morgan, JG; Phillips, J; Branda, JA			A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophilia - Onchocerca volvulus infection (onchocerciasis)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Trop & Geog Med Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Trop & Geog Med Ctr, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020					Abiose A, 2000, LANCET, V356, P1523, DOI 10.1016/S0140-6736(05)73271-2; [Anonymous], 2016, DIAGNOSTIC MED PARAS; Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Ash LR, 1990, ATLAS HUMAN PARASITO; Backhouse JL, 1998, AM J TROP MED HYG, V59, P388, DOI 10.4269/ajtmh.1998.59.388; CLARK E G, 1955, J Chronic Dis, V2, P311, DOI 10.1016/0021-9681(55)90139-9; Gjestland T, 1955, Acta Derm Venereol Suppl (Stockh), V35, P3; GLEICH LL, 1992, LARYNGOSCOPE, V102, P1255, DOI 10.1288/00005537-199211000-00010; HART G, 1986, ANN INTERN MED, V104, P368, DOI 10.7326/0003-4819-104-3-368; HEGGTVEIT HA, 1964, CIRCULATION, V29, P346, DOI 10.1161/01.CIR.29.3.346; Hoerauf A, 2003, BMJ-BRIT MED J, V326, P207, DOI 10.1136/bmj.326.7382.207; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; HUTCHINSON CM, 1990, MED CLIN N AM, V74, P1389, DOI 10.1016/S0025-7125(16)30487-4; JAFFE HW, 1984, SEXUALLY TRANSMITTED, P313; MacLean S, 1996, SEX TRANSM DIS, V23, P392, DOI 10.1097/00007435-199609000-00008; Meheus A., 1999, SEXUALLY TRANSMITTED, P511; ROMANOWSKI B, 1991, ANN INTERN MED, V114, P1005, DOI 10.7326/0003-4819-114-12-1005; ROSAHN P, 1947, J VENER DIS S21, V649, P1; Seketeli A, 2002, ANN TROP MED PARASIT, V96, P15, DOI 10.1179/000349802125000628; STECKELBERG JM, 1984, LARYNGOSCOPE, V94, P753; Swartz M. N., 1999, SEXUALLY TRANSMITTED, P487; Whetham J, 2003, J INFECTION, V46, P180, DOI 10.1053/jinf.2002.1108; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; WILSON ME, 1999, TROPICAL INFECT DIS, P1400	24	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2697	2705		10.1056/NEJMcpc059036	http://dx.doi.org/10.1056/NEJMcpc059036			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371636				2022-12-28	WOS:000234094400012
J	Madeb, R; Koniaris, LG; Schwartz, SI				Madeb, R; Koniaris, LG; Schwartz, SI			The discovery of insulin: The Rochester, New York, connection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The discovery of insulin in Toronto by Dr. Frederick G. Banting and colleagues has been well chronicled. The story of how insulin therapy was introduced into the United States has been less detailed. The first patient to be treated with insulin in the United States resided in Rochester, New York, a city with a then newly developed medical school that had also tried to recruit Banting. A series of letters from that period provides a description of the course of a juvenile patient with diabetes before and after the use of insulin as a therapeutic agent.	Univ Rochester, Sch Med, Dept Urol, Rochester, NY 14642 USA	University of Rochester	Madeb, R (corresponding author), Univ Rochester, Sch Med, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	ralph_madeb@urmc.rochester.edu		Madeb, Ralph/0000-0003-4628-593X				BANTING FG, 1922, COMMUNICATION   0611; BANTING FG, 1922, COMMUNICATION   0627; Bliss M., 1982, DISCOVERY INSULIN; Bliss M, 1982, DISCOVERY INSULIN, P136; BLISS M, 1984, BANTING BIOGRAOPHY; CORNELL SB, 1922, COMMUNICATION   0615; HAVEBS JS, 1922, COMMUNICATION   0613; HAVENS JD, 1957, COMMUNICATION   1122; HAVENS JS, 1922, COMMUNICATION   0617; HAVENS JS, 1921, COMMUNICATION   0103; HAVENS JS, 1922, COMMUNICATION   0411; HAVENS JS, 1922, COMMUNICATIONS  0405; HAVENS JS, 1920, COMMUNICATION   0503; HAVENS JS, 1922, COMMUNICATION   0524; JOSLIN EP, 1957, COMMUNICATION   0703; WILLIAMS JR, 1922, COMMUNICATION   0603; WILLIAMS JR, 1946, SIR F BANTING B, V4, P207; WILLIAMS JR, 1922, COMMUNICATION   0711; WILLIAMS JR, 1923, COMMUNICATION   0414; WILLIAMS JR, 1922, COMMUNICATION   0627; WOODBURY DO, 1962, LIBERTY         0622, P42	21	11	11	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					907	912		10.7326/0003-4819-143-12-200512200-00009	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365472				2022-12-28	WOS:000234077400007
J	Libman, RB; Menna, BL; Gulati, S				Libman, RB; Menna, BL; Gulati, S			Case report - Consequences of ephedra use in an athlete	LANCET			English	Article									Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY 11040 USA	Northwell Health; Yeshiva University	Libman, RB (corresponding author), Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Neurol, Long Isl Campus, New Hyde Pk, NY 11040 USA.	libman@lij.EDU							0	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S22	S22		10.1016/S0140-6736(05)67832-4	http://dx.doi.org/10.1016/S0140-6736(05)67832-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360736				2022-12-28	WOS:000234374400015
J	McCarthy, M				McCarthy, M			Profile - Richard W Pound, QC - Chairman of WADA	LANCET			English	Biographical-Item												michael.mccarthy@lancet.com						POUND R, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S20	S20		10.1016/S0140-6736(05)67830-0	http://dx.doi.org/10.1016/S0140-6736(05)67830-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360734				2022-12-28	WOS:000234374400013
J	Smith, IE; Chua, S				Smith, IE; Chua, S			ABC of breast diseases - Medical treatment of early breast cancer. II: endocrine therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL		Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Smith, IE (corresponding author), Royal Marsden Hosp, London SW3 6JJ, England.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baum M, 2002, LANCET, V359, P2131; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					101	103		10.1136/bmj.332.7533.101	http://dx.doi.org/10.1136/bmj.332.7533.101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410586	Green Published			2022-12-28	WOS:000234777000025
J	Ashraf, SI; McLoon, AL; Sclarsic, SM; Kunes, S				Ashraf, SI; McLoon, AL; Sclarsic, SM; Kunes, S			Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila	CELL			English	Article							LONG-TERM-MEMORY; MESSENGER-RNA; COMPUTATIONAL IDENTIFICATION; ANTENNAL LOBE; LOCALIZATION; NEURONS; KINASE; BRAIN; VISUALIZATION; ACTIVATION	Long-lasting forms of memory require protein synthesis, but how the pattern of synthesis is related to the storage of a memory has not been determined. Here we show that neural activity directs the mRNA of the Drosophila Ca2+ Calcium/Calmodulin-dependent Kinase II (CaMKII), to postsynaptic sites, where it is rapidly translated. These features of CaMKII synthesis are recapitulated during the induction of a long-term memory and produce patterns of local protein synthesis specific to the memory. We show that mRNA transport and synaptic protein synthesis are regulated by components of the RISC pathway, including the SDE3 helicase Armitage, which is specifically required for long-lasting memory. Armitage is localized to synapses and lost in a memory-specific pattern that is inversely related to the pattern of synaptic protein synthesis. Therefore, we propose that degradative control of the RISC pathway underlies the pattern of synaptic protein synthesis associated with a stable memory.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kunes, S (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kunes@fas.harvard.edu			NIMH NIH HHS [R01 MH081294] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081294] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; KUNES S, 1993, J NEUROSCI, V13, P752; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Menzel R, 1999, NATURE, V400, P718, DOI 10.1038/23371; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	36	348	368	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					191	205		10.1016/j.cell.2005.12.017	http://dx.doi.org/10.1016/j.cell.2005.12.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413491	Bronze			2022-12-28	WOS:000234969600019
J	Iglev, H; Schmeisser, M; Simeonidis, K; Thaller, A; Laubereau, A				Iglev, H; Schmeisser, M; Simeonidis, K; Thaller, A; Laubereau, A			Ultrafast superheating and melting of bulk ice	NATURE			English	Article							LIQUID WATER; SPECTROSCOPY; PRESSURE; DYNAMICS; AMORPHIZATION; TEMPERATURE; DEFECTS; PULSES	The superheating of a solid to a temperature beyond its melting point, without the solid actually melting, is a well-known phenomenon. It occurs with many substances(1-5), particularly those that can readily be produced as high-quality crystals. In principle, ice should also be amenable to superheating. But the complex three-dimensional network of hydrogen bonds that holds water molecules together and gives rise to unusual solid and liquid properties(6-11) strongly affects the melting behaviour of ice(12-14); in particular, ice usually contains many defects owing to the directionality of its hydrogen bonds. However, simulations are readily able to 'create' defect- free ice that can be superheated(15,16). Here we show that by exciting the OH stretching mode of water, it is possible to superheat ice. When using an ice sample at an initial temperature of 270 K, we observe an average temperature rise of 20 +/- 2K that persists over the monitored time interval of 250 ps without melting.	Tech Univ Munich, Dept Phys, D-85748 Garching, Germany	Technical University of Munich	Iglev, H (corresponding author), Tech Univ Munich, Dept Phys, James Franck Str, D-85748 Garching, Germany.	higlev@ph.tum.de						CAHN RW, 1986, NATURE, V323, P668, DOI 10.1038/323668a0; Donadio D, 2005, J PHYS CHEM B, V109, P5421, DOI 10.1021/jp050690z; Engemann S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.205701; FECHT HJ, 1992, NATURE, V356, P133, DOI 10.1038/356133a0; GORECKI T, 1977, SCRIPTA METALL MATER, V11, P1051, DOI 10.1016/0036-9748(77)90305-2; GRAENER H, 1991, PHYS REV LETT, V66, P2092, DOI 10.1103/PhysRevLett.66.2092; Grishina N, 2004, J CHEM PHYS, V120, P5217, DOI 10.1063/1.1647523; GROW AJ, 1972, J GEOPHYS RES, V77, P6348; Huang KC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.175702; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; Laenen R, 2002, J PHYS CHEM B, V106, P408, DOI 10.1021/jp011047p; Laenen R, 1998, PHYS REV LETT, V80, P2622, DOI 10.1103/PhysRevLett.80.2622; Laenen R, 1999, LASER PHYS, V9, P234; LAPLACA S, 1960, ACTA CRYSTALLOGR, V13, P503, DOI 10.1107/S0365110X60001205; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.3.CO;2-T; Luo SN, 2005, MODEL SIMUL MATER SC, V13, P321, DOI 10.1088/0965-0393/13/3/002; Luo SN, 2004, PHYS EARTH PLANET IN, V143, P369, DOI 10.1016/j.pepi.2003.04.001; Luo SN, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134206; McBride C, 2005, MOL PHYS, V103, P1, DOI 10.1080/00268970412331293820; MINCEVASUKAROVA B, 1984, J PHYS C SOLID STATE, V17, P5833, DOI 10.1088/0022-3719/17/32/017; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; SIVAKUMAR TC, 1978, NATURE, V275, P524, DOI 10.1038/275524a0; Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409; Tse JS, 1999, NATURE, V400, P647, DOI 10.1038/23216; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Woutersen S, 1998, PHYS REV LETT, V81, P1106, DOI 10.1103/PhysRevLett.81.1106; Woutersen S, 1997, SCIENCE, V278, P658, DOI 10.1126/science.278.5338.658	30	90	91	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					183	186		10.1038/nature04415	http://dx.doi.org/10.1038/nature04415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407948				2022-12-28	WOS:000234538400035
J	Topin, J; Mutlu, GM				Topin, J; Mutlu, GM			Splenic and mediastinal calcifications in histoplasmosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Topin, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.		Mutlu, Gokhan/HIR-2545-2022						0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					179	179		10.1056/NEJMicm050377	http://dx.doi.org/10.1056/NEJMicm050377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407513				2022-12-28	WOS:000234528600010
J	Coghlan, B; Brennan, R; Ngoy, P; Dofara, D; Otto, B; Clements, M; Stewart, T				Coghlan, B; Brennan, R; Ngoy, P; Dofara, D; Otto, B; Clements, M; Stewart, T			Mortality in the Democratic Republic of Congo: a nationwide survey	LANCET			English	Article								Background Commencing in 1998, the war in the Democratic Republic of Congo has been a humanitarian disaster, but has drawn little response from the international community. To document rates and trends in mortality and provide recommendations for political and humanitarian interventions, we did a nationwide mortality survey during April-July, 2004. Methods We used a stratified three-stage, household-based cluster sampling technique. Of 511 health zones, 49 were excluded because of insecurity, and four were purposely selected to allow historical comparisons. From the remainder, probability of selection was proportional to population size. Geographical distribution and size of cluster determined how households were selected: systematic random or classic proximity sampling. Heads of households were asked about all deaths of household members during January, 2003, to April, 2004. Findings 19 500 households were visited. The national crude mortality rate of 2.1 deaths per 1000 per month (95% CI 1.6-2.6) was 40% higher than the sub-Saharan regional level (1-5), corresponding to 600 000 more deaths than would be expected during the recall period and 38 000 excess deaths per month. Total death toll from the conflict (1998-2004) was estimated to be 3.9 million. Mortality rate was higher in unstable eastern provinces, showing the effect of insecurity. Most deaths were from easily preventable and treatable illnesses rather than violence. Regression analysis suggested that if the effects of violence were removed, all-cause mortality could fall to almost normal rates. Interpretation The conflict in the Democratic Republic of Congo remains the world's deadliest humanitarian crisis. To save lives, improvements in security and increased humanitarian assistance are urgently needed.	Int Rescue Comm, New York, NY 10168 USA; Int Rescue Comm, Kinshasa, DEM REP CONGO; Burnet Inst, Ctr Int Hlth, Bali, Indonesia; Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Burnet Institute; Australian National University	Brennan, R (corresponding author), Int Rescue Comm, New York, NY 10168 USA.	rbrennan@theirc.org	Clements, Mark/W-5906-2018	Clements, Mark/0000-0003-4518-5670				BECKER LB, 1993, ANN EMERG MED, V22, P1, DOI 10.1016/S0196-0644(05)80239-2; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P469; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; *INT CRIS GROUP, 2004, MAINT MOM CONG IT PR; *IRIN OCHA, 2005, AU MAY NEED 45000 TR; Roberts L., 2000, MORTALITY E DRC RESU; ROBERTS L, 2001, MORTALITY E DEMOCRAT; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Steering Committee of the Joint Evaluation of Emergency Assistance to Rwanda, 1996, INT RESP CONFL GEN L; TALBOT C, 2000, US INTERVENES SHAPE; TAYLOR WR, 1993, INT J EPIDEMIOL, V22, pS15, DOI 10.1093/ije/22.Supplement_1.S15; The Sphere Project, 2004, HUM CHART MIN STAND; *UNICEF, 1999, STAT WORLDS CHILDR R; *UNOCHA, 2004, HUM SIT DRC MONTHL U; *UNOCHA, 2003, TOT HUM ASS DEM REP; *UNOCHA, 2004, TOT HUM ASS DEM REP; *US BUR CENS, 2004, INT DAT BAS POP PYR; *US DEP STAT, BOSN HERZ COUNTR REP; *WHO, 2004, SUD MORT PROJ DARF; *WHO EXP PROGR IMM, 1991, TRAIN MIDL MAN EPI C; *WORLD BANK GROUP, WORLD DEV IND 2004; [No title captured]; 20 CENTURY ATLAS DEA	23	245	248	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					44	51		10.1016/S0140-6736(06)67923-3	http://dx.doi.org/10.1016/S0140-6736(06)67923-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399152				2022-12-28	WOS:000234443100029
J	Lakhani, M; Baker, M				Lakhani, M; Baker, M			Visions of primary care in 2015 - Good general practitioners will continue to be essential	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London SW1 7PU, England		Lakhani, M (corresponding author), Royal Coll Gen Practitioners, London SW1 7PU, England.	mlakhani@rcgp.org.uk						Baker R, 2005, BRIT J GEN PRACT, V55, P468; Baker R, 2005, LANCET, V365, P919, DOI 10.1016/S0140-6736(05)71059-X; COULTER A, 2005, EUR J PUBLIC HL 0623; *DEP HLTH, YOUR HLTH YOUR CAR Y; *EUR OBS HLTH SYST, GLOSS ENTR PRIM HLTH; *EUR OBS HLTH SYST, GLOSS ENGR PAT CTR; Gannon C, 2005, BRIT MED J, V330, P737, DOI 10.1136/bmj.330.7493.737; GRECO M, 2005, WHAT DO PATIENTS THI; Krogstad U, 2002, BRIT MED J, V324, P36, DOI 10.1136/bmj.324.7328.36; National Primary Care Research and Development Centre, 2005, WHAT PAT WANT PRIM C; *NIH CLIN EXC, 2003, GUID US PAT ED MOD D; Preston C, 1999, QUAL HEALTH CARE, V8, P16, DOI 10.1136/qshc.8.1.16; *ROYAL COLL GEN PR, 2004, FUT GEN PRACT STAT R; Starfield B, 2003, BRIT J GEN PRACT, V53, P723; STARFIELD B, 2004, EQUITY PRIMARY CARE; Starfield B, 2003, CELEBRATION GEN PRAC, P19; SYLVESTER S, 2003, QUAL PRIM CARE, V11, P29; Wilson T, 2002, BRIT MED J, V324, P584, DOI 10.1136/bmj.324.7337.584; World Organisation of Family Doctors, 2002, EUR DEF GEN PRACT FA	19	11	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					41	43		10.1136/bmj.332.7532.41	http://dx.doi.org/10.1136/bmj.332.7532.41			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399739	Green Published			2022-12-28	WOS:000234684200023
J	Johnson, WE; Eizirik, E; Pecon-Slattery, J; Murphy, WJ; Antunes, A; Teeling, E; O'Brien, SJ				Johnson, WE; Eizirik, E; Pecon-Slattery, J; Murphy, WJ; Antunes, A; Teeling, E; O'Brien, SJ			The Late Miocene radiation of modern Felidae: A genetic assessment	SCIENCE			English	Article							MITOCHONDRIAL-DNA; CHRONOLOGY; PHYLOGENY; CARNIVORA; GENOME	Modern fetid species descend from relatively recent (<11 million years ago) divergence and speciation events that produced successful predatory carnivores worldwide but that have confounded taxonomic classifications. A highly resolved molecular phylogeny with divergence dates for all living cat species, derived from autosomal, X-linked, Y-linked, and mitochondrial gene segments (22,789 base pairs) and 16 fossil calibrations define eight principal lineages produced through at least 10 intercontinental migrations facilitated by sea-level fluctuations. A ghost lineage analysis indicates that available fetid fossils underestimate (i.e., unrepresented basal branch length) first occurrence by an average of 76%, revealing a low representation of fetid lineages in paleontological remains. The phylogenetic performance of distinct gene classes showed that Y-chromosome segments are appreciably more informative than mitochondrial DNA, X-linked, or autosomal genes in resolving the rapid Felidae species radiation.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Ctr Biol Genom & Mol, BR-90619900 Porto Alegre, RS, Brazil; Univ Porto, Fac Ciencias, Dept Quim, REQUIMTE, P-4167007 Porto, Portugal	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade do Porto	Johnson, WE (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	johnsonw@ncifcrf.gov; obrien@ncifcrf.gov	Johnson, Warren/D-4149-2016; Pecon-Slattery, Jill/GXH-4494-2022; Eizirik, Eduardo/K-8034-2012; OBRIEN, STEPHEN/ABD-1346-2020	Johnson, Warren/0000-0002-5954-186X; Eizirik, Eduardo/0000-0002-9658-0999; Antunes, Agostinho/0000-0002-1328-1732	NATIONAL CANCER INSTITUTE [Z01BC005367] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1999, WALKERS MAMMALS WORL; Beaumont G. de, 1964, Eclogae Geologicae Helvetiae, V57, P837; Benveniste R. E., 1985, MOL EVOLUTIONARY GEN, P359; BORIEN SJ, 2005, ANN REV GENET HUM GE, V6, P407; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hunt Jr R. M., 1996, CARNIVORE BEHAV ECOL, V2, P485; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; KIM J, IN PRESS GENE; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MARSHALL LG, 1988, AM SCI, V76, P380; Mattern MY, 2000, CLADISTICS, V16, P232, DOI 10.1111/j.1096-0031.2000.tb00354.x; McKenna MC, 1997, CLASSIFICATION MAMMA; Nowell K., 1996, WILD CATS STATUS SUR; O'hUigin C, 2002, MOL BIOL EVOL, V19, P1501, DOI 10.1093/oxfordjournals.molbev.a004213; Pecon-Slattery J, 2004, MOL BIOL EVOL, V21, P2299, DOI 10.1093/molbev/msh241; Repenning CA, 2001, QUATERNARY SCI REV, V20, P25, DOI 10.1016/S0277-3791(00)00133-5; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Slattery JP, 1998, GENETICS, V148, P1245; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Woodruff DS, 2003, J BIOGEOGR, V30, P551, DOI 10.1046/j.1365-2699.2003.00846.x; Yang ZH, 2002, GENETICS, V162, P1811; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; ZHANXIANG Q, 2003, B AM MUS NAT HIST, V279, P163	28	489	541	8	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					73	77		10.1126/science.1122277	http://dx.doi.org/10.1126/science.1122277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400146	Green Published			2022-12-28	WOS:000234546300035
J	Amdam, GV; Csondes, A; Fondrk, MK; Page, RE				Amdam, GV; Csondes, A; Fondrk, MK; Page, RE			Complex social behaviour derived from maternal reproductive traits	NATURE			English	Article							COLONY-LEVEL SELECTION; HONEY-BEE; ORGANIZATION; EUSOCIALITY; ORIGIN	A fundamental goal of sociobiology is to explain how complex social behaviour evolves(1), especially in social insects, the exemplars of social living. Although still the subject of much controversy(2), recent theoretical explanations have focused on the evolutionary origins of worker behaviour ( assistance from daughters that remain in the nest and help their mother to reproduce) through expression of maternal care behaviour towards siblings(3,4). A key prediction of this evolutionary model is that traits involved in maternal care have been co-opted through heterochronous expression of maternal genes(5) to result in sib-care, the hallmark of highly evolved social life in insects(6). A coupling of maternal behaviour to reproductive status evolved in solitary insects, and was a ready substrate for the evolution of worker-containing societies(3,4,7,8). Here we show that division of foraging labour among worker honey bees ( Apis mellifera) is linked to the reproductive status of facultatively sterile females. We thereby identify the evolutionary origin of a widely expressed social-insect behavioural syndrome(1,5,7,9), and provide a direct demonstration of how variation in maternal reproductive traits gives rise to complex social behaviour in non-reproductive helpers.	Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; University of California System; University of California Davis	Amdam, GV (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Gro.Amdam@asu.edu; Robert.Page@asu.edu			NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG022500-04, P01 AG022500] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Bloch Guy, 2002, P195; BUTLER CG, 1957, EXPERIENTIA, V13, P256, DOI 10.1007/BF02157449; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Dunn T, 2003, BEHAV ECOL, V14, P417, DOI 10.1093/beheco/14.3.417; GARY N E, 1976, Journal of Apicultural Research, V15, P73; Hartfelder K, 2002, INSECT BIOCHEM MOLEC, V32, P211, DOI 10.1016/S0965-1748(01)00100-X; HARTFELDER K, 1995, ROUX ARCH DEV BIOL, V205, P73, DOI 10.1007/BF00188845; Hodin J, 2000, EVOLUTION, V54, P1638, DOI 10.1111/j.0014-3820.2000.tb00708.x; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; MAURIZIO A, 1954, LANDWIRTSCH JB SCHWE, V245, P115; Min KJ, 2004, ARCH INSECT BIOCHEM, V55, P33, DOI 10.1002/arch.10109; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 2002, GENES BRAIN BEHAV, V1, P197, DOI 10.1034/j.1601-183X.2002.10401.x; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Seeley T., 1995, WISDOM HIVE SOCIAL P; Simonet G, 2004, J NEUROENDOCRINOL, V16, P649, DOI 10.1111/j.1365-2826.2004.01222.x; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Winston M.L., 1991, BIOL HONEY BEE	30	203	212	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					76	78		10.1038/nature04340	http://dx.doi.org/10.1038/nature04340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397498	Green Accepted			2022-12-28	WOS:000234378700037
J	Korber, A; Dissemond, J				Korber, A; Dissemond, J			Black hairy tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Sch Med, D-45122 Essen, Germany		Korber, A (corresponding author), Univ Sch Med, D-45122 Essen, Germany.		Dissemond, Joachim/AFG-0691-2022						0	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					67	67		10.1056/NEJMicm050117	http://dx.doi.org/10.1056/NEJMicm050117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394303				2022-12-28	WOS:000234358600009
J	Quill, TE; Meier, DE				Quill, TE; Meier, DE			The big chill - Inserting the DEA into end-of-life care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAIN MANAGEMENT		Univ Rochester, Sch Med, Ctr Palliat Care & Clin Eth, Rochester, NY 14627 USA; Mt Sinai Sch Med, Lilian & Benjamin Hertzberg Palliat Care Inst, New York, NY USA; Mt Sinai Sch Med, Ctr Adv Palliat Care, New York, NY USA	University of Rochester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Quill, TE (corresponding author), Univ Rochester, Sch Med, Ctr Palliat Care & Clin Eth, Rochester, NY 14627 USA.							Drayer RA, 1999, J PAIN SYMPTOM MANAG, V17, P434, DOI 10.1016/S0885-3924(99)00022-6; Field MJ, 1997, APPROACHING DEATH IM; Gilson AM, 2005, HEALTH POLICY, V74, P192, DOI 10.1016/j.healthpol.2005.01.004; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Tucker KL, 2004, PAIN MED, V5, P214, DOI 10.1111/j.1526-4637.2004.4029_2.x	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					1	3		10.1056/NEJMp058289	http://dx.doi.org/10.1056/NEJMp058289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394295				2022-12-28	WOS:000234358600001
J	Stupack, DG; Teitz, T; Potter, MD; Mikolon, D; Houghton, PJ; Kidd, VJ; Lahti, JM; Cheresh, DA				Stupack, DG; Teitz, T; Potter, MD; Mikolon, D; Houghton, PJ; Kidd, VJ; Lahti, JM; Cheresh, DA			Potentiation of neuroblastoma metastasis by loss of caspase-8	NATURE			English	Article							CHILDHOOD NEUROBLASTOMAS; CELL-SURVIVAL; APOPTOSIS; INTEGRINS; DEATH; TUMOR; INACTIVATION; EXPRESSION; RECEPTORS; THERAPY	Neuroblastoma, the most common paediatric solid tumour, arises from defective neural crest cells(1). Genetic alterations occur frequently in the most aggressive neuroblastomas(1). In particular, deletion or suppression of the proapoptotic enzyme caspase-8 is common in malignant, disseminated disease, although the effect of this loss on disease progression is unclear(2-4). Here we show that suppression of caspase-8 expression occurs during the establishment of neuroblastoma metastases in vivo, and that reconstitution of caspase-8 expression in deficient neuroblastoma cells suppressed their metastases. Caspase-8 status was not a predictor of primary tumour growth; rather, caspase-8 selectively potentiated apoptosis in neuroblastoma cells invading the collagenous stroma at the tumour margin. Apoptosis was initiated by unligated integrins by means of a process known as integrin-mediated death(5). Loss of caspase-8 or integrin rendered these cells refractory to integrin-mediated death, allowed cellular survival in the stromal microenvironment, and promoted metastases. These findings define caspase-8 as a metastasis suppressor gene that, together with integrins, regulates the survival and invasive capacity of neuroblastoma cells.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA; St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Stupack, DG (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dstupack@ucsd.edu; jill.lahti@stjude.org	Lahti, Jari/P-7987-2018	Lahti, Jari/0000-0002-4310-5297	NCI NIH HHS [R01 CA107263] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Beltinger C, 2001, INT J CANCER, V92, P313, DOI 10.1002/ijc.1210; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bredesen DE, 2004, PHYSIOL REV, V84, P411, DOI 10.1152/physrev.00027.2003; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Patan S, 1997, MICROVASC RES, V53, P33, DOI 10.1006/mvre.1996.1989; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Teitz T, 2002, ONCOGENE, V21, P1848, DOI 10.1038/sj.onc.1205180; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Ziegler MM, 1997, CANCER-AM CANCER SOC, V79, P1757; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2002, CANCER RES, V62, P7083	30	216	223	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					95	99		10.1038/nature04323	http://dx.doi.org/10.1038/nature04323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397500				2022-12-28	WOS:000234378700041
J	Howard, BV; Manson, JE; Stefanick, ML; Beresford, SA; Frank, G; Jones, BT; Rodabough, RJ; Snetselaar, L; Thomson, C; Tinker, L; Vitolins, M; Prentice, R				Howard, BV; Manson, JE; Stefanick, ML; Beresford, SA; Frank, G; Jones, BT; Rodabough, RJ; Snetselaar, L; Thomson, C; Tinker, L; Vitolins, M; Prentice, R			Low-fat dietary pattern and weight change over 7 years - The Women's Health Initiative Dietary Modification Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONGITUDINAL DATA-ANALYSIS; LOW-CARBOHYDRATE-DIET; RANDOMIZED-TRIAL; BODY-WEIGHT; NUTRITION; RISK; PREVENTION; GUIDELINES; CALORIE; CANCER	Context Obesity in the United States has increased dramatically during the past several decades. There is debate about optimum calorie balance for prevention of weight gain, and proponents of some low-carbohydrate diet regimens have suggested that the increasing obesity may be attributed, in part, to low-fat, high-carbohydrate diets. Objectives To report data on body weight in a long-term, low-fat diet trial for which the primary end points were breast and colorectal cancer and to examine the relationships between weight changes and changes in dietary components. Design, Setting, and Participants Randomized intervention trial of 48835 postmenopausal women in the United States who were of diverse backgrounds and ethnicities and participated in the Women's Health Initiative Dietary Modification Trial; 40% (19 541) were randomized to the intervention and 60% (29 294) to a control group. Study enrollment was between 1993 and 1998, and this analysis includes a mean follow-up of 7.5 years (through August 31, 2004). Interventions The intervention included group and individual sessions to promote a decrease in fat intake and increases in vegetable, fruit, and grain consumption and did not include weight loss or caloric restriction goals. The control group received diet-related education materials. Main Outcome Measure Change in body weight from baseline to follow-up. Results Women in the intervention group lost weight in the first year (mean of 2.2 kg, P<.001) and maintained lower weight than control women during an average 7.5 years of follow-up (difference, 1.9 kg, P<.001 at 1 year and 0.4 kg, P=.01 at 7.5 years). No tendency toward weight gain was observed in intervention group women overall or when stratified by age, ethnicity, or body mass index. Weight loss was greatest among women in either group who decreased their percentage of energy from fat. A similar but lesser trend was observed with increases in vegetable and fruit servings, and a nonsignificant trend toward weight loss occurred with increasing intake of fiber. Conclusion A low-fat eating pattern does not result in weight gain in postmenopausal women.	MedStar Res Inst, Washington, DC USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Stanford Sch Med, Stanford, CA USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Calif Irvine, Orange, CA 92668 USA; Univ N Carolina, Sch Med & Publ Hlth, Durham, NC USA; Univ Iowa, Iowa City, IA USA; Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; Fred Hutchinson Cancer Center; University of California System; University of California Irvine; University of North Carolina; University of Iowa; University of Arizona; Arizona Center Cancer Care; University of Arizona; Wake Forest University; Wake Forest Baptist Medical Center	Howard, BV (corresponding author), MedStar Res Inst, 6495 New Hampshire Ave,Suite 201, Hyattsville, MD 20783 USA.	Barbara.V.Howard@MedStar.net						Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Astrup A, 2002, P NUTR SOC, V61, P299, DOI 10.1079/PNS2002149; Atkins RC, 1998, ATKINS NEW DIET REVO; Bowen D, 2002, J AM DIET ASSOC, V102, P1631, DOI 10.1016/S0002-8223(02)90347-0; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Buchholz AC, 2004, AM J CLIN NUTR, V79, P899; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Franz MJ, 2002, DIABETES CARE, V25, P148, DOI 10.2337/diacare.25.1.148; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Hall WD, 2003, ETHNIC DIS, V13, P337; Krauss RM, 2000, CIRCULATION, V102, P2284; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; *NAT CTR HLTH STAT, 2004, HLTH US; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Ritenbaugh C, 2003, ANN EPIDEMIOL, V13, pS87, DOI 10.1016/S1047-2797(03)00044-9; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SEARS B, 1995, ZONE DIET DIETARY RO; STEWARD HL, 1995, SUGAR BUSTERS; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Thomson CA, 2005, EUR J NUTR, V44, P18, DOI 10.1007/s00394-004-0487-x; Tinker Lesley Fels, 1996, P510; *USDA, 1995, HOM GARD B, V232; *USDA, 1990, HOM GARD B, V232; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wang CY, 1999, BIOMETRICS, V55, P711, DOI 10.1111/j.0006-341X.1999.00711.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	32	303	308	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					39	49		10.1001/jama.295.1.39	http://dx.doi.org/10.1001/jama.295.1.39			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391215	Bronze			2022-12-28	WOS:000234381100019
J	Lieb, JD; Clarke, ND				Lieb, JD; Clarke, ND			Control of transcription through intragenic patterns of nucleosome composition	CELL			English	Review							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; GENOME-WIDE; METHYLATION; PROMOTERS; CHROMATIN; VARIANT; DEACETYLATION; ELONGATION		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Genome Inst Singapore, Singapore 138672, Singapore	University of North Carolina; University of North Carolina Chapel Hill; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, 202 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu; clarken@gis.a-star.edu.sg	Clarke, Neil/D-9613-2014	Lieb, Jason/0000-0001-7601-8061				Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; JOSHI A, 2005, IN PRESS MOL CELL; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LI B, 2005, P NATL ACAD SCI; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Svejstrup JQ, 2003, SCIENCE, V301, P1053, DOI 10.1126/science.1088901; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	20	57	58	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1187	1190		10.1016/j.cell.2005.12.010	http://dx.doi.org/10.1016/j.cell.2005.12.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377560	Bronze			2022-12-28	WOS:000234584500008
J	Richardson, DR				Richardson, DR			24p3 and Its receptor: Dawn of a new iron age?	CELL			English	Article							LIPOCALIN		Childrens Canc Inst Australia Med Res, Iron Metab & Chelat Program, Sydney, NSW 2031, Australia; Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of Sydney	Richardson, DR (corresponding author), Childrens Canc Inst Australia Med Res, Iron Metab & Chelat Program, POB 81,High St, Sydney, NSW 2031, Australia.	d.richardson@pathology.usyd.edu.au		Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274				Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; FERNANDEZPOL JA, 1978, CELL, V14, P489, DOI 10.1016/0092-8674(78)90235-0; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; LEVI J, 1999, NAT GENET, V21, P369; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	11	53	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1175	1177		10.1016/j.cell.2005.12.008	http://dx.doi.org/10.1016/j.cell.2005.12.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377555	Bronze			2022-12-28	WOS:000234584500003
J	Bowling, A; Dieppe, P				Bowling, A; Dieppe, P			What is successful ageing and who should define it?	BRITISH MEDICAL JOURNAL			English	Article							OLDER-ADULTS; LIFE; PREDICTORS; MACARTHUR		UCL, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Bristol, MRC Hlth Serv Res Collaborat, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; University College London; University of Bristol	Bowling, A (corresponding author), UCL, Dept Primary Care & Populat Sci, London NW3 2PF, England.	a.bowling@ucl.ac.uk						Andrews G, 2002, J SOC ISSUES, V58, P749, DOI 10.1111/1540-4560.00288; Baltes PB, 1990, SUCCESSFUL AGING PER; BALTES PB, 1999, BERLIN AGEING STUDY; Callahan CM, 2003, ANN INTERN MED, V139, P389, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00001; Caspi A, 1986, PSYCHOL AGING, V1, P18; Crosnoe R, 2002, SOC PSYCHOL QUART, V65, P309, DOI 10.2307/3090105; Grundy E, 1999, AGING MENT HEALTH, V3, P199, DOI 10.1080/13607869956154; Havighurst R. J., 1968, MIDDLE AGE AGING, P161; Havighurst RJ., 1963, PROCESSES AGING SOCI, P299, DOI 10.1093/geront/1.1.8; Menec VH, 2003, J GERONTOL B-PSYCHOL, V58, pS74, DOI 10.1093/geronb/58.2.S74; Mor V, 2005, J AM GERIATR SOC, V53, pS308, DOI 10.1111/j.1532-5415.2005.53496.x; PALMORE E, 1979, GERONTOLOGIST, V19, P427, DOI 10.1093/geront/19.5_Part_1.427; Phelan EA, 2004, J AM GERIATR SOC, V52, P211, DOI 10.1111/j.1532-5415.2004.52056.x; ROOS NP, 1991, AM J PUBLIC HEALTH, V81, P63, DOI 10.2105/AJPH.81.1.63; Rowe JW, 1998, SUCCESSFUL AGING; RYFF CD, 1989, INT J BEHAV DEV, V12, P35, DOI 10.1177/016502548901200102; Sarkisian CA, 2002, J AM GERIATR SOC, V50, P1837, DOI 10.1046/j.1532-5415.2002.50513.x; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; Seligman M. E. P., 2002, AUTHENTIC HAPPINESS; Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727, DOI 10.1093/geront/42.6.727; Vaillant G. E., 2002, AGING WELL SURPRISIN; Vaillant GE, 2001, AM J PSYCHIAT, V158, P839, DOI 10.1176/appi.ajp.158.6.839; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; WILLIAMS RH, 1965, LIVES YEARS STYLES L	24	379	389	7	53	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1548	1551		10.1136/bmj.331.7531.1548	http://dx.doi.org/10.1136/bmj.331.7531.1548			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373748	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000234351300029
J	Boehm, M; Slack, F				Boehm, M; Slack, F			A developmental timing microRNA and its target regulate life span in C. elegans	SCIENCE			English	Article							TEMPORAL PATTERN-FORMATION; HETEROCHRONIC GENE LIN-14; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LONGEVITY; EXPRESSION; DAF-16; ENCODES; PROTEIN; EVENTS	The microRNA lin-4 and its target, the putative transcription factor lin-14, control the timing of larval development in Caenorhabditis elegans. Here, we report that lin-4 and lin-14 also regulate life span in the adult. Reducing the activity of lin-4 shortened life span and accelerated tissue aging, whereas overexpressing lin-4 or reducing the activity of lin-14 extended life span. Life-span extension conferred by a reduction in lin-14 was dependent on the DAF-16 and HSF-1 transcription factors, suggesting that the lin-4-lin-14 pair affects life span through the insulin/insulin-like growth factor-1 pathway. This work reveals a role for microRNAs and developmental timing genes in life-span regulation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University	Slack, F (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	frank.slack@yale.edu		Slack, Frank/0000-0001-8263-0409	NIGMS NIH HHS [GM64701, R01 GM064701] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064701] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Garigan D, 2002, GENETICS, V161, P1101; Hong Y, 2000, MOL CELL BIOL, V20, P2285, DOI 10.1128/MCB.20.6.2285-2295.2000; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813	30	347	383	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1954	1957		10.1126/science.1115596	http://dx.doi.org/10.1126/science.1115596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373574				2022-12-28	WOS:000234275400042
J	Gaskell, G; Einsiedel, E; Hallman, W; Priest, SH; Jackson, J; Olsthoorn, J				Gaskell, G; Einsiedel, E; Hallman, W; Priest, SH; Jackson, J; Olsthoorn, J			Communication - Social values and the governance of science	SCIENCE			English	Editorial Material									Univ London London Sch Econ & Polit Sci, Methodol Inst, London WC2A 2AE, England; Univ Calgary, Fac Commun & Culture, Calgary, AB T2N 1N4, Canada; Rutgers State Univ, Food Policy Inst, New Brunswick, NJ 08901 USA; Univ S Carolina, Coll Mass Commun & Informat Studies, Columbia, SC 29208 USA; Canadian Biotechnol Secretariat, Ottawa, ON K1A OH5, Canada	University of London; London School Economics & Political Science; University of Calgary; Rutgers State University New Brunswick; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Gaskell, G (corresponding author), Univ London London Sch Econ & Polit Sci, Methodol Inst, Houghton St, London WC2A 2AE, England.	g.gaskell@lse.ac.uk	Hallman, William K/G-3591-2017; Jackson, Jonathan/C-5156-2008; Priest, Susanna/B-1364-2009	Hallman, William K/0000-0002-4524-9876; Jackson, Jonathan/0000-0003-2426-2219; 				Bauer M.W., 2004, BIOTECHNOLOGY PUBLIC; GASKELL G, 2001, BIOTECHNOLOGY 1996 2; Gaskell G., 2003, EUROPEANS BIOTECHNOL; Leshner AI, 2005, SCIENCE, V307, P815, DOI 10.1126/science.1110260; Miller JD, 2004, PUBLIC UNDERST SCI, V13, P273, DOI 10.1177/0963662504044908; 2004, NATURE, V431, P883	6	67	69	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2005	310	5756					1908	1909		10.1126/science.1119444	http://dx.doi.org/10.1126/science.1119444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997UX	16373561				2022-12-28	WOS:000234275400026
J	Galagan, JE; Calvo, SE; Cuomo, C; Ma, LJ; Wortman, JR; Batzoglou, S; Lee, SI; Basturkmen, M; Spevak, CC; Clutterbuck, J; Kapitonov, V; Jurka, J; Scazzocchio, C; Farman, M; Butler, J; Purcell, S; Harris, S; Braus, GH; Draht, O; Busch, S; D'Enfert, C; Bouchier, C; Goldman, GH; Bell-Pedersen, D; Griffiths-Jones, S; Doonan, JH; Yu, J; Vienken, K; Pain, A; Freitag, M; Selker, EU; Archer, DB; Penalva, MA; Oakley, BR; Momany, M; Tanaka, T; Kumagai, T; Asai, K; Machida, M; Nierman, WC; Denning, DW; Caddick, M; Hynes, M; Paoletti, M; Fischer, R; Miller, B; Dyer, P; Sachs, MS; Osmani, SA; Birren, BW				Galagan, JE; Calvo, SE; Cuomo, C; Ma, LJ; Wortman, JR; Batzoglou, S; Lee, SI; Basturkmen, M; Spevak, CC; Clutterbuck, J; Kapitonov, V; Jurka, J; Scazzocchio, C; Farman, M; Butler, J; Purcell, S; Harris, S; Braus, GH; Draht, O; Busch, S; D'Enfert, C; Bouchier, C; Goldman, GH; Bell-Pedersen, D; Griffiths-Jones, S; Doonan, JH; Yu, J; Vienken, K; Pain, A; Freitag, M; Selker, EU; Archer, DB; Penalva, MA; Oakley, BR; Momany, M; Tanaka, T; Kumagai, T; Asai, K; Machida, M; Nierman, WC; Denning, DW; Caddick, M; Hynes, M; Paoletti, M; Fischer, R; Miller, B; Dyer, P; Sachs, MS; Osmani, SA; Birren, BW			Sequencing of Aspergillus nidulans and comparative analysis with A-fumigatus and A-oryzae	NATURE			English	Article							MATING-TYPE; CANDIDA-ALBICANS; GENE-EXPRESSION; BETA-OXIDATION; EVOLUTION; REGULATOR; FUNGUS; TRANSCRIPTION; DYNAMICS	The aspergilli comprise a diverse group of filamentous fungi spanning over 200 million years of evolution. Here we report the genome sequence of the model organism Aspergillus nidulans, and a comparative study with Aspergillus fumigatus, a serious human pathogen, and Aspergillus oryzae, used in the production of sake, miso and soy sauce. Our analysis of genome structure provided a quantitative evaluation of forces driving long-term eukaryotic genome evolution. It also led to an experimentally validated model of mating-type locus evolution, suggesting the potential for sexual reproduction in A. fumigatus and A. oryzae. Our analysis of sequence conservation revealed over 5,000 non-coding regions actively conserved across all three species. Within these regions, we identified potential functional elements including a previously uncharacterized TPP riboswitch and motifs suggesting regulation in filamentous fungi by Puf family genes. We further obtained comparative and experimental evidence indicating widespread translational regulation by upstream open reading frames. These results enhance our understanding of these widely studied fungi as well as provide new insight into eukaryotic genome evolution and gene regulation.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Inst Genome Res, Rockville, MD 20850 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Oregon Hlth & Sci Univ, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Paris 11, Inst Univ France, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; Univ Gottingen, Inst Microbiol & Genet, Dept Microbiol & Mol Genet, D-37077 Gottingen, Germany; INRA USC 2019, Inst Pasteur, Unite Postulante Biol & Pathogen Fong, F-75724 Paris, France; Inst Pasteur, F-75724 Paris, France; Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Sao Paulo, Brazil; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; Univ Karlsruhe, Inst Appl Biosci, D-76187 Karlsruhe, Germany; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; CSIC, Ctr Invest Biol, Madrid 28040, Spain; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; NITE, Shibuya Ku, Tokyo 1510066, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; Univ Manchester, Sch Med, Manchester M23 9PL, Lancs, England; Univ Manchester, Sch Biol Sci, Manchester M23 9PL, Lancs, England; Univ Liverpool, Sch Biol Sci, Donnan Labs, Plant Sci & Fungal Mol Biol Res Grp, Liverpool L69 7ZD, Merseyside, England; Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; J. Craig Venter Institute; Stanford University; Oregon Health & Science University; University of Glasgow; Institut Universitaire de France; UDICE-French Research Universities; Universite Paris Saclay; University of Kentucky; University of Nebraska System; University of Nebraska Lincoln; University of Gottingen; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology; University of Oregon; University of Nottingham; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University System of Ohio; Ohio State University; University System of Georgia; University of Georgia; National Institute of Advanced Industrial Science & Technology (AIST); George Washington University; University of Manchester; University of Manchester; University of Liverpool; University of Melbourne; Idaho; University of Idaho	Galagan, JE (corresponding author), MIT, Broad Inst, 320 Charles St, Cambridge, MA 02142 USA.	jgalag@mit.edu	Denning, David/AAC-6931-2019; Bell-Pedersen, Deborah/H-8012-2016; Fischer, Reinhard/I-1220-2016; Ma, Li-Jun/AAG-2359-2020; Asai, Kiyoshi/AAT-8344-2020; Braus, Gerhard H/G-3999-2012; Osmani, Stephen A./AAS-3904-2021; Goldman, Gustavo Henrique/F-1848-2013; Cuomo, Christina/L-2222-2019; Braus, Gerhard/ABC-6293-2021; Penalva, Miguel A/G-2295-2015; Pain, Arnab/L-5766-2015; Griffiths-Jones, Sam/H-2998-2014	Denning, David/0000-0001-5626-2251; Bell-Pedersen, Deborah/0000-0002-1639-8215; Fischer, Reinhard/0000-0002-6704-2569; Asai, Kiyoshi/0000-0003-0909-4982; Braus, Gerhard H/0000-0002-3117-5626; Goldman, Gustavo Henrique/0000-0002-2986-350X; Cuomo, Christina/0000-0002-5778-960X; Braus, Gerhard/0000-0002-3117-5626; Penalva, Miguel A/0000-0002-3102-2806; Pain, Arnab/0000-0002-1755-2819; Oakley, Berl/0000-0002-3046-8240; Sachs, Matthew/0000-0001-9891-9223; Galagan, James/0000-0003-0542-3291; d'Enfert, Christophe/0000-0002-6235-3886; doonan, john/0000-0001-6027-1919; Wortman, Jennifer/0000-0002-8713-1227; Momany, Michelle/0000-0001-7110-063X; Griffiths-Jones, Sam/0000-0001-6043-807X; Ma, Li-Jun/0000-0002-2733-3708; Dyer, Paul/0000-0003-0237-026X; Yu, Jae-Hyuk/0000-0002-6530-8407	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058529] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [CFB17726] Funding Source: Medline; NIGMS NIH HHS [R01 GM058529] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALZI E, 1994, J BIOL CHEM, V269, P2206; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dyer PS, 2003, MICROBIOL-SGM, V149, P2301, DOI 10.1099/mic.0.C0119-0; DYER PS, 2002, P 7 INT MYC C 2002 O, P331; Eckert SE, 2000, MOL GEN GENET, V263, P867, DOI 10.1007/s004380000250; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hoffmann B, 2001, MOL BIOL CELL, V12, P2846, DOI 10.1091/mbc.12.9.2846; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; KANG SC, 1994, GENETICS, V138, P289; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kerenyi Z, 2004, APPL ENVIRON MICROB, V70, P4419, DOI 10.1128/AEM.70.8.4419-4423.2004; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morozov IY, 2000, MOL MICROBIOL, V37, P1248, DOI 10.1046/j.1365-2958.2000.02085.x; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; NAUTA MJ, 1992, HEREDITY, V68, P537, DOI 10.1038/hdy.1992.76; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; PERKINS DD, 1987, GENETICS, V115, P215; PETERSON SW, 2000, INTEGRATION MODERN T, P323; Poggeler S, 2002, CURR GENET, V42, P153, DOI 10.1007/s00294-002-0338-3; PONTECORVO G, 1958, ADV GENET, V9, P71, DOI 10.1016/S0065-2660(08)60160-1; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Sharon A, 1996, MOL GEN GENET, V251, P60, DOI 10.1007/BF02174345; Slamovits CH, 2004, CURR BIOL, V14, P891, DOI 10.1016/j.cub.2004.04.041; TIMBERLAKE WE, 1989, SCIENCE, V244, P1313, DOI 10.1126/science.2525275; Valerius O, 2001, FUNGAL GENET BIOL, V32, P21, DOI 10.1006/fgbi.2000.1244; VERWEIJ PE, 1995, J MED VET MYCOL, V33, P185, DOI 10.1080/02681219580000381; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592	47	1001	2146	9	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1105	1115		10.1038/nature04341	http://dx.doi.org/10.1038/nature04341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372000	Green Published, Bronze			2022-12-28	WOS:000234111500040
J	Kujala, UM				Kujala, UM			Essay - Does training adversely affect long-term health?	LANCET			English	Article									Univ Jyvaskyla, Dept Hlth Sci, FIN-40014 Jyvaskyla, Finland	University of Jyvaskyla	Kujala, UM (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, POB 35 LL, FIN-40014 Jyvaskyla, Finland.	urho.kujala@sport.jyu.fi	Kujala, Urho/AAP-2547-2020	Kujala, Urho/0000-0002-9262-1992				Kujala UM, 2003, SPORTS MED, V33, P553, DOI 10.2165/00007256-200333080-00001; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Kujala UM, 1996, JAMA-J AM MED ASSOC, V276, P216, DOI 10.1001/jama.276.3.216; Morgan JE, 1987, U OARS; Saltin B, 2010, COMPR PHYSIOL, P555; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294	6	5	5	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S55	S56		10.1016/S0140-6736(05)67853-1	http://dx.doi.org/10.1016/S0140-6736(05)67853-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360758				2022-12-28	WOS:000234374400034
J	MacAuley, D				MacAuley, D			Profile - Roger Bannister	LANCET			English	Biographical-Item									Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland	Queens University Belfast	MacAuley, D (corresponding author), Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland.	Domhnall.macauley@NTLworld.com						BANNISTER R, PUBLICATION LIST	1	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S14	S15		10.1016/S0140-6736(05)67827-0	http://dx.doi.org/10.1016/S0140-6736(05)67827-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360731				2022-12-28	WOS:000234374400010
J	Madrenas, J; Potter, P; Cairns, E				Madrenas, J; Potter, P; Cairns, E			Giving credit where credit is due: John Hunter and the discovery of erythrocyte sedimentation rate	LANCET			English	Editorial Material									Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Hist Med, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Madrenas, J (corresponding author), Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada.	madrenas@robarts.ca	Madrenas, Quim/P-5008-2019; Cairns, Ewa/G-3284-2011					Biernacki E, 1897, DEUT MED WOCHENSCHR, V23, P769; Fahraeus R, 1918, BIOCHEM Z, V89, P355; FISK D, 1959, JENNER BERKELEY; Hunter J., 1794, TREATISE BLOOD INFLA; Hunter J., 1840, TREATISE BLOOD INFLA; KUCHARZ E J, 1988, Journal of Laboratory and Clinical Medicine, V112, P279; KUCHARZ EJ, 1987, LANCET, V329, P696; Paget Stephen, 1897, J HUNTER MAN SCI SUR; REINHART WH, 1989, BRIT J HAEMATOL, V73, P551, DOI 10.1111/j.1365-2141.1989.tb00296.x; TURK JL, 1994, INT J EXP PATHOL, V75, P385	10	6	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2140	2141		10.1016/S0140-6736(05)67337-0	http://dx.doi.org/10.1016/S0140-6736(05)67337-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360794				2022-12-28	WOS:000234146000032
J	Vire, E; Brenner, C; Deplus, R; Blanchon, L; Fraga, M; Didelot, C; Morey, L; Van Eynde, A; Bernard, D; Vanderwinden, JM; Bollen, M; Esteller, M; Di Croce, L; de Launoit, Y; Fuks, F				Vire, E; Brenner, C; Deplus, R; Blanchon, L; Fraga, M; Didelot, C; Morey, L; Van Eynde, A; Bernard, D; Vanderwinden, JM; Bollen, M; Esteller, M; Di Croce, L; de Launoit, Y; Fuks, F			The Polycomb group protein EZH2 directly controls DNA methylation	NATURE			English	Article							HISTONE H3 METHYLTRANSFERASE; LYSINE-27 METHYLATION; GROUP-COMPLEXES; X-INACTIVATION; RECRUITMENT; DNMT1; ESTABLISHMENT; TRANSCRIPTION; REPRESSOR; PATTERNS	The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function(1). The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins(2,3) and the DNA methylation(4,5) systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 ( Enhancer of Zeste homolog 2) interacts within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3) - with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.	Free Univ Brussels, Fac Med, Mol Virol Lab, B-1070 Brussels, Belgium; CNIO, Canc Epigenet Grp, Madrid 28029, Spain; ICREA, E-08003 Barcelona, Spain; CRG, E-08003 Barcelona, Spain; Katholieke Univ Leuven, Fac Geneeskunde, Div Biochem, B-3000 Louvain, Belgium; Free Univ Brussels, Fac Med, Neurophysiol Lab, B-1070 Brussels, Belgium; Univ Lille 1, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8117, F-59021 Lille, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centro Nacional de Investigaciones Oncologicas (CNIO); ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Fuks, F (corresponding author), Free Univ Brussels, Fac Med, Mol Virol Lab, 808 Route Lennik, B-1070 Brussels, Belgium.	ffuks@ulb.ac.be	jia, xu/A-8386-2016; Fraga, Mario F/H-7824-2017; Hu, Ruogu/B-2203-2008; Di Croce, Luciano/E-7759-2015; Esteller, Manel/L-5956-2014; Bernard, David/D-6265-2018	Fraga, Mario F/0000-0001-8450-2603; Di Croce, Luciano/0000-0003-3488-6228; Esteller, Manel/0000-0003-4490-6093; Morey, Lluis/0000-0001-9851-4066; Bernard, David/0000-0002-1557-2074; Mirjolet Didelot, Celine/0000-0003-0047-9421; BLANCHON, LOIC/0000-0001-8842-0162; Vire, Emmanuelle/0000-0002-7868-9923	ICREA Funding Source: Custom	ICREA(ICREA)		Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	27	1595	1683	6	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					871	874		10.1038/nature04431	http://dx.doi.org/10.1038/nature04431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16357870				2022-12-28	WOS:000235333600055
J	Puhan, MA; Suarez, A; Lo Cascio, C; Zahn, A; Heitz, M; Braendli, O				Puhan, MA; Suarez, A; Lo Cascio, C; Zahn, A; Heitz, M; Braendli, O			Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE AIRWAY PRESSURE; CONTROLLED CROSSOVER TRIAL; STIMULATION; HYPOPNEA; OUTCOMES	Objective To assess the effects of didgeridoo playing on daytime sleepiness and other outcomes related to sleep by reducing collapsibility of the upper airways in patients with moderate obstructive sleep apnoea syndrome and snoring. Design Randomised controlled trial. Setting Private practice of a didgeridoo instructor and a single centre for sleep medicine. Participants 25 patients aged > 18 years with an apnoea-hypopnoea index between 15 mid 30 and who complained about snoring. Interventions Didgeridoo lessons,and daily practice at home with standardised instruments for four months. Participants in the control group remained on the waiting list for lessons. Main outcome measure Daytime sleepiness (Epworth scale from 0 (no daytime sleepiness) to 24), sleep quality (Pittsburgh quality of sleep index from 0 (excellent sleep quality) to 21), partner rating of sleep disturbance (visual analogue scale from 0 (not disturbed) to 10), apnoea-hypopnoea index, and health related quality of life (SF-36). Results Participants in the didgeridoo group practised an average of 5.9 days a week (SD 0.86) for 25.3 minutes (SD 3.4). Compared with the control group in the didgeridoo group daytime sleepiness (difference - 3.0, 95% confidence interval - 5.7 to - 0.3, P = 0.03) and apnoea-hypopnoea index (difference - 6.2, - 12.3 to - 0.1, P = 0.05) improved significantly and partners reported less sleep disturbance (difference -2.8, -4.7 to -0.9, P < 0.01). There was no effect on the quality of sleep (difference -0.7, -2.1 to 0.6, P = 0.27). The combined analysis of sleep related outcomes showed a moderate to large effect of didgeridoo playing (difference between summary z scores -0.78 SD units, -1.27 to -0.28, P < 0.01). Changes in health related quality of life did not differ between groups. Conclusion Regular didgeridoo playing is an effective treatment alternative well accepted by patients with moderate obstructive sleep apnoea syndrome.	Zuercher Hoehenklin Wald, Sleep Lab, CH-8639 Faltigberg Wald, Switzerland; Univ Zurich, Horten Ctr, CH-8091 Zurich, Switzerland; Asate Alex Suarez, CH-9630 Wattwil, Switzerland; Lungenpraxis Morgental, Zurich, Switzerland	University of Zurich	Braendli, O (corresponding author), Zuercher Hoehenklin Wald, Sleep Lab, CH-8639 Faltigberg Wald, Switzerland.	otto.braendli@zhw.ch	Puhan, Milo/ABE-6298-2020	Puhan, Milo/0000-0003-4721-1879				BACKHAUS J, 2001, WORLD J BIOL PSYCHIA, pS374; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; FURRERBOSCHUNG E, 1997, THESIS U ZURICH ZURI; FURRERBOSCHUNG E, 1997, THESIS U ZURICH; Kingshott RN, 2001, AM J RESP CRIT CARE, V163, P918, DOI 10.1164/ajrccm.163.4.2005036; Lewis KE, 2004, SLEEP, V27, P134, DOI 10.1093/sleep/27.1.134; Mann EA, 2002, LARYNGOSCOPE, V112, P351, DOI 10.1097/00005537-200202000-00027; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Pepin JL, 1999, AM J RESP CRIT CARE, V160, P1124, DOI 10.1164/ajrccm.160.4.9802027; Randerath WJ, 2004, SLEEP, V27, P254, DOI 10.1093/sleep/27.2.254; Schouten HJA, 2000, J CLIN EPIDEMIOL, V53, P1137, DOI 10.1016/S0895-4356(00)00238-9; SCHULZ H, 2005, KOMPENDIUM SCHLAFMED; Tarnopolsky A, 2005, NATURE, V436, P39, DOI 10.1038/43639a; Verse T, 2003, HNO, V51, P966, DOI 10.1007/s00106-003-0842-x; White J., 2002, COCHRANE DB SYST REV; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	21	134	139	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2006	332	7536					266	268B		10.1136/bmj.38705.470590.55	http://dx.doi.org/10.1136/bmj.38705.470590.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011HN	16377643	Green Published, Bronze			2022-12-28	WOS:000235259000015
J	Bhatt, DL; Steg, PG; Ohman, EM; Hirsch, AT; Ikeda, Y; Mas, JL; Goto, S; Liau, CS; Richard, AJ; Rother, J; Wilson, PWF; Andersen-Dalheim, H; Anderson, P; Anell, B; Arber, S; Armstrong, K; Arnot, D; Baldam, A; Barratt, I; Barresi, S; Beder, J; Benson, M; Bergman, F; Best, J; Bhasim, R; Bovell, G; Bowman, N; Brkic, M; Bromberger, D; Brown, D; Brown, J; Brownstein, M; Bruce, A; Buonopane, J; Burns, S; Butler, A; Byrne, D; Carson, J; Cassimatis, P; Chaffey, G; Chambers, D; Chan, WJ; Chan, B; Cheatham, J; Chen, R; Cheong, B; Cheung, C; Chin, J; Chiu, A; Choo, E; Chow, A; Chow, AM; Chung, D; Conos, M; Cooke, N; Cooper, S; Coulton, P; Cranswick, M; Crichton, G; Dabscheck, A; Dalitz, J; Danishar, J; Darzins, A; Davidson, D; Davis, P; Dawood, N; de Clifford, M; de Looze, F; de Sousa, A; Devi, S; Dickman, J; Donald, H; Dowell, B; Dowey, K; Eizenberg, P; Eizenberg, C; Elberg, L; Enten, P; Erhardt, A; Fagan, R; Fairweather, D; Ferguson, N; Ferguson, P; Fernando, C; Ferres, M; Foley, P; Fong, S; Francis, P; Gaddie, D; Gallagher, B; Gan, R; Garland, J; Gault, A; Gianarakis, N; Gibson, D; Gill, I; Giltrap, M; Gingold, R; Gordon, N; Graham, M; Grave, M; Grigg, J; Hall, L; Hall, M; Hancock, K; Harrison, C; Harrison, R; Hayden, R; Heale, J; Healy, P; Herold, E; Hirst, E; Hodby, S; Hogan, C; Horsfall, P; Hutchinson, A; Irmgard, C; Jain, S; Jefferson, D; John, R; John, T; Kay, B; Kelly, P; Kester, D; Khury, J; Kirmos, J; Kloot, S; Kolos, D; Korner, J; Kratzing, C; Kubicek, J; Kumar, A; Lacey, C; Lahanis, C; Lajoie, D; Lam, L; Lancaster, M; Law, H; Lawlor-Smith, C; Laycock, R; Lee, I; Leung, C; Levitt, L; Lewi, L; Liew, J; Liew, S; Lleweslyn, D; Loth, P; Lyon, E; Maclaren, S; Maher, C; Maldari, F; Manderson, J; Mann, L; Mannan, MA; Marano, F; Marinucci, D; Matthews, A; Matthews, C; McGowan, R; McGrath, L; McKenna, J; McNaughton, E; McNiff, M; Meaney, J; Menzies, J; Michaelson, A; Michail, S; Mitchell, G; Molenaar, R; Molloy, P; Monaco-Mugliston, E; Mooney, C; Moor, M; Moylan, B; Nanayakkara, V; Nathan, P; Naughton, W; Ng, R; Nicholson, K; Nixon, M; Nuendorf, G; O'Brien, C; O'Hanlon, P; Olesen, J; Ong, A; Ong, SG; O'Toole, M; Page, M; Pahuja, P; Palmer, H; Parker, S; Partridge, S; Patroney, H; Pattison, J; Pellizzari, G; Perlesz, AM; Phillips, D; Phillips, A; Philpot, J; Piterman, L; Plenderleith, J; Preston, H; Preston, M; Priest, C; Psaradellis, A; Quarles, W; Quinn, M; Randle, J; Reeves, C; Rhodes, T; Rhodes, F; Rosen, N; Rounsevell, J; Rouse, W; Rozsa, E; Saharay, I; Sakowsky, J; Samararatna, M; Same, N; Sammut, V; Sands, L; Schepisi, D; Scurry, D; See, J; Sheringham, J; Shing, K; Simmons, H; Singh, H; Skardoon, L; Slonim, D; Smith, J; Smith, S; Spurling, G; Stowe, S; Stoyanova, V; Sundar, S; Sutcliffe, H; Sutherland, I; Swan, P; Tam, J; Tapsall, M; Teh, P; Theodoros, S; Thomas, S; Thomas, J; Thompson, K; Thompson, D; Thompson, M; Tiernan, S; Tillett, D; Tong, S; Tran, H; Tran, H; Tuan, T; Treagus, I; Tsiang, CT; Turner, T; Turner, E; van Bavel, J; Verrall, C; Vorich, R; Wall, H; Walton, W; Ward, G; Wauchope, B; Weatherall, C; Wexler, P; White, A; Wiehle, G; Wight, R; Williams, I; Williams, M; Williams, S; Wilson, F; Winterton, P; Wong, S; Wrennall, R; Yat, J; Yelland, M; Yip, G; Zhou, N; Ziccone, M; Zochowski, B; Allen, C; Andracher, G; Atteneder, M; Barbieri, G; Brandstetter, J; Bsteh, C; Deiser, HP; Doder, A; Eckert, W; Fahrleitner-Pammer, A; Fiala, W; Fiedler, L; Fiedler, F; Filip, W; Fochterle, J; Forstner, K; Freynhofer, K; Frieden, T; Fruhwirth, E; Gegenhuber, A; Gewessler, A; Goldsteiner, H; Grisold, M; Gruber, F; Gspandl, W; Hauer, W; Herg, M; Herk, J; Heyer, G; Hiemetzberger, H; Hof, W; Hohenecker, J; Hohensinn, F; Honsig, T; Huber, G; Hutter, H; Iampaglia-Springer, G; Itzlroither, K; Jenny, K; Jenull, E; Jung, M; Jungbauer, K; Kaserbacher, R; Katzenschlager, R; Kimeswenger, J; Kittler, E; Kitzler, G; Koschutnik, M; Kotzmann, H; Krasselt, W; Kuhler, M; Kunauer, B; Kunczicky, H; Kurzemann, S; Lachner, P; Lux, W; Maca, T; Mayer, B; Mika, R; Morz, B; Meller-Ringl, H; Nimmerfall, H; Nowotny, W; Ortner, H; Patzold, D; Perger, T; Petuely, F; Pichler, P; Pinter, K; Pollak, J; Pressl, H; Pusarnig, S; Pusch, K; Radi, M; Rausch, M; Reisenbichler, S; Riedl, R; Sattler, H; Schatz, J; Scheibner, P; Schimbach, H; Schmidauer, C; Schmidt, D; Schossleitner, H; Schumacher, M; Schutzenberger, J; Schwaiger, H; Seit, HP; Sepp, G; Stadlbauer, G; Steiner, EH; Stradner, F; Streichsbier, W; Stummer, A; Stumpflen, A; Teleky, U; Tiesenhausen, K; Topakian, R; Toplak, H; Turkis, M; Unterberger, W; Wais, E; Waitzer, H; Waschnig, A; Waxenegger, H; Weber, WF; Weindl, M; Werner, W; Zadra, E; Zaruba, E; Ziegelmeyer, W; Zitt, K; Blecic, S; Bouhdid, Y; Champagne, P; Coenegrachts, W; Cras, P; Dalcq, JM; Decock, E; Di Mascio, A; Dieudonne, L; Dobbelaere, R; Duhoux, S; Fesler, B; Friart, A; Gallez, L; Jaumotte, JM; Jeangette, S; Knop, JM; Leuridan, R; Libbrecht, N; Massart, JM; Mehuys, G; Merlin, JM; Motte, S; Sprynger, M; Surma, J; Thijs, V; Thoeng, J; Vanholsbeeck, F; Vanhooren, G; Varga, J; Vermassen, F; Vermeulen, M; Ataide, L; Atie, J; Avezum, A; Bandeira, F; Bodanese, L; Brasileiro, A; Carvalho, AC; Esporcatte, R; Esteves, JP; Eugenio, AM; Feitosa, G; Fernandes, J; Halpern, A; Lopes, C; Lyra, R; Machado, N; Maciel, L; Marino, R; Massaro, A; Matos, A; Mesquita, E; Moreira, M; Nagato, Y; Nicolau, JC; Nogueira, PR; Pazin, A; Pires, MT; Rocha, A; Rocha, R; Saraiva, JF; Schmid, H; Azul, JS; Tambascia, M; Xavier, S; Yamamoto, F; Yoshida, W; Zanella, MT; Alexandrova, M; Andonova, V; Assenov, O; Atanassova, P; Baleva, V; Benov, H; Bogdanova, V; Bonev, V; Botushanov, N; Daskalov, T; Daskalov, A; Deltchev, I; Denchev, S; Dimitrov, S; Dimitrov, M; Dimov, B; Donova, T; Draganov, T; Dramov, A; Enicheynova, E; Finkov, B; Genov, K; Georgiev, S; Georgiev, S; Georgieva-Tyaneva, Z; Gospodinova, M; Grigorova, V; Hadjolian, E; Hergeldjieva, V; Hrant, E; Ivanova, L; Hristova, SI; Kaneva, D; Karagiozov, Z; Karakaneva-Cholakova, S; Klissurski, M; Kolarov, R; Konteva, M; Lekushev, S; Loukanova, D; Madjarov, A; Manchev, I; Maslarska, Z; Matosyan-Bogdanova, H; Mazhdrakov, G; Micheva, T; Mihailov, M; Milanov, I; Milyotev, I; Naidenova, E; Naydenov, V; Nedialkov, E; Nikolova, G; Panova, M; Panteleeva, S; Papazian, Z; Pasheva, V; Peltekov, A; Penev, A; Petranov, S; Petrov, I; Petrova, J; Petrova, E; Postadjian, A; Raychev, I; Rifai, N; Rousseva, I; Runev, N; Runkov, R; Rusinov, V; Shotekov, P; Simeonova, N; Smilkova, D; Staikov, I; Staikova, E; Stamenova, P; Stankova, K; Stefanov, G; Stoyanov, V; Stoyanovsky, V; Teneva, V; Tisheva, S; Traykov, L; Trendafilova-Lazarova, D; Tsolova, M; Tsonevska, G; Tzekova, M; Tzolov, M; Valcheva, L; Valcheva, E; Valtcheva, R; Vassileva, E; Velchev, V; Velkova, T; Vlahova, M; Yancheva, S; Zahariev, Z; Zhelev, V; Abdulla, A; Andrea, G; Andrew, C; April, G; Ashley, J; Audet, R; Avinashi, R; Axler, J; Baer, C; Bailey, A; Banta, G; Bell, A; Bernstein, I; Berube, C; Bolduc, P; Bouthillier, J; Bree, T; Brown, G; Caplan, D; Chan, J; Chan, W; Chan, C; Chen, R; Cherry, J; Chiu, J; Cho, K; Choi-Fung, B; Chouinard, G; Ciavarella, A; Constance, C; Conway, JR; Cote, M; Cox, R; Crelinsten, G; Cucuzza, MJ; Damji, M; de Young, JP; Dionne, L; Doane, F; Duckett, J; Emond, S; Esmail, S; Faiers, A; Fay, D; Ferguson, L; Ferguson, M; Gaudreau, G; Geenen, C; Gendron, JP; Giannoccaro, P; Godbout, J; Gonzalez, Y; Goodman, S; Govender, K; Goyer, P; Gregus, V; Habert, J; Habib, N; Henein, S; Herman, RJ; Hii, J; Hill, M; Hinnawi, HM; Hollands, R; Hong, T; Hrabarchuk, B; Hum, P; Ismail, S; Jaffer, N; Janmohamed, A; Kelly, A; Kenshole, A; Kessel, B; Kooy, J; Lafrance, G; Lam, SY; Landry, D; Lang, C; Lanthier, L; Lauriston, C; Lauzon, C; Lavigueur, D; Leung, A; Lipsett, W; Lubelsky, B; Luftspring, L; Luton, R; Ma, P; Mackey, A; Marsh, D; Martel, JM; Mawji, A; Mehta, P; Melvin, K; Merali, K; Meunier, P; Meyerson, J; Miron, MJ; Misik, K; Mitha, P; Morgenthau, D; Neu, RD; Nguyen, PB; Nirwan, A; Nunes-Vaz, C; Nykiforuk, E; O'Mahony, W; Omichinski, M; Paquin, M; Patel, K; Patel, R; Payer, P; Payne, A; Pazuki, K; Peer, I; Phaneuf, C; Plamondon, G; Pluta, H; Pottle, K; Price, J; Rebane, A; Rebane, T; Roberge, C; Rockman, G; Rosenberg, D; Rosenthall, W; Ross, J; Rudner, H; Saad, S; Saunders, K; Savvidou, G; Sharma, N; Sobkowski, W; St-Amour, E; Strom, B; Sussman, J; Szparaga, C; Talbot, P; Talwalkar, PA; Theriault, L; Turpie, G; Veloso, F; Vertes, G; Villeneuve, J; Vu, T; Weinstock, M; White, R; Wong, D; Wong, W; Yim, D; Yip, D; Yolles, L; Zimmermann, B; Acevedo, M; Araya, F; Barrientos, N; Bianchi, V; Chavez, E; Diaz, R; Dighero, H; Gajardo, J; Garayar, B; Garrido, B; Gutierrez, V; Hoppe, A; Kauffmann, R; Kramer, A; Kunstmann, S; Manriquez, L; Srur, E; Tapia, J; Varleta, P; Villar, R; Cai, NS; Cao, SP; Di Chen, S; Chen, JL; Chen, XP; Cheng, Y; Cui, LY; Di, Q; Ding, XS; Du, ZM; Fan, W; Fu, JH; Gai, LY; Gao, W; He, GX; Hu, CL; Huang, YN; Huang, SW; Huang, QY; Jin, DX; Li, W; Li, J; Li, CJ; Li, ZY; Lin, JW; Liu, MY; Liu, XF; Liu, M; Luo, BY; Lv, L; Ma, AQ; Miao, L; Ni, HC; Niu, GZ; Peng, GG; Pu, CQ; Pu, PL; Qi, GX; Rao, ML; Song, J; Song, SJ; Sun, XJ; Tao, QL; Teng, JJ; Wan, Z; Wang, SS; Wang, WQ; Wang, YJ; Wang, DX; Wang, JA; Wang, W; Wang, LJ; Wei, JP; Weng, SX; Wu, ZG; Wu, SY; Bin Wu, C; Xiao, B; Xu, F; Xu, Y; Yan, XW; Yu, B; Zhagn, HQ; Zhang, FR; Zhang, BW; Zhang, Y; Zhou, SN; Zhou, YL; Zhu, JH; Agner, E; Boysen, G; Davidsen, O; Engby, B; Frifeldt, JJ; Fruergaard, P; Geisler, K; Gulliksen, G; Hansen, AK; Holck, P; Iversen, HK; Johannesen, N; Kahr, O; Kastrup, A; Kjaergaard, JO; Klausen, IC; Lessing, M; Lund, P; Madsen, H; McNair, A; Meden, P; Michley, H; Mickley, H; Mortensen, TM; Nielsen, W; Kjaer, MO; Oskoie, M; Petersen, J; Poulsen, T; Ralfkiaer, N; Romer, FK; Sondergaard, M; Sorensen, T; Svaneborg, N; Tuxen, C; Hansen, AW; Wolff, B; Aittola, V; Eralinna, JP; Hallberg, V; Harjola, VP; Huikuri, H; Hyttinen, R; Icen, R; Ikonen, T; Kaitila, T; Karmakoski, J; Keinanen-Kiukaanniemi, S; Kettunen, R; Kohonen-Jalonen, P; Koistinen, J; Korhonen, P; Korkeila, P; Kuisma, I; Laaksonen, M; Melin, J; Nissila, M; Ohisalo, J; Pammo, O; Puranen, J; Railo, M; Rantala, A; Repo-Outakoski, M; Sako, E; Sallinen, O; Strandberg, A; Sulosaari, S; Taurio, J; Tuominen, ML; Virkamaki, A; Abdi-Kriaa, L; Abenhaim, N; Aerts, P; Aigle, L; Albert, JP; Albouy, A; Ali-Mirode, A; Allix, J; Amendola, M; Amigues, G; Amougay, H; Anderson, P; Andreani, P; Antoine, C; Arnold, C; Arnould, M; Arrondel, MA; Attali, P; Attuil, R; Aubois, P; Aucouturier, M; Audibert, M; Audouy, P; Auge, C; Auriault, JR; Azoulay, JL; Bachongy, P; Badoc, G; Baehrel, M; Baer, C; Baissas, O; Barada, Y; Baragnon, M; Baranes, C; Barbellion, M; Barberet, G; Bardoux, A; Bargier, J; Bariaud, A; Barjhoux, C; Baron, F; Baron, D; Bartoli, S; Bayle, P; Beck, C; Bell, C; Benais, O; Benichou, H; Bensoussan, JL; Vincent, B; Berdague, P; Bernet-Bernady, P; Bernier, JM; Berrut, G; Berto, N; Berville, D; Bessette, P; Betta, T; Bindler, G; Birry, G; Bisch, O; Bismuth, M; Blanc-Vannet, P; Blouin, P; Boccalon, H; Bodiou, PJ; Boely, T; Eric,; Boitelle, G; Bontemps, T; Bortolotti, C; Bortolotti, D; Bosselut, G; Bouche, M; Bouche, P; Bouchetoux, H; Boulanger, P; Bourahoui, A; Bourgoin, M; Boutelier, F; Boutfol, E; Boyer, P; Boyer, P; Brachet, A; Brafman, O; Brassac, R; Breton, N; Bringer-Raingeard, I; Broussaud, J; Broutin, F; Brunaud, C; Bruneau, P; Brunet, O; Buchon, D; Buffler, P; Cabane, J; Cadinot, D; Calmeiro, A; Campagnac, A; Campagnac, J; Canali, T; Cano, ME; Cano, E; Canu, P; Caparros, D; Cardon, C; Carlotti, M; Carniaux, F; Carre, P; Casanova, M; Casanova, I; Casedevant, B; Castaner, M; Castany, J; Cauchy, B; Causse, P; Cavat, C; Cayron, P; Cazale-Richier, MA; Cazals, C; Cazard, C; Ceccarelli, B; Cerda, P; Cerna, C; Chabreron, P; Chalaux, P; Chaleon, A; Chalvignac, A; Chaperon, R; Chaplin, P; Chapuis, S; Charbonnel, L; Charbonnel, P; Chatelet, MF; Chauvois, C; Chay, M; Chemouni, P; Cherbi, C; Chevalier, JM; Cheynel, JF; Chiausa, B; Choussat, R; Chretien, M; Cibois-Honnorat, I; Cimino, L; Cini, S; Claudel, C; Claudel, Y; Codron, G; Coeure, T; Cohen, M; Cohen, S; Cohen-Bacry, JP; Cohen-Seban, F; Coispeau, MP; Colin, H; Collet, JP; Colobert, A; Combet, R; Conchonnet, P; Conri, C; Coppe, B; Cordier, C; Coriol, F; Coriol, I; Corre, V; Cosson, S; Costargent, A; Cothenet, M; Cottencin, JF; Cottin, Y; Coudert, G; Courreges, JP; Cuisinier, B; Custoza, E; Dages, L; Dahan, S; Dary, P; Daumas, C; Daumas, ML; David, M; de Almeida, A; de Guibert, A; de Joux, E; de la Grandville, B; de Mautort, E; de Saint-Martin, E; Debout, J; Decloux, O; Defrance, F; Defreyn, F; Degeilh, M; Delan, E; Delandre, T; Delbachian, I; Delcros, A; Delefosse, D; Delplace, C; Dely, B; Deme, JC; Demortiere, MH; Deneuville, P; Depoisier, M; Depret-Bixio, G; Derochet, M; Descombes, S; Desgranges, JP; Dessales-Quentin, P; Dewulf, J; Dimon, B; Doat, P; Doazan, JP; Doerr, JY; Domenech, A; Domigo, V; Donal, E; Dormard, C; Doucet, B; Dreux, D; Dubedout, B; Ducarme, JC; Duclos, G; Dugny, G; Dumond, P; Dunand, T; Dupouy, P; Dupre, JP; Dupuy, O; Durantel, T; Durbiano, JF; Dutilleul, P; Duval, M; Duvochel, L; Eckert, V; Edet, D; Ehrlich, JM; Eisele, P; Elbhar-Pouchoue, C; Escourrou, B; Espinasse, P; Etienne, JC; Etienney, J; Eveillard, FX; Eveno, D; Fabregue, C; Farhat, S; Fauchard-Renard, C; Fauchier, V; Favre, S; Fayard, P; Feldmann, I; Felten, D; Ferchaud, P; Feret, D; Ferreira-Maldent, N; Ferrier, R; Ferrieres, J; Feuillet, J; Fivel, C; Fleury, C; Flizot, M; Flosi, M; Foltzer, E; Fontaine, X; Fonteny, R; Forestier, B; Forne, M; Fortis, A; Fouillat, C; Fouillen, B; Foure, Y; Fournier, P; Fournillou, JC; Franchet, M; Francillotti, A; Francois, C; Frayssinhes, M; Gabrielli, JL; Galy, P; Garnier, J; Garnier, P; Garnier, E; Garrel, E; Gasior, C; Gaudisart-Amblard, I; Gauthier, B; Gay, P; Genoud, D; Geoffray, B; Germain, P; Geronimi, O; Gilles, L; Gin, H; Ginestet, P; Giorgi, JP; Giraldi, C; Girard, C; Gissler, M; Gleye, V; Glorieux, I; Goepfert, L; Gournay-Lahoussine, MC; Gouron, P; Grabovescu, M; Grange, P; Gran-Ortiz, SM; Grazzini, JP; Grevet, D; Grivet, B; Grivet, F; Groell, R; Grohar, M; Grollier, G; Gros, P; Gros, B; Grutter, S; Guichard, G; Guilharretze, R; Guillaumot, H; Guillemot, D; Haller, C; Hamel-Desnos, C; Hannoush, E; Harroch, M; Haus, JC; Hebert, M; Helms, E; Hemocq, M; Frederic, H; Henry, B; Herent, M; Hertling, R; Hild, P; Hild, C; Hosseini, H; Hourcq, JC; Hovine, JL; Huberschwiller, JL; Huet, R; Huet, D; Humbert, T; Ihli, D; Iriart, JL; Jacamon, Y; Jacqueminet, S; Jacques, V; Jacquet, C; Jacquet, JP; Jacquot, A; Jamet, JF; Jamilloux, D; Jappy, L; Jaudon, P; Jean, F; Jean, G; Jeanjean, F; Jedynak, C; Jonot, F; Jordan, E; Joseph, T; Jouin, C; Jourdan, P; Jusserand, JT; Kaltenbach, E; Kerharo-Nicolas, A; Khennouf, A; Kleimberg, C; Kleimberg, D; Kohser, P; Koubbi, A; Krempf, M; Kuhn, P; Kurtz, C; Lacoin, F; Lagrange, V; Lahoussine, S; Lambert, P; Lamperin, JM; Lanusse-Cazale, G; Largillier, C; Lascaux, D; Latour, R; Lauer, JM; Lauga, D; Laulhe, F; Launay, J; Laur, MP; Laureille, B; Laurent, P; Laurent-Montero, F; Lavallee, P; Lavigne, MC; Le Devehat, C; Le Diagon, R; Le Du, J; Le Mouel, S; Lecaignard, D; Lecarme, C; Leclercq, F; Lecue, V; Ledru, F; Lefort, D; Legrand, C; Leguerrier, AM; Lelgouarch, J; Lemaire, L; Lemaire, M; Lemaire, P; Lemarie, B; Lemettre, B; Lemoine, P; Lenormand, M; Lepoutre, JL; Lerich, B; Lerouge, JM; Lescoute-Jabot, M; Letellier, PY; Letzelter, JM; Leveque, M; Levy, M; Levy-Casson, B; Leygnac, P; Lhosmot, JP; Liard, F; Lion, A; Locquet, J; Loewert, JF; Lormeau, B; Louis, J; Louison, A; Louveau, P; Louy, M; Lussiana, G; Mabire, P; Machero, Y; Macian-Montoro, F; Magnaval, C; Magnus, P; Maillan-Martin, M; Mainetti, P; Mallemont, C; Mallet, P; Manigold, P; Marchand, P; Marciano, D; Marger, JL; Marino, B; Marissal, P; Martial, P; Martin, R; Martin, J; Martin-Peridier, M; Martins, H; Martocq, G; Masson, JJ; Mathys, I; Maupin, Y; Maury, D; Medvedowsky, A; Meimoun, P; Mercey, Y; Mercier, A; Meresse, C; Messner, P; Metivier, M; Meyrand, B; Mezin, J; Michalak, B; Michel, C; Michellier, P; Milhaud, D; Mohsen, M; Molinier, JF; Molinier, M; Mollet, G; Molleville, J; Monsegur, P; Montloin, F; Moreno, R; Moritz, D; Morvan, P; Mottin, J; Mougenot-Pierson, B; Moura, H; Mours, P; Moussu, P; Moutier, P; Mteirek, M; Muller, JJ; Nabedian, E; Naybodokama, J; Neau, JP; Nejman, M; Nerson, J; Nevians, P; N'guyen, B; Nicodeme, JL; Niel, L; Nivelleau, E; Noel, R; Nusimovici, JC; Obadia, D; Oger, T; Olive, A; Olivier, C; Olland, PL; Orenstein, D; Outteryck, A; Pabst, JM; Pachod, D; Page, E; Paillard, F; Panacciulli, JE; Paneau, D; Paradis, C; Parent, D; Paris, M; Pellenc, C; Penfornis, A; Percheron, CA; Perez, G; Perez-Martin, A; Perin, B; Pernin, D; Perreur, P; Perrier, E; Perrin, B; Perrotel, JL; Perrousse, M; Perroux, V; Petit, L; Petit, O; Peyraud, J; Philipp, JM; Philippeau, F; Picard, Y; Piera, JF; Pieretti, M; Pierini, J; Pierre-Justin, E; Pietri, P; Pinaud, D; Pinel, JF; Pinel, G; Pinson, FX; Piot, C; Pistorius, MA; Pithon, M; Pithon, A; Plan, P; Poggi, JN; Poinot, P; Poisson, P; Poquet, A; Pouedras, YY; Pouedras-Raton, F; Pouget, M; Pourcin, J; Pradeau, R; Prat, J; Prat-Caillol, C; Prieur, T; Prijac, B; Proville, JM; Pucheu, A; Pueyo, JB; Puiggali, CP; Pujol, F; Quadrelli, J; Queguiner, A; Quere, I; Quilliou, F; Quiqempois-Kaminski, A; Rabut, F; Rahili-Polette, S; Rambaud, J; Raucourt, P; Ravel, S; Ravoire, P; Rebiere, S; Rebmann, S; Regnier, J; Reichard, MT; Reinard, JF; Reins, P; Remacle, A; Remerieras, JJ; Renucci, JF; Reny, JL; Resslen, Y; Reumont, G; Reynier, JL; Riera, C; Rietsch, JF; Ripoll, M; Ritz, P; Robert, JP; Robert, J; Robert, D; Robin, F; Roche, C; Rodier, G; Roger, JJ; Rolland, JF; Romen, E; Rondeau, JL; Ronziere, G; Roques, A; Rosenberg, S; Rosier, F; Rosset, E; Rouchaud, E; Roudiere, C; Roussel, R; Rousset, A; Rouviere, G; Ruetsch, M; Ruivard, M; Sacareau, D; Sagez, JF; Saillard, D; Salerno, P; Salloum, A; Salzmann, M; Samat, J; Saouma, N; Sarfati, H; Sastourne, JP; Saunier, JL; Saurat, A; Savoyen, D; Scellier, C; Schaal, C; Schatzkine, P; Schmitt, A; Schnebelen, C; Schordan, R; Schroeder, K; Schultz, Y; Schwab, R; Seinturier, C; Sement, S; Senk, D; Sesoren, I; Seveyrac, JF; Simorre, O; Sinoir, PF; Slama, G; Sorbe, G; Soret, F; Soria-Berdugo, S; Soskin, P; Soulary, JC; Spiess, P; Spilthooren, F; Steinberger, M; Stoll, JJ; Stoll, A; Strentz, P; Tallet, N; Taminau, D; Tan, S; Tap, M; Tarouel, P; Taverne, P; Templier-Gauthier, E; Terrail, M; Terrien, JP; Theoule, J; Tiberghien, P; Tiev, KP; Tisserand, R; Toledano, J; Tomaszenwski, B; Toto-Grisoni, C; Touzet, P; Tricoire, E; Tricot, F; Triot, P; Valette, T; Vandooren, E; Vanhoutte, C; Vanier, S; Vayre, F; Vedrenne, J; Venjus, P; Venturini, G; Verlet, E; Verney, G; Vernhes, JF; Verquerre, M; Vialette, JC; Vienne, R; Vigier, P; Vignoulle, JL; Villon, L; Vincey, C; Vogel, JY; Vogt, P; Vonarx, J; Vuong, MH; Weigel, JL; Wencker, C; Wey, N; Winter, P; Wodey, V; Wurtz, JL; Yoh, F; Yvenov, S; Zaknoune, A; Zamaria, G; Zerbib, F; Zoro, P; Abdul-Malak, P; Abel, C; Achatz, M; Akalin, S; Alexander, C; Altenkaamper, H; Andres, M; Angenvoort, C; Appy, M; Arkenau, C; Bach, M; Baier, S; Ballstaedt, C; Baran, C; Barbuia, M; Barho, C; auf dem Brinke, AB; Bauer, O; Bauersachs, M; Bauknecht, C; Baumann, I; Beck, C; Becker, R; Becker, HJ; Beermann, H; Bemmann, D; Berdermann, S; Besser, O; Beyer, R; Birke, R; Bodammer, M; Bodenschatz, R; Bogel, M; Bohe, JP; Bohm, G; Bohme, J; Bondke, C; Bonenkamp, A; Booz, S; Borgmann, A; Brachmann, R; Brado, B; Braun, HJ; Braun, RM; Breuer, HH; Brockmann, S; Broer, F; Bronder, B; Bruck, G; Bruck, H; Bruckmann-Stautner, C; Bruckner, C; Brune, S; Buchholz, P; Buchkremer, R; Bunge, K; Burczyk, U; Burgei-Seifert, G; Busch, HM; Buschmann, L; Butz, U; Cebulski, AC; Clob, R; Coppenrath, K; Cornely, D; Daikeler, R; Daniel, J; Daxer, A; Deeg, W; Degering, H; Delank, C; Diehls, K; Dobiasch, F; Dobner, M; Doumit, A; Drechsler, C; Dresler, R; Drews, H; Droese, K; Drummer, J; Drzymalla, R; Dubowy, J; Dursch, M; Dusold, F; Ebeling, K; Ebert, HH; Eckert, D; Eckert, V; Eichner, R; El, SJ; Eltges, N; Emde, E; Engeser, P; Esmaty, A; Exner, H; Faber, U; Facius, H; Falkenhahn, D; Feldmann, T; Fiala, G; Fiedler, A; Finck, M; Finkenthei, J; Fissan, H; Fleischer, U; Flohr, K; Franke, D; Franke, H; Franz, R; Franzmann, F; Frees, U; Freimuth, M; Freundl, D; Frieling, A; Froehlich, B; Frohlich, A; Frommhold, M; Garten, H; Gartner, J; Gerbaulet, U; Gerhardt, A; Gerlach, T; Glaser, W; Glomm, H; Glos, J; Godt, U; Goudarzi, G; Grams, O; Greie, KD; Grosschaedl, A; Grobkopf, J; Grun, LKJ; Grutzner, E; Grzeschik, HG; Haaf, J; Haas-Weber, M; Hadlich, G; Hafender, K; Hagenow, A; Hahn, W; Hailer, D; Hammerl, M; Hanselle, U; Hansen, S; Hardt, M; Hauer, R; Hauk-Westerhoff, L; Hauser, ER; Hecht, JP; Hedtkamp, CU; Hefftler, V; Heimann, D; Heinl, T; Heinrich, U; Heinz, GU; Henke, S; Hentrich, W; Herber, H; Herbers, J; Herbst, H; Herman, G; Hertzer, P; Herzog, W; Hess, H; Hebeling, C; Hestermann, M; Heyenbrock, M; Hietkamp, S; Hildebrand, P; Hilgedieck, M; Hofmann, M; Hohensee, H; Hohnstein, E; Huch, H; Humke, G; Hundgen, R; Huning, H; Huntemann, R; Huppertz, W; Hutt, T; Huttner, H; Ihle, W; Jacobi, S; Jager, J; Jager, BU; Jahnke, N; Jankowski, A; Jansch, S; Jesinghaus, D; Jeske, J; Jung, M; Jungblut, G; Junge, U; Jungmann, WG; Kaiser, J; Kaiser, W; Kajzar, M; Karakas, T; Karatay, E; Karl, S; Kaviani-Nejad, K; Kayali, N; Keienburg, T; Keller, H; Kebler, GR; Kirsch, A; Klein, C; Klein, M; Kleinert, A; Klementz, A; Klopper, JW; Kmoth, E; Knispel, O; Knobloch, E; Koch, V; Kochen, S; Kochhauser, W; Koeppel, A; Kohl, SC; Kohler, A; Kohler, C; Kohlhas, K; Kohn, RD; Konemann, K; Konschak, A; Konstanzer, A; Kopplin, U; Kornadt, T; Kortas, R; Kossow, T; Kraaz, K; Kramer, A; Krause, G; Kreckel, P; Kretschmer, K; Kretschmer, S; Kretzschmar, W; Krupp, C; Kuhn, R; Kuhnen, R; Kunert, H; Kunze, S; Kuther, D; Kutscherskij, C; Kutz, B; Labitzke, S; Lang, HJ; Lange, T; Lanta, L; Lanzendorfer, C; Lasana, JE; Lederle, S; Lempke, K; Lenfers, M; Lenk, U; Leyer, M; Lipp, I; Lippert, R; Litzinger, B; Loprich, B; Lossl, K; Ludewig, S; Ludwig, G; Lukannek, S; Magdefrau, M; Mantaj, R; Markreiter, M; Martak, F; Marten, T; May, A; Herbert,; Meier, U; Meier, S; Meinecke, E; Meinung, U; Meisel, E; Meibner, M; Merbach, U; Messner, H; Methfessel, FH; Metscher, B; Meub, H; Meyer-Bender, B; Micke, L; Mietaschk, A; Mohr, W; Moltzahn, S; Mondorf, C; Morell, R; Moritz-Lippmeyer, M; Muller, W; Mueller-Buehl, U; Mura, R; Naumann, R; Nedder, KH; Neeff, A; Nehrig, P; Neu, A; Neumann, E; Neumann, RM; Nikolaus, HP; Nissen, L; Nold, R; Oertel, R; Ofer, H; Offermann, R; Opel, G; Opitz, T; Ostmann, B; Pankow, PM; Patschan, R; Patz, A; Pellens, A; Perlwitz, R; Pfetsch, KH; Philippi, H; Piepenbrock, N; Pinterowitsch, J; Pohle, B; Poll, A; Pomiersky, C; Poten, B; Prange, E; Preissner-Kiebling, A; Puls, HD; Puth, P; Puttbach, R; Putz, H; Quosigk, R; Raab, H; Rabahieh, R; Raddant, R; Ramm, F; Rapp, G; Ratzmann, KP; Rau, M; Rautenberg, W; Reiff, T; Reike, N; Reinhard, BD; Reischl, A; Rentz, U; Reul, A; Rieker, E; Ries, S; Rink, V; Rippl, CE; Rissel, U; Ritter, U; Rohl, S; Rohlfing, H; Rohrich, M; Rosenthal, A; Roth, V; Roth, M; Rotsel-Schafer, U; Rottenberger, M; Rudolph, K; Ruider, H; Ruland, D; Rupp, H; Ruter, J; Ruthlein, V; Sach, A; Safavi, A; Sagemuller, P; Sakrib, U; Sayegh, A; Schafer, T; Scharrel, H; Schellenberg, G; Schenk, W; Schiffmann, O; Schimek, J; Schladitz, K; Schlegl, J; Schlick, M; Schluter, HJ; Schluter-Block, G; Schmid, G; Schmidtke, S; Schmiedeberg, K; Schneider, G; Schnittert, K; Schnittert, M; Scholl, N; Scholz, M; Schon, D; Schone, S; Schonecker, W; Schonen, J; Schonfelder, T; Schonrock, E; Schreiner, M; Schreiner, M; Schriek, J; Schroder, T; Schroder, B; Schroder, P; Schroter, W; Schulte, D; Schulten, K; Schultz, D; Schumacher, A; Schuster, J; Schutz, M; Schwadorf, H; Schwarz, T; Schweighofer, HG; Schweyer, L; Sczesni, B; Schon, N; Segebrecht, P; Seidel, B; Seifert, K; Seifert, HP; Seiler, AM; Seitz, C; Senftleber, I; Simon, J; Sindl, A; Sinn, L; Sinning, UH; Sliwka, U; Sommerlatte, T; Sorncharoen, T; Sperle, W; Spitzer, A; Stadt, D; Stadtmuller, J; Stahl, A; Stegner, A; Stein, W; Stein, J; Steindorf, J; Steinle, M; Steinmeier, A; Stenzel, G; Stiegler, K; Stocking, B; Stohrer, HG; Stroh, HJ; Strubel, G; Swistowski, J; Tagder, A; Taggeselle, J; Taubert, G; Tauchert, S; Thamm, ME; Thiel, G; Thinesse-Mallwitz, M; Thum, J; Tietz, M; Todoroff, K; Traub-Bobrich, E; Troger, S; Tuchscherer, U; Tulaj, B; Turowski, A; Tymiec, S; Udvari, E; Ullerich, G; Unger, C; Utz, I; van Hasselt, P; Villis, R; Vogt, A; Volckers, C; Volker, J; Voller, T; von Bilderling, PB; von Molitor, S; Voskamp, A; Wagner, A; Wagner, B; Walther, F; Weider, CM; Weier, B; Weilacher, J; Weirich, C; Weislogel, R; Weissinger, G; Wenck, M; Werner, J; Werner, M; Weyers, G; Wiedemann, K; Wiedemann, ML; Wiegank, S; Wilbrandt, E; Wildenauer, W; Willers, B; Winter, WR; Wirtz, D; Wissmuller, HF; Wolde, CH; Woschech, M; Wunderlich, M; Zeese, V; Zens, V; Zimmermann, K; Zorn, A; Asimi, G; Bakalis, C; Bakopoulos, C; Balis, D; Baltatzis, K; Basdekidis, A; Caraindros, I; Chatsiou, A; Chatzigiannis, P; Dakos, G; Dantsi, G; Deligianinis, G; Demiris, A; Dermitzakis, I; Dima, C; Dimitriadis, C; Fatsis, M; Floros, G; Garbis, A; Georgiadis, I; Georgogiannis, N; Groutsis, T; Kapetanakis, L; Kapsoudas, N; Karabali, S; Karagiannis, D; Karalioliou, S; Klitsas, A; Kotsis, N; Koulouzakis, P; Ktistakis, S; Liberakis, S; Mandalaki, E; Manolakos, A; Maranga, A; Markoglou, N; Meramvoliotakis, N; Milopoulos, C; Mimilas, N; Moschonas, I; Navrouzoglou, I; Panagiotopoulos, P; Papaeconomou, D; Papathanasiou, N; Pappa, I; Parissis, D; Petras, C; Petropoulos, I; Pontikakis, N; Pontikis, C; Ragias, G; Rigas, S; Riza, P; Sabatakakis, P; Sitis, V; Skanavis, A; Skirla, F; Sotiriou, M; Stakiadis, M; Stilianoudaki, S; Syrigou, A; Tachmatzidis, I; Takis, K; Tassopoulou, P; Tekos, K; Theodorakis, A; Theodoropoulos, I; Tsakiris, T; Tserkezou, M; Varnavas, I; Venetia, P; Vrachnakis, N; Ziros, G; Zouberis, I; Yeong, CKA; Chan, N; Choi, K; Chow, SL; Chu, CL; Chung, HK; Goh, V; Kong, YF; Ku, CS; Lam, ACK; Lau, YT; Lo, CW; Ng, WF; Tong, P; Tong, WK; Tsang, CA; Tsui, HS; Wong, BL; Wong, WK; Yu, YK; Adam, A; Antalics, G; Balas, V; Bartfai, E; Bartha, Z; Bata, M; Bernath, B; Bodnar, I; Csomos, I; Csordas, M; Czucza, E; Darvai, L; Dulai, I; Eberling, G; Endre, V; Farkas, K; Foldesi, G; Forgacs, S; Garai, B; Gergely, G; Gubucz, I; Hajdara, I; Hamvas, J; Harcos, P; Hasitz, A; Hegedus, G; Hegyi, M; Hermann, Z; Jakab, K; Juhasz, I; Juhasz, K; Katalin, G; Keresztes, A; Kosa, I; Koves, A; Lakatos, J; Lippai, L; Lovasz, T; Lupkovics, G; Magyar, A; Magyarosy, E; Major, T; Makai, A; Marton, R; Mede, K; Metz, E; Molnar, M; Muranyi, A; Nagy, Z; Olasz, M; Paulo, K; Penner, I; Revesz, Z; Roth, P; Rozsa, S; Sarkadi, C; Semjen, J; Sipos, TA; Sitkei, E; Strebely, G; Sudar, Z; Szabo, Z; Szepesvari, S; Toth, G; Trapp, G; Zsigmond, A; Zuberecz, Z; Adam, J; Agoes, A; Andaningsih-Rahardja, I; Arjuna, R; Asdie, A; Basyah, A; Budiarsa, IGNK; Dirdjaningrat, D; Djokomoeljanto, R; Fathoni, M; Gunawan, BI; Hendromartono, MA; Kadarjono, LA; Kalim, H; Kaoy, IN; Karim, S; Kasiman, S; Kusmana, D; Limantoro, C; Limoa, RA; Arifin, AL; Mardianto, LHM; Maryono, D; Mazwar, I; Misbach, J; Nangoi, P; Pudjowidyanto, H; Purnomo, H; Gunadhi, IGNP; Rahmawati, D; Rifqi, S; Ritarwan, K; Santoso, A; Santoso, T; Sastrosukarno, S; Setiati, S; Setijorumekso, S; Soehartono, Y; Suhana, D; Susilo, JAH; Sutanegara, IND; Syawal, A; Tanuwidjaja, S; Wasyanto, T; Wita, IW; Yeo, HC; Arango, AC; Chavarria, JA; Cohen, AB; Cabrera, J; Castillo, B; Huepella, EHC; Ku, CHC; Alvarez, ED; Jimenez, RED; Espinosa, H; Cedeno, SNE; Rivera, CEH; Hernandez, D; Hernandez, J; Alvaro, JLM; Medina, F; Haro, JAM; Mini, M; Molina, G; Moya, J; Ortiz, ME; Parajeles, A; Ramos, CA; Rodriguez, E; Risso, GLS; Sprok, JM; Villagomez, DRT; Tortos-Guzman, J; Urrutia, V; Sanchez, DV; Dupont, JPV; Martinez, PVG; Vinocour, M; Abramovitz, A; Amar, S; Avrahami, R; Biderman, A; Davidov, N; Faibel, D; Flechner, ON; Glikberg, F; Hefer, M; Henkin, Y; Klain, E; Kleiman, R; Kornboim, B; Lev, T; Levie, P; Mahmoud, AK; Mendelson, A; Mor, L; Moran, ZC; Nitay, G; Ostrovski, I; Pshetizkj, Y; Reinitz, A; Reiss, H; Rivkind, R; Roch-Klipper, L; Rosner-Kamana, D; Sabah, T; Schuldman, M; Segal, E; Shtraikher, I; Sophia, B; Strausberg, I; Umansky, M; Wainsztok, S; Wertmann, E; Wrobel-Zaher, D; Zeltcer, C; Zhuravlove, C; Zibuleusky, G; Abe, K; Abe, N; Adachi, M; Adachi, H; Akiyama, H; Anami, Y; Aosaki, M; Aoyagi, T; Araki, R; Ashiba, A; Atou, K; Awano, K; Azuma, N; Azuma, A; Bujo, H; Chida, K; Date, H; Degawa, T; Doniwa, K; Ebihara, K; Egusa, G; Eki, Y; Endo, M; Enomoto, T; Fujii, T; Fujimori, H; Fujimoto, Y; Fujimoto, K; Fujimura, H; Fujio, N; Fujita, M; Fujiwara, T; Fukuda, A; Fukuda, Y; Fukunaga, R; Furuya, T; Fuse, S; Fuse, T; Goto, J; Goto, K; Hamada, R; Hamada, T; Hamamoto, S; Hanabusa, T; Hanafusa, T; Handa, N; Hara, K; Harada, Y; Haruta, S; Hashizume, T; Hattori, A; Hayashi, M; Hayashi, Y; Hida, K; Higahi, K; Higaki, S; Higashi, Y; Higashidate, M; Hiramoto, T; Hirano, K; Hirata, K; Hiratani, K; Hirono, O; Hirotani, A; Hisatome, I; Hondo, H; Hoshino, J; Hosoi, T; Hosomi, N; Ibayashi, S; Igaki, T; Iijima, T; Iikuni, K; Ikenouchi, H; Imai, K; Imai, K; Imai, T; Imamura, S; Inatsu, T; Inoue, I; Ishibashi, S; Ishibashi, T; Ishida, K; Ishida, S; Ishige, N; Ishihara, M; Ishihara, H; Ishii, Y; Ishimaru, Y; Itakura, H; Ito, T; Ito, T; Iwaki, N; Iwamoto, M; Iwao, T; Iwase, T; Izumi, Y; Jinnouchi, Y; Joki, H; Kagawa, N; Kaieda, H; Kajikawa, T; Kamiya, T; Kamiya, H; Kaneko, K; Kanemaru, Y; Kashiwagi, A; Kato, H; Kato, K; Katsume, H; Kawabata, T; Kawaguchi, T; Kawahara, K; Kawamoto, T; Kida, Y; Kihara, M; Kimura, T; Kimura, H; Kinoshita, A; Kitagawa, T; Kitagawa, K; Kitamura, K; Kitamura, H; Kitano, T; Kitaoka, H; Kobayashi, K; Kobayashi, Y; Kobayashi, H; Kobayashi, Y; Kobayasi, M; Kohara, N; Koide, J; Koizumi, J; Komachi, H; Konno, H; Koretsune, Y; Koriyama, T; Koseki, S; Kotorii, S; Koyama, K; Kubo, M; Kume, M; Kunimoto, M; Kunisaki, M; Kunitomo, R; Kuniyoshi, Y; Kuroki, K; Kuzuya, M; Makino, M; Manabe, Y; Maruyama, K; Maruyama, T; Masaki, M; Masuda, R; Masuda, M; Matsubara, S; Matsubara, J; Matsuda, M; Matsumura, M; Matsuo, T; Matsuoka, T; Matsushima, T; Matsuura, Y; Matsuyama, H; Memezawa, H; Mii, S; Mitsuo, K; Miyai, H; Miyakawa, Y; Miyamoto, S; Miyatani, K; Miyazaki, Y; Miyazawa, Y; Mochizuki, H; Momomura, SI; Mori, Y; Mori, H; Mori, N; Morimoto, K; Morita, I; Moriyama, H; Motokawa, K; Mukai, T; Murahashi, M; Murao, S; Nagamitsu, T; Nagao, T; Nagata, K; Nakada, Y; Nakagami, T; Nakagawara, J; Nakahara, K; Nakajima, T; Nakamura, Y; Nakamura, T; Nakamura, Y; Nakamura, Y; Nakamura, T; Nakamura, M; Nakamura, M; Nakane, H; Nakato, T; Nakatsuka, M; Nakayama, S; Nakazato, T; Nanjo, K; Narimiya, M; Negishi, T; Nemoto, T; Niinomi, M; Nishigaki, K; Nishikawa, H; Nishimura, H; Nitta, M; Nitta, M; Noda, K; v; Noma, K; Obata, H; Ochi, Y; Ochi, T; Ogawa, Y; Ogawa, T; Ogawa, A; Ogo, A; Ohagi, S; Oishi, Y; Oiwa, K; Ojiro, M; Okada, K; Okada, K; Okada, M; Okada, Y; Okamoto, M; Okamoto, Y; Okamoto, S; Okubo, M; Okuda, S; Onishi, T; Ono, N; Onodera, T; Onohara, T; Osumi, K; Ota, T; Otani, M; Otani, N; Ozaki, H; Ozawa, H; Sairenji, H; Sakai, K; Sakai, K; Sakamoto, S; Sano, R; Sato, A; Sato, H; Sato, J; Sato, K; Sato, R; Sato, S; Sawamura, N; Segawa, K; Seki, T; Sekiya, T; Senda, T; Shibasaki, Y; Shida, M; Shigeyama, T; Shiiya, N; Shimada, I; Shindo, S; Shinno, K; Shinohara, I; Shintani, U; Shiraki, T; Siomi, K; Sonobe, M; Sugisaki, K; Sugiura, H; Suto, N; Suwa, T; Suyama, K; Suzuki, S; Suzuki, M; Suzuki, S; Suzuki, M; Suzuki, A; Suzuki, M; Tabuchi, A; Tada, M; Tadokoro, N; Taguchi, S; Taguchi, S; Tajiri, Y; Takahashi, T; Takata, T; Takeda, Y; Takei, M; Takeichi, N; Takekawa, H; Takemoto, Y; Takenaka, T; Takeuchi, T; Takeyasu, N; Takita, M; Takizawa, S; Tanahashi, N; Tanaka, K; Tanaka, K; Taniguchi, S; Tanzawa, T; Tashima, K; Tashiro, H; Tatsuoka, Y; Tenda, K; Teramoto, T; Tobita, M; Todo, R; Tominaga, R; Tominaga, M; Tomohiro, A; Toshimori, H; Tsubokura, T; Tsuchihashi, T; Tsukahara, T; Tsukahara, K; Tsutsui, H; Uchida, N; Ueda, H; Uematsu, D; Uenohara, H; Ujihara, M; Umemoto, T; Uno, M; Urakaze, M; Wada, Y; Wakuta, Y; Wasada, K; Watanabe, K; Watanabe, T; Watarai, T; Yabe, T; Yamada, Z; Yamada, K; Yamada, A; Yamada, T; Yamada, T; Yamagata, H; Yamaguchi, T; Yamaguchi, K; Yamaguchi, K; Yamaguchi, S; Yamamoto, M; Yamamoto, Y; Yamanari, H; Yamane, K; Yamano, M; Yamasaki, M; Yamasaki, K; Yamashita, K; Yamashita, M; Yamashita, I; Yamatani, K; Yamazaki, Y; Yanagihara, K; Yasugi, T; Yasuoka, S; Yokochi, H; Yokomori, N; Yokota, H; Yokota, H; Yokota, N; Yokota, N; Yokotani, T; Yokoyama, H; Yokoyama, S; Yonezawa, K; Yonezawa, Y; Yoshida, M; Yoshikawa, M; Yoshimura, K; Yoshimura, R; Yoshimura, K; Yoshimura, S; Yoshioka, K; Yoshioka, N; Yududo, T; Algahtani, H; Hammouda, A; Khoja, W; Ghany, MA; Al Zamzami, AA; Ali, MA; Alshamiri, MAA; Bohlega, S; El Shaer, F; Elmaleeh, Y; Gamal, IW; Kinsara, A; Kurdi, M; Mabrouk, A; Malik, A; Raslan, H; Shaaban, A; Taha, H; Zaidan, R; Ahn, TH; Baik, SH; Chae, IH; Cho, KH; Choi, WH; Choi, YK; Chung, KC; Heo, JH; Jang, Y; Jeong, MH; Jung, DS; Kang, HS; Kim, SW; Kim, JS; Kim, KS; Kim, SK; Kim, YK; Kim, KS; Lee, DH; Lee, KH; Lee, KS; Lee, BC; Lee, I; Park, KS; Park, JE; Park, SW; Park, SW; Rhim, CY; Seung, KB; Son, HY; Woo, JT; Yi, SD; Yoon, BW; Abdallah, H; Raad, JA; Rizk, GA; Abu Salbi, M; Ashkar, K; Atallah, F; Awwad, P; Chammas, E; El Nakib, M; Ezzeddine, K; Ghaddar, A; Khater, B; Maaliki, S; Makarem, M; Matar, M; Mattar, H; Mounir, R; Musharrafieh, U; Nasr, C; Riachi, N; Saleh, M; Stephan, E; Tabet, G; Bodindorfiene, N; Docka, V; Jankauskiene, L; Kojeliene, J; Kovaite, M; Petrulioniene, Z; Tamosuitis, I; Terbetiene, B; Zaronskiene, D; Abd Ghapar, RAK; Khalid, NA; Mahayiddin, HAA; Ambrose, TF; Ang, CK; Azizi, ZA; Ali, RA; Basri, H; Chan, WL; Chan, SP; Chang, SK; Chee, KH; Chia, YC; Chong, YS; Choong, CH; Puvanarajah, SD; Fung, YK; Goh, EL; Hussein, H; Ismail, O; Ismail, Z; Ismail, SB; Ismail, N; Kamaruddin, NA; Kamarudin, N; Kandasamy, B; Lee, SK; Leong, YP; Liew, HB; Liew, CK; Mahadasa, P; Mak, CS; Merican, JS; Mohamad, M; Ng, CJ; Hasni, HN; Ong, TK; Quek, DKL; Rajasingam, V; Sim, KH; Veriah, RS; Sinnadurai, J; Tan, KS; Tee, LK; Tiang, SW; Mohamad, WBW; Yusuf, Z; Velasco, AA; Aguayo, G; Gamba, MAA; Alexanderson, G; Alpizar, M; Amaya, LE; Arauz, A; Astorga, A; Azpiri, JR; Barinagarrementeria, F; Esbrada, EB; Ramirez, HMB; Calvo, C; Cauto, C; Colorado, H; Cortes, J; Cossio, J; Ibarra, MOD; De Zatarain, R; Diaz, C; Eng, L; Esparragoza, J; Sierra, LE; Espinoza, C; Bonetti, PF; Cantu, EG; Martinez, RG; Guerra, AG; Camid, FDG; Pasqueira, FG; Hernandez, I; Kostine, A; Leiva, JL; Llamas-Lopez, L; Lopez, B; Cuellar, JL; Meneses, ML; Marcos, A; Lopez, SN; Nettel, J; Galvan, FO; Peralta, R; Garcia, JCP; Ranero, A; Rangel-Guerra, R; Rodriguez, J; Leyva, IR; Rojas, JA; Romero, A; Rubio, G; Ruiz, JL; Sagastegui, A; Talamas, O; Tapia, M; Melchor, JLA; Uribe, A; Vazquez, J; Velasco, JA; Ortega, ECV; Sanchez, RGV; Villarreal, J; Barendregt, W; Buth, J; Cheng, J; Agata, AD; De Haan, J; Deckers, J; Driesen, J; Erjavec, Z; Kupper, AF; Ho, G; Jutte, J; Keizer, K; Koning, J; Kranendonk, S; Oomen, A; Sanders, E; Sie, H; Valk, N; van Brussel, B; van Daele, M; van de Pavoordt, E; van der Heijden, R; van Dortmont, L; van Iersel, J; van Urk, H; Verhagen, W; Withagen, A; Aguilar, E; Alferos, MEG; Ang, MG; Anlacan, VM; Aportadera, MAL; Aquino, A; Aquino, C; Araniego, JE; Atilano, A; Bacsal, F; Balleza, Y; Barbas, B; Barcinas, RJ; Belonguel, N; Beltran, J; Bernardo, D; Bilocura, FE; Bitanga, E; Brillantes, A; Cabral-Lim, L; Calderon, E; Camarao, W; Canto, ML; Changco, RJ; Chua, C; Crisostomo, M; Cuanang, J; Cuasay, E; Decolongon, R; Del Moro, M; Del Rosario, E; de los Reyes, E; Diaz, A; Dioquino, CP; Doctora, J; Durante, M; Encarnacion, D; Entienza, R; Estalilla, C; Evangelista, R; Fandialan, E; Fernandez, C; Ferrer, R; Fuentes, F; Ganzon, MS; Garcia, F; Go, R; Guerrero, M; Gutierrez, L; Hojilla, AF; Javelosa, R; Kho, S; Libarnes, R; Lim, M; Llarena, AC; Lokin, J; Maglana, M; Maleza, F; Maranon, E; Marcelo, MC; Matias, A; Mendoza, C; Montes, R; Navarro, J; Neri, R; Pacioles, O; Palmes, P; Paz, J; Punsalan, R; Punzalan, FE; Purino, FM; Renales, ML; Reyes, E; Rivera, C; Robeniol, G; Rosales, R; Rosales, R; Rosita, RR; Roxas, DJ; Roxas, A; Sedilla, E; Shia, J; Tan, E; Tanzo, A; Torres, DJ; Tria, R; Tulmo, W; Willing, TT; Villacin, LL; Bimbo, L; Duarte, R; Ferreira, A; Ferreira, J; Correia Junior; Macedo, F; Medon, R; Morais, J; Noronha, D; Osorio, J; Perdigao, C; De Andrade, PP; Puig, J; Rodrigues, E; Sampaio, J; Costa, MV; Wellenkamp, E; Albu, VC; Anghel, DC; Antochi, FA; Apetrei, E; Arsenescu, MC; Badiu, VG; Bajenaru, OA; Balasa, RI; Bangau, V; Banica, C; Barbulescu, C; Bicescu, G; Bobescu, E; Boeru, G; Bogdan, RS; Bohotin, V; Bucsa, AC; Bustan, M; Buzea, AC; Campeanu, AV; Capalneanu, R; Carp, A; Chioncel, O; Chiriac, C; Chirileanu, RD; Cinteza, M; Constantinescu, A; Constantinescu, E; Craiu, E; Cristea, C; Cruce, R; Cuciureanu, DI; Daha, IC; Dan, A; Dan, GA; Darabont, RO; Darabont, O; Dimulescu, DR; Dina, C; Dina, C; Dorobantu, M; Dragulescu, A; Dragulescu, SI; Dumitriu, B; Ene, A; Falup-Pecurariu, C; Fischer, TS; Gavenea, AM; Geleriu, S; Georgescu, G; Gheorghe, IT; Gherasim, L; Ghiorghiu, IA; Ginghina, C; Giuca, A; Gutiu, IL; Hancu, A; Hodorog, DN; Ignat, B; Ionac, A; Ionescu, DD; Isai, FV; Istratoaie, O; Jianu, DC; Lungut, E; Macarie, C; Macovei, L; Marginean, IC; Marian, M; Marinescu, DC; Matcau, L; Matei, C; Maximov, DM; Miliaru, C; Minea, ID; Mitre, A; Moldovan, M; Moraru, E; Muresan, CM; Mut-Vitcu, B; Niculescu, GM; Opris, MM; Panea, CA; Pascu, I; Patru, DM; Pereanu, M; Perju-Dumbrava, L; Petria, F; Petrica, M; Petrutiu, SH; Poalelungi, V; Popescu, MR; Popescu, AC; Popescu, D; Popescu, DC; Prodan, MR; Protopopescu, T; Radoi, M; Rotaru, M; Rugina, M; Rus, H; Rusu, AP; Sascau, RA; Serban, M; Serban, A; Stamate, CS; Stanca, DM; Stanescu, L; Statescu, C; Stefanache, F; Tanaseanu, CM; Ticmeanu, M; Tint, D; Tirziu, C; Tiu, C; Toldisan, I; Toma, L; Tovirnac, NA; Treidler, SO; Tudor, L; Tudorica, V; Turdeanu, D; Tuta, S; Vacaras, V; Varga, I; Vasile, M; Vatasescu, RG; Vilciu, C; Vinereanu, D; Vintila, MM; Vulpe, G; Zaharia, C; Zaharia, S; Zarma, L; Ageev, F; Akasheva, D; Aroutiounov, G; Bart, B; Bondarenko, B; Chernyavski, V; Demidova, I; Drapkina, O; Egorova, N; Evdokimov, A; Fomin, I; Freydlina, M; Galyavich, A; Glezer, M; Gratsiansky, N; Grinstein, Y; Horev, N; Ivleva, A; Karpenko, M; Karpov, Y; Katelnitskaya, L; Kazantchian, P; Khokhlov, R; Khrustalev, O; Kiritchenko, A; Kobalava, Z; Kolina, I; Komarov, A; Korenko, L; Koshkin, V; Kotov, S; Koziolova, N; Kropacheva, E; Kukharchuk, V; Laguta, P; Lebedev, P; Lipchenko, A; Lopukhova, V; Markov, V; Martunov, A; Mironova, I; Naumov, V; Nebieridze, D; Novitsky, I; Orlova, I; Pavlov, N; Pokrovsky, A; Rapovka, V; Rodnenkov, O; Sankova, A; Shalaev, S; Shaposhnik, I; Shestakova, M; Shmirev, V; Shpektor, A; Shulman, V; Sidorenko, B; Sizov, A; Skvortsov, A; Skvortsova, V; Sokolov, I; Statsenko, M; Storozhakov, G; Stratchounski, L; Sukhinina, T; Sulimov, V; Sysoeva, N; Tanashyan, M; Tebloev, K; Tutunov, V; Upnitsky, A; Yarokhno, N; Yeliseyeva, L; Zadionchenko, V; Zakirova, A; Zharova, Y; Ang, PK; Cumaraswamy, S; Chan, B; Chan, NF; Chang, HM; Chen, CLH; Cherian, T; Chia, KH; Chong, PN; Chua, SM; Chua, PK; Da Costa, MLA; De Silva, DA; Deb, B; Doshi, M; Eng, P; Gan, R; Goh, KH; Ho, KH; Kurugulasigamoney, G; Kek, PC; Koh, PSS; Koh, ATK; Koo, SL; Koo, CC; Lee, CS; Lee, TY; Liew, S; Liew, AK; Lim, IH; Lim, M; Lim, CH; Lim, SC; Lingamanaicker, J; Low, LP; Mahtani, S; Mak, KH; Mathew, S; Ng, RMH; Venketasubramanian, RN; Ng, PTH; Omar, S; Pang, J; Seet, RCS; Sharma, V; Bin Siah, K; Siow, C; Sng, LC; Tan, HC; Tan, RS; Tan, M; Tan, JCH; Tan, YT; Tan, V; Tay, JC; Teoh, HL; Tong, HI; Tong, TS; Tran, J; Wee, A; Wong, TW; Wong, MC; Abeytua, M; Adarriaga, MD; Agarrado, A; Alias, EJ; Alonso, G; Alonso, JL; Alvarenga, NM; Alvarez, LJ; Alvarez, A; Andreu, J; Anton, JA; Castano, JCA; Artigues, I; Baldo, EC; Bautista, JG; Bellera, MN; Bello, J; Beloqui, O; Bermudez, JM; Blanco, M; Bohorquez, JC; Bolanos, A; Brossa, V; Bruguera, J; Cabarcos, A; Cacabelos, P; Cairols, M; Calvo, C; Camacho, I; Canoves, J; Carbonell, P; Carreno, MC; Casado, I; Catalan, JI; Catalan, P; Caudevilla, A; Cerda, J; Chamarro, PR; Charles, AB; Claramonte, B; Climent, VE; Colas, J; Comas, P; Corrochano, JJ; Culebras, C; Davila, MF; Novales, JD; de Luis, MD; Perez, FD; Duran, I; Egido, JA; Escribano, JB; Escudier, JM; Espinosa, A; Espinosa, R; Fernandez, JR; Fernandez, O; de la Cigona, FF; Ros, MF; Flores, A; Folgado, RM; Formiga, F; Franco, C; Franco, J; Freire, E; Galan, M; Galiana, J; Garcia, I; Garcia, F; Garcia, JP; Garcia, B; Garcia, G; Garcia, JM; de Burgos, FG; de la Villa, BG; Diaz, JDG; Garcia-Mongo, JC; Geffner, DE; Gesto, R; Giron, JM; Goicolea, I; Gomez, F; Cerezo, JFG; Gonzalez, E; Gonzalez, C; Gonzalez, A; Gonzalez, MI; Gonzalez, M; Gracia-Naya, M; Gusi, G; Guzman, G; Hevia, JS; Hidalgo, ML; Horcajo, P; Ibanez, M; Idoate, A; Idoate, M; Gay, JI; Irurita, M; Iser, J; Izquierdo, G; Jansen, S; Jimenez, C; Jimenez, B; Jimenez, MD; Junca, E; Laynez, F; Ligero, JM; Lis, JM; Llagostera, S; Llort, C; Llovet, A; Lopez, JC; Lopez, L; de la Osa, AL; Lopez-Ibarra, PJ; Lozano, F; Luna, MDR; Macingirar, JL; Maraver, JM; Marey, JM; Marin, J; Martin, A; Martin, JC; de la Torre, EM; Martinez-Berganza, A; Martinez-Perez, M; Martos, R; Masjuan, J; Mateos, A; Medrano, V; Merce, J; Merchante, A; Davood, SM; Mirete, C; Molina, F; Molto, JM; Montero, MJ; Montero, M; Montero, M; Montes, PM; Monzon, FJ; Morillas, M; Morillas, PJ; Munilla, A; Nicolas, R; Niembro, P; Numancia, R; Nuno, E; Olaz, F; Oller, N; Ortega, J; Ortega, J; Orts, E; Otero, A; Paules, A; Paz, MA; Pena, JL; Perez, JL; Perez, G; Molino, AP; Pia, G; Pinedo, J; Plaza, A; Plaza, I; Pons, JM; Pontes, JC; Portoles, A; Poveda, F; Prat, MI; Puras, E; Rasel, J; Real, JT; Redondo, S; Rico, MA; Rius, A; Roca, JM; Rodilla, E; Rodriguez, JA; Rodriguez, MA; Rodriguez, J; Roldan, AC; Romero, A; Roquer, J; Roure, J; Vela, TR; Ruiz, JI; Ruiz, M; de Castroviejo, JR; Ortiz, MR; Saavedra, O; Saban, J; Sadurni, J; Saez, L; de Quevedo, JAS; Salas, J; Salvador, A; Sanchez, JM; Sanchez, P; Santos, S; Saura, J; Sedeno, JM; Segura, T; Serrano, FJ; Serrano, PJ; Solis, J; Soriano, C; Sotillo, JF; Soto, AI; Suarez, C; Suarez, M; Tamargo, LM; Teigell, L; Trejo, JM; Trulla, J; Tura, D; Urtasun, M; Val, E; Valdes, M; Vaque, J; Vaquero, F; Varona, L; Vazquez, A; Vega, F; Velasco, A; Vicente, T; Vidan, JA; Vilaseca, B; Vilchez, R; Villar, I; Vinas, J; Volo, G; Zarauza, MJ; Abetel, G; Ackermann, F; Alexander-David, N; Andreoli, P; Badan, M; Boillat, B; Bopp, HJ; Bosshardt, R; Budmiger, H; Cadisch, R; Chapuis, P; Chen, HT; Collioud-Robert, Y; Cornut, JP; Croci, JP; Delorme, P; Di Stefano, RG; Duerst, U; Durrer, D; Enggist-Rueesch, U; Facchini, M; Flueckiger-Keller, HC; Frangos, A; Fust, F; Gallati, M; Genond, D; Gerber, A; Ghirlanda, A; Giroud, D; Gross, W; Haeuptle, C; Haldy, P; Hany, M; Hecker, E; Henny, C; Hug, M; Ingold, B; Jachertz, G; Jaques, O; Jotterand, S; Keller, U; Kieliger, F; Kramis, A; Kraszewski, M; Kuske, A; Landolt, M; Lanz, M; Limacher, T; Luthi, JF; Martin, PA; Niesper, J; Nuesch, K; Oechslin, H; Pfaeffli, A; Pinzello, A; Pithon, M; Richter, M; Schneider, T; Schwarzenbach, HR; Staubli, P; Stricker, H; Tjon-A-Meeuw, L; Togni, P; Tschurr, E; Tutta, P; Wigger, BV; Von Planta, I; Vuilleumier, D; Waldis, N; Wandeler, JM; Wasem, YM; Widler, J; Widmer, C; Woolley, S; Zauner, B; Z'Brun, A; Chan, L; Chan, CS; Chang, CJ; Chang, HY; Chang, CC; Chang, KC; Chang, PC; Chang, RY; Chang, JY; Chen, IC; Chen, CL; Chen, YW; Chen, JR; Chen, CW; Chen, CY; Chen, YP; Chen, TS; Chen, WH; Chen, YH; Chen, ZC; Chen, KC; Chen, MH; Cheng, TJ; Chin, CH; Chiung, CZ; Chou, LP; Chu, IT; Chung, WT; Fong, CS; Hsia, CP; Hsieh, IC; Hsieh, Y; Hsieh, JC; Hsu, RB; Hsu, MC; Huang, CF; Huang, CW; Huang, YY; Jeng, JS; Ko, CC; Kuo, WK; Lai, WT; Lee, CC; Lee, TH; Lee, KH; Lien, LM; Lin, SK; Lin, RT; Lin, TK; Lin, KC; Liu, RT; Liu, AB; Lo, HM; Pei, D; Ryu, SJ; Sung, ML; Tang, SC; Tang, S; Tsao, WL; Ueng, KC; Wang, TD; Wang, SY; Wang, KY; Wei, CY; Wu, TY; Wu, JC; Wu, WS; Yang, SS; Yeh, SJ; Yeh, CH; Yeh, SB; Yip, PK; Yip, BS; Benjasuratwong, Y; Boonsom, W; Buddhari, W; Bunnag, P; Suwanwela, NC; Chulakadabba, A; Deerochanawong, C; Hanchaiphiboolkol, S; Jirasiritham, S; Kanjanavanit, R; Khositsakulchai, W; Kiatchoosakun, S; Leelanipon, P; Mahanonda, N; Nidhinandana, S; Niramaxnsakul, S; Nopparat, S; Phrommintikul, A; Piamsomboon, C; Pienvichit, P; Piriyawat, P; Poungvarin, N; Puavilai, W; Ratanakorn, D; Siriwanij, T; Suntrapiwat, K; Suraamornkul, S; Suwanugsorn, S; Suwanwalaikorn, S; Tokavanich, V; Tresukosol, D; Veerakul, G; Vichayanrat, A; Vivekaphirat, V; Amosova, K; Andriyevskaya, S; Bereznyakov, I; Bezyuk, M; Dyadyk, O; Dzyak, G; Dzyak, L; Goloborodko, B; Grytsay, N; Kobza, I; Korkushko, O; Koval, O; Kovalenko, V; Kuznetsova, S; Mishchenko, T; Mishchuk, N; Netiazhenko, V; Nikonenko, A; Nikonov, V; Parkhomenko, A; Pertseva, T; Polyvoda, S; Rodin, Y; Rudenko, A; Rudenko, V; Rudyk, Y; Sergeyev, O; Sirenko, Y; Svyshchenko, Y; Sychov, S; Tashchuk, V; Vakalyuk, I; Vinychuk, S; Vizir, V; Volkov, V; Voronkov, L; Yagensky, A; Yavorskaya, V; Rahuman, AA; Bakir, S; Bazargani, N; Binbrek, A; Elkilany, GE; Inshasi, J; Kayed, DM; Lange, C; Wassef, A; Elabdin, TZ; Addlestone, M; Agarwal, R; Barker, R; Barnett, A; Baskaran, B; Bowen-Jones, D; Brooks, A; Courtney, JR; Cummin, P; Donnelly, R; Duckworth, M; Dwight, J; Egerton, T; Farker, I; Ferguson, J; Fuat, A; Gietzen, T; Hamling, J; Hole, J; Vanniasinkam, SH; Hughes, I; Husselbee, P; James, M; Kassianos, G; Kent, M; King, B; Kingsland, J; Kirby, M; Lalsarin, R; Lawrence, R; Lee, PS; MacLeod, M; Manning, G; Martin, R; McKinnon, C; McKeith, DD; Mistry, D; Morgan, S; Morgan, S; Page, M; Penney, BF; Rowlands, S; Sharma, J; Shearman, C; Sherman, L; Singh, M; Thorburn, W; Watson, DPB; Watt, A; Weir, R; Wiggins, PS; Brass, L; Brown, M; Cooke, J; Coull, B; Creager, M; Criqui, M; Fonarow, G; Golden, W; Greenland, P; Jaff, M; Levy, P; McBride, P; McDermott, M; Ofili, E; Reasner, C; Sacco, R; Saunders, E; Saver, J; Sheehan, P; Watson, K; Abbas, R; Abbott, L; Abdehou, D; Abedmahmoud, I; Abisalih, D; Abraham, W; Ackerman, K; Addo, J; Adelizzi, A; Aggarwal, S; Agha, M; Agustsson, T; Ahmad, B; Ahmad, A; Ahmed, S; Ajani, D; Alarcon, F; Albarracin, C; Albright, K; Aleman, CJ; Aleman, R; Alexander, JS; Alexander, M; Alexander, S; Ali, A; Al-Khadour, H; Al-Khateeb, D; Allan, D; Allen, R; Alley, R; Allison, MD; Alloju, M; Alpert, B; Altafullah, I; Altema, R; Alugubelli, V; Alvarez, F; Alvarez, H; Alvarez, S; Alza, G; Aman, S; Amanambu, C; Amer, S; Amin, J; Amin, K; Amin, NJ; Amin, Y; Amine, M; Amos, D; Anders, DL; Anderson, CP; Anderson, W; Anderson, PB; Andrea, B; Anez, L; Angra, S; Anjum, S; Anton, S; Aponte, J; Aquino, V; Aranador, D; Arcuri, P; Areephanthu, A; Arian, L; Arkin, D; Arora, J; Arthur, A; Artz , WJ; Arumugham, P; Arunasalam, S; Arvan, T; Ascarelli, ED; Ascher, R; Asciuto, L; Asfour, W; Asgar, M; Ashley, S; Asin, G; Assar, M; Ataya, H; Atkinson, J; Attenello, F; Atwood, L; Augustin, D; Aung, T; Austin, B; Axe, H; Axelrod, A; Aycock, G; Ayeni, O; Ayers, B; Azam, M; Azar, N; Azarva, H; Babb, S; Babin, K; Bacani, O; Badami, U; Bailey, TS; Bailey-Walton, P; Baiocchi, G; Baird, D; Baker, J; Bakhtari, L; Bala, R; Balaji, G; Baldys, J; Ballesteros, JV; Balusu, P; Banjo, C; Banna, A; Barbato, T; Barber, F; Barrett, H; Bartkowiak, A; Barkley, T; Bartos, S; Batarseh, B; Bathija, N; Bazzi, A; Beach, JL; Beamer, T; Beane, M; Beck, WC; Becker, H; Becker, R; Becker, S; Becker, T; Bedel, G; Bedi, H; Beham, R; Belt, S; Benge, JW; Bennett, D; Bennett, C; Bennett, N; Benson, P; Berard, M; Berenson, Z; Berger, RE; Berkenstock, O; Berland, G; Berman, G; Bermudez, Y; Bernard, S; Bernstein, J; Berry, JF; Bevill, R; Bhagwat, R; Bhat, A; Bhatia, HS; Bhatia, D; Bhatia, A; Bhatt, D; Bhimani, J; Bicek, P; Bidner, S; Bierman, R; Bieser, D; Biggers, J; Biggs, B; Bijlani, S; Bilik, I; Bilsky, A; Birkholz, KL; Bishara, I; Bishara, I; Bland, V; Blank, B; Blaze, K; Bleiman, M; Bleser, S; Blizzard, D; Blonder, R; Bobson, CM; Bodemann, D; Bodemann, S; Boehm, T; Bohannon, N; Boinay, P; Bojrab, G; Bommareddi, A; Bond, WM; Bonezz, D; Bornfreund, J; Bornheimer, JF; Borowski, DT; Borrego, R; Bottar, P; Bouchette, A; Boudreaux, C; Boune, M; Bourque, JC; Bowling, RL; Brandstater, C; Breen, G; Breitenbach, R; Brender, AJ; Bressler, P; Brideau, D; Bright, TJ; Briker, AJ; Britt-Armstrong, C; Brodie, H; Brodowski, M; Brodsky, N; Bronstein, B; Brooks, GA; Brooks, C; Brovar, GT; Brown, J; Brown, K; Brunkow, G; Brunner, JE; Buben, M; Buch, H; Buckingham, R; Buencamino, E; Buening, R; Bully, A; Bultman, R; Bunney, N; Buoscio, B; Burch, J; Burger, M; Burkard, J; Bush, J; Butcher, R; Butler-Sumner, S; Buynak, RJ; Cacchione, JG; Cacho, A; Cadigan, D; Cahn, D; Caifano, R; Caivano, R; Calkins, B; Cameron, D; Camisa, S; Camiscoli, D; Campbell, J; Campbell, DR; Campbell, R; Caperton, M; Capo, JP; Cappiello, A; Caputo, A; Caputo, RA; Caras, J; Carley, JE; Carluen, L; Carmouche, D; Caro, R; Carpenter, K; Carter, K; Carter, G; Carver, S; Castor, T; Caughron, SD; Cavanaugh, G; Cavero, P; Celio, L; Cevasco, R; Chadha, V; Chakravarty, J; Chambers, D; Chandler, BL; Chapnick, M; Charmatz, A; Charron, M; Chaskes, M; Chaves, I; Chaves, I; Chawla, O; Chen, KC; Chen, CK; Cheng, E; Cheng, T; Cherny, Y; Chervu, I; Chesar, T; Chesoni, S; Chess, D; Chhabria, P; Chidester, M; Chieffalo, A; Chien, OL; Chin, D; Chinnici, A; Chisholm, D; Chisolm, O; Chochinov, RH; Choi, S; Choi, M; Chopra, J; Chung, N; Ciemiega, R; Cirilli, M; Ciubotaru, R; Civitarese, FA; Civitarese, LA; Clark, D; Clark, D; Coburn, W; Cochran, SL; Cohen, JL; Cohen, L; Cohen, S; Colbert-Threats, S; Cole, R; Coleman, G; Coleman, SL; Coles, M; Comazzi, J; Conlan, B; Conrad, M; Conroy, S; Conti, S; Cook, R; Cook, N; Cook, JP; Cook, J; Cooley, DL; Cooper, D; Cooperman, M; Cope, J; Corales, D; Corbett, B; Coreil, E; Cornett, G; Cossman, D; Courtnage, SL; Cox, L; Cox, W; Cox, M; Crabtree, Y; Craig, JM; Crider, J; Crider, J; Crisostomo, E; Cromer, M; Cronin, J; Crosnoe, J; Cueto, IL; Cummins, FE; Cyriac, C; Dailey, R; Daisley, SJ; Damien, G; Damsker, K; Dandapani, B; Dang, TY; Darwin, C; Dasani, S; Dasilva, LD; Dausch, R; Dave, AN; Dave, K; Davidson, R; Davis, G; Davis, K; Davis, P; Davis, P; Davis, R; Davis, S; Davis, W; Sullivan, HD; Dawes, TM; Dawson, M; Dayon, DL; Dayon, PM; De, NK; de Feria, A; de Meireles, M; de Souza, J; Dearmitt, D; Debin, S; Decker, G; Defazio, E; del Fierro, R; Delaguardia, B; Deleon, ER; Delgaizo, C; Delrosario, S; Deluca, J; Demopulos, JA; Dempsey, M; Den, M; Denker, M; Denker, P; Denlinger, K; Denyer, G; Deol, SS; Depetris, G; Desai, PR; Desai, J; Detulio, A; Deveranez, D; Devoss, G; Dharma, C; di Sarli, R; Diamond, R; Diamond, S; Diasti, S; Diaz, F; di Diaz, M; Dickson, S; Diethelm, J; Dietz, M; Disharoon, P; Dixon, J; Dobish, M; Dobrose, C; Doctor, D; Dodani, HB; Doehring, L; Doerfler, F; Donnan, P; Donovan, J; Doroshow, L; Dorsey, J; Doyle, N; Dreslinski, G; D'Souza, N; Dugano-Daphnis, P; Duggal, NM; Dunbar, J; Dunleavy, K; Dupee, RM; Durazo, A; Eastburn, T; Ecker, AM; Eckert, J; Eckert, J; Edwards, J; Edwards, T; Egan, R; Egelman, A; Ehly, C; Eickmeyer, J; Eidelman, Z; Eisenberg, BM; Eisner, G; Elias, RA; Elkind, A; Emerson, R; Enders, J; Englund, M; Enns, R; Enriquez, JA; Epperson, T; Erbay, G; Erickson, K; Eisenmenger, J; Eshenaur, O; Eshenaur, O; Espinoza, W; Espinoza, W; Estronza, N; Eustace, MW; Evans, B; Fahey, P; Faiz, F; Farber, A; Farhoud, H; Farmer, J; Faron, M; Fast, D; Fazenbaker, S; Fazio, GT; Fearon, K; Featherston, DP; Fedak, M; Fedak, M; Fei, H; Feingold, B; Feinsinger, G; Feldman, B; Felice, FM; Ferreira, A; Fielding, DP; Fields, C; Figueroa, R; Fine, A; First, B; Fischer, J; Fischgrund, J; Fishman, R; Fishman, E; Fittingoff, DB; Fitzgerald, K; Fitzgerald, M; Fitz-Patrick, D; Flamion, P; Flanagan, T; Flanzman, S; Flatt, J; Fleischer, LR; Flershem, D; Flowers, A; Fong, PK; Foster, R; Fouchi, D; Fowler, D; Fox, D; Fox, J; Frank, C; Frank, G; Frank, R; Frankel, M; Franklin, M; Franks, E; Franz, J; Freberg, D; Freesemann, JM; Frein, D; Freitas, JB; French, G; Freyer, C; Friedel, J; Friedlander, R; Friedman, E; Freilich, L; Frumkin, S; Fuentes, D; Fuller, J; Fusco, F; Fuson, D; Gadani, M; Gadani, P; Gaikwad, N; Gaines, M; Gaither, A; Galvan, P; Gamponia, M; Gandhi, A; Gandhi, J; Gandhi, B; Garcia-Septien, RM; Garb, J; Gardner, S; Garfias, D; Garfield, M; Garg, R; Garner, J; Garretson, D; Garrett, D; Garza, D; Gastman, IJ; Gebara, S; Gebara, S; Gedia, L; Gehant, J; Geller, S; Gelston, W; Gendel, M; Gentry, S; George, W; George, M; Geronemus, R; Gerstenmeier, L; Giant, D; Gibbs, JE; Gil, F; Gilbertson, DL; Gilinsky, M; Gill, S; Gillick, R; Gilliam, D; Gillman, E; Gindi, M; Gindi, G; Glaser, LA; Glass, J; Glazer, E; Gliner, B; Glowacki, J; Go, E; Goetz, J; Gokani, R; Goldberg, BH; Goldberg, R; Goldman, J; Goldner, S; Goldsmith, D; Goldstein, A; Goldstein, F; Goldstein, R; Gonzales, WA; Gonzalez, J; Gonzalez, M; Goodale, D; Goodfield, P; Goodman, D; Gosalia, A; Gosling, J; Goswami, A; Gottlieb, D; Goyco, O; Grabensetter, N; Grady, J; Graves, K; Greblya, V; Green, R; Green, R; Greenberg, D; Greenfield, M; Greenfield, RM; Greenman, SB; Greenspan, M; Griffel, P; Griffin, D; Griffith, C; Grill, H; Gross, WS; Guanzon, T; Guice, M; Guidot, C; Gulati, R; Guneratne, F; Gupta, S; Hack, M; Haffizulla, E; Haffizulla, F; Haffizulla, J; Hagedorn, J; Haggenjos, J; Hall, S; Hallgren, R; Halpern, B; Hamilton, A; Hamilton, M; Hammond, T; Hamner, J; Hamroff, G; Han, MY; Hanke, F; Hanrahan, B; Hansen, E; Hansen, R; Hanshaw, C; Harless, M; Harris, MD; Harris, N; Harris, RW; Harrison, S; Hart, ME; Hartley, P; Haspert, D; Hassan, J; Hassen, IW; Hatharasinghe, R; Hatimi, T; Hauptschein, M; Hawrot, GC; Hays, R; Head, GG; Heffess, L; Heggeness, O; Hein, J; Heinegg, P; Hekmat, M; Hellman, R; Hemme, H; Henderson, S; Henes, G; Henriquez, M; Henry, D; Herle, A; Hermany, P; Hernandez, A; Herrera, CR; Herrera, M; Herrera, R; Herrington, S; Hershkowitz, J; Hertzman, P; Herz, P; Hiland, S; Hillis, S; Hilton, D; Himot, E; Hindawi, A; Hines, R; Hirtz, S; Hitz, DL; Hnatiuk, G; Ho, M; Ho, V; Hofbauer, H; Hoffman, B; Hoffman, D; Hoffman, M; Holik, J; Hollis, D; Hong, K; Hong, L; Honig, P; Hood, M; Hooker, B; Hooks, D; Hopland, A; Horowitz, S; House, J; Howard, J; Hoyt, W; Hozakowska, E; Hsu, JC; Huang, Y; Hubbard, D; Vaughn, YH; Hugar, M; Hughes, G; Huh, I; Hulson, T; Huntley, R; Hurlock, J; Hussain, N; Huver, A; Iannamorelli, A; Imam, S; Imperial, G; In, Y; Ingram, F; Inocencio, C; Ip, K; Irvin, J; Irvine, J; Isaiants, A; Isajiw, G; Isenberg, H; Isenberg, G; Ishimori, T; Ishkanian, G; Ison, R; Issa, R; Iyer, L; Izurieta, H; Izzi, S; Izzo, M; Jabbour, N; Jackson, B; Jackson, J; Jackson, MR; Jackson, RA; Jackson, R; Jacob, P; Jacobs, W; Jain, S; Jain, A; Jain, J; Jalowsky, H; Jamal, K; Jansen, R; Jeanfreau, R; Jeffreys, R; Jenckes, G; Jennewine, P; Johary, A; Johnson, K; Johnson, C; Johnson, D; Jones, MB; Jordan, R; Joslyn, EW; Kagan, J; Kahan, B; Kahney, S; Kaissar, A; Kajencki, S; Kakarala, V; Kalahasty, S; Kalici, N; Kamenetsky, L; Kamiel, M; Kammerling, J; Kania, R; Kaplan, I; Kaplan, M; Kaplan, R; Karim, K; Karkar, G; Karty, D; Karu, R; Kastrul, JJ; Katira, MN; Katsetos, J; Katzenberger, C; Katzman, S; Kaufman, R; Kauk, B; Kavalier, M; Kawaja, T; Kawakami, S; Kaylin, M; Kazymyra, M; Kelly, A; Kelter, R; Kenney, N; Kenton, D; Keshavamurthy, J; Kesireddy, D; Kessler, W; Ketels, C; Khalidi, N; Khan, A; Khan, M; Khan, M; Khan, W; Khatcherian, Y; Khoshaba, A; Khosla, R; Khwaja, S; Kiefer, G; Kiefer, P; Kim, D; Kim, I; Kim, S; Kimmel, A; Kini, G; Kipnes, M; Kipp, J; Kipreos, NT; Kirby, W; Kleinhaus, R; Kleinsteuber, K; Klipec, M; Klufas, A; Knecht, J; Knoll, H; Ko, G; Koch, H; Koch, S; Koenig, PP; Koepke, C; Koepke, K; Koganski, V; Kohli, A; Kohli, S; Kolanchick, G; Kollmeyer, K; Kondan, R; Koppel, W; Koppenbrink, W; Koreff-Wolff, B; Kovtun, N; Kraft, D; Kramer, H; Kramer, L; Kramer, M; Kramer, M; Kramer, S; Krems, S; Kress, M; Kricsfeld, B; Krishnan, A; Krishnan, M; Kroopnick, R; Kumar, P; Kumar, R; Kumar, S; Kumar, VH; Kundra, A; Kunkel, M; Kurian, A; Kurtz, R; Kurzrok, S; Kushner, D; Kuttappan, M; Kval, T; Kwon, P; Kwong, S; Labuda, J; Lachterman, B; Lacorte, A; Lacy, J; Lahasky, D; Lakhani, V; Lakhani, H; Laliotis, A; Lamb, C; Lami, J; Lamsal, S; Lang, C; Langburd, A; Lange, L; Lanier, A; Laracuente, R; Lariosa, A; Lash, J; Lau, A; Lauer, M; Laughlin, DB; Lavergne, C; Lawrence, G; Lawson, T; Lazarevic, M; Leach, K; Leavitt, R; Leblanc, M; Trinidad, CL; Ledbetter, J; Lee, C; Lee, DW; Lee, J; Lee, J; Lee, K; Lee, K; Lee, N; Lee, T; Lefkovic, L; Leone, A; Lerman, E; Lerner, K; Leshin, S; Leung, YY; Levenson, D; Levin, P; Levine, M; Levy, B; Levy, M; Levy, R; Lewen, M; Lewis, R; Lewison, G; Li, C; Li, M; Li, M; Liboon, R; Lick, D; Lief, L; Light, C; Lim, A; Lim, DB; Limjoco, FR; Lin, S; Lindenbaum, J; Linkner, E; Liporace, D; Lippoff, O; Lipsky, J; Lira, R; Lischwe, DH; Lisse, S; Liu, JP; Liu, P; Loa, H; Lobaton, CB; Lopez-Arostegui, F; Lopresti, P; Louis-Charles, J; Lovato, J; Loya, F; Lubowitz, H; Luck, D; Lueg, M; Luengas, J; Luna, M; Luoma, J; Le Luu, L; Lycksell, RL; Lynn, L; Lyon-Loftus, G; Ma, S; Mabourakh, S; Macadams, M; Mackenzie, J; Mackrell, J; Madris, R; Maffezzoli, R; Magee, J; Mahaffey, R; Mahakala, A; Maheshwari, Y; Mahmoud, S; Mahon, G; Maislos, F; Makam, P; Maletz, L; Malicay, M; Malinow, L; Malinow, S; Malkin, S; Mally, A; Maltz, J; Malz, M; Manalac, J; Mandel, R; Mandell, B; Manja, G; Manuli, S; Maoud, RF; Maqueda, T; Maramreddy, P; Marar, I; Margolis, D; Margolis, J; Margolis, M; Margolis, S; Marks, E; Marsh, S; Martin, R; Martin, L; Martin, D; Martinez, D; Martinez, E; Martinez, R; Massien, S; Massih, N; Masud, A; Matheu, J; Mathew, J; Matthias, M; Mattson, E; May, P; Maybach, E; Mayer, DA; Mazariegos, M; McCann, D; McCarty, D; McEntire, B; McLeroth, P; McAllen, S; McCarthy, E; McCauley, TE; McClure, T; McConnell, J; McCracken, B; McCrary, DG; McDavid, C; McDonald, C; McEwan, R; Mcgee, J; Mcgee, R; McGettigan, J; McGuire, K; McShane, JM; Meade, N; Meadows, R; Mecca, A; Mecca, W; Mecklai, A; Medina, E; Medley, H; Medoff, S; Mehra, R; Mehta, M; Meller, J; Mendez, J; Mendez, A; Mendez, C; Mendez, A; Mendizabal, M; Mendoza, C; Menio, J; Menon, R; Mercurio, G; Merillat, J; Merritt, L; Meyer, B; Meyers, G; Meza, R; Miccio, A; Michelsen, T; Miele, A; Mignoli, M; Mikus, J; Milko, T; Miller, E; Miller, JB; Miller, L; Miller, M; Miller, P; Miller, R; Miller, S; Mintz, G; Mintz, M; Mirchandani, B; Mishra, S; Mittal, S; Mittal, S; Miyakawa, J; Modesta-Keyhani, A; Modi, P; Modi, T; Mody, R; Mohan, P; Mohsin, S; Mollen, MD; Molter, D; Montana, J; Montgomery, D; Moon, D; Moore, G; Moore, J; Moosa, A; Moran, J; Morayati, S; Morcos, C; Moreci, J; Moreland, J; Moretsky, R; Morgan, M; Morris, W; Morrison, B; Moss, JB; Moss, R; Moss, T; Moyer, JP; Muckala, K; Mukherjee, R; Mundra, S; Munjapara, V; Munshower, J; Murachanian, R; Murashige, J; Murphy, A; Murphy, R; Murray, K; Musa, M; Muse, D; Myers, B; Myers, S; Nadaud, M; Nahum, L; Naidu, JB; Naini, GR; Nanda, J; Nasir, I; Nasser, MM; Nassir, J; Nations, J; Navarro, H; Nayeem, A; Nelson, K; Nemirov, S; Neno, R; Neumann, F; Newton, T; Nguyen, V; Nguyen, B; Nguyen, K; Nielsen, E; Normile, C; Obarr, T; Oblena, J; Octain, B; Odugbesan, O; Ogilvie, P; Ogundipe, A; O'Keefe, T; Olash, F; Ollins, R; Olszowska, A; O'Neill, D; Ong, Y; Orengo, O; Orlang, L; Orth, D; Oteyza, B; Oung, BY; Packer, J; Paek, N; Palandjian, R; Palchick, B; Pacia, AG; Panchal, V; Pangtay, D; Panik, G; Parker, G; Parker, J; Parker, D; Parmer, K; Paronish, W; Parsey, C; Paruchuri, S; Pastermack, F; Patel, A; Patel, A; Patel, A; Patel, C; Patel, M; Patel, M; Patel, N; Patel, P; Patel, P; Patil, LR; Patnam, S; Patton, H; Paulding, S; Paulish, J; Payne, F; Peabody, B; Peacock, M; Pearson, G; Pearson, A; Peet, J; Pelayo, J; Perez, C; Persoft, N; Peschiera, M; Peters, K; Peters, C; Peterson, D; Petit, W; Pewitt, C; Pham, TM; Phelps, CW; Phillips, GJ; Pintauro, F; Pittleman, K; Pitzl, GA; Ploss, L; Podet, E; Pogue, D; Polinsky, C; Pollock, J; Pomposini, D; Pongonis, J; Poochikian, V; Post, G; Potts, G; Pounds, K; Powers, F; Prack, A; Prack, E; Prasad, J; Prelutsky, D; Presant, L; Prescott-Coraggio, J; Prosser, J; Protacio, R; Prouty-Moore, J; Proy, B; Punjabi, H; Punjabi, P; Purdy, A; Purighalla, R; Purighalla, U; Purpura, A; Pyle, H; Qureshi, K; Rabadi-Marar, D; Racho, ZE; Radparvar, A; Rafool, G; Raghu, P; Raghunathan, C; Raheja, S; Rahman, A; Rahmanian, N; Rahnama, M; Raikhel, M; Railan, P; Rainey, J; Rajaratnam, Y; Rajasekaran, G; Ramdas, K; Ramirez, P; Ramiro, L; Ramkishun, L; Randolph, R; Rane, S; Rao, M; Raphael, R; Rassen, J; Rastogi, N; Rattes, M; Rauzi, F; Rawlings, W; Ray, S; Reaves, L; Recio, S; Redding, M; Reddy, N; Reddy, P; Reddy, R; Reddy, S; Reddy, V; Reed, G; Reimer, J; Reinbold, P; Resnick, H; Reynolds, W; Richardson, B; Rifat, R; Ritchey, W; Rivera, A; Rivero, M; Rizk, G; Rizzo, M; Robbin, M; Robbins, R; Roberson, W; Roberts, B; Roberts, K; Robinson, J; Robinson, R; Robison, W; Rocco, J; Rodgers, R; Rodriguez, H; Rodwick, B; Roethemeyer, J; Rojas, B; Romulus, C; Rosen, G; Rosen, R; Rosenbaum, D; Rosenbaum, S; Rosenberg, L; Rosenberg, M; Rosenblit, P; Rosenthal, A; Rosenthal, JE; Rosin, B; Ross, A; Ross, D; Ross, G; Ross, J; Ross, R; Royce, J; Rucker, M; Rudic, G; Rufus, E; Ruxin, R; Rybicki, J; Saavedra, O; Sabol, D; Sadhwani, D; Sadhwani, H; Sadr, F; Sakran, B; Sakurai, K; Saliba, P; Salom, I; Salomon, A; Samaan, R; Samaras, T; Sandberg, J; Sandoval, J; Sanharival, A; Santangelo, D; Sarikonda, K; Sarkar, C; Sasser, L; Savory, R; Sawhney, S; Sawka, M; Sawrey, P; Saxena, R; Saxena, V; Say, CC; Schachere, R; Schafermeyer, KE; Scheerer, JF; Schendel, K; Scheuermann, R; Schlapper, B; Schmidt, J; Schmitt, CJ; Schoenberger, J; Schuhmacher, C; Schultz, J; Schwager, V; Schwartz, D; Schwartz, D; Schwartzman, J; Schwartzman, N; Schweizer, D; Scialabba, M; Scivoletti, P; Secouler, H; Secunda, E; Seek, M; Seet, E; Segal, A; Sehapayak, G; Seidman, B; Selagamsetty, M; Selinger, H; Seltan, M; Selvakumarraj, P; Seth, U; Sethi, M; Seuc, C; Seymour, ZG; Sgalilia, A; Shah, D; Shah, G; Shah, M; Shah, S; Shah, V; Shaikh, M; Shams, F; Shansky, M; Shapiro, D; Shapiro, E; Sharma, R; Sharma, S; Sharpe, CR; Shaw, B; Shaw, G; Shaw, M; Sheaffer, M; Sheer, L; Shepard, M; Shepler, N; Sherer, S; Sheth, Y; Shiffman, S; Shik, M; Shimek, J; Shoaf, E; Shore, M; Shore, D; Shorenstein, R; Shorenstein, M; Shou, P; Shpaner, A; Shrestha, D; Shroff, K; Shukla, A; Siegel, S; Siegelheim, M; Silva, A; Silverman, M; Silverman, W; Simmonsii, C; Simon, RJ; Simons, S; Sinatra, L; Sing, G; Sing, HP; Singh, L; Singh, S; Singla, V; Sinha, P; Siouty, H; Sivalingam, K; Skowsky, W; Slabic, S; Slandzicki, A; Slesers, J; Sloan, L; Smallow, S; Smith, A; Smith, GS; Smith, G; Smith, H; Smith, J; Smith, J; Smith, J; Smith, K; Smith, M; Smothers, R; Sobel, B; Soberano, C; Sobol, T; Socha, B; Sofley, C; Soni, N; Sood, OP; Soper, W; Sotolongo, R; Soung, SC; Spanolios, P; Sparagna, A; Speck, L; Spector, G; Spees, R; Spilseth, P; Spingarn, D; Squire, K; Sraow, J; Sriram, I; Stade, E; Staehling, S; Stafford, D; Staller, R; Staller, S; Stalnaker, J; Stamp, I; Stark, M; Steele, S; Stefanos, G; Stein, P; Stevens, G; Stevens, J; Stickle, HE; Stillwagon, D; Stoltz, R; Stonerock, G; Storey, M; Story, H; Stram, M; Straub, R; Streja, D; Strumillo, C; Strzinek, R; Stuntz, R; Subich, D; Sumulong-Tomacruz, M; Sundheimer, D; Suresh, DP; Surso, J; Suter, M; Swauger, J; Swick, T; Swofford, W; Szanto, M; Szelag, H; Szeto, JS; Tannenbaum, A; Tanner, JR; Tatar, S; Taube, T; Taxin, R; Taylor, D; Taylor, J; Taylor, J; Taylor, L; Tedder, M; Tejada, AQ; Tengco, R; Tepastte, S; Terrell, W; Thai, R; Thepveera, K; Thomas, C; Thomas, F; Thomas, J; Thomas, L; Thompson, R; Thomson, R; Tice, D; Tigges, GA; To, AN; Ton, A; Tong, S; Topacio, A; Torres, E; Torres, J; Tran, L; Tran, T; Trevino, M; Trinkle, S; Trollman, J; Tsai, S; Tsun, M; Tuan, CYC; Tuen, C; Tuffli, C; Turkson, E; Turullols, G; Ugarte, J; Ukwade, P; Ulrich, G; Underwood, H; Underwood, R; Urdanivia, E; Urlanda, J; Vacker, M; Vail, R; Vallecillo, J; van Weelden, G; Vandam, J; Vanderzyl, J; Vandewall, L; Vanvranken, B; Vargo, R; Varma, C; Varns, R; Vashi, D; Vega, S; Venhuizen, G; Venkataraman, S; Verma, D; Verma, K; Verma, R; Verma, Y; Verzosa, S; Vevaina, J; Villa, A; Villafria, A; Villafria, R; Vinton, T; Vo, J; Vyas, P; Vyge, R; Waddell, D; Wade, T; Wagner, W; Wai, SS; Waikar, S; Walker, J; Wallace, M; Walter, L; Walters, B; Wang, J; Wang, P; Wang, P; Wania, D; Wansker, P; Ward, S; Ware, D; Wargovich, T; Warren, C; Warren, J; Warren, W; Waseem, M; Weathers, L; Weaver, H; Webb, B; Webb, W; Weddle, R; Weingarten, G; Weinstein, M; Weinstock, F; Weinstock, R; Weisbrot, A; Weiss, R; Weissman, L; Welling, M; Wellner, M; Wells, A; Welsh, J; Welsh, WD; Wenneker, A; Wessel, C; Wheeler, R; Whiddon, G; White, E; White, M; White, R; Wien, T; Wiggers, A; Wilkins, CE; Willadsen, K; Willard, J; Williams, B; Williams, BJ; Williams, C; Williams, H; Williams, K; Wilson, I; Winik, J; Winkel, RD; Winokur, A; Winters, M; Witt, M; Wong, Y; Wood, R; Woodberry, W; Wool, M; Woronoff, R; Wortman, J; Wozniak, D; Wu, WS; Yakel, D; Yang, M; Yaros, J; Yathiraj, S; Yee, W; Yip, I; Yu, H; Yu, ZJ; Yuan, T; Yut, C; Zador-Silverman, C; Zagha, M; Zaidi, S; Zajac, R; Zalcberg, L; Zampani, R; Zaniewski, M; Zaremba, J; Zazaian, A; Zazaian, J; Zeddies, C; Zeitlin, M; Zias, J; Ziman, R; Zofakis, A; Zolten, R; Zumpano, A; Zuzarte, K				Bhatt, DL; Steg, PG; Ohman, EM; Hirsch, AT; Ikeda, Y; Mas, JL; Goto, S; Liau, CS; Richard, AJ; Rother, J; Wilson, PWF; Andersen-Dalheim, H; Anderson, P; Anell, B; Arber, S; Armstrong, K; Arnot, D; Baldam, A; Barratt, I; Barresi, S; Beder, J; Benson, M; Bergman, F; Best, J; Bhasim, R; Bovell, G; Bowman, N; Brkic, M; Bromberger, D; Brown, D; Brown, J; Brownstein, M; Bruce, A; Buonopane, J; Burns, S; Butler, A; Byrne, D; Carson, J; Cassimatis, P; Chaffey, G; Chambers, D; Chan, WJ; Chan, B; Cheatham, J; Chen, R; Cheong, B; Cheung, C; Chin, J; Chiu, A; Choo, E; Chow, A; Chow, AM; Chung, D; Conos, M; Cooke, N; Cooper, S; Coulton, P; Cranswick, M; Crichton, G; Dabscheck, A; Dalitz, J; Danishar, J; Darzins, A; Davidson, D; Davis, P; Dawood, N; de Clifford, M; de Looze, F; de Sousa, A; Devi, S; Dickman, J; Donald, H; Dowell, B; Dowey, K; Eizenberg, P; Eizenberg, C; Elberg, L; Enten, P; Erhardt, A; Fagan, R; Fairweather, D; Ferguson, N; Ferguson, P; Fernando, C; Ferres, M; Foley, P; Fong, S; Francis, P; Gaddie, D; Gallagher, B; Gan, R; Garland, J; Gault, A; Gianarakis, N; Gibson, D; Gill, I; Giltrap, M; Gingold, R; Gordon, N; Graham, M; Grave, M; Grigg, J; Hall, L; Hall, M; Hancock, K; Harrison, C; Harrison, R; Hayden, R; Heale, J; Healy, P; Herold, E; Hirst, E; Hodby, S; Hogan, C; Horsfall, P; Hutchinson, A; Irmgard, C; Jain, S; Jefferson, D; John, R; John, T; Kay, B; Kelly, P; Kester, D; Khury, J; Kirmos, J; Kloot, S; Kolos, D; Korner, J; Kratzing, C; Kubicek, J; Kumar, A; Lacey, C; Lahanis, C; Lajoie, D; Lam, L; Lancaster, M; Law, H; Lawlor-Smith, C; Laycock, R; Lee, I; Leung, C; Levitt, L; Lewi, L; Liew, J; Liew, S; Lleweslyn, D; Loth, P; Lyon, E; Maclaren, S; Maher, C; Maldari, F; Manderson, J; Mann, L; Mannan, MA; Marano, F; Marinucci, D; Matthews, A; Matthews, C; McGowan, R; McGrath, L; McKenna, J; McNaughton, E; McNiff, M; Meaney, J; Menzies, J; Michaelson, A; Michail, S; Mitchell, G; Molenaar, R; Molloy, P; Monaco-Mugliston, E; Mooney, C; Moor, M; Moylan, B; Nanayakkara, V; Nathan, P; Naughton, W; Ng, R; Nicholson, K; Nixon, M; Nuendorf, G; O'Brien, C; O'Hanlon, P; Olesen, J; Ong, A; Ong, SG; O'Toole, M; Page, M; Pahuja, P; Palmer, H; Parker, S; Partridge, S; Patroney, H; Pattison, J; Pellizzari, G; Perlesz, AM; Phillips, D; Phillips, A; Philpot, J; Piterman, L; Plenderleith, J; Preston, H; Preston, M; Priest, C; Psaradellis, A; Quarles, W; Quinn, M; Randle, J; Reeves, C; Rhodes, T; Rhodes, F; Rosen, N; Rounsevell, J; Rouse, W; Rozsa, E; Saharay, I; Sakowsky, J; Samararatna, M; Same, N; Sammut, V; Sands, L; Schepisi, D; Scurry, D; See, J; Sheringham, J; Shing, K; Simmons, H; Singh, H; Skardoon, L; Slonim, D; Smith, J; Smith, S; Spurling, G; Stowe, S; Stoyanova, V; Sundar, S; Sutcliffe, H; Sutherland, I; Swan, P; Tam, J; Tapsall, M; Teh, P; Theodoros, S; Thomas, S; Thomas, J; Thompson, K; Thompson, D; Thompson, M; Tiernan, S; Tillett, D; Tong, S; Tran, H; Tran, H; Tuan, T; Treagus, I; Tsiang, CT; Turner, T; Turner, E; van Bavel, J; Verrall, C; Vorich, R; Wall, H; Walton, W; Ward, G; Wauchope, B; Weatherall, C; Wexler, P; White, A; Wiehle, G; Wight, R; Williams, I; Williams, M; Williams, S; Wilson, F; Winterton, P; Wong, S; Wrennall, R; Yat, J; Yelland, M; Yip, G; Zhou, N; Ziccone, M; Zochowski, B; Allen, C; Andracher, G; Atteneder, M; Barbieri, G; Brandstetter, J; Bsteh, C; Deiser, HP; Doder, A; Eckert, W; Fahrleitner-Pammer, A; Fiala, W; Fiedler, L; Fiedler, F; Filip, W; Fochterle, J; Forstner, K; Freynhofer, K; Frieden, T; Fruhwirth, E; Gegenhuber, A; Gewessler, A; Goldsteiner, H; Grisold, M; Gruber, F; Gspandl, W; Hauer, W; Herg, M; Herk, J; Heyer, G; Hiemetzberger, H; Hof, W; Hohenecker, J; Hohensinn, F; Honsig, T; Huber, G; Hutter, H; Iampaglia-Springer, G; Itzlroither, K; Jenny, K; Jenull, E; Jung, M; Jungbauer, K; Kaserbacher, R; Katzenschlager, R; Kimeswenger, J; Kittler, E; Kitzler, G; Koschutnik, M; Kotzmann, H; Krasselt, W; Kuhler, M; Kunauer, B; Kunczicky, H; Kurzemann, S; Lachner, P; Lux, W; Maca, T; Mayer, B; Mika, R; Morz, B; Meller-Ringl, H; Nimmerfall, H; Nowotny, W; Ortner, H; Patzold, D; Perger, T; Petuely, F; Pichler, P; Pinter, K; Pollak, J; Pressl, H; Pusarnig, S; Pusch, K; Radi, M; Rausch, M; Reisenbichler, S; Riedl, R; Sattler, H; Schatz, J; Scheibner, P; Schimbach, H; Schmidauer, C; Schmidt, D; Schossleitner, H; Schumacher, M; Schutzenberger, J; Schwaiger, H; Seit, HP; Sepp, G; Stadlbauer, G; Steiner, EH; Stradner, F; Streichsbier, W; Stummer, A; Stumpflen, A; Teleky, U; Tiesenhausen, K; Topakian, R; Toplak, H; Turkis, M; Unterberger, W; Wais, E; Waitzer, H; Waschnig, A; Waxenegger, H; Weber, WF; Weindl, M; Werner, W; Zadra, E; Zaruba, E; Ziegelmeyer, W; Zitt, K; Blecic, S; Bouhdid, Y; Champagne, P; Coenegrachts, W; Cras, P; Dalcq, JM; Decock, E; Di Mascio, A; Dieudonne, L; Dobbelaere, R; Duhoux, S; Fesler, B; Friart, A; Gallez, L; Jaumotte, JM; Jeangette, S; Knop, JM; Leuridan, R; Libbrecht, N; Massart, JM; Mehuys, G; Merlin, JM; Motte, S; Sprynger, M; Surma, J; Thijs, V; Thoeng, J; Vanholsbeeck, F; Vanhooren, G; Varga, J; Vermassen, F; Vermeulen, M; Ataide, L; Atie, J; Avezum, A; Bandeira, F; Bodanese, L; Brasileiro, A; Carvalho, AC; Esporcatte, R; Esteves, JP; Eugenio, AM; Feitosa, G; Fernandes, J; Halpern, A; Lopes, C; Lyra, R; Machado, N; Maciel, L; Marino, R; Massaro, A; Matos, A; Mesquita, E; Moreira, M; Nagato, Y; Nicolau, JC; Nogueira, PR; Pazin, A; Pires, MT; Rocha, A; Rocha, R; Saraiva, JF; Schmid, H; Azul, JS; Tambascia, M; Xavier, S; Yamamoto, F; Yoshida, W; Zanella, MT; Alexandrova, M; Andonova, V; Assenov, O; Atanassova, P; Baleva, V; Benov, H; Bogdanova, V; Bonev, V; Botushanov, N; Daskalov, T; Daskalov, A; Deltchev, I; Denchev, S; Dimitrov, S; Dimitrov, M; Dimov, B; Donova, T; Draganov, T; Dramov, A; Enicheynova, E; Finkov, B; Genov, K; Georgiev, S; Georgiev, S; Georgieva-Tyaneva, Z; Gospodinova, M; Grigorova, V; Hadjolian, E; Hergeldjieva, V; Hrant, E; Ivanova, L; Hristova, SI; Kaneva, D; Karagiozov, Z; Karakaneva-Cholakova, S; Klissurski, M; Kolarov, R; Konteva, M; Lekushev, S; Loukanova, D; Madjarov, A; Manchev, I; Maslarska, Z; Matosyan-Bogdanova, H; Mazhdrakov, G; Micheva, T; Mihailov, M; Milanov, I; Milyotev, I; Naidenova, E; Naydenov, V; Nedialkov, E; Nikolova, G; Panova, M; Panteleeva, S; Papazian, Z; Pasheva, V; Peltekov, A; Penev, A; Petranov, S; Petrov, I; Petrova, J; Petrova, E; Postadjian, A; Raychev, I; Rifai, N; Rousseva, I; Runev, N; Runkov, R; Rusinov, V; Shotekov, P; Simeonova, N; Smilkova, D; Staikov, I; Staikova, E; Stamenova, P; Stankova, K; Stefanov, G; Stoyanov, V; Stoyanovsky, V; Teneva, V; Tisheva, S; Traykov, L; Trendafilova-Lazarova, D; Tsolova, M; Tsonevska, G; Tzekova, M; Tzolov, M; Valcheva, L; Valcheva, E; Valtcheva, R; Vassileva, E; Velchev, V; Velkova, T; Vlahova, M; Yancheva, S; Zahariev, Z; Zhelev, V; Abdulla, A; Andrea, G; Andrew, C; April, G; Ashley, J; Audet, R; Avinashi, R; Axler, J; Baer, C; Bailey, A; Banta, G; Bell, A; Bernstein, I; Berube, C; Bolduc, P; Bouthillier, J; Bree, T; Brown, G; Caplan, D; Chan, J; Chan, W; Chan, C; Chen, R; Cherry, J; Chiu, J; Cho, K; Choi-Fung, B; Chouinard, G; Ciavarella, A; Constance, C; Conway, JR; Cote, M; Cox, R; Crelinsten, G; Cucuzza, MJ; Damji, M; de Young, JP; Dionne, L; Doane, F; Duckett, J; Emond, S; Esmail, S; Faiers, A; Fay, D; Ferguson, L; Ferguson, M; Gaudreau, G; Geenen, C; Gendron, JP; Giannoccaro, P; Godbout, J; Gonzalez, Y; Goodman, S; Govender, K; Goyer, P; Gregus, V; Habert, J; Habib, N; Henein, S; Herman, RJ; Hii, J; Hill, M; Hinnawi, HM; Hollands, R; Hong, T; Hrabarchuk, B; Hum, P; Ismail, S; Jaffer, N; Janmohamed, A; Kelly, A; Kenshole, A; Kessel, B; Kooy, J; Lafrance, G; Lam, SY; Landry, D; Lang, C; Lanthier, L; Lauriston, C; Lauzon, C; Lavigueur, D; Leung, A; Lipsett, W; Lubelsky, B; Luftspring, L; Luton, R; Ma, P; Mackey, A; Marsh, D; Martel, JM; Mawji, A; Mehta, P; Melvin, K; Merali, K; Meunier, P; Meyerson, J; Miron, MJ; Misik, K; Mitha, P; Morgenthau, D; Neu, RD; Nguyen, PB; Nirwan, A; Nunes-Vaz, C; Nykiforuk, E; O'Mahony, W; Omichinski, M; Paquin, M; Patel, K; Patel, R; Payer, P; Payne, A; Pazuki, K; Peer, I; Phaneuf, C; Plamondon, G; Pluta, H; Pottle, K; Price, J; Rebane, A; Rebane, T; Roberge, C; Rockman, G; Rosenberg, D; Rosenthall, W; Ross, J; Rudner, H; Saad, S; Saunders, K; Savvidou, G; Sharma, N; Sobkowski, W; St-Amour, E; Strom, B; Sussman, J; Szparaga, C; Talbot, P; Talwalkar, PA; Theriault, L; Turpie, G; Veloso, F; Vertes, G; Villeneuve, J; Vu, T; Weinstock, M; White, R; Wong, D; Wong, W; Yim, D; Yip, D; Yolles, L; Zimmermann, B; Acevedo, M; Araya, F; Barrientos, N; Bianchi, V; Chavez, E; Diaz, R; Dighero, H; Gajardo, J; Garayar, B; Garrido, B; Gutierrez, V; Hoppe, A; Kauffmann, R; Kramer, A; Kunstmann, S; Manriquez, L; Srur, E; Tapia, J; Varleta, P; Villar, R; Cai, NS; Cao, SP; Di Chen, S; Chen, JL; Chen, XP; Cheng, Y; Cui, LY; Di, Q; Ding, XS; Du, ZM; Fan, W; Fu, JH; Gai, LY; Gao, W; He, GX; Hu, CL; Huang, YN; Huang, SW; Huang, QY; Jin, DX; Li, W; Li, J; Li, CJ; Li, ZY; Lin, JW; Liu, MY; Liu, XF; Liu, M; Luo, BY; Lv, L; Ma, AQ; Miao, L; Ni, HC; Niu, GZ; Peng, GG; Pu, CQ; Pu, PL; Qi, GX; Rao, ML; Song, J; Song, SJ; Sun, XJ; Tao, QL; Teng, JJ; Wan, Z; Wang, SS; Wang, WQ; Wang, YJ; Wang, DX; Wang, JA; Wang, W; Wang, LJ; Wei, JP; Weng, SX; Wu, ZG; Wu, SY; Bin Wu, C; Xiao, B; Xu, F; Xu, Y; Yan, XW; Yu, B; Zhagn, HQ; Zhang, FR; Zhang, BW; Zhang, Y; Zhou, SN; Zhou, YL; Zhu, JH; Agner, E; Boysen, G; Davidsen, O; Engby, B; Frifeldt, JJ; Fruergaard, P; Geisler, K; Gulliksen, G; Hansen, AK; Holck, P; Iversen, HK; Johannesen, N; Kahr, O; Kastrup, A; Kjaergaard, JO; Klausen, IC; Lessing, M; Lund, P; Madsen, H; McNair, A; Meden, P; Michley, H; Mickley, H; Mortensen, TM; Nielsen, W; Kjaer, MO; Oskoie, M; Petersen, J; Poulsen, T; Ralfkiaer, N; Romer, FK; Sondergaard, M; Sorensen, T; Svaneborg, N; Tuxen, C; Hansen, AW; Wolff, B; Aittola, V; Eralinna, JP; Hallberg, V; Harjola, VP; Huikuri, H; Hyttinen, R; Icen, R; Ikonen, T; Kaitila, T; Karmakoski, J; Keinanen-Kiukaanniemi, S; Kettunen, R; Kohonen-Jalonen, P; Koistinen, J; Korhonen, P; Korkeila, P; Kuisma, I; Laaksonen, M; Melin, J; Nissila, M; Ohisalo, J; Pammo, O; Puranen, J; Railo, M; Rantala, A; Repo-Outakoski, M; Sako, E; Sallinen, O; Strandberg, A; Sulosaari, S; Taurio, J; Tuominen, ML; Virkamaki, A; Abdi-Kriaa, L; Abenhaim, N; Aerts, P; Aigle, L; Albert, JP; Albouy, A; Ali-Mirode, A; Allix, J; Amendola, M; Amigues, G; Amougay, H; Anderson, P; Andreani, P; Antoine, C; Arnold, C; Arnould, M; Arrondel, MA; Attali, P; Attuil, R; Aubois, P; Aucouturier, M; Audibert, M; Audouy, P; Auge, C; Auriault, JR; Azoulay, JL; Bachongy, P; Badoc, G; Baehrel, M; Baer, C; Baissas, O; Barada, Y; Baragnon, M; Baranes, C; Barbellion, M; Barberet, G; Bardoux, A; Bargier, J; Bariaud, A; Barjhoux, C; Baron, F; Baron, D; Bartoli, S; Bayle, P; Beck, C; Bell, C; Benais, O; Benichou, H; Bensoussan, JL; Vincent, B; Berdague, P; Bernet-Bernady, P; Bernier, JM; Berrut, G; Berto, N; Berville, D; Bessette, P; Betta, T; Bindler, G; Birry, G; Bisch, O; Bismuth, M; Blanc-Vannet, P; Blouin, P; Boccalon, H; Bodiou, PJ; Boely, T; Eric,; Boitelle, G; Bontemps, T; Bortolotti, C; Bortolotti, D; Bosselut, G; Bouche, M; Bouche, P; Bouchetoux, H; Boulanger, P; Bourahoui, A; Bourgoin, M; Boutelier, F; Boutfol, E; Boyer, P; Boyer, P; Brachet, A; Brafman, O; Brassac, R; Breton, N; Bringer-Raingeard, I; Broussaud, J; Broutin, F; Brunaud, C; Bruneau, P; Brunet, O; Buchon, D; Buffler, P; Cabane, J; Cadinot, D; Calmeiro, A; Campagnac, A; Campagnac, J; Canali, T; Cano, ME; Cano, E; Canu, P; Caparros, D; Cardon, C; Carlotti, M; Carniaux, F; Carre, P; Casanova, M; Casanova, I; Casedevant, B; Castaner, M; Castany, J; Cauchy, B; Causse, P; Cavat, C; Cayron, P; Cazale-Richier, MA; Cazals, C; Cazard, C; Ceccarelli, B; Cerda, P; Cerna, C; Chabreron, P; Chalaux, P; Chaleon, A; Chalvignac, A; Chaperon, R; Chaplin, P; Chapuis, S; Charbonnel, L; Charbonnel, P; Chatelet, MF; Chauvois, C; Chay, M; Chemouni, P; Cherbi, C; Chevalier, JM; Cheynel, JF; Chiausa, B; Choussat, R; Chretien, M; Cibois-Honnorat, I; Cimino, L; Cini, S; Claudel, C; Claudel, Y; Codron, G; Coeure, T; Cohen, M; Cohen, S; Cohen-Bacry, JP; Cohen-Seban, F; Coispeau, MP; Colin, H; Collet, JP; Colobert, A; Combet, R; Conchonnet, P; Conri, C; Coppe, B; Cordier, C; Coriol, F; Coriol, I; Corre, V; Cosson, S; Costargent, A; Cothenet, M; Cottencin, JF; Cottin, Y; Coudert, G; Courreges, JP; Cuisinier, B; Custoza, E; Dages, L; Dahan, S; Dary, P; Daumas, C; Daumas, ML; David, M; de Almeida, A; de Guibert, A; de Joux, E; de la Grandville, B; de Mautort, E; de Saint-Martin, E; Debout, J; Decloux, O; Defrance, F; Defreyn, F; Degeilh, M; Delan, E; Delandre, T; Delbachian, I; Delcros, A; Delefosse, D; Delplace, C; Dely, B; Deme, JC; Demortiere, MH; Deneuville, P; Depoisier, M; Depret-Bixio, G; Derochet, M; Descombes, S; Desgranges, JP; Dessales-Quentin, P; Dewulf, J; Dimon, B; Doat, P; Doazan, JP; Doerr, JY; Domenech, A; Domigo, V; Donal, E; Dormard, C; Doucet, B; Dreux, D; Dubedout, B; Ducarme, JC; Duclos, G; Dugny, G; Dumond, P; Dunand, T; Dupouy, P; Dupre, JP; Dupuy, O; Durantel, T; Durbiano, JF; Dutilleul, P; Duval, M; Duvochel, L; Eckert, V; Edet, D; Ehrlich, JM; Eisele, P; Elbhar-Pouchoue, C; Escourrou, B; Espinasse, P; Etienne, JC; Etienney, J; Eveillard, FX; Eveno, D; Fabregue, C; Farhat, S; Fauchard-Renard, C; Fauchier, V; Favre, S; Fayard, P; Feldmann, I; Felten, D; Ferchaud, P; Feret, D; Ferreira-Maldent, N; Ferrier, R; Ferrieres, J; Feuillet, J; Fivel, C; Fleury, C; Flizot, M; Flosi, M; Foltzer, E; Fontaine, X; Fonteny, R; Forestier, B; Forne, M; Fortis, A; Fouillat, C; Fouillen, B; Foure, Y; Fournier, P; Fournillou, JC; Franchet, M; Francillotti, A; Francois, C; Frayssinhes, M; Gabrielli, JL; Galy, P; Garnier, J; Garnier, P; Garnier, E; Garrel, E; Gasior, C; Gaudisart-Amblard, I; Gauthier, B; Gay, P; Genoud, D; Geoffray, B; Germain, P; Geronimi, O; Gilles, L; Gin, H; Ginestet, P; Giorgi, JP; Giraldi, C; Girard, C; Gissler, M; Gleye, V; Glorieux, I; Goepfert, L; Gournay-Lahoussine, MC; Gouron, P; Grabovescu, M; Grange, P; Gran-Ortiz, SM; Grazzini, JP; Grevet, D; Grivet, B; Grivet, F; Groell, R; Grohar, M; Grollier, G; Gros, P; Gros, B; Grutter, S; Guichard, G; Guilharretze, R; Guillaumot, H; Guillemot, D; Haller, C; Hamel-Desnos, C; Hannoush, E; Harroch, M; Haus, JC; Hebert, M; Helms, E; Hemocq, M; Frederic, H; Henry, B; Herent, M; Hertling, R; Hild, P; Hild, C; Hosseini, H; Hourcq, JC; Hovine, JL; Huberschwiller, JL; Huet, R; Huet, D; Humbert, T; Ihli, D; Iriart, JL; Jacamon, Y; Jacqueminet, S; Jacques, V; Jacquet, C; Jacquet, JP; Jacquot, A; Jamet, JF; Jamilloux, D; Jappy, L; Jaudon, P; Jean, F; Jean, G; Jeanjean, F; Jedynak, C; Jonot, F; Jordan, E; Joseph, T; Jouin, C; Jourdan, P; Jusserand, JT; Kaltenbach, E; Kerharo-Nicolas, A; Khennouf, A; Kleimberg, C; Kleimberg, D; Kohser, P; Koubbi, A; Krempf, M; Kuhn, P; Kurtz, C; Lacoin, F; Lagrange, V; Lahoussine, S; Lambert, P; Lamperin, JM; Lanusse-Cazale, G; Largillier, C; Lascaux, D; Latour, R; Lauer, JM; Lauga, D; Laulhe, F; Launay, J; Laur, MP; Laureille, B; Laurent, P; Laurent-Montero, F; Lavallee, P; Lavigne, MC; Le Devehat, C; Le Diagon, R; Le Du, J; Le Mouel, S; Lecaignard, D; Lecarme, C; Leclercq, F; Lecue, V; Ledru, F; Lefort, D; Legrand, C; Leguerrier, AM; Lelgouarch, J; Lemaire, L; Lemaire, M; Lemaire, P; Lemarie, B; Lemettre, B; Lemoine, P; Lenormand, M; Lepoutre, JL; Lerich, B; Lerouge, JM; Lescoute-Jabot, M; Letellier, PY; Letzelter, JM; Leveque, M; Levy, M; Levy-Casson, B; Leygnac, P; Lhosmot, JP; Liard, F; Lion, A; Locquet, J; Loewert, JF; Lormeau, B; Louis, J; Louison, A; Louveau, P; Louy, M; Lussiana, G; Mabire, P; Machero, Y; Macian-Montoro, F; Magnaval, C; Magnus, P; Maillan-Martin, M; Mainetti, P; Mallemont, C; Mallet, P; Manigold, P; Marchand, P; Marciano, D; Marger, JL; Marino, B; Marissal, P; Martial, P; Martin, R; Martin, J; Martin-Peridier, M; Martins, H; Martocq, G; Masson, JJ; Mathys, I; Maupin, Y; Maury, D; Medvedowsky, A; Meimoun, P; Mercey, Y; Mercier, A; Meresse, C; Messner, P; Metivier, M; Meyrand, B; Mezin, J; Michalak, B; Michel, C; Michellier, P; Milhaud, D; Mohsen, M; Molinier, JF; Molinier, M; Mollet, G; Molleville, J; Monsegur, P; Montloin, F; Moreno, R; Moritz, D; Morvan, P; Mottin, J; Mougenot-Pierson, B; Moura, H; Mours, P; Moussu, P; Moutier, P; Mteirek, M; Muller, JJ; Nabedian, E; Naybodokama, J; Neau, JP; Nejman, M; Nerson, J; Nevians, P; N'guyen, B; Nicodeme, JL; Niel, L; Nivelleau, E; Noel, R; Nusimovici, JC; Obadia, D; Oger, T; Olive, A; Olivier, C; Olland, PL; Orenstein, D; Outteryck, A; Pabst, JM; Pachod, D; Page, E; Paillard, F; Panacciulli, JE; Paneau, D; Paradis, C; Parent, D; Paris, M; Pellenc, C; Penfornis, A; Percheron, CA; Perez, G; Perez-Martin, A; Perin, B; Pernin, D; Perreur, P; Perrier, E; Perrin, B; Perrotel, JL; Perrousse, M; Perroux, V; Petit, L; Petit, O; Peyraud, J; Philipp, JM; Philippeau, F; Picard, Y; Piera, JF; Pieretti, M; Pierini, J; Pierre-Justin, E; Pietri, P; Pinaud, D; Pinel, JF; Pinel, G; Pinson, FX; Piot, C; Pistorius, MA; Pithon, M; Pithon, A; Plan, P; Poggi, JN; Poinot, P; Poisson, P; Poquet, A; Pouedras, YY; Pouedras-Raton, F; Pouget, M; Pourcin, J; Pradeau, R; Prat, J; Prat-Caillol, C; Prieur, T; Prijac, B; Proville, JM; Pucheu, A; Pueyo, JB; Puiggali, CP; Pujol, F; Quadrelli, J; Queguiner, A; Quere, I; Quilliou, F; Quiqempois-Kaminski, A; Rabut, F; Rahili-Polette, S; Rambaud, J; Raucourt, P; Ravel, S; Ravoire, P; Rebiere, S; Rebmann, S; Regnier, J; Reichard, MT; Reinard, JF; Reins, P; Remacle, A; Remerieras, JJ; Renucci, JF; Reny, JL; Resslen, Y; Reumont, G; Reynier, JL; Riera, C; Rietsch, JF; Ripoll, M; Ritz, P; Robert, JP; Robert, J; Robert, D; Robin, F; Roche, C; Rodier, G; Roger, JJ; Rolland, JF; Romen, E; Rondeau, JL; Ronziere, G; Roques, A; Rosenberg, S; Rosier, F; Rosset, E; Rouchaud, E; Roudiere, C; Roussel, R; Rousset, A; Rouviere, G; Ruetsch, M; Ruivard, M; Sacareau, D; Sagez, JF; Saillard, D; Salerno, P; Salloum, A; Salzmann, M; Samat, J; Saouma, N; Sarfati, H; Sastourne, JP; Saunier, JL; Saurat, A; Savoyen, D; Scellier, C; Schaal, C; Schatzkine, P; Schmitt, A; Schnebelen, C; Schordan, R; Schroeder, K; Schultz, Y; Schwab, R; Seinturier, C; Sement, S; Senk, D; Sesoren, I; Seveyrac, JF; Simorre, O; Sinoir, PF; Slama, G; Sorbe, G; Soret, F; Soria-Berdugo, S; Soskin, P; Soulary, JC; Spiess, P; Spilthooren, F; Steinberger, M; Stoll, JJ; Stoll, A; Strentz, P; Tallet, N; Taminau, D; Tan, S; Tap, M; Tarouel, P; Taverne, P; Templier-Gauthier, E; Terrail, M; Terrien, JP; Theoule, J; Tiberghien, P; Tiev, KP; Tisserand, R; Toledano, J; Tomaszenwski, B; Toto-Grisoni, C; Touzet, P; Tricoire, E; Tricot, F; Triot, P; Valette, T; Vandooren, E; Vanhoutte, C; Vanier, S; Vayre, F; Vedrenne, J; Venjus, P; Venturini, G; Verlet, E; Verney, G; Vernhes, JF; Verquerre, M; Vialette, JC; Vienne, R; Vigier, P; Vignoulle, JL; Villon, L; Vincey, C; Vogel, JY; Vogt, P; Vonarx, J; Vuong, MH; Weigel, JL; Wencker, C; Wey, N; Winter, P; Wodey, V; Wurtz, JL; Yoh, F; Yvenov, S; Zaknoune, A; Zamaria, G; Zerbib, F; Zoro, P; Abdul-Malak, P; Abel, C; Achatz, M; Akalin, S; Alexander, C; Altenkaamper, H; Andres, M; Angenvoort, C; Appy, M; Arkenau, C; Bach, M; Baier, S; Ballstaedt, C; Baran, C; Barbuia, M; Barho, C; auf dem Brinke, AB; Bauer, O; Bauersachs, M; Bauknecht, C; Baumann, I; Beck, C; Becker, R; Becker, HJ; Beermann, H; Bemmann, D; Berdermann, S; Besser, O; Beyer, R; Birke, R; Bodammer, M; Bodenschatz, R; Bogel, M; Bohe, JP; Bohm, G; Bohme, J; Bondke, C; Bonenkamp, A; Booz, S; Borgmann, A; Brachmann, R; Brado, B; Braun, HJ; Braun, RM; Breuer, HH; Brockmann, S; Broer, F; Bronder, B; Bruck, G; Bruck, H; Bruckmann-Stautner, C; Bruckner, C; Brune, S; Buchholz, P; Buchkremer, R; Bunge, K; Burczyk, U; Burgei-Seifert, G; Busch, HM; Buschmann, L; Butz, U; Cebulski, AC; Clob, R; Coppenrath, K; Cornely, D; Daikeler, R; Daniel, J; Daxer, A; Deeg, W; Degering, H; Delank, C; Diehls, K; Dobiasch, F; Dobner, M; Doumit, A; Drechsler, C; Dresler, R; Drews, H; Droese, K; Drummer, J; Drzymalla, R; Dubowy, J; Dursch, M; Dusold, F; Ebeling, K; Ebert, HH; Eckert, D; Eckert, V; Eichner, R; El, SJ; Eltges, N; Emde, E; Engeser, P; Esmaty, A; Exner, H; Faber, U; Facius, H; Falkenhahn, D; Feldmann, T; Fiala, G; Fiedler, A; Finck, M; Finkenthei, J; Fissan, H; Fleischer, U; Flohr, K; Franke, D; Franke, H; Franz, R; Franzmann, F; Frees, U; Freimuth, M; Freundl, D; Frieling, A; Froehlich, B; Frohlich, A; Frommhold, M; Garten, H; Gartner, J; Gerbaulet, U; Gerhardt, A; Gerlach, T; Glaser, W; Glomm, H; Glos, J; Godt, U; Goudarzi, G; Grams, O; Greie, KD; Grosschaedl, A; Grobkopf, J; Grun, LKJ; Grutzner, E; Grzeschik, HG; Haaf, J; Haas-Weber, M; Hadlich, G; Hafender, K; Hagenow, A; Hahn, W; Hailer, D; Hammerl, M; Hanselle, U; Hansen, S; Hardt, M; Hauer, R; Hauk-Westerhoff, L; Hauser, ER; Hecht, JP; Hedtkamp, CU; Hefftler, V; Heimann, D; Heinl, T; Heinrich, U; Heinz, GU; Henke, S; Hentrich, W; Herber, H; Herbers, J; Herbst, H; Herman, G; Hertzer, P; Herzog, W; Hess, H; Hebeling, C; Hestermann, M; Heyenbrock, M; Hietkamp, S; Hildebrand, P; Hilgedieck, M; Hofmann, M; Hohensee, H; Hohnstein, E; Huch, H; Humke, G; Hundgen, R; Huning, H; Huntemann, R; Huppertz, W; Hutt, T; Huttner, H; Ihle, W; Jacobi, S; Jager, J; Jager, BU; Jahnke, N; Jankowski, A; Jansch, S; Jesinghaus, D; Jeske, J; Jung, M; Jungblut, G; Junge, U; Jungmann, WG; Kaiser, J; Kaiser, W; Kajzar, M; Karakas, T; Karatay, E; Karl, S; Kaviani-Nejad, K; Kayali, N; Keienburg, T; Keller, H; Kebler, GR; Kirsch, A; Klein, C; Klein, M; Kleinert, A; Klementz, A; Klopper, JW; Kmoth, E; Knispel, O; Knobloch, E; Koch, V; Kochen, S; Kochhauser, W; Koeppel, A; Kohl, SC; Kohler, A; Kohler, C; Kohlhas, K; Kohn, RD; Konemann, K; Konschak, A; Konstanzer, A; Kopplin, U; Kornadt, T; Kortas, R; Kossow, T; Kraaz, K; Kramer, A; Krause, G; Kreckel, P; Kretschmer, K; Kretschmer, S; Kretzschmar, W; Krupp, C; Kuhn, R; Kuhnen, R; Kunert, H; Kunze, S; Kuther, D; Kutscherskij, C; Kutz, B; Labitzke, S; Lang, HJ; Lange, T; Lanta, L; Lanzendorfer, C; Lasana, JE; Lederle, S; Lempke, K; Lenfers, M; Lenk, U; Leyer, M; Lipp, I; Lippert, R; Litzinger, B; Loprich, B; Lossl, K; Ludewig, S; Ludwig, G; Lukannek, S; Magdefrau, M; Mantaj, R; Markreiter, M; Martak, F; Marten, T; May, A; Herbert,; Meier, U; Meier, S; Meinecke, E; Meinung, U; Meisel, E; Meibner, M; Merbach, U; Messner, H; Methfessel, FH; Metscher, B; Meub, H; Meyer-Bender, B; Micke, L; Mietaschk, A; Mohr, W; Moltzahn, S; Mondorf, C; Morell, R; Moritz-Lippmeyer, M; Muller, W; Mueller-Buehl, U; Mura, R; Naumann, R; Nedder, KH; Neeff, A; Nehrig, P; Neu, A; Neumann, E; Neumann, RM; Nikolaus, HP; Nissen, L; Nold, R; Oertel, R; Ofer, H; Offermann, R; Opel, G; Opitz, T; Ostmann, B; Pankow, PM; Patschan, R; Patz, A; Pellens, A; Perlwitz, R; Pfetsch, KH; Philippi, H; Piepenbrock, N; Pinterowitsch, J; Pohle, B; Poll, A; Pomiersky, C; Poten, B; Prange, E; Preissner-Kiebling, A; Puls, HD; Puth, P; Puttbach, R; Putz, H; Quosigk, R; Raab, H; Rabahieh, R; Raddant, R; Ramm, F; Rapp, G; Ratzmann, KP; Rau, M; Rautenberg, W; Reiff, T; Reike, N; Reinhard, BD; Reischl, A; Rentz, U; Reul, A; Rieker, E; Ries, S; Rink, V; Rippl, CE; Rissel, U; Ritter, U; Rohl, S; Rohlfing, H; Rohrich, M; Rosenthal, A; Roth, V; Roth, M; Rotsel-Schafer, U; Rottenberger, M; Rudolph, K; Ruider, H; Ruland, D; Rupp, H; Ruter, J; Ruthlein, V; Sach, A; Safavi, A; Sagemuller, P; Sakrib, U; Sayegh, A; Schafer, T; Scharrel, H; Schellenberg, G; Schenk, W; Schiffmann, O; Schimek, J; Schladitz, K; Schlegl, J; Schlick, M; Schluter, HJ; Schluter-Block, G; Schmid, G; Schmidtke, S; Schmiedeberg, K; Schneider, G; Schnittert, K; Schnittert, M; Scholl, N; Scholz, M; Schon, D; Schone, S; Schonecker, W; Schonen, J; Schonfelder, T; Schonrock, E; Schreiner, M; Schreiner, M; Schriek, J; Schroder, T; Schroder, B; Schroder, P; Schroter, W; Schulte, D; Schulten, K; Schultz, D; Schumacher, A; Schuster, J; Schutz, M; Schwadorf, H; Schwarz, T; Schweighofer, HG; Schweyer, L; Sczesni, B; Schon, N; Segebrecht, P; Seidel, B; Seifert, K; Seifert, HP; Seiler, AM; Seitz, C; Senftleber, I; Simon, J; Sindl, A; Sinn, L; Sinning, UH; Sliwka, U; Sommerlatte, T; Sorncharoen, T; Sperle, W; Spitzer, A; Stadt, D; Stadtmuller, J; Stahl, A; Stegner, A; Stein, W; Stein, J; Steindorf, J; Steinle, M; Steinmeier, A; Stenzel, G; Stiegler, K; Stocking, B; Stohrer, HG; Stroh, HJ; Strubel, G; Swistowski, J; Tagder, A; Taggeselle, J; Taubert, G; Tauchert, S; Thamm, ME; Thiel, G; Thinesse-Mallwitz, M; Thum, J; Tietz, M; Todoroff, K; Traub-Bobrich, E; Troger, S; Tuchscherer, U; Tulaj, B; Turowski, A; Tymiec, S; Udvari, E; Ullerich, G; Unger, C; Utz, I; van Hasselt, P; Villis, R; Vogt, A; Volckers, C; Volker, J; Voller, T; von Bilderling, PB; von Molitor, S; Voskamp, A; Wagner, A; Wagner, B; Walther, F; Weider, CM; Weier, B; Weilacher, J; Weirich, C; Weislogel, R; Weissinger, G; Wenck, M; Werner, J; Werner, M; Weyers, G; Wiedemann, K; Wiedemann, ML; Wiegank, S; Wilbrandt, E; Wildenauer, W; Willers, B; Winter, WR; Wirtz, D; Wissmuller, HF; Wolde, CH; Woschech, M; Wunderlich, M; Zeese, V; Zens, V; Zimmermann, K; Zorn, A; Asimi, G; Bakalis, C; Bakopoulos, C; Balis, D; Baltatzis, K; Basdekidis, A; Caraindros, I; Chatsiou, A; Chatzigiannis, P; Dakos, G; Dantsi, G; Deligianinis, G; Demiris, A; Dermitzakis, I; Dima, C; Dimitriadis, C; Fatsis, M; Floros, G; Garbis, A; Georgiadis, I; Georgogiannis, N; Groutsis, T; Kapetanakis, L; Kapsoudas, N; Karabali, S; Karagiannis, D; Karalioliou, S; Klitsas, A; Kotsis, N; Koulouzakis, P; Ktistakis, S; Liberakis, S; Mandalaki, E; Manolakos, A; Maranga, A; Markoglou, N; Meramvoliotakis, N; Milopoulos, C; Mimilas, N; Moschonas, I; Navrouzoglou, I; Panagiotopoulos, P; Papaeconomou, D; Papathanasiou, N; Pappa, I; Parissis, D; Petras, C; Petropoulos, I; Pontikakis, N; Pontikis, C; Ragias, G; Rigas, S; Riza, P; Sabatakakis, P; Sitis, V; Skanavis, A; Skirla, F; Sotiriou, M; Stakiadis, M; Stilianoudaki, S; Syrigou, A; Tachmatzidis, I; Takis, K; Tassopoulou, P; Tekos, K; Theodorakis, A; Theodoropoulos, I; Tsakiris, T; Tserkezou, M; Varnavas, I; Venetia, P; Vrachnakis, N; Ziros, G; Zouberis, I; Yeong, CKA; Chan, N; Choi, K; Chow, SL; Chu, CL; Chung, HK; Goh, V; Kong, YF; Ku, CS; Lam, ACK; Lau, YT; Lo, CW; Ng, WF; Tong, P; Tong, WK; Tsang, CA; Tsui, HS; Wong, BL; Wong, WK; Yu, YK; Adam, A; Antalics, G; Balas, V; Bartfai, E; Bartha, Z; Bata, M; Bernath, B; Bodnar, I; Csomos, I; Csordas, M; Czucza, E; Darvai, L; Dulai, I; Eberling, G; Endre, V; Farkas, K; Foldesi, G; Forgacs, S; Garai, B; Gergely, G; Gubucz, I; Hajdara, I; Hamvas, J; Harcos, P; Hasitz, A; Hegedus, G; Hegyi, M; Hermann, Z; Jakab, K; Juhasz, I; Juhasz, K; Katalin, G; Keresztes, A; Kosa, I; Koves, A; Lakatos, J; Lippai, L; Lovasz, T; Lupkovics, G; Magyar, A; Magyarosy, E; Major, T; Makai, A; Marton, R; Mede, K; Metz, E; Molnar, M; Muranyi, A; Nagy, Z; Olasz, M; Paulo, K; Penner, I; Revesz, Z; Roth, P; Rozsa, S; Sarkadi, C; Semjen, J; Sipos, TA; Sitkei, E; Strebely, G; Sudar, Z; Szabo, Z; Szepesvari, S; Toth, G; Trapp, G; Zsigmond, A; Zuberecz, Z; Adam, J; Agoes, A; Andaningsih-Rahardja, I; Arjuna, R; Asdie, A; Basyah, A; Budiarsa, IGNK; Dirdjaningrat, D; Djokomoeljanto, R; Fathoni, M; Gunawan, BI; Hendromartono, MA; Kadarjono, LA; Kalim, H; Kaoy, IN; Karim, S; Kasiman, S; Kusmana, D; Limantoro, C; Limoa, RA; Arifin, AL; Mardianto, LHM; Maryono, D; Mazwar, I; Misbach, J; Nangoi, P; Pudjowidyanto, H; Purnomo, H; Gunadhi, IGNP; Rahmawati, D; Rifqi, S; Ritarwan, K; Santoso, A; Santoso, T; Sastrosukarno, S; Setiati, S; Setijorumekso, S; Soehartono, Y; Suhana, D; Susilo, JAH; Sutanegara, IND; Syawal, A; Tanuwidjaja, S; Wasyanto, T; Wita, IW; Yeo, HC; Arango, AC; Chavarria, JA; Cohen, AB; Cabrera, J; Castillo, B; Huepella, EHC; Ku, CHC; Alvarez, ED; Jimenez, RED; Espinosa, H; Cedeno, SNE; Rivera, CEH; Hernandez, D; Hernandez, J; Alvaro, JLM; Medina, F; Haro, JAM; Mini, M; Molina, G; Moya, J; Ortiz, ME; Parajeles, A; Ramos, CA; Rodriguez, E; Risso, GLS; Sprok, JM; Villagomez, DRT; Tortos-Guzman, J; Urrutia, V; Sanchez, DV; Dupont, JPV; Martinez, PVG; Vinocour, M; Abramovitz, A; Amar, S; Avrahami, R; Biderman, A; Davidov, N; Faibel, D; Flechner, ON; Glikberg, F; Hefer, M; Henkin, Y; Klain, E; Kleiman, R; Kornboim, B; Lev, T; Levie, P; Mahmoud, AK; Mendelson, A; Mor, L; Moran, ZC; Nitay, G; Ostrovski, I; Pshetizkj, Y; Reinitz, A; Reiss, H; Rivkind, R; Roch-Klipper, L; Rosner-Kamana, D; Sabah, T; Schuldman, M; Segal, E; Shtraikher, I; Sophia, B; Strausberg, I; Umansky, M; Wainsztok, S; Wertmann, E; Wrobel-Zaher, D; Zeltcer, C; Zhuravlove, C; Zibuleusky, G; Abe, K; Abe, N; Adachi, M; Adachi, H; Akiyama, H; Anami, Y; Aosaki, M; Aoyagi, T; Araki, R; Ashiba, A; Atou, K; Awano, K; Azuma, N; Azuma, A; Bujo, H; Chida, K; Date, H; Degawa, T; Doniwa, K; Ebihara, K; Egusa, G; Eki, Y; Endo, M; Enomoto, T; Fujii, T; Fujimori, H; Fujimoto, Y; Fujimoto, K; Fujimura, H; Fujio, N; Fujita, M; Fujiwara, T; Fukuda, A; Fukuda, Y; Fukunaga, R; Furuya, T; Fuse, S; Fuse, T; Goto, J; Goto, K; Hamada, R; Hamada, T; Hamamoto, S; Hanabusa, T; Hanafusa, T; Handa, N; Hara, K; Harada, Y; Haruta, S; Hashizume, T; Hattori, A; Hayashi, M; Hayashi, Y; Hida, K; Higahi, K; Higaki, S; Higashi, Y; Higashidate, M; Hiramoto, T; Hirano, K; Hirata, K; Hiratani, K; Hirono, O; Hirotani, A; Hisatome, I; Hondo, H; Hoshino, J; Hosoi, T; Hosomi, N; Ibayashi, S; Igaki, T; Iijima, T; Iikuni, K; Ikenouchi, H; Imai, K; Imai, K; Imai, T; Imamura, S; Inatsu, T; Inoue, I; Ishibashi, S; Ishibashi, T; Ishida, K; Ishida, S; Ishige, N; Ishihara, M; Ishihara, H; Ishii, Y; Ishimaru, Y; Itakura, H; Ito, T; Ito, T; Iwaki, N; Iwamoto, M; Iwao, T; Iwase, T; Izumi, Y; Jinnouchi, Y; Joki, H; Kagawa, N; Kaieda, H; Kajikawa, T; Kamiya, T; Kamiya, H; Kaneko, K; Kanemaru, Y; Kashiwagi, A; Kato, H; Kato, K; Katsume, H; Kawabata, T; Kawaguchi, T; Kawahara, K; Kawamoto, T; Kida, Y; Kihara, M; Kimura, T; Kimura, H; Kinoshita, A; Kitagawa, T; Kitagawa, K; Kitamura, K; Kitamura, H; Kitano, T; Kitaoka, H; Kobayashi, K; Kobayashi, Y; Kobayashi, H; Kobayashi, Y; Kobayasi, M; Kohara, N; Koide, J; Koizumi, J; Komachi, H; Konno, H; Koretsune, Y; Koriyama, T; Koseki, S; Kotorii, S; Koyama, K; Kubo, M; Kume, M; Kunimoto, M; Kunisaki, M; Kunitomo, R; Kuniyoshi, Y; Kuroki, K; Kuzuya, M; Makino, M; Manabe, Y; Maruyama, K; Maruyama, T; Masaki, M; Masuda, R; Masuda, M; Matsubara, S; Matsubara, J; Matsuda, M; Matsumura, M; Matsuo, T; Matsuoka, T; Matsushima, T; Matsuura, Y; Matsuyama, H; Memezawa, H; Mii, S; Mitsuo, K; Miyai, H; Miyakawa, Y; Miyamoto, S; Miyatani, K; Miyazaki, Y; Miyazawa, Y; Mochizuki, H; Momomura, SI; Mori, Y; Mori, H; Mori, N; Morimoto, K; Morita, I; Moriyama, H; Motokawa, K; Mukai, T; Murahashi, M; Murao, S; Nagamitsu, T; Nagao, T; Nagata, K; Nakada, Y; Nakagami, T; Nakagawara, J; Nakahara, K; Nakajima, T; Nakamura, Y; Nakamura, T; Nakamura, Y; Nakamura, Y; Nakamura, T; Nakamura, M; Nakamura, M; Nakane, H; Nakato, T; Nakatsuka, M; Nakayama, S; Nakazato, T; Nanjo, K; Narimiya, M; Negishi, T; Nemoto, T; Niinomi, M; Nishigaki, K; Nishikawa, H; Nishimura, H; Nitta, M; Nitta, M; Noda, K; v; Noma, K; Obata, H; Ochi, Y; Ochi, T; Ogawa, Y; Ogawa, T; Ogawa, A; Ogo, A; Ohagi, S; Oishi, Y; Oiwa, K; Ojiro, M; Okada, K; Okada, K; Okada, M; Okada, Y; Okamoto, M; Okamoto, Y; Okamoto, S; Okubo, M; Okuda, S; Onishi, T; Ono, N; Onodera, T; Onohara, T; Osumi, K; Ota, T; Otani, M; Otani, N; Ozaki, H; Ozawa, H; Sairenji, H; Sakai, K; Sakai, K; Sakamoto, S; Sano, R; Sato, A; Sato, H; Sato, J; Sato, K; Sato, R; Sato, S; Sawamura, N; Segawa, K; Seki, T; Sekiya, T; Senda, T; Shibasaki, Y; Shida, M; Shigeyama, T; Shiiya, N; Shimada, I; Shindo, S; Shinno, K; Shinohara, I; Shintani, U; Shiraki, T; Siomi, K; Sonobe, M; Sugisaki, K; Sugiura, H; Suto, N; Suwa, T; Suyama, K; Suzuki, S; Suzuki, M; Suzuki, S; Suzuki, M; Suzuki, A; Suzuki, M; Tabuchi, A; Tada, M; Tadokoro, N; Taguchi, S; Taguchi, S; Tajiri, Y; Takahashi, T; Takata, T; Takeda, Y; Takei, M; Takeichi, N; Takekawa, H; Takemoto, Y; Takenaka, T; Takeuchi, T; Takeyasu, N; Takita, M; Takizawa, S; Tanahashi, N; Tanaka, K; Tanaka, K; Taniguchi, S; Tanzawa, T; Tashima, K; Tashiro, H; Tatsuoka, Y; Tenda, K; Teramoto, T; Tobita, M; Todo, R; Tominaga, R; Tominaga, M; Tomohiro, A; Toshimori, H; Tsubokura, T; Tsuchihashi, T; Tsukahara, T; Tsukahara, K; Tsutsui, H; Uchida, N; Ueda, H; Uematsu, D; Uenohara, H; Ujihara, M; Umemoto, T; Uno, M; Urakaze, M; Wada, Y; Wakuta, Y; Wasada, K; Watanabe, K; Watanabe, T; Watarai, T; Yabe, T; Yamada, Z; Yamada, K; Yamada, A; Yamada, T; Yamada, T; Yamagata, H; Yamaguchi, T; Yamaguchi, K; Yamaguchi, K; Yamaguchi, S; Yamamoto, M; Yamamoto, Y; Yamanari, H; Yamane, K; Yamano, M; Yamasaki, M; Yamasaki, K; Yamashita, K; Yamashita, M; Yamashita, I; Yamatani, K; Yamazaki, Y; Yanagihara, K; Yasugi, T; Yasuoka, S; Yokochi, H; Yokomori, N; Yokota, H; Yokota, H; Yokota, N; Yokota, N; Yokotani, T; Yokoyama, H; Yokoyama, S; Yonezawa, K; Yonezawa, Y; Yoshida, M; Yoshikawa, M; Yoshimura, K; Yoshimura, R; Yoshimura, K; Yoshimura, S; Yoshioka, K; Yoshioka, N; Yududo, T; Algahtani, H; Hammouda, A; Khoja, W; Ghany, MA; Al Zamzami, AA; Ali, MA; Alshamiri, MAA; Bohlega, S; El Shaer, F; Elmaleeh, Y; Gamal, IW; Kinsara, A; Kurdi, M; Mabrouk, A; Malik, A; Raslan, H; Shaaban, A; Taha, H; Zaidan, R; Ahn, TH; Baik, SH; Chae, IH; Cho, KH; Choi, WH; Choi, YK; Chung, KC; Heo, JH; Jang, Y; Jeong, MH; Jung, DS; Kang, HS; Kim, SW; Kim, JS; Kim, KS; Kim, SK; Kim, YK; Kim, KS; Lee, DH; Lee, KH; Lee, KS; Lee, BC; Lee, I; Park, KS; Park, JE; Park, SW; Park, SW; Rhim, CY; Seung, KB; Son, HY; Woo, JT; Yi, SD; Yoon, BW; Abdallah, H; Raad, JA; Rizk, GA; Abu Salbi, M; Ashkar, K; Atallah, F; Awwad, P; Chammas, E; El Nakib, M; Ezzeddine, K; Ghaddar, A; Khater, B; Maaliki, S; Makarem, M; Matar, M; Mattar, H; Mounir, R; Musharrafieh, U; Nasr, C; Riachi, N; Saleh, M; Stephan, E; Tabet, G; Bodindorfiene, N; Docka, V; Jankauskiene, L; Kojeliene, J; Kovaite, M; Petrulioniene, Z; Tamosuitis, I; Terbetiene, B; Zaronskiene, D; Abd Ghapar, RAK; Khalid, NA; Mahayiddin, HAA; Ambrose, TF; Ang, CK; Azizi, ZA; Ali, RA; Basri, H; Chan, WL; Chan, SP; Chang, SK; Chee, KH; Chia, YC; Chong, YS; Choong, CH; Puvanarajah, SD; Fung, YK; Goh, EL; Hussein, H; Ismail, O; Ismail, Z; Ismail, SB; Ismail, N; Kamaruddin, NA; Kamarudin, N; Kandasamy, B; Lee, SK; Leong, YP; Liew, HB; Liew, CK; Mahadasa, P; Mak, CS; Merican, JS; Mohamad, M; Ng, CJ; Hasni, HN; Ong, TK; Quek, DKL; Rajasingam, V; Sim, KH; Veriah, RS; Sinnadurai, J; Tan, KS; Tee, LK; Tiang, SW; Mohamad, WBW; Yusuf, Z; Velasco, AA; Aguayo, G; Gamba, MAA; Alexanderson, G; Alpizar, M; Amaya, LE; Arauz, A; Astorga, A; Azpiri, JR; Barinagarrementeria, F; Esbrada, EB; Ramirez, HMB; Calvo, C; Cauto, C; Colorado, H; Cortes, J; Cossio, J; Ibarra, MOD; De Zatarain, R; Diaz, C; Eng, L; Esparragoza, J; Sierra, LE; Espinoza, C; Bonetti, PF; Cantu, EG; Martinez, RG; Guerra, AG; Camid, FDG; Pasqueira, FG; Hernandez, I; Kostine, A; Leiva, JL; Llamas-Lopez, L; Lopez, B; Cuellar, JL; Meneses, ML; Marcos, A; Lopez, SN; Nettel, J; Galvan, FO; Peralta, R; Garcia, JCP; Ranero, A; Rangel-Guerra, R; Rodriguez, J; Leyva, IR; Rojas, JA; Romero, A; Rubio, G; Ruiz, JL; Sagastegui, A; Talamas, O; Tapia, M; Melchor, JLA; Uribe, A; Vazquez, J; Velasco, JA; Ortega, ECV; Sanchez, RGV; Villarreal, J; Barendregt, W; Buth, J; Cheng, J; Agata, AD; De Haan, J; Deckers, J; Driesen, J; Erjavec, Z; Kupper, AF; Ho, G; Jutte, J; Keizer, K; Koning, J; Kranendonk, S; Oomen, A; Sanders, E; Sie, H; Valk, N; van Brussel, B; van Daele, M; van de Pavoordt, E; van der Heijden, R; van Dortmont, L; van Iersel, J; van Urk, H; Verhagen, W; Withagen, A; Aguilar, E; Alferos, MEG; Ang, MG; Anlacan, VM; Aportadera, MAL; Aquino, A; Aquino, C; Araniego, JE; Atilano, A; Bacsal, F; Balleza, Y; Barbas, B; Barcinas, RJ; Belonguel, N; Beltran, J; Bernardo, D; Bilocura, FE; Bitanga, E; Brillantes, A; Cabral-Lim, L; Calderon, E; Camarao, W; Canto, ML; Changco, RJ; Chua, C; Crisostomo, M; Cuanang, J; Cuasay, E; Decolongon, R; Del Moro, M; Del Rosario, E; de los Reyes, E; Diaz, A; Dioquino, CP; Doctora, J; Durante, M; Encarnacion, D; Entienza, R; Estalilla, C; Evangelista, R; Fandialan, E; Fernandez, C; Ferrer, R; Fuentes, F; Ganzon, MS; Garcia, F; Go, R; Guerrero, M; Gutierrez, L; Hojilla, AF; Javelosa, R; Kho, S; Libarnes, R; Lim, M; Llarena, AC; Lokin, J; Maglana, M; Maleza, F; Maranon, E; Marcelo, MC; Matias, A; Mendoza, C; Montes, R; Navarro, J; Neri, R; Pacioles, O; Palmes, P; Paz, J; Punsalan, R; Punzalan, FE; Purino, FM; Renales, ML; Reyes, E; Rivera, C; Robeniol, G; Rosales, R; Rosales, R; Rosita, RR; Roxas, DJ; Roxas, A; Sedilla, E; Shia, J; Tan, E; Tanzo, A; Torres, DJ; Tria, R; Tulmo, W; Willing, TT; Villacin, LL; Bimbo, L; Duarte, R; Ferreira, A; Ferreira, J; Correia Junior; Macedo, F; Medon, R; Morais, J; Noronha, D; Osorio, J; Perdigao, C; De Andrade, PP; Puig, J; Rodrigues, E; Sampaio, J; Costa, MV; Wellenkamp, E; Albu, VC; Anghel, DC; Antochi, FA; Apetrei, E; Arsenescu, MC; Badiu, VG; Bajenaru, OA; Balasa, RI; Bangau, V; Banica, C; Barbulescu, C; Bicescu, G; Bobescu, E; Boeru, G; Bogdan, RS; Bohotin, V; Bucsa, AC; Bustan, M; Buzea, AC; Campeanu, AV; Capalneanu, R; Carp, A; Chioncel, O; Chiriac, C; Chirileanu, RD; Cinteza, M; Constantinescu, A; Constantinescu, E; Craiu, E; Cristea, C; Cruce, R; Cuciureanu, DI; Daha, IC; Dan, A; Dan, GA; Darabont, RO; Darabont, O; Dimulescu, DR; Dina, C; Dina, C; Dorobantu, M; Dragulescu, A; Dragulescu, SI; Dumitriu, B; Ene, A; Falup-Pecurariu, C; Fischer, TS; Gavenea, AM; Geleriu, S; Georgescu, G; Gheorghe, IT; Gherasim, L; Ghiorghiu, IA; Ginghina, C; Giuca, A; Gutiu, IL; Hancu, A; Hodorog, DN; Ignat, B; Ionac, A; Ionescu, DD; Isai, FV; Istratoaie, O; Jianu, DC; Lungut, E; Macarie, C; Macovei, L; Marginean, IC; Marian, M; Marinescu, DC; Matcau, L; Matei, C; Maximov, DM; Miliaru, C; Minea, ID; Mitre, A; Moldovan, M; Moraru, E; Muresan, CM; Mut-Vitcu, B; Niculescu, GM; Opris, MM; Panea, CA; Pascu, I; Patru, DM; Pereanu, M; Perju-Dumbrava, L; Petria, F; Petrica, M; Petrutiu, SH; Poalelungi, V; Popescu, MR; Popescu, AC; Popescu, D; Popescu, DC; Prodan, MR; Protopopescu, T; Radoi, M; Rotaru, M; Rugina, M; Rus, H; Rusu, AP; Sascau, RA; Serban, M; Serban, A; Stamate, CS; Stanca, DM; Stanescu, L; Statescu, C; Stefanache, F; Tanaseanu, CM; Ticmeanu, M; Tint, D; Tirziu, C; Tiu, C; Toldisan, I; Toma, L; Tovirnac, NA; Treidler, SO; Tudor, L; Tudorica, V; Turdeanu, D; Tuta, S; Vacaras, V; Varga, I; Vasile, M; Vatasescu, RG; Vilciu, C; Vinereanu, D; Vintila, MM; Vulpe, G; Zaharia, C; Zaharia, S; Zarma, L; Ageev, F; Akasheva, D; Aroutiounov, G; Bart, B; Bondarenko, B; Chernyavski, V; Demidova, I; Drapkina, O; Egorova, N; Evdokimov, A; Fomin, I; Freydlina, M; Galyavich, A; Glezer, M; Gratsiansky, N; Grinstein, Y; Horev, N; Ivleva, A; Karpenko, M; Karpov, Y; Katelnitskaya, L; Kazantchian, P; Khokhlov, R; Khrustalev, O; Kiritchenko, A; Kobalava, Z; Kolina, I; Komarov, A; Korenko, L; Koshkin, V; Kotov, S; Koziolova, N; Kropacheva, E; Kukharchuk, V; Laguta, P; Lebedev, P; Lipchenko, A; Lopukhova, V; Markov, V; Martunov, A; Mironova, I; Naumov, V; Nebieridze, D; Novitsky, I; Orlova, I; Pavlov, N; Pokrovsky, A; Rapovka, V; Rodnenkov, O; Sankova, A; Shalaev, S; Shaposhnik, I; Shestakova, M; Shmirev, V; Shpektor, A; Shulman, V; Sidorenko, B; Sizov, A; Skvortsov, A; Skvortsova, V; Sokolov, I; Statsenko, M; Storozhakov, G; Stratchounski, L; Sukhinina, T; Sulimov, V; Sysoeva, N; Tanashyan, M; Tebloev, K; Tutunov, V; Upnitsky, A; Yarokhno, N; Yeliseyeva, L; Zadionchenko, V; Zakirova, A; Zharova, Y; Ang, PK; Cumaraswamy, S; Chan, B; Chan, NF; Chang, HM; Chen, CLH; Cherian, T; Chia, KH; Chong, PN; Chua, SM; Chua, PK; Da Costa, MLA; De Silva, DA; Deb, B; Doshi, M; Eng, P; Gan, R; Goh, KH; Ho, KH; Kurugulasigamoney, G; Kek, PC; Koh, PSS; Koh, ATK; Koo, SL; Koo, CC; Lee, CS; Lee, TY; Liew, S; Liew, AK; Lim, IH; Lim, M; Lim, CH; Lim, SC; Lingamanaicker, J; Low, LP; Mahtani, S; Mak, KH; Mathew, S; Ng, RMH; Venketasubramanian, RN; Ng, PTH; Omar, S; Pang, J; Seet, RCS; Sharma, V; Bin Siah, K; Siow, C; Sng, LC; Tan, HC; Tan, RS; Tan, M; Tan, JCH; Tan, YT; Tan, V; Tay, JC; Teoh, HL; Tong, HI; Tong, TS; Tran, J; Wee, A; Wong, TW; Wong, MC; Abeytua, M; Adarriaga, MD; Agarrado, A; Alias, EJ; Alonso, G; Alonso, JL; Alvarenga, NM; Alvarez, LJ; Alvarez, A; Andreu, J; Anton, JA; Castano, JCA; Artigues, I; Baldo, EC; Bautista, JG; Bellera, MN; Bello, J; Beloqui, O; Bermudez, JM; Blanco, M; Bohorquez, JC; Bolanos, A; Brossa, V; Bruguera, J; Cabarcos, A; Cacabelos, P; Cairols, M; Calvo, C; Camacho, I; Canoves, J; Carbonell, P; Carreno, MC; Casado, I; Catalan, JI; Catalan, P; Caudevilla, A; Cerda, J; Chamarro, PR; Charles, AB; Claramonte, B; Climent, VE; Colas, J; Comas, P; Corrochano, JJ; Culebras, C; Davila, MF; Novales, JD; de Luis, MD; Perez, FD; Duran, I; Egido, JA; Escribano, JB; Escudier, JM; Espinosa, A; Espinosa, R; Fernandez, JR; Fernandez, O; de la Cigona, FF; Ros, MF; Flores, A; Folgado, RM; Formiga, F; Franco, C; Franco, J; Freire, E; Galan, M; Galiana, J; Garcia, I; Garcia, F; Garcia, JP; Garcia, B; Garcia, G; Garcia, JM; de Burgos, FG; de la Villa, BG; Diaz, JDG; Garcia-Mongo, JC; Geffner, DE; Gesto, R; Giron, JM; Goicolea, I; Gomez, F; Cerezo, JFG; Gonzalez, E; Gonzalez, C; Gonzalez, A; Gonzalez, MI; Gonzalez, M; Gracia-Naya, M; Gusi, G; Guzman, G; Hevia, JS; Hidalgo, ML; Horcajo, P; Ibanez, M; Idoate, A; Idoate, M; Gay, JI; Irurita, M; Iser, J; Izquierdo, G; Jansen, S; Jimenez, C; Jimenez, B; Jimenez, MD; Junca, E; Laynez, F; Ligero, JM; Lis, JM; Llagostera, S; Llort, C; Llovet, A; Lopez, JC; Lopez, L; de la Osa, AL; Lopez-Ibarra, PJ; Lozano, F; Luna, MDR; Macingirar, JL; Maraver, JM; Marey, JM; Marin, J; Martin, A; Martin, JC; de la Torre, EM; Martinez-Berganza, A; Martinez-Perez, M; Martos, R; Masjuan, J; Mateos, A; Medrano, V; Merce, J; Merchante, A; Davood, SM; Mirete, C; Molina, F; Molto, JM; Montero, MJ; Montero, M; Montero, M; Montes, PM; Monzon, FJ; Morillas, M; Morillas, PJ; Munilla, A; Nicolas, R; Niembro, P; Numancia, R; Nuno, E; Olaz, F; Oller, N; Ortega, J; Ortega, J; Orts, E; Otero, A; Paules, A; Paz, MA; Pena, JL; Perez, JL; Perez, G; Molino, AP; Pia, G; Pinedo, J; Plaza, A; Plaza, I; Pons, JM; Pontes, JC; Portoles, A; Poveda, F; Prat, MI; Puras, E; Rasel, J; Real, JT; Redondo, S; Rico, MA; Rius, A; Roca, JM; Rodilla, E; Rodriguez, JA; Rodriguez, MA; Rodriguez, J; Roldan, AC; Romero, A; Roquer, J; Roure, J; Vela, TR; Ruiz, JI; Ruiz, M; de Castroviejo, JR; Ortiz, MR; Saavedra, O; Saban, J; Sadurni, J; Saez, L; de Quevedo, JAS; Salas, J; Salvador, A; Sanchez, JM; Sanchez, P; Santos, S; Saura, J; Sedeno, JM; Segura, T; Serrano, FJ; Serrano, PJ; Solis, J; Soriano, C; Sotillo, JF; Soto, AI; Suarez, C; Suarez, M; Tamargo, LM; Teigell, L; Trejo, JM; Trulla, J; Tura, D; Urtasun, M; Val, E; Valdes, M; Vaque, J; Vaquero, F; Varona, L; Vazquez, A; Vega, F; Velasco, A; Vicente, T; Vidan, JA; Vilaseca, B; Vilchez, R; Villar, I; Vinas, J; Volo, G; Zarauza, MJ; Abetel, G; Ackermann, F; Alexander-David, N; Andreoli, P; Badan, M; Boillat, B; Bopp, HJ; Bosshardt, R; Budmiger, H; Cadisch, R; Chapuis, P; Chen, HT; Collioud-Robert, Y; Cornut, JP; Croci, JP; Delorme, P; Di Stefano, RG; Duerst, U; Durrer, D; Enggist-Rueesch, U; Facchini, M; Flueckiger-Keller, HC; Frangos, A; Fust, F; Gallati, M; Genond, D; Gerber, A; Ghirlanda, A; Giroud, D; Gross, W; Haeuptle, C; Haldy, P; Hany, M; Hecker, E; Henny, C; Hug, M; Ingold, B; Jachertz, G; Jaques, O; Jotterand, S; Keller, U; Kieliger, F; Kramis, A; Kraszewski, M; Kuske, A; Landolt, M; Lanz, M; Limacher, T; Luthi, JF; Martin, PA; Niesper, J; Nuesch, K; Oechslin, H; Pfaeffli, A; Pinzello, A; Pithon, M; Richter, M; Schneider, T; Schwarzenbach, HR; Staubli, P; Stricker, H; Tjon-A-Meeuw, L; Togni, P; Tschurr, E; Tutta, P; Wigger, BV; Von Planta, I; Vuilleumier, D; Waldis, N; Wandeler, JM; Wasem, YM; Widler, J; Widmer, C; Woolley, S; Zauner, B; Z'Brun, A; Chan, L; Chan, CS; Chang, CJ; Chang, HY; Chang, CC; Chang, KC; Chang, PC; Chang, RY; Chang, JY; Chen, IC; Chen, CL; Chen, YW; Chen, JR; Chen, CW; Chen, CY; Chen, YP; Chen, TS; Chen, WH; Chen, YH; Chen, ZC; Chen, KC; Chen, MH; Cheng, TJ; Chin, CH; Chiung, CZ; Chou, LP; Chu, IT; Chung, WT; Fong, CS; Hsia, CP; Hsieh, IC; Hsieh, Y; Hsieh, JC; Hsu, RB; Hsu, MC; Huang, CF; Huang, CW; Huang, YY; Jeng, JS; Ko, CC; Kuo, WK; Lai, WT; Lee, CC; Lee, TH; Lee, KH; Lien, LM; Lin, SK; Lin, RT; Lin, TK; Lin, KC; Liu, RT; Liu, AB; Lo, HM; Pei, D; Ryu, SJ; Sung, ML; Tang, SC; Tang, S; Tsao, WL; Ueng, KC; Wang, TD; Wang, SY; Wang, KY; Wei, CY; Wu, TY; Wu, JC; Wu, WS; Yang, SS; Yeh, SJ; Yeh, CH; Yeh, SB; Yip, PK; Yip, BS; Benjasuratwong, Y; Boonsom, W; Buddhari, W; Bunnag, P; Suwanwela, NC; Chulakadabba, A; Deerochanawong, C; Hanchaiphiboolkol, S; Jirasiritham, S; Kanjanavanit, R; Khositsakulchai, W; Kiatchoosakun, S; Leelanipon, P; Mahanonda, N; Nidhinandana, S; Niramaxnsakul, S; Nopparat, S; Phrommintikul, A; Piamsomboon, C; Pienvichit, P; Piriyawat, P; Poungvarin, N; Puavilai, W; Ratanakorn, D; Siriwanij, T; Suntrapiwat, K; Suraamornkul, S; Suwanugsorn, S; Suwanwalaikorn, S; Tokavanich, V; Tresukosol, D; Veerakul, G; Vichayanrat, A; Vivekaphirat, V; Amosova, K; Andriyevskaya, S; Bereznyakov, I; Bezyuk, M; Dyadyk, O; Dzyak, G; Dzyak, L; Goloborodko, B; Grytsay, N; Kobza, I; Korkushko, O; Koval, O; Kovalenko, V; Kuznetsova, S; Mishchenko, T; Mishchuk, N; Netiazhenko, V; Nikonenko, A; Nikonov, V; Parkhomenko, A; Pertseva, T; Polyvoda, S; Rodin, Y; Rudenko, A; Rudenko, V; Rudyk, Y; Sergeyev, O; Sirenko, Y; Svyshchenko, Y; Sychov, S; Tashchuk, V; Vakalyuk, I; Vinychuk, S; Vizir, V; Volkov, V; Voronkov, L; Yagensky, A; Yavorskaya, V; Rahuman, AA; Bakir, S; Bazargani, N; Binbrek, A; Elkilany, GE; Inshasi, J; Kayed, DM; Lange, C; Wassef, A; Elabdin, TZ; Addlestone, M; Agarwal, R; Barker, R; Barnett, A; Baskaran, B; Bowen-Jones, D; Brooks, A; Courtney, JR; Cummin, P; Donnelly, R; Duckworth, M; Dwight, J; Egerton, T; Farker, I; Ferguson, J; Fuat, A; Gietzen, T; Hamling, J; Hole, J; Vanniasinkam, SH; Hughes, I; Husselbee, P; James, M; Kassianos, G; Kent, M; King, B; Kingsland, J; Kirby, M; Lalsarin, R; Lawrence, R; Lee, PS; MacLeod, M; Manning, G; Martin, R; McKinnon, C; McKeith, DD; Mistry, D; Morgan, S; Morgan, S; Page, M; Penney, BF; Rowlands, S; Sharma, J; Shearman, C; Sherman, L; Singh, M; Thorburn, W; Watson, DPB; Watt, A; Weir, R; Wiggins, PS; Brass, L; Brown, M; Cooke, J; Coull, B; Creager, M; Criqui, M; Fonarow, G; Golden, W; Greenland, P; Jaff, M; Levy, P; McBride, P; McDermott, M; Ofili, E; Reasner, C; Sacco, R; Saunders, E; Saver, J; Sheehan, P; Watson, K; Abbas, R; Abbott, L; Abdehou, D; Abedmahmoud, I; Abisalih, D; Abraham, W; Ackerman, K; Addo, J; Adelizzi, A; Aggarwal, S; Agha, M; Agustsson, T; Ahmad, B; Ahmad, A; Ahmed, S; Ajani, D; Alarcon, F; Albarracin, C; Albright, K; Aleman, CJ; Aleman, R; Alexander, JS; Alexander, M; Alexander, S; Ali, A; Al-Khadour, H; Al-Khateeb, D; Allan, D; Allen, R; Alley, R; Allison, MD; Alloju, M; Alpert, B; Altafullah, I; Altema, R; Alugubelli, V; Alvarez, F; Alvarez, H; Alvarez, S; Alza, G; Aman, S; Amanambu, C; Amer, S; Amin, J; Amin, K; Amin, NJ; Amin, Y; Amine, M; Amos, D; Anders, DL; Anderson, CP; Anderson, W; Anderson, PB; Andrea, B; Anez, L; Angra, S; Anjum, S; Anton, S; Aponte, J; Aquino, V; Aranador, D; Arcuri, P; Areephanthu, A; Arian, L; Arkin, D; Arora, J; Arthur, A; Artz , WJ; Arumugham, P; Arunasalam, S; Arvan, T; Ascarelli, ED; Ascher, R; Asciuto, L; Asfour, W; Asgar, M; Ashley, S; Asin, G; Assar, M; Ataya, H; Atkinson, J; Attenello, F; Atwood, L; Augustin, D; Aung, T; Austin, B; Axe, H; Axelrod, A; Aycock, G; Ayeni, O; Ayers, B; Azam, M; Azar, N; Azarva, H; Babb, S; Babin, K; Bacani, O; Badami, U; Bailey, TS; Bailey-Walton, P; Baiocchi, G; Baird, D; Baker, J; Bakhtari, L; Bala, R; Balaji, G; Baldys, J; Ballesteros, JV; Balusu, P; Banjo, C; Banna, A; Barbato, T; Barber, F; Barrett, H; Bartkowiak, A; Barkley, T; Bartos, S; Batarseh, B; Bathija, N; Bazzi, A; Beach, JL; Beamer, T; Beane, M; Beck, WC; Becker, H; Becker, R; Becker, S; Becker, T; Bedel, G; Bedi, H; Beham, R; Belt, S; Benge, JW; Bennett, D; Bennett, C; Bennett, N; Benson, P; Berard, M; Berenson, Z; Berger, RE; Berkenstock, O; Berland, G; Berman, G; Bermudez, Y; Bernard, S; Bernstein, J; Berry, JF; Bevill, R; Bhagwat, R; Bhat, A; Bhatia, HS; Bhatia, D; Bhatia, A; Bhatt, D; Bhimani, J; Bicek, P; Bidner, S; Bierman, R; Bieser, D; Biggers, J; Biggs, B; Bijlani, S; Bilik, I; Bilsky, A; Birkholz, KL; Bishara, I; Bishara, I; Bland, V; Blank, B; Blaze, K; Bleiman, M; Bleser, S; Blizzard, D; Blonder, R; Bobson, CM; Bodemann, D; Bodemann, S; Boehm, T; Bohannon, N; Boinay, P; Bojrab, G; Bommareddi, A; Bond, WM; Bonezz, D; Bornfreund, J; Bornheimer, JF; Borowski, DT; Borrego, R; Bottar, P; Bouchette, A; Boudreaux, C; Boune, M; Bourque, JC; Bowling, RL; Brandstater, C; Breen, G; Breitenbach, R; Brender, AJ; Bressler, P; Brideau, D; Bright, TJ; Briker, AJ; Britt-Armstrong, C; Brodie, H; Brodowski, M; Brodsky, N; Bronstein, B; Brooks, GA; Brooks, C; Brovar, GT; Brown, J; Brown, K; Brunkow, G; Brunner, JE; Buben, M; Buch, H; Buckingham, R; Buencamino, E; Buening, R; Bully, A; Bultman, R; Bunney, N; Buoscio, B; Burch, J; Burger, M; Burkard, J; Bush, J; Butcher, R; Butler-Sumner, S; Buynak, RJ; Cacchione, JG; Cacho, A; Cadigan, D; Cahn, D; Caifano, R; Caivano, R; Calkins, B; Cameron, D; Camisa, S; Camiscoli, D; Campbell, J; Campbell, DR; Campbell, R; Caperton, M; Capo, JP; Cappiello, A; Caputo, A; Caputo, RA; Caras, J; Carley, JE; Carluen, L; Carmouche, D; Caro, R; Carpenter, K; Carter, K; Carter, G; Carver, S; Castor, T; Caughron, SD; Cavanaugh, G; Cavero, P; Celio, L; Cevasco, R; Chadha, V; Chakravarty, J; Chambers, D; Chandler, BL; Chapnick, M; Charmatz, A; Charron, M; Chaskes, M; Chaves, I; Chaves, I; Chawla, O; Chen, KC; Chen, CK; Cheng, E; Cheng, T; Cherny, Y; Chervu, I; Chesar, T; Chesoni, S; Chess, D; Chhabria, P; Chidester, M; Chieffalo, A; Chien, OL; Chin, D; Chinnici, A; Chisholm, D; Chisolm, O; Chochinov, RH; Choi, S; Choi, M; Chopra, J; Chung, N; Ciemiega, R; Cirilli, M; Ciubotaru, R; Civitarese, FA; Civitarese, LA; Clark, D; Clark, D; Coburn, W; Cochran, SL; Cohen, JL; Cohen, L; Cohen, S; Colbert-Threats, S; Cole, R; Coleman, G; Coleman, SL; Coles, M; Comazzi, J; Conlan, B; Conrad, M; Conroy, S; Conti, S; Cook, R; Cook, N; Cook, JP; Cook, J; Cooley, DL; Cooper, D; Cooperman, M; Cope, J; Corales, D; Corbett, B; Coreil, E; Cornett, G; Cossman, D; Courtnage, SL; Cox, L; Cox, W; Cox, M; Crabtree, Y; Craig, JM; Crider, J; Crider, J; Crisostomo, E; Cromer, M; Cronin, J; Crosnoe, J; Cueto, IL; Cummins, FE; Cyriac, C; Dailey, R; Daisley, SJ; Damien, G; Damsker, K; Dandapani, B; Dang, TY; Darwin, C; Dasani, S; Dasilva, LD; Dausch, R; Dave, AN; Dave, K; Davidson, R; Davis, G; Davis, K; Davis, P; Davis, P; Davis, R; Davis, S; Davis, W; Sullivan, HD; Dawes, TM; Dawson, M; Dayon, DL; Dayon, PM; De, NK; de Feria, A; de Meireles, M; de Souza, J; Dearmitt, D; Debin, S; Decker, G; Defazio, E; del Fierro, R; Delaguardia, B; Deleon, ER; Delgaizo, C; Delrosario, S; Deluca, J; Demopulos, JA; Dempsey, M; Den, M; Denker, M; Denker, P; Denlinger, K; Denyer, G; Deol, SS; Depetris, G; Desai, PR; Desai, J; Detulio, A; Deveranez, D; Devoss, G; Dharma, C; di Sarli, R; Diamond, R; Diamond, S; Diasti, S; Diaz, F; di Diaz, M; Dickson, S; Diethelm, J; Dietz, M; Disharoon, P; Dixon, J; Dobish, M; Dobrose, C; Doctor, D; Dodani, HB; Doehring, L; Doerfler, F; Donnan, P; Donovan, J; Doroshow, L; Dorsey, J; Doyle, N; Dreslinski, G; D'Souza, N; Dugano-Daphnis, P; Duggal, NM; Dunbar, J; Dunleavy, K; Dupee, RM; Durazo, A; Eastburn, T; Ecker, AM; Eckert, J; Eckert, J; Edwards, J; Edwards, T; Egan, R; Egelman, A; Ehly, C; Eickmeyer, J; Eidelman, Z; Eisenberg, BM; Eisner, G; Elias, RA; Elkind, A; Emerson, R; Enders, J; Englund, M; Enns, R; Enriquez, JA; Epperson, T; Erbay, G; Erickson, K; Eisenmenger, J; Eshenaur, O; Eshenaur, O; Espinoza, W; Espinoza, W; Estronza, N; Eustace, MW; Evans, B; Fahey, P; Faiz, F; Farber, A; Farhoud, H; Farmer, J; Faron, M; Fast, D; Fazenbaker, S; Fazio, GT; Fearon, K; Featherston, DP; Fedak, M; Fedak, M; Fei, H; Feingold, B; Feinsinger, G; Feldman, B; Felice, FM; Ferreira, A; Fielding, DP; Fields, C; Figueroa, R; Fine, A; First, B; Fischer, J; Fischgrund, J; Fishman, R; Fishman, E; Fittingoff, DB; Fitzgerald, K; Fitzgerald, M; Fitz-Patrick, D; Flamion, P; Flanagan, T; Flanzman, S; Flatt, J; Fleischer, LR; Flershem, D; Flowers, A; Fong, PK; Foster, R; Fouchi, D; Fowler, D; Fox, D; Fox, J; Frank, C; Frank, G; Frank, R; Frankel, M; Franklin, M; Franks, E; Franz, J; Freberg, D; Freesemann, JM; Frein, D; Freitas, JB; French, G; Freyer, C; Friedel, J; Friedlander, R; Friedman, E; Freilich, L; Frumkin, S; Fuentes, D; Fuller, J; Fusco, F; Fuson, D; Gadani, M; Gadani, P; Gaikwad, N; Gaines, M; Gaither, A; Galvan, P; Gamponia, M; Gandhi, A; Gandhi, J; Gandhi, B; Garcia-Septien, RM; Garb, J; Gardner, S; Garfias, D; Garfield, M; Garg, R; Garner, J; Garretson, D; Garrett, D; Garza, D; Gastman, IJ; Gebara, S; Gebara, S; Gedia, L; Gehant, J; Geller, S; Gelston, W; Gendel, M; Gentry, S; George, W; George, M; Geronemus, R; Gerstenmeier, L; Giant, D; Gibbs, JE; Gil, F; Gilbertson, DL; Gilinsky, M; Gill, S; Gillick, R; Gilliam, D; Gillman, E; Gindi, M; Gindi, G; Glaser, LA; Glass, J; Glazer, E; Gliner, B; Glowacki, J; Go, E; Goetz, J; Gokani, R; Goldberg, BH; Goldberg, R; Goldman, J; Goldner, S; Goldsmith, D; Goldstein, A; Goldstein, F; Goldstein, R; Gonzales, WA; Gonzalez, J; Gonzalez, M; Goodale, D; Goodfield, P; Goodman, D; Gosalia, A; Gosling, J; Goswami, A; Gottlieb, D; Goyco, O; Grabensetter, N; Grady, J; Graves, K; Greblya, V; Green, R; Green, R; Greenberg, D; Greenfield, M; Greenfield, RM; Greenman, SB; Greenspan, M; Griffel, P; Griffin, D; Griffith, C; Grill, H; Gross, WS; Guanzon, T; Guice, M; Guidot, C; Gulati, R; Guneratne, F; Gupta, S; Hack, M; Haffizulla, E; Haffizulla, F; Haffizulla, J; Hagedorn, J; Haggenjos, J; Hall, S; Hallgren, R; Halpern, B; Hamilton, A; Hamilton, M; Hammond, T; Hamner, J; Hamroff, G; Han, MY; Hanke, F; Hanrahan, B; Hansen, E; Hansen, R; Hanshaw, C; Harless, M; Harris, MD; Harris, N; Harris, RW; Harrison, S; Hart, ME; Hartley, P; Haspert, D; Hassan, J; Hassen, IW; Hatharasinghe, R; Hatimi, T; Hauptschein, M; Hawrot, GC; Hays, R; Head, GG; Heffess, L; Heggeness, O; Hein, J; Heinegg, P; Hekmat, M; Hellman, R; Hemme, H; Henderson, S; Henes, G; Henriquez, M; Henry, D; Herle, A; Hermany, P; Hernandez, A; Herrera, CR; Herrera, M; Herrera, R; Herrington, S; Hershkowitz, J; Hertzman, P; Herz, P; Hiland, S; Hillis, S; Hilton, D; Himot, E; Hindawi, A; Hines, R; Hirtz, S; Hitz, DL; Hnatiuk, G; Ho, M; Ho, V; Hofbauer, H; Hoffman, B; Hoffman, D; Hoffman, M; Holik, J; Hollis, D; Hong, K; Hong, L; Honig, P; Hood, M; Hooker, B; Hooks, D; Hopland, A; Horowitz, S; House, J; Howard, J; Hoyt, W; Hozakowska, E; Hsu, JC; Huang, Y; Hubbard, D; Vaughn, YH; Hugar, M; Hughes, G; Huh, I; Hulson, T; Huntley, R; Hurlock, J; Hussain, N; Huver, A; Iannamorelli, A; Imam, S; Imperial, G; In, Y; Ingram, F; Inocencio, C; Ip, K; Irvin, J; Irvine, J; Isaiants, A; Isajiw, G; Isenberg, H; Isenberg, G; Ishimori, T; Ishkanian, G; Ison, R; Issa, R; Iyer, L; Izurieta, H; Izzi, S; Izzo, M; Jabbour, N; Jackson, B; Jackson, J; Jackson, MR; Jackson, RA; Jackson, R; Jacob, P; Jacobs, W; Jain, S; Jain, A; Jain, J; Jalowsky, H; Jamal, K; Jansen, R; Jeanfreau, R; Jeffreys, R; Jenckes, G; Jennewine, P; Johary, A; Johnson, K; Johnson, C; Johnson, D; Jones, MB; Jordan, R; Joslyn, EW; Kagan, J; Kahan, B; Kahney, S; Kaissar, A; Kajencki, S; Kakarala, V; Kalahasty, S; Kalici, N; Kamenetsky, L; Kamiel, M; Kammerling, J; Kania, R; Kaplan, I; Kaplan, M; Kaplan, R; Karim, K; Karkar, G; Karty, D; Karu, R; Kastrul, JJ; Katira, MN; Katsetos, J; Katzenberger, C; Katzman, S; Kaufman, R; Kauk, B; Kavalier, M; Kawaja, T; Kawakami, S; Kaylin, M; Kazymyra, M; Kelly, A; Kelter, R; Kenney, N; Kenton, D; Keshavamurthy, J; Kesireddy, D; Kessler, W; Ketels, C; Khalidi, N; Khan, A; Khan, M; Khan, M; Khan, W; Khatcherian, Y; Khoshaba, A; Khosla, R; Khwaja, S; Kiefer, G; Kiefer, P; Kim, D; Kim, I; Kim, S; Kimmel, A; Kini, G; Kipnes, M; Kipp, J; Kipreos, NT; Kirby, W; Kleinhaus, R; Kleinsteuber, K; Klipec, M; Klufas, A; Knecht, J; Knoll, H; Ko, G; Koch, H; Koch, S; Koenig, PP; Koepke, C; Koepke, K; Koganski, V; Kohli, A; Kohli, S; Kolanchick, G; Kollmeyer, K; Kondan, R; Koppel, W; Koppenbrink, W; Koreff-Wolff, B; Kovtun, N; Kraft, D; Kramer, H; Kramer, L; Kramer, M; Kramer, M; Kramer, S; Krems, S; Kress, M; Kricsfeld, B; Krishnan, A; Krishnan, M; Kroopnick, R; Kumar, P; Kumar, R; Kumar, S; Kumar, VH; Kundra, A; Kunkel, M; Kurian, A; Kurtz, R; Kurzrok, S; Kushner, D; Kuttappan, M; Kval, T; Kwon, P; Kwong, S; Labuda, J; Lachterman, B; Lacorte, A; Lacy, J; Lahasky, D; Lakhani, V; Lakhani, H; Laliotis, A; Lamb, C; Lami, J; Lamsal, S; Lang, C; Langburd, A; Lange, L; Lanier, A; Laracuente, R; Lariosa, A; Lash, J; Lau, A; Lauer, M; Laughlin, DB; Lavergne, C; Lawrence, G; Lawson, T; Lazarevic, M; Leach, K; Leavitt, R; Leblanc, M; Trinidad, CL; Ledbetter, J; Lee, C; Lee, DW; Lee, J; Lee, J; Lee, K; Lee, K; Lee, N; Lee, T; Lefkovic, L; Leone, A; Lerman, E; Lerner, K; Leshin, S; Leung, YY; Levenson, D; Levin, P; Levine, M; Levy, B; Levy, M; Levy, R; Lewen, M; Lewis, R; Lewison, G; Li, C; Li, M; Li, M; Liboon, R; Lick, D; Lief, L; Light, C; Lim, A; Lim, DB; Limjoco, FR; Lin, S; Lindenbaum, J; Linkner, E; Liporace, D; Lippoff, O; Lipsky, J; Lira, R; Lischwe, DH; Lisse, S; Liu, JP; Liu, P; Loa, H; Lobaton, CB; Lopez-Arostegui, F; Lopresti, P; Louis-Charles, J; Lovato, J; Loya, F; Lubowitz, H; Luck, D; Lueg, M; Luengas, J; Luna, M; Luoma, J; Le Luu, L; Lycksell, RL; Lynn, L; Lyon-Loftus, G; Ma, S; Mabourakh, S; Macadams, M; Mackenzie, J; Mackrell, J; Madris, R; Maffezzoli, R; Magee, J; Mahaffey, R; Mahakala, A; Maheshwari, Y; Mahmoud, S; Mahon, G; Maislos, F; Makam, P; Maletz, L; Malicay, M; Malinow, L; Malinow, S; Malkin, S; Mally, A; Maltz, J; Malz, M; Manalac, J; Mandel, R; Mandell, B; Manja, G; Manuli, S; Maoud, RF; Maqueda, T; Maramreddy, P; Marar, I; Margolis, D; Margolis, J; Margolis, M; Margolis, S; Marks, E; Marsh, S; Martin, R; Martin, L; Martin, D; Martinez, D; Martinez, E; Martinez, R; Massien, S; Massih, N; Masud, A; Matheu, J; Mathew, J; Matthias, M; Mattson, E; May, P; Maybach, E; Mayer, DA; Mazariegos, M; McCann, D; McCarty, D; McEntire, B; McLeroth, P; McAllen, S; McCarthy, E; McCauley, TE; McClure, T; McConnell, J; McCracken, B; McCrary, DG; McDavid, C; McDonald, C; McEwan, R; Mcgee, J; Mcgee, R; McGettigan, J; McGuire, K; McShane, JM; Meade, N; Meadows, R; Mecca, A; Mecca, W; Mecklai, A; Medina, E; Medley, H; Medoff, S; Mehra, R; Mehta, M; Meller, J; Mendez, J; Mendez, A; Mendez, C; Mendez, A; Mendizabal, M; Mendoza, C; Menio, J; Menon, R; Mercurio, G; Merillat, J; Merritt, L; Meyer, B; Meyers, G; Meza, R; Miccio, A; Michelsen, T; Miele, A; Mignoli, M; Mikus, J; Milko, T; Miller, E; Miller, JB; Miller, L; Miller, M; Miller, P; Miller, R; Miller, S; Mintz, G; Mintz, M; Mirchandani, B; Mishra, S; Mittal, S; Mittal, S; Miyakawa, J; Modesta-Keyhani, A; Modi, P; Modi, T; Mody, R; Mohan, P; Mohsin, S; Mollen, MD; Molter, D; Montana, J; Montgomery, D; Moon, D; Moore, G; Moore, J; Moosa, A; Moran, J; Morayati, S; Morcos, C; Moreci, J; Moreland, J; Moretsky, R; Morgan, M; Morris, W; Morrison, B; Moss, JB; Moss, R; Moss, T; Moyer, JP; Muckala, K; Mukherjee, R; Mundra, S; Munjapara, V; Munshower, J; Murachanian, R; Murashige, J; Murphy, A; Murphy, R; Murray, K; Musa, M; Muse, D; Myers, B; Myers, S; Nadaud, M; Nahum, L; Naidu, JB; Naini, GR; Nanda, J; Nasir, I; Nasser, MM; Nassir, J; Nations, J; Navarro, H; Nayeem, A; Nelson, K; Nemirov, S; Neno, R; Neumann, F; Newton, T; Nguyen, V; Nguyen, B; Nguyen, K; Nielsen, E; Normile, C; Obarr, T; Oblena, J; Octain, B; Odugbesan, O; Ogilvie, P; Ogundipe, A; O'Keefe, T; Olash, F; Ollins, R; Olszowska, A; O'Neill, D; Ong, Y; Orengo, O; Orlang, L; Orth, D; Oteyza, B; Oung, BY; Packer, J; Paek, N; Palandjian, R; Palchick, B; Pacia, AG; Panchal, V; Pangtay, D; Panik, G; Parker, G; Parker, J; Parker, D; Parmer, K; Paronish, W; Parsey, C; Paruchuri, S; Pastermack, F; Patel, A; Patel, A; Patel, A; Patel, C; Patel, M; Patel, M; Patel, N; Patel, P; Patel, P; Patil, LR; Patnam, S; Patton, H; Paulding, S; Paulish, J; Payne, F; Peabody, B; Peacock, M; Pearson, G; Pearson, A; Peet, J; Pelayo, J; Perez, C; Persoft, N; Peschiera, M; Peters, K; Peters, C; Peterson, D; Petit, W; Pewitt, C; Pham, TM; Phelps, CW; Phillips, GJ; Pintauro, F; Pittleman, K; Pitzl, GA; Ploss, L; Podet, E; Pogue, D; Polinsky, C; Pollock, J; Pomposini, D; Pongonis, J; Poochikian, V; Post, G; Potts, G; Pounds, K; Powers, F; Prack, A; Prack, E; Prasad, J; Prelutsky, D; Presant, L; Prescott-Coraggio, J; Prosser, J; Protacio, R; Prouty-Moore, J; Proy, B; Punjabi, H; Punjabi, P; Purdy, A; Purighalla, R; Purighalla, U; Purpura, A; Pyle, H; Qureshi, K; Rabadi-Marar, D; Racho, ZE; Radparvar, A; Rafool, G; Raghu, P; Raghunathan, C; Raheja, S; Rahman, A; Rahmanian, N; Rahnama, M; Raikhel, M; Railan, P; Rainey, J; Rajaratnam, Y; Rajasekaran, G; Ramdas, K; Ramirez, P; Ramiro, L; Ramkishun, L; Randolph, R; Rane, S; Rao, M; Raphael, R; Rassen, J; Rastogi, N; Rattes, M; Rauzi, F; Rawlings, W; Ray, S; Reaves, L; Recio, S; Redding, M; Reddy, N; Reddy, P; Reddy, R; Reddy, S; Reddy, V; Reed, G; Reimer, J; Reinbold, P; Resnick, H; Reynolds, W; Richardson, B; Rifat, R; Ritchey, W; Rivera, A; Rivero, M; Rizk, G; Rizzo, M; Robbin, M; Robbins, R; Roberson, W; Roberts, B; Roberts, K; Robinson, J; Robinson, R; Robison, W; Rocco, J; Rodgers, R; Rodriguez, H; Rodwick, B; Roethemeyer, J; Rojas, B; Romulus, C; Rosen, G; Rosen, R; Rosenbaum, D; Rosenbaum, S; Rosenberg, L; Rosenberg, M; Rosenblit, P; Rosenthal, A; Rosenthal, JE; Rosin, B; Ross, A; Ross, D; Ross, G; Ross, J; Ross, R; Royce, J; Rucker, M; Rudic, G; Rufus, E; Ruxin, R; Rybicki, J; Saavedra, O; Sabol, D; Sadhwani, D; Sadhwani, H; Sadr, F; Sakran, B; Sakurai, K; Saliba, P; Salom, I; Salomon, A; Samaan, R; Samaras, T; Sandberg, J; Sandoval, J; Sanharival, A; Santangelo, D; Sarikonda, K; Sarkar, C; Sasser, L; Savory, R; Sawhney, S; Sawka, M; Sawrey, P; Saxena, R; Saxena, V; Say, CC; Schachere, R; Schafermeyer, KE; Scheerer, JF; Schendel, K; Scheuermann, R; Schlapper, B; Schmidt, J; Schmitt, CJ; Schoenberger, J; Schuhmacher, C; Schultz, J; Schwager, V; Schwartz, D; Schwartz, D; Schwartzman, J; Schwartzman, N; Schweizer, D; Scialabba, M; Scivoletti, P; Secouler, H; Secunda, E; Seek, M; Seet, E; Segal, A; Sehapayak, G; Seidman, B; Selagamsetty, M; Selinger, H; Seltan, M; Selvakumarraj, P; Seth, U; Sethi, M; Seuc, C; Seymour, ZG; Sgalilia, A; Shah, D; Shah, G; Shah, M; Shah, S; Shah, V; Shaikh, M; Shams, F; Shansky, M; Shapiro, D; Shapiro, E; Sharma, R; Sharma, S; Sharpe, CR; Shaw, B; Shaw, G; Shaw, M; Sheaffer, M; Sheer, L; Shepard, M; Shepler, N; Sherer, S; Sheth, Y; Shiffman, S; Shik, M; Shimek, J; Shoaf, E; Shore, M; Shore, D; Shorenstein, R; Shorenstein, M; Shou, P; Shpaner, A; Shrestha, D; Shroff, K; Shukla, A; Siegel, S; Siegelheim, M; Silva, A; Silverman, M; Silverman, W; Simmonsii, C; Simon, RJ; Simons, S; Sinatra, L; Sing, G; Sing, HP; Singh, L; Singh, S; Singla, V; Sinha, P; Siouty, H; Sivalingam, K; Skowsky, W; Slabic, S; Slandzicki, A; Slesers, J; Sloan, L; Smallow, S; Smith, A; Smith, GS; Smith, G; Smith, H; Smith, J; Smith, J; Smith, J; Smith, K; Smith, M; Smothers, R; Sobel, B; Soberano, C; Sobol, T; Socha, B; Sofley, C; Soni, N; Sood, OP; Soper, W; Sotolongo, R; Soung, SC; Spanolios, P; Sparagna, A; Speck, L; Spector, G; Spees, R; Spilseth, P; Spingarn, D; Squire, K; Sraow, J; Sriram, I; Stade, E; Staehling, S; Stafford, D; Staller, R; Staller, S; Stalnaker, J; Stamp, I; Stark, M; Steele, S; Stefanos, G; Stein, P; Stevens, G; Stevens, J; Stickle, HE; Stillwagon, D; Stoltz, R; Stonerock, G; Storey, M; Story, H; Stram, M; Straub, R; Streja, D; Strumillo, C; Strzinek, R; Stuntz, R; Subich, D; Sumulong-Tomacruz, M; Sundheimer, D; Suresh, DP; Surso, J; Suter, M; Swauger, J; Swick, T; Swofford, W; Szanto, M; Szelag, H; Szeto, JS; Tannenbaum, A; Tanner, JR; Tatar, S; Taube, T; Taxin, R; Taylor, D; Taylor, J; Taylor, J; Taylor, L; Tedder, M; Tejada, AQ; Tengco, R; Tepastte, S; Terrell, W; Thai, R; Thepveera, K; Thomas, C; Thomas, F; Thomas, J; Thomas, L; Thompson, R; Thomson, R; Tice, D; Tigges, GA; To, AN; Ton, A; Tong, S; Topacio, A; Torres, E; Torres, J; Tran, L; Tran, T; Trevino, M; Trinkle, S; Trollman, J; Tsai, S; Tsun, M; Tuan, CYC; Tuen, C; Tuffli, C; Turkson, E; Turullols, G; Ugarte, J; Ukwade, P; Ulrich, G; Underwood, H; Underwood, R; Urdanivia, E; Urlanda, J; Vacker, M; Vail, R; Vallecillo, J; van Weelden, G; Vandam, J; Vanderzyl, J; Vandewall, L; Vanvranken, B; Vargo, R; Varma, C; Varns, R; Vashi, D; Vega, S; Venhuizen, G; Venkataraman, S; Verma, D; Verma, K; Verma, R; Verma, Y; Verzosa, S; Vevaina, J; Villa, A; Villafria, A; Villafria, R; Vinton, T; Vo, J; Vyas, P; Vyge, R; Waddell, D; Wade, T; Wagner, W; Wai, SS; Waikar, S; Walker, J; Wallace, M; Walter, L; Walters, B; Wang, J; Wang, P; Wang, P; Wania, D; Wansker, P; Ward, S; Ware, D; Wargovich, T; Warren, C; Warren, J; Warren, W; Waseem, M; Weathers, L; Weaver, H; Webb, B; Webb, W; Weddle, R; Weingarten, G; Weinstein, M; Weinstock, F; Weinstock, R; Weisbrot, A; Weiss, R; Weissman, L; Welling, M; Wellner, M; Wells, A; Welsh, J; Welsh, WD; Wenneker, A; Wessel, C; Wheeler, R; Whiddon, G; White, E; White, M; White, R; Wien, T; Wiggers, A; Wilkins, CE; Willadsen, K; Willard, J; Williams, B; Williams, BJ; Williams, C; Williams, H; Williams, K; Wilson, I; Winik, J; Winkel, RD; Winokur, A; Winters, M; Witt, M; Wong, Y; Wood, R; Woodberry, W; Wool, M; Woronoff, R; Wortman, J; Wozniak, D; Wu, WS; Yakel, D; Yang, M; Yaros, J; Yathiraj, S; Yee, W; Yip, I; Yu, H; Yu, ZJ; Yuan, T; Yut, C; Zador-Silverman, C; Zagha, M; Zaidi, S; Zajac, R; Zalcberg, L; Zampani, R; Zaniewski, M; Zaremba, J; Zazaian, A; Zazaian, J; Zeddies, C; Zeitlin, M; Zias, J; Ziman, R; Zofakis, A; Zolten, R; Zumpano, A; Zuzarte, K		REACH Registry Investigators	International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ACUTE CORONARY SYNDROMES; WAIST CIRCUMFERENCE; MYOCARDIAL-INFARCTION; GLOBAL BURDEN; MANAGEMENT; QUALITY; BMI; ATHEROSCLEROSIS; OVERWEIGHT	Context Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. Objective To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. Design, Setting, and Participants The Reduction of Atherothrombosis for Continued Health (REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67 888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease (coronary artery disease [CAD], n = 40 258; cerebrovascular disease, n = 18 843; peripheral arterial disease, n = 8273) or 3 or more risk factors for atherothrombosis (n = 12 389) between 2003 and 2004. Main Outcome Measures Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. Results Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension (81.8%), hypercholesterolemia (72.4%), and diabetes (44.3%). The prevalence of overweight (39.8%), obesity (26.6%), and morbid obesity (3.6%) were similar in most geographic locales, but was highest in North America (overweight: 37.1 %, obese: 36.5%, and morbidly obese: 5.8%; P<.001 vs other regions). Patients were generally undertreated with statins (69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents (78.6% overall; range: 53.9% for >= 3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial (14.4%). Undertreated hypertension (50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia (4.9%), and impaired fasting glucose (36.5% in those not known to be diabetic) were common. Among those with symptomatic atherothrombosis, 15.9% had symptomatic polyvascular disease. Conclusion This large, international, contemporary database shows that classic cardiovascular risk factors are consistent and common but are largely undertreated and undercontrolled in many regions of the world.	Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave,Desk F25, Cleveland, OH 44195 USA; Hop Bichat Claude Bernard, Dept Cardiol, F-75877 Paris 18, France; Duke Univ, Div Cardiol, Durham, NH USA; Univ Minnesota, Minneapolis Heart Inst Fdn, Sch Publ Hlth, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; Hop St Anne, Serv Neurol, Ctr Raymond Garcin, F-75674 Paris, France; Tokai Univ, Sch Med, Dept Med, Kanagawa 2591100, Japan; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Sch Med, Taipei, Taiwan; Sanofi Aventis, Global Med Affairs, Clin Operat, Paris, France; Klinikum Minden, Dept Neurol, Minden, Germany; Med Univ S Carolina, Gen Clin Res Ctr, Charleston, SC 29425 USA; Cleveland Clin Fdn, Cleveland, OH USA; Duke Univ, Med Ctr, Durham, NC USA; Klinikum Minden, Minden, Germany; Hop Bichat Claude Bernard, Paris, France; Med Univ South Carolina, Charleston, SC USA; Tokai Univ, Sch Med, Isehara, Kanagawa, Japan; Taiwan Univ Hosp & Coll Med, Taipei, Taiwan; Ctr Raymond Garcin, Paris, France; Monash Univ, Victoria, Australia; Landes Nervenklin Wagner Jauregg, Linz, Austria; Med Univ Klin, Graz, Austria; Clin Univ UCL, Mont Godinne, Belgium; Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; Univ Hosp St Ekaterina, Sofia, Bulgaria; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Hosp Clin Pontificia Univ Catol Chile, Santiago, Chile; Shanghai Huashan Hosp, Shanghai, Peoples R China; Fu Wai Hosp, Beijing, Peoples R China; H S Frederiksberg Hosp, Frederiksberg, Denmark; Helsinki Univ Hosp, Helsinki, Finland; Hop St Anne, Paris, France; Grp Hosp Univ Pitie Salpetriere, Paris, France; Univ Grosshadern, Med Klin & Poliklin 2, Marchioninistr 15, Munich, Germany; Klinikum Ludwigshafen Med, Klin B Bremserstrasse 79, Ludwigshafen, Germany; Klinikum Minden, Friedrichstr 17, Minden, France; Univ Ioannina, Med Sch, Ioannina, Greece; Ctr Diagnost, Guatemala City, Guatemala; Prince Wales Hosp, Shatin, Peoples R China; Univ Debrecen Med & Hlth Sci Ctr, Inst Med, Div Rare Dis, Debrecen, Hungary; Univ Indonesia, Jakarta, Indonesia; Soroka Med Ctr, Beer Sheva, Israel; Keio Univ, Sch Med, Tokyo, Japan; Amer Univ Hosp Hamra, Beirut, Lebanon; Univ Hosp, Kaunas, Lithuania; Inst Jantung Negara, Kuala Lumpur, Malaysia; Inst Cardiovasc Guadalajara, Jalisco, Mexico; Erasmus MC, Rotterdam, Netherlands; Philippine Heart Ctr, Quezon City, Philippines; Hosp Fernando Fonseca, Amadora, Portugal; Inst Boli Cerebrovasc, Bucharest, Romania; Cardiol Res Complex, Moscow, Russia; King Fahd Mil Hosp, Jeddah, Saudi Arabia; Natl Univ Singapore Hosp, Singapore, Singapore; Korea Hosp, Seoul, South Korea; Hosp Univ Princesa, Internal Med, Madrid, Spain; Univ Bern, Klin & Poliklinik Angiol, Bern, Switzerland; Natl Taiwan Univ Hosp, Taipei, Taiwan; Ramathibodi Hosp, Bangkok, Thailand; Jazeera Hosp, Abu Dhabi, U Arab Emirates; Conquest Hosp, St Leonards On Sea, England; Kharkov Med Acad Postgrad Educ, Kharkov, Ukraine; Northwestern Univ, Med Ctr, Chicago, IL USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; Univ Michigan, Cardiovasc Ctr, Ann Arbor, MI USA	Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Duke University; Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Keio University; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Tokai University; National Taiwan University; National Taiwan University Hospital; Sanofi-Aventis; Sanofi France; Ruhr University Bochum; Medical University of South Carolina; Cleveland Clinic Foundation; Duke University; Ruhr University Bochum; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of South Carolina; Tokai University; Monash University; Kepler University Hospital; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Universidade do Estado do Rio de Janeiro; Medical University Sofia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Helsinki; Helsinki University Central Hospital; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Ioannina; Chinese University of Hong Kong; Prince of Wales Hospital; University of Debrecen; University of Indonesia; Ben Gurion University; Soroka Medical Center; Keio University; Erasmus University Rotterdam; Erasmus MC; Philippine Heart Center; Hospital Professor Doutor Fernando Fonseca, EPE; National Medical Research Center of Cardiology; National University of Singapore; Hospital de La Princesa; University of Bern; National Taiwan University; National Taiwan University Hospital; Mahidol University; Kharkiv Medical Academy of Postgraduate Education; Northwestern University; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan	Bhatt, DL (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave,Desk F25, Cleveland, OH 44195 USA.	bhattd@ccf.org	macovei, luana andreea/R-9354-2019; Govender, Kaymarlin/M-1660-2019; García, José Carlos Fernández/X-3910-2019; Roquer, Jaume/G-8919-2017; Kovrazhkina, Elena/AAR-2425-2021; Ferguson, Niall/D-7619-2019; Tiu, Cristina/AAN-7335-2021; Hays, Ronald/D-5629-2013; Tint, Diana/AAF-6635-2022; Gamba, Mônica Antar/K-8903-2013; Idoate, Miguel-Ángel/D-8502-2019; STEG, Philippe Gabriel/Z-1567-2019; Hosomi, Naohisa/H-8660-2019; Gentry, Sommer/H-7101-2019; Chee, Kok Han/I-2138-2013; Buzea, Catalin/F-4201-2014; Rodilla, Enrique/L-1284-2014; Seet, Edwin/AAD-8896-2022; Chin, Chia Yook/B-8379-2010; Tint, Diana/ADG-0902-2022; Quere, Isabelle/AAB-8519-2020; Kinsara, Abdulhalim/X-8618-2018; STANCA, DIANA/GYU-2717-2022; Rizk, Nasser M/C-5174-2015; Sprynger, Muriel/ABD-6552-2021; donal, erwan/ABC-9736-2020; simons, sinno/AAC-7442-2019; Woo, Jeong-Taek/AAF-7691-2021; Vanhooren, Geert/H-4433-2011; ESTEBAN, MACARENA/H-2939-2015; de los Reyes, Emily C/AAP-3836-2020; Toplak, Hermann/ABG-3269-2020; Sorin, Tuta/ADT-6160-2022; Tanashyan, Marine Movsesovna/F-8483-2014; Tanashyan, Marine/AAH-5289-2019; Rodriguez-Leyva, Ildefonso/G-8398-2018; Postadzhiyan, Arman/GRS-2161-2022; Drapkina, Oxana/G-8443-2016; Greenland, Philip/ABD-5528-2021; Bobescu, Elena/AAC-6840-2021; Anlacan, Veeda Michelle/CAF-1536-2022; Thijs, Vincent/C-3647-2009; Akasheva, Dariga U/K-2764-2017; Phrommintikul, Arintaya/X-1881-2019; Drapkina, Oksana/AAE-5376-2021; Vacaras, Vitalie/AAT-5438-2020; Vichayanrat, apichati/AAS-9225-2020; Sawka, Michael/R-7222-2019; Kinsara, Abdulhalim/AAL-1207-2020; Jianu, Dragos Catalin/AAJ-4907-2021; Karatay, Eylem/K-4652-2019; Kropacheva, Ekaterina/AAN-1691-2020; Chawla, Omna/AAE-4118-2021; Bobescu, Elena/ABD-6951-2020; DOROBANTU, MARIA/AAS-2934-2020; Sirenko, Yuriy M/C-8012-2019; Uno, Masatoshi/V-7934-2019; sprynger, muriel/ABB-2766-2020; Nicolau, Jose C/E-1487-2012; Riachi, Naji/AAH-9156-2019; Martak, Fahimah/AAC-9282-2021; Kashiwagi, Atsunori/H-8712-2019; García, José Carlos Fernández/B-3723-2013; Chia, Yook Chin/L-2977-2019; Galyavich, Albert/L-6327-2015; Antochi, Florina A/F-9093-2016; CABRAL-LIM, LEONOR/ABA-9945-2021; Goto, Shinya/AAU-6045-2020; Chioncel, Ovidiu/R-7556-2017; Shalaev, Sergei V./D-4321-2018; ramos, cristian/GQP-7665-2022; Statsenko, Mikhail E./N-7573-2015; Dziak, Georgii/ABD-6506-2021; Dan, G.Andrei/N-6744-2015; Guillemot, Didier/AAN-3051-2020; Goh, Vicky/AAG-2708-2020; Iversen, Helle Klingenberg/P-5726-2019; Комаров, Андрей Леонидович/AAN-1678-2020; Serrano-Castro, Pedro/A-7537-2008; Ritarwan, Kiking/AAC-7995-2021; COTTIN, YVES/ABA-4622-2020; Cruce, Roxana/AAQ-1070-2020; Avezum, Alvaro/AAP-7687-2020; Wasyanto, Trisulo/GPF-3476-2022; Kósa, István Dr./N-3366-2019; Higashi, Yukihito/G-5343-2019; Koziolova, Natalya/K-5657-2019; Pazin Filho, Antonio/E-9495-2010; Milanov, Ivan G./D-4318-2015; Ignat, Emilian Bogdan/R-3900-2017; Facchini, Mario/AAB-1622-2020; Vatasescu, Radu/Y-7770-2018; OMAR, SHARIFAH FARIDAH SFSO SYED/B-9752-2010; Wilson, Peter W.F./J-2455-2016; Olivier, Christoph/AAK-2882-2021; Falup-Pecurariu, Cristian/AAP-9286-2020; Fonarow, Gregg C/D-5988-2014	García, José Carlos Fernández/0000-0003-2308-2865; Roquer, Jaume/0000-0001-5992-2606; Ferguson, Niall/0000-0002-6213-5264; Tiu, Cristina/0000-0001-8532-6218; Hays, Ronald/0000-0001-6697-907X; Tint, Diana/0000-0002-6204-1364; Gamba, Mônica Antar/0000-0003-1470-4474; Idoate, Miguel-Ángel/0000-0002-1596-1192; Gentry, Sommer/0000-0003-4530-8917; Chee, Kok Han/0000-0002-4485-0504; Buzea, Catalin/0000-0002-3365-9149; Rodilla, Enrique/0000-0003-3669-4270; Seet, Edwin/0000-0002-5036-2507; Chin, Chia Yook/0000-0003-1995-0359; Tint, Diana/0000-0002-6204-1364; Quere, Isabelle/0000-0002-1492-9764; Kinsara, Abdulhalim/0000-0002-6414-8720; STANCA, DIANA/0000-0002-5965-8590; Rizk, Nasser M/0000-0002-6288-3609; Woo, Jeong-Taek/0000-0001-9201-0713; Vanhooren, Geert/0000-0001-6818-9346; Toplak, Hermann/0000-0002-7513-5167; Tanashyan, Marine Movsesovna/0000-0002-5883-8119; Tanashyan, Marine/0000-0002-5883-8119; Rodriguez-Leyva, Ildefonso/0000-0002-3316-1471; Drapkina, Oxana/0000-0002-4453-8430; Anlacan, Veeda Michelle/0000-0002-1241-8805; Thijs, Vincent/0000-0002-6614-8417; Akasheva, Dariga U/0000-0003-0694-7062; Phrommintikul, Arintaya/0000-0003-3986-1951; Drapkina, Oksana/0000-0002-4453-8430; Vacaras, Vitalie/0000-0002-1491-5952; Kinsara, Abdulhalim/0000-0002-6414-8720; Jianu, Dragos Catalin/0000-0002-7827-818X; Karatay, Eylem/0000-0003-3738-3554; Kropacheva, Ekaterina/0000-0002-3092-8593; Bobescu, Elena/0000-0002-0945-9067; Sirenko, Yuriy M/0000-0002-4091-4910; Nicolau, Jose C/0000-0002-9680-3689; Riachi, Naji/0000-0002-8652-9698; García, José Carlos Fernández/0000-0003-2308-2865; Goto, Shinya/0000-0002-6821-1504; Chioncel, Ovidiu/0000-0002-3197-3628; Shalaev, Sergei V./0000-0003-2724-4016; Statsenko, Mikhail E./0000-0002-3306-0312; Dziak, Georgii/0000-0003-2352-1055; Dan, G.Andrei/0000-0001-9867-2582; Iversen, Helle Klingenberg/0000-0002-5880-6352; Комаров, Андрей Леонидович/0000-0001-9141-103X; Serrano-Castro, Pedro/0000-0002-3414-2707; Kósa, István Dr./0000-0002-8805-4307; Pazin Filho, Antonio/0000-0001-5242-329X; Milanov, Ivan G./0000-0002-4522-4070; Ignat, Emilian Bogdan/0000-0002-6952-9741; Vatasescu, Radu/0000-0001-7163-8528; Fonarow, Gregg C/0000-0002-3192-8093; Williams, Bryan/0000-0002-8094-1841; STEG, Philippe Gabriel/0000-0001-6896-2941; Punjabi, Prof Prakash P/0000-0002-6587-1603; Heo, Ji Hoe/0000-0001-9898-3321				Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Ardern CL, 2003, OBES RES, V11, P135, DOI 10.1038/oby.2003.22; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Bhatt Deepak L, 2003, J Invasive Cardiol, V15 Suppl B, p3B; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eagle KA, 2004, AM J MED, V117, P73, DOI 10.1016/j.amjmed.2003.12.041; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Foucan L, 2002, J CLIN EPIDEMIOL, V55, P990, DOI 10.1016/S0895-4356(02)00430-4; Fox KAA, 2000, EUR HEART J, V21, P1440, DOI 10.1053/euhj.2000.2185; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Ho SY, 2003, ANN EPIDEMIOL, V13, P683, DOI 10.1016/S1047-2797(03)00067-X; Lee TH, 2000, JAMA-J AM MED ASSOC, V283, P94, DOI 10.1001/jama.283.1.94; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; OHMAN EM, IN PRESS AM HEART J; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Ramachandran A, 2004, DIABETES RES CLIN PR, V65, P189, DOI 10.1016/j.diabres.2004.03.012; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Wilson Peter W F, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS34; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	33	1262	1340	11	258	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					180	189		10.1001/jama.295.2.180	http://dx.doi.org/10.1001/jama.295.2.180			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403930	Bronze			2022-12-28	WOS:000234544300025
J	Diehl, R; Halloin, H; Kretschmer, K; Lichti, GG; Schonfelder, V; Strong, AW; von Kienlin, A; Wang, W; Jean, P; Knodlseder, J; Roques, JP; Weidenspointner, G; Schanne, S; Hartmann, DH; Winkler, C; Wunderer, C				Diehl, R; Halloin, H; Kretschmer, K; Lichti, GG; Schonfelder, V; Strong, AW; von Kienlin, A; Wang, W; Jean, P; Knodlseder, J; Roques, JP; Weidenspointner, G; Schanne, S; Hartmann, DH; Winkler, C; Wunderer, C			Radioactive Al-26 from massive stars in the Galaxy	NATURE			English	Article							EVOLUTION	Gamma-rays from radioactive Al-26 ( half-life similar to 7.2 x 10(5) years) provide a 'snapshot' view of continuing nucleosynthesis in the Galaxy(1). The Galaxy is relatively transparent to such gamma-rays, and emission has been found concentrated along its plane(2). This led to the conclusion(1) that massive stars throughout the Galaxy dominate the production of Al-26. On the other hand, meteoritic data show evidence for locally produced Al-26, perhaps from spallation reactions in the protosolar disk(3-5). Furthermore, prominent gamma-ray emission from the Cygnus region suggests that a substantial fraction of Galactic Al-26 could originate in localized star-forming regions. Here we report high spectral resolution measurements of Al-26 emission at 1808.65 keV, which demonstrate that the Al-26 source regions corotate with the Galaxy, supporting its Galaxy-wide origin. We determine a present-day equilibrium mass of 2.8 (+/- 0.8) solar masses of Al-26. We use this to determine that the frequency of core collapse ( that is, type Ib/c and type II) supernovae is 1.9 (+/- 1.1) events per century.	Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; Univ Toulouse 3, F-31028 Toulouse, France; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; CEA Saclay, DSM, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France; Clemson Univ, Clemson, SC 29634 USA; ESA, ESTEC, SCI SD, NL-2201 AZ Noordwijk, Netherlands; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	Max Planck Society; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; UDICE-French Research Universities; Universite Paris Saclay; Clemson University; European Space Agency; University of California System; University of California Berkeley	Diehl, R (corresponding author), Max Planck Inst Extraterr Phys, D-85748 Garching, Germany.	rod@mpe.mpg.de	Diehl, Roland/K-4496-2016	Diehl, Roland/0000-0002-8337-9022; Halloin, Hubert/0000-0002-9250-4622; Jean, Pierre/0000-0002-1757-9560; Wunderer, Cornelia/0000-0001-8211-3604				Asplund M, 2005, ASTR SOC P, V336, P25; Boissier S, 1999, MON NOT R ASTRON SOC, V307, P857, DOI 10.1046/j.1365-8711.1999.02699.x; CORDES JM, 2002, ARXIVORGASTROPH02071; DIEHL R, 1995, ASTRON ASTROPHYS, V298, P445; Gilmore G, 2001, ASTR SOC P, V230, P3; Knodlseder J, 1999, ASTRON ASTROPHYS, V344, P68; Kretschmer K, 2003, ASTRON ASTROPHYS, V412, pL47, DOI 10.1051/0004-6361:20034604; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; Lee T, 1998, ASTROPHYS J, V506, P898, DOI 10.1086/306284; Limongi M, 2005, NUCL PHYS A, V758, p11C, DOI 10.1016/j.nuclphysa.2005.05.006; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKee CF, 1997, ASTROPHYS J, V476, P144, DOI 10.1086/303587; Palacios A, 2005, ASTRON ASTROPHYS, V429, P613, DOI 10.1051/0004-6361:20041757; Pluschke S, 2001, ESA SP PUBL, V459, P55; Prantzos N, 1996, PHYS REP, V267, P2; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Reed BC, 2005, ASTRON J, V130, P1652, DOI 10.1086/444474; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Ward-Thompson D, 2002, SCIENCE, V295, P76, DOI 10.1126/science.1067354; Young ED, 2005, SCIENCE, V308, P223, DOI 10.1126/science.1108140	22	532	537	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					45	47		10.1038/nature04364	http://dx.doi.org/10.1038/nature04364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397491	Green Submitted			2022-12-28	WOS:000234378700029
J	Davenport, RJ				Davenport, RJ			Drumming up dollars for stem cell research	CELL			English	Article																			0	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1169	1171		10.1016/j.cell.2005.12.012	http://dx.doi.org/10.1016/j.cell.2005.12.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377553	Bronze			2022-12-28	WOS:000234584500001
J	Kumar, S; Hedges, SB				Kumar, S; Hedges, SB			Pushing back the expansion of introns in animal genomes	CELL			English	Article							GENES		Arizona State Univ, Ctr Evolut Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kumar, S (corresponding author), Arizona State Univ, Ctr Evolut Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA.	s.kumar@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212				Blair JE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-53; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; LUNCH M, 2005, MOL BIOL EVOL; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0	8	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1182	1184		10.1016/j.cell.2005.12.007	http://dx.doi.org/10.1016/j.cell.2005.12.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377558	Bronze			2022-12-28	WOS:000234584500006
J	Platt, R; Ommaya, A				Platt, R; Ommaya, A			A beneficial side effect of the Medicare drug benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; HMO Res Network Ctr Educ & Res Therapeut, Boston, MA USA; Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; National Academies of Sciences, Engineering & Medicine	Platt, R (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.							*CTR MED MED SERV, MED PRESCR DRUG DAT; DeStefano F, 2001, PHARMACOEPIDEM DR S, V10, P403, DOI 10.1002/pds.613; Gottlieb S, 2005, HEALTH AFFAIR, V24, P938, DOI 10.1377/hlthaff.24.4.938; GUIDELINE IND EXTENT	4	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2742	2743		10.1056/NEJMp058297	http://dx.doi.org/10.1056/NEJMp058297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	997LK	16382059				2022-12-28	WOS:000234246700004
J	Macqueen, AJ; Phillips, CM; Bhalla, N; Weiser, P; Villeneuve, AM; Dernburg, AF				Macqueen, AJ; Phillips, CM; Bhalla, N; Weiser, P; Villeneuve, AM; Dernburg, AF			Chromosome sites play dual roles to establish homologous synapsis during meiosis in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; NUCLEAR REORGANIZATION; GENETIC-ANALYSIS; CROSSING-OVER; X-CHROMOSOME; PROPHASE; TRANSLOCATION; MECHANISM; COMPONENT	We have investigated the role of pairing centers (PCs), cis-acting sites required for accurate segregation of homologous chromosomes during meiosis in C. elegans. We find that these sites play two distinct roles that contribute to proper segregation. Chromosomes lacking PCs usually fail to synapse and also lack a synapsis-independent stabilization activity. The presence of a PC on just one copy of a chromosome pair promotes synapsis but does not support synapsis independent pairing stabilization, indicating that these functions are separable. Once initiated, synapsis is highly processive, even between nonhomologous chromosomes of disparate lengths, elucidating how translocations suppress meiotic recombination in C. elegans. These findings suggest a multistep pathway for chromosome synapsis in which PCs impart selectivity and efficiency through a "kinetic proofreading" mechanism. We speculate that concentration of these activities at one region per chromosome may have coevolved with the loss of a point centromere to safeguard karyotype stability.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Lawrence Berkeley Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Macqueen, AJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011	Phillips, Carolyn/0000-0002-6228-6468; Dernburg, Abby/0000-0001-8037-1079	NIGMS NIH HHS [F32 GM067408-01A1, R01 GM655591, R01 GM53804, R01 GM065591, GM067408, R01 GM053804, F32 GM067408-02, F32 GM067408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804, R01GM065591, F32GM067408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBAZUK WB, 1994, GENETICS, V136, P129; CARLTON PM, 2005, IN PRESS PLOS GENET; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; Edgley ML, 1995, METHOD CELL BIOL, V48, P147; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GOLDSTEIN P, 1986, CHROMOSOMA, V93, P256, DOI 10.1007/BF00292746; HAWLEY RS, 1980, GENETICS, V94, P625; HERMAN RK, 1982, GENETICS, V102, P379; HERMAN RK, 1989, GENETICS, V121, P723; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Koh K, 2004, DEV BIOL, V267, P252, DOI 10.1016/j.ydbio.2003.11.014; Loidl J, 2004, CHROMOSOM T, V14, P93; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; MCKIM KS, 1988, GENETICS, V120, P987; MCKIM KS, 1993, GENETICS, V134, P749; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; Riddle D. L, 1997, C ELEGANS, P47; Rinaldo C, 2002, GENETICS, V160, P471; ROSENBLUTH RE, 1981, GENETICS, V99, P415; Sherizen D, 2005, GENETICS, V169, P767, DOI 10.1534/genetics.104.035824; SIGURDSON DC, 1986, MOL GEN GENET, V202, P212, DOI 10.1007/BF00331639; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; VILLENEUVE AM, 1994, GENETICS, V136, P887; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	37	196	204	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1037	1050		10.1016/j.cell.2005.09.034	http://dx.doi.org/10.1016/j.cell.2005.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360034	Green Accepted, Bronze			2022-12-28	WOS:000234177200013
J	Carlson, A				Carlson, A			Essay - Suspect sex	LANCET			English	Article									Commonweal Inst, San Francisco, CA 94109 USA		Carlson, A (corresponding author), Commonweal Inst, 2075 Calif St, San Francisco, CA 94109 USA.	Alison_Carlson@sbcglobal.net							0	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S39	S40		10.1016/S0140-6736(05)67842-7	http://dx.doi.org/10.1016/S0140-6736(05)67842-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360747	Bronze			2022-12-28	WOS:000234374400025
J	Dixon-Woods, M; Jackson, C; Windridge, KC; Kenyon, S				Dixon-Woods, M; Jackson, C; Windridge, KC; Kenyon, S			Receiving a summary of the results of a trial: qualitative study of participants' views	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BROAD-SPECTRUM ANTIBIOTICS; RANDOMIZED TRIAL; CLINICAL-TRIAL; INFORMATION; PRETERM; CONSENT	Objective To explore trial participants' responses to receiving a summary of the results of a trial in pregnancy. Design Qualitative study with semistructured interviews. Participants 20 women who had when pregnant participated in the ORACLE trial of antibiotics for preterm labour and preterm rupture of the membranes and requested a copy of the trial results. Results Less than a fifth of women who participated in the ORACLE trial indicated that they wished to receive the trial results. Reactions to the leaflet summarising the trial results were generally positive or neutral, although some women had difficulty in understanding the leaflet, and there was evidence of possible negative implications for women who had adverse outcomes. Women requested the results because they were interested in being able to complete their own personal narrative. They wished to know to which arm of the trial they had been allocated and the implications for their own pregnancy, and they were disappointed with receiving a generic summary. Women's accounts indicated some confusion about the trial findings. Conclusions Recommendations that research participants be routinely provided with the results of studies have been made without the benefit of research to show the consequences of doing this or how it should best be managed. Caution is needed, as is more evaluation of how feedback of results should be handled, and assessment of the risks, benefits, and costs.	Univ Leicester, Dept Hlth Sci, Social Sci Grp, Leicester LE1 6TP, Leics, England; Univ Leicester, Dept Hlth Sci, Trent Res & Dev Support Unit, Leicester LE1 6TP, Leics, England; Univ Leicester, Dept Canc & Mol Studies, Reprod Sci Sect, MRC Oracle Childrens Study, Leicester LE2 7LX, Leics, England	University of Leicester; University of Leicester; University of Leicester	Dixon-Woods, M (corresponding author), Univ Leicester, Dept Hlth Sci, Social Sci Grp, Leicester LE1 6TP, Leics, England.	mdll@le.ac.uk	Jackson, Clare/A-1421-2013	Dixon-Woods, Mary/0000-0002-5915-0041; Kenyon, Sara/0000-0002-0756-9617				AIMS: Association for Improvements in Maternity Care, 1997, CHART ETH RES MAT CA; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Department of Health, 2005, RES GOV FRAM HLTH SO; Di Blasi Z, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-30; Dixon-Woods M, 2001, SOC SCI MED, V52, P1417, DOI 10.1016/S0277-9536(00)00247-1; Fernandez Conrad V, 2003, IRB, V25, P12, DOI 10.2307/3564300; Fernandez CV, 2004, CAN MED ASSOC J, V170, P1417, DOI 10.1503/cmaj.1031668; Glaser B.G., 1965, AWARENESS DYING; GOODARE H, 1995, BMJ-BRIT MED J, V310, P1277, DOI 10.1136/bmj.310.6990.1277; Kenyon S, 2004, BJOG-INT J OBSTET GY, V111, P1341, DOI 10.1111/j.1471-0528.2004.00293.x; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Lopez J, 2004, SOCIOL HEALTH ILL, V26, P875, DOI 10.1111/j.0141-9889.2004.00421.x; Marshall S, 1996, BRIT MED J, V312, P186; Partridge AH, 2005, LANCET, V365, P963, DOI 10.1016/S0140-6736(05)71085-0; Partridge AH, 2003, J NATL CANCER I, V95, P491, DOI 10.1093/jnci/95.6.491; Partridge AH, 2002, JAMA-J AM MED ASSOC, V288, P363, DOI 10.1001/jama.288.3.363; Richards MPM, 2003, J MED ETHICS, V29, P93, DOI 10.1136/jme.29.2.93; Robinson EJ, 2005, HEALTH TECHNOL ASSES, V9, pIII; Schulz CJ, 2003, MED PEDIATR ONCOL, V41, P36, DOI 10.1002/mpo.10278; SHAUL RDZ, 2005, ACCOUNT RES, V12, P1; Snowdon C, 1998, BMJ-BRIT MED J, V317, P21, DOI 10.1136/bmj.317.7150.21; SNOWDON C, 1998, BRIT MED J, V317, P24; Thornton Hazel, 2003, Health Expect, V6, P189, DOI 10.1046/j.1369-6513.2003.00231.x; *UK PARL, DRAFT GUID ETH RES A; *UK PARL, DRAFT GUID ETH RES P	26	80	81	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2006	332	7535					206	209		10.1136/bmj.38675.677963.3A	http://dx.doi.org/10.1136/bmj.38675.677963.3A			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009BU	16401631	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000235086900017
J	Fisher, CB				Fisher, CB			Clinical trials results databases: Unanswered questions	SCIENCE			English	Editorial Material									Fordham Univ, Ctr Eth Educ, Bronx, NY 10458 USA	Fordham University	Fisher, CB (corresponding author), Fordham Univ, Ctr Eth Educ, Bronx, NY 10458 USA.	fisher@fordham.edu		Fisher, Celia/0000-0002-3849-7281				*AM MED ASS, AM MED ASS OFF GUID; Couzin J, 2005, SCIENCE, V307, P189; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; *FOOD DRUG ADM, QUEST ANSW FDA REG A; GARDNER A, 2005, HEALTHDAY NEWS  0829; *GEMCRIS, GEN MOD CLIN RES INF; GILPIN K, 2004, NY TIMES        0602; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; *RESP SUST PUBL TR, 2005, P FORDH U SUMM BIOPH; WHO, INT CLIN TRIALS REG; *WHO, 2005, WHO INT CLIN TRIALS; 2004, FDA WEEK        1112	12	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					180	181		10.1126/science.1119685	http://dx.doi.org/10.1126/science.1119685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410509				2022-12-28	WOS:000234722200024
J	Rape, M; Reddy, SK; Kirschner, MW				Rape, M; Reddy, SK; Kirschner, MW			The processivity of multiubiquitination by the APC determines the order of substrate degradation	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE ENTRY; DESTRUCTION BOX; CYCLIN; RECOGNITION; MITOSIS; PROTEOLYSIS; DOMAIN; ACCUMULATION; MECHANISM	The anaphase-promoting complex (APC) coordinates mitosis and G1 by sequentially promoting the degradation of key cell-cycle regulators. Following the degradation of its substrates in G1, the APC catalyzes the autoubiquitination of its E2 UbcH10. This stabilizes cyclin A and allows it to inactivate ApC(Cdh1). How the APC establishes this complex temporal sequence of ubiquitinations, referred to as substrate ordering, is not understood. Here we show that substrate ordering depends on the relative processivity of substrate multiubiquitination by the APC. Processive substrates obtain ubiquitin chains in a single APC binding event. The multi ubiquitination of distributive substrates requires multiple rounds of APC binding, which render it sensitive to lower APC concentrations, competition by processive substrates, and deubiquitination. Consequently, more processive substrates are preferentially multiubiquitinated in vitro and degraded earlier in vivo. The processivity of multiubiquitination is strongly influenced by the D box within the substrate, suggesting that substrate ordering is established by a mechanism intrinsic to APC and its substrates and similar to kinetic proofreading.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu		Rape, Michael/0000-0003-4849-6343				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5	26	222	231	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					89	103		10.1016/j.cell.2005.10.032	http://dx.doi.org/10.1016/j.cell.2005.10.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413484	Green Submitted, Bronze			2022-12-28	WOS:000234969600012
J	Depoortere, E; Checchi, F				Depoortere, E; Checchi, F			Pre-emptive war epidemiology: lessons from the Democratic Republic of Congo	LANCET			English	Editorial Material							MORTALITY		Epicentre, F-75011 Paris, France; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Depoortere, E (corresponding author), Epicentre, F-75011 Paris, France.	evelyn.depoortere@brussels.msf.org		Checchi, Francesco/0000-0001-9030-5382				Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Human Security Centre, 2005, HUM SEC REP 2005 WAR; *INT CRIS GROUP, 2005, CONG ACT PLAN AFR BR; *MED SANS FRONT, 2004, DRC NEV END HLTH CRI; Oxfam International, 2005, YEAR DIS; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; *UN WORLD FOOD PRO, 2004, WORLD HUNG DEM REP C; *UNICEF, 2005, GLANC DEM REP CONG S; *WHO, 2005, HLTH ACT CRIS DEM RE; *WHO FED MIN HLTH, 2005, MORT SURV INT DISPL; *WHO REP UG MIN HL, 2005, HLTH MORT SURV INT D	13	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					7	9		10.1016/S0140-6736(06)67900-2	http://dx.doi.org/10.1016/S0140-6736(06)67900-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000EG	16399134				2022-12-28	WOS:000234443100006
J	Leon, DA; McCambridge, J				Leon, DA; McCambridge, J			Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data	LANCET			English	Article							BEER-DRINKING COUNTRIES; ALCOHOL-CONSUMPTION; COMMENTARIES; SCOTLAND; ENGLAND; OBESITY; COHORT	Background Rates of mortality due to cirrhosis of the liver are an important indicator of population levels of alcohol harm. Total recorded alcohol consumption in Britain doubled between 1960 and 2002, giving rise to a need to examine and assess cirrhosis mortality trends. Methods Mortality rates were calculated for all ages and for specific age-groups (15-44 years and 45-64 years) for cirrhosis of the liver. Rates were directly age-standardised to the European standard population and compared with rates from 12 western European countries for the period 1955-2001. Findings Cirrhosis mortality rates increased steeply in Britain during the 1990s. Between the periods 1987-1991, and 1997-2001, cirrhosis mortality in men in Scotland more than doubled (104% increase) and in England and Wales rose by over two-thirds (69%). Mortality in women increased by almost half (46% in Scotland and 44% in England and Wales). These relative increases are the steepest in western Europe, and contrast with the declines apparent in most other countries examined, particularly those of southern Europe. Cirrhosis mortality rates in Scotland are now one of the highest in western Europe, in 2002 being 45.2 per 100 000 in men and 19.9 in women. Interpretation Current alcohol policies in Britain should be assessed by the extent to which they can successfully halt the adverse trends in liver cirrhosis mortality. The situation in Scotland warrants particular attention.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; Kings Coll London, Natl Addict Ctr, Inst Psychiat, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	david.leon@lshtm.ac.uk	Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; McCambridge, Jim/0000-0002-5461-7001	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; [Anonymous], 2000, SCOTT NEEDS ASS PROG; Babor TF, 2003, ALCOHOL NO ORDINARY; Bruun K., 1975, ALCOHOL CONTROL POLI; *CAB OFF, 2004, ALC HARM RED STRAT E; Desenclos J-C, 2003, Euro Surveill, V8, P99; DONALDSON L, 2001, STATE PUBLIC HLTH; DUFFY JC, 1986, J ROY STAT SOC A STA, V149, P45, DOI 10.2307/2981884; DUFFY JC, 1986, BRIT MED J, V292, P36, DOI 10.1136/bmj.292.6512.36; Edwards G., 1994, ALCOHOL POLICY PUBLI; *EUR MON CTR DRUGS, 2004, STAT DRUGS PROBL EUR; Gruenewald PJ, 2000, ADDICTION, V95, P347; Gutierrez-Fisac JL, 2000, INT J OBESITY, V24, P1677, DOI 10.1038/sj.ijo.0801445; Henry JA, 2002, J CLIN PATHOL, V55, P704, DOI 10.1136/jcp.55.9.704; Ioannou GN, 2003, GASTROENTEROLOGY, V125, P1053, DOI 10.1016/S0016-5085(03)01200-9; Kerr WC, 2000, ADDICTION, V95, P355; Kerr WC, 2000, ADDICTION, V95, P339, DOI 10.1046/j.1360-0443.2000.9533394.x; Leon D. A., 2003, UNDERSTANDING HLTH S; NORSTROM T, 1987, BRIT J ADDICT, V82, P633; *ORG EC COOP DEV, 2005, OECD HLTH DAT 2005 S; Ramstedt M, 2001, ADDICTION, V96, pS19; Roizen R, 1999, BRIT MED J, V319, P666, DOI 10.1136/bmj.319.7211.666; Room R, 2004, ADDICTION, V99, P1083, DOI 10.1111/j.1360-0443.2004.00803.x; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; SEELEY J R, 1960, Can Med Assoc J, V83, P1361; SHAW A, 2000, SCOTTISH HLTH SURVEY, V1; TERRIS M, 1967, AM J PUBLIC HEALTH N, V57, P2076, DOI 10.2105/AJPH.57.12.2076; WALKER A, 2001, LIVING BRITAIN RESUL; WILSON P, 1980, POPUL TRENDS     WIN, P14; [No title captured]	30	307	312	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					52	56		10.1016/S0140-6736(06)67924-5	http://dx.doi.org/10.1016/S0140-6736(06)67924-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399153	Green Accepted			2022-12-28	WOS:000234443100030
J	Norton, P; Brubaker, L				Norton, P; Brubaker, L			Urinary incontinence in women	LANCET			English	Review							GENUINE STRESS-INCONTINENCE; FREE VAGINAL TAPE; MULTICENTER RANDOMIZED-TRIAL; PELVIC ORGAN PROLAPSE; 5-YEAR FOLLOW-UP; RISK-FACTORS; BURCH COLPOSUSPENSION; SURGICAL-TREATMENT; TRACT SYMPTOMS; PHARMACOLOGICAL-TREATMENT	Urinary incontinence is common in women, but is under-reported and under-treated. Urine storage and emptying is a complex coordination between the bladder and urethra, and disturbances in the system due to childbirth, aging, or other medical conditions can lead to urinary incontinence. The two main types of incontinence in women, stress urinary incontinence and urge urinary incontinence, can be evaluated by history and simple clinical assessment available to most primary care physicians. There is a wide range of therapeutic options, but the recent proliferation of new drug treatments and surgical devices for urinary incontinence have had mixed results; direct-to-consumer advertising has increased public awareness of the problem of urinary incontinence, but many new products are being introduced without long-term assessment of their safety and efficacy.	Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA	Utah System of Higher Education; University of Utah; Loyola University Chicago	Norton, P (corresponding author), Univ Utah, Sch Med, 50 N Med Dr, Salt Lake City, UT 84132 USA.	peggy.norton@hsc.utah.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589				Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; ALCALAY M, 1995, BRIT J OBSTET GYNAEC, V102, P740, DOI 10.1111/j.1471-0528.1995.tb11434.x; Andersson KE, 2004, SCAND J UROL NEPHROL, V38, P54, DOI 10.1080/03008880410015192; Andersson KE, 1999, BJU INT, V84, P923; Ankardal M, 2004, BJOG-INT J OBSTET GY, V111, P974, DOI 10.1111/j.1471-0528.2004.00220.x; [Anonymous], 2000, SCAND J CLIN LAB INV, V60, P1; Berghmans LCM, 2000, BJU INT, V85, P254, DOI 10.1046/j.1464-410x.2000.00434.x; BERGMAN A, 1995, AM J OBSTET GYNECOL, V173, P66, DOI 10.1016/0002-9378(95)90171-X; Bidmead J, 2000, CURR OPIN OBSTET GYN, V12, P421, DOI 10.1097/00001703-200010000-00013; BLAIVAS JG, 1987, J UROLOGY, V138, P597, DOI 10.1016/S0022-5347(17)43269-1; Blok BFM, 1999, BJU INT, V83, P1, DOI 10.1046/j.1464-410X.83.s2.2.x; Bo K, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P36; Boyles SH, 2003, AM J OBSTET GYNECOL, V189, P70, DOI 10.1067/mob.2003.376; Boyles SH, 2003, AM J OBSTET GYNECOL, V188, P108, DOI 10.1067/mob.2003.101; BRINK CA, 1994, NURS RES, V43, P352; Brittain KR, 2000, STROKE, V31, P886, DOI 10.1161/01.STR.31.4.886; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Brubaker L, 2004, GASTROENTEROLOGY, V126, pS71, DOI 10.1053/j.gastro.2003.10.002; Brubaker L, 1997, AM J OBSTET GYNECOL, V177, P536, DOI 10.1016/S0002-9378(97)70142-X; Bryan NP, 2004, EUR UROL, V46, P636, DOI 10.1016/j.eururo.2004.07.023; BUMP RC, 1993, OBSTET GYNECOL, V81, P421; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; BUMP RC, 1994, AM J OBSTET GYNECOL, V170, P579, DOI 10.1016/S0002-9378(94)70231-4; Bump RG, 2003, OBSTET GYNECOL, V102, P76, DOI 10.1016/S0029-7844(03)00376-4; Burgio Kathryn L, 2004, J Am Acad Nurse Pract, V16, P4; BURGIO KL, 1991, J UROLOGY, V145, P728, DOI 10.1016/S0022-5347(17)38436-7; Cardozo L, 2004, OBSTET GYNECOL, V104, P511, DOI 10.1097/01.AOG.0000134525.86480.0f; Chai T C, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P85, DOI 10.1007/BF02764824; Chaliha C, 1999, OBSTET GYNECOL, V94, P689, DOI 10.1016/S0029-7844(99)00364-6; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Collas D M, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P24, DOI 10.1007/BF01895101; Corcos J, 2002, J UROLOGY, V168, P896, DOI 10.1016/S0022-5347(05)64540-5; Costa P, 2004, CURR OPIN UROL, V14, P313, DOI 10.1097/00042307-200411000-00003; Costa P, 2004, EUR UROL, V46, P102, DOI 10.1016/j.eururo.2004.03.005; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2; Diokno AC, 2004, AM J MANAG CARE, V10, P69; Dmochowski RR, 2002, J UROLOGY, V168, P580, DOI 10.1016/S0022-5347(05)64684-8; Dmochowski RR, 2000, UROLOGY, V56, P32, DOI 10.1016/S0090-4295(00)01019-0; DWYER PL, 1988, BRIT J OBSTET GYNAEC, V95, P91, DOI 10.1111/j.1471-0528.1988.tb06486.x; Fantl AJ, 1996, URINARY INCONTINENCE; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Fleischmann N, 2003, J UROLOGY, V169, P999, DOI 10.1097/01.ju.0000051895.28240.12; Flynn MK, 2004, J UROLOGY, V172, P2316, DOI 10.1097/01.ju.0000143889.00681.3f; Fultz NH, 2003, AM J OBSTET GYNECOL, V189, P1275, DOI 10.1067/S0002-9378(03)00598-2; Glazener CM, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003195, DOI 10.1002/14651858.CD003195]; Goode PS, 2004, UROLOGY, V63, P58, DOI 10.1016/j.urology.2003.10.032; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Hagglund D, 2003, INT UROGYNECOL J, V14, P296, DOI 10.1007/s00192-003-1077-9; Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hay-Smith EJ, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001407; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; HONNA Y, 2002, INCONTINENCE; Howard D, 2000, OBSTET GYNECOL, V95, P713, DOI 10.1016/S0029-7844(00)00786-9; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; Jackson SL, 1997, OBSTET GYNECOL, V89, P423; JARVIS GJ, 1993, BRIT MED J, V306, P809, DOI 10.1136/bmj.306.6881.809; KAPLAN SA, 1991, J UROLOGY, V146, P113, DOI 10.1016/S0022-5347(17)37727-3; KJOLHEDE P, 1994, ACTA OBSTET GYN SCAN, V73, P642, DOI 10.3109/00016349409013459; Klein MC, 1997, AM J OBSTET GYNECOL, V176, P403, DOI 10.1016/S0002-9378(97)70506-4; Kobashi KC, 2003, J UROLOGY, V170, P1918, DOI 10.1097/01.ju.0000092403.58592.69; Koelbl H, 1998, OBSTET GYNECOL, V92, P332, DOI 10.1016/S0029-7844(98)00215-4; La Grenade L, 2001, JAMA-J AM MED ASSOC, V286, P3081, DOI 10.1001/jama.286.24.3081; Landis JR, 2004, J UROLOGY, V171, P752, DOI 10.1097/01.ju.0000103540.71683.e5; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; LEIGH RJ, 1982, LANCET, V1, P1349; Levin I, 2004, NEUROUROL URODYNAM, V23, P7, DOI 10.1002/nau.10164; Lightner Deborah J, 2002, Curr Opin Urol, V12, P333, DOI 10.1097/00042307-200207000-00012; LUXEM M, 1994, J DEV BEHAV PEDIATR, V15, P370; MaLossi Jennifer, 2002, Curr Urol Rep, V3, P61, DOI 10.1007/s11934-002-0012-9; Miller JL, 1996, J ENDOUROL, V10, P287, DOI 10.1089/end.1996.10.287; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; MILSOM I, 1993, J UROLOGY, V149, P1459, DOI 10.1016/S0022-5347(17)36415-7; Moller LA, 2000, BMJ-BRIT MED J, V320, P1429, DOI 10.1136/bmj.320.7247.1429; Moller LA, 2000, ACTA OBSTET GYN SCAN, V79, P298, DOI 10.1080/j.1600-0412.2000.079004298.x; Mushkat Y, 1996, AM J OBSTET GYNECOL, V174, P617, DOI 10.1016/S0002-9378(96)70437-4; Nilsson CG, 2001, INT UROGYNECOL J, V12, pS5, DOI 10.1007/s001920170003; NORTON PA, 1988, BRIT MED J, V297, P1187, DOI 10.1136/bmj.297.6657.1187; NYGAARD I, 1995, J REPROD MED, V40, P89; Nygaard I, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P340, DOI 10.1007/BF02765593; Nygaard IE, 2004, OBSTET GYNECOL, V104, P607, DOI 10.1097/01.AOG.0000137874.84862.94; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; REKERS H, 1992, EUR J OBSTET GYN R B, V43, P229, DOI 10.1016/0028-2243(92)90178-2; RESNICK NM, 1985, NEW ENGL J MED, V313, P800, DOI 10.1056/NEJM198509263131307; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Rovner E S, 2004, Minerva Ginecol, V56, P327; Rovner ES, 2003, CURR OPIN UROL, V13, P273, DOI 10.1097/00042307-200307000-00002; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Sampselle CM, 1998, OBSTET GYNECOL, V91, P406, DOI 10.1016/S0029-7844(97)00672-8; Samuelsson EC, 2000, AM J OBSTET GYNECOL, V183, P568, DOI 10.1067/mob.2000.106763; SAND PK, 1991, OBSTET GYNECOL, V77, P453; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SIMON SR, 1992, ARCH INTERN MED, V152, P1698, DOI 10.1001/archinte.152.8.1698; SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587; SMITH ARB, 1989, BRIT J OBSTET GYNAEC, V96, P29, DOI 10.1111/j.1471-0528.1989.tb01572.x; SNOOKS SJ, 1986, INT J COLORECTAL DIS, V1, P20, DOI 10.1007/BF01648831; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; Subak LL, 2002, INT UROGYNECOL J PEL, V13, P40, DOI 10.1007/s001920200008; SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601; Thom DH, 1997, OBSTET GYNECOL, V90, P983, DOI 10.1016/S0029-7844(97)00537-1; Thor KB, 2004, J UROLOGY, V172, P27, DOI 10.1097/01.ju.0000118381.04432.22; THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014; Ulmsten U, 1999, BRIT J OBSTET GYNAEC, V106, P345, DOI 10.1111/j.1471-0528.1999.tb08272.x; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002; van Kerrebroeck P, 2004, BJOG-INT J OBSTET GY, V111, P249, DOI 10.1111/j.1471-0528.2004.00067.x; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Wall LL, 1999, J WOMENS HEALTH, V8, P149, DOI 10.1089/jwh.1999.8.149; Wallace SA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001308.PUB2; Ward K, 2002, BMJ-BRIT MED J, V325, P67, DOI 10.1136/bmj.325.7355.67; Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029; Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x; Wilson PD, 1999, INCONTINENCE, P579	116	297	316	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					57	67		10.1016/S0140-6736(06)67925-7	http://dx.doi.org/10.1016/S0140-6736(06)67925-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399154				2022-12-28	WOS:000234443100031
J	Polu, KR; Wolf, M				Polu, KR; Wolf, M			Needle in a haystack	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATHEROEMBOLIC RENAL-DISEASE; FAILURE; PATIENT		Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Wolf, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, 55 Fruit St,Bartlett 917, Boston, MA 02114 USA.	mswolf@partners.org						Espejo B, 2003, NEFROLOGIA, V23, P125; GOLDMAN M, 1985, BRIT MED J, V290, P205, DOI 10.1136/bmj.290.6463.205; Greenberg A, 1997, AM J KIDNEY DIS, V29, P334, DOI 10.1016/S0272-6386(97)90193-1; Liss KA, 1997, CLIN NEPHROL, V47, P125; Mayo RR, 1996, AM J MED, V100, P524, DOI 10.1016/S0002-9343(95)00059-3; Moll S, 2004, AM J HEMATOL, V77, P194, DOI 10.1002/ajh.20210; Scolari F, 2003, J AM SOC NEPHROL, V14, P1584, DOI 10.1097/01.ASN.0000069220.60954.F1; Scolari F, 2000, AM J KIDNEY DIS, V36, P1089, DOI 10.1053/ajkd.2000.19809; Scolari F, 2003, J NEPHROL, V16, P139; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005; WONG FKM, 1995, AM J KIDNEY DIS, V26, P508	11	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					68	73		10.1056/NEJMcps051939	http://dx.doi.org/10.1056/NEJMcps051939			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394304				2022-12-28	WOS:000234358600011
J	Yoshida, T; Jones, LE; Ellner, SP; Hairston, NG				Yoshida, T; Jones, LE; Ellner, SP; Hairston, NG			Mechanisms for consumer diversity	NATURE			English	Editorial Material							RESOURCE COMPETITION; PREY; DAPHNIA; CYCLES		Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Yoshida, T (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	ty59@cornell.edu	Yoshida, Takehito/ABB-2490-2020; Yoshida, Takehito/O-9983-2014	Yoshida, Takehito/0000-0001-9178-3634; Yoshida, Takehito/0000-0001-9178-3634				Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; Nelson WA, 2005, NATURE, V433, P413, DOI 10.1038/nature03212; ROTHHAUPT KO, 1988, NATURE, V333, P660, DOI 10.1038/333660a0; Tilman D., 1982, Monographs in Population Biology, pi; VOLTERRA V, 1928, J CONS INT EXPLOR ME, V3, P3, DOI DOI 10.1093/ICESJMS/3.1.3; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	10	0	0	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					E1	E2		10.1038/nature04526	http://dx.doi.org/10.1038/nature04526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999HA	16397458				2022-12-28	WOS:000234378700025
J	Petry, S; Brodersen, DE; Murphy, FV; Dunham, CM; Selmer, M; Tarry, MJ; Kelley, AC; Ramakrishnan, V				Petry, S; Brodersen, DE; Murphy, FV; Dunham, CM; Selmer, M; Tarry, MJ; Kelley, AC; Ramakrishnan, V			Crystal structures of the ribosome in complex with release factors RF1 and RF2 bound to a cognate stop codon	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CONSERVED GGQ MOTIF; POLYPEPTIDE RELEASE; TRANSLATION TERMINATION; THERMUS-THERMOPHILUS; GTPASE CENTER; ACTIVE-SITE; FACTOR ERF1; PEPTIDE; RECOGNITION	During protein synthesis, translational release factors catalyze the release of the polypeptide chain when a stop codon on the mRNA reaches the A site of the ribosome. The detailed mechanism of this process is currently unknown. We present here the crystal structures of the ribosome from Thermus thermophilus with RF1 and RF2 bound to their cognate stop codons, at resolutions of 5.9 angstrom and 6.7 angstrom, respectively. The structures reveal details of interactions of the factors with the ribosome and mRNA, including elements previously implicated in decoding and peptide release. They also shed light on conformational changes both in the factors and in the ribosome during termination. Differences seen in the interaction of RF1 and RF2 with the RF1 region of the ribosome allow us to rationalize previous biochemical data. Finally, this work demonstrates the feasibility of crystallizing ribosomes with bound factors at a defined state along the translational pathway.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020	Ramakrishnan, V/0000-0002-4699-2194; Selmer, Maria/0000-0001-9079-2774; Brodersen, Ditlev/0000-0002-5413-4667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067624] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: Medline; NIGMS NIH HHS [GM67624] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Arkov AL, 1998, EMBO J, V17, P1507, DOI 10.1093/emboj/17.5.1507; Arkov AL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; CASKEY CT, 1968, SCIENCE, V162, P135, DOI 10.1126/science.162.3849.135; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Jacobs GH, 2002, NUCLEIC ACIDS RES, V30, P310, DOI 10.1093/nar/30.1.310; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Junemann R, 1996, NUCLEIC ACIDS RES, V24, P907, DOI 10.1093/nar/24.5.907; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; KONECKI DS, 1977, J BIOL CHEM, V252, P4514; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Mottagui-Tabar S, 1998, NUCLEIC ACIDS RES, V26, P2789, DOI 10.1093/nar/26.11.2789; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Ravelli RBG, 1997, J APPL CRYSTALLOGR, V30, P551, DOI 10.1107/S0021889897003543; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TATE WP, 1983, J BIOL CHEM, V258, P2816; THOMPSON J, 1979, EUR J BIOCHEM, V98, P261, DOI 10.1111/j.1432-1033.1979.tb13184.x; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Van Dyke N, 2003, J MOL BIOL, V330, P9, DOI 10.1016/S0022-2836(03)00537-0; Van Dyke N, 2002, J MOL BIOL, V319, P329, DOI 10.1016/S0022-2836(02)00304-2; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xu WB, 2002, J BACTERIOL, V184, P1200, DOI 10.1128/jb.184.4.1200-1203.2002; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	56	196	232	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1255	1266		10.1016/j.cell.2005.09.039	http://dx.doi.org/10.1016/j.cell.2005.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377566	Bronze			2022-12-28	WOS:000234584500014
J	de Jong, MD; Thanh, TT; Khanh, TH; Hien, VM; Smith, GJD; Chau, NV; Cam, BV; Qui, PT; Ha, DQ; Guan, Y; Peiris, JSM; Hien, TT; Farrar, J				de Jong, MD; Thanh, TT; Khanh, TH; Hien, VM; Smith, GJD; Chau, NV; Cam, BV; Qui, PT; Ha, DQ; Guan, Y; Peiris, JSM; Hien, TT; Farrar, J			Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS; VIRULENCE	Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resistance to oseltamivir was isolated from two of eight Vietnamese patients during oseltamivir treatment. Both patients died of influenza A (H5N1) infection, despite early initiation of treatment in one patient. Surviving patients had rapid declines in the viral load to undetectable levels during treatment. observations suggest that resistance can emerge during the currently recommended regimen of oseltamivir therapy and may be associated with clinical deterioration and that the strategy for the treatment of influenza A ( H5N1) virus infection include additional antiviral agents.	Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; Pediat Hosp 1, Ho Chi Minh City, Vietnam; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Oxford; University of Hong Kong	de Jong, MD (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, 190 Ben Ham Tu,Dist 5, Ho Chi Minh City, Vietnam.	mddejong@hcm.vnn.vn	Farrar, Jeremy J./HGA-7610-2022	Smith, Gavin JD/0000-0001-5031-468X; Tran Tan, Thanh/0000-0002-8096-7750; Farrar, Jeremy/0000-0002-2700-623X; Guan, Yi/0000-0001-6057-9243	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boom R, 1999, J CLIN MICROBIOL, V37, P615, DOI 10.1128/JCM.37.3.615-619.1999; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Ward Penelope, 2005, J Antimicrob Chemother, V55 Suppl 1, pi5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P421; WHO, 2002, GLOB SOL UV IND PRAC; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008	17	685	741	0	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2667	2672		10.1056/NEJMoa054512	http://dx.doi.org/10.1056/NEJMoa054512			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371632	Green Published, Bronze			2022-12-28	WOS:000234094400007
J	Pielke, RA				Pielke, RA			Meteorology - Are there trends in hurricane destruction?	NATURE			English	Editorial Material							UNITED-STATES; DAMAGES		Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pielke, RA (corresponding author), Univ Colorado, Ctr Sci & Technol Policy Res, Campus Box 488, Boulder, CO 80309 USA.	pielke@cires.colorado.edu						Downton MW, 2005, NAT HAZARDS, V35, P211, DOI 10.1007/s11069-004-4808-4; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Katz RW, 2002, J APPL METEOROL, V41, P754, DOI 10.1175/1520-0450(2002)041<0754:SMOHD>2.0.CO;2; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; Pielke R., 1999, J INSUR REGUL, V18, P177; Pielke RA, 2005, B AM METEOROL SOC, V86, P1571, DOI 10.1175/BAMS-86-11-1571; Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; Raghavan S, 2003, B AM METEOROL SOC, V84, P635, DOI 10.1175/BAMS-84-5-635	9	62	64	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					E11	E11		10.1038/nature04426	http://dx.doi.org/10.1038/nature04426			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371954	Bronze			2022-12-28	WOS:000234111500036
J	Hao, LY; Armanios, M; Strong, MA; Karim, B; Feldser, DM; Huso, D; Greider, CW				Hao, LY; Armanios, M; Strong, MA; Karim, B; Feldser, DM; Huso, D; Greider, CW			Short telomeres, even in the presence of telomerase, limit tissue renewal capacity	CELL			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; APLASTIC-ANEMIA; REVERSE-TRANSCRIPTASE; MAMMALIAN TELOMERES; MOUSE CELLS; T-CELLS; RNA; MUTATIONS	Autosomal-dominant dyskeratosis congenita is associated with heterozygous mutations in telomerase. To examine the dosage effect of telomerase, we generated a line of mTR(-/-) mice on the CAST/EiJ background, which has short telomeres. Interbreeding of heterozygotes resulted in progressive telomere shortening, indicating that limiting telomerase compromises telomere maintenance. In later-generation heterozygotes, we observed a decrease in tissue renewal capacity in the bone marrow, intestines, and testes that resembled defects seen in dyskeratosis congenita patients. The progressive worsening of disease with decreasing telomere length suggests that short telomeres, not telomerase level, cause stem cell failure. Further, wild-type mice derived from the late-generation heterozygous parents, termed wt*, also had short telomeres and displayed a germ cell defect, indicating that telomere length determines these phenotypes. We propose that short telomeres in mice that have normal telomerase levels can cause an occult form of genetic disease.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Grad Program Human Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hao, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Greider, Carol/0000-0002-5494-8126; Strong, Margaret/0000-0002-0055-6573	NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA16519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cerone MA, 2005, CELL CYCLE, V4, P585; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; SANDERSON JH, 1981, ATLAS LAB ANIMAL HAE; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wynn RF, 1998, LANCET, V351, P178, DOI 10.1016/S0140-6736(97)08256-1; Yabe M, 1997, BONE MARROW TRANSPL, V19, P389, DOI 10.1038/sj.bmt.1700674; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	49	230	246	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1121	1131		10.1016/j.cell.2005.11.020	http://dx.doi.org/10.1016/j.cell.2005.11.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360040	Bronze			2022-12-28	WOS:000234177200019
J	Janssens, S; Tinel, A; Lippens, S; Tschopp, J				Janssens, S; Tinel, A; Lippens, S; Tschopp, J			PIDD mediates NF-kappa B activation in response to DNA damage	CELL			English	Article							DOMAIN-CONTAINING PROTEIN; NECROSIS-FACTOR-ALPHA; TOPOISOMERASE-II; SUMO-1 MODIFICATION; GENOTOXIC STRESS; NEMO/IKK-GAMMA; KINASE RIP; NUCLEAR; COMPLEX; SIGNAL	Activation of NF-kappa B following genotoxic stress allows time for DNA-damage repair and ensures cell survival accounting for acquired chemoresistance, an impediment to effective cancer therapy. Despite this clinical relevance, little is known about pathways that enable genotoxic-stress-induced NF-kappa B induction. Previously, we reported a role for the p53-inducible death-domain-containing protein, PIDD, in caspase-2 activation and apoptosis in response to DNA damage. We now demonstrate that PIDD plays a critical role in DNA-damage-induced NF-kappa B activation. Upon genotoxic stress, a complex between PIDD, the kinase RIP1, and a component of the NF-kappa B-activating kinase complex, NEMO, is formed. PIDD expression enhances genotoxic-stress-induced NF-kappa B activation through augmented sumoylation and ubiquitination of NEMO. Depletion of PIDD and RIP1, but not caspase-2, abrogates DNA-damage-induced NEMO modification and NF-kappa B activation. We propose that PIDD acts as a molecular switch, controlling the balance between life and death upon DNA damage.	Univ Lausanne, BIL Biomed Res Ctr, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Janssens, S (corresponding author), Univ Lausanne, BIL Biomed Res Ctr, Dept Biochem, Chemin Boveressess 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Janssens, Sophie/HHN-1756-2022; Lippens, Saskia/C-1343-2009; 高, 雨莉/HGU-8187-2022	Lippens, Saskia/0000-0002-8261-3462				AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Boland MP, 2000, J BIOL CHEM, V275, P25231, DOI 10.1074/jbc.275.33.25231; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jung M, 1997, CANCER RES, V57, P24; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Rangasamy D, 2000, J BIOL CHEM, V275, P37999, DOI 10.1074/jbc.M007777200; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	45	266	276	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1079	1092		10.1016/j.cell.2005.09.036	http://dx.doi.org/10.1016/j.cell.2005.09.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360037	Bronze			2022-12-28	WOS:000234177200016
J	Reversade, B; De Robertis, EM				Reversade, B; De Robertis, EM			Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field	CELL			English	Article							NEGATIVE FEEDBACK REGULATOR; NEURAL INDUCTION; TWISTED GASTRULATION; ORGANIZER; XENOPUS; CHORDIN; CLEAVAGE; RECEPTOR; PROTEIN; METALLOPROTEASE	Embryos have the ability to self-regulate and regenerate normal structures after being sectioned in half. How is such a morphogenetic field established? We discovered that quadruple knockdown of ADMP and BMP2/4/7 in Xenopus embryos eliminates self-regulation, causing ubiquitous neural induction throughout the ectoderm. ADMP transcription in the Spemann organizer is activated at low BMP levels. When ventral BMP2/4/7 signals are depleted, Admp expression increases, allowing for self-regulation. ADMP has BMP-like activity and signals via the ALK-2 receptor. It is unable to signal dorsally because of inhibition by Chordin. The ventral BMP antagonists Sizzled and Bambi further refine the pattern. By transplanting dorsal or ventral wild-type grafts into ADMP/BMP2/4/7-depleted hosts, we demonstrate that both poles serve as signaling centers that can induce histotypic differentiation over considerable distances. We conclude that dorsal and ventral BMP signals and their extracellular antagonists expressed under opposing transcriptional regulation provide a molecular mechanism for embryonic self-regulation.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Reversade, B (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		REVERSADE, Bruno/0000-0002-4070-7997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD021502-19, R37 HD21502-19, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bertocchini F, 2004, DEVELOPMENT, V131, P3381, DOI 10.1242/dev.01178; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Enders AC, 2002, PLACENTA, V23, P71, DOI 10.1053/plac.2001.0753; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Harrison RG, 1918, J EXP ZOOL, V25, P413, DOI 10.1002/jez.1400250204; Huxley J.S., 1934, ELEMENTS EXPT EMBRYO; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; KLEIN SL, 1987, DEV BIOL, V120, P299, DOI 10.1016/0012-1606(87)90127-8; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MEINHARDT H, 1992, REP PROG PHYS, V55, P797, DOI 10.1088/0034-4885/55/6/003; Moos M, 1995, DEVELOPMENT, V121, P4293; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Sadler T. W, 2018, LANGMANS MED EMBRYOL, V13th; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Spemann H, 1903, ARCH ENTWICKLUNG ORG, V16, P551, DOI 10.1007/BF02301267; Spemann H., 1938, EMBRYONIC DEV INDUCT; SPRATT NT, 1960, J EXP ZOOL, V145, P97, DOI 10.1002/jez.1401450202; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506	39	197	202	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1147	1160		10.1016/j.cell.2005.08.047	http://dx.doi.org/10.1016/j.cell.2005.08.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360041	Bronze, Green Accepted			2022-12-28	WOS:000234177200021
J	Kayser, B; Mauron, A; Miah, A				Kayser, B; Mauron, A; Miah, A			Viewpoint - Legalisation of performance-enhancing drugs	LANCET			English	Editorial Material									Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland; Univ Paisley, Paisley PA1 2BE, Renfrew, Scotland	University of Geneva; University of West Scotland	Kayser, B (corresponding author), Ecole Educ Phys & Sport, Inst Sci Mouvement & Med Sport, Campus Battelle, CH-1227 Carouge, Switzerland.	bengt.kayser@medecine.unige.ch	Kayser, Bengt/M-8643-2013; Miah, Andy/C-1467-2015	Kayser, Bengt/0000-0002-9776-7501; Miah, Andy/0000-0003-0137-674X					0	25	25	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S21	S21		10.1016/S0140-6736(05)67831-2	http://dx.doi.org/10.1016/S0140-6736(05)67831-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999FO	16360735				2022-12-28	WOS:000234374400014
J	Kostelny, K; Wessells, M				Kostelny, K; Wessells, M			Psychosocial aid to children after the Dec 26 tsunami	LANCET			English	Editorial Material									Erickson Inst Early Childhood Dev, Chicago, IL 60611 USA; Christian Childrens Fund, Richmond, VA USA		Kostelny, K (corresponding author), Erickson Inst Early Childhood Dev, Chicago, IL 60611 USA.	KKostelny@Erikson.edu						AGGER I, 2001, PEACE CONFLICT VIOLE, P240; HUBBARD J, 2004, CLIN COMMUNITY ECOLO, P95; NICOLAI S, 2005, ROLE ED PROTECTING C; WESSELLS M, 2003, CHILD PROTECTION WEL; WHO, MENT HLTH ASS POP AF	5	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2066	2067		10.1016/S0140-6736(05)67866-X	http://dx.doi.org/10.1016/S0140-6736(05)67866-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996AE	16360772				2022-12-28	WOS:000234146000005
J	Mummery, K				Mummery, K			Essay - Depression in sport	LANCET			English	Article									Univ Cent Queensland, Sch Hlth & Human Performance, Rockhampton, Qld 4702, Australia	Central Queensland University	Mummery, K (corresponding author), Univ Cent Queensland, Sch Hlth & Human Performance, Rockhampton, Qld 4702, Australia.	k.mummery@cqu.edu.au							0	20	21	2	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S36	S37		10.1016/S0140-6736(05)67840-3	http://dx.doi.org/10.1016/S0140-6736(05)67840-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360745				2022-12-28	WOS:000234374400023
J	Watts, J				Watts, J			Feature - Olympian pins and needles	LANCET			English	Article											Watts, J (corresponding author), 81 Fangyuan,Quan Fa,2 Xiangjiang Beilu, Beijing, Peoples R China.	jon@wattshome.com							0	3	3	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S62	S63		10.1016/S0140-6736(05)67857-9	http://dx.doi.org/10.1016/S0140-6736(05)67857-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360761				2022-12-28	WOS:000234374400037
J	Voss, TS; Healer, J; Marty, AJ; Duffy, MF; Thompson, JK; Beeson, JG; Reeder, JC; Crabb, BS; Cowman, AF				Voss, TS; Healer, J; Marty, AJ; Duffy, MF; Thompson, JK; Beeson, JG; Reeder, JC; Crabb, BS; Cowman, AF			A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria	NATURE			English	Article							ANTIGENIC VARIATION; INFECTED ERYTHROCYTES; EXPRESSION; PROTEINS; DISTINCT; TRANSCRIPTION; CHROMOSOMES; PHENOTYPES; PARASITES; SWITCHES	Mono-allelic expression of gene families is used by many organisms to mediate phenotypic variation of surface proteins. In the apicomplexan parasite Plasmodium falciparum, responsible for the severe form of malaria in humans, this is exemplified by antigenic variation of the highly polymorphic P. falciparum erythrocyte membrane protein 1 ( PfEMP1)(1,2). PfEMP1, encoded by the 60-member var gene family(3-6), represents a major virulence factor due to its central role in immune evasion and intravascular parasite sequestration. Mutually exclusive expression of PfEMP1 is controlled by epigenetic mechanisms involving chromatin modification and perinuclear var locus repositioning(7,8). Here we show that a var promoter mediates the nucleation and spreading of stably inherited silenced chromatin. Transcriptional activation of this promoter occurs at the nuclear periphery in association with chromosome-end clusters. Additionally, the var promoter sequence is sufficient to infiltrate a transgene into the allelic exclusion programme of var gene expression, as transcriptional activation of this transgene results in silencing of endogenous var gene transcription. These results show that a var promoter is sufficient for epigenetic silencing and mono-allelic transcription of this virulence gene family, and are fundamental for our understanding of antigenic variation in P. falciparum. Furthermore, the PfEMP1 knockdown parasites obtained in this study will be important tools to increase our understanding of P. falciparum-mediated virulence and immune evasion.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; Papua New Guinea Inst Med Res, Goroka EHP 441, Papua N Guinea	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Monash University; Royal Melbourne Hospital; University of Melbourne; PNG Institute Of Medical Research	Cowman, AF (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	cowman@wehi.edu.au	Duffy, Michael/A-8618-2012; Cowman, Alan F/C-7642-2013; Jackson, Allison/D-6528-2012; Crabb, Brendan/F-5287-2013	Duffy, Michael/0000-0001-5635-4033; Cowman, Alan F/0000-0001-5145-9004; Jackson, Allison/0000-0002-9614-6471; Reeder, John/0000-0003-1395-1289	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; de Koning-Ward TF, 2001, MOL BIOCHEM PARASIT, V117, P155, DOI 10.1016/S0166-6851(01)00344-9; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gannoun-Zaki L, 2005, EUKARYOT CELL, V4, P490, DOI 10.1128/EC.4.2.490-492.2005; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rubio JP, 1996, EMBO J, V15, P4069, DOI 10.1002/j.1460-2075.1996.tb00780.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6	29	203	208	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					1004	1008		10.1038/nature04407	http://dx.doi.org/10.1038/nature04407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16382237				2022-12-28	WOS:000235486100053
J	Donnelly, CA; Woodroffe, R; Cox, DR; Bourne, FJ; Cheeseman, CL; Clifton-Hadley, RS; Wei, G; Gettinby, G; Gilks, P; Jenkins, H; Johnston, WT; Le Fevre, AM; McInerney, JP; Morrison, WI				Donnelly, CA; Woodroffe, R; Cox, DR; Bourne, FJ; Cheeseman, CL; Clifton-Hadley, RS; Wei, G; Gettinby, G; Gilks, P; Jenkins, H; Johnston, WT; Le Fevre, AM; McInerney, JP; Morrison, WI			Positive and negative effects of widespread badger culling on tuberculosis in cattle	NATURE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; MELES-MELES; IMPACT; REMOVAL; IRELAND; WELFARE	Human and livestock diseases can be difficult to control where infection persists in wildlife populations. For three decades, European badgers (Meles meles) have been culled by the British government in a series of attempts to limit the spread of Mycobacterium bovis, the causative agent of bovine tuberculosis (TB), to cattle(1). Despite these efforts, the incidence of TB in cattle has risen consistently, re-emerging as a primary concern for Britain's cattle industry. Recently, badger culling has attracted controversy because experimental studies have reached contrasting conclusions ( albeit using different protocols), with culled areas showing either markedly reduced(2,3) or increased(4,5) incidence of TB in cattle. This has confused attempts to develop a science-based management policy. Here we use data from a large-scale, randomized field experiment to help resolve these apparent differences. We show that, as carried out in this experiment, culling reduces cattle TB incidence in the areas that are culled, but increases incidence in adjoining areas. These findings are biologically consistent with previous studies(2-5) but will present challenges for policy development.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Dept Environm Food & Rural Affairs, Independent Sci Grp Cattle TB, London SW1P 4PQ, England; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; Univ Oxford Nuffield Coll, Oxford OX1 1NF, England; Cent Sci Lab, York YO41 1LZ, N Yorkshire, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England; Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow G1 1XH, Lanark, Scotland; Univ Exeter, Ctr Rural Res, Exeter EX4 6TL, Devon, England; Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland	Imperial College London; University of California System; University of California Davis; University of Oxford; Food & Environment Research Agency; Veterinary Laboratories Agency; University of Strathclyde; University of Exeter; University of Edinburgh	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	c.donnelly@imperial.ac.uk	Rehman, Andrea M/H-1351-2015; Clifton-Hadley, Richard S/C-2503-2011; Rehman, Andrea/AAP-3172-2020; Gao, Wei/G-8653-2011	Rehman, Andrea M/0000-0001-9967-5822; Rehman, Andrea/0000-0001-9967-5822; Gao, Wei/0000-0001-8298-3415; Donnelly, Christl/0000-0002-0195-2463; Johnston, Tom/0000-0002-5204-0966; Jenkins, Helen/0000-0003-4749-1591				BOURNE J, 1998, 1 MIN AGR FISH FOOD; BOURNE J, 2005, EPIDEMIOLOGICAL INVE; Cheeseman C.L., 1993, P78; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; *CRESSW ASS, 2001, TB CATTL REP IND AUD; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Eves JA, 1999, IRISH VET J, V52, P199; Godfray HCJ, 2004, INDEPENDENT SCI REV; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; KIRKWOOD JK, 2000, HUMANENESS MAFFS BAD; Krebs J., 1997, PB3423 HMSO; LEFEVRE AM, IMPACT LOCALISED REA; LEFEVRE AM, 2003, CHANGES BADGER SETTS; OCorryCrowe G, 1996, BIOL ENVIRON, V96B, P147; ROPER TJ, 1993, Z SAUGETIERKD, V58, P252; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; White PCL, 2000, VET REC, V147, P179, DOI 10.1136/vr.147.7.179; Woodroffe R, 2005, J APPL ECOL, V42, P852, DOI 10.1111/j.1365-2664.2005.01081.x; Woodroffe R, 2005, ANIM WELFARE, V14, P19; Woodroffe R, 2005, ANIM WELFARE, V14, P11; Woodroffe R, 1999, J APPL ECOL, V36, P494, DOI 10.1046/j.1365-2664.1999.00418.x; WOODROFFE R, IN PRESS J APPL ECOL; Woolhouse MEJ, 2005, NATURE, V435, P431, DOI 10.1038/435431a; ZUCKERMAN S, 1980, BADGERS CATTLE TUBER; [No title captured]	25	291	291	8	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2006	439	7078					843	846		10.1038/nature04454	http://dx.doi.org/10.1038/nature04454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16357869				2022-12-28	WOS:000235333600049
J	Choudhry, NK; Anderson, GM; Laupacis, A; Ross-Degnan, D; Normand, SLT; Soumerai, SB				Choudhry, NK; Anderson, GM; Laupacis, A; Ross-Degnan, D; Normand, SLT; Soumerai, SB			Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE PREVENTION; ANTICOAGULATION; PREVALENCE; MANAGEMENT; THERAPY; TRENDS; CARE	Objectives To quantify the influence of physicians' experiences of adverse events in patients with atrial fibrillation who were taking warfarin. Design Population based, matched pair before and after analysis. Setting Database study in Ontario, Canada. Participants The physicians of patients with atrial fibrillation admitted to hospital for adverse events (major haemorrhage while taking warfarin and thromboembolic strokes while not taking warfarin). Pairs of other patients with atrial fibrillation treated by the same physicians. Main outcome measures Odds of receiving warfarin by matched pairs of a given physician's patients (one treated after and one treated before the event) were compared, with adjustment for stroke and bleeding risk factors that might also influence warfarin use. The odds of prescriptions for angiotensin converting enzyme (ACE) inhibitor before and after die event was assessed as a neutral control. Results For the 530 physicians who had a patient with an adverse bleeding event (exposure) and who treated other patients with atrial fibrillation during the 90 days before mid the 90 days after the exposure, the odds of prescribing warfarin was 21% lower for patients after the exposure (adjusted odds ratio 0.79, 95% confidence interval 0.62 to 1.00). Greater reductions in warfarin prescribing were found in analyses with patients for whom more time had elapsed between the physician's exposure and the patient's treatment. There were no significant changes in warfarin prescribing after a physician had a patient who had a stroke while not on warfarin or in the prescribing of ACE inhibitors by physicians who had patients with either bleeding events or strokes. Conclusions A physician's experience with bleeding events associated with warfarin can influence prescribing warfarin. Adverse events that are possibly associated with underuse of warfarin may not affect subsequent prescribing.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02120 USA; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02120 USA.	nchoudhry@partners.org		Normand, Sharon-Lise/0000-0001-7027-4769	NATIONAL INSTITUTE ON AGING [R01AG022362] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG022362-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Beyth RJ, 1996, J GEN INTERN MED, V11, P721, DOI 10.1007/BF02598985; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Cohen N, 2000, STROKE, V31, P1217, DOI 10.1161/01.STR.31.6.1217; Damoiseaux RAMJ, 1999, FAM PRACT, V16, P50, DOI 10.1093/fampra/16.1.50; Fang MC, 2004, ARCH INTERN MED, V164, P55, DOI 10.1001/archinte.164.1.55; FEINSTEIN AR, 1985, ARCH INTERN MED, V145, P1257, DOI 10.1001/archinte.145.7.1257; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gross CP, 2003, CLIN THER, V25, P1750, DOI 10.1016/S0149-2918(03)80167-4; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kellen JC, 1998, CAN J CARDIOL, V14, P365; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; Raiford DS, 1996, EPIDEMIOLOGY, V7, P101, DOI 10.1097/00001648-199601000-00018; SALEMSCHATZ SR, 1990, JAMA-J AM MED ASSOC, V264, P476, DOI 10.1001/jama.264.4.476; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	24	128	131	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					141	143		10.1136/bmj.38698.709572.55	http://dx.doi.org/10.1136/bmj.38698.709572.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16403771	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000234905800014
J	Steinbrook, R				Steinbrook, R			Research in the hot zone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*CDCP NIH, 1999, BIOS MICR BIOM LAB B; *COMM RES STAND PR, BIOT RES AG TERR; Hirschberg R, 2004, NEW ENGL J MED, V350, P2119, DOI 10.1056/NEJMp048123; Richardson L, 2004, NEW ENGL J MED, V350, P2121, DOI 10.1056/NEJMp048053	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					109	112		10.1056/NEJMp058245	http://dx.doi.org/10.1056/NEJMp058245			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407504				2022-12-28	WOS:000234528600001
J	Rainville, S; Thompson, JK; Myers, EG; Brown, JM; Dewey, MS; Kessler, EG; Deslattes, RD; Borner, HG; Jentschel, M; Mutti, P; Pritchard, DE				Rainville, S; Thompson, JK; Myers, EG; Brown, JM; Dewey, MS; Kessler, EG; Deslattes, RD; Borner, HG; Jentschel, M; Mutti, P; Pritchard, DE			World year of physics - A direct test of E = mc(2)	NATURE			English	Editorial Material							MASS		MIT, Dept Phys, Cambridge, MA 02139 USA; MIT Harvard Ctr Ultracold Atoms, Elect Res Lab, Cambridge, MA 02139 USA; Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); State University System of Florida; Florida State University; University of Oxford; National Institute of Standards & Technology (NIST) - USA; Institut Laue-Langevin (ILL)	Rainville, S (corresponding author), Univ Laval, Dept Phys, Quebec City, PQ G1K 7P4, Canada.	rainville@alum.mit.edu		Thompson, James/0000-0003-1160-5112; Jentschel, Michael/0000-0001-8932-4682; Rainville, Simon/0000-0001-7087-5943				[Anonymous], 1998, J PHYS CHEM REF DATA, V9, P1951; Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; DEWEY MS, 2005, NUCLEX050701; GREENE GL, 1991, PHYS REV D, V44, pR2216, DOI 10.1103/PhysRevD.44.R2216; Kessler EG, 2001, NUCL INSTRUM METH A, V457, P187, DOI 10.1016/S0168-9002(00)00753-1; Kessler EG, 1999, PHYS LETT A, V255, P221, DOI 10.1016/S0375-9601(99)00078-X; Mohr PJ, 2005, REV MOD PHYS, V77, P1, DOI 10.1103/RevModPhys.77.1; *NIST, 2003, 69 NIST; Rainville S, 2004, SCIENCE, V303, P334, DOI 10.1126/science.1092320; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682	10	109	109	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1096	1097		10.1038/4381096a	http://dx.doi.org/10.1038/4381096a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371997				2022-12-28	WOS:000234111500034
J	Scheffler, M; Dressel, M; Jourdan, M; Adrian, H				Scheffler, M; Dressel, M; Jourdan, M; Adrian, H			Extremely slow Drude relaxation of correlated electrons	NATURE			English	Article							ELECTRODYNAMIC RESPONSE; HEAVY; UPD2AL3; SUPERCONDUCTIVITY; CEPD3	The electrical conduction of metals is governed by how freely mobile electrons can move throughout the material. This movement is hampered by scattering with other electrons, as well as with impurities or thermal excitations (phonons). Experimentally, the scattering processes of single electrons are not observed, but rather the overall response of all mobile charge carriers within a sample. The ensemble dynamics can be described by the relaxation rates, which express how fast the system approaches equilibrium after an external perturbation(1-3). Here we measure the frequency-dependent microwave conductivity of the heavy-fermion metal UPd2Al3 ( ref. 4), finding that it is accurately described by the prediction for a single relaxation rate ( the so-called Drude response(5)). This is notable, as UPd2Al3 has strong interactions among the electrons(4) that might be expected to lead to more complex behaviour. Furthermore, the relaxation rate of just a few gigahertz is extremely low - this is several orders of magnitude below those of conventional metals ( which are typically around 10 THz), and at least one order of magnitude lower than previous estimates for comparable metals. These observations are directly related to the high effective mass of the charge carriers in this material and reveal the dynamics of interacting electrons.	Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany	Johannes Gutenberg University of Mainz; University of Stuttgart	Scheffler, M (corresponding author), Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany.	scheffl@pi1.physik.uni-stuttgart.de	Jourdan, Martin/D-8506-2016; Scheffler, Matthias/O-4649-2016; Dressel, Martin/D-3244-2012	Jourdan, Martin/0000-0001-6785-0518; Scheffler, Matthias/0000-0002-1280-9873; Dressel, Martin/0000-0003-1907-052X				ASHCORFT NW, 1976, SOLID STATE PHYS; AWASTHI AM, 1993, PHYS REV B, V48, P10692, DOI 10.1103/PhysRevB.48.10692; BEYERMANN WP, 1988, PHYS REV LETT, V60, P216, DOI 10.1103/PhysRevLett.60.216; BONN DA, 1988, PHYS REV LETT, V61, P1305, DOI 10.1103/PhysRevLett.61.1305; Burke PJ, 2000, APPL PHYS LETT, V76, P745, DOI 10.1063/1.125881; Degiorgi L, 1999, REV MOD PHYS, V71, P687, DOI 10.1103/RevModPhys.71.687; Degiorgi L, 1997, Z PHYS B CON MAT, V102, P367, DOI 10.1007/s002570050300; Donovan S, 1997, PHYS REV LETT, V79, P1401, DOI 10.1103/PhysRevLett.79.1401; Dordevic SV, 2001, PHYS REV LETT, V86, P684, DOI 10.1103/PhysRevLett.86.684; Dressel M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186404; Dressel M, 2002, ELECTRODYNAMICS SOLI, DOI 10.1017/CBO9780511606168; Drude P, 1900, PHYS Z, V1, P161; GEIBEL C, 1991, Z PHYS B CON MAT, V84, P1, DOI 10.1007/BF01453750; Grewe N., 1991, HDB PHYS CHEM RARE E, V14, P343; Holden AAB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.136401; HUTH M, 1993, SOLID STATE COMMUN, V87, P1133, DOI 10.1016/0038-1098(93)90816-6; Jourdan M, 1999, NATURE, V398, P47, DOI 10.1038/17977; MILLIS AJ, 1987, PHYS REV B, V35, P3394, DOI 10.1103/PhysRevB.35.3394; Pines D, 1966, THEORY QUANTUM LIQUI, V1; Scheffler M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1947881; Singley EJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161101; Tran P, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205102; VARMA CM, 1985, PHYS REV LETT, V55, P2723, DOI 10.1103/PhysRevLett.55.2723; WEBB BC, 1986, PHYS REV LETT, V57, P1951, DOI 10.1103/PhysRevLett.57.1951; Ziman J. M., 1972, PRINCIPLES THEORY SO	25	84	84	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1135	1137		10.1038/nature04232	http://dx.doi.org/10.1038/nature04232			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372004				2022-12-28	WOS:000234111500045
J	Lehrke, M; Lazar, MA				Lehrke, M; Lazar, MA			The many faces of PPAR gamma	CELL			English	Review							ACTIVATED-RECEPTOR-GAMMA; MACROPHAGE FOAM-CELL; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ANTIDIABETIC THIAZOLIDINEDIONE; NUCLEAR RECEPTORS; GENE-EXPRESSION; ACID; PPAR-GAMMA-2; LIGAND	In an era marked by the increasing prevalence of obesity, diabetes, and cardiovascular disease, the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) has emerged as a transcriptional regulator of metabolism whose activity can be modulated by direct binding of small molecules. As the master regulator of fat-cell formation, PPAR gamma is required for the accumulation of adipose tissue and hence contributes to obesity. Yet PPAR gamma ligands are clinically effective antidiabetic drugs, although side effects limit their utility. Can PPAR gamma be targeted with greater benefit and with less risk to patients? The answer depends upon the basic biology of PPAR gamma, and the possibility of selectively modulating the activity of this nuclear receptor in a tissue- and target-gene-specific manner.	Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lehrke, M (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019; Lehrke, Michael/AAY-7558-2021					Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1818, DOI 10.1210/jc.83.5.1818; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	76	1113	1186	2	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					993	999		10.1016/j.cell.2005.11.026	http://dx.doi.org/10.1016/j.cell.2005.11.026			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360030	Bronze			2022-12-28	WOS:000234177200009
J	Baroch, T				Baroch, T			Profile - Alex Galvez - Transitions of fortune	LANCET			English	Biographical-Item									Transit Fdn Guatemala, Miami Springs, FL 33266 USA		Baroch, T (corresponding author), Transit Fdn Guatemala, POB 669004,A1-46, Miami Springs, FL 33266 USA.	transitionsdevelop@conexion.com.gt						GALVEZ A, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S7	S7		10.1016/S0140-6736(05)67822-1	http://dx.doi.org/10.1016/S0140-6736(05)67822-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360764	Bronze			2022-12-28	WOS:000234374400005
J	Frith, D; Yeung, K; Thrush, S; Hunt, BJ; Hubbard, JGH				Frith, D; Yeung, K; Thrush, S; Hunt, BJ; Hubbard, JGH			Lead poisoning - a different diagnosis for abdominal pain	LANCET			English	Editorial Material									St Thomas Hosp, Dept Surg, London SE1 7EH, England; St Thomas Hosp, Dept Haematol, London SE1 7EH, England; Royal Free Hosp, Emergency Dept, London NW3 2QG, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Frith, D (corresponding author), St Thomas Hosp, Dept Surg, London SE1 7EH, England.	danielfrith@hotmail.com						Anderson NR, 2001, ANN CLIN BIOCHEM, V38, P408, DOI 10.1258/0004563011900759; Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1016/S0965-2299(00)90833-1; KEW J, 1993, BRIT MED J, V306, P506, DOI 10.1136/bmj.306.6876.506; Saper RB, 2004, JAMA-J AM MED ASSOC, V292, P2868, DOI 10.1001/jama.292.23.2868; Sood Ajit, 2002, Indian J Gastroenterol, V21, P225	5	20	22	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2146	2146		10.1016/S0140-6736(05)67893-2	http://dx.doi.org/10.1016/S0140-6736(05)67893-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360796				2022-12-28	WOS:000234146000034
J	Endres, NF; Yoshioka, C; Milligan, RA; Vale, RD				Endres, NF; Yoshioka, C; Milligan, RA; Vale, RD			A lever-arm rotation drives motility of the minus-end-directed kinesin Ncd	NATURE			English	Article							HAND-OVER-HAND; MOTOR PROTEIN; MICROTUBULE MOTOR; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; DROSOPHILA; MECHANISM; DOMAINS; DIRECTIONALITY; MOVEMENT	Kinesins are microtubule-based motor proteins that power intracellular transport(1,2). Most kinesin motors, exemplified by Kinesin-1, move towards the microtubule plus end, and the structural changes that govern this directional preference have been described(3-5). By contrast, the nature and timing of the structural changes underlying the minus-end-directed motility of Kinesin-14 motors (such as Drosophila Ncd(6,7)) are less well understood. Using cryo-electron microscopy, here we demonstrate that a coiled-coil mechanical element of microtubule-bound Ncd rotates similar to 70 degrees towards the minus end upon ATP binding. Extending or shortening this coiled coil increases or decreases velocity, respectively, without affecting ATPase activity. An unusual Ncd mutant that lacks directional preference(8) shows unstable nucleotide-dependent conformations of its coiled coil, underscoring the role of this mechanical element in motility. These results show that the force-producing conformational change in Ncd occurs on ATP binding, as in other kinesins, but involves the swing of a lever-arm mechanical element similar to that described for myosins.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Scripps Res Inst, Dept Cell Biol, Ctr Integrat Mol Biosci, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94107 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [P01 AR042895-130005, P01 AR042895] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arnal I, 1996, CURR BIOL, V6, P1265, DOI 10.1016/S0960-9822(02)70712-4; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	30	82	84	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					875	878		10.1038/nature04320	http://dx.doi.org/10.1038/nature04320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16382238	Green Accepted			2022-12-28	WOS:000235333600056
J	Volfson, D; Marciniak, J; Blake, WJ; Ostroff, N; Tsimring, LS; Hasty, J				Volfson, D; Marciniak, J; Blake, WJ; Ostroff, N; Tsimring, LS; Hasty, J			Origins of extrinsic variability in eukaryotic gene expression	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NOISE; STOCHASTICITY; NETWORKS	Variable gene expression within a clonal population of cells has been implicated in a number of important processes including mutation and evolution(1,2), determination of cell fates(3,4) and the development of genetic disease(5,6). Recent studies have demonstrated that a significant component of expression variability arises from extrinsic factors thought to influence multiple genes simultaneously(7-10), yet the biological origins of this extrinsic variability have received little attention. Here we combine computational modelling(11-18) with fluorescence data generated from multiple promoter - gene inserts in Saccharomyces cerevisiae to identify two major sources of extrinsic variability. One unavoidable source arising from the coupling of gene expression with population dynamics leads to a ubiquitous lower limit for expression variability. A second source, which is modelled as originating from a common upstream transcription factor, exemplifies how regulatory networks can convert noise in upstream regulator expression into extrinsic noise at the output of a target gene(9). Our results highlight the importance of the interplay of gene regulatory networks with population heterogeneity for understanding the origins of cellular diversity.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu		Volfson, Dmitri/0000-0002-5167-7834; Tsimring, Lev/0000-0003-0709-3548				Adalsteinsson D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-24; Arkin A, 1998, GENETICS, V149, P1633; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; REANNEY D, 1984, NATURE, V307, P318, DOI 10.1038/307318a0; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Sternberg PW, 1997, CURR OPIN GENET DEV, V7, P543, DOI 10.1016/S0959-437X(97)80084-6; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	24	212	215	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					861	864		10.1038/nature04281	http://dx.doi.org/10.1038/nature04281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16372021				2022-12-28	WOS:000235333600053
J	Sawamoto, K; Wichterle, H; Gonzalez-Perez, O; Cholfin, JA; Yamada, M; Spassky, N; Murcia, NS; Garcia-Verdugo, JM; Marin, O; Rubenstein, JLR; Tessier-Lavigne, M; Okano, H; Alvarez-Buylla, A				Sawamoto, K; Wichterle, H; Gonzalez-Perez, O; Cholfin, JA; Yamada, M; Spassky, N; Murcia, NS; Garcia-Verdugo, JM; Marin, O; Rubenstein, JLR; Tessier-Lavigne, M; Okano, H; Alvarez-Buylla, A			New neurons follow the flow of cerebrospinal fluid in the adult brain	SCIENCE			English	Article							CELL-MIGRATION; PROLIFERATION; FOREBRAIN; PATHWAYS	In the adult brain, neuroblasts born in the subventricular zone migrate from the watts of the lateral ventricles to the olfactory bulb. How do these cells orient over such a tong distance and through complex territories? Here we show that neuroblast migration parallels cerebrospinal fluid (CSF) flow. Beating of ependymal cilia is required for normal CSF flow, concentration gradient formation of CSF guidance molecules, and directional migration of neuroblasts. Results suggest that polarized epithelial. cells contribute important vectorial information-for guidance of young, migrating neurons.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Keio Univ, Sch Med, Bridgestone Lab Dev & Regenerat Neurobiol, Tokyo 1608582, Japan; Cent Inst Expt Anim, Kanagawa, Japan; Case Western Reserve Univ, Rainbow Ctr Childhood Polycyst Kideny Dis, Dept Pediat, Cleveland, OH 44106 USA; Univ Valencia, E-46100 Burjassot, Spain; CSIC, Inst Neurosci Alicante, Alicante 03550, Spain; Univ Miguel Hernandez, Alicante 03550, Spain; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Keio University; Keio University; Case Western Reserve University; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Roche Holding; Genentech	Sawamoto, K (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	sawamoto@sc.itc.keio.ac.jp; abuylla@stemcell.ucsf.edu	Cholfin, Jeremy/AAF-7611-2021; Gonzalez-Perez, Oscar/B-3680-2008; Spassky, Nathalie/E-3932-2016; García-Verdugo, José Manuel/L-8421-2017; Marin, Oscar/F-3856-2012; Okano, Hideyuki/I-7584-2019	Gonzalez-Perez, Oscar/0000-0002-6527-485X; García-Verdugo, José Manuel/0000-0001-9872-6499; Marin, Oscar/0000-0001-6264-7027; spassky, nathalie/0000-0003-4722-6464; Sawamoto, Kazunobu/0000-0003-1984-5129; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Wichterle, Hynek/0000-0002-7817-0080	NICHD NIH HHS [HD 32116] Funding Source: Medline; NINDS NIH HHS [NS 28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS028478, R37NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIRD RB, 1984, EXP NEUROL, V86, P342, DOI 10.1016/0014-4886(84)90192-4; Alberts B., 1994, MOL BIOL CELL; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BRIGHTMA.MW, 1965, J CELL BIOL, V26, P99, DOI 10.1083/jcb.26.1.99; DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; GONZALEZPEREZ O, UNPUB; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; YAMADORI T, 1979, Scanning Electron Microscopy, P335; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	22	562	583	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					629	632		10.1126/science.1119133	http://dx.doi.org/10.1126/science.1119133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16410488				2022-12-28	WOS:000235257400038
J	Kappler, M; Krauss-Etschmann, S; Diehl, V; Zeilhofer, H; Koletzko, S				Kappler, M; Krauss-Etschmann, S; Diehl, V; Zeilhofer, H; Koletzko, S			Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate two commercial stool tests for detection of secretory IgA antibodies against gliadin mid human tissue transglutaminase for diagnosis of coeliac disease in children with symptoms. Setting Tertiary care children's hospital. Participants Coded stool samples from 20 children with newly diagnosed coeliac disease and 64 controls. Six children with coeliac disease had stool tests every two weeks for three months after starting a gluten-free diet. Main outcome measures Secretory IgA antibodies against gliadin and human tissue transglutaminase in stool samples, determined in duplicate by using recommended cut-off limits. Results Sensitivity of faecal antibodies against human tissue transglutaminase was 10% (95% confidence interval 1% to 32%), and specificity was 98% (91% to 100%). For antibodies against gliadin, sensitivity was 6% (0% to 29%) and specificity was 97% (89% to 100%). Optimisation of cut-off limits by receiver operating characteristic analysis and use of results of both tests increased sensitivity to 82%, but specificity decreased to 58%. All follow-up stool tests remained negative, except for two positive anti-gliadin results ill one patient, six and 10 weeks after the gluten-free diet was started. Conclusions Neither stool test was suitable for screening for coeliac disease in children with symptoms.	Univ Munich, Dr von Haunersches Kinderspital, Div Gastroenterol, D-80337 Munich, Germany; GSF Natl Ctr Environm & Hlth, Clin Cooperat Grp Pediat Immune Regulat, Munich, Germany	University of Munich	Koletzko, S (corresponding author), Univ Munich, Dr von Haunersches Kinderspital, Div Gastroenterol, Lindwurmstr 4, D-80337 Munich, Germany.	Sibylle.Koletzko@med.uni-muenchen.de	Krauss-Etschmann, Susanne/H-5198-2018	Krauss-Etschmann, Susanne/0000-0001-5945-5702				Marschang P, 2000, CIRCULATION, V102, P330; PATINEN P, 1995, EUR J ORAL SCI, V103, P280, DOI 10.1111/j.1600-0722.1995.tb00027.x; Picarelli A, 2002, AM J GASTROENTEROL, V97, P95, DOI 10.1016/S0002-9270(01)03988-0	3	25	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2006	332	7535					213	214		10.1136/bmj.38688.654028.AE	http://dx.doi.org/10.1136/bmj.38688.654028.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009BU	16377644	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000235086900019
J	Poinar, HN; Schwarz, C; Qi, J; Shapiro, B; MacPhee, RDE; Buigues, B; Tikhonov, A; Huson, DH; Tomsho, LP; Auch, A; Rampp, M; Miller, W; Schuster, SC				Poinar, HN; Schwarz, C; Qi, J; Shapiro, B; MacPhee, RDE; Buigues, B; Tikhonov, A; Huson, DH; Tomsho, LP; Auch, A; Rampp, M; Miller, W; Schuster, SC			Metagenomics to paleogenomics: Large-scale sequencing of mammoth DNA	SCIENCE			English	Article							MOUSE; RETRIEVAL; DIVERSITY	We sequenced 28 million base pairs of DNA in a metagenomics approach, using a woolly mammoth (Mammuthus primigenius) sample from Siberia. As a result of exceptional sample preservation and the use of a recently developed emulsion polymerase chain reaction and pyrosequencing technique, 13 million base pairs (45.4%) of the sequencing reads were identified as mammoth DNA. Sequence identity between our data and African elephant (Loxodonta africana) was 98.55%, consistent with a paleontologically based divergence date of 5 to 6 million years. The sample includes a surprisingly small diversity of environmental DNAs. The high percentage of endogenous DNA recoverable from this single mammoth would allow for completion of its genome, unleashing the field of paleogenomics.	McMaster Univ, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L9, Canada; McMaster Univ, Dept Anthropol, Hamilton, ON L8S 4L9, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L9, Canada; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Amer Museum Nat Hist, Div Vertebrate Zool Mammal, New York, NY 10024 USA; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; Univ Tubingen, Inst Comp Sci, Ctr Bioinformat, D-72076 Tubingen, Germany; Garching Comp Ctr, D-85748 Garching, Germany	McMaster University; McMaster University; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Oxford; American Museum of Natural History (AMNH); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Eberhard Karls University of Tubingen	Poinar, HN (corresponding author), McMaster Univ, McMaster Ancient DNA Ctr, 1280 Main St W, Hamilton, ON L8S 4L9, Canada.	poinarh@mcmaster.ca; scs@bx.psu.edu	QI, JI/E-2797-2016; Tikhonov, Alexei/G-7478-2016; Huson, Daniel H./AAC-5494-2019	Tikhonov, Alexei/0000-0002-7227-5797	NHGRI NIH HHS [HG02238] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; Debruyne R, 2003, MOL PHYLOGENET EVOL, V26, P421, DOI 10.1016/S1055-7903(02)00292-0; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Handt O, 1996, AM J HUM GENET, V59, P368; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; HUSON DH, UNPUB; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacPhee RDE, 2002, J ARCHAEOL SCI, V29, P1017, DOI 10.1006/jasc.2001.0802; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	26	388	424	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					392	394		10.1126/science.1123360	http://dx.doi.org/10.1126/science.1123360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AE	16368896				2022-12-28	WOS:000234938500048
J	Moss, S; Gray, A; Legood, R; Vessey, M; Patnick, J; Kitchener, H				Moss, S; Gray, A; Legood, R; Vessey, M; Patnick, J; Kitchener, H		Liquid Based Cytol Human Papilloma	Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study	BRITISH MEDICAL JOURNAL			English	Article							WOMEN	Objective To assess the effect of introducing testing for human papillomavirus combined with liquid based cytology in women with low grade cytological abnormalities. Design Observational before and after study. Setting Three cervical screening laboratories, England. Participants 5654 women aged 20-64 with low grade cytological abnormalities found at routine cervical screening in a pilot; 5254 similar women in the period before the pilot. Interventions Human papillomavirus testing combined with liquid based cytology in the management of women with borderline or mildly dyskaryotic cervical smear results compared with conventional smear tests, with immediate referral colposcopy of Women positive for human papillomavirus. Results 57.9% (3187/5506) of women tested in the pilot were positive for human papillomavirus. The rate of repeat smears fell by 74%, but the rate of referral to colposcopy for low grade cytological abnormalities more than doubled. The estimated negative predictive value of human papillomavirus testing varied between 93.8% and 99.7%. Conclusion The addition of testing for human papillomavirus in women with low grade cytological abnormalities resulted in a reduction in the rate of repeat smears, but an increase in rates of referral to colposcopy.	Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England; Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England; NHS Canc Screening Programmes, Sheffield S10 3TH, S Yorkshire, England; Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England	University of London; Institute of Cancer Research - UK; University of Oxford; University of Oxford; University of Manchester	Moss, S (corresponding author), Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England.	sue.moss@icr.ac.uk	Legood, Rosa/GQZ-9121-2022	Legood, Rosa/0000-0003-2761-5227				Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; CUZICK J, 1999, HEALTH TECHNOL ASSES, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1995, IARC MON EV CARC RIS; Rana DN, 2004, CYTOPATHOLOGY, V15, P263, DOI 10.1111/j.1365-2303.2004.00194.x; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946	5	51	52	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					83	85		10.1136/bmj.38701.440961.7C	http://dx.doi.org/10.1136/bmj.38701.440961.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16399706	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000234777000018
J	Milanesi, R; Baruscotti, M; Gnecchi-Ruscone, T; DiFrancesco, D				Milanesi, R; Baruscotti, M; Gnecchi-Ruscone, T; DiFrancesco, D			Brief report - Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODULATION; HEART; NODE; VOLTAGE; CAMP; ACETYLCHOLINE; INHIBITION; ACTIVATION; DISEASE	We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel. Pacemaker channels of the sinoatrial node generate spontaneous activity and mediate cyclic AMP (cAMP)-dependent autonomic modulation of the heart rate. The mutation associated with bradycardia is located near the cAMP-binding site; functional analysis found that mutant channels respond normally to cAMP but are activated at more negative voltages than are wild-type channels. These changes, which mimic those of mild vagal stimulation, sow the heart rate by decreasing the inward diastolic current. Thus, diminished function of pacemaker channels is linked to familial bradycardia.	Univ Milan, Dept Biomol Sci & Biotechnol, Lab Mol Physiol & Neurobiol, I-20133 Milan, Italy; Merate Hosp, Dept Cardiol, Merate, Italy	University of Milan	DiFrancesco, D (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Lab Mol Physiol & Neurobiol, Via Celoria 26, I-20133 Milan, Italy.	dario.difrancesco@unimi.it	DiFrancesco, Dario/G-8408-2017; BARUSCOTTI, MIRKO/D-7017-2017	DiFrancesco, Dario/0000-0002-7322-1790; BARUSCOTTI, MIRKO/0000-0002-6155-8388				Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P477, DOI 10.1113/jphysiol.1988.sp017343; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Macfarlane PW, 1989, COMPREHENSIVE ELECTR, P315; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roden DM, 2002, ANNU REV PHYSIOL, V64, P431, DOI 10.1146/annurev.physiol.64.083101.145105; SARACHEK NS, 1972, AM J CARDIOL, V29, P451, DOI 10.1016/0002-9149(72)90432-8; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shi WM, 1999, CIRC RES, V85, pE1; Singh Bramah N., 2001, Journal of Cardiovascular Pharmacology and Therapeutics, V6, P313, DOI 10.1177/107424840100600401; TERWILLINGER JD, 1994, HDB HUMAN GENETICS; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Vaca L, 2000, FEBS LETT, V479, P35, DOI 10.1016/S0014-5793(00)01837-8; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	25	296	317	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					151	157		10.1056/NEJMoa052475	http://dx.doi.org/10.1056/NEJMoa052475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407510				2022-12-28	WOS:000234528600007
J	Stevenson, RM; Young, RJ; Atkinson, P; Cooper, K; Ritchie, DA; Shields, AJ				Stevenson, RM; Young, RJ; Atkinson, P; Cooper, K; Ritchie, DA; Shields, AJ			A semiconductor source of triggered entangled photon pairs	NATURE			English	Article							QUANTUM-DOT; CRYPTOGRAPHY; CONVERSION; VIOLATION	Entangled photon pairs are an important resource in quantum optics(1), and are essential for quantum information(2) applications such as quantum key distribution(3,4) and controlled quantum logic operations(5). The radiative decay of biexcitons - that is, states consisting of two bound electron - hole pairs - in a quantum dot has been proposed as a source of triggered polarization-entangled photon pairs(6). To date, however, experiments have indicated that a splitting of the intermediate exciton energy yields only classically correlated emission(7-9). Here we demonstrate triggered photon pair emission from single quantum dots suggestive of polarization entanglement. We achieve this by tuning the splitting to zero, through either application of an in-plane magnetic field or careful control of growth conditions. Entangled photon pairs generated 'on demand' have significant fundamental advantages over other schemes(10-13), which can suffer from multiple pair emission, or require post-selection techniques or the use of photon-number discriminating detectors. Furthermore, control over the pair generation time is essential for scaling many quantum information schemes beyond a few gates. Our results suggest that a triggered entangled photon pair source could be implemented by a simple semiconductor light-emitting diode(14).	Toshiba Res Europe Ltd, Cambridge CB4 OWE, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Toshiba Corporation; University of Cambridge	Stevenson, RM (corresponding author), Toshiba Res Europe Ltd, 260 Cambridge Sci Pk, Cambridge CB4 OWE, England.	mark.stevenson@crl.toshiba.co.uk	Young, Robert J/D-8454-2011; Ritchie, David/K-2206-2014	Young, Robert J/0000-0002-5719-2205; Ritchie, David/0000-0002-9844-8350	Engineering and Physical Sciences Research Council [GR/S05779/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		[Anonymous], 1999, QUANTUM DOT HETEROST; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.041308; Bennett AJ, 2005, OPT EXPRESS, V13, P50, DOI 10.1364/OPEX.13.000050; Bouwmeester D., 2000, PHYS QUANTUM INFORM; Edamatsu K, 2004, NATURE, V431, P167, DOI 10.1038/nature02838; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fattal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037903; Gammon D, 1996, PHYS REV LETT, V76, P3005, DOI 10.1103/PhysRevLett.76.3005; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; KIESS TE, 1993, PHYS REV LETT, V71, P3893, DOI 10.1103/PhysRevLett.71.3893; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kwiat PG, 2001, NATURE, V409, P1014, DOI 10.1038/35059017; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; Pelton M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.233602; Rodt S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035331; Santori C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045308; Santori C, 2001, PHYS REV LETT, V86, P1502, DOI 10.1103/PhysRevLett.86.1502; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; Stevenson RM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.081302; STEVENSON RM, IN PRESS PHYS REV B; Thompson RM, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.201302; Ulrich SM, 2003, APPL PHYS LETT, V83, P1848, DOI 10.1063/1.1605809; Walls D. F., 1994, QUANTUM OPT; White AG, 1999, PHYS REV LETT, V83, P3103, DOI 10.1103/PhysRevLett.83.3103; Young RJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.113305; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790	30	763	784	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					179	182		10.1038/nature04446	http://dx.doi.org/10.1038/nature04446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407947				2022-12-28	WOS:000234538400034
J	Zeh, JA; Zeh, DW				Zeh, JA; Zeh, DW			Outbred embryos rescue inbred half-siblings in mixed-paternity broods of live-bearing females	NATURE			English	Article							GENETIC BENEFITS; INBREEDING AVOIDANCE; REPRODUCTIVE FAILURE; POLYANDROUS FEMALES; FIELD CRICKET; SELECTION; FITNESS	Females commonly mate with more than one male(1), and polyandry has been shown to increase reproductive success in many species(2-4). Insemination by multiple males shifts the arena for sexual selection from the external environment to the female reproductive tract, where sperm competition or female choice of sperm could bias fertilization against sperm from genetically inferior(5) or genetically incompatible males(6,7). Evidence that polyandry can be a strategy for avoiding incompatibility comes from studies showing that inbreeding cost is reduced in some egg-laying species by postcopulatory mechanisms that favour fertilization by sperm from unrelated males(8-10). In viviparous (live-bearing) species, inbreeding not only reduces offspring genetic quality but might also disrupt feto-maternal interactions that are crucial for normal embryonic development(11-13). Here we show that polyandry in viviparous pseudoscorpions reduces inbreeding cost not through paternity-biasing mechanisms favouring outbred offspring, but rather because outbred embryos exert a rescuing effect on inbred half-siblings in mixed-paternity broods. The benefits of polyandry may thus be more complex for live-bearing females than for females that lay eggs.	Univ Nevada, Dept Biol, Reno, NV 89557 USA; Univ Nevada, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Zeh, JA (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	jaz@unr.edu		Zeh, Jeanne/0000-0003-1012-9978				BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Caucheteux SM, 2003, IMMUNITY, V18, P169, DOI 10.1016/S1074-7613(03)00028-1; Choudhury SR, 2001, HUM REPROD UPDATE, V7, P135, DOI 10.1093/humupd/7.2.135; Davies CJ, 2004, ANIM REPROD SCI, V82-3, P267, DOI 10.1016/j.anireprosci.2004.05.016; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hill JA, 1995, IMMUNOLOGY HUMAN REP, P401; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 2004, EVOLUTION, V58, P2472; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; SAS Institute, 2001, SAS SYST WIND REL 8; SCHLUTER D, 1994, AM NAT, V143, P597, DOI 10.1086/285622; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Stockley P, 2003, P ROY SOC B-BIOL SCI, V270, P271, DOI 10.1098/rspb.2002.2228; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Weygoldt P., 1969, BIOL PSEUDOSCORPIONS; ZEH DW, 1994, MOL ECOL, V3, P517, DOI 10.1111/j.1365-294X.1994.tb00130.x; Zeh DW, 1997, P ROY SOC B-BIOL SCI, V264, P119, DOI 10.1098/rspb.1997.0018; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	27	49	49	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					201	203		10.1038/nature04260	http://dx.doi.org/10.1038/nature04260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407952				2022-12-28	WOS:000234538400039
J	Meldrum, H				Meldrum, H			General practice under pressure	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA, Gen Practitioners Comm, London WC1H 9JP, England		Meldrum, H (corresponding author), BMA, Gen Practitioners Comm, London WC1H 9JP, England.	hmeldrum@bma.org.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					46	47		10.1136/bmj.332.7532.46	http://dx.doi.org/10.1136/bmj.332.7532.46			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399742	Green Published			2022-12-28	WOS:000234684200026
J	August, M; Caruso, PA; Lahey, ET; Faquin, WC; Kaban, LB				August, M; Caruso, PA; Lahey, ET; Faquin, WC; Kaban, LB			Case 40-2005: An 18-year-old man with a one-month history of nontender left mandibular swelling - Odontogenic keratocyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TERM-FOLLOW-UP; NEEDLE-ASPIRATION BIOPSY; EPITHELIAL-CELL MARKERS; BENIGN CYSTIC NEOPLASM; AGGRESSIVE NATURE; DECOMPRESSION; CYTOKERATIN; EXPRESSION		Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Oral & Maxillofacial Surg, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	August, M (corresponding author), Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA.							ANAND VK, 1994, OTOLARYNG HEAD NECK, V111, P124, DOI 10.1177/019459989411100122; August M, 1999, J ORAL MAXIL SURG, V57, P1282, DOI 10.1016/S0278-2391(99)90859-5; August M, 2000, J ORAL MAXIL SURG, V58, P935, DOI 10.1053/joms.2000.8731; August M, 2003, J ORAL MAXIL SURG, V61, P678, DOI 10.1053/joms.2003.50137; Bataineh AB, 1998, ORAL SURG ORAL MED O, V86, P42, DOI 10.1016/S1079-2104(98)90148-2; BRONDUM N, 1991, ORAL SURG ORAL MED O, V72, P265, DOI 10.1016/0030-4220(91)90211-T; Chow HT, 1998, ORAL SURG ORAL MED O, V86, P573; Dammer R, 1997, BRIT J ORAL MAX SURG, V35, P46, DOI 10.1016/S0266-4356(97)90009-7; El-Hajj Fuleihan G, 1996, INT J ORAL MAX SURG, V25, P124, DOI 10.1016/S0901-5027(96)80057-9; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Lench NJ, 1996, ORAL ONCOL, V32B, P202, DOI 10.1016/0964-1955(95)00053-4; MACDONALD AW, 1989, J CLIN PATHOL, V42, P736, DOI 10.1136/jcp.42.7.736; Marker P, 1996, ORAL SURG ORAL MED O, V82, P122, DOI 10.1016/S1079-2104(96)80214-9; MATTHEWS JB, 1988, J PATHOL, V156, P283, DOI 10.1002/path.1711560403; Ohki K, 2004, INT J ORAL MAX SURG, V33, P584, DOI 10.1016/j.ijom.2004.01.013; Philipsen H.P, 1956, TANDLAEGEBLADET, V60, P963; Schmidt B. L., 1999, J ORAL MAXILLOFAC SU, V57, P46; SCIUBBA JJ, 2001, TUMORS CYSTS JAW ATL; Shear M, 2002, ORAL ONCOL, V38, P407, DOI 10.1016/S1368-8375(01)00067-7; Shear M, 2002, ORAL ONCOL, V38, P219, DOI 10.1016/S1368-8375(01)00065-3; SHULER CF, 1987, ORAL SURG ORAL MED O, V64, P439, DOI 10.1016/0030-4220(87)90149-6; Stoelinga PJW, 2001, INT J ORAL MAX SURG, V30, P14, DOI 10.1054/ijom.2000.0027; VOORSMIT RAC, 1984, THESIS U NIJMEGEN NI; ZACHARIADES N, 1985, J ORAL MAXIL SURG, V43, P177, DOI 10.1016/0278-2391(85)90156-9	24	2	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2798	2805		10.1056/NEJMcpc059034	http://dx.doi.org/10.1056/NEJMcpc059034			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382067				2022-12-28	WOS:000234246700013
J	Devireddy, LR; Gazin, C; Zhu, XC; Green, MR				Devireddy, LR; Gazin, C; Zhu, XC; Green, MR			A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC PROGENITORS; DOWN-REGULATION; EXPRESSION; BIM; DEATH; SURVIVAL; ACTIVATION; PROTEIN; FAMILY	The lipocalin mouse 24p3 has been implicated in diverse physiological processes, including apoptosis due to interleukin-3 (IL-3) deprivation and iron transport. Here we report cloning of the 24p3 cell-surface receptor (24p3R). Ectopic 24p3R expression confers on cells the ability to undergo either iron uptake or apoptosis, dependent upon the iron content of the ligand: Iron-loaded 24p3 increases intracellular iron concentration without promoting apoptosis; iron-lacking 24p3 decreases intracellular iron levels, which induces expression of the proapoptotic protein Bim, resulting in apoptosis. Intracellular iron delivery blocks Bim induction and suppresses apoptosis due to 24p3 addition or IL-3 deprivation. We find, unexpectedly, that the BCR-ABL oncoprotein activates expression of 24p3 and represses 24p3R expression, rendering BCR-ABL(+) cells refractory to secreted 24p3. By inhibiting BCR-ABL, imatinib induces 24p3R expression and, consequently, apoptosis. Our results reveal an unanticipated role for intracellular iron regulation in an apoptotic pathway relevant to BCR-ABL-induced myeloproliferative disease and its treatment.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express & Mol Med, Worcester, MA 01605 USA.	michael.green@umassmed.edu						Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; Chong TW, 2002, CANCER RES, V62, P6924; COHEN JJ, 1984, J IMMUNOL, V132, P38; Coumailleau F, 2004, MOL BIOL CELL, V15, P4444, DOI 10.1091/mbc.E04-04-0274; Cross NCP, 2002, LEUKEMIA, V16, P1207, DOI 10.1038/sj.leu.2402556; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Eaves C, 1998, LEUKEMIA RES, V22, P1085, DOI 10.1016/S0145-2126(98)00113-1; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Flower DR, 1996, BIOCHEM J, V318, P1; GALILI U, 1982, CANCER RES, V42, P1433; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kaneta Y, 2003, INT J ONCOL, V23, P681; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leardi A, 1998, BRIT J HAEMATOL, V102, P746, DOI 10.1046/j.1365-2141.1998.00834.x; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin F, 2001, ONCOGENE, V20, P1873, DOI 10.1038/sj.onc.1204409; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Okuda K, 1996, ONCOGENE, V13, P1147; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wojnar P, 2003, J BIOL CHEM, V278, P16209, DOI 10.1074/jbc.M210922200; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	37	472	498	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1293	1305		10.1016/j.cell.2005.10.027	http://dx.doi.org/10.1016/j.cell.2005.10.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377569	Bronze			2022-12-28	WOS:000234584500017
J	Ware, LB; Matthay, MA				Ware, LB; Matthay, MA			Acute pulmonary edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; NATRIURETIC PEPTIDE LEVELS; LEFT-VENTRICULAR FUNCTION; INTENSIVE-CARE-UNIT; HEART-FAILURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ARTERY CATHETERIZATION; RADIOGRAPHIC CRITERIA; MEDICAL PROGRESS	A 62-year-old man presents with a three-day history of progressive dyspnea, nonproductive cough, and low-grade fever. He had been hospitalized two years earlier for congestive heart failure. His blood pressure is 95/55 mm Hg, his heart rate 110 beats per minute, his temperature 37.9 degrees C, and his oxygen saturation while breathing ambient air 86 percent. Chest auscultation reveals rales and rhonchi bilaterally. A chest radiograph shows bilateral pulmonary infiltrates consistent with pulmonary edema and borderline enlargement of the cardiac silhouette. How should this patient be evaluated to establish the cause of the acute pulmonary edema and to determine appropriate therapy?	Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37232 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA	Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ware, LB (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, 1161 21st Ave S,T1218 MCN, Nashville, TN 37232 USA.		Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702	NHLBI NIH HHS [HL51856, HL74005] Funding Source: Medline; PHS HHS [081332, 70521] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, P50HL074005, R01HL051856] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERLE DR, 1988, RADIOLOGY, V168, P73, DOI 10.1148/radiology.168.1.3380985; Ammann P, 2001, INTENS CARE MED, V27, P965, DOI 10.1007/s001340100920; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arlati S, 2000, INTENS CARE MED, V26, P31, DOI 10.1007/s001340050008; Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cheitlin MD, ACC AHA ASE 2003 GUI; Cook CH, 2002, J TRAUMA, V52, P280, DOI 10.1097/00005373-200202000-00013; Duane PG, 2000, CHEST, V118, P1709, DOI 10.1378/chest.118.6.1709; Ely EW, 2002, CHEST, V121, P942, DOI 10.1378/chest.121.3.942; FEIN AM, 1984, AM REV RESPIR DIS, V129, P1006; GRAHAM SP, 1991, AM J CARDIOL, V68, P1614, DOI 10.1016/0002-9149(91)90318-F; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Huttemann E, 2004, ACTA ANAESTH SCAND, V48, P827, DOI 10.1111/j.0001-5172.2004.00423.x; Jefic D, 2005, CHEST, V128, P288, DOI 10.1378/chest.128.1.288; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kaul S, 1994, J Am Soc Echocardiogr, V7, P598; Kazanegra R, 2001, J CARD FAIL, V7, P21, DOI 10.1054/jcaf.2001.23355; Krishnaswamy P, 2001, AM J MED, V111, P274, DOI 10.1016/S0002-9343(01)00841-5; Maeder M, 2003, SWISS MED WKLY, V133, P515; MAEDER M, IN PRESS EUR J HEART; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Marcus GM, 2005, JAMA-J AM MED ASSOC, V293, P2238, DOI 10.1001/jama.293.18.2238; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Meade MO, 2000, AM J RESP CRIT CARE, V161, P85, DOI 10.1164/ajrccm.161.1.9809003; MILNE ENC, 1985, AM J ROENTGENOL, V144, P879, DOI 10.2214/ajr.144.5.879; MINIATI M, 1988, INVEST RADIOL, V23, P433, DOI 10.1097/00004424-198806000-00005; NAGUEH SF, 1995, AM J CARDIOL, V75, P1256, DOI 10.1016/S0002-9149(99)80773-5; Neff MJ, 1999, AM J RESP CRIT CARE, V159, pA716; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; PATEL R, 1993, WESTERN J MED, V158, P606; PISTOLESI M, 1978, RADIOL CLIN N AM, V16, P551; PISTOLESI M, 1985, CLIN CHEST MED, V6, P315; POELAERT JI, 1995, CHEST, V107, P774, DOI 10.1378/chest.107.3.774; RIHAL CS, 1995, AM J CARDIOL, V75, P220, DOI 10.1016/0002-9149(95)80023-L; Rubenfeld GD, 1999, CHEST, V116, P1347, DOI 10.1378/chest.116.5.1347; SHAH PM, 1968, NEW ENGL J MED, V278, P753, DOI 10.1056/NEJM196804042781402; SIBBALD WJ, 1983, CHEST, V84, P452, DOI 10.1378/chest.84.4.452; Silver Marc A, 2004, Congest Heart Fail, V10, P1, DOI 10.1111/j.1527-5299.2004.03271.x; Spies C, 1998, CHEST, V113, P1055, DOI 10.1378/chest.113.4.1055; STAUB NC, 1974, PHYSIOL REV, V54, P678, DOI 10.1152/physrev.1974.54.3.678; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; Tung RH, 2004, CRIT CARE MED, V32, P1643, DOI 10.1097/01.CCM.0000133694.28370.7F; ver Elst KM, 2000, CLIN CHEM, V46, P650; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; ZIMMERMAN GA, 1982, AM J MED, V73, P25, DOI 10.1016/0002-9343(82)90920-2	50	335	366	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2788	2796		10.1056/NEJMcp052699	http://dx.doi.org/10.1056/NEJMcp052699			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382065				2022-12-28	WOS:000234246700010
J	Pornillos, O; Chen, YJ; Chen, AP; Chang, G				Pornillos, O; Chen, YJ; Chen, AP; Chang, G			X-ray structure of the EmrE multidrug transporter in complex with a substratei	SCIENCE			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; BINDING; ANTIPORTER; RESISTANCE; TOPOLOGY; REVEALS; PARADIGM; PROTEINS; OLIGOMER	EmrE is a prototype of the Small Multidrug Resistance family of efflux transporters and actively expels positively charged hydrophobic drugs across the inner membrane of Escherichia coli. Here, we report the x-ray crystal structure, at 3.7 angstrom resolution, of one conformational state of the EmrE transporter in complex with a translocation substrate, tetraphenylphosphonium. Two EmrE polypeptides form a homodimeric transporter that binds substrate at the dimerization interface. The two subunits have opposite orientations in the membrane and adopt slightly different folds, forming an asymmetric antiparallel dimer. This unusual architecture likely confers unidirectionality to transport by creating an asymmetric substrate translocation pathway. On the basis of available structural data, we propose a model for the proton-dependent drug efflux mechanism of EmrE.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB-105, La Jolla, CA 92037 USA.	gchang@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067644, P50GM073197] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67644, GM073197] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; Abramson J, 2004, MOL MEMBR BIOL, V21, P227, DOI 10.1080/09687680410001716862; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Lebendiker M, 1996, J BIOL CHEM, V271, P21193, DOI 10.1074/jbc.271.35.21193; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044	31	69	73	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1950	1953		10.1126/science.1119776	http://dx.doi.org/10.1126/science.1119776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373573				2022-12-28	WOS:000234275400041
J	Featherstone, PJ; George, LD				Featherstone, PJ; George, LD			Gastric dilatation secondary to diabetic autonomic neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Llandough Hosp, Llandough CF64 2XX, Wales		Featherstone, PJ (corresponding author), Llandough Hosp, Llandough CF64 2XX, Wales.			Featherstone, Peter/0000-0002-1760-2361					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2696	2696		10.1056/NEJMicm041173	http://dx.doi.org/10.1056/NEJMicm041173			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371635				2022-12-28	WOS:000234094400010
J	Koss, JO; Alexandrova, A				Koss, JO; Alexandrova, A			Essay - HIV/AIDS prevention and peace through sport	LANCET			English	Article									Right Play, Toronto, ON M5H 2M5, Canada		Koss, JO (corresponding author), Right Play, Toronto, ON M5H 2M5, Canada.	info@righttoplay.com							0	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S3	S4		10.1016/S0140-6736(05)67820-8	http://dx.doi.org/10.1016/S0140-6736(05)67820-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360741	Bronze			2022-12-28	WOS:000234374400003
J	Ljungqvist, A; Genel, M				Ljungqvist, A; Genel, M			Essay - Transsexual athletes - when is competition fair?	LANCET			English	Article									Swedish Sports Confederat, S-11473 Stockholm, Sweden; Yale Univ, Child Hlth Res Ctr, New Haven, CT 06520 USA	Swedish Sports Confederation; Yale University	Ljungqvist, A (corresponding author), Swedish Sports Confederat, Idrottens Hus, S-11473 Stockholm, Sweden.	arne.ljungqvist@rf.se						Gooren LJG, 2004, EUR J ENDOCRINOL, V151, P425, DOI 10.1530/eje.0.1510425; MEYER W, STANDARDS CARE GENDE; Reeser JC, 2005, BRIT J SPORT MED, V39, P695, DOI 10.1136/bjsm.2005.018119; STAEMENT STOCKHOLM C	4	13	13	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S42	S43		10.1016/S0140-6736(05)67844-0	http://dx.doi.org/10.1016/S0140-6736(05)67844-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360749				2022-12-28	WOS:000234374400027
J	Barber, DL; Wherry, EJ; Masopust, D; Zhu, BG; Allison, JP; Sharpe, AH; Freeman, GJ; Ahmed, R				Barber, DL; Wherry, EJ; Masopust, D; Zhu, BG; Allison, JP; Sharpe, AH; Freeman, GJ; Ahmed, R			Restoring function in exhausted CD8 T cells during chronic viral infection	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IN-VIVO; B7 FAMILY; PD-1; PERSISTENCE; TOLERANCE; RESPONSES; MEMORY; MEMBER; IMMUNOTHERAPY	Functional impairment of antigen-specific T cells is a defining characteristic of many chronic infections, but the underlying mechanisms of T-cell dysfunction are not well understood. To address this question, we analysed genes expressed in functionally impaired virus-specific CD8 T cells present in mice chronically infected with lymphocytic choriomeningitis virus ( LCMV), and compared these with the gene profile of functional memory CD8 T cells. Here we report that PD-1 ( programmed death 1; also known as Pdcd1) was selectively upregulated by the exhausted T cells, and that in vivo administration of antibodies that blocked the interaction of this inhibitory receptor with its ligand, PD-L1 ( also known as B7-H1), enhanced T-cell responses. Notably, we found that even in persistently infected mice that were lacking CD4 T-cell help, blockade of the PD-1/PD-L1 inhibitory pathway had a beneficial effect on the 'helpless' CD8 T cells, restoring their ability to undergo proliferation, secrete cytokines, kill infected cells and decrease viral load. Blockade of the CTLA-4 ( cytotoxic T-lymphocyte-associated protein 4) inhibitory pathway had no effect on either T-cell function or viral control. These studies identify a specific mechanism of T-cell exhaustion and define a potentially effective immunological strategy for the treatment of chronic viral infections.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Dept Med, New York, NY 10021 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Emory University; Emory University; The Wistar Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ra@microbio.emory.edu	Yang, Chen/G-1379-2010; Freeman, Gordon/AAC-5380-2019; Wherry, John/ABI-1280-2020; Barber, Daniel L./V-1190-2019; masopust, david/B-5027-2008	Freeman, Gordon/0000-0002-7210-5616; Allison, James/0000-0001-8980-5697				Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Dong HD, 1999, NAT MED, V5, P1365; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	2862	3171	9	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					682	687		10.1038/nature04444	http://dx.doi.org/10.1038/nature04444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16382236				2022-12-28	WOS:000235193100035
J	Adams, GB; Chabner, KT; Alley, IR; Olson, DP; Szczepiorkowski, ZM; Poznansky, MC; Kos, CH; Pollak, MR; Brown, EM; Scadden, DT				Adams, GB; Chabner, KT; Alley, IR; Olson, DP; Szczepiorkowski, ZM; Poznansky, MC; Kos, CH; Pollak, MR; Brown, EM; Scadden, DT			Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor	NATURE			English	Article							BONE-MARROW; IN-VIVO; HEMATOPOIETIC MICROENVIRONMENT; MICE; EXPRESSION	During mammalian ontogeny, haematopoietic stem cells (HSCs) translocate from the fetal liver to the bone marrow, where haematopoiesis occurs throughout adulthood(1). Unique features of bone that contribute to a microenvironmental niche for stem cells might include the known high concentration of calcium ions at the HSC-enriched endosteal surface. Cells respond to extracellular ionic calcium concentrations through the seven-transmembrane-spanning calcium-sensing receptor (CaR), which we identified as being expressed on HSCs. Here we show that, through the CaR, the simple ionic mineral content of the niche may dictate the preferential localization of adult mammalian haematopoiesis in bone. Antenatal mice deficient in CaR had primitive haematopoietic cells in the circulation and spleen, whereas few were found in bone marrow. CaR-/- HSCs from fetal liver were normal in number, in proliferative and differentiative function, and in migration and homing to the bone marrow. Yet they were highly defective in localizing anatomically to the endosteal niche, behaviour that correlated with defective adhesion to the extracellular matrix protein, collagen I. CaR has a function in retaining HSCs in close physical proximity to the endosteal surface and the regulatory niche components associated with it.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Blood Transfus Serv, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Membrane Biol Program,Endocrine Hypertens Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu	Szczepiorkowski, Zbigniew M./A-1359-2007; Poznansky, Mark C/M-4996-2015	Szczepiorkowski, Zbigniew M./0000-0003-2357-9564; Poznansky, Mark C/0000-0003-1344-7103				An J, 1996, EXP HEMATOL, V24, P768; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Garner SC, 2001, ENDOCRINOLOGY, V142, P3996, DOI 10.1210/en.142.9.3996; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; KAWAI M, 1994, BLOOD CELLS, V20, P191; LORD BI, 1975, BLOOD, V46, P65; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Olszak IT, 2000, J CLIN INVEST, V105, P1299, DOI 10.1172/JCI9799; Orschell-Traycoff CM, 2000, BLOOD, V96, P1380, DOI 10.1182/blood.V96.4.1380.h8001380_1380_1387; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; TAVASSOLI M, 1991, BLOOD CELLS, V17, P269; WOLF NS, 1974, CELL TISSUE KINET, V7, P89, DOI 10.1111/j.1365-2184.1974.tb00402.x; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZHOU H, 1995, BONE, V17, P407, DOI 10.1016/S8756-3282(95)00264-2	25	526	555	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					599	603		10.1038/nature04247	http://dx.doi.org/10.1038/nature04247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16382241				2022-12-28	WOS:000235033900043
J	Fox, M; Forgacs, I				Fox, M; Forgacs, I			Gastro-oesophageal reflux disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROTON PUMP INHIBITORS; BARRETTS-ESOPHAGUS; GASTRIC-ACID; AMBULATORY ESOPHAGEAL; HELICOBACTER-PYLORI; ANTIREFLUX THERAPY; PROXIMAL EXTENT; FOLLOW-UP; PH; IMPEDANCE		Kings Coll Hosp London, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Forgacs, I (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	ian.forgacs@kcl.ac.uk						Anderson LA, 2003, GUT, V52, P1081, DOI 10.1136/gut.52.8.1081; Arguedas MR, 2004, AM J GASTROENTEROL, V99, P1023, DOI 10.1111/j.1572-0241.2004.30891.x; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Castell DO, 2002, AM J GASTROENTEROL, V97, P575; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Donnellan C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003245.pub2; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; ElSerag HB, 1997, GASTROENTEROLOGY, V113, P755, DOI 10.1016/S0016-5085(97)70168-9; Emerenziani S, 2005, AM J GASTROENTEROL, V100, P1251, DOI 10.1111/j.1572-0241.2005.41695.x; Fass R, 2001, GUT, V48, P310, DOI 10.1136/gut.48.3.310; Fass R, 2002, AM J GASTROENTEROL, V97, P1901; Field SK, 1998, CHEST, V114, P275, DOI 10.1378/chest.114.1.275; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; HANSON DG, 1995, ANN OTO RHINOL LARYN, V104, P550, DOI 10.1177/000348949510400709; HOLLOWAY RH, 1985, GASTROENTEROLOGY, V89, P779, DOI 10.1016/0016-5085(85)90572-4; Jankowski J, 2004, ALIMENT PHARM THER, V19, P54, DOI 10.1111/j.0953-0673.2004.01839.x; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; KATZ PO, 1990, AM J GASTROENTEROL, V85, P38; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Lagergren J, 2005, GUT, V54, pI1, DOI 10.1136/gut.2004.041517; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lauritsen K, 2003, ALIMENT PHARM THER, V17, P333, DOI 10.1046/j.1365-2036.2003.01464.x; LITTLE FB, 1985, ANN OTO RHINOL LARYN, V94, P516, DOI 10.1177/000348948509400521; Locke GR, 2005, NEUROGASTROENT MOTIL, V17, P29, DOI 10.1111/j.1365-2982.2004.00581.x; Mainie I, 2005, THORAX, V60, P521, DOI 10.1136/thx.2005.040139; Martinez SD, 2003, ALIMENT PHARM THER, V17, P537, DOI 10.1046/j.1365-2036.2003.01423.x; Moayyedi P, 2001, GASTROENTEROLOGY, V121, P1120, DOI 10.1053/gast.2001.29332; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; Nilsson G, 2004, BRIT J SURG, V91, P552, DOI 10.1002/bjs.4483; North of England Dyspepsia Guideline Development G. National Institute for Health and Clinical Excellence: Guidance, 2004, DYSP MAN DYSP AD PRI; Olberg P, 2005, SCAND J GASTROENTERO, V40, P264, DOI 10.1080/00365520510011588; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Pandolfino JE, 2003, AM J GASTROENTEROL, V98, P740, DOI 10.1016/S0002-9270(03)00062-5; Pandolfino JE, 2002, AM J PHYSIOL-GASTR L, V282, pG1052, DOI 10.1152/ajpgi.00279.2001; Pehlivanov N, 2001, AM J PHYSIOL-GASTR L, V281, pG743, DOI 10.1152/ajpgi.2001.281.3.G743; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Richter JE, 1996, GASTROENTEROL CLIN N, V25, P75, DOI 10.1016/S0889-8553(05)70366-6; Schwizer W, 2001, LANCET, V357, P1738, DOI 10.1016/S0140-6736(00)04894-7; SHAKER R, 1995, GASTROENTEROLOGY, V109, P1575, DOI 10.1016/0016-5085(95)90646-0; Shay SS, 2001, GASTROENTEROLOGY, V120, pA420; Sifrim D, 2005, GUT, V54, P449, DOI 10.1136/gut.2004.055418; Sifrim D, 2005, GUT, V54, P175, DOI 10.1136/gut.2004.043984; Spechler SJ, 2003, BRIT MED J, V326, P892, DOI 10.1136/bmj.326.7395.892; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Tharalson EF, 2002, AM J GASTROENTEROL, V97, P851; Todd JA, 2002, EUR J CANCER PREV, V11, P215, DOI 10.1097/00008469-200206000-00004; TRIMBLE KC, 1995, GUT, V37, P7, DOI 10.1136/gut.37.1.7; Trudgill NJ, 2001, AM J GASTROENTEROL, V96, P2569; Vakil N, 2003, ALIMENT PHARM THERAP, V17, P1427, DOI 10.1046/j.1365-2036.2003.01601.x; Van Herwaarden MA, 2000, GASTROENTEROLOGY, V119, P1439, DOI 10.1053/gast.2000.20191; van Pinxteren B, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002095.PUB2, 10.1002/14651858.cd002095.pub2]; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; WATSON A, 2005, GUIDELINES DIAGNOSIS, P1; Williams RBH, 2004, AM J GASTROENTEROL, V99, P777, DOI 10.1111/j.1572-0241.2004.04151.x; WYNNE JW, 1981, AM REV RESPIR DIS, V124, P728; Xue S, 2001, ALIMENT PHARM THERAP, V15, P1351, DOI 10.1046/j.1365-2036.2001.01050.x	60	55	57	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					88	93		10.1136/bmj.332.7533.88	http://dx.doi.org/10.1136/bmj.332.7533.88			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410582	Green Published			2022-12-28	WOS:000234777000021
J	Buban, JP; Matsunaga, K; Chen, J; Shibata, N; Ching, WY; Yamamoto, T; Ikuhara, Y				Buban, JP; Matsunaga, K; Chen, J; Shibata, N; Ching, WY; Yamamoto, T; Ikuhara, Y			Grain boundary strengthening in alumina by rare earth impurities	SCIENCE			English	Article							PLASTIC-DEFORMATION; DIFFUSIONAL CREEP; ATOMIC-STRUCTURE; ALPHA-AL2O3; BICRYSTALS; TILT; INTERFACE; AL2O3; BEHAVIOR; YTTRIUM	Impurity doping often alters or improves the properties of materials. In alumina, grain boundaries play a key rote in deformation mechanisms, particularly in the phenomenon of grain boundary sliding during creep at high temperatures. We elucidated the atomic-scale structure in alumina grain boundaries and its relationship to the suppression of creep upon doping with yttrium by using atomic resolution microscopy and high-precision calculations. We find that the yttrium segregates to very localized regions along the grain boundary and alters the local bonding environment, thereby strengthening the boundary against mechanical creep.	Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; Univ Missouri, Dept Phys, Kansas City, MO 64110 USA; Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan	University of Tokyo; University of Missouri System; University of Missouri Kansas City; University of Tokyo	Ikuhara, Y (corresponding author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	ikuhara@sigma.t.u-tokyo.ac.jp	Shibata, Naoya/E-5327-2013; Ching, Wai-Yim/B-4686-2009; Ikuhara, Yuichi/F-3066-2010; Ikuhara, Yuichi/N-1001-2015	Ching, Wai-Yim/0000-0001-7738-8822; Ikuhara, Yuichi/0000-0003-3886-005X				ASHBY MF, 1972, SURF SCI, V31, P498, DOI 10.1016/0039-6028(72)90273-7; CANNON RM, 1980, J AM CERAM SOC, V63, P46, DOI 10.1111/j.1151-2916.1980.tb10648.x; CATLOW CRA, 1982, PHYS REV B, V25, P1006, DOI 10.1103/PhysRevB.25.1006; CHEN FR, 1995, PHILOS MAG A, V72, P529, DOI 10.1080/01418619508243784; Chen J, 2005, ACTA MATER, V53, P403, DOI 10.1016/j.actamat.2004.09.035; Ching WY, 1999, PHYS REV B, V59, P12815, DOI 10.1103/PhysRevB.59.12815; Cho JH, 1997, J AM CERAM SOC, V80, P1013; CHOKSHI AH, 1990, J MATER SCI, V25, P3221, DOI 10.1007/BF00587678; Duscher G, 2004, NAT MATER, V3, P621, DOI 10.1038/nmat1191; Fabris S, 2003, ACTA MATER, V51, P71, DOI 10.1016/S1359-6454(02)00270-7; GALE JD, 1993, GEN UTILITY LATTICE; Gemming T, 2003, J AM CERAM SOC, V86, P581, DOI 10.1111/j.1151-2916.2003.tb03344.x; HEUER AH, 1980, J AM CERAM SOC, V63, P53, DOI 10.1111/j.1151-2916.1980.tb10649.x; HOCHE T, 1994, J AM CERAM SOC, V77, P339, DOI 10.1111/j.1151-2916.1994.tb07001.x; Ikuhara Y, 1999, MATER SCI FORUM, V294-2, P273, DOI 10.4028/www.scientific.net/MSF.294-296.273; JESSON DE, 1993, P ROY SOC LOND A MAT, V441, P261, DOI 10.1098/rspa.1993.0060; LEWIS GV, 1985, J PHYS C SOLID STATE, V18, P1149, DOI 10.1088/0022-3719/18/6/010; Marinopoulos AG, 2000, ACTA MATER, V48, P4375, DOI 10.1016/S1359-6454(00)00224-X; MASTUNAGA K, 2003, PHILOS MAG A, V83, P4071; Matsunaga K, 2003, APPL PHYS LETT, V82, P1179, DOI 10.1063/1.1555690; Nishimura H, 2003, J AM CERAM SOC, V86, P574, DOI 10.1111/j.1151-2916.2003.tb03343.x; Sheikh-Ali AD, 1998, MAT SCI ENG A-STRUCT, V245, P49, DOI 10.1016/S0921-5093(97)00697-7; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Yoshida H, 1998, J MATER RES, V13, P2597, DOI 10.1557/JMR.1998.0362	24	319	335	13	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					212	215		10.1126/science.1119839	http://dx.doi.org/10.1126/science.1119839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410521				2022-12-28	WOS:000234722200037
J	de Almodovar, CR; Luttun, A; Carmeliet, P				de Almodovar, CR; Luttun, A; Carmeliet, P			An SDF-1 trap for myeloid cells stimulates angiogenesis	CELL			English	Editorial Material							STEM-CELLS	In this issue of Cell, Grunewald et al. (2006) examine the role of hematopoietic cells in the formation of new blood vessels. They show that organ-specific expression of vascular endothelial growth factor (VEGF) is sufficient to mobilize and recruit hematopoietic cells from the bone marrow to the blood, but retention of the proangiogenic subpopulation of hematopoietic cells in peripheral organs requires an additional factor, stromal-derived factor 1 (SDF-1).	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Luttun, Aernout/AAZ-6540-2020; Carmeliet, Peter/AAQ-5140-2020	Luttun, Aernout/0000-0001-7902-9524; Carmeliet, Peter/0000-0001-7961-1821; Ruiz de Almodovar, Carmen/0000-0001-5975-7815				Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2001, THROMB HAEMOSTASIS, V86, P289; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; FOO SE, 2006, CELL; GRUNEWALD M, 2006, CELL; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Quesenberry PJ, 2005, EXP HEMATOL, V33, P9, DOI 10.1016/j.exphem.2004.10.012; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78	12	44	44	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					18	21		10.1016/j.cell.2005.12.023	http://dx.doi.org/10.1016/j.cell.2005.12.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413476	Bronze			2022-12-28	WOS:000234969600004
J	Dodick, DW				Dodick, DW			Clinical practice - Chronic daily headache	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; MEDICATION OVERUSE HEADACHE; TERM FOLLOW-UP; DOUBLE-BLIND; MIGRAINE PREVENTION; POPULATION; TOPIRAMATE; PREVALENCE; TRIAL; EPIDEMIOLOGY		Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Dodick, DW (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dodick.david@mayo.edu						Bigal ME, 2002, CEPHALALGIA, V22, P432, DOI 10.1046/j.1468-2982.2002.00384.x; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Castillo J, 1999, HEADACHE, V39, P190, DOI 10.1046/j.1526-4610.1999.3903190.x; Colas R, 2004, NEUROLOGY, V62, P1338, DOI 10.1212/01.WNL.0000120545.45443.93; D'Amico D, 2003, NEUROL SCI, V24, pS97; Freitag DG, 2001, HEADACHE, V41, P271, DOI 10.1046/j.1526-4610.2001.111006271.x; Freitag FG, 2004, HEADACHE, V44, P342, DOI 10.1111/j.1526-4610.2004.04093.x; Freitag FG, 2002, NEUROLOGY, V58, P1652, DOI 10.1212/WNL.58.11.1652; Fritsche G, 2001, EUR NEUROL, V45, P229, DOI 10.1159/000052134; Guitera V, 2002, NEUROLOGY, V58, P1062, DOI 10.1212/WNL.58.7.1062; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Katsarava Z, 2003, NEUROLOGY, V60, P1682, DOI 10.1212/01.WNL.0000063322.14078.90; Katsarava Z, 2001, NEUROLOGY, V57, P1694, DOI 10.1212/WNL.57.9.1694; Krymchantowski AV, 2002, HEADACHE, V42, P510, DOI 10.1046/j.1526-4610.2002.02125.x; Lanteri-Minet M, 2003, PAIN, V102, P143, DOI 10.1016/S0304-3959(02)00348-2; Limmroth V, 2004, CURR OPIN NEUROL, V17, P301, DOI 10.1097/00019052-200406000-00011; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; MATHEW NT, 1982, HEADACHE, V22, P66, DOI 10.1111/j.1526-4610.1982.hed2202066.x; MATHEW NT, 1990, HEADACHE, V30, P634, DOI 10.1111/j.1526-4610.1990.hed3010634.x; Mathew NT, 2005, HEADACHE, V45, P293, DOI 10.1111/j.1526-4610.2005.05066.x; MATHEW NT, 1987, HEADACHE, V27, P102, DOI 10.1111/j.1526-4610.1987.hed2702102.x; PAGELER L, 2004, CEPHALALGIA, V24, P72; Pini LA, 2001, CEPHALALGIA, V21, P878, DOI 10.1046/j.1468-2982.2001.00288.x; SAPER JR, 1990, NEUROL CLIN, V8, P891, DOI 10.1016/S0733-8619(18)30324-4; Saper JR, 2004, NEUROLOGY, V62, P1687, DOI 10.1212/01.WNL.0000125189.17830.02; SAPER JR, 1987, HEADACHE, V27, P435, DOI 10.1111/j.1526-4610.1987.hed2708435.x; Saper JR, 2002, HEADACHE, V42, P470, DOI 10.1046/j.1526-4610.2002.02122.x; SAPER JR, 1994, HEADACHE, V34, P497, DOI 10.1111/j.1526-4610.1994.hed3409497.x; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Scher Ann I, 2002, Curr Pain Headache Rep, V6, P486, DOI 10.1007/s11916-002-0068-8; Silberstein SD, 2004, ARCH NEUROL-CHICAGO, V61, P490, DOI 10.1001/archneur.61.4.490; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 1996, NEUROLOGY, V47, P871, DOI 10.1212/WNL.47.4.871; Silvestrini M, 2003, CEPHALALGIA, V23, P820, DOI 10.1046/j.1468-2982.2003.00592.x; Smith TR, 2002, HEADACHE, V42, P175, DOI 10.1046/j.1526-4610.2002.02048.x; Spira PJ, 2003, NEUROLOGY, V61, P1753, DOI 10.1212/01.WNL.0000100121.58594.11; Verri AP, 1998, CEPHALALGIA, V18, P45, DOI 10.1177/0333102498018S2112; Wang SJ, 2001, PAIN, V89, P285, DOI 10.1016/S0304-3959(00)00380-8; Wang SJ, 2000, NEUROLOGY, V54, P314, DOI 10.1212/WNL.54.2.314; Welch KMA, 2002, CURR OPIN NEUROL, V15, P287, DOI 10.1097/00019052-200206000-00011; Zwart JA, 2003, NEUROLOGY, V61, P160, DOI 10.1212/01.WNL.0000069924.69078.8D	43	139	142	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					158	165		10.1056/NEJMcp042897	http://dx.doi.org/10.1056/NEJMcp042897			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407511				2022-12-28	WOS:000234528600008
J	van Belle, A; Buller, HR; Huisman, MV; Huisman, PM; Kaasjager, K; Kamphuisen, PW; Kramer, MHH; Kruip, MJHA; Kwakkel-van Erp, JM; Leebeek, FWG; Nijkeuter, M; Prins, MH; Sohne, M; Tick, LW				van Belle, A; Buller, HR; Huisman, MV; Huisman, PM; Kaasjager, K; Kamphuisen, PW; Kramer, MHH; Kruip, MJHA; Kwakkel-van Erp, JM; Leebeek, FWG; Nijkeuter, M; Prins, MH; Sohne, M; Tick, LW		Writing Grp Christopher Study Inve	Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSTIC WORK-UP; MANAGEMENT; VALIDATION	Context Previous studies have evaluated the safety of relatively complex combinations of clinical decision rules and diagnostic tests in patients with suspected pulmonary embolism. Objective To assess the clinical effectiveness of a simplified algorithm using a dichotomized clinical decision rule, D-dimer testing, and computed tomography (CT) in patients with suspected pulmonary embolism. Design, Setting, and Patients Prospective cohort study of consecutive patients with clinically suspected acute pulmonary embolism, conducted in 12 centers in the Netherlands from November 2002 through December 2004. The study population of 3306 patients included 82% outpatients and 57% women. Interventions Patients were categorized as "pulmonary embolism unlikely" or "pulmonary embolism likely" using a dichotomized version of the Wells clinical decision rule. Patients classified as unlikely had D-dimer testing, and pulmonary embolism was considered excluded if the D-dimer test result was normal. All other patients underwent CT, and pulmonary embolism was considered present or excluded based on the results. Anticoagulants were withheld from patients classified as excluded, and all patients were followed up for 3 months. Main Outcome Measure Symptomatic or fatal venous thromboembolism (VTE) during 3-month follow-up. Results Pulmonary embolism was classified as unlikely in 2206 patients (66.7%). The combination of pulmonary embolism unlikely and a normal D-dimer test result occurred in 1057 patients (32.0%), of whom 1028 were not treated with anticoagulants; subsequent nonfatal VTE occurred in 5 patients (0.5% [95% confidence interval (CI], 0.2 % -1.1%]). Computed tomography showed pulmonary embolism in 674 3 patients (20.4%). Computed tomography excluded pulmonary embolism in 1505 patients, of whom 1436 patients were not treated with anticoagulants; in these patients the 3-month incidence of VTE was 1.3% (95% Cl, 0.7%-2.0%). Pulmonary embolism was considered a possible cause of death in 7 patients after a negative CT scan (0.5% [95% Cl, 0.2%-1.0%]). The algorithm was completed and allowed a management decision in 97.9% of patients. Conclusions A diagnostic management strategy using a simple clinical decision rule, D-dimer testing, and CT is effective in the evaluation and management of patients with clinically suspected pulmonary embolism. Its use is associated with low risk for subsequent fatal and nonfatal VTE.	Leiden Univ, Med Ctr, Dept Gen Internal Med, Sect Vasc Med, NL-2333 ZA Leiden, Netherlands; Acad Hosp Maastricht, Dept Pulm Med, Maastricht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Gen Internal Med Endocrinol, Leiden, Netherlands; Hilversum Hosp, Dept Radiol, Hilversum, Netherlands; Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands; Radboud Univ, Dept Gen Internal Med, Med Ctr, Nijmegen, Netherlands; Meander Med Ctr, Dept Internal Med, Amersfoort, Netherlands; Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; Rijnstate Hosp, Dept Pulm Med, Arnhem, Netherlands; Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Gen Internal Med Endocrinol, Leiden, Netherlands; Acad Hosp Maastricht, Dept Clin Epidemiol, Maastricht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnstate Hospital; Radboud University Nijmegen; Meander Medisch Centrum; Erasmus University Rotterdam; Erasmus MC; Rijnstate Hospital; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Huisman, MV (corresponding author), Leiden Univ, Med Ctr, Dept Gen Internal Med, Sect Vasc Med, C4-68,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	m.v.huisman@lumc.nl	Kramer, Mark/GWQ-3502-2022					Buller HR, 2003, NEW ENGL J MED, V349, P1695; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Lee AYY, 2002, ANNU REV MED, V53, P15, DOI 10.1146/annurev.med.53.082901.103957; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2005, J THROMB HAEMOST, V3, P14, DOI 10.1111/j.1538-7836.2004.01073.x; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Schoepf UJ, 2004, CIRCULATION, V109, P2160, DOI 10.1161/01.CIR.0000128813.04325.08; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P17, DOI 10.1111/j.1538-7836.2004.01064.x; van Strijen MJL, 2003, ANN INTERN MED, V138, P307, DOI 10.7326/0003-4819-138-4-200302180-00009; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wolf SJ, 2004, ANN EMERG MED, V44, P503, DOI 10.1016/j.annemergmed.2004.04.002	20	741	789	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					172	179						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403929				2022-12-28	WOS:000234544300024
J	Smith, DE; Zuber, MT; Sun, XL; Neumann, GA; Cavanaugh, JF; McGarry, JF; Zagwodzki, TW				Smith, DE; Zuber, MT; Sun, XL; Neumann, GA; Cavanaugh, JF; McGarry, JF; Zagwodzki, TW			Two-way laser link over interplanetary distance	SCIENCE			English	Article									NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT)	Smith, DE (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA.	dsmith@tharsis.gsfc.nasa.gov	Sun, Xiaoli/B-5120-2013; Neumann, Gregory A/I-5591-2013; McGarry, Jan/C-4109-2013	Neumann, Gregory A/0000-0003-0644-9944; 				BLANDHAWTHORN J, 2002, SCIENCE, V523, P293; CAVANAUGH JA, UNPUB; Degnan JJ, 2002, J GEODYN, V34, P551, DOI 10.1016/S0264-3707(02)00044-3; EDWARDS BL, 2003, AIAA; Santo AG, 2001, PLANET SPACE SCI, V49, P1481, DOI 10.1016/S0032-0633(01)00087-3; SMITH DE, 1997, M GROSSM 8 JER; WILSON KE, 1993, P SOC PHOTO-OPT INS, V1866, P138, DOI 10.1117/12.149251	7	94	97	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2006	311	5757					53	53		10.1126/science.1120091	http://dx.doi.org/10.1126/science.1120091			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400141				2022-12-28	WOS:000234546300028
J	Wilson, IH				Wilson, IH			Influenza, 1918	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Wilson, IH (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.								0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1536	1536		10.1136/bmj.331.7531.1536	http://dx.doi.org/10.1136/bmj.331.7531.1536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373743	Green Published, Bronze			2022-12-28	WOS:000234351300024
J	Hayton, TW; Boncella, JM; Scott, BL; Palmer, PD; Batista, ER; Hay, PJ				Hayton, TW; Boncella, JM; Scott, BL; Palmer, PD; Batista, ER; Hay, PJ			Synthesis of imido analogs of the uranyl ion	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; COMPLEXES; ACTINIDES; CHEMISTRY; URANIUM; ROUTE; METAL	Here we describe the synthesis of two imido analogs of the uranyl ion, UO22+, in which the oxygens are replaced by divalent alkyi or aryl nitrogen groups: U((NBu)-Bu-t)(2)I-2(THF)(2) (1) and U(NPh)(2)I-2(THF)(3) (2) (where Bu-t is tert-butyl and THF is tetrahydrofuran). Both compounds have been fully characterized by standard analytical techniques, including x-ray crystallography, and the chemical bonding between the metal center and the nitrogen ligands was quantified by using hybrid density functional theory calculations. As expected for a uranyl analog, these complexes exhibit linear N-U-N linkages and very short U-N bonds. In addition, the theoretical calculations show strong involvement of the 5f and 6d electrons in the U-N bonding.	Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Boncella, JM (corresponding author), Los Alamos Natl Lab, Div Chem, MS J514, Los Alamos, NM 87545 USA.	boncella@lanl.gov	Scott, Brian/D-8995-2017; Batista, Enrique/AAO-8385-2020	Scott, Brian/0000-0003-0468-5396; Boncella, James/0000-0001-8393-392X				ANHAUS JT, 1990, J AM CHEM SOC, V112, P1642, DOI 10.1021/ja00160a061; ARNEY DSJ, 1995, J AM CHEM SOC, V117, P9448, DOI 10.1021/ja00142a011; ARNEY DSJ, 1992, J AM CHEM SOC, V114, P10068, DOI 10.1021/ja00051a053; BARRIE P, 1999, DALTON T, P4519; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brown DR, 1996, INORG CHEM, V35, P6158, DOI 10.1021/ic951386v; BROWN DR, 1994, CHEM COMMUN, V2004, P2601; Cao XY, 2003, J CHEM PHYS, V118, P487, DOI 10.1063/1.1521431; Castro-Rodriguez I, 2004, SCIENCE, V305, P1757, DOI 10.1126/science.1102602; Clark D. L., 1997, INORG SYNTH, V31, P307; COMYNS AE, 1960, CHEM REV, V60, P115, DOI 10.1021/cr60204a001; Cotton FA, 1999, ADV INORG CHEM, P1146; DANOPOULOS AA, 1992, POLYHEDRON, V11, P2961, DOI 10.1016/S0277-5387(00)83602-5; DENNING RG, 1992, STRUCT BOND, V79, P215; Evans WJ, 2005, SCIENCE, V309, P1835, DOI 10.1126/science.1116452; Kaltsoyannis N, 2000, INORG CHEM, V39, P6009, DOI 10.1021/ic000891b; Katz J.J., 1986, CHEM ACTINIDE ELEMEN; Korolev AV, 1997, INORG CHEM, V36, P2647, DOI 10.1021/ic961360j; KUCHLE W, 1994, J CHEM PHYS, V100, P7535, DOI 10.1063/1.466847; Li ZY, 1997, INORG CHEM, V36, P3064, DOI 10.1021/ic961228j; PEPPER M, 1991, CHEM REV, V91, P719, DOI 10.1021/cr00005a005; Warner BP, 1998, ANGEW CHEM INT EDIT, V37, P959, DOI 10.1002/(SICI)1521-3773(19980420)37:7<959::AID-ANIE959>3.0.CO;2-D; Williams VC, 2000, INORG CHEM, V39, P2538, DOI 10.1021/ic991294w; ZALKIN A, 1988, ACTA CRYSTALLOGR C, V44, P1553, DOI 10.1107/S0108270188005116	24	192	192	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1941	1943		10.1126/science.1120069	http://dx.doi.org/10.1126/science.1120069			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373571				2022-12-28	WOS:000234275400038
J	Parmiani, G				Parmiani, G			Tumor-infiltrating T-cells - Friend or foe of neoplastic cells?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ist Nazl Tumori, Unit Immunotherapy Human Tumors, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Parmiani, G (corresponding author), Ist Nazl Tumori, Unit Immunotherapy Human Tumors, Via Venezian 1, I-20133 Milan, Italy.								0	34	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2640	2641		10.1056/NEJMp058236	http://dx.doi.org/10.1056/NEJMp058236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371629				2022-12-28	WOS:000234094400004
J	Rest, A; Suntzeff, NB; Olsen, K; Prieto, JL; Smith, RC; Welch, DL; Becker, A; Bergmann, M; Clocchiatti, A; Cook, K; Garg, A; Huber, M; Miknaitis, G; Minniti, D; Nikolaev, S; Stubbs, C				Rest, A; Suntzeff, NB; Olsen, K; Prieto, JL; Smith, RC; Welch, DL; Becker, A; Bergmann, M; Clocchiatti, A; Cook, K; Garg, A; Huber, M; Miknaitis, G; Minniti, D; Nikolaev, S; Stubbs, C			Light echoes from ancient supernovae in the Large Magellanic Cloud	NATURE			English	Article							SN 1991T; SEARCH; REFLECTIONS; REMNANTS; 1993J	The light from historical supernovae could in principle still be visible as scattered-light echoes centuries after the explosion(1-6). The detection of light echoes could allow us to pinpoint the supernova event both in position and age and, most importantly, permit the acquisition of spectra to determine the 'type' of the supernova centuries after the direct light from the explosion first reached Earth. Although echoes have been discovered around some nearby extragalactic supernovae(7-13), targeted searches have not found any echoes in the regions of historical Galactic supernovae(14-16). Here we report three faint variable-surface-brightness complexes with high apparent proper motions pointing back to three of the six smallest ( and probably youngest) previously catalogued supernova remnants in the Large Magellanic Cloud, which are believed to have been thermonuclear ( type Ia) supernovae(17). Using the distance and apparent proper motions of these echo arcs, we estimate ages of 610 and 410 years for two of them.	Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile; Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Gemini Observ, La Serena, Chile; Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago, Chile; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	National Optical Astronomy Observatory; University System of Ohio; Ohio State University; McMaster University; University of Washington; University of Washington Seattle; Pontificia Universidad Catolica de Chile; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Suntzeff, NB (corresponding author), Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile.	nsuntzeff@ctio.noao.edu	Minniti, Dante/AAD-7251-2021; Rest, Armin/ABE-6469-2020; Stubbs, Christopher W/C-2829-2012	Stubbs, Christopher W/0000-0003-0347-1724; Welch, Doug/0000-0002-2350-0898; Prieto, Jose/0000-0003-1072-2712; Suntzeff, Nicholas/0000-0002-8102-181X; Clocchiatti, Alejandro/0000-0003-3068-4258; Minniti, Dante/0000-0002-7064-099X; Olsen, Knut/0000-0002-7134-8296				Boffi FR, 1999, ASTRON ASTROPHYS SUP, V138, P253, DOI 10.1051/aas:1999274; Cappellaro E, 2001, ASTROPHYS J, V549, pL215, DOI 10.1086/319178; CHEVALIER RA, 1986, ASTROPHYS J, V308, P225, DOI 10.1086/164492; Couderc P., 1939, ANAP, V2, P271; CROTTS A, 1988, 4561 IAU; CROTTS APS, 1988, ASTROPHYS J, V333, pL51, DOI 10.1086/185286; Hughes J. P., 1995, APJ, V444, P81; Liu JF, 2003, ASTROPHYS J, V582, P919, DOI 10.1086/344719; MATHEWSON DS, 1985, ASTROPHYS J SUPPL S, V58, P197, DOI 10.1086/191037; Patat F, 2005, MON NOT R ASTRON SOC, V357, P1161, DOI 10.1111/j.1365-2966.2005.08568.x; Romaniello M, 2005, ASTROPHYS J, V629, P250, DOI 10.1086/431470; SCHAEFER BE, 1987, ASTROPHYS J, V323, pL47, DOI 10.1086/185054; SCHMIDT BP, 1994, ASTROPHYS J, V434, pL19, DOI 10.1086/187562; SHKLOVSKII IS, 1964, ASTRON CIRC USSR, V306, P2; SMITH RC, 1991, ASTROPHYS J, V375, P652, DOI 10.1086/170228; SPARKS WB, 1994, ASTROPHYS J, V433, P19, DOI 10.1086/174621; Sparks WB, 1999, ASTROPHYS J, V523, P585, DOI 10.1086/307766; Sugerman BEK, 2003, ASTRON J, V126, P1939, DOI 10.1086/378358; Sugerman BEK, 2002, ASTROPHYS J, V581, pL97, DOI 10.1086/346016; SUNTZEFF NB, 1988, NATURE, V334, P135, DOI 10.1038/334135a0; VANDENBERGH S, 1966, PUBL ASTRON SOC PAC, V78, P74, DOI 10.1086/128299; VANDENBERGH S, 1975, ASTROPHYS SPACE SCI, V38, P447, DOI 10.1007/BF00647145; VANDENBERGH S, 1965, PASP, V77, P269; XU J, 1995, ASTROPHYS J, V451, P806, DOI 10.1086/176267; Zwicky F, 1940, REV MOD PHYS, V12, P0066, DOI 10.1103/RevModPhys.12.66	25	116	118	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1132	1134		10.1038/nature04365	http://dx.doi.org/10.1038/nature04365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372003	Green Submitted			2022-12-28	WOS:000234111500044
J	Bamias, G; Nyce, MR; De La Rue, SA; Cominelli, F				Bamias, G; Nyce, MR; De La Rue, SA; Cominelli, F			New concepts in the pathophysiology of inflammatory bowel disease	ANNALS OF INTERNAL MEDICINE			English	Review							RECOMBINANT HUMAN INTERLEUKIN-10; INTESTINAL EPITHELIAL-CELLS; ACTIVE CROHNS-DISEASE; ULCERATIVE-COLITIS; MUCOSAL INFLAMMATION; MURINE MODEL; IFN-GAMMA; NOD2 GENE; CYTOKINE; SUSCEPTIBILITY	Clinical Principles The inflammatory bowel diseases (IBDs), that is, Crohn disease and ulcerative colitis, affect approximately 1 million persons in North America and several million persons worldwide. Approximately 30% of patients present between 10 and 30 years of age. Current therapeutic options are limited and include nonspecific anti-inflammatory and immunosuppresive medications. Surgery is required for 50% to 80% of patients with Crohn disease, while only 20% of patients with ulcerative colitis have surgery. Novel biological therapeutics have greatly improved the quality of life of patients with IBD. Pathophysiologic Principles Both genetic and environmental factors play important roles in disease pathogenesis. New hypotheses implicate the innate immune system and the intestinal epithelium in the pathogenesis of the disease. Lymphocytes, cytokines, and adhesion molecules are dysregulated and have been targeted for therapeutic intervention. Based on a new understanding of the complicated mechanisms that underlie the disease process, combination therapies are currently being pursued. A better understanding of the pathophysiologic mechanisms will aid in prevention and more effective maintenance of remission of IBDs.	Univ Virginia, Charlottesville, VA 22908 USA	University of Virginia	Cominelli, F (corresponding author), Univ Virginia Hlth Syst, Div Gastroenterol & Hepatol, POB 800708, Charlottesville, VA 22908 USA.	fc4q@virginia.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK055812] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK-67629, DK-55812, DK-44540, DK-42195] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Armuzzi A, 2004, Eur Rev Med Pharmacol Sci, V8, P231; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bevins CL, 2004, CURR OPIN GASTROEN, V20, P572, DOI 10.1097/00001574-200411000-00012; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bullens DMA, 2001, SCAND J IMMUNOL, V53, P455, DOI 10.1046/j.1365-3083.2001.00900.x; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cominelli F, 2004, NEW ENGL J MED, V351, P2045, DOI 10.1056/NEJMp048253; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Desreumaux P, 1997, GASTROENTEROLOGY, V113, P118, DOI 10.1016/S0016-5085(97)70116-1; Duerr RH, 2003, J CLIN GASTROENTEROL, V37, P358, DOI 10.1097/00004836-200311000-00003; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Eidelwein AP, 2005, INFLAMM BOWEL DIS, V11, P213, DOI 10.1097/01.MIB.0000160803.44449.a5; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fort MM, 2001, J IMMUNOL, V166, P2793, DOI 10.4049/jimmunol.166.4.2793; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kohn A, 2004, Eur Rev Med Pharmacol Sci, V8, P235; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Kugathasan S, 2000, AM J GASTROENTEROL, V95, P3189; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Linskens RK, 2001, SCAND J GASTROENTERO, V36, P29, DOI 10.1080/003655201753265082; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Markowitz J, 2000, GASTROENTEROLOGY, V119, P895, DOI 10.1053/gast.2000.18144; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Mow WS, 2004, DIGEST DIS SCI, V49, P1280, DOI 10.1023/B:DDAS.0000037824.66186.e2; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Panwala CM, 1998, J IMMUNOL, V161, P5733; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pizarro TT, 2003, TRENDS MOL MED, V9, P218, DOI 10.1016/S1471-4914(03)00052-2; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Rivera-Nieves J, 2005, J IMMUNOL, V174, P2343, DOI 10.4049/jimmunol.174.4.2343; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; Sutton CL, 2000, GASTROENTEROLOGY, V119, P23, DOI 10.1053/gast.2000.8519; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Tsukada Y, 2002, AM J GASTROENTEROL, V97, P2820; Yu YM, 2004, IMMUNOL RES, V29, P55, DOI 10.1385/IR:29:1-3:055	64	161	173	2	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					895	904		10.7326/0003-4819-143-12-200512200-00007	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365470				2022-12-28	WOS:000234077400005
J	Sander, PM; Klein, N				Sander, PM; Klein, N			Developmental plasticity in the life history of a prosauropod dinosaur	SCIENCE			English	Article							GROWTH-PATTERNS; BONE-HISTOLOGY; RATES; EVOLUTION	Long-bone histology indicates that the most common early dinosaur, the prosauropod Plateosaurus engelhardti from the Upper Triassic of Central Europe, had variable life histories. Although Plateosaurus grew at the fast rates typical for dinosaurs, as indicated by fibrolamellar bone, qualitative (growth stop) and quantitative (growth-mark counts) features of its histology are poorly correlated with body size. Individual life histories of P. engelhardti were influenced by environmental factors, as in modern ectothermic reptiles, but not in mammals, birds, or other dinosaurs.	Univ Bonn, Inst Palaontol, D-53115 Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Inst Palaontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de						Apanius V., 1998, AVIAN GROWTH DEV EVO; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; LEGLER JOHN M., 1960, UNIV KANSAS PUBL MUS NAT HIST, V11, P527; Moser M, 2003, ZITTELIANA B, VB24, P1; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Ricqlesde A, 2000, ZOOL J LINN SOC-LOND, V129, P271; SANDER PM, 1992, PALAEOGEOGR PALAEOCL, V93, P255; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SMITHGILL SJ, 1983, AM ZOOL, V23, P47; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Weishampel D.B., 1990, P43, DOI 10.1017/CBO9780511608377.006; Yates Adam M., 2004, Postilla, V230, P1; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; ZUG G R, 1987, Amphibia-Reptilia, V8, P237, DOI 10.1163/156853887X00289; Zug G.R., 1986, SMITHSONIAN CONTRIBU, V427, P1, DOI 10.5479/si.00810282.427; Zug G. R., 2001, HERPETOLOGY, P57; [No title captured]	32	120	121	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1800	1802		10.1126/science.1120125	http://dx.doi.org/10.1126/science.1120125			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357257				2022-12-28	WOS:000234093600042
J	Baumgartner, C; Aull-Watschinger, S				Baumgartner, C; Aull-Watschinger, S			The pre-ictal state in focal epilepsy	LANCET			English	Editorial Material							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE EPILEPSY; FUNCTIONAL MRI; PREDICTION; SEIZURES		Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria	Medical University of Vienna	Baumgartner, C (corresponding author), Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria.	christoph.baumgartner@meduniwien.ac.at						Baumgartner C, 1998, J NUCL MED, V39, P978; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; JACKSON GD, 1994, NEUROLOGY, V44, P850, DOI 10.1212/WNL.44.5.850; Krings T, 2000, NEUROLOGY, V54, P524, DOI 10.1212/WNL.54.2.524; Lehnertz K, 2003, IEEE ENG MED BIOL, V22, P57, DOI 10.1109/MEMB.2003.1191451; Lindenberg CS, 1999, INT J NURS STUD, V36, P3, DOI 10.1016/S0020-7489(98)00046-7; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; WALLSTEDT L, 1996, EPILEPSIA S4, V37, P163; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; WEINAND ME, 1994, NEUROSURGERY, V35, P657, DOI 10.1227/00006123-199410000-00011	11	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2065	2066		10.1016/S0140-6736(05)67865-8	http://dx.doi.org/10.1016/S0140-6736(05)67865-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360771				2022-12-28	WOS:000234146000004
J	Sanders, CJG				Sanders, CJG			The road	LANCET			English	Article									Univ Med Ctr, Dept Dermatol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Sanders, CJG (corresponding author), Univ Med Ctr, Dept Dermatol, G02-124,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	c.sanders@umcutrecht.nl							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2135	2136		10.1016/S0140-6736(05)67892-0	http://dx.doi.org/10.1016/S0140-6736(05)67892-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360792				2022-12-28	WOS:000234146000030
J	Tsukada, Y; Fang, J; Erdjument-Bromage, H; Warren, ME; Borchers, CH; Tempst, P; Zhang, Y				Tsukada, Y; Fang, J; Erdjument-Bromage, H; Warren, ME; Borchers, CH; Tempst, P; Zhang, Y			Histone demethylation by a family of JmjC domain-containing proteins	NATURE			English	Article							F-BOX PROTEINS; LYSINE METHYLATION; OXIDATIVE DEMETHYLATION; ARGININE METHYLATION; ESCHERICHIA-COLI; COMPLEX; LSD1; IDENTIFICATION; REPRESSION; RECEPTOR	Covalent modification of histones has an important role in regulating chromatin dynamics and transcription. Whereas most covalent histone modifications are reversible, until recently it was unknown whether methyl groups could be actively removed from histones. Using a biochemical assay coupled with chromatography, we have purified a novel JmjC domain-containing protein, JHDM1 ( JmjC domain-containing histone demethylase 1), that specifically demethylates histone H3 at lysine 36 (H3-K36). In the presence of Fe(II) and alpha-ketoglutarate, JHDM1 demethylates H3-methyl-K36 and generates formaldehyde and succinate. Overexpression of JHDM1 reduced the level of dimethyl-H3-K36 (H3K36me2) in vivo. The demethylase activity of the JmjC domain-containing proteins is conserved, as a JHDM1 homologue in Saccharomyces cerevisiae also has H3-K36 demethylase activity. Thus, we identify the JmjC domain as a novel demethylase signature motif and uncover a protein demethylation mechanism that is conserved from yeast to human.	Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	BORCHERS, Christoph/U-5964-2019; Hu, Ruogu/B-2203-2008	Tempst, Paul/0000-0002-6680-3987; Fang, Jia/0000-0001-8583-1652; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Zhang, Yi/0000-0002-2789-0811				Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; KLEEBERG U, 1982, J PHARMACOL METHOD, V8, P19, DOI 10.1016/0160-5402(82)90004-3; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	27	1509	1603	7	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					811	816		10.1038/nature04433	http://dx.doi.org/10.1038/nature04433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16362057				2022-12-28	WOS:000235333600041
J	Huxley, R; Barzi, F; Woodward, M				Huxley, R; Barzi, F; Woodward, M			Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEX-DIFFERENCES; CARDIOVASCULAR-DISEASE; ASPIRIN USE; FOLLOW-UP; MORTALITY; MELLITUS; INSULIN; IMPACT; HEALTH; NIDDM	Objective To estimate the relative risk for fatal coronary heart disease associated with diabetes in men and women. Design Meta-analysis of prospective cohort studies. Data sources Studies published between 1966 and March 2005, identified through Embase and Medline, using a combined text word and MESH heading search strategy, in addition to studies from the Asia Pacific Cohort Studies Collaboration. Review methods Studies were eligible if they had reported estimates of the relative risk for fatal coronary heart disease comparing men and women with and without diabetes. Studies were excluded if the estimates were not adjusted at least for age. Results 37 studies of type 2 diabetes and fatal coronary heart disease among a total of 447 064 patients were identified. The rate of fatal coronary heart disease was higher in patients with diabetes than in those without (5.4 v 1.6%). The overall summary relative risk for fatal coronary heart disease in patients with diabetes compared with no diabetes was significantly greater among women than it was among men: 3.50, 95% confidence interval 2.70 to 4.53 v 2.06, 1.81 to 2.34. After exclusion of the eight studies that had adjusted only for age, the difference in risk between the sexes was substantially reduced but still highly significant. The pooled ratio of the relative risks (women:men) from the 29 studies with multiple adjusted estimates was 1.46 (1.14 to 1.88). Conclusions The relative risk for fatal coronary heart disease associated with diabetes is 50% higher in women than it is in men. This greater excess coronary risk may be explained by more adverse cardiovascular risk profiles among women with diabetes, combined with possible disparities in treatment that favour men.	Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia	University of Sydney	Huxley, R (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	rhuxley@thegeorgeinstitute.org	Barzi, Federica/AAI-7465-2021; Huxley, Rachel R/J-4638-2013; Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015; Huxley, Rachel R/C-7032-2013; Barzi, Federica/L-3553-2013	Barzi, Federica/0000-0001-7427-0167; Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Woodward, Mark/0000-0001-9800-5296				BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BUTLER WJ, 1985, AM J EPIDEMIOL, V121, P541; CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1553, DOI 10.1016/0002-9378(88)90189-5; Collins VR, 1996, DIABETIC MED, V13, P125, DOI 10.1002/(SICI)1096-9136(199602)13:2<125::AID-DIA13>3.0.CO;2-P; Cull CA, 2004, DIABETIC MED, V21, P1368, DOI 10.1111/j.1464-5491.2004.01328.x; Folsom AR, 1997, DIABETES CARE, V20, P935, DOI 10.2337/diacare.20.6.935; FRASER GE, 1992, CIRCULATION, V86, P406, DOI 10.1161/01.CIR.86.2.406; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; FULLER JH, 1979, BMJ-BRIT MED J, V2, P964, DOI 10.1136/bmj.2.6196.964; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; HEYDEN S, 1980, J CHRON DIS, V33, P265, DOI 10.1016/0021-9681(80)90021-1; Imazu M, 2002, DIABETES RES CLIN PR, V57, P61, DOI 10.1016/S0168-8227(02)00016-5; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; KANNEL WB, 1995, ARCH INTERN MED, V155, P57, DOI 10.1001/archinte.155.1.57; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; KEIL JE, 1993, NEW ENGL J MED, V329, P73, DOI 10.1056/NEJM199307083290201; KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; LAAKSO M, 1995, DIABETOLOGIA, V38, P487, DOI 10.1007/s001250050310; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; Nilsson PM, 1998, DIABETIC MED, V15, P213, DOI 10.1002/(SICI)1096-9136(199803)15:3<213::AID-DIA569>3.3.CO;2-R; Orchard TJ, 1996, ANN MED, V28, P323, DOI 10.3109/07853899608999089; PAN WH, 1986, AM J EPIDEMIOL, V123, P504, DOI 10.1093/oxfordjournals.aje.a114266; Persell SD, 2004, ARCH INTERN MED, V164, P2492, DOI 10.1001/archinte.164.22.2492; Qvist J, 1996, SCAND J SOC MED, V24, P67, DOI 10.1177/140349489602400111; SEEMAN T, 1993, AM J EPIDEMIOL, V138, P1037, DOI 10.1093/oxfordjournals.aje.a116822; SIEVERS ML, 1992, DIABETES CARE, V15, P1541, DOI 10.2337/diacare.15.11.1541; Simons LA, 1996, AUST NZ J MED, V26, P66, DOI 10.1111/j.1445-5994.1996.tb02909.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tonstad S, 2004, J INTERN MED, V255, P494, DOI 10.1111/j.1365-2796.2004.01315.x; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Vilbergsson S, 1998, J INTERN MED, V244, P309, DOI 10.1046/j.1365-2796.1998.00368.x; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; Wexler DJ, 2005, DIABETES CARE, V28, P514, DOI 10.2337/diacare.28.3.514; WINGARD DL, 1995, DIABETES CARE, V18, P1299, DOI 10.2337/diacare.18.9.1299; Woodward M, 2003, DIABETES CARE, V26, P360; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	1023	1056	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					73	76		10.1136/bmj.38678.389583.7C	http://dx.doi.org/10.1136/bmj.38678.389583.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16371403	Green Published, Bronze			2022-12-28	WOS:000234777000015
J	Hallikas, O; Palin, K; Sinjushina, N; Rautiainen, R; Partanen, J; Ukkonen, E; Taipale, J				Hallikas, O; Palin, K; Sinjushina, N; Rautiainen, R; Partanen, J; Ukkonen, E; Taipale, J			Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity	CELL			English	Article							CIS-REGULATORY MODULES; C-MYC; N-MYC; HEDGEHOG; EXPRESSION; DROSOPHILA; GENE; IDENTIFICATION; PROLIFERATION; REQUIREMENT	Understanding the regulation of human gene expression requires knowledge of the "second genetic code," which consists of the binding specificities of transcription factors (TFs) and the combinatorial code by which TF binding sites are assembled to form tissue-specific enhancer elements. Using a novel high-throughput method, we determined the DNA binding specificities of GLIs 1-3, Tcf4, and c-Ets1, which mediate transcriptional responses to the Hedgehog (Hh), Wnt, and Ras/MAPK signaling pathways. To identify mammalian enhancer elements regulated by these pathways on a genomic scale, we developed a computational tool, enhancer element locator (EEL). We show that EEL can be used to identify Hh and Wnt target genes and to predict activated TFs based on changes in gene expression. Predictions validated in transgenic mouse embryos revealed the presence of multiple tissue-specific enhancers in mouse c-Myc and N-Myc genes, which has implications for organ-specific growth control and tumor-type specificity of oncogenes.	Univ Helsinki, Mol & Canc Biol Program, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Comp Sci, FIN-00014 Helsinki, Finland; Univ Helsinki, Dev Biol Program, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Ukkonen, E (corresponding author), Univ Helsinki, Mol & Canc Biol Program, Biomedicum Helsinki, POB 63, FIN-00014 Helsinki, Finland.	ukkonen@cs.helsinki.fi; jussi.taipale@helsinki.fi	Palin, Kimmo/ABG-5710-2020	Palin, Kimmo/0000-0002-4621-6128; Ukkonen, Esko/0000-0002-5978-1505; Partanen, Juha/0000-0001-8850-4825				Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Charron J, 2002, PEDIATR RES, V51, P48, DOI 10.1203/00006450-200201000-00010; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; LAVENU A, 1994, ONCOGENE, V9, P527; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Liu X, 2002, J MOL BIOL, V323, P1, DOI 10.1016/S0022-2836(02)00894-X; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Michelson AM, 2002, P NATL ACAD SCI USA, V99, P546, DOI 10.1073/pnas.032685999; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nagy A., 2003, MANIPULATING MOUSE E; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pellegrini M, 1998, DEV DYNAM, V213, P431, DOI 10.1002/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.0.CO;2-7; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	45	366	380	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					47	59		10.1016/j.cell.2005.10.042	http://dx.doi.org/10.1016/j.cell.2005.10.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413481	Bronze			2022-12-28	WOS:000234969600009
J	Michaels, JA				Michaels, JA			Health policy - Improving NICE's social value judgments	BRITISH MEDICAL JOURNAL			English	Editorial Material									No Gen Hosp, Acad Vasc Unit, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Michaels, JA (corresponding author), No Gen Hosp, Acad Vasc Unit, Sheffield S5 7AU, S Yorkshire, England.	j.michaels@sheffield.ac.uk	Michaels, Jonathan/N-8893-2019	Michaels, Jonathan/0000-0002-3422-7102				Harris J, 2005, J MED ETHICS, V31, P373, DOI 10.1136/jme.2005.012906; Mayor S, 2005, BRIT MED J, V330, P1102, DOI 10.1136/bmj.330.7500.1102-a; *NAT I CLIN EXC, 2003, 58 NAT I CLIN EXC; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; *NICE, 2005, APPR CONS DOC ALZH D; *NIH, 2005, SOC VAL JUDG GUID I; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; *ROYAL COLL PHYS, 2005, RESP FAC OLD AG PSYC; [No title captured]	9	3	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					48	50		10.1136/bmj.332.7532.48	http://dx.doi.org/10.1136/bmj.332.7532.48			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399744	Green Published			2022-12-28	WOS:000234684200028
J	Papagiannis, A				Papagiannis, A			The nursing profession's coming of age - Separate but complementary	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									St Lukes Hosp, Thessaloniki, Greece		Papagiannis, A (corresponding author), St Lukes Hosp, Thessaloniki, Greece.	antpap@the.forthnet.gr						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					52	52		10.1136/bmj.332.7532.52-a	http://dx.doi.org/10.1136/bmj.332.7532.52-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399756	Green Published			2022-12-28	WOS:000234684200037
J	Hoegh-Guldberg, O				Hoegh-Guldberg, O			Ecology - Complexities of coral reef recovery	SCIENCE			English	Editorial Material							RESERVES		Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia	University of Queensland	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia.	oveh@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713				BRYANT D, 1998, REEFS RISK; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Wilkinson C., 2004, STATUS CORAL REEFS W, V1; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	6	13	20	5	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					42	43		10.1126/science.1122951	http://dx.doi.org/10.1126/science.1122951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400136				2022-12-28	WOS:000234546300023
J	Fan, YH; Nikitina, T; Zhao, J; Fleury, TJ; Bhattacharyya, R; Bouhassira, EE; Stein, A; Woodcock, CL; Skoultchi, AI				Fan, YH; Nikitina, T; Zhao, J; Fleury, TJ; Bhattacharyya, R; Bouhassira, EE; Stein, A; Woodcock, CL; Skoultchi, AI			Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation	CELL			English	Article							LINKER HISTONES; DNA METHYLATION; IN-VIVO; PERICENTRIC HETEROCHROMATIN; SACCHAROMYCES-CEREVISIAE; CELL-DIFFERENTIATION; MOUSE DEVELOPMENT; NUCLEOSOME; EXPRESSION; TRANSCRIPTION	Linker histone H1 plays an important role in chromatin folding in vitro. To study the role of H1 in vivo, mouse embryonic stem cells null for three 111 genes were derived and were found to have 50% of the normal level of H1. H1 depletion caused dramatic chromatin structure changes, including decreased global nucleosome spacing, reduced local chromatin compaction, and decreases in certain core histone modifications. Surprisingly, however, microarray analysis revealed that expression of only a small number of genes is affected. Many of the affected genes are imprinted or are on the X chromosome and are therefore normally regulated by DNA methylation. Although global DNA methylation is not changed, methylation of specific CpGs within the regulatory regions of some of the H1 regulated genes is reduced. These results indicate that linker histones can participate in epigenetic regulation of gene expression by contributing to the maintenance or establishment of specific DNA methylation patterns.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Yeshiva University; Albert Einstein College of Medicine; University of Massachusetts System; University of Massachusetts Amherst; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Skoultchi, AI (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	skoultch@aecom.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NATIONAL CANCER INSTITUTE [R56CA079057, R01CA079057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062857, R01GM043786] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079057, CA79057] Funding Source: Medline; NIGMS NIH HHS [GM43786, GM62857] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BERKOWITZ EM, 1981, BIOCHEMISTRY-US, V20, P7284, DOI 10.1021/bi00528a036; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DASSO M, 1994, P NATL ACAD SCI USA, V91, P12477, DOI 10.1073/pnas.91.26.12477; Dean W, 1998, DEVELOPMENT, V125, P2273; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; HASLIE ND, 1989, GENETIC VARIANTS STR; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; KALILIS P, 1989, CENTROMERE; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Schmidt JV, 2000, GENE DEV, V14, P1997; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; van Holde KE., 1989, SPRINGER SERIES MOL; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Warnecke PM, 1998, DEV GENET, V22, P111, DOI 10.1002/(SICI)1520-6408(1998)22:2&lt;111::AID-DVG1&gt;3.0.CO;2-9; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Wolffe A., 1998, CHROMATIN STRUCTURE; WOODCOCK CL, 1991, J CELL SCI, V99, P99; Woodcock CL, 1998, METHOD CELL BIOL, V53, P167; WOODCOCK CL, 2003, IN PRESS CHROMOSOME; ZLATANOVA J, 1994, FASEB J, V8, P1260, DOI 10.1096/fasebj.8.15.8001738; ZLATANOVA J, 1992, J CELL SCI, V103, P889	62	408	415	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1199	1212		10.1016/j.cell.2005.10.028	http://dx.doi.org/10.1016/j.cell.2005.10.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377562	Bronze			2022-12-28	WOS:000234584500010
J	Brett, AS; Zuger, A				Brett, AS; Zuger, A			The run on Tamilflu - Should physicians prescribe on demand?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ S Carolina, Sch Med, Columbia, SC 29208 USA; St Lukes Roosevelt Hosp, New York, NY USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mount Sinai St. Luke's; Mount Sinai West	Brett, AS (corresponding author), Univ S Carolina, Sch Med, Columbia, SC 29208 USA.							BROWN D, 2005, WASH POST       0417, pA1; *HARV VANG MED ASS, AV INFL BIRD FLU FRE; *INF DIS SOC AM, JOINT POS STAT INF D; Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776; Lee TH, 2004, NEW ENGL J MED, V351, P2365, DOI 10.1056/NEJMp048328	5	19	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2636	2637		10.1056/NEJMp058290	http://dx.doi.org/10.1056/NEJMp058290			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371627				2022-12-28	WOS:000234094400002
J	Silliman, BR; van de Koppel, J; Bertness, MD; Stanton, LE; Mendelssohn, IA				Silliman, BR; van de Koppel, J; Bertness, MD; Stanton, LE; Mendelssohn, IA			Drought, snails, and large-scale die-off of southern US salt marshes	SCIENCE			English	Article							RECRUITMENT; ABUNDANCE; COLLAPSE; FAILURE; DECLINE	Salt marshes in the southeastern United States have recently experienced massive die-off, one of many examples of widespread degradation in marine and coastal ecosystems. Although intense drought is thought to be the primary cause of this die-off, we found snail grazing to be a major contributing factor. Survey of marsh die-off areas in three states revealed high-density fronts of snails on dieoff edges at 11 of 12 sites. Exclusion experiments demonstrated that snails actively converted marshes to exposed mudflats. Salt addition and comparative field studies suggest that drought-induced stress and grazers acted synergistically and to varying degrees to cause initial plant death. After these disturbances, snail fronts formed on die-off edges and subsequently propagated through healthy marsh, leading to cascading vegetation loss. These results, combined with model analyses, reveal strong interactions between increasing climatic stress and grazer pressure, both potentially related to human environmental impacts, which amplify the likelihood and intensity of runaway collapse in these coastal systems.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, NIOO KNAW, NL-4401 NT7 Yerseke, Netherlands; Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Brown University; Louisiana State University System; Louisiana State University	Silliman, BR (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	brs@ufl.edu	Van de Koppel, Johan/E-7266-2010	Silliman, Brian/0000-0001-6360-650X				BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; *BROWN MARSH DAT I, 2002, SALT MARSH DIEB LOUI; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Farnsworth EJ, 1997, AMBIO, V26, P328; *GA COAST RES COUN, 2004, SALT MARSH DIEB COAS; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies R. L., 1997, DISTURBANCE RECOVERY, P151; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lipcius RN, 2002, MAR ECOL PROG SER, V226, P45, DOI 10.3354/meps226045; McKee KL, 2004, GLOBAL ECOL BIOGEOGR, V13, P65, DOI 10.1111/j.1466-882X.2004.00075.x; Mitsch W.J., 2001, WETLANDS; REID WV, 2005, WORLD BANK MILLENNIU; SCHNEIDER R, 2005, P 14 BIENN COAST ZON; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Silliman BR, 2003, OIKOS, V101, P549, DOI 10.1034/j.1600-0706.2003.12070.x; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; SWENSON EM, 2003, REPORT COASTAL RESTO; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211	21	317	328	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1803	1806		10.1126/science.1118229	http://dx.doi.org/10.1126/science.1118229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357258				2022-12-28	WOS:000234093600043
J	Deuss, A; Redfern, SAT; Chambers, K; Woodhouse, JH				Deuss, A; Redfern, SAT; Chambers, K; Woodhouse, JH			The nature of the 660-kilometer discontinuity in Earth's mantle from global seismic observations of PP precursors	SCIENCE			English	Article							TRANSITION ZONE; PHASE; TRANSFORMATIONS; TOPOGRAPHY; VELOCITY	The 660-kilometer discontinuity, which separates Earth's upper and lower mantle, has been detected routinely on a global scale in underside reflections of precursors to SS shear waves. Here, we report observations of this discontinuity in many different regions, using precursors to compressional PP waves. The apparent absence of such precursors in previous studies had posed major problems for models of mantle composition. We find a complicated structure, showing single and double reflections ranging in depth from 640 to 720 kilometers, that requires the existence of multiple phase transitions at the base of the transition zone. The results are consistent with a pyrolite mantle composition.	Univ Cambridge, Dept Earth Sci, Cambridge CB3 0EZ, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Cambridge; University of Oxford	Deuss, A (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB3 0EZ, England.	deuss@esc.cam.ac.uk	Deuss, Arwen/F-6254-2012; Redfern, Simon A T/B-3733-2010	Redfern, Simon A T/0000-0001-9513-0147; Deuss, Arwen/0000-0003-3193-5987				Aki K., 1980, QUANTITATIVE SEISMOL, VI and II, DOI [10.1002/gj.3350160110, DOI 10.1002/GJ.3350160110]; ANDERSON DL, 1989, THEORY EARTH; BASS JD, 1984, GEOPHYS RES LETT, V11, P237, DOI 10.1029/GL011i003p00229; BENZ HM, 1993, NATURE, V365, P147, DOI 10.1038/365147a0; Chambers K, 2005, EARTH PLANET SC LETT, V235, P610, DOI 10.1016/j.epsl.2005.05.014; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Estabrook CH, 1996, SCIENCE, V274, P1179, DOI 10.1126/science.274.5290.1179; Helffrich G, 2000, REV GEOPHYS, V38, P141, DOI 10.1029/1999RG000060; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; HIROSE K, 2002, J GEOPHYS RES, V107, P278; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; IRIFUNE T, 1987, EARTH PLANET SC LETT, V86, P365, DOI 10.1016/0012-821X(87)90233-0; ITA J, 1992, J GEOPHYS RES-SOL EA, V97, P6849, DOI 10.1029/92JB00068; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Lebedev S, 2002, SCIENCE, V296, P1300, DOI 10.1126/science.1069407; MOONEY WD, 1995, EOS T AGU S, V76, pF421; Ringwood A.E, 1975, COMPOSITION PETROLOG; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Schubert G, 2001, MANTLE CONVECTION EA; Shearer PM, 1999, SCIENCE, V285, P1545, DOI 10.1126/science.285.5433.1545; Shearer PM, 2000, GEOPHYS MONOGR SER, V117, P115, DOI DOI 10.1029/GM117P0115; Simmons NA, 2000, NATURE, V405, P559, DOI 10.1038/35014589; Vacher P, 1998, PHYS EARTH PLANET IN, V106, P275, DOI 10.1016/S0031-9201(98)00076-4; Weidner DJ, 1998, J GEOPHYS RES-SOL EA, V103, P7431, DOI 10.1029/97JB03511	24	129	133	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					198	201		10.1126/science.1120020	http://dx.doi.org/10.1126/science.1120020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410518				2022-12-28	WOS:000234722200033
J	Wei, CL; Wu, Q; Vega, VB; Chiu, KP; Ng, P; Zhang, T; Shahab, A; Yong, HC; Fu, YT; Weng, ZP; Liu, JJ; Zhao, XD; Chew, JL; Lee, YL; Kuznetsov, VA; Sung, WK; Miller, LD; Lim, B; Liu, ET; Yu, Q; Ng, HH; Ruan, YJ				Wei, CL; Wu, Q; Vega, VB; Chiu, KP; Ng, P; Zhang, T; Shahab, A; Yong, HC; Fu, YT; Weng, ZP; Liu, JJ; Zhao, XD; Chew, JL; Lee, YL; Kuznetsov, VA; Sung, WK; Miller, LD; Lim, B; Liu, ET; Yu, Q; Ng, HH; Ruan, YJ			A global map of p53 transcription-factor binding sites in the human genome	CELL			English	Article							CHROMATIN IMMUNOPRECIPITATION; TARGET GENES; IONIZING-RADIATION; ESTROGEN-RECEPTOR; EXPRESSION; IDENTIFICATION; SIGNATURE; APOPTOSIS; SURVIVAL; PROGRAM	The ability to derive a whole-genome map of transcription-factor binding sites (TFBS) is crucial for elucidating gene regulatory networks. Herein, we describe a robust approach that couples chromatin immunoprecipitation (ChIP) with the paired-end ditag (PET) sequencing strategy for unbiased and precise global localization of TFBS. We have applied this strategy to map p53 targets in the human genome. From a saturated sampling of over half a million PET sequences, we characterized 65,572 unique p53 ChIP DNA fragments and established overlapping PET clusters as a readout to define p53 binding loci with remarkable specificity. Based on this information, we refined the consensus p53 binding motif, identified at least 542 binding loci with high confidence, discovered 98 previously unidentified p53 target genes that were implicated in novel aspects of p53 functions, and showed their clinical relevance to p53-dependent tumorigenesis in primary cancer samples.	Genome Inst Singapore, Singapore 138672, Singapore; Bioinformat Inst, Singapore 138671, Singapore; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Harvard Univ, Sch Med, Inst Med, Boston, MA 02115 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Boston University; Boston University; Harvard University; Harvard Medical School; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg; ruanyj@gis.a-star.edu.sg	Miller, Lance/A-5633-2009; Liu, Jianjun/AAK-4989-2020; Liu, Edison/C-4141-2008; Ng, Huck Hui/A-1135-2009; Chiu, Kuo-Ping/AAG-8855-2020	Liu, Jianjun/0000-0002-3255-3019; Chiu, Kuo-Ping/0000-0001-9144-0674; Yu, Qiang/0000-0003-2132-8278; Miller, Lance/0000-0003-3799-2528; Sung, Wing-Kin/0000-0001-7806-7086; Wu, Qiang/0000-0003-2049-1639	NHGRI NIH HHS [1R01HG00352-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000352] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JG, 2005, P NATL ACAD SCI USA, V102, P4813, DOI 10.1073/pnas.0407069102; Coates PJ, 2003, J PATHOL, V201, P377, DOI 10.1002/path.1456; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crosby ME, 2004, J ENVIRON PATHOL TOX, V23, P67, DOI 10.1615/JEnvPathToxOncol.v23.i1.70; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P189, DOI 10.1093/nar/gkh169; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hug BA, 2004, J BIOL CHEM, V279, P825, DOI 10.1074/jbc.M309524200; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kuznetsov V, 2005, SAGE: CURRENT TECHNOLOGIES AND APPLICATIONS, P139; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TISTY TD, 1998, CURR OPIN CELL BIOL, V10, P647; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhao RB, 2000, GENE DEV, V14, P981	49	901	952	1	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					207	219		10.1016/j.cell.2005.10.043	http://dx.doi.org/10.1016/j.cell.2005.10.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413492	Bronze			2022-12-28	WOS:000234969600020
J	Pui, CH; Evans, WE				Pui, CH; Evans, WE			Drug therapy - Treatment of acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE LYMPHOCYTIC-LEUKEMIA; GENE-EXPRESSION SIGNATURES; THYMIDYLATE SYNTHASE GENE; CENTRAL-NERVOUS-SYSTEM; TERM-FOLLOW-UP; STANDARD-RISK; TREATMENT RESPONSE; BONE-MARROW; CELL TRANSPLANTATION; CRANIAL RADIOTHERAPY		St Jude Childrens Res Hosp, Dept Hematol & Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Hematol & Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018	Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658	NCI NIH HHS [CA21765, R37 CA36401, R01 CA78224, R01 CA60419, R01 CA51001] Funding Source: Medline; NIGMS NIH HHS [U01 GM61393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA060419, R01CA078224, R37CA036401, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Annino L, 2002, BLOOD, V99, P863, DOI 10.1182/blood.V99.3.863; Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Boissel N, 2003, J CLIN ONCOL, V21, P774, DOI 10.1200/JCO.2003.02.053; Bomgaars L, 2004, J CLIN ONCOL, V22, P3916, DOI 10.1200/JCO.2004.01.046; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Brown P, 2005, BLOOD, V105, P812, DOI 10.1182/blood-2004-06-2498; Burger B, 2003, J CLIN ONCOL, V21, P184, DOI 10.1200/JCO.2003.04.096; Cario G, 2005, BLOOD, V105, P821, DOI 10.1182/blood-2004-04-1552; Cheng Q, 2005, NAT GENET, V37, P878, DOI 10.1038/ng1612; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Cheok MH, 2003, NAT GENET, V34, P231, DOI 10.1038/ng0603-231b; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Conter V, 2000, LEUKEMIA, V14, P2196, DOI 10.1038/sj.leu.2401963; Davies SM, 2002, BLOOD, V100, P67, DOI 10.1182/blood.V100.1.67; de Bont JM, 2004, LEUKEMIA, V18, P2032, DOI 10.1038/sj.leu.2403538; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; French D, 2005, HUM MOL GENET, V14, P1621, DOI 10.1093/hmg/ddi170; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; Gleissner B, 2002, BLOOD, V99, P1536, DOI 10.1182/blood.V99.5.1536; Goekbuget N, 2001, BLOOD, V98, p802A; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Hallbook H, 2002, BRIT J HAEMATOL, V118, P748, DOI 10.1046/j.1365-2141.2002.03685.x; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hijiya N, 2005, LEUKEMIA, V19, P1399, DOI 10.1038/sj.leu.2403843; Hill FGH, 2004, BRIT J HAEMATOL, V124, P33, DOI 10.1046/j.1365-2141.2003.04738.x; Hoelzer D, 2000, SEMIN ONCOL, V27, P540; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Howard SC, 2002, JAMA-J AM MED ASSOC, V288, P2001, DOI 10.1001/jama.288.16.2001; Hunault M, 2004, BLOOD, V104, P3028, DOI 10.1182/blood-2003-10-3560; Hurwitz CA, 2000, CANCER-AM CANCER SOC, V88, P1964; Igarashi S, 2005, J CLIN ONCOL, V23, P6489, DOI 10.1200/JCO.2005.01.982; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kamps WA, 2002, LEUKEMIA, V16, P1099, DOI 10.1038/sj.leu.2402489; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Kurtzberg J, 2005, J CLIN ONCOL, V23, P3396, DOI 10.1200/JCO.2005.03.199; Lange BJ, 2002, BLOOD, V99, P825, DOI 10.1182/blood.V99.3.825; Larson R. A., 2004, Annals of Hematology, V83, pS127; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lauten M, 2003, HAEMATOLOGICA, V88, P353; Lee EJ, 2001, J CLIN ONCOL, V19, P4014, DOI 10.1200/JCO.2001.19.20.4014; Lee S, 2005, BLOOD, V105, P3449, DOI 10.1182/blood-2004-09-3785; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Lipshultz SE, 2004, NEW ENGL J MED, V351, P145, DOI 10.1056/NEJMoa035153; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Mancini M, 2005, BLOOD, V105, P3434, DOI 10.1182/blood-2004-07-2922; Mattano LA, 2000, J CLIN ONCOL, V18, P3262, DOI 10.1200/JCO.2000.18.18.3262; McCarville MB, 2005, CANCER-AM CANCER SOC, V104, P380, DOI 10.1002/cncr.21134; Mitchell BS, 2003, NEW ENGL J MED, V348, P2597, DOI 10.1056/NEJMp030092; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Nemecek ER, 2002, CURR OPIN HEMATOL, V9, P316, DOI 10.1097/00062752-200207000-00009; Nygaard U, 2004, CLIN PHARMACOL THER, V75, P274, DOI 10.1016/j.clpt.2003.12.-001; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Pession A, 2005, J CLIN ONCOL, V23, P7161, DOI 10.1200/JCO.2005.11.411; Pinheiro JPV, 2004, BRIT J HAEMATOL, V125, P117, DOI 10.1111/j.1365-2141.2004.04863.x; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2003, LEUKEMIA, V17, P700, DOI 10.1038/sj.leu.2402883; Pui CH, 2005, NAT REV DRUG DISCOV, V4, P369, DOI 10.1038/nrd1724; Pui CH, 2003, NEW ENGL J MED, V349, P1299; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; Pui CH, 2002, BEST PRACT RES CL HA, V15, P741, DOI 10.1053/beha.2002.0225; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2001, LEUKEMIA, V15, P707, DOI 10.1038/sj.leu.2402111; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Relling MV, 2000, LANCET, V356, P285, DOI 10.1016/S0140-6736(00)02503-4; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Rubnitz JE, 2004, CANCER-AM CANCER SOC, V101, P1677, DOI 10.1002/cncr.20532; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schrappe M, 2000, BLOOD, V95, P3310; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Sutcliffe MJ, 2005, LEUKEMIA, V19, P734, DOI 10.1038/sj.leu.2403673; Takeuchi J, 2002, LEUKEMIA, V16, P1259, DOI 10.1038/sj.leu.2402526; ten Bosch JV, 2005, LEUKEMIA, V19, P721, DOI 10.1038/sj.leu.2403689; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Thomas X, 2004, J CLIN ONCOL, V22, P4075, DOI 10.1200/JCO.2004.10.050; Toyoda Y, 2000, J CLIN ONCOL, V18, P1508, DOI 10.1200/JCO.2000.18.7.1508; Tsutsumi S, 2003, CANCER RES, V63, P4882; Vilmer E, 2000, LEUKEMIA, V14, P2257, DOI 10.1038/sj.leu.2401960; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willenbrock H, 2004, LEUKEMIA, V18, P1270, DOI 10.1038/sj.leu.2403392; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zaza G, 2005, BLOOD, V106, P1778, DOI 10.1182/blood-2005-01-0143	111	1381	1545	4	159	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					166	178		10.1056/NEJMra052603	http://dx.doi.org/10.1056/NEJMra052603			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407512				2022-12-28	WOS:000234528600009
J	Ray, WA; Stein, CM				Ray, WA; Stein, CM			Reform of drug regulation - Beyond an independent drug-safety board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; POSTMARKETING SURVEILLANCE; EDUCATIONAL OUTREACH; CLINICAL-TRIALS; PUBLIC-HEALTH; OF-INTEREST; FDA; ROFECOXIB; RISK; RHABDOMYOLYSIS		Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Rheumatol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Rheumatol, Nashville, TN 37212 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Ray, WA (corresponding author), Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA.							Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Angell M., 2004, TRUTH DRUG CO; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Avorn J, 2004, POWERFUL MED BENEFIT; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bradley EH, 2005, HEALTH SERV RES, V40, P459, DOI 10.1111/j.1475-6773.2005.0y368.x; Briss PA, 2005, LANCET, V365, P828, DOI 10.1016/S0140-6736(05)71019-9; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Califf RM, 2002, PHARMACOEPIDEM DR S, V11, P319, DOI 10.1002/pds.699; Campbell WH, 2003, PHARMACOEPIDEM DR S, V12, P183, DOI 10.1002/pds.761; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Connolly HM, 1997, NEW ENGL J MED, V337, P1783; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; *GEN ACC OFF, 2002, GAO02958; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Graham DJ, 2001, JAMA-J AM MED ASSOC, V286, P831, DOI 10.1001/jama.286.7.831; Griffin MR, 2004, CLIN PHARMACOL THER, V75, P491, DOI 10.1016/j.clpt.2004.01.017; Griffin MR, 2004, PHARMACOEPIDEM DR S, V13, P339, DOI 10.1002/pds.879; Harris G., 2005, NY TIMES 0225, pA1; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Joint Commission on Prescription Drug Use, 1980, FIN REP; Landefeld CS, 2004, AM J MED, V117, P876, DOI 10.1016/j.amjmed.2004.10.001; Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037; MEADOWS M, 2002, FDA CONSUM, V36, P3; Meadows Michelle, 2002, FDA Consum, V36, P19; Meadows Michelle, 2002, FDA Consum, V36, P11; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P1365, DOI 10.1001/jama.292.11.1365; Okie S, 2005, NEW ENGL J MED, V352, P1063, DOI 10.1056/NEJMp058003; Okie S, 2005, NEW ENGL J MED, V352, P2563; Okie S, 2005, NEW ENGL J MED, V352, P1173, DOI 10.1056/NEJMp058029; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Rawlins MD, 2005, LANCET, V365, P904, DOI 10.1016/S0140-6736(05)71050-3; RAY WA, 1993, NEW ENGL J MED, V329, P2029, DOI 10.1056/NEJM199312303292710; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; Silverman Milton, 1974, PILLS PROFITS POLITI; Slater EE, 2005, NEW ENGL J MED, V352, P293, DOI 10.1056/NEJMsb042278; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Steinbrook R, 2005, NEW ENGL J MED, V353, P116, DOI 10.1056/NEJMp058108; Temple RJ, 1997, CONTROL CLIN TRIALS, V18, P613, DOI 10.1016/S0197-2456(97)00058-5; TEMPLE RJ, 1989, MED CLIN N AM, V79, P495; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Ward RM, 2002, PEDIATRICS, V110, P181; WISEMAN LR, 1994, DRUGS, V47, P116, DOI 10.2165/00003495-199447010-00008; Wood AJJ, 1998, NEW ENGL J MED, V339, P1851, DOI 10.1056/NEJM199812173392512; Wood AJJ, 2005, NEW ENGL J MED, V353, P1197, DOI 10.1056/NEJMp058222; WOOSLEY RL, 1994, CLIN PHARMACOL THER, V55, P249, DOI 10.1038/clpt.1994.24; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Woosley RL, 1996, ANNU REV PHARMACOL, V36, P233, DOI 10.1146/annurev.pa.36.040196.001313; Woosley RL, 2000, JAMA-J AM MED ASSOC, V284, P3047, DOI 10.1001/jama.284.23.3047; 2000, MED MARKETING MEDIA, V35, P6	56	87	90	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					194	201		10.1056/NEJMsb053432	http://dx.doi.org/10.1056/NEJMsb053432			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	001JE	16407517				2022-12-28	WOS:000234528600015
J	Warlow, C				Warlow, C			A new NHS research strategy	LANCET			English	Editorial Material									Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Warlow, C (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	charles.warlow@ed.ac.uk						*DEP HLTH, 2005, BEST RES BEST HLTH N; WHAT IS RAE 2008	2	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					12	13		10.1016/S0140-6736(06)67902-6	http://dx.doi.org/10.1016/S0140-6736(06)67902-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399137				2022-12-28	WOS:000234443100009
J	Steinbrook, R				Steinbrook, R			Searching for the right search - Reaching the medical literature	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS											FOX S, 2005, HLTH INFORMATION ONL; Sack J, 2005, LEARN PUBL, V18, P131, DOI 10.1087/0953151053584948; Steinbrook R, 2005, NEW ENGL J MED, V352, P1739, DOI 10.1056/NEJMp058088; Wren JD, 2005, BRIT MED J, V330, P1128, DOI 10.1136/bmj.38422.611736.E0; Wysocki Jr B., 2005, WALL STREET J, pA1	5	75	84	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					4	7		10.1056/NEJMp058128	http://dx.doi.org/10.1056/NEJMp058128			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998ZO	16394296				2022-12-28	WOS:000234358600002
J	Murabito, JM; Pencina, MJ; Nam, BH; D'Agostino, RB; Wang, TJ; Lloyd-Jones, D; Wilson, PWF; O'Donnell, CJ				Murabito, JM; Pencina, MJ; Nam, BH; D'Agostino, RB; Wang, TJ; Lloyd-Jones, D; Wilson, PWF; O'Donnell, CJ			Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; FAMILY-HISTORY; MYOCARDIAL-INFARCTION; DEATH; PREVALENCE	Context While parental cardiovascular disease (CVD) doubles the risk for CVD in offspring, the extent of increased risk associated with sibling CVD is unclear. Objective To determine, using validated events, whether sibling CVD predicts outcome in middle-aged adults independent of other risk factors. Design, Setting, and Participants The Framingham Offspring Study, an inception cohort of the Framingham Heart Study, a prospective population-based cohort study initiated in 1948 with the offspring cohort initiated in 1971. Participants (n = 2475) were members of the offspring cohort aged 30 years or older, free of CVD, and with at least I sibling in the study; all were followed up for 8 years. Main Outcome Measures Association of sibling CVD with 8-year personal risk for CVD using pooled logistic regression. A secondary analysis restricted to offspring with both parents in the study assessed the joint impact of parental and sibling CVD occurrence. Results Among 973 person-examinations in the sibling CVD group (mean age, 57 years) and 4506 person-examinations in the no sibling CVD group (mean age, 47 years), 329 CVD events occurred during follow-up. Baseline risk factors were more prevalent in the sibling CVD group compared with the no sibling CVD group. Sibling CVD was associated with a significantly increased risk for incident CVD (age- and sex-adjusted odds ratio [OR], 1.55; 95% confidence interval [CI], 1.19-2.03). Adjustment for risk factors did not substantially attenuate the risk (adjusted OR, 1.45; 95% Cl, 1.10-1.91). In the analysis restricted to persons with both parents in the study, in models adjusting for both sibling and parental CVD, the multivariable-adjusted OR for sibling CVD (1.99; 95% Cl, 1.32-3.00) exceeded that for parental CVD (1.45; 95% Cl, 1.02-2.05). Conclusion Using validated events, sibling CVD conferred increased risk of future CVD events above and beyond established risk factors and parental CVD in middle-aged adults.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA USA; Boston Univ, Stat & Consulting Unit, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA; Northwestern Univ, Feinberg Sch Med, Bluhm Cardiovasc Inst, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; Med Univ S Carolina, Dept Endocrinol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Diabet, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med Genet, Charleston, SC 29425 USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Murabito, JM (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	murabito@bu.edu	Lloyd-Jones, Donald M/C-5899-2009; Wilson, Peter W.F./J-2455-2016	Lloyd-Jones, Donald/0000-0003-0847-6110; Murabito, Joanne/0000-0002-0192-7516; Pencina, Michael/0000-0001-5798-8855	NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott RD, 1987, FRAMINGHAM STUDY EPI; Allen JK, 1996, ARCH INTERN MED, V156, P1654, DOI 10.1001/archinte.156.15.1654; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; BECKER DM, 1988, J AM COLL CARDIOL, V12, P1273, DOI 10.1016/0735-1097(88)92611-3; Becker DM, 1998, AM J CARDIOL, V82, P1046, DOI 10.1016/S0002-9149(98)00553-0; Bertuzzi M, 2003, PREV MED, V37, P183, DOI 10.1016/S0091-7435(03)00094-X; Brenn T, 1998, J Cardiovasc Risk, V5, P325, DOI 10.1097/00043798-199810000-00007; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1044; Ciruzzi M, 1997, AM J CARDIOL, V80, P122, DOI 10.1016/S0002-9149(97)00304-4; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KHOURY MJ, 1995, EPIDEMIOLOGY, V6, P511, DOI 10.1097/00001648-199509000-00009; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; Pankow JS, 2004, HUM HERED, V57, P80, DOI 10.1159/000077545; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	27	167	171	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3117	3123		10.1001/jama.294.24.3117	http://dx.doi.org/10.1001/jama.294.24.3117			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380592	Bronze			2022-12-28	WOS:000234274200028
J	Blair, NA; Yue, SK; Singh, R; Bernhardt, JM				Blair, NA; Yue, SK; Singh, R; Bernhardt, JM			Depictions of substance use in reality television: a content analysis of The Osbournes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOBACCO USE; MOVIES; ALCOHOL	Objective To determine the source and slant of messages in a reality television programme that may promote or inhibit health related or risky behaviours. Design Coding visual and verbal references to alcohol, tobacco, and other drug (ATOD) use in The Osbournes. Review methods Three reviewers watched all 10 episodes of the first season and coded incidents of substance use according to die substance used (alcohol, tobacco, or drugs), the way use was portrayed (visually or verbally), the source of the message (the character in the show involved in the incident), and the slant of the incident (endorsement or rejection). Main outcome measures The variation in number of messages in an average episode, the slant of messages, and message source. Results The average number of messages per episode was 9.1 (range 2-17). Most drug use messages (15, 54%) implied rejection of drugs, but most alcohol messages (30, 64%) and tobacco messages (12, 75%) implied endorsements for using these substances. Most rejections (34, 94%) were conveyed verbally, but most endorsements (36, 65%) were conveyed Visually. Messages varied in frequency and slant by source. Conclusions The reality television show analysed in this study contains numerous messages on Substance use that imply both rejection and endorsement Of use. The juxtaposition of verbal rejection messages and visual endorsement messages, and the depiction of contradictory messages about substance use from show characters, may send mixed messages to viewers about substance use.	Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA; Emory Univ, Career Master Publ Hlth Program, Atlanta, GA 30322 USA; NYU, Coll Dent, New York, NY USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; New York University; Emory University; Rollins School Public Health	Blair, NA (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA.	nblair@cdc.gov		Bernhardt, Jay/0000-0002-2045-4005				*AM LUNG ASS SACR, 2000, THUMBS THUMBS TOB US; Bandura A., 1986, SOCIAL FDN THOUGHT A; Brier Noah Rubin, 2004, AM DEMOGR, V26, P14; Brown WJ, 2004, LEA COMMUN SER, P97; CAFISO J, 1982, J STUD ALCOHOL, V43, P1232, DOI 10.15288/jsa.1982.43.1232; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Dalton MA, 2002, PREV MED, V34, P516, DOI 10.1006/pmed.2002.1013; DuRant RH, 1997, AM J PUBLIC HEALTH, V87, P1131, DOI 10.2105/AJPH.87.7.1131; GERBNER G, 1997, ALCOHOL TOBACCO ILLI; KIESEWELTER J, 2002, CINCINNATI ENQU 1229; Kilbourne J., 1999, DEADLY PERSUASION WH; *NEILS MED RES, 1998, 1998 REP TEL; *NIELS MED RES, 2000, 1998 REP TEL; *OFF NAT DRUG CONT, 2000, SUBST US POP PRIM TI; Roberts D. F., 2000, HERES LOOKING YOU KI; Salomon G., 1979, INTERACTION MEDIA CO, DOI DOI 10.4324/9780203052945; Sargent JD, 2002, AM J PREV MED, V22, P137, DOI 10.1016/S0749-3797(01)00434-2; Sargent JD, 2001, BRIT MED J, V323, P1; SCHMUCKLER E, 2004, MEDIAWEEK, V14, pSR32; Strasburger VC, 1995, ADOLESCENTS MEDIA ME; TITLES AIR DATES GUI	21	29	29	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1517	+		10.1136/bmj.331.7531.1517	http://dx.doi.org/10.1136/bmj.331.7531.1517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373737	Green Published			2022-12-28	WOS:000234351300017
J	Martyn, C				Martyn, C			Slow tracking for BMJ papers	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Martyn, C (corresponding author), BMJ, London WC1H 9JR, England.	cmartyn@bmj.com						BECKSVOORT C, 2000, SHAKER LEGACY; Goldbeck-Wood S, 1999, BRIT MED J, V318, P620, DOI 10.1136/bmj.318.7184.620; MACNAMEE D, 1997, LANCET, V349, P970; SHAKESPEARE W, MACBETH; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Winker MA, 1999, JAMA-J AM MED ASSOC, V281, P1754, DOI 10.1001/jama.281.18.1754	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1551	1552		10.1136/bmj.331.7531.1551	http://dx.doi.org/10.1136/bmj.331.7531.1551			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373749	Green Published, Bronze			2022-12-28	WOS:000234351300030
J	Kim, SF; Huri, DA; Snyder, SH				Kim, SF; Huri, DA; Snyder, SH			Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2	SCIENCE			English	Article							PROSTAGLANDIN PRODUCTION; INFLAMMATION; INHIBITORS; INDUCTION; CELLS	Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) are two major inflammatory mediators. Here we show that iNOS specifically binds to COX-2 and S-nitrosylates it, enhancing COX-2 catalytic activity. Selectively disrupting iNOS-COX-2 binding prevented NO-mediated activation of COX-2. This synergistic molecular interaction between two inflammatory systems may inform the development of anti-inflammatory drugs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			NIDA NIH HHS [DA00074, DA000266] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Appleton I, 1996, Adv Pharmacol, V35, P27, DOI 10.1016/S1054-3589(08)60274-4; BRAUGHLER JM, 1979, J BIOL CHEM, V254, P2450; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd1034; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE, pP61; KENNEDY TA, 1994, J BIOL CHEM, V269, P27357; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; MISKO TP, 1995, J NEUROIMMUNOL, V61, P195, DOI 10.1016/0165-5728(95)00091-F; Moncada S, 1999, J ROY SOC MED, V92, P164, DOI 10.1177/014107689909200402; Murad F, 1978, Adv Cyclic Nucleotide Res, V9, P145; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P366, DOI 10.1001/jama.293.3.366; TSAI AL, 1994, ARCH BIOCHEM BIOPHYS, V313, P367, DOI 10.1006/abbi.1994.1400; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102	23	411	441	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1966	1970		10.1126/science.1119407	http://dx.doi.org/10.1126/science.1119407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373578				2022-12-28	WOS:000234275400046
J	Rokas, A; Kruger, D; Carroll, SB				Rokas, A; Kruger, D; Carroll, SB			Animal evolution and the molecular signature of radiations compressed in time	SCIENCE			English	Article							MISSING DATA; LIFE; PHYLOGENY; ECDYSOZOA; GENES; FUNGI; TAXA; TREE	The phylogenetic relationships among most metazoan phyla remain uncertain. We obtained large numbers of gene sequences from metazoans, including key understudied taxa. Despite the amount of data and breadth of taxa analyzed, relationships among most metazoan phyla remained unresolved. In contrast, the same genes robustly resolved phylogenetic relationships within a major clade of Fungi of approximately the same age as the Metazoa. The differences in resolution within the two kingdoms suggest that the early history of metazoans was a radiation compressed in time, a finding that is in agreement with paleontological inferences. Furthermore, simulation analyses as well as studies of other radiations in deep time indicate that, given adequate sequence data, the lack of resolution in phylogenetic trees is a signature of closely spaced series of cladogenetic events.	Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Krüger, Dirk/C-3316-2012; Rokas, Antonis/A-9775-2008	Krüger, Dirk/0000-0002-7305-5104; Rokas, Antonis/0000-0002-7248-6551				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Ane C, 2005, MOL BIOL EVOL, V22, P914, DOI 10.1093/molbev/msi076; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; BALDWIN TF, 1972, TELEVISION SOCIAL BE, V1, P290; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Clack JA., 2012, GAINING GROUND ORIGI; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; ERWIN DH, 1991, TRENDS ECOL EVOL, V6, P131, DOI 10.1016/0169-5347(91)90092-C; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; FIALA KI, 1985, EVOLUTION, V39, P609, DOI 10.1111/j.1558-5646.1985.tb00398.x; Giribet G, 2002, MOL PHYLOGENET EVOL, V24, P345, DOI 10.1016/S1055-7903(02)00206-3; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; PHILIPPE H, 1994, DEVELOPMENT, P15; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; RAUP DM, 1983, PALEOBIOLOGY, V9, P107, DOI 10.1017/S0094837300007491; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Rowe T, 2004, ASSEMBLING THE TREE OF LIFE, P384; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Sober E, 2002, J THEOR BIOL, V218, P395, DOI 10.1006/jtbi.2002.3086; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Valentine JW, 1996, DEV BIOL, V173, P373, DOI 10.1006/dbio.1996.0033; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	45	250	260	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1933	1938		10.1126/science.1116759	http://dx.doi.org/10.1126/science.1116759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373569				2022-12-28	WOS:000234275400036
J	Gupta, A; Kedhar, S				Gupta, A; Kedhar, S			Eye worm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Baltimore, MD 21287 USA	Johns Hopkins University	Gupta, A (corresponding author), Johns Hopkins Univ, Baltimore, MD 21287 USA.		Kedhar, Sanjay/AAF-5164-2021						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					E22	E22		10.1056/NEJMicm050807	http://dx.doi.org/10.1056/NEJMicm050807			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371625				2022-12-28	WOS:000234094400011
J	Phillips, CM; Wong, C; Bhalla, N; Carlton, PM; Weiser, P; Meneely, PM; Dernburg, AF				Phillips, CM; Wong, C; Bhalla, N; Carlton, PM; Weiser, P; Meneely, PM; Dernburg, AF			HIM-8 binds to the X chromosome pairing center and mediates chromosome-specific meiotic synapsis	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NUCLEAR REORGANIZATION; HOP1 PROTEIN; RECOMBINATION; MEIOSIS; MUTANTS; EXPANSION	The him-8 gene is essential for proper meiotic segregation of the X chromosomes in C. elegans. Here we show that loss of him-8 function causes profound X chromosome-specific defects in homolog pairing and synapsis. him-8 encodes a C2H2 zinc-finger protein that is expressed during meiosis and concentrates at a site on the X chromosome known as the meiotic pairing center (PC). A role for HIM-8 in PC function is supported by genetic interactions between PC lesions and him-8 mutations. HIM-8 bound chromosome sites associate with the nuclear envelope (NE) throughout meiotic prophase. Surprisingly, a point mutation in him8 that retains both chromosome binding and NE localization fails to stabilize pairing or promote synapsis. These observations indicate that stabilization of homolog pairing is an active process in which the tethering of chromosome sites to the NE may be necessary but is not sufficient.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Life Sci Div, Berkeley, CA 94720 USA; Haverford Coll, Dept Biol, Haverford, PA 19041 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Haverford College	Phillips, CM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011; Carlton, Peter/AAD-2403-2021	Phillips, Carolyn/0000-0002-6228-6468; Carlton, Peter/0000-0002-5320-6024; Dernburg, Abby/0000-0001-8037-1079	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067408] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM067408-01A1, F32 GM067408, F32 GM067408-02, GM067408, R01 GM/CA655591] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Anuradha S, 2004, J BIOL CHEM, V279, P28961, DOI 10.1074/jbc.M403727200; Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; BAKER BS, 1972, GENETICS, V71, P255; BHALLA N, 2005, IN PRESS SCIENCE, V310; BRENNER S, 1974, GENETICS, V77, P71; BROVERMAN SA, 1994, GENETICS, V136, P119; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; GOLDSTEIN P, 1982, CHROMOSOMA, V84, P585, DOI 10.1007/BF00292857; HERMAN RK, 1989, GENETICS, V121, P723; HODGKIN J, 1979, GENETICS, V91, P67; HOLLSTEN DA, 1990, OPHTHALMIC PLAST REC, V6, P1; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Lieb JD, 2000, GENETICS, V156, P1603; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; MCKIM KS, 1993, GENETICS, V134, P749; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Tomkiel JE, 2001, GENETICS, V157, P273; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; VILLENEUVE AM, 1994, GENETICS, V136, P887; ZETKA MC, 1992, GENETICS, V131, P321; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	28	194	199	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1051	1063		10.1016/j.cell.2005.09.035	http://dx.doi.org/10.1016/j.cell.2005.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360035	Green Accepted, Bronze			2022-12-28	WOS:000234177200014
J	Baudouin, SV; Saunders, D; Tiangyou, W; Elson, JL; Poynter, J; Pyle, A; Keers, S; Turnbull, DM; Howell, N; Chinnery, PF				Baudouin, SV; Saunders, D; Tiangyou, W; Elson, JL; Poynter, J; Pyle, A; Keers, S; Turnbull, DM; Howell, N; Chinnery, PF			Mitochondrial DNA and survival after sepsis: a prospective study	LANCET			English	Article							SEPTIC SHOCK; DISEASE; HAPLOGROUPS; DYSFUNCTION; POLYMORPHISMS; EPIDEMIOLOGY; SEVERITY; FEVER; RISK	Background Human genome evolution has been shaped by infectious disease. Although most genetic studies have focused on the immune system, recovery after sepsis is directly related to physiological reserve that is critically dependent on mitochondrial function. We investigated whether haplogroup H, the most common type of mitochondrial DNA (mtDNA) in Europe, contributes to the subtle genetic variation in survival after sepsis. Methods In a prospective study, we included 150 individuals who were sequentially admitted to the intensive care unit in a hospital in Newcastle upon Tyne, UK. After clinical data were obtained, patients underwent mtDNA haplotyping by analysis with PCR and restriction fragment length polymorphism. As endpoints, we used death during the 6-month period or survival at 6 months. Findings Follow-up was complete for all study participants, although the haplotype of two patients could not be reliably determined. On admission to the intensive care unit, the frequency of mtDNA haplogroup H in study patients did not differ between study patients admitted with severe sepsis and 542 age-matched controls from the northeast of England. MtDNA haplogroup H was a strong independent predictor of outcome during severe sepsis, conferring a 2.12-fold (95% CI 1.02-4.43) increased chance of survival at 180 days compared with individuals without the haplogroup H. Interpretation Although haplogroup H is the most recent addition to the group of European mtDNA, paradoxically it is also the most common. increased survival after sepsis provides one explanation for this observation. MtDNA haplotyping offers a new means of risk stratification of patients with severe infections, which suggests new avenues for therapeutic intervention.	Newcastle Univ, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Univ Dept Surg & Reprod Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Migenix Corp, San Diego, CA USA	Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk		/0000-0002-3551-5624; Saunders, David/0000-0003-0251-020X; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; HIRAI F, 1984, EUR SURG RES, V16, P148, DOI 10.1159/000128402; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin MT, 2004, CRIT CARE MED, V32, P569, DOI 10.1097/01.CCM.0000110878.49476.42; OHTOSHI M, 1984, RES EXP MED, V184, P209, DOI 10.1007/BF01852379; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SIMONSON SG, 1994, CIRC SHOCK, V43, P34; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	25	134	139	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2118	2121		10.1016/S0140-6736(05)67890-7	http://dx.doi.org/10.1016/S0140-6736(05)67890-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360789				2022-12-28	WOS:000234146000027
J	Corrado, D; Basso, C; Thiene, G				Corrado, D; Basso, C; Thiene, G			Essay - Sudden death in young athletes	LANCET			English	Article									Univ Padua, Div Cardiol, I-35121 Padua, Italy; Univ Padua, Inst Pathol Anat, I-35121 Padua, Italy	University of Padua; University of Padua	Corrado, D (corresponding author), Univ Padua, Div Cardiol, Via Giustiniani 2, I-35121 Padua, Italy.	domenico.corrado@unipd.it		CORRADO, DOMENICO/0000-0003-1487-0392; basso, cristina/0000-0002-0195-9753				Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Thiene G, 2001, CARDIOVASC PATHOL, P326	3	75	78	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S47	S48		10.1016/S0140-6736(05)67847-6	http://dx.doi.org/10.1016/S0140-6736(05)67847-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360752				2022-12-28	WOS:000234374400030
J	Spiegel, SJ; Yassi, A; Spiegel, JM; Veiga, MM				Spiegel, SJ; Yassi, A; Spiegel, JM; Veiga, MM			Reducing mercury and responding to the global gold rush	LANCET			English	Editorial Material									Univ British Columbia, Dept Min Engn, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Inst Hlth Promot Res, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Spiegel, SJ (corresponding author), Univ British Columbia, Dept Min Engn, Vancouver, BC V6T 1Z4, Canada.	samspiegel@gmail.com		Spiegel, Samuel/0000-0003-2163-3512				Attaran A, 2000, NAT MED, V6, P729, DOI 10.1038/77438; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; *EEB, WORLD URG NEEDS EUR; International Labour Organisation, 1999, SOC LAB ISS SMALL SC; Labonte R, 2003, BRIT MED J, V326, P722, DOI 10.1136/bmj.326.7392.722; SPIEGEL SJ, 2005, ECOHEALTH       1019, DOI DOI 10.1007/S10393-005-8389-9; *UN ENV PROGR, STOCKH CONV ENT FORC; *UNIDO PIL PROJ RE, 2005, REP UNIDO BLACKSM I; Veiga M, 2004, REPORT GLOBAL MERCUR; Veiga M.M., 1997, INTRO NEW TECHNOLOGI, P94; VEIGA MM, IN PRESS J CLEANER P; World Health Organization, 1991, ENV HLTH CRIT, V118	12	37	40	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2070	2072		10.1016/S0140-6736(05)67868-3	http://dx.doi.org/10.1016/S0140-6736(05)67868-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360774				2022-12-28	WOS:000234146000007
J	Wann, DL				Wann, DL			Essay - Aggression in sport	LANCET			English	Article									Murray State Univ, Dept Psychol, Murray, KY 42071 USA	Murray State University	Wann, DL (corresponding author), Murray State Univ, Dept Psychol, Murray, KY 42071 USA.	dan.wann@murraystate.edu						Baron R., 1994, HUMAN AGGRESSION, DOI 10.1002/1098-2337(1994)20:63.0.CO;2-O; Wann, 1997, SPORT PSYCHOL; Wann D., 2001, SPORTS FANS PSYCHOL	3	4	4	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S31	S32		10.1016/S0140-6736(05)67837-3	http://dx.doi.org/10.1016/S0140-6736(05)67837-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360742				2022-12-28	WOS:000234374400020
J	Stinaff, EA; Scheibner, M; Bracker, AS; Ponomarev, IV; Korenev, VL; Ware, ME; Doty, MF; Reinecke, TL; Gammon, D				Stinaff, EA; Scheibner, M; Bracker, AS; Ponomarev, IV; Korenev, VL; Ware, ME; Doty, MF; Reinecke, TL; Gammon, D			Optical signatures of coupled quantum dots	SCIENCE			English	Article							MOLECULES; ISLANDS	An asymmetric pair of coupled InAs quantum dots is tuned into resonance by applying an electric field so that a single hole forms a coherent molecular wave function. The optical spectrum shows a rich pattern of level anticrossings and crossings that can be understood as a superposition of charge and spin configurations of the two dots. Coulomb interactions shift the molecular resonance of the optically excited state (charged exciton) with respect to the ground-state (single charge), enabling light-induced coupling of the quantum dots. This result demonstrates the possibility of optically coupling quantum dots for application in quantum information processing.	USN, Res Lab, Washington, DC 20375 USA; AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia	United States Department of Defense; United States Navy; Naval Research Laboratory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Gammon, D (corresponding author), USN, Res Lab, Washington, DC 20375 USA.	gammon@nrl.navy.mil	Doty, Matthew/S-5271-2019; Korenev, Vladimir/C-1107-2014; Ponomarev, Ilya V/F-5183-2010; Doty, Matthew F/B-5075-2010; Ware, Morgan E/I-8233-2012	Doty, Matthew/0000-0001-7999-3567; Ponomarev, Ilya V/0000-0002-8584-6034; Doty, Matthew F/0000-0001-7999-3567; Ware, Morgan E/0000-0002-9998-4139; Korenev, Vladimir/0000-0003-2839-2934				Bayer M, 2001, SCIENCE, V291, P451, DOI 10.1126/science.291.5503.451; Bellucci D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205332; Bester G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075325; Biolatti E, 2000, PHYS REV LETT, V85, P5647, DOI 10.1103/PhysRevLett.85.5647; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Chen PC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067401; Cortez S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.207401; Gammon D, 2002, PHYS TODAY, V55, P36, DOI 10.1063/1.1522165; Garcia JM, 1997, APPL PHYS LETT, V71, P2014, DOI 10.1063/1.119772; Hatano T, 2005, SCIENCE, V309, P268, DOI 10.1126/science.1111205; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Krenner HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057402; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; Lyanda-Geller YB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.161308; Ortner G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157401; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Schedelbeck G, 1997, SCIENCE, V278, P1792, DOI 10.1126/science.278.5344.1792; Solomon GS, 1996, PHYS REV LETT, V76, P952, DOI 10.1103/PhysRevLett.76.952; Szafran B, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205316; Villas-Boas JM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125342; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; Ware ME, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177403; Wasilewski ZR, 1999, J CRYST GROWTH, V201, P1131, DOI 10.1016/S0022-0248(98)01539-5; Woods LM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125330; XIE QH, 1995, PHYS REV LETT, V75, P2542, DOI 10.1103/PhysRevLett.75.2542; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	27	409	416	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2006	311	5761					636	639		10.1126/science.1121189	http://dx.doi.org/10.1126/science.1121189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16410487				2022-12-28	WOS:000235257400040
J	McColl, K; Pickworth, S; Raymond, I				McColl, K; Pickworth, S; Raymond, I			Primary care - Project: London - supporting vulnerable populations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Med Monde UK, London E14 5AA, England		McColl, K (corresponding author), Med Monde UK, London E14 5AA, England.	karen.mccoll@medecinsdumonde.org.uk						*BRIT MED ASS, 2003, BMA RESP GOV PLANS C; *CONS ASS, 2002, WHICH MAGAZINE   OCT, P34; *DEP HLTH, 2005, TACKL HLTH IN STAT R; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2003, TACKL HLTH IN PROGR; Department of Health, 2004, PROP EXCL OV VIS EL; *DETR, 1999, HOM SHEET HOM PEOPL; *LOND ASS MAYOR LO, 2003, ACC PRIM CAR JOINT L; *LOND BOR TOW HAML, 2005, TOW HAML PROF; *LOND HLTH COMM, 2005, HLTH LOND REV LOND H; *MED PRACT UN, 2004, RESP PROP EXCL OV VI; Office of the Deputy Prime Minister, 2004, ENGL IND DEPR 2004	12	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					115	117		10.1136/bmj.332.7533.115	http://dx.doi.org/10.1136/bmj.332.7533.115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410592	Green Published			2022-12-28	WOS:000234777000029
J	Foo, SS; Turner, CJ; Adams, S; Compagni, A; Aubyn, D; Kogata, N; Lindblom, P; Shani, M; Zicha, D; Adams, RH				Foo, SS; Turner, CJ; Adams, S; Compagni, A; Aubyn, D; Kogata, N; Lindblom, P; Shani, M; Zicha, D; Adams, RH			Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly	CELL			English	Article							VASCULAR SMOOTH-MUSCLE; RECEPTOR TYROSINE KINASES; CARDIOVASCULAR DEVELOPMENT; MOLECULAR REGULATION; ENDOTHELIAL-CELLS; A LIGANDS; PDGF-B; PHOSPHORYLATION; ANGIOGENESIS; EXPRESSION	New blood vessels are initially formed through the assembly or sprouting of endothelial cells, but the recruitment of supporting pericytes and vascular smooth muscle cells (mural cells) ensures the formation of a mature and stable vascular network. Defective mural-cell coverage is associated with the poorly organized and leaky vasculature seen in tumors or other human diseases. Here we report that mural cells require ephrin-B2, a ligand for Eph receptor tyrosine kinases, for normal association with small-diameter blood vessels (microvessels). Tissue-specific mutant mice display perinatal lethality; vascular defects in skin, lung, gastrointestinal tract, and kidney glomeruli; and abnormal migration of smooth muscle cells to lymphatic capillaries. Cultured ephrin-B2-deficient smooth muscle cells are defective in spreading, focal-adhesion formation, and polarized migration and show increased motility. Our results indicate that the role of ephrin-B2 and EphB receptors in these processes involves Crk-p130(CAS) signaling and suggest that ephrin-B2 has some cell-cell-contact-independent functions.	Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Light Microscopy Lab, London WC2A 3PX, England; Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel	Cancer Research UK; Cancer Research UK; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@cancer.org.uk	Adams, Ralf H/AAE-9274-2019; Zicha, Daniel/H-9310-2016	compagni, amelia/0000-0003-1744-3134; Tomita, Naoko/0000-0002-7777-0797; Zicha, Daniel/0000-0002-8808-8064; Turner, Christopher/0000-0003-1715-0382				Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Andres AC, 2003, J MAMMARY GLAND BIOL, V8, P475, DOI 10.1023/B:JOMG.0000017433.83226.22; Betsholtz C, 2005, EXP SUPPL, V94, P115; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Faxon DP, 2004, CIRCULATION, V109, P2617, DOI 10.1161/01.CIR.0000128520.37674.EF; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pepper MS, 2003, J CELL BIOL, V163, P209, DOI 10.1083/jcb.200308082; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Saharinen P, 2004, ANN NY ACAD SCI, V1014, P76, DOI 10.1196/annals.1294.008; SAKAMOTO H, 2004, BIOCH BIOHPYS RES CO, V231, P681; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Uyen HD, 2002, J CELL SCI, V115, P3073; Wang JH, 2002, AM J OPHTHALMOL, V134, P93, DOI 10.1016/S0002-9394(02)01517-9; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	44	339	351	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					161	173		10.1016/j.cell.2005.10.034	http://dx.doi.org/10.1016/j.cell.2005.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413489	Bronze			2022-12-28	WOS:000234969600017
J	Woodruff, BA				Woodruff, BA			Interpreting mortality data in humanitarian emergencies	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Maternal & Child Nutr Branch, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Woodruff, BA (corresponding author), Ctr Dis Control & Prevent, Maternal & Child Nutr Branch, Atlanta, GA 30341 USA.	BWoodruff@cdc.gov						[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Checchi F, 2005, INTERPRETING USING M; Ronald C, 1999, BMJ, V318; *SAV CHILDR UK, 2004, SURV MAN; World Food Programme (WFP) and the Centers for Disease Control and Prevention (CDC), 2005, MANUAL MEASURING INT; 2005, MEASURING MORTALITY	6	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					9	10		10.1016/S0140-6736(05)67637-4	http://dx.doi.org/10.1016/S0140-6736(05)67637-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399135				2022-12-28	WOS:000234443100007
J	Brown, SS; Ryerson, TB; Wollny, AG; Brock, CA; Peltier, R; Sullivan, AP; Weber, RJ; Dube, WP; Trainer, M; Meagher, JF; Fehsenfeld, FC; Ravishankara, AR				Brown, SS; Ryerson, TB; Wollny, AG; Brock, CA; Peltier, R; Sullivan, AP; Weber, RJ; Dube, WP; Trainer, M; Meagher, JF; Fehsenfeld, FC; Ravishankara, AR			Variability in nocturnal nitrogen oxide processing and its role in regional air quality	SCIENCE			English	Article							VOLATILE ORGANIC-COMPOUNDS; SULFURIC-ACID; HETEROGENEOUS HYDROLYSIS; AQUEOUS AEROSOLS; SULFATE AEROSOLS; N2O5 HYDROLYSIS; CHEMISTRY; KINETICS; PHASE	Nitrogen oxides in the lower troposphere catalyze the photochemical production of ozone (O-3) pollution during the day but react to form nitric acid, oxidize hydrocarbons, and remove O-3 at night. A key nocturnal reaction is the heterogeneous hydrolysis of dinitrogen pentoxide, N2O5. We report aircraft measurements of NO3 and N2O5, which show that the N2O5 uptake coefficient, gamma(N2O5), on aerosol particles is highly variable and depends strongly on aerosol composition, particularly sulfate content. The results have implications for the quantification of regional-scale O-3 production and suggest a stronger interaction between anthropogenic sulfur and nitrogen oxide emissions than previously recognized.	NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University System of Georgia; Georgia Institute of Technology; University of Colorado System; University of Colorado Boulder	Brown, SS (corresponding author), NOAA, Earth Syst Res Lab, R-CSD2,325 Broadway, Boulder, CO 80305 USA.	steven.s.brown@noaa.gov	Ravishankara, Akkihebbal R/A-2914-2011; Dube, William/I-1658-2013; Brock, Charles/G-3406-2011; Fehsenfeld, Frederick C/I-4876-2013; Brown, Steven S/I-1762-2013; Ryerson, Tom/AAA-8399-2021; Ryerson, Thomas/C-9611-2009; Trainer, Michael/H-5168-2013	Dube, William/0000-0003-1286-4087; Brock, Charles/0000-0002-4033-4668; Ryerson, Thomas/0000-0003-2800-7581; Trainer, Michael/0000-0002-1668-2961; Sullivan, Amy/0000-0003-0143-8197				Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Braban CF, 2004, ATMOS CHEM PHYS, V4, P1451, DOI 10.5194/acp-4-1451-2004; Brown SS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003407; Brown SS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019412; CRUTZEN PJ, 1979, ANNU REV EARTH PL SC, V7, P443, DOI 10.1146/annurev.ea.07.050179.002303; DENTENER FJ, 1993, J GEOPHYS RES-ATMOS, V98, P7149, DOI 10.1029/92JD02979; Derwent RG, 2001, J AIR WASTE MANAGE, V51, P699, DOI 10.1080/10473289.2001.10464297; Evans MJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022469; Folkers M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017168; Hallquist M, 2003, PHYS CHEM CHEM PHYS, V5, P3453, DOI 10.1039/b301827j; Hallquist M, 2000, J PHYS CHEM A, V104, P3984, DOI 10.1021/jp9939625; Hu JH, 1997, J PHYS CHEM A, V101, P871, DOI 10.1021/jp9627436; Kane SM, 2001, J PHYS CHEM A, V105, P6465, DOI 10.1021/jp010490x; LOVEJOY ER, 1995, J PHYS CHEM-US, V99, P2080, DOI 10.1021/j100007a043; Mentel TF, 1999, PHYS CHEM CHEM PHYS, V1, P5451, DOI 10.1039/a905338g; MOZURKEWICH M, 1988, J GEOPHYS RES-ATMOS, V93, P15889, DOI 10.1029/JD093iD12p15889; Murphy DM, 2005, SCIENCE, V307, P1888, DOI 10.1126/science.1108160; PLATT U, 1994, ISRAEL J CHEM, V34, P289; PLATT UF, 1984, ENVIRON SCI TECHNOL, V18, P365, DOI 10.1021/es00123a015; Riemer N, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002436; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Thornton JA, 2005, J PHYS CHEM A, V109, P10004, DOI 10.1021/jp054183t; Thornton JA, 2003, PHYS CHEM CHEM PHYS, V5, P4593, DOI 10.1039/b307498f; Tie X, 2001, J GEOPHYS RES-ATMOS, V106, P22931, DOI 10.1029/2001JD900206; Wahner A, 1998, GEOPHYS RES LETT, V25, P2169, DOI 10.1029/98GL51596; WAYNE RP, 1991, ATMOS ENVIRON A-GEN, V25, P1, DOI 10.1016/0960-1686(91)90192-A; WINER AM, 1984, SCIENCE, V224, P156, DOI 10.1126/science.224.4645.156	27	279	280	9	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					67	70		10.1126/science.1120120	http://dx.doi.org/10.1126/science.1120120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400145				2022-12-28	WOS:000234546300033
J	Camerer, CF; Fehr, E				Camerer, CF; Fehr, E			When does "economic man" dominate social behavior?	SCIENCE			English	Review							GAMES; RATIONALITY; COOPERATION; RECIPROCITY; FAIRNESS; STAKES	The canonical model in economics considers people to be rational and self-regarding. However much evidence challenges this view, raising the question of when "Economic Man" dominates he outcome of social interactions, and when bounded rationality or other-regarding preferences dominate. Here we show that strategic incentives are the key to answering this question. A minority of self-regarding individuals can trigger a "noncooperative" aggregate outcome if their behavior generates incentives for the majority of other-regarding individuals to mimic the minority's behavior. Likewise, a minority of other-regarding individuals can generate a "cooperative" aggregate outcome if their behavior generates incentives for a majority of self-regarding people to behave cooperatively. Similarly, in strategic games, aggregate outcomes can be either far from or close to Nash equilibrium if players with high degrees of strategic thinking mimic or erase the effects of others who do very little strategic thinking. Recently developed theories of other-regarding preferences and bounded rationality explain these findings and provide better predictions of actual aggregate behavior than does traditional economic theory.	CALTECH, Div HSS 22877, Pasadena, CA 91125 USA; Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Collegium Helveticum, CH-8092 Zurich, Switzerland	California Institute of Technology; University of Zurich	Camerer, CF (corresponding author), CALTECH, Div HSS 22877, Pasadena, CA 91125 USA.	camerer@hss.cattech.edu; efehr@iew.unizh.ch						AKERLOF GA, 1985, AM ECON REV, V75, P708; [Anonymous], 1982, JUDGMENT UNCERTAINTY; BERG J, IN PRESS HDB EXPT EC; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BULOW JI, 1985, J POLIT ECON, V93, P488, DOI 10.1086/261312; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Costa-Gomes M, 2001, ECONOMETRICA, V69, P1193, DOI 10.1111/1468-0262.00239; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; FALK A, IN PRESS GAMES EC BE; Fehr E, 1999, J POLIT ECON, V107, P106, DOI 10.1086/250052; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2001, AM ECON REV, V91, P1239, DOI 10.1257/aer.91.5.1239; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E., 2003, ADV EC EC THEORY APP, VI, P208, DOI [10.1017/CBO9780511610240.008, DOI 10.1017/CBO9780511610240.008]; FISCHBACHER U, 2002, 133 U ZUR I EMP RES; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1984, AM ECON REV, V74, P361; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Grosskopf B., 2003, Experimental Economics, V6, P141, DOI 10.1023/A:1025305020751; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; HALTIWANGER J, 1985, AM ECON REV, V75, P326; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Ho TH, 1998, AM ECON REV, V88, P947; Kahneman D., 1988, BOUNDED RATIONAL BEH; Keynes J.M., 1973, GEN THEORY EMPLOYMEN; Kluger BD, 2004, J FINANC, V59, P969, DOI 10.1111/j.1540-6261.2004.00654.x; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Lamont OA, 2003, J ECON PERSPECT, V17, P191, DOI 10.1257/089533003772034952; Levine DK, 1998, REV ECON DYNAM, V1, P593; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Nagel R, 1995, AM ECON REV, V85, P1313; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; PLOTT CR, 1986, J BUS, V59, pS301, DOI 10.1086/296368; RABIN M, 1993, AM ECON REV, V83, P1281; ROLL R, 1984, AM ECON REV, V74, P861; ROTH AE, 1991, AM ECON REV, V81, P1068; Shleifer A., 2000, INEFFICIENT MARKETS; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; STAHL DO, 1995, GAME ECON BEHAV, V10, P218, DOI 10.1006/game.1995.1031; Wolfers J, 2004, J ECON PERSPECT, V18, P107, DOI 10.1257/0895330041371321	47	400	407	9	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					47	52		10.1126/science.1110600	http://dx.doi.org/10.1126/science.1110600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400140				2022-12-28	WOS:000234546300027
J	Devine, JA; Baker, KD; Haedrich, RL				Devine, JA; Baker, KD; Haedrich, RL			Deep-sea fishes qualify as endangered	NATURE			English	Editorial Material							ATLANTIC		Mem Univ Newfoundland, Dept Biol, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Devine, JA (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF A1C 5S7, Canada.	jdevine@mun.ca						Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Haedrich RL, 2001, FISH RES, V51, P113, DOI 10.1016/S0165-7836(01)00239-9; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT CR; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Moore JA, 1999, FISHERIES, V24, P22; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017	9	181	189	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2006	439	7072					29	29		10.1038/439029a	http://dx.doi.org/10.1038/439029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397489	Bronze			2022-12-28	WOS:000234378700024
J	Yin, HS; Wen, XL; Paterson, RG; Lamb, RA; Jardetzky, TS				Yin, HS; Wen, XL; Paterson, RG; Lamb, RA; Jardetzky, TS			Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation	NATURE			English	Article							PARAMYXOVIRUS FUSION PROTEIN; VIRAL MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; INFLUENZA-VIRUS; NIPAH VIRUS; HEMAGGLUTININ; RECEPTOR; ACTIVATION; BINDING; DOMAIN	Enveloped viruses have evolved complex glycoprotein machinery that drives the fusion of viral and cellular membranes, permitting entry of the viral genome into the cell. For the paramyxoviruses, the fusion ( F) protein catalyses this membrane merger and entry step, and it has been postulated that the F protein undergoes complex refolding during this process. Here we report the crystal structure of the parainfluenza virus 5 F protein in its prefusion conformation, stabilized by the addition of a carboxy-terminal trimerization domain. The structure of the F protein shows that there are profound conformational differences between the pre- and postfusion states, involving transformations in secondary and tertiary structure. The positions and structural transitions of key parts of the fusion machinery, including the hydrophobic fusion peptide and two helical heptad repeat regions, clarify the mechanism of membrane fusion mediated by the F protein.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Jardetzky, TS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	tedj@northwestern.edu						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Calder LJ, 2000, VIROLOGY, V271, P122, DOI 10.1006/viro.2000.0279; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen B, 2004, J VIROL, V78, P4508, DOI 10.1128/JVI.78.9.4508-4516.2004; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Ito M, 2000, J GEN VIROL, V81, P719, DOI 10.1099/0022-1317-81-3-719; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi SB, 1998, VIROLOGY, V248, P20, DOI 10.1006/viro.1998.9242; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Paterson RG, 2000, VIROLOGY, V270, P17, DOI 10.1006/viro.2000.0267; PATERSON RG, 1989, J VIROL, V63, P1293, DOI 10.1128/JVI.63.3.1293-1301.1989; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Strokopytov BV, 2005, ACTA CRYSTALLOGR D, V61, P285, DOI 10.1107/S0907444904033037; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsurudome M, 2001, J VIROL, V75, P8999, DOI 10.1128/JVI.75.19.8999-9009.2001; Waning DL, 2004, P NATL ACAD SCI USA, V101, P9217, DOI 10.1073/pnas.0403339101; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yanagi Y, 2002, VIROLOGY, V299, P155, DOI 10.1006/viro.2002.1471; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102	49	337	378	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					38	44		10.1038/nature04322	http://dx.doi.org/10.1038/nature04322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397490	Green Published			2022-12-28	WOS:000234378700028
J	Schulman, SP; Becker, LC; Kass, DA; Champion, HC; Terrin, ML; Forman, S; Ernst, KV; Kelemen, MD; Townsend, SN; Capriotti, A; Hare, JM; Gerstenblith, G				Schulman, SP; Becker, LC; Kass, DA; Champion, HC; Terrin, ML; Forman, S; Ernst, KV; Kelemen, MD; Townsend, SN; Capriotti, A; Hare, JM; Gerstenblith, G			L-arginine therapy in acute myocardial infarction - The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL L-ARGININE; CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR FUNCTION; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASES; THROMBOLYTIC THERAPY; MAJOR SHAREHOLDERS; HEART-DISEASE; IN-VIVO	Context The amino acid L-arginine is a substrate for nitric oxide synthase and is increasingly used as a health supplement. Prior studies suggest that L-arginine has the potential to reduce vascular stiffness. Objective To determine whether the addition of L-arginine to standard postinfarction therapy reduces vascular stiffness and improves ejection fraction over 6-month follow-up in patients following acute ST-segment elevation myocardial infarction. Design and Setting Single-center, randomized, double-blind, placebo-controlled trial with enrollment from February 2002 to June 2004. Patients A total of 153 patients following a first ST-segment elevation myocardial infarction were enrolled; 77 patients were 60 years or older. Intervention Patients were randomly assigned to receive L-arginine (goal dose of 3 g 3 times a day) or matching placebo for 6 months. Main Outcome Measures Change in gated blood pool-derived ejection fraction over 6 months in patients 60 years or older randomized to receive L-arginine compared with those assigned to receive placebo. Secondary outcomes included change in ejection fraction in all patients enrolled, change in noninvasive measures of vascular stiffness, and clinical events. Results Baseline characteristics, vascular stiffness measurements, and left ventricular function were similar between participants randomized to receive placebo or L I arginine. The mean (SD) age was 60 (13.6) years; of the participants, 104 (68%) were men. There was no significant change from baseline to 6 months in the vascular stiffness measurements or left ventricular ejection fraction in either of the 2 groups, including those 60 years or older and the entire study group. However, 6 participants (8.6%) in the L-arginine group died during the 6-month study period vs none in the placebo group (P=.01). Because of the safety concerns, the data and safety monitoring committee closed enrollment. Conclusions L-Arginine, when added to standard postinfarction therapies, does not improve vascular stiffness measurements or ejection fraction and may be associated with higher postinfarction mortality. L-Arginine should not be recommended following acute myocardial infarction.	Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA; Maryland Med Res Inst, Baltimore, MD USA; Univ Maryland, Sch Med, Div Cardiol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Schulman, SP (corresponding author), Johns Hopkins Univ Hosp, Halstead 500, Baltimore, MD 21287 USA.	sschulma@jhmi.edu			NHLBI NIH HHS [HL70059] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams MR, 1997, ATHEROSCLEROSIS, V129, P261, DOI 10.1016/S0021-9150(96)06044-3; AGUIRRE FV, 1994, CIRCULATION, V90, P78, DOI 10.1161/01.CIR.90.1.78; ASANOI H, 1989, CIRC RES, V65, P483, DOI 10.1161/01.RES.65.2.483; AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; BANK AJ, 1995, CIRC RES, V77, P1008, DOI 10.1161/01.RES.77.5.1008; Berger VW, 2002, CONTROL CLIN TRIALS, V23, P502, DOI 10.1016/S0197-2456(02)00233-7; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Blum A, 2000, CIRCULATION, V101, P2160, DOI 10.1161/01.CIR.101.18.2160; Boger RH, 2005, ALTERN MED REV, V10, P14; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Cannon RO, 2002, J AM COLL CARDIOL, V39, P46, DOI 10.1016/S0735-1097(01)01693-X; CASTILLO L, 1994, P NATL ACAD SCI USA, V91, P6393, DOI 10.1073/pnas.91.14.6393; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chauhan A, 1996, J AM COLL CARDIOL, V28, P1796, DOI 10.1016/S0735-1097(96)00394-4; Chen CH, 1997, CIRCULATION, V95, P1827; Chen JQ, 2003, ARTERIOSCL THROM VAS, V23, P97, DOI 10.1161/01.ATV.0000040223.74255.5A; Cheng JWM, 2001, ANN PHARMACOTHER, V35, P755, DOI 10.1345/aph.10216; Clarkson P, 1996, J CLIN INVEST, V97, P1989, DOI 10.1172/JCI118632; *COMM US COMPL ALT, 2005, COMPL ALT MED CAM US; Cooke JP, 1997, CIRCULATION, V96, P379; Drexler H, 1997, PROG CARDIOVASC DIS, V39, P287, DOI 10.1016/S0033-0620(97)80030-8; ERVIN RB, 2004, ADV DATA, V349, P1; Franklin SS, 1997, CIRCULATION, V96, P308; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; ISHIHARA H, 1994, J AM COLL CARDIOL, V23, P406, DOI 10.1016/0735-1097(94)90428-6; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Lee J, 2003, P NATL ACAD SCI USA, V100, P4843, DOI 10.1073/pnas.0735876100; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; LIU ZR, 1989, HYPERTENSION, V14, P129, DOI 10.1161/01.HYP.14.2.129; Loscalzo J, 2000, CIRCULATION, V101, P2126, DOI 10.1161/01.CIR.101.18.2126; Loscalzo J, 2003, ARTERIOSCL THROM VAS, V23, P3, DOI 10.1161/01.ATV.0000040860.71626.9D; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MAGGIONI AP, 1993, NEW ENGL J MED, V329, P1442, DOI 10.1056/NEJM199311113292002; Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; Mason RP, 2004, CIRCULATION, V109, P34, DOI 10.1161/01.CIR.0000129503.62747.03; Mitchell GF, 1997, CIRCULATION, V96, P4254; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MORRIS SM, 1992, ANNU REV NUTR, V12, P81, DOI 10.1146/annurev.nu.12.070192.000501; Najjar SS, 2004, J AM COLL CARDIOL, V44, P611, DOI 10.1016/j.jacc.2004.04.041; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Rector TS, 1996, CIRCULATION, V93, P2135, DOI 10.1161/01.CIR.93.12.2135; SCHULMAN SP, 1995, AM J CARDIOL, V76, P764, DOI 10.1016/S0002-9149(99)80223-9; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; TADDEI S, 1995, CIRCULATION, V91, P1981, DOI 10.1161/01.CIR.91.7.1981; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; VALLANCE P, 1989, LANCET, V2, P997; White HD, 1996, CIRCULATION, V94, P1826, DOI 10.1161/01.CIR.94.8.1826; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970	54	249	261	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					58	64		10.1001/jama.295.1.58	http://dx.doi.org/10.1001/jama.295.1.58			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391217	Bronze			2022-12-28	WOS:000234381100021
J	Gwilym, S; Howard, DPJ; Davies, N; Willett, K				Gwilym, S; Howard, DPJ; Davies, N; Willett, K			Harry Potter casts a spell on accident prone children	BRITISH MEDICAL JOURNAL			English	Article									John Radcliffe Hosp, Dept Orthopaed Trauma Surg, Oxford OX3 9DU, England	University of Oxford	Gwilym, S (corresponding author), John Radcliffe Hosp, Dept Orthopaed Trauma Surg, Oxford OX3 9DU, England.	s_gwilym@yahoo.com	Howard, Dominic/AAX-1890-2020	Howard, Dominic/0000-0001-7564-436X				Rowling J., 2005, H POTTER HALF BLOOD; Rowling J.K., 2003, H POTTER ORDER PHOEN	2	1	1	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1505	1506		10.1136/bmj.331.7531.1505	http://dx.doi.org/10.1136/bmj.331.7531.1505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373731	Green Published, Bronze			2022-12-28	WOS:000234351300011
J	Pittler, MH; Verster, JC; Ernst, E				Pittler, MH; Verster, JC; Ernst, E			Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BINGE DRINKING; HEALTHY-SUBJECTS; CLINICAL-TRIALS; BIAS; SYMPTOMS; INTOXICATION; CONSUMPTION; LOCATION; FRUCTOSE; GLUCOSE	Objective To assess the clinical evidence on the effectiveness of any medical intervention for preventing or treating alcohol hangover. Data sources Systematic searches on Medline, Embase, Amed, Cochrane Central, the National Research Register (UK), and ClincalTrials.gov (USA); hand searches of conference proceedings and bibliographies; contact with experts and manufacturers of commercial preparations. Language of publication was not restricted. Study selection and data extraction All randomised controlled trials of any medical intervention for preventing or treating alcohol hangover were included. Trials were considered if they were placebo controlled or controlled against a comparator intervention. Titles and abstracts of identified articles were read and hard copies were obtained. The selection of studies, data extraction, and validation were done independently by two reviewers. The Jadad score was used to evaluate methodological quality Results Fifteen potentially relevant trials were identified. Seven publications failed to meet all inclusion criteria. Eight randomised controlled trials assessing eight different interventions were reviewed. ne agents tested were propranolol, tropisetron, tolfenamic acid, fructose or glucose, and the dietary supplements Borago officinalis (borage), Cynara. scolymus (artichoke), Opuntia ficus-indica (prickly pear), and a yeast based preparation. All studies were double blind. Significant intergroup differences for overall symptom scores and individual symptoms were reported only for tolfenamic acid, gamma linolenic acid from B officinalis, and a yeast based preparation. Conclusion No compelling evidence exists to suggest that any conventional or complementary intervention is effective for preventing or treating alcohol hangover. The most effective way to avoid the symptoms of alcohol induced hangover is to practise abstinence or moderation.	Univ Exeter, Peninsula Med Sch, Exeter EX2 4NT, Devon, England; Univ Plymouth, Peninsula Med Sch, Exeter EX2 4NT, Devon, England; Univ Utrecht, Dept Psychopharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	University of Exeter; University of Exeter; University of Plymouth; Utrecht University	Pittler, MH (corresponding author), Univ Exeter, Peninsula Med Sch, Exeter EX2 4NT, Devon, England.	M.H.Pittler@exeter.ac.uk	Verster, Joris C/A-9017-2008	Verster, Joris/0000-0002-6455-2096				*BBC ESS, XMAS EXC ESS; Becker J, 2001, ANN INTERN MED, V134, P533, DOI 10.7326/0003-4819-134-6-200103200-00027; BOGIN RM, 1987, AM J DRUG ALCOHOL AB, V13, P175, DOI 10.3109/00952998709001507; Calder I, 1997, BRIT MED J, V314, P2, DOI 10.1136/bmj.314.7073.2; CHANHAN BL, 1991, EUR J CLIN PHARMACOL, V40, P187; CHAUHAN BL, 1991, EUR J CLIN PHARMACOL, V40, P187; CROFTON J, 1987, ALCOHOL ALCOHOLISM, V22, P321; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ernst E, 1997, NATURE, V385, P480, DOI 10.1038/385480c0; GOLDBERG L, 1979, BLUTALKOHOL, V16, P439; Holland P, 1999, Stat Bull Metrop Insur Co, V80, P2; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KAIVOLA S, 1983, CEPHALALGIA, V3, P31, DOI 10.1046/j.1468-2982.1983.0301031.x; KHAN MA, 1973, Q J STUD ALCOHOL, V34, P1195; Kim DJ, 2003, ALCOHOL, V31, P167, DOI 10.1016/j.alcohol.2003.09.003; Kim DJ, 2003, INT J NEUROSCI, V113, P581, DOI 10.1080/00207450390162308; Laas I., 1999, J CLIN RES, V2, P9; *LICHTW PHARM UK, CYN ART; MOESGAARD S, UNPUB GLA EFFECTIVEL; Muhonen T, 1997, ADDICT BIOL, V2, P461, DOI 10.1080/13556219772525; MYRSTEN AL, 1980, PSYCHOPHARMACOLOGY, V69, P117, DOI 10.1007/BF00427636; Pincock S, 2003, LANCET, V362, P1126, DOI 10.1016/S0140-6736(03)14502-3; Pittler MH, 2000, J CLIN EPIDEMIOL, V53, P485, DOI 10.1016/S0895-4356(99)00220-6; Pittler MH, 2003, CAN MED ASSOC J, V169, P1269; Poikolainen K, 2002, ADDICTION, V97, P1037, DOI 10.1046/j.1360-0443.2002.00177.x; Schmidt K, 2004, ANN ONCOL, V15, P733, DOI 10.1093/annonc/mdh174; Seppa K, 1999, HYPERTENSION, V33, P79, DOI 10.1161/01.HYP.33.1.79; SEPPALA T, 1976, ACTA PHARMACOL TOX, V38, P209; Slutske WS, 2003, ALCOHOL CLIN EXP RES, V27, P1442, DOI 10.1097/01.ALC.0000085585.81711.AE; STREUFERT S, 1995, ALCOHOL CLIN EXP RES, V19, P1141, DOI 10.1111/j.1530-0277.1995.tb01592.x; Sumi Hiroyuki, 1995, Japanese Journal of Alcohol Studies and Drug Dependence, V30, P69; Vahtera J, 2002, AM J EPIDEMIOL, V156, P969, DOI 10.1093/aje/kwf138; Verster JC, 2003, NEUROPSYCHOPHARMACOL, V28, P740, DOI 10.1038/sj.npp.1300090; Wechsler H, 2000, J AM COLL HEALTH, V48, P199, DOI 10.1080/07448480009599305; White IR, 2002, BRIT MED J, V325, P191, DOI 10.1136/bmj.325.7357.191; Wiese J, 2004, ARCH INTERN MED, V164, P1334, DOI 10.1001/archinte.164.12.1334; Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008; YLIKAHRI RH, 1976, EUR J CLIN INVEST, V6, P93, DOI 10.1111/j.1365-2362.1976.tb00498.x; 2004, BMJ, V329, P10; RU21 HANGOVER PILLS	41	41	46	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1515	+		10.1136/bmj.331.7531.1515	http://dx.doi.org/10.1136/bmj.331.7531.1515			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373736	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000234351300016
J	Polyn, SM; Natu, VS; Cohen, JD; Norman, KA				Polyn, SM; Natu, VS; Cohen, JD; Norman, KA			Category-specific cortical activity precedes retrieval during memory search	SCIENCE			English	Article							REPRESENTATION; RECOGNITION	Here we describe a functional magnetic resonance imaging study of humans engaged in memory search during a free recall task. Patterns of cortical activity associated with the study of three categories of pictures (faces, locations, and objects) were identified by a pattern-classification algorithm. The algorithm was used to track the reappearance of these activity patterns during the recall period. The reappearance of a given category's activity pattern correlates with verbal recalls made from that category and precedes the recall event by several seconds. This result is consistent with the hypothesis that category-specific activity is cueing the memory system to retrieve studied items.	Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University; Princeton University	Polyn, SM (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	polyn@psych.upenn.edu		Natu, Vaidehi/0000-0001-8012-2822	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069456, R01MH052864] Funding Source: NIH RePORTER; NIMH NIH HHS [MH070177-01, R01MH052864, R01MH069456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McClelland J. L., 1986, PARALLEL DISTRIBUTED, P170; McClelland JL, 1995, MEMORY DISTORTION, P69; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; NORMAN KA, 1996, IMPLICIT MEMORY META; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; SHIFFRIN RM, 1990, J EXP PSYCHOL LEARN, V16, P179, DOI 10.1037/0278-7393.16.2.179; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Smith S.M., 1988, MEMORY CONTEXT CONTE, P13; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E., 1993, CURRENT DIRECTIONS P, V2, P67, DOI [10.1111/1467-8721.ep10770899, DOI 10.1111/1467-8721.EP10770899]; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125	24	446	457	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1963	1966		10.1126/science.1117645	http://dx.doi.org/10.1126/science.1117645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373577				2022-12-28	WOS:000234275400045
J	Nierman, WC; Pain, A; Anderson, MJ; Wortman, JR; Kim, HS; Arroyo, J; Berriman, M; Abe, K; Archer, DB; Bermejo, C; Bennett, J; Bowyer, P; Chen, D; Collins, M; Coulsen, R; Davies, R; Dyer, PS; Farman, M; Fedorova, N; Fedorova, N; Feldblyum, TV; Fischer, R; Fosker, N; Fraser, A; Garcia, JL; Garcia, MJ; Goble, A; Goldman, GH; Gomi, K; Griffith-Jones, S; Gwilliam, R; Haas, B; Haas, H; Harris, D; Horiuchi, H; Huang, J; Humphray, S; Jimenez, J; Keller, N; Khouri, H; Kitamoto, K; Kobayashi, T; Konzack, S; Kulkarni, R; Kumagai, T; Lafton, A; Latge, JP; Li, WX; Lord, A; Majoros, WH; May, GS; Miller, BL; Mohamoud, Y; Molina, M; Monod, M; Mouyna, I; Mulligan, S; Murphy, L; O'Neil, S; Paulsen, I; Penalva, MA; Pertea, M; Price, C; Pritchard, BL; Quail, MA; Rabbinowitsch, E; Rawlins, N; Rajandream, MA; Reichard, U; Renauld, H; Robson, GD; de Cordoba, SR; Rodriguez-Pena, JM; Ronning, CM; Rutter, S; Salzberg, SL; Sanchez, M; Sanchez-Ferrero, JC; Saunders, D; Seeger, K; Squares, R; Squares, S; Takeuchi, M; Tekaia, F; Turner, G; de Aldana, CRV; Weidman, J; White, O; Woodward, J; Yu, JH; Fraser, C; Galagan, JE; Asai, K; Machida, M; Hall, N; Barrell, B; Denning, DW				Nierman, WC; Pain, A; Anderson, MJ; Wortman, JR; Kim, HS; Arroyo, J; Berriman, M; Abe, K; Archer, DB; Bermejo, C; Bennett, J; Bowyer, P; Chen, D; Collins, M; Coulsen, R; Davies, R; Dyer, PS; Farman, M; Fedorova, N; Fedorova, N; Feldblyum, TV; Fischer, R; Fosker, N; Fraser, A; Garcia, JL; Garcia, MJ; Goble, A; Goldman, GH; Gomi, K; Griffith-Jones, S; Gwilliam, R; Haas, B; Haas, H; Harris, D; Horiuchi, H; Huang, J; Humphray, S; Jimenez, J; Keller, N; Khouri, H; Kitamoto, K; Kobayashi, T; Konzack, S; Kulkarni, R; Kumagai, T; Lafton, A; Latge, JP; Li, WX; Lord, A; Majoros, WH; May, GS; Miller, BL; Mohamoud, Y; Molina, M; Monod, M; Mouyna, I; Mulligan, S; Murphy, L; O'Neil, S; Paulsen, I; Penalva, MA; Pertea, M; Price, C; Pritchard, BL; Quail, MA; Rabbinowitsch, E; Rawlins, N; Rajandream, MA; Reichard, U; Renauld, H; Robson, GD; de Cordoba, SR; Rodriguez-Pena, JM; Ronning, CM; Rutter, S; Salzberg, SL; Sanchez, M; Sanchez-Ferrero, JC; Saunders, D; Seeger, K; Squares, R; Squares, S; Takeuchi, M; Tekaia, F; Turner, G; de Aldana, CRV; Weidman, J; White, O; Woodward, J; Yu, JH; Fraser, C; Galagan, JE; Asai, K; Machida, M; Hall, N; Barrell, B; Denning, DW			Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus	NATURE			English	Article							CELL-WALL; SACCHAROMYCES-CEREVISIAE; GENE-CLUSTER; SENSITIZATION; ARSENITE; COMPOST	Aspergillus fumigatus is exceptional among microorganisms in being both a primary and opportunistic pathogen as well as a major allergen(1-3). Its conidia production is prolific, and so human respiratory tract exposure is almost constant(4). A. fumigatus is isolated from human habitats(5) and vegetable compost heaps(6,7). In immunocompromised individuals, the incidence of invasive infection can be as high as 50% and the mortality rate is often about 50% (ref. 2). The interaction of A. fumigatus and other airborne fungi with the immune system is increasingly linked to severe asthma and sinusitis(8). Although the burden of invasive disease caused by A. fumigatus is substantial, the basic biology of the organism is mostly obscure. Here we show the complete 29.4-megabase genome sequence of the clinical isolate Af293, which consists of eight chromosomes containing 9,926 predicted genes. Microarray analysis revealed temperature-dependent expression of distinct sets of genes, as well as 700 A. fumigatus genes not present or significantly diverged in the closely related sexual species Neosartorya fischeri, many of which may have roles in the pathogenicity phenotype. The Af293 genome sequence provides an unparalleled resource for the future understanding of this remarkable fungus.	Inst Genom Res, Rockville, MD 20850 USA; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Manchester M13 9PT, Lancs, England; Univ Complutense Madrid, Dept Microbiol 2, E-28040 Madrid, Spain; Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808555, Japan; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; European Bioinformat Inst, Hinxton CB10 1SD, England; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; CSIC, Ctr Invest Biol, Madrid 28040, Spain; Univ Salamanca, Dept Genet & Microbiol, Salamanca 37007, Spain; Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Sao Paulo, Brazil; Innsbruck Med Univ, Dept Mol Biol, A-6020 Innsbruck, Austria; Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi 4648601, Japan; Natl Inst Adv Ind Sci 7 Technol AIST, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; Inst Pasteur, INRA USC 2019, Unite Postulante Biol & Pathogen Fong, F-75015 Paris, France; Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Univ Idaho, Ctr Reprod Biol, Dept Microbiol, Moscow, ID 83844 USA; Univ Idaho, Ctr Reprod Biol, Dept Mol Biol & Biochem, Moscow, ID 83844 USA; CHU Vaudois, Dept Dermatol, CH-1011 Lausanne, Switzerland; Univ Gottingen, Dept Bacteriol, D-37077 Gottingen, Germany; Tokyo Univ Agr & Technol, Tokyo 1830054, Japan; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan	J. Craig Venter Institute; George Washington University; Wellcome Trust Sanger Institute; University of Manchester; University of Manchester; Complutense University of Madrid; Tohoku University; University of Nottingham; Tulane University; European Molecular Biology Laboratory (EMBL); University of Kentucky; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Salamanca; Universidade de Sao Paulo; Medical University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Nagoya University; National Institute of Advanced Industrial Science & Technology (AIST); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Texas System; UTMD Anderson Cancer Center; Idaho; University of Idaho; Idaho; University of Idaho; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Gottingen; Tokyo University of Agriculture & Technology; University of Sheffield; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; National Institute of Advanced Industrial Science & Technology (AIST)	Nierman, WC (corresponding author), Inst Genom Res, Rockville, MD 20850 USA.	wnierman@tigr.org	Quail, michael/ABE-6131-2020; Jiménez, Javier/ABE-1795-2020; Kim, Heenam Stanley/L-2279-2016; Kobayashi, Tetsuo/I-6901-2014; Molina, Maria/ABE-7186-2021; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021; Berriman, Matthew/A-7618-2011; de Aldana, Carlos Vazquez/B-7772-2008; Abrams, Natalie/F-4845-2011; TAKEUCHI, Michio/H-6592-2013; Latge, Jean Paul/C-9846-2014; Hall, Neil/A-8717-2013; mouyna, isabelle/F-3578-2011; Goldman, Gustavo Henrique/F-1848-2013; Tekaia, Fredj/H-4553-2012; Penalva, Miguel A/G-2295-2015; Denning, David/AAC-6931-2019; Rodriguez-Peña, Jose M/E-9624-2016; Abrams, Natalie/AAM-5468-2021; Asai, Kiyoshi/AAT-8344-2020; Paulsen, Ian T/K-3832-2012; Mouyna, Isabelle/O-7697-2018; Arroyo, Javier/E-9308-2016; de Cordoba, Santiago Rodriguez/K-6727-2014; Pain, Arnab/L-5766-2015; Rawlings, Neil/M-5566-2013; Griffiths-Jones, Sam/H-2998-2014; Garcia Lopez, Jose Luis/G-9139-2015	Jiménez, Javier/0000-0002-0402-4427; Kim, Heenam Stanley/0000-0003-4856-3518; Kobayashi, Tetsuo/0000-0002-4008-454X; Molina, Maria/0000-0003-0074-3309; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637; Berriman, Matthew/0000-0002-9581-0377; de Aldana, Carlos Vazquez/0000-0002-4513-3654; Abrams, Natalie/0000-0001-9698-2819; Hall, Neil/0000-0002-7995-3810; Goldman, Gustavo Henrique/0000-0002-2986-350X; Penalva, Miguel A/0000-0002-3102-2806; Denning, David/0000-0001-5626-2251; Rodriguez-Peña, Jose M/0000-0002-8792-362X; Abrams, Natalie/0000-0001-9698-2819; Asai, Kiyoshi/0000-0003-0909-4982; Paulsen, Ian T/0000-0001-9015-9418; Mouyna, Isabelle/0000-0003-3140-5927; Arroyo, Javier/0000-0002-1971-1721; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Pain, Arnab/0000-0002-1755-2819; Dyer, Paul/0000-0003-0237-026X; Robson, Geoff/0000-0003-4959-042X; Rawlings, Neil/0000-0001-5557-7665; Wortman, Jennifer/0000-0002-8713-1227; Griffiths-Jones, Sam/0000-0001-6043-807X; Yu, Jae-Hyuk/0000-0002-6530-8407; Hall, Neil/0000-0003-2808-0009; Galagan, James/0000-0003-0542-3291; GARCIA SALGADO, MARIA JESUS/0000-0001-6921-8938; Murphy, Lee/0000-0001-6467-7449; bowyer, paul/0000-0002-1083-9286; Fraser, Claire/0000-0003-1462-2428; Yates, Bethan/0000-0003-1658-1762; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Tekaia, Fredj/0000-0003-1934-2396	Biotechnology and Biological Sciences Research Council [CFB17726] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amin S, 2004, MICROBIOL-SGM, V150, P1937, DOI 10.1099/mic.0.26830-0; Beffa T, 1998, MED MYCOL, V36, P137; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; BLYTH W, 1977, CLIN ALLERGY, V7, P549, DOI 10.1111/j.1365-2222.1977.tb01485.x; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Hirsch T, 2000, ALLERGY, V55, P79, DOI 10.1034/j.1398-9995.2000.00250.x; Kim H, 2002, BIOTECHNIQUES, V33, P924, DOI 10.2144/02334mt06; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kodzius R, 2003, COMB CHEM HIGH T SCR, V6, P147, DOI 10.2174/1386207033329751; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Thrane C, 2004, FUNGAL GENET BIOL, V41, P361, DOI 10.1016/j.fgb.2003.11.003; Weichel M, 2003, CLIN EXP ALLERGY, V33, P72, DOI 10.1046/j.1365-2222.2003.01574.x; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhou SG, 2003, GENOME RES, V13, P2142, DOI 10.1101/gr.1128803; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	28	1025	2007	1	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1151	1156		10.1038/nature04332	http://dx.doi.org/10.1038/nature04332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372009	Green Submitted, Bronze			2022-12-28	WOS:000234111500050
J	Salter, MG; Fern, R				Salter, MG; Fern, R			NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; RAT OPTIC-NERVE; MULTIPLE-SCLEROSIS; WHITE-MATTER; GLUTAMATE RELEASE; CELL-DEATH; LINEAGE; EXCITOTOXICITY; VULNERABILITY; ASTROCYTES	Injury to oligodendrocyte processes, the structures responsible for myelination, is implicated in many forms of brain disorder(1-4). Here we show NMDA (N-methyl-D-aspartate) receptor subunit expression on oligodendrocyte processes, and the presence of NMDA receptor subunit messenger RNA in isolated white matter. NR1, NR2A, NR2B, NR2C, NR2D and NR3A subunits showed clustered expression in cell processes, but NR3B was absent. During modelled ischaemia, NMDA receptor activation resulted in rapid Ca2+-dependent detachment and disintegration of oligodendroglial processes in the white matter of mice expressing green fluorescent protein (GFP) specifically in oligodendrocytes (CNP-GFP mice). This effect occurred at mouse ages corresponding to both the initiation and the conclusion of myelination. NR1 subunits were found mainly in oligodendrocyte processes, whereas AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptor subunits were mainly found in the somata. Consistent with this observation, injury to the somata was prevented by blocking AMPA/kainate receptors, and preventing injury to oligodendroglial processes required the blocking of NMDA receptors. The presence of NMDA receptors in oligodendrocyte processes explains why previous studies that have focused on the somata have not detected a role for NMDA receptors in oligodendrocyte injury. These NMDA receptors bestow a high sensitivity to acute injury and represent an important new target for drug development in a variety of brain disorders.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Fern, R (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rf34@le.ac.uk		fern, robert/0000-0002-0625-3434				Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; BUTT AM, 1993, J COMP NEUROL, V338, P141, DOI 10.1002/cne.903380110; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Ludwin S K, 1981, Adv Neurol, V31, P123; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; RODRIGUEZ M, 1993, MAYO CLIN PROC, V68, P627, DOI 10.1016/S0025-6196(12)60597-7; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wilke SR, 2004, J NEUROPATH EXP NEUR, V63, P872, DOI 10.1093/jnen/63.8.872; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Ziak D, 1998, PHYSIOL RES, V47, P365	28	406	426	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1167	1171		10.1038/nature04301	http://dx.doi.org/10.1038/nature04301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372012				2022-12-28	WOS:000234111500053
J	Ramsay, SE; Whincup, PH; Lawlor, DA; Papacosta, O; Lennon, LT; Thomas, MC; Ebrahim, S; Morris, RW				Ramsay, SE; Whincup, PH; Lawlor, DA; Papacosta, O; Lennon, LT; Thomas, MC; Ebrahim, S; Morris, RW			Secondary prevention of coronary heart disease in older patients after the national service framework: population based study	BRITISH MEDICAL JOURNAL			English	Article								Objective To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework. Design Two population based, longitudinal studies of men and women aged 60-79 in 1998-2001, based in one general practice in each of 24 British towns. Participants Men and women with established coronary heart disease at the two time points (respectively 817 and 465 in 1998-2001, 857 mid 548 in 2003), aged 60-79 in 1998-2001. Main outcome measures Prevalence of use of antiplatelet medication, statins, beta blockers, angiotensin converting enzyme (ACE) inhibitors, and other blood pressure lowering treatments (individually and in combination) assessed in 1998-2001 and 2003. Results Between 1998-2001 and 2003, the use of all individual drugs had increased in both men and women, especially for statins (from 34% to 65% in men and from 48% to 67% in women with myocardial infarction). However, less than half received beta blockers and ACE inhibitors, even by 2003. Prevalences of medication rise were lower in patients with angina than in those with myocardial infarction. The proportions of patients receiving more than one drug increased over time; by 2003 about half of patients with myocardial infarction and a third of those with angina were receiving antiplatelet medication, statins, and blood pressure lowering treatments. 0 Conclusions Between 1998-2001 and 2003, statin uptake and the use of combined drug treatment in elderly men mid women increased markedly Further potential exists, however, for reducing the risk of recurrent coronary heart disease in older patients, particularly by improving the uptake of medication among angina patients, and by more extensive use of blood pressure lowering treatment (particularly with beta blockers and ACE inhibitors).	UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London NW3 2PF, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; University College London; UCL Medical School; University of Bristol	Ramsay, SE (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London NW3 2PF, England.	s.ramsay@pcps.ucl.ac.uk	Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Lawlor, Debbie A/0000-0002-6793-2262; Papacosta, Olia/0000-0001-8781-6747; Ramsay, Sheena/0000-0002-0391-9704; Whincup, Peter/0000-0002-5589-4107; Morris, Richard/0000-0001-7240-4563	Medical Research Council [G0501859, G0501859(76641)] Funding Source: Medline; MRC [G0501859] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*DOH, 2000, NAT SERV FRAM COR HE; Lawlor DA, 2004, FAM PRACT, V21, P582, DOI 10.1093/fampra/cmh516; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295	4	22	22	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 21	2006	332	7534					144	145		10.1136/bmj.38704.770127.BE	http://dx.doi.org/10.1136/bmj.38704.770127.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16401630	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000234905800015
J	Bader, JS; Chant, J				Bader, JS; Chant, J			When proteomes collide	SCIENCE			English	Editorial Material							PROTEIN; MAP; TOPOLOGY; NETWORK		Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21215 USA; Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21215 USA; Genentech Inc, San Francisco, CA 94080 USA	Johns Hopkins University; Johns Hopkins University; Roche Holding; Genentech	Bader, JS (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21215 USA.	joel.bader@jhu.edu; jchant@gene.com	Bader, Joel/A-1818-2009	Bader, Joel/0000-0002-6020-4625				Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009	12	13	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					187	188		10.1126/science.1123221	http://dx.doi.org/10.1126/science.1123221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410514				2022-12-28	WOS:000234722200029
J	Rubin, RH; Gilman, MD; Kradin, RL; Harris, NL; Ginns, L				Rubin, RH; Gilman, MD; Kradin, RL; Harris, NL; Ginns, L			A 64-year-old male lung-transplant recipient with fever, cough, hemoptysis, and abdominal pain - Cytomegalovirus colitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rubin, RH (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.							Battaglino MP, 1999, GASTROINTEST ENDOSC, V50, P697, DOI 10.1016/S0016-5107(99)80025-X; JOHNSON RA, 2002, CLIN APPROACH INFECT, P49; Mukhopadhya A, 2001, Indian J Gastroenterol, V20, P114; Rubin RH, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1111/j.1399-0012.2001.00011.x; Rubin RH, 2002, CLIN APPROACH INFECT, V4th, P573; Soderberg-Naucler C, 2000, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, P399; VANDERMEER JWM, 2002, CLIN APPROACH INFECT, P5; WOODS GL, 2000, INFECT DIS PATHOLOGY	8	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					180	187		10.1056/NEJMcpc059039	http://dx.doi.org/10.1056/NEJMcpc059039			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407514				2022-12-28	WOS:000234528600012
J	Wells, PS; Owen, C; Doucette, S; Fergusson, D; Tran, HY				Wells, PS; Owen, C; Doucette, S; Fergusson, D; Tran, HY			Does this patient have deep vein thrombosis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-DIAGNOSIS MODEL; D-DIMER ASSAY; VENOUS THROMBOSIS; COMPRESSION ULTRASONOGRAPHY; EMERGENCY-DEPARTMENT; NONINVASIVE DIAGNOSIS; PRETEST PROBABILITY; PULMONARY-EMBOLISM; MANAGEMENT; THROMBOEMBOLISM	Context Outpatients with suspected deep vein thrombosis (DVT) have nonspecific signs and symptoms. Missed DVT diagnosis may result in fatal pulmonary embolism. Since many patients may have DVT, a selective and efficient diagnostic process is needed. Objective To systematically review trials that determined the prevalence of DVT using clinical prediction rules either with or without D-dimer, for the diagnosis of DVT. Data Sources English- and French-language studies were identified from MEDLINE from 1990 to July 2004 and supplemented by a review of all relevant bibliographies. Study Selection We included studies that prospectively enrolled consecutive, unselected outpatients with suspected DVT and applied clinical prediction rules before D-dimer testing or diagnostic imaging. All studies included sufficient information to allow the calculation of the prevalence of DVT for at least 1 of the 3 clinical probability estimates (low, moderate, or high). We required that patients be followed up for a minimum 3-month period. Unless the clinical model incorporated prior DVT, studies were excluded if patients with a history of prior DVT were enrolled. Data Extraction Two reviewers independently reviewed and abstracted data for estimating the prevalence of DVT, sensitivity, specificity, and likelihood ratios (LRs) of D-dimer in each of the 3 clinical probability estimates. Data for the D-dimer in all studies were pooled and analyzed as high-sensitivity/low-specificity test or a moderate-sensitivity/moderate-specificity test. Data Synthesis Fourteen studies involving more than 8000 patients used 1 clinical prediction rule for diagnosing DVT, of which 11 incorporated D-dimer testing in the diagnostic algorithm. The prevalence of DVT in the low, moderate, and high clinical probability groups was 5.0% (95% Cl, 4.0%-8.0%), 17% (95% CI, 13%-23%), and 53 % (95% Cl, 44%-61%), respectively. The overall prevalence of DVT was 19% (95% Cl, 16%-23%). Pooling all studies, the sensitivity, specificity, and negative LRs of D-dimer testing in the low probability group were 88% (95% CI, 81%-92%), 72% (95% Cl, 65%-78%), and 0.18% (95% Cl, 0.12-0.18); in the moderate probability group: 90% (95% Cl, 80%-95%),58% (95% Cl, 49%-67%), and 0.19% (95% Cl, 0.11-0.32); and in the high probability group: 92% (95% Cl, 85%-96%), 45% (95% Cl, 37%-52%), and 0.16% (95% Cl, 0.09-0.30). The LRs for a normal result on a high or moderately sensitive D-dimer assay among patients with: (1) low clinical suspicion were 0.10 (95% Cl, 0.03-0.37) and 0.20 (95% Cl, 0.12-0.31); (2) moderate clinical suspicion were 0.05 (95% Cl, 0.01-0.21) and 0.23 (95% Cl, 0.13-0.39); and (3) high clinical suspicion were 0.07 (95% Cl, 0.03-0.18) and 0.15 (95% Cl, 0.10-0.38). Conclusions Diagnostic accuracy for DVT improves when clinical probability is estimated before diagnostic tests. Patients with low clinical probability on the predictive rule have prevalence of DVT of less than 5%. In low-probability patients with negative D-dimer results, diagnosis of DVT can be excluded without ultrasound; in patients with high clinical suspicion for DVT, results should not affect clinical decisions.	Univ Ottawa, Dept Med, Ottawa, ON, Canada; Ottawa Hosp, Div Hematol, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Ottawa Hlth Res Inst, Ottawa, ON, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; McMaster University	Wells, PS (corresponding author), Ottawa Hosp, Div Hematol, Civ Campus,Suite F649,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	pwells@ohri.ca		Fergusson, Dean/0000-0002-3389-2485				Aguilar C, 2002, BRIT J HAEMATOL, V118, P275, DOI 10.1046/j.1365-2141.2002.03614.x; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Anderson DR, 2000, J EMERG MED, V19, P225, DOI 10.1016/S0736-4679(00)00225-0; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Bucek RA, 2002, THROMB RES, V105, P43, DOI 10.1016/S0049-3848(01)00411-X; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; Fancher TL, 2004, BRIT MED J, V329, P1236; Fedullo PF, 2001, CLIN CHEST MED, V22, P561, DOI 10.1016/S0272-5231(05)70292-6; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Gottlieb RH, 2003, AM J ROENTGENOL, V180, P241, DOI 10.2214/ajr.180.1.1800241; Heim SW, 2004, CLIN CHEM, V50, P1136, DOI 10.1373/clinchem.2004.031765; Hirsh J, 1999, LANCET, V353, P1375, DOI 10.1016/S0140-6736(99)90053-3; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Lee AYY, 1999, ANN INTERN MED, V131, P417, DOI 10.7326/0003-4819-131-6-199909210-00004; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Prandoni P, 1998, Vasc Med, V3, P57, DOI 10.1177/1358836X9800300112; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Shields GP, 2002, ACAD EMERG MED, V9, P561, DOI 10.1111/j.1553-2712.2002.tb02292.x; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; Stricker H, 1999, THROMB HAEMOSTASIS, V82, P1227; Tamariz LJ, 2004, AM J MED, V117, P676, DOI 10.1016/j.amjmed.2004.04.021; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Wells P S, 2000, Curr Opin Pulm Med, V6, P309, DOI 10.1097/00063198-200007000-00010; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1995, THROMB HAEMOSTASIS, V74, P1423; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	40	237	244	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					199	207		10.1001/jama.295.2.199	http://dx.doi.org/10.1001/jama.295.2.199			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403932				2022-12-28	WOS:000234544300027
J	Johnston, SG				Johnston, SG			Patient's journey - My bipolar expedition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									The Cairn, Helensburgh G84 9AW, England		Johnston, SG (corresponding author), The Cairn, Dhuhill Drive W, Helensburgh G84 9AW, England.	suzygj@yahoo.co.uk						JOHNSTON S, 2004, NAKED BIRD WATCHER; *SCOTT EX, NAT PROGR IMPR MENT	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					30	32		10.1136/bmj.332.7532.30	http://dx.doi.org/10.1136/bmj.332.7532.30			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399734	Green Published			2022-12-28	WOS:000234684200018
J	Altschuler, EL; Bryce, TN				Altschuler, EL; Bryce, TN			Pellegrini-Stieda syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CUNY Mt Sinai Sch Med, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Altschuler, EL (corresponding author), CUNY Mt Sinai Sch Med, New York, NY 10029 USA.			Bryce, Thomas/0000-0002-8388-1338					0	12	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					E1	E1		10.1056/NEJMicm040406	http://dx.doi.org/10.1056/NEJMicm040406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394294				2022-12-28	WOS:000234358600010
J	Shackleton, M; Vaillant, F; Simpson, KJ; Stingl, J; Smyth, GK; Asselin-Labat, ML; Wu, L; Lindeman, GJ; Visvader, JE				Shackleton, M; Vaillant, F; Simpson, KJ; Stingl, J; Smyth, GK; Asselin-Labat, ML; Wu, L; Lindeman, GJ; Visvader, JE			Generation of a functional mammary gland from a single stem cell	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; MORPHOGENESIS; MODEL; MICE; INDUCE	The existence of mammary stem cells (MaSCs) has been postulated from evidence that the mammary gland can be regenerated by transplantation of epithelial fragments in mice(1-3). Interest in MaSCs has been further stimulated by their potential role in breast tumorigenesis(4). However, the identity and purification of MaSCs has proved elusive owing to the lack of defined markers. We isolated discrete populations of mouse mammary cells on the basis of cell-surface markers and identified a subpopulation (Lin(-) CD29(hi) CD24(+)) that is highly enriched for MaSCs by transplantation. Here we show that a single cell, marked with a LacZ transgene, can reconstitute a complete mammary gland in vivo. The transplanted cell contributed to both the luminal and myoepithelial lineages and generated functional lobuloalveolar units during pregnancy. The self-renewing capacity of these cells was demonstrated by serial transplantation of clonal outgrowths. In support of a potential role for MaSCs in breast cancer, the stem-cell-enriched subpopulation was expanded in premalignant mammary tissue from MMTV-wnt-1 mice and contained a higher number of MaSCs. Our data establish that single cells within the Lin(-) CD29(hi) CD24(+) population are multipotent and self-renewing, properties that define them as MaSCs.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Royal Melbourne Hosp, Bone Marrow Res Labs, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Stem Cell Technol Inc, Vancouver, BC V5Z 1B3, Canada	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Melbourne; British Columbia Cancer Agency	Visvader, JE (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	lindeman@wehi.edu.au; visvader@wehi.edu.au	Smyth, Gordon/B-5276-2008	Smyth, Gordon/0000-0001-9221-2892; Lindeman, Geoffrey/0000-0001-9386-2416; Simpson, Kaylene/0000-0001-9136-1781				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2003, NATURE, V423, P231, DOI 10.1038/423231a; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kenney Nicholas J., 2001, Journal of Biomedicine and Biotechnology, V1, P133, DOI 10.1155/S1110724301000304; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; STINGL J, 2006, NATURE          0104; Sum EYM, 2005, J HISTOCHEM CYTOCHEM, V53, P475, DOI 10.1369/jhc.4A6553.2005; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6	30	1500	1596	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					84	88		10.1038/nature04372	http://dx.doi.org/10.1038/nature04372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397499				2022-12-28	WOS:000234378700039
J	Dale, KM; Coleman, CI; Henyan, NN; Kluger, J; White, CM				Dale, KM; Coleman, CI; Henyan, NN; Kluger, J; White, CM			Statins and cancer risk - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; CARDIAC OUTCOMES; ATHEROSCLEROSIS; PROGRESSION; PRAVASTATIN; PREVENTION; ATORVASTATIN; MULTICENTER; INTERVENTION; FLUVASTATIN	Context Statins are cholesterol - lowering drugs that have been proven in randomized controlled trials to prevent cardiac events. Recent retrospective analyses have suggested that statins also prevent cancer. Objectives To investigate the effect of statin therapy on cancer incidence and cancer death and to analyze the effect of statins on specific cancers and the effect of statin lipophilicity or derivation. Data Sources A systematic literature search of MEDLINE, EMBASE, CINAHL, Web of Science, CANCERLIT, and the Cochrane Systematic Review Database through July 2005 was conducted using specific search terms. A review of cardiology and cancer abstracts and manual review of references was also performed. Study Selection Twenty-seven of the 8943 articles (n = 86 936 participants) initially identified met the inclusion criteria, reporting 26 randomized controlled trials of statins, with a mean duration of follow-up of at least 1 year, enrolling a minimum of 100 patients, and reporting data on either cancer incidence (n = 20 studies) or cancer death (n = 22 studies). Data Extraction All data were independently extracted by 3 investigators using a standardized data abstraction tool. Weighted averages were reported as odds ratios (ORs) with 95% confidence intervals (CIs) using a random-effects model (DerSimonian and Laird methods). Statistical heterogeneity scores were assessed with the Q statistic. Data Synthesis In meta-analyses including 6662 incident cancers and 2407 cancer deaths, statins did not reduce the incidence of cancer (OR, 1.02; 95% Cl, 0.97-1.07) or cancer deaths (OR, 1.01; 95% Cl, 0.93-1.09). No reductions were noted for any individual cancer type. This null effect on cancer incidence persisted when only hydrophilic, lipophilic, naturally derived, or synthetically derived statins were evaluated. Conclusions Statins have a neutral effect on cancer and cancer death risk in randomized controlled trials.. We found that no type of cancer was affected by statin use and no subtype of statin affected the risk of cancer.	Hartford Hosp, Div Drug Informat, Hartford, CT 06102 USA; Hartford Hosp, Div Cardiol, Hartford, CT 06102 USA; Univ Connecticut, Sch Med, Farmington, CT USA	Hartford Hospital; Hartford Hospital; University of Connecticut	White, CM (corresponding author), Univ Connecticut, Sch Pharm, Hartford, CT 06102 USA.	cmwhite@harthosp.org		Coleman, Craig/0000-0003-4868-7158				*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; [Anonymous], 2000, J Atheroscler Thromb, V7, P110; Beishuizen ED, 2004, DIABETES CARE, V27, P2887, DOI 10.2337/diacare.27.12.2887; Bestehorn HP, 1997, EUR HEART J, V18, P226; Bjerre LM, 2001, AM J MED, V110, P716, DOI 10.1016/S0002-9343(01)00705-7; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; BLANKENHORN DH, 1993, ANN INTERN MED, V119, P969, DOI 10.7326/0003-4819-119-10-199311150-00002; Boudreau DM, 2004, CANCER-AM CANCER SOC, V100, P2308, DOI 10.1002/cncr.20271; Cafforio P, 2005, CARCINOGENESIS, V26, P883, DOI 10.1093/carcin/bgi036; Campeau L, 1997, NEW ENGL J MED, V336, P153; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coogan PF, 2002, EPIDEMIOLOGY, V13, P262, DOI 10.1097/00001648-200205000-00005; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; Demierre MF, 2003, J CLIN ONCOL, V21, P158, DOI 10.1200/JCO.2003.07.173; Downs JR, 2001, AM J CARDIOL, V87, P1074, DOI 10.1016/S0002-9149(01)01464-3; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Herd JA, 1997, AM J CARDIOL, V80, P278, DOI 10.1016/S0002-9149(97)00346-9; Hillyard DZ, 2004, ATHEROSCLEROSIS, V175, P305, DOI 10.1016/j.atherosclerosis.2004.03.018; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kaushal V, 2003, ENDOTHELIUM-J ENDOTH, V10, P49, DOI 10.1080/10623320303358; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; KHURANA V, 2005, J CLIN ONCOL, V23, P1006; Klerkx AHEM, 2004, EUR J CLIN INVEST, V34, P21, DOI 10.1111/j.1365-2362.2004.01281.x; Kochhar R KV, 2005, J CLIN ONCOL, P514, DOI DOI 10.1200/jco.2005.23.16_suppl.514; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; OLIVER MF, 1994, LANCET, V344, P633; PITT B, 1995, J AM COLL CARDIOL, V26, P1133, DOI 10.1016/0735-1097(95)00301-0; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALONEN R, 1995, AM J CARDIOL, V76, pC34, DOI 10.1016/S0002-9149(99)80468-8; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Simes RJ, 2002, LANCET, V359, P1379; Singal R, 2005, J CLIN ONCOL, V23, p107S; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Teo KK, 2000, CIRCULATION, V102, P1748; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Watanabe M, 1997, BIOORGAN MED CHEM, V5, P437, DOI 10.1016/S0968-0896(96)00248-9; WATERS D, 1994, CIRCULATION, V89, P959, DOI 10.1161/01.CIR.89.3.959	48	475	487	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					74	80		10.1001/jama.295.1.74	http://dx.doi.org/10.1001/jama.295.1.74			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391219				2022-12-28	WOS:000234381100023
J	Alexander, KP; Chen, AY; Roe, MT; Newby, LK; Gibson, CM; Allen-LaPointe, NM; Pollack, C; Gibler, WB; Ohman, EM; Peterson, ED				Alexander, KP; Chen, AY; Roe, MT; Newby, LK; Gibson, CM; Allen-LaPointe, NM; Pollack, C; Gibler, WB; Ohman, EM; Peterson, ED		CRUSADE Investigators	Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; BLOOD-TRANSFUSION; MEDICATION ERRORS; AMERICAN-COLLEGE; UNSTABLE ANGINA; TASK-FORCE; CARE; ENOXAPARIN; MANAGEMENT	Context Effective medical care assumes delivery of evidence-based medicines to appropriate patients with doses comparable to those studied. Objective To investigate dosing of unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), and glycoprotein IIb/IIIa inhibitors, and the association between dosing and major outcomes. Design, Setting, and Participants A prospective observational analysis in 387 US academic and nonacademic hospitals of 30136 patients from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative Registry who had non-ST-segment elevation acute coronary syndromes (NSTE ACS) with chest pain and either positive electrocardiograms or cardiac biomarkers between January 1 and September 30, 2004. Main Outcome Measures Excessive dosing of UFH, LMWH, and glycoprotein IIb/ IIIa inhibitors and major clinical outcomes, including bleeding, in-hospital mortality, and length of stay. Results A total of 3354 patients (42%) with NSTE ACS who were administered antithrombotic agents received at least 1 initial dose outside the recommended range. An excess dose was administered to 2934 patients (32.8%) treated with UFH, 1378 (13.8%) treated with LMWH, and 2784 (26.8%) treated with glycoprotein IIb/IIIa inhibitors. Factors associated with excess dosing included older age, as well as female sex, renal insufficiency, low body weight, diabetes mellitus, and congestive heart failure. Relative to those patients not administered excess dosages, patients with excess dosages of UFH, LMWH, and glycoprotein IIb/IIa inhibitors either tended toward or had higher risks for major bleeding (adjusted odds ratio [OR], 1.08; 95% confidence interval [CI], 0.94-1.26; OR, 1.39; 95% Cl, 1.11-1.74; and OR, 1.36; 95% Cl, 1.10-1.68; respectively). Bleeding increased relative to the degree of excess dose and to the number of agents administered in excess (6.6% [237/3590] if neither heparin nor glycoprotein IIb/IIIa excess vs 22.2% [93/419] if both excess). Mortality and length of stay were also higher among those patients administered excess dosing. We estimated that 15% (400/2766) of major bleeding in this population may be attributable to excess dosing. Conclusions Patients with NSTE ACS treated in the community often receive excess doses of antithrombotic therapy. Dosing errors occur more often in vulnerable populations and predict an increased risk of major bleeding.	Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; Harvard Univ, Clin Res Inst, Boston, MA 02115 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Duke University; Harvard University; University of Pennsylvania; University System of Ohio; University of Cincinnati	Alexander, KP (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	karen.alexander@duke.edu	Gibson, C. Michael/AAE-8212-2019; Peterson, Eric David/ABF-5033-2021	, Nancy/0000-0002-6390-8337	NIA NIH HHS [R01 AG025312-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG025312] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; *AV PHARM, 2003, EN PACK INS; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Becker RC, 2002, AM HEART J, V143, P753, DOI 10.1067/mhj.2002.120774; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Cannon CP, 2000, AM J CARDIOL, V85, p17C; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chew DP, 2005, AM J CARDIOL, V95, P581, DOI 10.1016/j.amjcard.2004.11.003; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Collet JP, 2003, J AM COLL CARDIOL, V41, P8, DOI 10.1016/S0735-1097(02)02664-5; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Freedman JE, 2002, CIRCULATION, V106, P2623, DOI 10.1161/01.CIR.0000037748.19282.7D; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gilchrist IC, 2002, AM HEART J, V144, P73, DOI 10.1067/mhj.2002.123112; Gretler DD, 2004, CLIN THER, V26, P390, DOI 10.1016/S0149-2918(04)90034-3; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Jefferies LC, 2001, TRANSFUSION, V41, P522, DOI 10.1046/j.1537-2995.2001.41040522.x; Krumholz HM, 1998, J AM COLL CARDIOL, V31, P973, DOI 10.1016/S0735-1097(98)00022-9; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mehta RH, 2005, JAMA-J AM MED ASSOC, V293, P1746, DOI 10.1001/jama.293.14.1746; *MERCK CO, 2002, TIR PACK INS; *MILL PHARM, 2003, INT EPT PACK INS; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Peterson ED, 2004, CIRCULATION, V110, P785; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Ringold DJ, 2000, AM J HEALTH-SYST PH, V57, P1759, DOI 10.1093/ajhp/57.19.1759; Roe MT, 2003, AM HEART J, V146, P605, DOI 10.1016/S0002-8703(03)00388-0; Spinler SA, 2003, AM HEART J, V146, P33, DOI 10.1016/S0002-8703(03)00121-2; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Topol E, 1998, NEW ENGL J MED, V339, P436; Wallentin L, 1999, LANCET, V354, P701; WALTER P, 1982, PARACELSUS INTRO PHI; White RH, 1997, ARCH INTERN MED, V157, P2468, DOI 10.1001/archinte.157.21.2468; Yusuf S, 2001, NEW ENGL J MED, V345, P494	40	403	417	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3108	3116		10.1001/jama.294.24.3108	http://dx.doi.org/10.1001/jama.294.24.3108			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380591	Bronze			2022-12-28	WOS:000234274200027
J	McManus, IC				McManus, IC			The wealth of distinguished doctors: retrospective survey	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess changes in the wealth of distinguished doctors in the United Kingdom between 1860 and 2001. Design Retrospective survey. Setting The UK. Participants 980 doctors of sufficient distinction to be included in the Oxford Dictionary of National Biography and who died between 1860 and 2001. Main outcome measures Wealth at death, based on probate records and adjusted relative to average earnings in 2002. Results The wealth of distinguished doctors declined substantially between 1860 and 2001, and paralleled a decline in the relative income of doctors in general. The wealth of distinguished doctors also declined relative to other groups of distinguished individuals. Conclusions In the 19th century, distinction in doctors was accompanied by substantial wealth, whereas by the end of die 20th century, the most distinguished doctors were less wealthy than their contemporaries who had achieved national distinction in other areas.	UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London	McManus, IC (corresponding author), UCL, Dept Psychol, Mortimer St, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk		McManus, Ian/0000-0003-3510-4814				Aitchison J, 1996, LOG NORMAL DISTRIBUT; [Anonymous], LINE BEAUTY; Atkinson AB, 1975, EC INEQUALITY; Barker William., 2004, OXFORD DICT NATL BIO, Vonline; Burnett John, 1969, HIST COST LIVING; COWELL F, 1998, MEASUREMENT INEQUALT; COWELL FA, MEASUREMENT INEQUALT; Freidson E., 2001, PROFESSIONALISM 3 LO; Matthew H. C. G., 2004, OXFORD DICT NATL BIO; McManus I.C., 2002, RIGHT HAND LEFT HAND; McManus IC, 2005, LANCET, V366, P506, DOI 10.1016/S0140-6736(05)67064-X; OFFICER LH, WHAT IS ITS RELATIVE; Paget J., 1903, MEMOIRS LETT J PAGET; PAGET J, 2004, OXFORD DICT NATL BIO; PAGET J, 1871, LANCET, V1, P736; PAGET J, 1871, LANCET, V1, P774; PARKIN GD, 1996, J NEUROL NEUROSUR PS, V60, P288; Perkin H., 1989, RISE PROFESSIONAL SO; Routh G., 1980, OCCUPATION PAY GREAT; Smith A, 1986, WEALTH NATIONS; Soltow L., 1968, ECON HIST REV, P17; Tallis R, 2004, HIPPOCRATIC OATHS ME; TAYLOR F, 1918, PRACTICE MED; WATSON T, 1836, MED GAZETTE, V18, P393; Watson T, 1843, LECT PRINCIPLES PRAC; WATSON T, 1871, LECT PRINCIPLES PRAC	26	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1520	1523		10.1136/bmj.331.7531.1520	http://dx.doi.org/10.1136/bmj.331.7531.1520			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373738	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000234351300018
J	Curl, RF				Curl, RF			Richard E. Smalley (1943-2005) - Obituary	NATURE			English	Biographical-Item									Rice Univ, Dept Chem, Houston, TX 77251 USA	Rice University	Curl, RF (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77251 USA.		Curl, Robert/R-7252-2019						0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1094	1094		10.1038/4381094a	http://dx.doi.org/10.1038/4381094a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371995				2022-12-28	WOS:000234111500032
J	Nathan, DM; Cleary, PA; Backlund, JYC; Genuth, SM; Lachin, JM; Orchard, TJ; Raskin, P; Zinman, B				Nathan, DM; Cleary, PA; Backlund, JYC; Genuth, SM; Lachin, JM; Orchard, TJ; Raskin, P; Zinman, B		DCCT EDIC Stury Res Grp	Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNRECOGNIZED MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HEART-DISEASE; MORTALITY; GLYCATION; COHORT; COMPLICATIONS; ASSOCIATION; PRODUCTS; PREDICTS	Background: Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neurologic complications of type 1 diabetes. We studied whether the use of intensive therapy as compared with conventional therapy during the Diabetes Control and Complications Trial (DCCT) affected the long-term incidence of cardiovascular disease. Methods: The DCCT randomly assigned 1441 patients with type 1 diabetes to intensive or conventional therapy, treating them for a mean of 6.5 years between 1983 and 1993. Ninety-three percent were subsequently followed until February 1, 2005, during the observational Epidemiology of Diabetes Interventions and Complications study. Cardiovascular disease (defined as nonfatal myocardial infarction, stroke, death from cardiovascular disease, confirmed angina, or the need for coronary-artery revascularization) was assessed with standardized measures and classified by an independent committee. Results: During the mean 17 years of follow-up, 46 cardiovascular disease events occurred in 31 patients who had received intensive treatment in the DCCT, as compared with 98 events in 52 patients who had received conventional treatment. Intensive treatment reduced the risk of any cardiovascular disease event by 42 percent (95 percent confidence interval, 9 to 63 percent; P=0.02) and the risk of nonfatal myocardial infarction, stroke, or death from cardiovascular disease by 57 percent (95 percent confidence interval, 12 to 79 percent; P=0.02). The decrease in glycosylated hemoglobin values during the DCCT was significantly associated with most of the positive effects of intensive treatment on the risk of cardiovascular disease. Microalbuminuria and albuminuria were associated with a significant increase in the risk of cardiovascular disease, but differences between treatment groups remained significant (P lessthan/equal 0.05) after adjusting for these factors. Conclusions: Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes.	Case Western Reserve Univ, Cleveland, OH 44106 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; George Washington Univ, Ctr Biostat, Data Coordinating Ctr, Washington, DC 20052 USA; Med Univ S Carolina, Mol Risk Factors Project, Charleston, SC 29425 USA	Case Western Reserve University; Harvard University; Massachusetts General Hospital; George Washington University; Medical University of South Carolina	Nathan, DM (corresponding author), DCCT EDIC Res Grp, Box NDIC DCCT, Bethesda, MD 20892 USA.	dnathan@partners.org	Peeters, Annouk/AAK-7117-2021; Zinman, Bernard/E-7266-2013; Hramiak, Irene/G-3305-2011	Lachin, John/0000-0001-9838-2841; orchard, trevor/0000-0001-9552-3215	NIDDK NIH HHS [N01 DK062204-007] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backlund JY, 2003, CONTROL CLIN TRIALS, V23, p2S; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Cleary P, 2003, DIABETES, V52, pA152; *DCCT, 1987, CLIN CHEM, V33, P267; DCCT Res Grp, 1986, DIABETES, V35, P530; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Diabet Control Complications Trial Res Grp, 1998, DIABETOLOGIA, V41, P416; Didangelos TP, 2003, DIABETES CARE, V26, P1955, DOI 10.2337/diacare.26.7.1955; DORMAN JS, 1984, DIABETES, V33, P271, DOI 10.2337/diabetes.33.3.271; Engel S, 2003, NEW ENGL J MED, V348, P2294; *EP DIAB INT COMPL, 1996, PROT; Genuth S, 1999, DIABETES CARE, V22, P99; GRIMM RH, 1987, CIRCULATION, V75, P6; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Lachin J. M., 2000, WILEY SER PROB STAT; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Lehto S, 1999, ARTERIOSCL THROM VAS, V19, P1014, DOI 10.1161/01.ATV.19.4.1014; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Snedecor GW, 1980, STAT METHODS, V7th; The Diabetes Control and Complications Trial Research Group, 1997, JAMA-J AM MED ASSOC, V278, P25; Tuomilehto J, 1998, DIABETOLOGIA, V41, P784, DOI 10.1007/s001250050988; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x	34	3451	3649	1	170	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2643	2653		10.1056/nejmoa052187	http://dx.doi.org/10.1056/nejmoa052187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371630	Green Accepted			2022-12-28	WOS:000234094400005
J	Berthier, L; Biroli, G; Bouchaud, JP; Cipelletti, L; El Masri, D; L'Hote, D; Ladieu, F; Pierno, M				Berthier, L; Biroli, G; Bouchaud, JP; Cipelletti, L; El Masri, D; L'Hote, D; Ladieu, F; Pierno, M			Direct experimental evidence of a growing length scale accompanying the glass transition	SCIENCE			English	Article							SUPERCOOLED LIQUIDS; DYNAMIC HETEROGENEITIES; RELAXATION; PREDICTIONS; BEHAVIOR; FORMERS; MODEL	Understanding glass formation is a challenge, because the existence of a true glass state, distinct from liquid and solid, remains elusive: Glasses are liquids that have become too viscous to flow. An old idea, as yet unproven experimentally, is that the dynamics becomes sluggish as the glass transition approaches, because increasingly larger regions of the material have to move simultaneously to allow flow. We introduce new multipoint dynamical susceptibilities to estimate quantitatively the size of these regions and provide direct experimental evidence that the glass formation of molecular liquids and colloidal suspensions is accompanied by growing dynamic correlation length scales.	Univ Montpellier 2, Lab Colloides Verres & Nanomat, UMR 5587, F-34095 Montpellier, France; CNRS, F-34095 Montpellier, France; CEA Saclay, Serv Phys Theor Orme Merisiers, F-91191 Gif Sur Yvette, France; Capital Fund Management, Sci & Finance, F-75009 Paris, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Berthier, L (corresponding author), Univ Montpellier 2, Lab Colloides Verres & Nanomat, UMR 5587, F-34095 Montpellier, France.	berthier@lcvn.univ-montp2.fr	Cipelletti, Luca/Q-2310-2018; Berthier, Ludovic/I-7104-2012; Pierno, Matteo/B-9397-2013; biroli, giulio/C-2086-2008	Berthier, Ludovic/0000-0003-2059-702X; Pierno, Matteo/0000-0002-8973-0338; Cipelletti, Luca/0000-0003-2956-7580				Bennemann C, 1999, NATURE, V399, P246, DOI 10.1038/20406; Berthier L, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.020201; Biroli G, 2004, EUROPHYS LETT, V67, P21, DOI 10.1209/epl/i2004-10044-6; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Deschenes LA, 2001, SCIENCE, V292, P255, DOI 10.1126/science.1056430; Donati C, 2002, J NON-CRYST SOLIDS, V307, P215, DOI 10.1016/S0022-3093(02)01461-8; Donth E, 2001, GLASS TRANSITION; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; El Masri D, 2005, J PHYS-CONDENS MAT, V17, pS3543, DOI 10.1088/0953-8984/17/45/046; Garrahan JP, 2003, P NATL ACAD SCI USA, V100, P9710, DOI 10.1073/pnas.1233719100; Garrahan JP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.035704; Hansen J.-P., 2013, THEORY SIMPLE LIQUID, V4th; Hempel E, 2000, J PHYS CHEM B, V104, P2460, DOI 10.1021/jp991153f; HURLEY MM, 1995, PHYS REV E, V52, P1694, DOI 10.1103/PhysRevE.52.1694; KIRKPATRICK TR, 1989, PHYS REV A, V40, P1045, DOI 10.1103/PhysRevA.40.1045; KOB W, 1994, PHYS REV LETT, V73, P1376, DOI 10.1103/PhysRevLett.73.1376; LEBOWITZ JL, 1967, PHYS REV, V153, P250, DOI 10.1103/PhysRev.153.250; Mayer P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.115701; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Qiu XH, 2003, J PHYS CHEM B, V107, P459, DOI 10.1021/jp021888b; Reinsberg SA, 2002, J NON-CRYST SOLIDS, V307, P208, DOI 10.1016/S0022-3093(02)01460-6; Reinsberg SA, 2001, J CHEM PHYS, V114, P7299, DOI 10.1063/1.1369160; Russell E. V., 2000, Nature, V408, P695, DOI 10.1038/35047037; Stevenson JD, 2005, J PHYS CHEM B, V109, P15093, DOI 10.1021/jp052279h; Tarjus G, 2004, J CHEM PHYS, V120, P6135, DOI 10.1063/1.1649732; Toninelli C, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041505; Tracht U, 1998, PHYS REV LETT, V81, P2727, DOI 10.1103/PhysRevLett.81.2727; Viot P, 2000, J CHEM PHYS, V112, P10368, DOI 10.1063/1.481674; WANG LM, 2003, J CHEM PHYS, V118, P10184; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Whitelam S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.185705; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990	32	657	659	1	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1797	1800		10.1126/science.1120714	http://dx.doi.org/10.1126/science.1120714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357256	Green Submitted			2022-12-28	WOS:000234093600041
J	Bierie, B; Moses, HL				Bierie, B; Moses, HL			Under pressure: Stromal fibroblasts change their ways	CELL			English	Editorial Material							MAMMARY-CARCINOMA; BREAST CARCINOMAS; GROWTH; CELLS	In this issue of Cell, Hill et al. (2005) demonstrate in a mouse model of prostate cancer that the tumor cells can initiate and promote expansion of stromal fibroblasts that lack the tumor-suppressor protein p53 through a paracrine mechanism. This results in selection of highly proliferative fibroblasts associated with the carcinoma that further promote tumor progression.	Vanderbilt Univ, Ctr Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Bierie, B (corresponding author), Vanderbilt Univ, Ctr Med, Dept Canc Biol, 691 Preston Bldg, Nashville, TN 37232 USA.	hal.moses@vanderbilt.edu						Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Hayward SW, 2001, CANCER RES, V61, P8135; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Moinfar F, 2000, CANCER RES, V60, P2562; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034	9	19	20	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					985	987		10.1016/j.cell.2005.11.029	http://dx.doi.org/10.1016/j.cell.2005.11.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360028	Bronze			2022-12-28	WOS:000234177200007
J	Loucks, AB; Nattiv, A				Loucks, AB; Nattiv, A			Essay - The female athlete triad	LANCET			English	Article							DISORDERS		Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; Univ Calif Los Angeles, Dept Family Med, Div Sports Med, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA	Ohio University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Loucks, AB (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	loucks@ohio.edu						Beals KA, 2002, INT J SPORT NUTR EXE, V12, P281, DOI 10.1123/ijsnem.12.3.281; Bennell K, 1999, SPORTS MED, V28, P91, DOI 10.2165/00007256-199928020-00004; De Souza MJ, 1998, J CLIN ENDOCR METAB, V83, P4220, DOI 10.1210/jc.83.12.4220; Dusek T, 2001, CROAT MED J, V42, P79	4	16	17	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S49	S50		10.1016/S0140-6736(05)67848-8	http://dx.doi.org/10.1016/S0140-6736(05)67848-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360753				2022-12-28	WOS:000234374400031
J	Martinon, F; Petrilli, V; Mayor, A; Tardivel, A; Tschopp, J				Martinon, F; Petrilli, V; Mayor, A; Tardivel, A; Tschopp, J			Gout-associated uric acid crystals activate the NALP3 inflammasome	NATURE			English	Article							COLD AUTOINFLAMMATORY SYNDROME; NECROSIS-FACTOR-ALPHA; MONOSODIUM URATE; IMMUNE-SYSTEM; PROTEIN; PYRIN; IDENTIFICATION; INTERLEUKIN-1; ANTAGONIST; COLCHICINE	Development of the acute and chronic inflammatory responses known as gout and pseudogout are associated with the deposition of monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals, respectively, in joints and periarticular tissues. Although MSU crystals were first identified as the aetiological agent of gout in the eighteenth century(1) and more recently as a 'danger signal' released from dying cells(2), little is known about the molecular mechanisms underlying MSU- or CPPD-induced inflammation. Here we show that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the production of active interleukin (IL)-1 beta and IL-18. Macrophages from mice deficient in various components of the inflammasome such as caspase-1, ASC and NALP3 are defective in crystal-induced IL-1 beta activation. Moreover, an impaired neutrophil influx is found in an in vivo model of crystal-induced peritonitis in inflammasome-deficient mice or mice deficient in the IL-1 beta receptor (IL-1R). These findings provide insight into the molecular processes underlying the inflammatory conditions of gout and pseudogout, and further support a pivotal role of the inflammasome in several autoinflammatory diseases.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Petrilli, Virginie/ABI-8199-2020; Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X; Petrilli, Virginie/0000-0001-8502-6979				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI [10.1093/rheumatology/keh640, 10.1186/ar2952]; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; FAIRES JS, 1962, LANCET, V2, P682; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Getting SJ, 1997, J PHARMACOL EXP THER, V283, P123; GOLDFINGER SE, 1965, ARTHRITIS RHEUM-US, V8, P1112, DOI 10.1002/art.1780080610; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; MALAWIST.SE, 1965, ANN INTERN MED, V62, P648, DOI 10.7326/0003-4819-62-4-648; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meng ZH, 1997, J RHEUMATOL, V24, P2385; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; WOLLASTON HW, 1797, PHIL T, V87, P386; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	30	3531	3720	23	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					237	241		10.1038/nature04516	http://dx.doi.org/10.1038/nature04516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407889	Bronze			2022-12-28	WOS:000235839500052
J	Ramiro, AR; Jankovic, M; Callen, E; Difilippantonio, S; Chen, HT; McBride, KM; Eisenreich, TR; Chen, JJ; Dickins, RA; Lowe, SW; Nussenzweig, A; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Callen, E; Difilippantonio, S; Chen, HT; McBride, KM; Eisenreich, TR; Chen, JJ; Dickins, RA; Lowe, SW; Nussenzweig, A; Nussenzweig, MC			Role of genomic instability and p53 in AID-induced c-myc-Igh translocations	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; URACIL-DNA GLYCOSYLASE; CHROMOSOMAL TRANSLOCATIONS; SOMATIC HYPERMUTATION; DEFICIENT MICE; B-CELLS; ACTIVATION; REGIONS; 53BP1	Chromosomal translocations involving the immunoglobulin switch region are a hallmark feature of B-cell malignancies(1). However, little is known about the molecular mechanism by which primary B cells acquire or guard against these lesions. Here we find that translocations between c-myc and the IgH locus (Igh) are induced in primary B cells within hours of expression of the catalytically active form of activation-induced cytidine deaminase (AID), an enzyme that deaminates cytosine to produce uracil in DNA(2,3). Translocation also requires uracil DNA glycosylase (UNG), which removes uracil from DNA to create abasic sites that are then processed to double-strand breaks(4,5). The pathway that mediates aberrant joining of c-myc and Igh differs from intrachromosomal repair during immunoglobulin class switch recombination in that it does not require histone H2AX(6), p53 binding protein 1 ( 53BP1)(7,8) or the non-homologous end-joining protein Ku80(9). In addition, translocations are inhibited by the tumour suppressors ATM, Nbs1, p19 (Arf) and p53, which is consistent with activation of DNA damage- and oncogenic stress-induced checkpoints during physiological class switching. Finally, we demonstrate that accumulation of AID-dependent, IgH-associated chromosomal lesions is not sufficient to enhance c-myc-Igh translocations. Our findings reveal a pathway for surveillance and protection against AID-dependent DNA damage, leading to chromosomal translocations.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Mayo Clin, Div Oncol, Rochester, MN 55905 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Mayo Clinic; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov; nussen@mail.rockefeller.edu	Dickins, Ross A/K-2852-2012; mcbride, kevin/E-8230-2011; Nussenzweig, Michel/AAE-7292-2019; Ramiro, Almudena R/H-6037-2015	Dickins, Ross A/0000-0003-4112-5304; Ramiro, Almudena R/0000-0002-7539-3844	NATIONAL CANCER INSTITUTE [Z01BC010283, P01CA013106, P30CA008748] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [P01 CA013106, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Endres M, 2004, J CLIN INVEST, V113, P1711, DOI 10.1172/JCI200420926; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021	30	259	265	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					105	109		10.1038/nature04495	http://dx.doi.org/10.1038/nature04495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16400328	Green Accepted			2022-12-28	WOS:000235685700049
J	Partridge, GB; Li, WH; Kamar, RI; Liao, YA; Hulet, RG				Partridge, GB; Li, WH; Kamar, RI; Liao, YA; Hulet, RG			Pairing and phase separation in a polarized fermi gas	SCIENCE			English	Article							SUPERCONDUCTIVITY; SUPERFLUIDITY	We report the observation of pairing in a gas of atomic fermions with unequal numbers of two components. Beyond a critical polarization, the gas separates into a phase that is consistent with a superfluid paired core surrounded by a shell of normal unpaired fermions. The critical polarization diminishes with decreasing attractive interaction. For near-zero polarization, we measured the parameter beta = -0.54 +/- 0.05, describing the universal energy of a strongly interacting paired Fermi gas, and found good agreement with recent theory. These results are relevant to predictions of exotic new phases of quark matter and of strongly magnetized superconductors.	Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Rice Univ, Rice Quantum Inst, Houston, TX 77251 USA	Rice University; Rice University	Hulet, RG (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA.	randy@rice.edu	Li, Wenhui/A-6406-2009	Li, Wenhui/0000-0001-9976-6871				Astrakharchik GE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.200404; Bartenstein M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.103201; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203201; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bedaque PF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247002; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; Caldas H, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063602; Carlson J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060401; Carlson J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.050401; Casalbuoni R, 2004, REV MOD PHYS, V76, P263, DOI 10.1103/RevModPhys.76.263; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Gehm ME, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.011401; HO TL, COMMUNICATION; Houbiers M, 1998, PHYS REV A, V57, pR1497, DOI 10.1103/PhysRevA.57.R1497; Kakuyanagi K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047602; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Kinast J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150402; LARKIN AI, 1965, ZH EKSP TEOR FIZ, V20, P762; Liu WV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047002; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Partridge GB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020404; Perali A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.100404; PETHICK CJ, 2002, BOSEEINSTEIN CONDENS, P402; Petrov DS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.090404; Radovan HA, 2003, NATURE, V425, P51, DOI 10.1038/nature01842; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; SARMA G, 1963, J PHYS CHEM SOLIDS, V24, P1029, DOI 10.1016/0022-3697(63)90007-6; Strecker KE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080406; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Viverit L, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053605; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	34	801	808	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					503	505		10.1126/science.1122876	http://dx.doi.org/10.1126/science.1122876			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16373534	Green Submitted			2022-12-28	WOS:000235071400040
J	Becker, PB				Becker, PB			Wolfram Horz - 1944-2005	CELL			English	Biographical-Item									Adolf Butenandt Inst, D-80336 Munich, Germany	University of Munich	Becker, PB (corresponding author), Adolf Butenandt Inst, D-80336 Munich, Germany.	pbecker@med.uni-muenchen.de		Becker, Peter/0000-0001-7186-0372				HORZ W, PUBLICATION LIST	1	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					13	14		10.1016/j.cell.2005.12.021	http://dx.doi.org/10.1016/j.cell.2005.12.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413474	Bronze			2022-12-28	WOS:000234969600002
J	Grunewald, M; Avraham, I; Dor, Y; Bachar-Lustig, E; Itin, A; Yung, S; Chimenti, S; Landsman, L; Abramovitch, R; Keshet, E				Grunewald, M; Avraham, I; Dor, Y; Bachar-Lustig, E; Itin, A; Yung, S; Chimenti, S; Landsman, L; Abramovitch, R; Keshet, E			VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARROW-DERIVED CELLS; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; TUMOR ANGIOGENESIS; STEM; TRANSPLANTATION; VASCULARIZATION; EXPRESSION; INDUCTION	Adult neovascularization relies on the recruitment of circulating cells, but their angiogenic roles and recruitment mechanisms are unclear. We show that the endothelial growth factor VEGF is sufficient for organ homing of circulating mononuclear myeloid cells and is required for their perivascular positioning and retention. Recruited bone marrow-derived circulating cells (RBCCs) summoned by VEGF serve a function distinct from endothelial progenitor cells. Retention of RBCCs in close proximity to angiogenic vessels is mediated by SDF1, a chemokine induced by VEGF in activated perivascular myofibroblasts. RBCCs enhance in situ proliferation of endothelial cells via secreting proangiogenic activities distinct from locally induced activities. Precluding RBCCs strongly attenuated the proangiogenic response to VEGF and addition of purified RBCCs enhanced angiogenesis in excision wounds. Together, the data suggest a model for VEGF-programmed adult neovascularization highlighting the essential paracrine role of recruited myeloid cells and a role for SDF1 in their perivascular retention.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	Hebrew University of Jerusalem; Weizmann Institute of Science; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Keshet, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.	keshet@cc.huji.ac.il	Landsman, Limor/AAT-5982-2020; Dor, Yuval/C-2405-2011; Keshet, Eli/GQR-0445-2022	Landsman, Limor/0000-0002-8974-1344; 				Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chimenti Stefano, 2004, Methods Mol Med, V98, P217; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Infanger M, 2004, BURNS, V30, P305, DOI 10.1016/j.burns.2003.12.006; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kraft A, 1999, CANCER-AM CANCER SOC, V85, P178; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Machein MR, 2003, BRAIN PATHOL, V13, P582; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NISSANOV J, 1995, LAB INVEST, V73, P734; Ogawa H, 2000, CARDIOLOGY, V93, P93, DOI 10.1159/000007008; ORLMO A, 2005, CELL, V121, P335; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Salven P, 1997, CLIN CANCER RES, V3, P647; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	41	932	987	3	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					175	189		10.1016/j.cell.2005.10.036	http://dx.doi.org/10.1016/j.cell.2005.10.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413490	Bronze			2022-12-28	WOS:000234969600018
J	Rannou, P; Montmessin, F; Hourdin, F; Lebonnois, S				Rannou, P; Montmessin, F; Hourdin, F; Lebonnois, S			The latitudinal distribution of clouds on Titan	SCIENCE			English	Article							TROPOSPHERIC CLOUDS; HAZE; ABUNDANCES; ATMOSPHERE; WINDS; MODEL	Clouds have been observed recently on Titan, through the thick haze, using near-infrared spectroscopy and images near the south pole and in temperate regions near 40 degrees S. Recent telescope and Cassini orbiter observations are now providing an insight into cloud climatology. To study clouds, we have developed a general circulation model of Titan that includes cloud microphysics. We identify and explain the formation of several types of ethane and methane clouds, including south polar clouds and sporadic clouds in temperate regions and especially at 40 degrees in the summer hemisphere. The locations, frequencies, and composition of these cloud types are essentially explained by the large-scale circulation.	Univ Versailles St Quentin, Inst Pierre Simon Laplace, Serv Aeron, F-91371 Verrieres Le Buisson, France; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Paris 06, Meteorol Dynam Lab, IPSL, F-75252 Paris 05, France	UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Rannou, P (corresponding author), Univ Versailles St Quentin, Inst Pierre Simon Laplace, Serv Aeron, BP3, F-91371 Verrieres Le Buisson, France.	pra@aero.jussieu.fr	RANNOU, Pascal/I-9059-2012	Montmessin, Franck/0000-0002-4187-1457; LEBONNOIS, SEBASTIEN/0000-0002-2390-8164; RANNOU, pascal/0000-0003-0836-723X				Barth EL, 2003, ICARUS, V162, P94, DOI 10.1016/S0019-1035(02)00067-2; Bouchez AH, 2005, ASTROPHYS J, V618, pL53, DOI 10.1086/427693; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Castelao RM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024401; COURTIN R, 1995, ICARUS, V114, P144, DOI 10.1006/icar.1995.1050; Gibbard SG, 2004, ICARUS, V169, P429, DOI 10.1016/j.icarus.2003.12.026; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Hauglustaine DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003957; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; LORENZ RD, 1993, PLANET SPACE SCI, V41, P647, DOI 10.1016/0032-0633(93)90048-7; Mayo LA, 2005, ICARUS, V176, P316, DOI 10.1016/j.icarus.2005.01.020; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2004, ICARUS, V170, P443, DOI 10.1016/j.icarus.2004.03.007; Rannou P, 2002, NATURE, V418, P853, DOI 10.1038/nature00961; Roe H. G., 2002, ASTRON J, V591, P1399; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; Samuelson RE, 1997, PLANET SPACE SCI, V45, P949, DOI 10.1016/S0032-0633(97)00089-5; Samuelson RE, 1997, PLANET SPACE SCI, V45, P941, DOI 10.1016/S0032-0633(97)00088-3; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tokano T, 2001, ICARUS, V153, P130, DOI 10.1006/icar.2001.6659; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Young EF, 2002, ASTRON J, V123, P3473, DOI 10.1086/339826	29	165	166	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					201	205		10.1126/science.1118424	http://dx.doi.org/10.1126/science.1118424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410519				2022-12-28	WOS:000234722200034
J	Yan, LJL; Daviglus, ML; Liu, K; Stamler, J; Wang, RW; Pirzada, A; Garside, DB; Dyer, AR; Van Horn, L; Liao, YL; Fries, JF; Greenland, P				Yan, LJL; Daviglus, ML; Liu, K; Stamler, J; Wang, RW; Pirzada, A; Garside, DB; Dyer, AR; Van Horn, L; Liao, YL; Fries, JF; Greenland, P			Midlife body mass index and hospitalization and mortality in older age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR PROFILE; LIFE EXPECTANCY; BLOOD-PRESSURE; UNITED-STATES; MIDDLE-AGE; OBESITY; WEIGHT; PREVENTION; ASSOCIATION	Context Abundant evidence links overweight and obesity with impaired health. However, controversies persist as to whether overweight and obesity have additional impact on cardiovascular outcomes independent of their strong associations with established coronary risk factors, eg, high blood pressure and high cholesterol level. Objective To assess the relation of midlife body mass index with morbidity and mortality outcomes in older age among individuals without and with other major risk factors at baseline. Design Chicago Heart Association Detection Project in Industry study, a prospective study with baseline (1967-1973) cardiovascular risk classified as low risk (blood pressure <= 120/<= 80 mm Hg, serum total cholesterol level <200 mg/dL [5.2 mmol/L], and not currently smoking); moderate risk (nonsmoking and systolic blood pressure 121-139 mm Hg, diastolic blood pressure 81-89 mm Hg, and/or total cholesterol level 200-239 mg/dL [5.2-6.2 mmol/L]); or having any 1, any 2, or all 3 of the following risk factors: blood pressure >= 140/90 mm Hg, total cholesterol level >= 240 mg/dL (6.2 mmol/L), and current cigarette smoking. Body mass index was classified as normal weight (18.5-24.9), overweight, (25.0-29.9), or obese ( >= 30). Mean follow-up was 32 years. Setting and Participants Participants were 17643 men and women aged 31 through 64 years, recruited from Chicago-area companies or organizations and free of coronary heart disease (CHD), diabetes, or major electrocardiographic abnormalities at baseline. Main Outcome Measures Hospitalization and mortality from CHD, cardiovascular disease, or diabetes, beginning at age 65 years. Results In multivariable analyses that included adjustment for systolic blood pressure and total cholesterol level, the odds ratio (95% confidence interval) for CHD death for obese participants compared with those of normal weight in the same risk category was 1.43 (0.33-6.25) for low risk and 2.07 (1.29-3.31) for moderate risk; for CHID hospitalization, the corresponding results were 4.25 (1.57-11.5) for low risk and 2.04 (1.29-3.24) for moderate risk. Results were similar for other risk groups and for cardiovascular disease, but stronger for diabetes (eg, low risk: 11.0 [2.21-54.5] for mortality and 7.84 [3.95-15.6] for hospitalization). Conclusion For individuals with no cardiovascular risk factors as well as for those with 1 or more risk factors, those who are obese in middle age have a higher risk of hospitalization and mortality from CHID, cardiovascular disease, and diabetes in older age than those who are normal weight.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA USA; Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Northwestern University; Feinberg School of Medicine; Peking University; Centers for Disease Control & Prevention - USA; Stanford University	Yan, LJL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	lijing@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021	Pirzada, Amber/0000-0003-0526-3611; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010, R21HL075259, R01HL062684] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2002, HEART DIS STROK STAT; Beaglehole R, 2002, INT J EPIDEMIOL, V31, P1117, DOI 10.1093/ije/31.6.1117; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; *CTR MED MED SERV, 2002, HLTH CAR FIN REV M S; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; FARINARO E, 1977, ANN INTERN MED, V86, P147, DOI 10.7326/0003-4819-86-2-147; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Fowles J B, 1998, J Ambul Care Manage, V21, P24; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LAUDERDALE DS, 1993, EPIDEMIOL REV, V15, P319, DOI 10.1093/oxfordjournals.epirev.a036123; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; RISSANEN A, 1991, J CLIN EPIDEMIOL, V44, P787, DOI 10.1016/0895-4356(91)90131-R; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; US Department of Health and Human Services, 2000, RED TOB US REP SURG; WAALER HT, 1984, ACTA MED SCAND, P1; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YAO CH, 1991, AM J EPIDEMIOL, V134, P1278, DOI 10.1093/oxfordjournals.aje.a116031	46	175	177	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					190	198		10.1001/jama.295.2.190	http://dx.doi.org/10.1001/jama.295.2.190			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403931	Bronze			2022-12-28	WOS:000234544300026
J	Lapsley, P				Lapsley, P			The magic roundabout	BRITISH MEDICAL JOURNAL			English	Editorial Material												peter.lapsley@btopenworld.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					43	44		10.1136/bmj.332.7532.43	http://dx.doi.org/10.1136/bmj.332.7532.43			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399740	Green Published			2022-12-28	WOS:000234684200024
J	Opie, LH				Opie, LH			Controversies in cardiology	LANCET			English	Editorial Material							TRIAL; PARTICIPANTS; THERAPY; EVENTS; HEART; RISK		Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Heart Res Inst, ZA-7925 Cape Town, South Africa	University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Heart Res Inst, Chris Barnard Bldg, ZA-7925 Cape Town, South Africa.	opie@capeheart.uct.ac.za						Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BERGMANN SR, 1983, SCIENCE, V220, P1181; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; *ISIS 1 STUD, 1986, LANCET, V2, P56; Kaplan NM, 2000, LANCET, V356, P1933, DOI 10.1016/S0140-6736(05)73487-5; KAPLAN NM, 2005, KAPLANS CLIN HYPERTE; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; OPIE LH, 1980, LANCET, V1, P693; Opie LH, 2005, DRUGS FOR THE HEART; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	14	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					13	14		10.1016/S0140-6736(06)67903-8	http://dx.doi.org/10.1016/S0140-6736(06)67903-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399138				2022-12-28	WOS:000234443100010
J	Tyring, S; Gottlieb, A; Papp, K; Gordon, K; Leonardi, C; Wang, A; Lalla, D; Woolley, M; Jahreis, A; Zitnik, R; Cella, D; Krishnan, R				Tyring, S; Gottlieb, A; Papp, K; Gordon, K; Leonardi, C; Wang, A; Lalla, D; Woolley, M; Jahreis, A; Zitnik, R; Cella, D; Krishnan, R			Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial	LANCET			English	Article							QUALITY-OF-LIFE; FUNCTIONAL ASSESSMENT; RHEUMATOID-ARTHRITIS; THERAPY; EFFICACY; CYTOKINES; BURDEN; MONOTHERAPY; IMPROVEMENT; EFALIZUMAB	Background Psoriasis has substantial psychological and emotional effects. We assessed the effect of etanercept, an effective treatment for the clinical symptoms of psoriasis, on fatigue and symptoms of depression associated with the condition. Methods 618 patients with moderate to severe psoriasis received double-blind treatment with placebo or 50 mg twice-weekly etanercept. The primary efficacy endpoint was a 75% or greater improvement from baseline in psoriasis area and severity index score (PASI 75) at week 12. Secondary and other endpoints included the functional assessment of chronic illness therapy fatigue (FACIT-F) scale, the Hamilton rating scale for depression (Ham-D), the Beck depression inventory (BDI), and adverse events. Efficacy analyses were based on the allocated treatment. Analyses and summaries of safety data were based on the actual treatment received. This study is registered with ClinicalTrials.gov with the identifier NCT00111449. Findings 47% (147 of 311) of patients achieved PASI 75 at week 12, compared with 5% (15 of 306) of those receiving placebo (p<0.0001; difference 42%, 95% Cl 36-48). Greater proportions of patients receiving etanercept had at least a 50% improvement in Ham-D or BDI at week 12 compared with the placebo group; patients treated with etanercept also had significant and clinically meaningful improvements in fatigue (mean FACIT-F improvement 5.0 vs 1.9; p<0.0001, difference 3.0, 95% CI 1.6-4.5). Improvements in fatigue were correlated with decreasing joint pain, whereas improvements in symptoms of depression were less correlated with objective measures of skin clearance or joint pain. Interpretation Etanercept treatment might relieve fatigue and symptoms of depression associated with this chronic disease.	Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Univ Texas, Hlth Sci Ctr, Dept Dermatol, Houston, TX USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Psoriasis Ctr Excellence, New Brunswick, NJ USA; Univ Western Ontario, London, ON, Canada; Prob Med Res, Waterloo, ON, Canada; Evanston NW Healthcare, Div Dermatol, Skokie, IL USA; St Louis Univ, Sch Med, Dept Dermatol, St Louis, MO USA; Amgen Inc, Thousand Oaks, CA USA; Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL USA	Duke University; University of Texas System; University of Texas Health Science Center Houston; Rutgers State University New Brunswick; Rutgers State University Medical Center; Western University (University of Western Ontario); NorthShore University Health System; Saint Louis University; Amgen; NorthShore University Health System	Krishnan, R (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Box 3950, Durham, NC 27710 USA.	krish001@mc.duke.edu		Papp, Kim A./0000-0001-9557-3642				Akay A, 2002, J EUR ACAD DERMATOL, V16, P347, DOI 10.1046/j.1468-3083.2002.00467.x; Alpsoy E, 1998, J AM ACAD DERMATOL, V38, P197, DOI 10.1016/S0190-9622(98)70240-3; Amini H, 2005, J CLIN PHARM THER, V30, P133, DOI 10.1111/j.1365-2710.2004.00585.x; Beck A., 1993, BECK DEPRESSION INVE; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; Evers AWM, 2005, BRIT J DERMATOL, V152, P1275, DOI 10.1111/j.1365-2133.2005.06565.x; Feldman SR, 2005, J AM ACAD DERMATOL, V53, P887, DOI 10.1016/j.jaad.2005.06.053; Feldman SR, 2005, BRIT J DERMATOL, V152, P954, DOI 10.1111/j.1365-2133.2005.06510.x; Feldman SR, 2004, BRIT J DERMATOL, V150, P317, DOI 10.1111/j.1365-2133.2004.05697.x; Fortune DG, 2004, BRIT J DERMATOL, V151, P1219, DOI 10.1111/j.1365-2133.2004.06222.x; Gottlieb AB, 2003, ARCH DERMATOL, V139, P1627, DOI 10.1001/archderm.139.12.1627; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heydendael VMR, 2004, J INVEST DERM SYMP P, V9, P131, DOI 10.1111/j.1087-0024.2004.09115.x; Illman James, 2005, J Support Oncol, V3, P37; Iosifescu DV, 2005, J CLIN PSYCHIAT, V66, P1038, DOI 10.4088/JCP.v66n0812; Khan A, 2005, J PSYCHIAT RES, V39, P145, DOI 10.1016/j.jpsychires.2004.06.005; Kimball AB, 2004, J AM ACAD DERMATOL, V50, pP156, DOI 10.1016/j.jaad.2003.10.547; Kirby B, 2000, BRIT J DERMATOL, V142, P728, DOI 10.1046/j.1365-2133.2000.03418.x; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger GG, 2005, BRIT J DERMATOL, V153, P1192, DOI 10.1111/j.1365-2133.2005.06948.x; Krueger GG, 2002, J AM ACAD DERMATOL, V47, P821, DOI 10.1067/mjd.2002.127247; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Menter A, 2005, ARCH DERMATOL, V141, P31, DOI 10.1001/archderm.141.1.31; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; PATARCA R, 1994, CLIN INFECT DIS, V18, pS147, DOI 10.1093/clinids/18.Supplement_1.S147; Prins M, 2005, ACTA DERM-VENEREOL, V85, P304, DOI 10.1080/00015550510027801; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Stokes ME, 2000, CATEGORICAL DATA ANA; Szuba MP, 2005, J CLIN PSYCHOPHARM, V25, P325, DOI 10.1097/01.jcp.0000169037.17884.79; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Wolfe F, 2004, J RHEUMATOL, V31, P2115; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6	38	823	853	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					29	35		10.1016/S0140-6736(05)67763-X	http://dx.doi.org/10.1016/S0140-6736(05)67763-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399150				2022-12-28	WOS:000234443100027
J	Mahonen, AP; Bishopp, A; Higuchi, M; Nieminen, KM; Kinoshita, K; Tormakangas, K; Ikeda, Y; Oka, A; Kakimoto, T; Helariutta, Y				Mahonen, AP; Bishopp, A; Higuchi, M; Nieminen, KM; Kinoshita, K; Tormakangas, K; Ikeda, Y; Oka, A; Kakimoto, T; Helariutta, Y			Cytokinin signaling and its inhibitor AHP6 regulate cell fate during vascular development	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; HISTIDINE KINASE; DIFFERENTIATION; ROOT; RECEPTOR; TRANSDUCTION; EXPRESSION; GROWTH	The cell lineages that form the transporting tissues (xylem and phloem) and the intervening pluripotent procambial tissue originate from stem cells near the root tip. We demonstrate that in Arabidopsis, cytokinin phytohormones negatively regulate protoxylem specification. AHP6, an inhibitory pseudophosphotransfer protein, counteracts cytokinin signaling, allowing protoxylem formation. Conversely, cytokinin signaling negatively regulates the spatial domain of AHP6 expression. Thus, by controlling the identity of cell lineages, the reciprocal interaction of cytokinin signaling and its spatially specific modulator regulates proliferation and differentiation of cell lineages during vascular development, demonstrating a previously unrecognized regulatory circuit underlying meristem organization.	Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FIN-00014 Helsinki, Finland; Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; Kyoto Univ, Inst Chem Res, Mol Biol Lab, Uji 6110011, Japan; Univ Turku, Dept Biol, FI-20014 Turku, Finland; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden	University of Helsinki; Osaka University; Rockefeller University; Kyoto University; University of Turku; Swedish University of Agricultural Sciences; Umea University	Kakimoto, T (corresponding author), Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, POB 56, FIN-00014 Helsinki, Finland.	kakimoto@bio.sci.osaka-u.ac.jp; yhetariu@operoni.helsinki.fi	Ikeda, Yoshihisa/B-4614-2013; Nieminen, Kaisa/N-9051-2015; Helariutta, Yrjo/AAE-8149-2020; Mähönen, Ari Pekka/B-9764-2015	Helariutta, Yrjo/0000-0002-7287-8459; Mähönen, Ari Pekka/0000-0001-6051-866X; Bishopp, Anthony/0000-0003-2962-9542; Nieminen, Kaisa/0000-0001-7004-9422				ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Esau K., 1977, ANATOMY SEED PLANTS; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kiba T, 2002, PLANT CELL PHYSIOL, V43, P1059, DOI 10.1093/pcp/pcf121; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Pyo H, 2004, PLANT CELL PHYSIOL, V45, P1529, DOI 10.1093/pcp/pch175; SCHERES B, 1995, DEVELOPMENT, V121, P53; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	18	406	424	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					94	98		10.1126/science.1118875	http://dx.doi.org/10.1126/science.1118875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400151				2022-12-28	WOS:000234546300041
J	Mumby, PJ; Dahlgren, CP; Harborne, AR; Kappel, CV; Micheli, F; Brumbaugh, DR; Holmes, KE; Mendes, JM; Broad, K; Sanchirico, JN; Buch, K; Box, S; Stoffle, RW; Gill, AB				Mumby, PJ; Dahlgren, CP; Harborne, AR; Kappel, CV; Micheli, F; Brumbaugh, DR; Holmes, KE; Mendes, JM; Broad, K; Sanchirico, JN; Buch, K; Box, S; Stoffle, RW; Gill, AB			Fishing, trophic cascades, and the process of grazing on coral reefs	SCIENCE			English	Article							ALGAL COMMUNITIES; MARINE RESERVE; MASS MORTALITY; FISHES; DYNAMICS; HERBIVORY; BIOMASS; SIZE	Since the mass mortality of the urchin Diadema antillarum in 1983, parrotfishes have become the dominant grazer on Caribbean reefs. The grazing capacity of these fishes could be impaired if marine reserves achieve their long-term goal of restoring large consumers, several of which prey on parrotfishes. Here we compare the negative impacts of enhanced predation with the positive impacts of reduced fishing mortality on parrotfishes inside reserves. Because large-bodied parrotfishes escape the risk of predation from a large piscivore (the Nassau grouper), the predation effect reduced grazing by only 4 to 8%. This impact was overwhelmed by the increase in density of large parrotfishes, resulting in a net doubling of grazing. Increased grazing caused a fourfold reduction in the cover of macroalgae, which, because they are the principal competitors of corals, highlights the potential importance of reserves for coral reef resilience.	Univ Exeter, Marine Spatial Ecol Lab, Sch Biosci, Exeter EX4 4PS, Devon, England; Perry Inst Marine Sci, Jupiter, FL 33477 USA; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; Univ W Indies, Dept Life Sci, Kingston 7, Jamaica; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Affairs & Policy, Miami, FL 33149 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Arizona, Bur Appl Res Anthropol, Tucson, AZ 85721 USA; Cranfield Univ, Inst Water & Environm, Silsoe MK45 4DT, Beds, England	University of Exeter; Stanford University; American Museum of Natural History (AMNH); University West Indies Mona Jamaica; University of Miami; Resources for the Future; University of Arizona; Cranfield University	Mumby, PJ (corresponding author), Univ Exeter, Marine Spatial Ecol Lab, Sch Biosci, Prince Wales Rd, Exeter EX4 4PS, Devon, England.		Harborne, Alastair R/F-6155-2013; Stoffle, Richard/GVU-1766-2022; Mumby, Peter/F-9914-2010; Gill, Andrew/ABE-1092-2020; Kappel, Carrie Vanessa/B-9534-2009	Harborne, Alastair R/0000-0002-6818-8615; Mumby, Peter/0000-0002-6297-9053; Gill, Andrew/0000-0002-3379-6952; Kappel, Carrie Vanessa/0000-0003-2507-8042; Micheli, Fiorenza/0000-0002-6865-1438	Natural Environment Research Council [NER/A/S/2001/01127] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Bruggemann J. H., 1995, THESIS RIJKSUNIVERSI; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Claro R, 2001, ECOLOGY MARINE FISHE; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Eggleston DB, 1998, B MAR SCI, V63, P111; Gill AB, 2003, J FISH BIOL, V63, P105, DOI 10.1111/j.1095-8649.2003.00214.x; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Rakitin A, 1996, MAR ECOL PROG SER, V131, P97, DOI 10.3354/meps131097; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sluka Robert, 1996, Bahamas Journal of Science, V3, P17; Sogard SM, 1997, B MAR SCI, V60, P1129; Steneck R., 1997, P 8 INT COR REEF S, P695; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Winn H. E., 1964, Zeitschrift fuer Tierpsychologie, V21, P798	24	629	644	7	406	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					98	101		10.1126/science.1121129	http://dx.doi.org/10.1126/science.1121129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400152				2022-12-28	WOS:000234546300042
J	Nunes, F; Norris, RD				Nunes, F; Norris, RD			Abrupt reversal in ocean overturning during the Palaeocene/Eocene warm period	NATURE			English	Article							PALEOCENE THERMAL MAXIMUM; CHRONOLOGY; ISOTOPE	An exceptional analogue for the study of the causes and consequences of global warming occurs at the Palaeocene/ Eocene Thermal Maximum, 55 million years ago. A rapid rise of global temperatures during this event accompanied turnovers in both marine(1-3) and terrestrial biota(4), as well as significant changes in ocean chemistry(5,6) and circulation(7,8). Here we present evidence for an abrupt shift in deep-ocean circulation using carbon isotope records from fourteen sites. These records indicate that deep-ocean circulation patterns changed from Southern Hemisphere overturning to Northern Hemisphere overturning at the start of the Palaeocene/ Eocene Thermal Maximum. This shift in the location of deep-water formation persisted for at least 40,000 years, but eventually recovered to original circulation patterns. These results corroborate climate model inferences that a shift in deep-ocean circulation would deliver relatively warmer waters to the deep sea, thus producing further warming(9). Greenhouse conditions can thus initiate abrupt deep-ocean circulation changes in less than a few thousand years, but may have lasting effects; in this case taking 100,000 years to revert to background conditions.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92092 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Nunes, F (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92092 USA.	fnunes@ucsd.edu	Nunes, Flavia/AAK-1390-2020; Nunes, Flavia/B-5041-2011	Nunes, Flavia/0000-0002-3947-6634; Nunes, Flavia/0000-0002-3947-6634				Bains S, 2000, NATURE, V407, P171, DOI 10.1038/35025035; Beerling DJ, 2000, PALAEOGEOGR PALAEOCL, V161, P395, DOI 10.1016/S0031-0182(00)00095-X; Bice K.L., 2002, PALEOCEANOGRAPHY, V17; Bice KL, 2001, J GEOPHYS RES-OCEANS, V106, P11529, DOI 10.1029/2000JC000561; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Brady EC, 1998, GEOPHYS RES LETT, V25, P4205, DOI 10.1029/1998GL900072; BRALOWER TJ, 2002, PALEOCEANOGRAPHY, V17, P1029, DOI DOI 10.1029/2001PA000662; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Kelly DC, 1998, PALAEOGEOGR PALAEOCL, V141, P139, DOI 10.1016/S0031-0182(98)00017-0; Kennett J.P., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P865, DOI 10.2973/odp.proc.sr.113.188.1990; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Pak DK, 1992, PALEOCEANOGRAPHY, V7, P405, DOI 10.1029/92PA01234; Quillevere F, 2002, PALAEOGEOGR PALAEOCL, V184, P371, DOI 10.1016/S0031-0182(02)00275-4; Ravizza G, 2001, PALEOCEANOGRAPHY, V16, P155, DOI 10.1029/2000PA000541; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Stoll HM, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000875; Thomas DJ, 2003, EARTH PLANET SC LETT, V209, P309, DOI 10.1016/S0012-821X(03)00096-7; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	24	127	136	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					60	63		10.1038/nature04386	http://dx.doi.org/10.1038/nature04386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397495				2022-12-28	WOS:000234378700033
J	Wildwater, M; Campilho, A; Perez-Perez, JM; Heidstra, R; Blilou, I; Korthout, H; Chatterjee, J; Mariconti, L; Gruissem, W; Scheres, B				Wildwater, M; Campilho, A; Perez-Perez, JM; Heidstra, R; Blilou, I; Korthout, H; Chatterjee, J; Mariconti, L; Gruissem, W; Scheres, B			The RETINOBLASTOMA-RELATED gene regulates stem cell maintenance in Arabidopsis roots	CELL			English	Article							SELF-RENEWAL; PROTEIN HOMOLOG; FUSION PROTEIN; DIFFERENTIATION; MERISTEM; DROSOPHILA; CYCLE; SCARECROW; DIVISION; NICHE	The maintenance of stem cells in defined locations is crucial for all multicellular organisms. Although intrinsic factors and signals for stem cell fate have been identified in several species, it has remained unclear how these connect to the ability to reenter the cell cycle that is one of the defining properties of stem cells. We show that local reduction of expression of the RETINOBLASTOMA-RELATED (RBR) gene in Arabidopsis roots increases the amount of stem cells without affecting cell cycle duration in mitotically active cells. Conversely, induced RBR overexpression dissipates stem cells prior to arresting other mitotic cells. Overexpression of D cyclins, KIP-related proteins, and E2F factors also affects root stem cell pool size, and genetic interactions suggest that these factors function in a canonical RBR pathway to regulate somatic stem cells. Expression analysis and genetic interactions position RBR-mediated regulation of the stem cell state downstream of the patterning gene SCARECROW.	Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; ETH Zentrum, Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; TNO Qual Life Appl Plant Sci, NL-2333 CK Leiden, Netherlands	Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Netherlands Organization Applied Science Research	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Perez-Perez, Jose Manuel/B-4247-2011; Campilho, Ana/H-8790-2013; Campilho, Ana/U-8263-2019; Gruissem, Wilhelm/H-1752-2013	Perez-Perez, Jose Manuel/0000-0003-2848-4919; Campilho, Ana/0000-0002-3470-1943; Campilho, Ana/0000-0002-3470-1943; Scheres, Ben/0000-0001-5400-9578; Blilou, Ikram/0000-0001-8003-3782; Gruissem, Wilhelm/0000-0002-1872-2998				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Dewitte W, 2003, PLANT CELL, V15, P79, DOI 10.1105/tpc.004838; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Huntley R, 1998, PLANT MOL BIOL, V37, P155, DOI 10.1023/A:1005902226256; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu HP, 2004, CURR OPIN GENET DEV, V14, P55, DOI 10.1016/j.gde.2003.11.005; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nakagami H, 1999, PLANT J, V18, P243, DOI 10.1046/j.1365-313X.1999.00449.x; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ross JF, 2001, GENE DEV, V15, P392, DOI 10.1101/gad.858501; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Willemsen V, 1998, DEVELOPMENT, V125, P521; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	62	265	289	1	57	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1337	1349		10.1016/j.cell.2005.09.042	http://dx.doi.org/10.1016/j.cell.2005.09.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377572	Bronze, Green Submitted			2022-12-28	WOS:000234584500020
J	Dennell, R; Roebroeks, W				Dennell, R; Roebroeks, W			An Asian perspective on early human dispersal from Africa	NATURE			English	Review							HOMO-ERECTUS; EARLY HOMINID; LATE PLEISTOCENE; EAST GEORGIA; PLIOCENE; DMANISI; GENUS; JAVA; EVOLUTION; REMAINS	The past decade has seen the Pliocene and Pleistocene fossil hominin record enriched by the addition of at least ten new taxa, including the Early Pleistocene, small-brained hominins from Dmanisi, Georgia, and the diminutive Late Pleistocene Homo floresiensis from Flores, Indonesia. At the same time, Asia's earliest hominin presence has been extended up to 1.8 Myr ago, hundreds of thousands of years earlier than previously envisaged. Nevertheless, the preferred explanation for the first appearance of hominins outside Africa has remained virtually unchanged. We show here that it is time to develop alternatives to one of palaeoanthropology's most basic paradigms: 'Out of Africa 1'.	Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Leiden Univ, Dept Archaeol, NL-2300 RA Leiden, Netherlands	University of Sheffield; Leiden University; Leiden University - Excl LUMC	Dennell, R (corresponding author), Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England.	r.dennell@sheffield.ac.uk		Roebroeks, Wil/0000-0002-5075-6899				Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; Anton SC, 1997, AM J PHYS ANTHROPOL, V102, P497, DOI 10.1002/(SICI)1096-8644(199704)102:4<497::AID-AJPA6>3.0.CO;2-P; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Belmaker M, 2002, J HUM EVOL, V43, P43, DOI 10.1006/jhev.2002.0556; BILSBOROUGH A., 1999, STRUCTURE CONTINGENC, P43; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Brauer Gunter, 1994, Courier Forschungsinstitut Senckenberg, V171, P301; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CLARKE RJ, 2000, INT J ANTHR, V15, P185; Coqueugniot H, 2004, NATURE, V431, P299, DOI 10.1038/nature02852; Darwin C., 1871, P475; de Heinzelin J, 1999, SCIENCE, V284, P625; Dennell R., 2004, EARLY HOMININ LANDSC; Dennell Robin W., 2001, P45; DENNELL RW, 1988, ANTIQUITY, V62, P98, DOI 10.1017/S0003598X00073555; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; DOWSETT H, 1994, GLOBAL PLANET CHANGE, V9, P169, DOI 10.1016/0921-8181(94)90015-9; FLYNN LJ, 1991, PALEOBIOLOGY, V17, P246, DOI 10.1017/S0094837300010599; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Hemmer H, 2004, NEUES JAHRB GEOL P-A, V233, P197; Hooijer D.A., 1958, B BRIT MUS NAT HIST, V3, P267; HOWELL FC, 1996, CONT ISSUES HUMAN EV, P1; HUANG WP, 1995, NATURE, V378, P275; Huffman OF, 2005, J HUM EVOL, V48, P321, DOI 10.1016/j.jhevol.2004.09.001; KRAMER A, 1993, AM J PHYS ANTHROPOL, V91, P161, DOI 10.1002/ajpa.1330910203; Lahr MM, 2004, NATURE, V431, P1043, DOI 10.1038/4311043a; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Lee Richard, 1968, MAN HUNTER; LINDSAY EH, 1980, NATURE, V287, P135, DOI 10.1038/287135a0; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Maschenko E.N., 1994, P15; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; Mithen S, 2002, J HUM EVOL, V43, P433, DOI 10.1006/jhev.2002.0584; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Nanda AC, 2002, J ASIAN EARTH SCI, V21, P47, DOI 10.1016/S1367-9120(02)00013-5; Parfitt SA, 2005, NATURE, V438, P1008, DOI 10.1038/nature04227; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; Ron H, 2001, GEOLOGY, V29, P887, DOI 10.1130/0091-7613(2001)029<0887:WDHFLA>2.0.CO;2; Sahnouni M, 2002, J HUM EVOL, V43, P925, DOI 10.1006/jhev.2002.0608; Schwartz JH, 1996, NATURE, V381, P201, DOI 10.1038/381201a0; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; SONKALIA A, 1995, AM ANTHROPOL, V87, P612; Sotnikova MV, 1997, PALAEOGEOGR PALAEOCL, V133, P243, DOI 10.1016/S0031-0182(97)00078-3; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Tattersall I, 1997, SCI AM, V276, P60, DOI 10.1038/scientificamerican0497-60; TATTERSALL I, 2000, EXTINCT HUMANS; Tyler DE, 2004, QUATERN INT, V117, P125, DOI 10.1016/S1040-6182(03)00122-8; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Vekua A., 1995, JB R MISCH GERMANISC, V42, P77; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Walker A., 1996, WISDOM BONES SEARCH; White TD, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P369; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 1999, EVOL ANTHROPOL, V8, P195, DOI 10.1002/(SICI)1520-6505(1999)8:6<195::AID-EVAN1>3.0.CO;2-2; WOOD B, 1995, NATURE, V378, P239; Wu Xinzhi, 2000, Acta Anthropologica Sinica, V19, P1; Zhu RX, 2004, NATURE, V431, P559, DOI 10.1038/nature02829	68	250	261	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1099	1104		10.1038/nature04259	http://dx.doi.org/10.1038/nature04259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995OF	16371999				2022-12-28	WOS:000234111500039
J	Landsea, CW				Landsea, CW			Meteorology - Hurricanes and global warming	NATURE			English	Editorial Material							TROPICAL CYCLONE CORE; BOUNDARY-LAYER JETS; REANALYSIS; INTENSITY; DYNAMICS		NOAA, Atlantic Oceanog & Meteorol Lab, Hurricane Res Div, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Landsea, CW (corresponding author), NOAA, Atlantic Oceanog & Meteorol Lab, Hurricane Res Div, Miami, FL 33149 USA.	chris.landsea@noaa.gov						BLAKE ES, 2005, TPC4 NWS NAT OC ATM; Dunion JP, 2003, MON WEATHER REV, V131, P1992, DOI 10.1175/1520-0493(2003)131<1992:AROTSW>2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Franklin JL, 2003, WEATHER FORECAST, V18, P32, DOI 10.1175/1520-0434(2003)018<0032:GDWPIH>2.0.CO;2; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Kepert J, 2001, J ATMOS SCI, V58, P2469, DOI 10.1175/1520-0469(2001)058<2469:TDOBLJ>2.0.CO;2; Kepert J, 2001, J ATMOS SCI, V58, P2485, DOI 10.1175/1520-0469(2001)058<2485:TDOBLJ>2.0.CO;2; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Landsea CW, 2004, B AM METEOROL SOC, V85, P1699, DOI 10.1175/BAMS-85-11-1699; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; LANDSEA CW, 1993, MON WEATHER REV, V121, P1703, DOI 10.1175/1520-0493(1993)121<1703:ACOIMA>2.0.CO;2; LANDSEA CW, HURRICANES TYPHOONS, P177	12	203	213	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					E11	E13		10.1038/nature04477	http://dx.doi.org/10.1038/nature04477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371953				2022-12-28	WOS:000234111500037
J	Kimelman, D; Pyati, UJ				Kimelman, D; Pyati, UJ			Bmp signaling: Turning a half into a whole	CELL			English	Editorial Material							SPEMANN ORGANIZER; XENOPUS EMBRYOS; DEPLETION; POSTERIOR; ADMP	In a famous experiment over a century ago, Hans Spemann demonstrated that amphibians have a remarkable ability to compensate for perturbations to the embryo. In this issue of Cell, Reversade and De Robertis (2005) uncover the basis of this phenomenon. They demonstrate that interactions between bone morphogenetic proteins (Bmps) and their inhibitors on both the dorsal and ventral sides of the early Xenopus embryo are involved in creating the body plan.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kimelman, D (corresponding author), Univ Washington, Dept Biochem, Box 367350, Seattle, WA 98195 USA.	kimelman@u.washington.edu						De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Moos M, 1995, DEVELOPMENT, V121, P4293; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Spemann H., 1938, EMBRYONIC DEV INDUCT; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494	8	12	13	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					982	984		10.1016/j.cell.2005.11.028	http://dx.doi.org/10.1016/j.cell.2005.11.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360027	Bronze			2022-12-28	WOS:000234177200006
J	Rubin, SM; Gall, AL; Zheng, N; Pavletich, NP				Rubin, SM; Gall, AL; Zheng, N; Pavletich, NP			Structure of the RbC-terminal domain bound to E2F1-DP1: A mechanism for phosphorylation-induced E2F release	CELL			English	Article							RETINOBLASTOMA GENE-PRODUCT; CYCLIN-CDK COMPLEXES; TRANSCRIPTION FACTOR DRTF1/E2F; TUMOR-SUPPRESSOR PROTEIN; LARGE T-ANTIGEN; FAMILY-MEMBERS; ONCOGENIC ACTIVITY; BINDING-SITE; PRB; TRANSACTIVATION	The retinoblastoma (Rb) protein negatively regulates the G1-S transition by binding to the E2F transcription factors, until cyclin-dependent kinases phosphorylate Rb, causing E2F release. The Rb pocket domain is necessary for E2F binding, but the Rb C-terminal domain (RbC) is also required for growth suppression. Here we demonstrate a high-affinity interaction between RbC and E2F-DP heterodimers shared by all Rb and E2F family members. The crystal structure of an RbC-E2F1-DP1 complex reveals an intertwined heterodimer in which the marked box domains of both E2F1 and DP1 contact RbC. We also demonstrate that phosphorylation of RbC at serines 788 and 795 destabilizes one set of RbC-E2F-DP interactions directly, while phosphorylation at threonines 821 and 826 induces an intramolecular interaction between RbC and the Rb pocket that destabilizes the remaining interactions indirectly. Our findings explain the requirement of RbC for high-affinity E2F binding and growth suppression and establish a mechanism for the regulation of Rb-E2F association by phosphorylation.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA.	nikola@xray2.mskcc.org						Adams PD, 1999, MOL CELL BIOL, V19, P1068; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brown VD, 2002, MOL CELL BIOL, V22, P1390, DOI 10.1128/MCB.22.5.1390-1401.2002; Brown VD, 1999, MOL CELL BIOL, V19, P3246; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HLEBERT SW, 1993, MOL CELL BIOL, V13, P3384; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3525, DOI 10.1073/pnas.90.8.3525; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Jost CA, 1996, VIROLOGY, V220, P78, DOI 10.1006/viro.1996.0288; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; NEVINS JR, 1994, CURR OPIN GENET DEV, V4, P130, DOI 10.1016/0959-437X(94)90101-5; OCONNOR RJ, 1994, J VIROL, V68, P6848, DOI 10.1128/JVI.68.11.6848-6862.1994; Pan WJ, 2001, CANCER RES, V61, P2885; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wallace M, 2004, MOL CELL BIOL, V24, P5606, DOI 10.1128/MCB.24.12.5606-5619.2004; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x	48	177	188	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1093	1106		10.1016/j.cell.2005.09.044	http://dx.doi.org/10.1016/j.cell.2005.09.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360038	Bronze			2022-12-28	WOS:000234177200017
J	Mariathasan, S; Weiss, DS; Newton, K; McBride, J; O'Rourke, K; Roose-Girma, M; Lee, WP; Weinrauch, Y; Monack, DM; Dixit, VM				Mariathasan, S; Weiss, DS; Newton, K; McBride, J; O'Rourke, K; Roose-Girma, M; Lee, WP; Weinrauch, Y; Monack, DM; Dixit, VM			Cryopyrin activates the inflammasome in response to toxins and ATP	NATURE			English	Article							NF-KAPPA-B; INTERLEUKIN-1-BETA SECRETION; MURAMYL DIPEPTIDE; GENE; PROTEIN; ASC; MUTATIONS; MICE; MAITOTOXIN; CASPASE-1	A crucial part of the innate immune response is the assembly of the inflammasome, a cytosolic complex of proteins that activates caspase-1 to process the proinflammatory cytokines interleukin (IL)-1 beta and IL-18. The adaptor protein ASC is essential for inflammasome function(1,2), binding directly to caspase-1 (refs 3, 4), but the triggers of this interaction are less clear. ASC also interacts with the adaptor cryopyrin (also known as NALP3 or CIAS1)(5,6). Activating mutations in cryopyrin are associated with familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal onset multisystem inflammatory disease, diseases that are characterized by excessive production of IL-1 beta(5,7). Here we show that cryopyrin-deficient macrophages cannot activate caspase-1 in response to Toll-like receptor agonists plus ATP, the latter activating the P2X(7) receptor to decrease intracellular K+ levels(8,9). The release of IL-1 beta in response to nigericin, a potassium ionophore, and maitotoxin, a potent marine toxin, was also found to be dependent on cryopyrin. In contrast to Asc(-/-) macrophages, cells deficient in the gene encoding cryopyrin (Cias1(-/-)) activated caspase-1 and secreted normal levels of IL-1 beta and IL-18 when infected with Gram-negative Salmonella typhimurium or Francisella tularensis. Macrophages exposed to Gram-positive Staphylococcus aureus or Listeria monocytogenes, however, required both ASC and cryopyrin to activate caspase-1 and secrete IL-1 beta. Therefore, cryopyrin is essential for inflammasome activation in response to signalling pathways triggered specifically by ATP, nigericin, maitotoxin, S. aureus or L. monocytogenes.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University; Stanford University; New York University	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com		Monack, Denise/0000-0003-3804-2209				Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Damiano JS, 2004, J IMMUNOL, V173, P6338, DOI 10.4049/jimmunol.173.10.6338; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDermott MF, 2002, TRENDS MOL MED, V8, P550, DOI 10.1016/S1471-4914(02)02425-5; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Verhoef PA, 2004, MOL PHARMACOL, V66, P909, DOI 10.1124/mol.66.4.909; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	25	2246	2327	2	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					228	232		10.1038/nature04515	http://dx.doi.org/10.1038/nature04515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407890	Bronze			2022-12-28	WOS:000235839500050
J	White-Grindley, E; Si, K				White-Grindley, E; Si, K			RISC-y memories	CELL			English	Editorial Material							PROTEIN-SYNTHESIS; MICRORNAS; DROSOPHILA	Local protein synthesis in the synapse is required for synaptic plasticity and has been implicated in learning and memory. However, direct evidence that behavioral training induces local protein synthesis has been lacking. In this issue of Cell, Ashraf et al. (2006) observe persistent local protein synthesis in the antennal lobe synapses of the fruit fly following olfactory-avoidance learning. This protein synthesis is regulated by the RNA-induced silencing complex (RISC).	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Si, K (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ksj@stowers-institute.org						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ASHRAF SI, 2006, CELL; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	11	4	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					23	26		10.1016/j.cell.2005.12.027	http://dx.doi.org/10.1016/j.cell.2005.12.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413478	Bronze			2022-12-28	WOS:000234969600006
J	Freedman, DO; Weld, LH; Kozarsky, PE; Fisk, T; Robins, R; von Sonnenburg, F; Keystone, JS; Pandey, P; Cetron, MS				Freedman, DO; Weld, LH; Kozarsky, PE; Fisk, T; Robins, R; von Sonnenburg, F; Keystone, JS; Pandey, P; Cetron, MS		GeoSentinel Surveillance Network	Spectrum of disease and relation to place of exposure among ill returned travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEVELOPING-COUNTRIES; TROPICAL COUNTRIES; HEALTH-PROBLEMS; FEVER; EPIDEMIOLOGY; DIARRHEA; AFRICA; RESIDENTS; ETIOLOGY; ILLNESS	BACKGROUND: Approximately 8 percent of travelers to the developing world require medical care during or after travel. Current understanding of morbidity profiles among ill returned travelers is based on limited data from the 1980s. METHODS: Thirty GeoSentinel sites, which are specialized travel or tropical-medicine clinics on six continents, contributed clinician-based sentinel surveillance data for 17,353 ill returned travelers. We compared the frequency of occurrence of each diagnosis among travelers returning from six developing regions of the world. RESULTS: Significant regional differences in proportionate morbidity were detected in 16 of 21 broad syndromic categories. Among travelers presenting to GeoSentinel sites, systemic febrile illness without localizing findings occurred disproportionately among those returning from sub-Saharan Africa or Southeast Asia, acute diarrhea among those returning from south central Asia, and dermatologic problems among those returning from the Caribbean or Central or South America. With respect to specific diagnoses, malaria was one of the three most frequent causes of systemic febrile illness among travelers from every region, although travelers from every region except sub-Saharan Africa and Central America had confirmed or probable dengue more frequently than malaria. Among travelers returning from sub-Saharan Africa, rickettsial infection, primarily tick-borne spotted fever, occurred more frequently than typhoid or dengue. Travelers from all regions except Southeast Asia presented with parasite-induced diarrhea more often than with bacterial diarrhea. CONCLUSIONS: When patients present to specialized clinics after travel to the developing world, travel destinations are associated with the probability of the diagnosis of certain diseases. Diagnostic approaches and empiric therapies can be guided by these destination-specific differences.	Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; Univ Munich, Dept Trop & Infect Dis, Munich, Germany; Univ Toronto, Div Infect Dis, Toronto, ON, Canada; CIWEC Clin, Kathmandu, Nepal	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Emory University; University of Munich; University of Toronto	Freedman, DO (corresponding author), Univ Alabama, Div Geog Med, 1530 3rd Ave S,BBRB 203, Birmingham, AL 35294 USA.	freedman@uab.edu	Freedman, David O./AAV-2999-2020	Freedman, David O./0000-0002-5642-5257; Weld, Leisa/0000-0001-6550-0135	ODCDC CDC HHS [U50/CCU412347] Funding Source: Medline	ODCDC CDC HHS		CAUMES E, 1995, CLIN INFECT DIS, V20, P542, DOI 10.1093/clinids/20.3.542; Caumes E, 2001, J TRAVEL MED, V8, P293, DOI 10.2310/7060.2001.22378; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; DUPONT HL, 1993, NEW ENGL J MED, V328, P1821, DOI 10.1056/NEJM199306243282507; Freedman DO, 1999, J TRAVEL MED, V6, P94, DOI 10.1111/j.1708-8305.1999.tb00839.x; Herwaldt BL, 2000, ANN INTERN MED, V132, P982, DOI 10.7326/0003-4819-132-12-200006200-00009; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Hoge CW, 1996, JAMA-J AM MED ASSOC, V275, P533, DOI 10.1001/jama.275.7.533; Humar A, 1996, BMJ-BRIT MED J, V312, P953, DOI 10.1136/bmj.312.7036.953; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Jensenius M, 2003, CLIN INFECT DIS, V36, P1411, DOI 10.1086/375083; Liese B, 1997, OCCUP ENVIRON MED, V54, P499, DOI 10.1136/oem.54.7.499; Patel D, 2000, J TRAVEL MED, V7, P64; Raoult D, 2001, NEW ENGL J MED, V344, P1504, DOI 10.1056/NEJM200105173442003; REID D, 1993, BRIT MED BULL, V49, P257, DOI 10.1093/oxfordjournals.bmb.a072609; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Shah Snehal, 2004, Morbidity and Mortality Weekly Report, V53, P21; Steffen R, 2003, INT J ANTIMICROB AG, V21, P89, DOI 10.1016/S0924-8579(02)00293-5; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; TAYLOR DN, 1988, JAMA-J AM MED ASSOC, V260, P1245, DOI 10.1001/jama.260.9.1245; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4	22	667	694	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					119	130		10.1056/NEJMoa051331	http://dx.doi.org/10.1056/NEJMoa051331			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407507				2022-12-28	WOS:000234528600004
J	Hill, DR				Hill, DR			The burden of illness in international travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Travel Hlth Network & Ctr, London, England; London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Hill, DR (corresponding author), Natl Travel Hlth Network & Ctr, London, England.							Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Jelinek T, 2005, INFECT DIS CLIN N AM, V19, P1, DOI 10.1016/j.idc.2004.10.005; World Bank, 2005, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-6226-6	3	44	45	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					115	117		10.1056/NEJMp058292	http://dx.doi.org/10.1056/NEJMp058292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407506				2022-12-28	WOS:000234528600003
J	Jeffries, D				Jeffries, D			Return of a system based on social values	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Marys, Ctr Hlth, Isles Of Scilly, England		Jeffries, D (corresponding author), St Marys, Ctr Hlth, Isles Of Scilly, England.	Dougal.Jeffries@ioshc.cornwall.nhs.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					44	45		10.1136/bmj.332.7532.44	http://dx.doi.org/10.1136/bmj.332.7532.44			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399741	Green Published			2022-12-28	WOS:000234684200025
J	Sharp, T				Sharp, T			Neuroscience - A new molecule to brighten the mood	SCIENCE			English	Editorial Material							DEPRESSION; RECEPTORS; SEROTONIN; PROTEIN; SUMATRIPTAN; DISORDER; CHANNEL; P11		Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Sharp, T (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	trevor.sharp@pharm.ox.ac.uk		Sharp, Trevor/0000-0001-7434-9713				Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Chaouloff F, 2000, J PSYCHOPHARMACOL, V14, P139, DOI 10.1177/026988110001400203; Cleare AJ, 1998, PSYCHOL MED, V28, P295, DOI 10.1017/S003329179700634X; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Huang YY, 2005, BIOORG MED CHEM LETT, V15, P4786, DOI 10.1016/j.bmcl.2005.07.024; Hudzik TJ, 2003, J PHARMACOL EXP THER, V304, P1072, DOI 10.1124/jpet.102.045468; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Miranda H, 2001, HEADACHE, V41, P680, DOI 10.1046/j.1526-4610.2001.041007680.x; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Stern L, 1998, EUR NEUROPSYCHOPHARM, V8, P325, DOI 10.1016/S0924-977X(97)00092-8; Stockmeier CA, 2003, J PSYCHIAT RES, V37, P357, DOI 10.1016/S0022-3956(03)00050-5; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Tatarczynska E, 2005, EUR J PHARMACOL, V516, P46, DOI 10.1016/j.ejphar.2005.04.025; Whale R, 2001, BRIT J PSYCHIAT, V178, P454, DOI 10.1192/bjp.178.5.454; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	20	7	11	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					45	46		10.1126/science.1122819	http://dx.doi.org/10.1126/science.1122819			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400139				2022-12-28	WOS:000234546300026
J	McDermott, MM; Liu, K; Ferrucci, L; Criqui, MH; Greenland, P; Guralnik, JM; Tian, L; Schneider, JR; Pearce, WH; Tan, J; Martin, GJ				McDermott, MM; Liu, K; Ferrucci, L; Criqui, MH; Greenland, P; Guralnik, JM; Tian, L; Schneider, JR; Pearce, WH; Tan, J; Martin, GJ			Physical performance in peripheral arterial disease: A slower rate of decline in patients who walk more	ANNALS OF INTERNAL MEDICINE			English	Article							ANKLE BRACHIAL INDEX; LEG SYMPTOMS; CLINICAL CHARACTERISTICS; EXERCISE REHABILITATION; CALTRAC ACCELEROMETER; OCCLUSIVE DISEASE; LONGITUDINAL DATA; 6-MINUTE WALK; RISK-FACTORS; PREVALENCE	Background: Exercise rehabilitation programs increase treadmill walking performance in patients with peripheral arterial disease (PAD) and intermittent claudication. However, it is unknown whether patients with PAD who walk for exercise regularly have less functional decline than those with less walking activity. Objective: To determine whether patients with PAD who report that they walk for exercise 3 or more times per week have less annual functional decline than those who walk for exercise less frequently. Design: Prospective cohort study with a median follow-up of 36 months (interquartile range, 24 to 36 months). Setting: Academic medical center. Participants: 417 men and women with PAID. Measurements: Participants were classified at baseline and annually according to the number of times they reportedly walked for exercise each week. Functional assessments (6-minute walk distance, 4-meter walking speed, summary performance score) were measured at baseline and annually. Results were adjusted for age, sex, ethnicity, comorbid conditions, body mass index, ankle-brachial index, education, leg symptoms, cigarette use, geriatric depression score, previous year's level of functioning, and patterns of missing data. Results: Compared with those who exercised less frequently, patients who walked for exercise 3 or more times per week had a significantly smaller average annual decline in 6-minute walking distance (-48.0 feet per year compared with - 56.6 feet per year for those who walked 1 to 2 times per week and - 79.4 feet per year for nonexercisers; P for trend = 0.037). Patients who walked for exercise at least 3 times per week experienced a smaller average annual decline in the usual-paced 4-meter walking velocity (-0.014 m/s per year compared with - 0.022 m/s per year for those who walked 1 to 2 times per week and - 0.045 m/s per year for nonexercisers; P = 0.005). Similar findings were observed for the fast-paced 4-meter walk. The subset of asymptomatic patients who walked for exercise 3 or more times per week had annual declines in 6-minute walking performance (P = 0.107), normal-paced walking velocity (P = 0.065), and the summary performance score (P = 0.115); however, these declines were smaller than those observed in asymptomatic participants who walked fewer than 3 times per week. Limitations: Because this was an observational study, associations reported here cannot be construed as causal relationships. Sample sizes for subgroup analyses were small, which limited statistical power. Conclusion: Among patients with PAD, self-directed walking exercise performed at least 3 times weekly is associated with significantly less functional decline during the subsequent year. Similar trends were observed in the subset of asymptomatic patients with PAD. These findings may be particularly important for the numerous patients with PAD who do not have access to supervised walking exercise programs.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Evanston NW Hosp, Evanston, IL USA; NIA, Baltimore, MD 21224 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Northwestern University; Feinberg School of Medicine; NorthShore University Health System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Greenland, Philip/ABD-5528-2021		NCRR NIH HHS [RR-00048] Funding Source: Medline; NHLBI NIH HHS [R01-HL58099, R01-HL64739] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064739, R01HL058099] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; Criqui M H, 1996, Vasc Med, V1, P65; Falcone Rita A, 2003, J Cardiopulm Rehabil, V23, P170, DOI 10.1097/00008483-200305000-00002; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; GURALNIK JM, 1995, N IH PUBL; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1191/135886301701568756; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; LENG GC, 2000, COCHRANE DB SYST REV, V2; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2002, J GEN INTERN MED, V17, P895, DOI 10.1046/j.1525-1497.2002.20307.x; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; McDermott MM, 1997, J GEN INTERN MED, V12, P209, DOI 10.1046/j.1525-1497.1997.012004209.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; Regensteiner Judith G., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P233, DOI 10.2174/1568006043336195; Richardson M T, 1995, J Cardiopulm Rehabil, V15, P107, DOI 10.1097/00008483-199503000-00003; Rucker-Whitaker C, 2004, J AM GERIATR SOC, V52, P922, DOI 10.1111/j.1532-5415.2004.52259.x; SALLIS JF, 1990, MED SCI SPORT EXER, V22, P698, DOI 10.1249/00005768-199010000-00023; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Stewart KJ, 2002, NEW ENGL J MED, V347, P1941, DOI 10.1056/NEJMra021135; Swan PD, 1997, BRIT J SPORT MED, V31, P235, DOI 10.1136/bjsm.31.3.235; *TASC, 2000, J VASC SURG, V31, pS118; *TASC, 2000, J VASC SURG 2, V31, pS83	40	88	96	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					10	20		10.7326/0003-4819-144-1-200601030-00005	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389250				2022-12-28	WOS:000234474200002
J	Ahringer, J				Ahringer, J			Playing ping pong with Pins: Cortical and microtubule-induced polarity	CELL			English	Article							ASYMMETRIC CELL-DIVISION; TUMOR-SUPPRESSOR; ELEGANS EMBRYOS; C-ELEGANS; DROSOPHILA; PROTEIN; NEUROBLAST; HOMOLOG; COMPLEX; SIZE		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Ahringer, J (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jaa@mole.bio.cam.ac.uk			Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Asaba N, 2003, J BIOL CHEM, V278, P8395, DOI 10.1074/jbc.M210362200; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Gomes JE, 2001, DEVELOPMENT, V128, P4301; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hanada N, 2000, INT J CANCER, V86, P480, DOI 10.1002/(SICI)1097-0215(20000515)86:4<480::AID-IJC6>3.0.CO;2-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756	12	2	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1184	1186		10.1016/j.cell.2005.12.011	http://dx.doi.org/10.1016/j.cell.2005.12.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377559	Bronze			2022-12-28	WOS:000234584500007
J	Cox, WM; Pesola, GR				Cox, WM; Pesola, GR			Buckshot ingestion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Norton Sound Reg Hosp, Nome, AK 99762 USA		Cox, WM (corresponding author), Norton Sound Reg Hosp, Nome, AK 99762 USA.			Pesola, Gene/0000-0002-3909-8039					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					E23	E23		10.1056/NEJMicm041154	http://dx.doi.org/10.1056/NEJMicm041154			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382055				2022-12-28	WOS:000234246700012
J	Gershlick, AH; Stephens-Lloyd, A; Hughes, S; Abrams, KR; Stevens, SE; Uren, NG; de Belder, A; Davis, J; Pitt, M; Banning, A; Baumbach, A; Shiu, MF; Schofield, P; Dawkins, KD; Henderson, RA; Oldroyd, KG; Wilcox, R				Gershlick, AH; Stephens-Lloyd, A; Hughes, S; Abrams, KR; Stevens, SE; Uren, NG; de Belder, A; Davis, J; Pitt, M; Banning, A; Baumbach, A; Shiu, MF; Schofield, P; Dawkins, KD; Henderson, RA; Oldroyd, KG; Wilcox, R		REACT Trial Investigators	Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT-ELEVATION; TISSUE-PLASMINOGEN ACTIVATOR; IMMEDIATE ANGIOPLASTY; NONINVASIVE DETECTION; GLOBAL REGISTRY; REPERFUSION; RESOLUTION; EVENTS; ARTERY; STREPTOKINASE	Background The appropriate treatment for patients in whom reperfusion fails to occur after thrombolytic therapy for acute myocardial infarction remains unclear. There are few data comparing emergency percutaneous coronary intervention (rescue PCI) with conservative care in such patients, and none comparing rescue PCI with repeated thrombolysis. Methods We conducted a multicenter trial in the United Kingdom involving 427 patients with ST-segment elevation myocardial infarction in whom reperfusion failed to occur (less than 50 percent ST-segment resolution) within 90 minutes after thrombolytic treatment. The patients were randomly assigned to repeated thrombolysis (142 patients), conservative treatment (141 patients), or rescue PCI (144 patients). The primary end point was a composite of death, reinfarction, stroke, or severe heart failure within six months. Results The rate of event-free survival among patients treated with rescue PCI was 84.6 percent, as compared with 70.1 percent among those receiving conservative therapy and 68.7 percent among those undergoing repeated thrombolysis (overall P=0.004). The adjusted hazard ratio for the occurrence of the primary end point for repeated thrombolysis versus conservative therapy was 1.09 (95 percent confidence interval, 0.71 to 1.67; P=0.69), as compared with adjusted hazard ratios of 0.43 (95 percent confidence interval, 0.26 to 0.72; P=0.001) for rescue PCI versus repeated thrombolysis and 0.47 (95 percent confidence interval, 0.28 to 0.79; P=0.004) for rescue PCI versus conservative therapy. There were no significant differences in mortality from all causes. Nonfatal bleeding, mostly at the sheath-insertion site, was more common with rescue PCI. At six months, 86.2 percent of the rescue-PCI group were free from revascularization, as compared with 77.6 percent of the conservative-therapy group and 74.4 percent of the repeated-thrombolysis group (overall P=0.05). Conclusions Event-free survival after failed thrombolytic therapy was significantly higher with rescue PCI than with repeated thrombolysis or conservative treatment. Rescue PCI should be considered for patients in whom reperfusion fails to occur after thrombolytic therapy.	Univ Hosp Leicester, Dept Cardiol, Leicester LE3 9QP, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Royal Infirm Edinburgh NHS Trust, Dept Cardiol, Edinburgh, Midlothian, Scotland; Royal Sussex Cty Hosp, Sussex Cardiac Ctr, Brighton BN2 5BE, E Sussex, England; N Staffordshire Hosp, Dept Cardiol, Stoke On Trent, Staffs, England; Birmingham Heartlands Hosp, Dept Cardiol, Birmingham B9 5ST, W Midlands, England; John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; Bristol Royal Infirm & Gen Hosp, Dept Cardiol, Bristol, Avon, England; Walsgrave Gen Hosp, Dept Cardiol, Coventry CV2 2DY, W Midlands, England; Papworth Hosp, Dept Cardiol, Cambridge CB3 8RE, England; Southampton Gen Hosp, Wessex Cardiac Unit, Southampton SO9 4XY, Hants, England; City Hosp Nottingham, Trent Cardiac Ctr, Nottingham, England; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland; Queens Med Ctr, Dept Cardiovasc Med, Nottingham NG7 2UH, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University of Leicester; Royal Infirmary of Edinburgh; University of Edinburgh; University of Brighton; Keele University; University Hospital of North Staffordshire NHS Trust; Heart of England NHS Foundation Trust; University of Birmingham; University of Oxford; Bristol Royal Infirmary; Papworth Hospital; University of Southampton; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Glasgow; University of Nottingham	Gershlick, AH (corresponding author), Univ Hosp Leicester, Dept Cardiol, Groby St, Leicester LE3 9QP, Leics, England.	agershlick@aol.com	Abrams, Keith/AAA-2557-2020; Oldroyd, Keith G/C-2281-2014; banning, adrian p/AAF-7229-2021	Oldroyd, Keith G/0000-0002-7842-3463; Abrams, Keith/0000-0002-7557-1567; Banning, Adrian/0000-0002-2842-7861; Baumbach, Andreas/0000-0001-7707-2254				Andrews J, 2000, CIRCULATION, V101, P2138, DOI 10.1161/01.CIR.101.18.2138; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Bar, 1997, J Thromb Thrombolysis, V4, P281, DOI 10.1023/A:1008807321037; Bovill EG, 1997, AM J CARDIOL, V79, P391, DOI 10.1016/S0002-9149(96)00773-4; Budaj A, 2003, AM HEART J, V146, P999, DOI 10.1016/S0002-8703(03)00509-X; Cannon CP, 1998, CIRCULATION, V98, P2805, DOI 10.1161/01.CIR.98.25.2805; Christenson RH, 1997, CIRCULATION, V96, P1776, DOI 10.1161/01.CIR.96.6.1776; de Lemos JA, 2001, AM J CARDIOL, V88, P353, DOI 10.1016/S0002-9149(01)01678-2; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; ELDEEB F, 1990, AM HEART J, V119, P786; ELLIS SG, 1994, CIRCULATION, V90, P2280, DOI 10.1161/01.CIR.90.5.2280; Ellis SG, 2000, AM HEART J, V139, P1046, DOI 10.1067/mhj.2000.106624; FathOrdoubadi F, 1997, AM HEART J, V134, P62, DOI 10.1016/S0002-8703(97)70107-8; FERNANDEZ AR, 1995, J AM COLL CARDIOL, V26, P675, DOI 10.1016/0735-1097(95)00208-L; Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994, LANCET, V343, P311; French JK, 1999, J AM COLL CARDIOL, V34, P62, DOI 10.1016/S0735-1097(99)00166-7; Gibson CM, 1997, AM J CARDIOL, V80, P21, DOI 10.1016/S0002-9149(97)00277-4; Gibson CM, 2004, AM HEART J, V147, P847, DOI 10.1016/j.ahj.2003.11.015; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; LAVIN F, 1995, BRIT HEART J, V73, P422; MCKENDALL GR, 1995, AM J CARDIOL, V76, P1108, DOI 10.1016/S0002-9149(99)80315-4; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Prendergast BD, 1997, INT J CARDIOL, V61, P39, DOI 10.1016/S0167-5273(97)00116-2; Puma JA, 1999, AM J CARDIOL, V83, P482, DOI 10.1016/S0002-9149(98)00899-6; Ross AM, 1998, J AM COLL CARDIOL, V31, P1511, DOI 10.1016/S0735-1097(98)00141-7; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Sarullo FM, 2000, CARDIOVASC DRUG THER, V14, P83, DOI 10.1023/A:1007803523966; SCHRODER R, 1995, J AM COLL CARDIOL, V26, P1657, DOI 10.1016/0735-1097(95)00372-X; Stewart JT, 1998, J AM COLL CARDIOL, V31, P1499, DOI 10.1016/S0735-1097(98)00139-9; Sutton AGC, 2004, J AM COLL CARDIOL, V44, P287, DOI 10.1016/j.jacc.2003.12.059; Sutton AGC, 2000, HEART, V84, P197, DOI 10.1136/heart.84.2.197; Tanasijevic MJ, 1999, J AM COLL CARDIOL, V34, P739, DOI 10.1016/S0735-1097(99)00274-0; The GUSTO Angiographic Investigators, 1994, NEW ENGL J MED, V330, P516; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Zeymer U, 2001, EUR HEART J, V22, P769, DOI 10.1053/euhj.2000.2290	36	286	313	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2758	2768		10.1056/NEJMoa050849	http://dx.doi.org/10.1056/NEJMoa050849			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382062	Green Published, Green Submitted			2022-12-28	WOS:000234246700007
J	Rupp, RAW; Becker, PB				Rupp, RAW; Becker, PB			Gene regulation by histone H1: New links to DNA methylation	CELL			English	Article							CHROMATIN; BINDING		Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	University of Munich	Becker, PB (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	pbecker@med.uni-muenchen.de		rupp, ralph/0000-0002-8068-9957; Becker, Peter/0000-0001-7186-0372				Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; JERZMANOWSKI J, 2004, CHROMATIN STRUCTURE, P75; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zlatanova J, 2000, FASEB J, V14, P1697, DOI 10.1096/fj.99-0869rev	11	19	24	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1178	+		10.1016/j.cell.2005.12.004	http://dx.doi.org/10.1016/j.cell.2005.12.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377556	Bronze			2022-12-28	WOS:000234584500004
J	Siegrist, SE; Doe, CQ				Siegrist, SE; Doe, CQ			Microtubule-induced Pins/G alpha i cortical polarity in Drosophila neuroblasts	CELL			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEINS; LARGE TUMOR-SUPPRESSOR; C-ELEGANS; NERVOUS-SYSTEM; DAUGHTER CELL; HUMAN HOMOLOG; 2 DISTINCT; LOCALIZATION; COMPLEX	Cortical polarity regulates cell division, migration, and differentiation. Microtubules induce cortical polarity in yeast, but few examples are known in metazoans. We show that astral microtubules, kinesin Khc-73, and Discs large (Dig) induce cortical polarization of Pins/G alpha i in Drosophila neuroblasts; this cortical domain is functional for generating spindle asymmetry, daughtercell-size asymmetry, and distinct sibling fates. Khc-73 localizes to astral microtubule plus ends, and Dlg/Khc-73 and Dig/Pins co-immunoprecipitate, suggesting that microtubules induce Pins/G alpha i cortical polarity through Dlg/Khc-73 interactions. The microtubule/Khc-73/Dlg pathway acts in parallel to the well-characterized Inscuteable/ Par pathway, but each provides unique spatial and temporal information: The Inscuteable/Par pathway initiates at prophase to coordinate neuroblast cortical polarity with CNS tissue polarity, whereas the microtubule/Khc-73/Dlg pathway functions at metaphase to coordinate neuroblast cortical polarity with the mitotic spindle axis. These results identify a role for microtubules in polarizing the neuroblast cortex, a fundamental step for generating cell diversity through asymmetric cell division.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu						Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Asaba N, 2003, J BIOL CHEM, V278, P8395, DOI 10.1074/jbc.M210362200; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Chou TB, 1996, GENETICS, V144, P1673; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Harlow E., 1999, USING ANTIBODIES LAB; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; KIEHART DP, 1994, METHOD CELL BIOL, V44, P507, DOI 10.1016/S0091-679X(08)60929-2; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Mok H, 2002, J NEUROSCI, V22, P5253; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; SIEGRIST SE, 2006, IN PRESS DEVELOPMENT; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002	55	198	206	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1323	1335		10.1016/j.cell.2005.09.043	http://dx.doi.org/10.1016/j.cell.2005.09.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377571	Bronze			2022-12-28	WOS:000234584500019
J	van Leeuwen, R; Boekhoorn, S; Vingerling, JR; Witteman, JCM; Klaver, CCW; Hofman, A; de Jong, PTVM				van Leeuwen, R; Boekhoorn, S; Vingerling, JR; Witteman, JCM; Klaver, CCW; Hofman, A; de Jong, PTVM			Dietary intake of antioxidants and risk of age-related macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-E SUPPLEMENTATION; BEAVER DAM EYE; 5-YEAR INCIDENCE; ZINC INTAKE; MACULOPATHY; ROTTERDAM; QUESTIONNAIRE; PATHOGENESIS; VALIDATION; TRIAL	Context Age-related macular degeneration (AMD) is the most prevalent cause of irreversible blindness in developed countries. Recently, high-dose supplementation with beta carotene, vitamins C and E, and zinc was shown to slow the progression of AMD. Objective To investigate whether regular dietary intake of antioxidants is associated with a lower risk of incident AMD. Design Dietary intake was assessed at baseline in the Rotterdam Study (19901993) using a semiquantitative food frequency questionnaire. Incident AMD until final follow-up in 2004 was determined by grading fundus color transparencies in a masked way according to the International Classification and Grading System. Setting Population-based cohort of all inhabitants aged 55 years or older in a middle-class suburb of Rotterdam, the Netherlands. Participants Of 5836 persons at risk of AMD at baseline, 4765 had reliable dietary data and 4170 participated in the follow-up. Main Outcome Measure Incident AMD, defined as soft distinct drusen with pigment alterations, indistinct or reticular drusen, geographic atrophy, or choroidal neovascularization. Results Incident AMD occurred in 560 participants after a mean follow-up of 8.0 years (range, 0.3-13.9 years). Dietary intake of both vitamin E and zinc was inversely associated with incident AMD. The hazard ratio (H R) per standard deviation increase of intake for vitamin E was 0.92 (95% confidence interval [CI], 0.84-1.00) and for zinc was 0.91 (95% Cl, 0.83-0.98). An above-median intake of all 4 nutrients, beta carotene, vitamin C, vitamin E, and zinc, was associated with a 35% reduced risk (HR, 0.65; 95% Cl, 0.46-0.92) of AMD. Exclusion of supplement users did not affect the results. Conclusion In this study, a high dietary intake of beta carotene, vitamins C and E, and zinc was associated with a substantially reduced risk of AMD in elderly persons.	Royal Netherlands Acad Arts & Sci, Netherlands Ophthalm Res Inst, KNAW, NL-1105 BA Amsterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	de Jong, PTVM (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Ophthalm Res Inst, KNAW, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.dejong@ioi.knaw.nl	Klaver, Caroline C.W./A-2013-2016	Klaver, Caroline/0000-0002-2355-5258				Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cho EY, 2001, ANN EPIDEMIOL, V11, P328, DOI 10.1016/S1047-2797(01)00217-4; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Flood V, 2002, OPHTHALMOLOGY, V109, P2272, DOI 10.1016/S0161-6420(02)01263-0; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Ott A, 1998, AM J EPIDEMIOL, V147, P574; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Smith W, 1999, OPHTHALMOLOGY, V106, P761, DOI 10.1016/S0161-6420(99)90164-1; Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; *VOORL VOED, 2001, DUTCH FOOD COMP TABL; Willett W., 2012, NUTR EPIDEMIOLOGY; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	27	244	254	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3101	3107		10.1001/jama.294.24.3101	http://dx.doi.org/10.1001/jama.294.24.3101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380590				2022-12-28	WOS:000234274200026
J	Hu, K; Scotcher, S				Hu, K; Scotcher, S			Seen from the other side: visual experiences during cataract surgery under topical anaesthesia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHACOEMULSIFICATION		Cty Hosp, Victoria Eye Unit, Hereford HR1 2ER, England		Scotcher, S (corresponding author), Cty Hosp, Victoria Eye Unit, Hereford HR1 2ER, England.	Stephen.Scotcher@hhtr.nhs.uk						Eong KGA, 2000, OPHTHALMOLOGY, V107, P248, DOI 10.1016/S0161-6420(99)00080-9; Newman DK, 2000, BRIT J OPHTHALMOL, V84, P13, DOI 10.1136/bjo.84.1.13; Rengaraj V, 2004, AM J OPHTHALMOL, V138, P782, DOI 10.1016/j.ajo.2004.06.023; Sumich PM, 1998, J CATARACT REFR SURG, V24, P1525, DOI 10.1016/S0886-3350(98)80178-8; Verma D, 2001, OPHTHALMOLOGY, V108, P1004, DOI 10.1016/S0161-6420(00)00424-3	5	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1511	1511		10.1136/bmj.331.7531.1511	http://dx.doi.org/10.1136/bmj.331.7531.1511			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373734	Green Published, Bronze			2022-12-28	WOS:000234351300014
J	Ogilvie, D; Hamlet, N				Ogilvie, D; Hamlet, N			Obesity: the elephant in the corner	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Forth Valley NHS Board, Stirling FK8 1DX, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Ogilvie, D (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	d.ogilvie@msoc.mrc.gla.ac.uk	Ogilvie, David/B-2444-2012	Ogilvie, David/0000-0002-0270-4672				[Anonymous], 2003, DIET NUTR PREV CHRON; ASP NG, 2002, OBESITY PROBLEMS INT; Day B.P.F., 2000, POSTHARV NEWS INFORM, V11, P27; *DEP TRANSP, ITS NO JOK; Department of Health, 2004, CHOOS HLTH MAK HLTH; Department of Transport, 2004, TRANSP STAT B NAT TR; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Ellaway A, 2003, J Epidemiol Community Health, V57, P315, DOI 10.1136/jech.57.5.315; ELLAWAY A, 2004, J EPIDEMIOLOGY COMMU, V58, P892; Hamilton Clive, 2004, GROWTH FETISH; Lean MEJ, 2005, BMJ-BRIT MED J, V330, P1339, DOI 10.1136/bmj.330.7504.1339; Neroth P, 2004, LANCET, V364, P651, DOI 10.1016/S0140-6736(04)16914-6; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; *ROYAL COLL PHYS L, 2004, STOR PROBL MED CAS S; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	17	17	17	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1545	1548		10.1136/bmj.331.7531.1545	http://dx.doi.org/10.1136/bmj.331.7531.1545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373747	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000234351300028
J	Schott, GD				Schott, GD			Sex symbols ancient and modern: their origins and iconography on the pedigree	BRITISH MEDICAL JOURNAL			English	Article									UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Schott, GD (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	geoffrey.schott@uclh.org						BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P466; Earle Pliny, 1845, AM J MED SCI, V9, P346; Pearson K, 1933, ANN EUGENIC, V5, P179, DOI 10.1111/j.1469-1809.1933.tb02091.x; RENKEMA HW, 1942, GEDENDENKBOEK J VALC, P96; Resta R G, 1993, J Genet Couns, V2, P235, DOI 10.1007/BF00961574; RESTA RG, 1995, AM J MED GENET, V59, P131, DOI 10.1002/ajmg.1320590202; STEARN WILLIAM T., 1962, TAXON, V11, P109, DOI 10.2307/1217734; Ulaki Esin E. Hanlar, 1989, GEDANKE WIRKUNG FEST, P113; 1913, EUGENICS REV, V5, P66	10	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1509	1510		10.1136/bmj.331.7531.1509	http://dx.doi.org/10.1136/bmj.331.7531.1509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	998WT	16373733	Green Published, Bronze			2022-12-28	WOS:000234351300013
J	Pittermann, J; Sperry, JS; Hacke, UG; Wheeler, JK; Sikkema, EH				Pittermann, J; Sperry, JS; Hacke, UG; Wheeler, JK; Sikkema, EH			Torus-margo pits help conifers compete with angiosperms	SCIENCE			English	Article									Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sperry, JS (corresponding author), Univ Utah, Dept Biol, 257S 1400E, Salt Lake City, UT 84112 USA.	sperry@biology.utah.edu	Hacke, Uwe/M-7719-2015	Hacke, Uwe/0000-0001-5983-3582				HACKE UG, IN PRESS TREE PHYSL; SIAU JF, 1984, TRANSPORT PROCESSES, P49	2	140	150	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1924	1924		10.1126/science.1120479	http://dx.doi.org/10.1126/science.1120479			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373568				2022-12-28	WOS:000234275400033
J	Moscona, A				Moscona, A			Oseltamivir resistance - Disabling our influenza defenses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITORS		Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA.							Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; McKimm-Breschkin Jennifer L, 2005, Treat Respir Med, V4, P107, DOI 10.2165/00151829-200504020-00004; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6	5	265	312	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2633	2636		10.1056/NEJMp058291	http://dx.doi.org/10.1056/NEJMp058291			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371626				2022-12-28	WOS:000234094400001
J	Kalil, AC; Levitsky, J; Lyden, E; Stoner, J; Freifeld, AG				Kalil, AC; Levitsky, J; Lyden, E; Stoner, J; Freifeld, AG			Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE ACYCLOVIR; PREEMPTIVE GANCICLOVIR THERAPY; PLACEBO-CONTROLLED TRIAL; PROPHYLACTIC ORAL GANCICLOVIR; BONE-MARROW TRANSPLANT; LONG-TERM PROPHYLAXIS; LIVER-TRANSPLANTATION; HEART-TRANSPLANTATION; INTRAVENOUS GANCICLOVIR	Background: Cytomegalovirus (CMV), the most common opportunistic viral infection in solid organ transplant recipients, is associated with substantial morbidity and mortality. Purpose: To assess the efficacy of universal prophylaxis and preemptive approaches in preventing CMV organ disease and other complications in solid organ transplant recipients. Data Sources: Using no language restrictions, the authors searched the following databases from their inception through May 2005: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Evidence-Based Medicine. The authors also reviewed abstracts from scientific meetings and contacted experts and pharmaceutical companies. Study Selection: Randomized, controlled trials that evaluated antiviral strategies for preventing CMV and associated complications in solid organ transplant recipients were selected. Data Extraction: Two reviewers. independently extracted and assessed the data. Data Synthesis: The authors found 17 trials involving 1980 patients. Compared with placebo or no therapy, both universal prophylaxis (odds ratio [OR], 0.20 [95% CI, 0.13 to 0.31]) and preemptive strategies (OR, 0.28 [CI, 0.11 to 0.69]) reduced CMV organ disease. However, only universal prophylaxis seemingly reduced CMV organ disease in subgroups of patients at highest risk (donors with positive CMV serostatus and recipients with negative CMV serostatus and induction with antibodies). Both strategies reduced the rate of allograft rejection. Only universal prophylaxis statistically significantly reduced bacterial and fungal infections (OR, 0.49 [CI, 0.36 to 0.67]) and death (OR, 0.62 [CI, 0.40 to 0.96]). Both acyclovir and ganciclovir statistically significantly prevented CMV organ disease in the universal prophylaxis trials. Limitations: Studies were of modest size, and few studies assessed all outcomes. Studies did not always provide data that discriminated between CMV organ disease and CMV syndrome or data about the timing of CMV organ disease. Conclusions: universal prophylaxis and preemptive strategies are beneficial in preventing CMV organ disease in solid organ transplant recipients. Both strategies are associated with a reduction in allograft rejection, but current data suggest that only universal prophylaxis reduces bacterial and fungal infections and death. Acyclovir and ganciclovir are both effective for universal prophylaxis.	Univ Nebraska Med Ctr, Coll Nursing, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Coll Nursing, 985400 Nebraska Med Ctr, Omaha, NE 68198 USA.	akalil@unmc.edu	Levitsky, Josh/AAF-8662-2019	Levitsky, Josh/0000-0001-7527-6093				Ahsan N, 1998, TRANSPL P, V30, P1383, DOI 10.1016/S0041-1345(98)00283-8; Badley AD, 1997, TRANSPLANTATION, V64, P66, DOI 10.1097/00007890-199707150-00013; BALFOUR HH, 1989, NEW ENGL J MED, V320, P1381, DOI 10.1056/NEJM198905253202105; Barkholt L, 1999, Transpl Infect Dis, V1, P89, DOI 10.1034/j.1399-3062.1999.010202.x; Brennan DC, 1997, TRANSPLANTATION, V64, P1843, DOI 10.1097/00007890-199712270-00036; Brennan DC, 1997, J AM SOC NEPHROL, V8, P118; Breslow N E, 1980, IARC Sci Publ, P5; Burnett MS, 2004, CIRCULATION, V109, P893, DOI 10.1161/01.CIR.0000112585.47513.45; Cockfield S M, 2001, Transpl Infect Dis, V3, P70; COHEN AT, 1993, J MED VIROL, V40, P5, DOI 10.1002/jmv.1890400103; CONTI DJ, 1995, ARCH SURG-CHICAGO, V130, P1217; Couchoud C, 1998, TRANSPLANTATION, V65, P641, DOI 10.1097/00007890-199803150-00007; Couchoud C., 2000, COCHRANE DB SYST REV; Das A, 2003, PHARMACOECONOMICS, V21, P469; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUNCAN SR, 1994, AM J RESP CRIT CARE, V150, P146, DOI 10.1164/ajrccm.150.1.8025741; Egan JJ, 2002, J HEART LUNG TRANSPL, V21, P460, DOI 10.1016/S1053-2498(01)00399-0; Evans PC, 2000, TRANSPLANTATION, V69, P30, DOI 10.1097/00007890-200001150-00007; Falagas ME, 1997, ANN INTERN MED, V126, P275, DOI 10.7326/0003-4819-126-4-199702150-00003; Falagas ME, 1998, TRANSPLANTATION, V66, P1020, DOI 10.1097/00007890-199810270-00010; Falagas ME, 1997, TRANSPLANTATION, V63, P1595, DOI 10.1097/00007890-199706150-00010; Falagas ME, 1996, CLIN INFECT DIS, V23, P468, DOI 10.1093/clinids/23.3.468; Fiddian P, 2002, J INFECT DIS, V186, pS110, DOI 10.1086/342965; Flechner SM, 1998, TRANSPLANTATION, V66, P1682, DOI 10.1097/00007890-199812270-00019; Gane E, 1997, LANCET, V350, P1729, DOI 10.1016/S0140-6736(97)05535-9; Gavalda J, 1997, TRANSPL INT, V10, P462; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Green M, 1997, CLIN INFECT DIS, V25, P1344, DOI 10.1086/516139; HIBBERD PL, 1995, ANN INTERN MED, V123, P18, DOI 10.7326/0003-4819-123-1-199507010-00002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kletzmayr J, 1996, J AM SOC NEPHROL, V7, P325; Kusne S, 1999, Transpl Infect Dis, V1, P187, DOI 10.1034/j.1399-3062.1999.010307.x; LEMSTROM K, 1995, CIRCULATION, V92, P2594, DOI 10.1161/01.CIR.92.9.2594; Leong RWL, 2004, INTERN MED J, V34, P410, DOI 10.1111/j.1445-5994.2004.00567.x; LERAY H, 1995, TRANSPLANT P, V27, P2448; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Losada I, 2002, ENFERM INFEC MICR CL, V20, P422, DOI 10.1016/S0213-005X(02)72837-1; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; MACDONALD PS, 1995, J HEART LUNG TRANSPL, V14, P32; Manez R, 1994, Transpl Int, V7 Suppl 1, pS235; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARTIN M, 1994, TRANSPLANTATION, V58, P779; McLaughlin K, 2002, TRANSPLANTATION, V74, P813, DOI 10.1097/00007890-200209270-00014; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; Moher D, 2000, BRIT J SURG, V87, P1448, DOI 10.1046/j.1365-2168.2000.01610.x; Munoz-Price LS, 2004, CLIN INFECT DIS, V39, P1293, DOI 10.1086/425002; NAKAZATO PZ, 1993, TRANSPLANT P, V25, P1935; Park SB, 2004, TRANSPL P, V36, P2154, DOI 10.1016/j.transproceed.2004.08.049; Paya C, 2004, AM J TRANSPLANT, V4, P611, DOI 10.1111/j.1600-6143.2004.00382.x; Paya CV, 2002, J INFECT DIS, V185, P854, DOI 10.1086/339449; PouteilNoble C, 1996, TRANSPLANT P, V28, P2811; Preiksaitis JK, 2005, AM J TRANSPLANT, V5, P218, DOI 10.1111/j.1600-6143.2004.00692.x; Rayes N, 2001, TRANSPLANTATION, V72, P881, DOI 10.1097/00007890-200109150-00024; Reischig T, 2002, TRANSPL INT, V15, P615, DOI 10.1007/s00147-002-0475-0; RONDEAU E, 1993, NEPHROL DIAL TRANSPL, V8, P858; Rostaing L, 1994, Transpl Int, V7 Suppl 1, pS331; Rubin R H, 2000, Transpl Infect Dis, V2, P112, DOI 10.1111/j.1399-3062.2000.020303.x; Sagedal S, 2003, NEPHROL DIAL TRANSPL, V18, P1899, DOI 10.1093/ndt/gfg302; Sagedal S, 2002, AM J TRANSPLANT, V2, P850, DOI 10.1034/j.1600-6143.2002.20907.x; SALIBA F, 1993, TRANSPLANT P, V25, P1444; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; Singh N, 2000, TRANSPLANTATION, V70, P717, DOI 10.1097/00007890-200009150-00002; Singh N, 2005, CLIN INFECT DIS, V40, P704, DOI 10.1086/427506; SINGH N, 1994, ANN INTERN MED, V120, P375, DOI 10.7326/0003-4819-120-5-199403010-00004; Singh N, 2001, CLIN INFECT DIS, V32, P742, DOI 10.1086/319225; Snydman DR, 2005, CLIN INFECT DIS, V40, P709, DOI 10.1086/427509; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; TOLLEMAR J, 1989, BONE MARROW TRANSPL, V4, P635; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; Wagner JA, 1995, TRANSPLANTATION, V60, P1473, DOI 10.1097/00007890-199560120-00018; Winston DJ, 2004, TRANSPLANTATION, V77, P305, DOI 10.1097/01.TP.0000093463.86584.AC; Winston DJ, 2003, TRANSPLANTATION, V75, P229, DOI 10.1097/01.TP.0000040601.60276.96; WINSTON DJ, 1995, LANCET, V346, P69, DOI 10.1016/S0140-6736(95)92110-9; Yango A, 2003, NEPHROL DIAL TRANSPL, V18, P809, DOI 10.1093/ndt/gfg039; 2004, AM J TRANSPLANY S10, V4, P51	76	284	304	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					870	880		10.7326/0003-4819-143-12-200512200-00005	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365468				2022-12-28	WOS:000234077400003
J	Ichiki, K; Takahashi, K; Ohno, H; Hanayama, H; Sugiyama, N				Ichiki, K; Takahashi, K; Ohno, H; Hanayama, H; Sugiyama, N			Cosmological magnetic field: A fossil of density perturbations in the early universe	SCIENCE			English	Article							INFLATIONARY UNIVERSE; PHASE-TRANSITION; GENERATION; RADIATION; MECHANISM; EVOLUTION; ORIGIN; RAYS	The origin of the substantial magnetic fields that are found in galaxies and on even larger scales, such as in clusters of galaxies, is yet unclear. If the second-order couplings between photons and electrons are considered, then cosmological density fluctuations, which explain the large-scale structure of the universe, can also produce magnetic fields on cosmological scales before the epoch of recombination. By evaluating the power spectrum of these cosmological magnetic fields on a range of scales, we show here that magnetic fields of 10(-18.1) gauss are generated at a 1-megaparsec scale and can be even stronger at smaller scales (10(-14.1) gauss at 10 kiloparsecs). These fields are large enough to seed magnetic fields in galaxies and may therefore have affected primordial star formation in the early universe.	Natl Astron Observ Japan, Tokyo 1818588, Japan; Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Toshiba Co Ltd, Ctr Corp Res & Dev, Kawasaki, Kanagawa 2128582, Japan; Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Princeton University; Toshiba Corporation; University of Tokyo	Ichiki, K (corresponding author), Natl Astron Observ Japan, Tokyo 1818588, Japan.	ichiki@th.nao.ac.jp	Ｉchiki, Kiyotomo/M-4862-2014; Takahashi, Keitaro/L-5930-2015	Ohno, Hiroshi/0000-0002-8267-6156; Hanayama, Hidekazu/0000-0001-8221-6048				Bamba K, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.043507; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Berezhiani Z, 2004, ASTROPART PHYS, V21, P59, DOI 10.1016/j.astropartphys.2003.11.002; BIERMANN L, 1951, PHYS REV, V82, P863, DOI 10.1103/PhysRev.82.863; Caprini C, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.023517; Davies G, 2000, ASTROPHYS J, V540, P755, DOI 10.1086/309358; Davis AC, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.021301; Gehrels N, 1999, ASTROPART PHYS, V11, P277, DOI 10.1016/S0927-6505(99)00066-3; Gnedin NY, 2000, ASTROPHYS J, V539, P505, DOI 10.1086/309272; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Hanayama H, 2005, ASTROPHYS J, V633, P941, DOI 10.1086/491575; HARRISON ER, 1970, MON NOT R ASTRON SOC, V147, P279, DOI 10.1093/mnras/147.3.279; Kulsrud RM, 1997, ASTROPHYS J, V480, P481, DOI 10.1086/303987; LEMOINE D, 1995, PHYS REV D, V52, P1955, DOI 10.1103/PhysRevD.52.1955; LESCH H, 1995, ASTRON ASTROPHYS, V297, P305; Maki H, 2004, ASTROPHYS J, V609, P467, DOI 10.1086/421103; Matarrese S, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.043502; MESTEL L, 1962, ASTROPHYS J, V136, P615, DOI 10.1086/147412; PLAGA R, 1995, NATURE, V374, P430, DOI 10.1038/374430a0; RATRA B, 1992, ASTROPHYS J, V391, pL1, DOI 10.1086/186384; Razzaque S, 2004, ASTROPHYS J, V613, P1072, DOI 10.1086/423166; SATO K, 1981, MON NOT R ASTRON SOC, V195, P467, DOI 10.1093/mnras/195.3.467; SILK J, 1968, ASTROPHYS J, V151, P459, DOI 10.1086/149449; STAROBINSKY AA, 1982, PHYS LETT B, V117, P175, DOI 10.1016/0370-2693(82)90541-X; Takahashi K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.121301; TURNER MS, 1988, PHYS REV D, V37, P2743, DOI 10.1103/PhysRevD.37.2743; Waxman E, 1996, ASTROPHYS J, V464, pL75, DOI 10.1086/310090; Widrow LM, 2002, REV MOD PHYS, V74, P775, DOI 10.1103/RevModPhys.74.775; Yamamoto K, 1998, ASTROPHYS J, V501, P442, DOI 10.1086/305841	29	114	114	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2006	311	5762					827	829		10.1126/science.1120690	http://dx.doi.org/10.1126/science.1120690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16400110	Green Submitted			2022-12-28	WOS:000235374900041
J	Field, DB; Baumgartner, TR; Charles, CD; Ferreira-Bartrina, V; Ohman, MD				Field, DB; Baumgartner, TR; Charles, CD; Ferreira-Bartrina, V; Ohman, MD			Planktonic foraminifera of the California Current reflect 20th-century warming	SCIENCE			English	Article							SANTA-BARBARA BASIN; DECADAL CLIMATE VARIABILITY; LONG-TERM CHANGES; CURRENT SYSTEM; WORLDS OCEANS; EL-NINO; PACIFIC; OSCILLATION; RECORD	It is currently unclear whether observed pelagic ecosystem responses to ocean warming, such as a mid-1970s change in the eastern North Pacific, depart from typical ocean variability. We report variations in planktonic foraminifera from varved sediments off southern California spanning the past 1400 years. Increasing abundances of tropical/subtropical species throughout the 20th century reflect a warming trend superimposed on decadal-scale fluctuations. Decreasing abundances of temperate/subpolar species in the late 20th century indicate a deep, penetrative warming not observed in previous centuries. These results imply that 20th-century warming, apparently anthropogenic, has already affected lower trophic levels of the California Current.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Ctr Invest Cient & Educ Super Ensenada, Ensenada 22860, Baja California, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Field, DB (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	dfield@mbari.org	Ohman, Mark D/C-8763-2009	Ohman, Mark D/0000-0001-8136-3695				BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Biondi F, 2001, J CLIMATE, V14, P5, DOI 10.1175/1520-0442(2001)014<0005:NPDCVS>2.0.CO;2; Black DE, 2001, GEOLOGY, V29, P1075, DOI 10.1130/0091-7613(2001)029<1075:PFRTTE>2.0.CO;2; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; D'Arrigo R, 2001, CLIM DYNAM, V18, P219, DOI 10.1007/s003820100177; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; EBBESMEYER CC, 1991, CALIFORNIA DEP WAT R, V26, P129; ENFIELD DB, 2001, INTERHEMISPHERIC CLI, P17; Field DB, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000970; FIELD DB, 2004, THESIS U CALIFORNIA; GRAHAM NE, 1995, SCIENCE, V267, P666, DOI 10.1126/science.267.5198.666; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Kincaid E, 2000, DEEP-SEA RES PT II, V47, P1157, DOI 10.1016/S0967-0645(99)00140-X; LANGE CB, 1987, MAR GEOL, V78, P153, DOI 10.1016/0025-3227(87)90074-0; Lavaniegos BE, 2003, DEEP-SEA RES PT II, V50, P2473, DOI 10.1016/S0967-0645(03)00132-2; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Miller A J, 1994, OCEANOGRAPHY, V7, P21, DOI [10.5670/oceanog.1994.11, DOI 10.5670/OCEANOG.1994.11]; ORTIZ JD, 1995, PALEOCEANOGRAPHY, V10, P987, DOI 10.1029/95PA02088; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; SAUTTER LR, 1991, J FORAMIN RES, V21, P347, DOI 10.2113/gsjfr.21.4.347; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Tegner MJ, 1996, CAL COOP OCEAN FISH, V37, P111; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; [No title captured]	34	127	131	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					63	66		10.1126/science.1116220	http://dx.doi.org/10.1126/science.1116220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400144	Green Submitted			2022-12-28	WOS:000234546300032
J	Adams, RJ; Brambilla, D				Adams, RJ; Brambilla, D		STOP 2 Trial Investigators	Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; CEREBROVASCULAR ACCIDENTS; TRANSCRANIAL DOPPLER; PLASMA HEMOGLOBIN; RECURRENT STROKE; ANEMIA; THERAPY; CHILDREN; RISK; ULTRASONOGRAPHY	Background Prophylactic transfusion prevents strokes in children with sickle cell anemia who have abnormalities on transcranial Doppler ultrasonographic examination. However, it is not known how long transfusion should be continued in these children. Methods We studied children with sickle cell disease who had a high risk of stroke on the basis of a transcranial Doppler screening examination and who had received transfusions for 30 months or longer, during which time the Doppler readings became normal. The children were randomly assigned to continued transfusion or no continued transfusion. Children with severe stenotic lesions on cerebral magnetic resonance angiography were excluded. The composite primary end point was stroke or reversion to a result on Doppler examination indicative of a high risk of stroke. Results The study was stopped after 79 children of a planned enrollment of 100 underwent randomization. Among the 41 children in the transfusion-halted group, high-risk Doppler results developed in 14 and stroke in 2 others within a mean (+/-SD) of 4.5+/-2.6 months (range, 2.1 to 10.1) of the last transfusion. Neither of these events of the composite end point occurred in the 38 children who continued to receive transfusions. The average of the last two transcranial Doppler results before transfusion was started was the only predictor of the composite end point (P=0.05). Conclusions Discontinuation of transfusion for the prevention of stroke in children with sickle cell disease results in a high rate of reversion to abnormal blood-flow velocities on Doppler studies and stroke.	Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Miami, Sch Med, Miami, FL USA; Childrens Hosp Oakland, Oakland, CA USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; E Carolina Univ, Greenville, NC USA; Columbia Univ, New York, NY USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Emory Univ, Sch Med, Atlanta, GA USA; Grady Hlth Syst, Atlanta, GA USA; Morehouse Sch Med, Atlanta, GA 30310 USA; Childrens Healthcare Atlanta, Atlanta, GA USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Hlth Network, Toronto, ON, Canada; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Childrens Mercy Hosp, Kansas City, MO 64108 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Baltimore WAshington Sickle Cell Res Consortium, Baltimore, MD USA; Sinai Hosp, Baltimore, MD 21215 USA; Univ Maryland, Baltimore, MD 21201 USA; Georgetown Univ, Washington, DC USA; Univ Alabama Birmingham, Birmingham, AL USA; Columbus Reg Med Ctr, Columbus, GA USA; Suny Downstate Med Ctr, Kings Cty Hosp Ctr, Brooklyn, NY 11203 USA; Univ So Calif, Los Angeles, CA USA; Louisiana State Univ, New Orleans, LA USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; NHLBI, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; Medical University of South Carolina; University of Miami; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's National Health System; University of North Carolina; East Carolina University; Columbia University; University of Mississippi; University of Mississippi Medical Center; Emory University; Morehouse School of Medicine; Children's Healthcare of Atlanta (CHOA); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Children's Mercy Hospital; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Sinai Hospital of Baltimore; University System of Maryland; University of Maryland Baltimore; Georgetown University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Southern California; Louisiana State University System; Tulane University; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adams, RJ (corresponding author), Med Coll Georgia, Dept Neurol, 1429 Harper St,HF 1154, Augusta, GA 30912 USA.	rjadams@mcg.edu	McCarville, M Beth/N-2471-2018; Warrier, Rajasekharan P/D-4512-2011	McCarville, M Beth/0000-0002-2888-443X; Brambilla, Donald/0000-0002-7276-4689	NHLBI NIH HHS [U01 HL 052193, U01 HL 052016] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL052016, U01HL052193] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Adams RJ, 1998, CONTROL CLIN TRIALS, V19, P110, DOI 10.1016/S0197-2456(97)00099-8; Bernaudin F, 2005, PEDIATR RADIOL, V35, P242, DOI 10.1007/s00247-005-1419-5; BRASS LM, 1991, STROKE, V22, P27, DOI 10.1161/01.STR.22.1.27; COHEN AR, 1992, BLOOD, V79, P1657; COX DR, 1972, J R STAT SOC B, V34, P187; Files B, 2002, J PEDIAT HEMATOL ONC, V24, P284, DOI 10.1097/00043426-200205000-00013; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; LAKATOS E, 1988, BIOMETRICS, V44, P923; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MILLER ST, 1992, J PEDIATR-US, V120, P54, DOI 10.1016/S0022-3476(05)80597-9; NEELY CL, 1969, AM J CLIN PATHOL, V52, P167; *NIH, 1997, CLIN AL PER TRANSF L; Ohene-Frempong K, 1998, BLOOD, V91, P288; Patel RP, 2004, FREE RADICAL BIO MED, V36, P399, DOI 10.1016/j.freeradbiomed.2003.11.019; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; Prengler M, 2002, ANN NEUROL, V51, P543, DOI 10.1002/ana.10192; Rana S, 1997, J PEDIATR-US, V131, P757, DOI 10.1016/S0022-3476(97)70108-2; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sakhalkar VS, 2004, AM J HEMATOL, V76, P57, DOI 10.1002/ajh.20016; SAS Institute, 2003, SAS STAT SOFTW VERS; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V290, P756; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Walters MC, 2000, BLOOD, V95, P1918; WANG WC, 1991, J PEDIATR-US, V118, P377, DOI 10.1016/S0022-3476(05)82150-X; Ware RE, 2004, J PEDIATR-US, V145, P346, DOI 10.1016/j.jpeds.2004.04.058; WILIMAS J, 1980, J PEDIATR-US, V96, P205, DOI 10.1016/S0022-3476(80)80803-1; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	30	385	394	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2769	2778						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382063				2022-12-28	WOS:000234246700008
J	Dinneny, JR; Benfey, PN				Dinneny, JR; Benfey, PN			Stem cell research goes underground: The Retinoblastoma-related gene in root development	CELL			English	Article							ARABIDOPSIS ROOT; SCARECROW; MERISTEM; NICHE; CYCLE		Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Dinneny, Jose/J-8312-2012	Dinneny, Jose/0000-0002-3998-724X				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	9	7	9	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1180	1182		10.1016/j.cell.2005.12.005	http://dx.doi.org/10.1016/j.cell.2005.12.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377557	Bronze			2022-12-28	WOS:000234584500005
J	Masip, J; Roque, M; Sanchez, B; Fernandez, R; Subirana, M; Exposito, JA				Masip, J; Roque, M; Sanchez, B; Fernandez, R; Subirana, M; Exposito, JA			Noninvasive ventilation in acute cardiogenic pulmonary edema - Systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSITIVE AIRWAY PRESSURE; ACUTE RESPIRATORY-FAILURE; SUPPORT VENTILATION; FACE MASK; RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; OXYGEN-THERAPY; HEART-FAILURE; BILEVEL; BIAS	Context In patients with acute cardiogenic pulmonary edema noninvasive ventilation may reduce intubation rate, but the impact on mortality and the superiority of one technique over another have not been clearly established. Objective To systematically review and quantitatively synthesize the short-term effect of noninvasive ventilation on major clinical outcomes. Data Sources MEDLINE and EMBASE (from inception to October 2005) and Cochrane databases (library issue 4, 2005) were searched to identify relevant randomized controlled trials and systematic reviews published from January 1, 1988, to October 31,2005. Study Selection and Data Extraction included trials were all parallel studies comparing noninvasive ventilation to conventional oxygen therapy in patients with acute pulmonary edema. Comparisons of different techniques, either continuous positive airway pressure (CPAP) or bilevel noninvasive pressure support ventilation (NIPSV), were also included. Data Synthesis Fifteen trials were selected. Overall, noninvasive ventilation significantly reduced the mortality rate by nearly 45% compared with conventional therapy (risk ratio [RR], 0.55; 95% confidence interval [CI], 0.40-0.78; P=.72 for heterogeneity). The results were significant for CPAP (RR, 0.53; 95% Cl, 0.35-0.81; P=.44 for heterogeneity) but not for NIPSV (RR, 0.60; 95% Cl, 0.34-1.05; P=.76 for heterogeneity), although there were fewer studies in the latter. Both modalities showed a significant decrease in the "need to intubate" rate compared with conventional therapy: CPAP (RR, 0.40; 95% Cl, 0.27-0.58; P=.21 for heterogeneity), NIPSV (RR, 0.48; 95% Cl, 0.30-0.76; P=.24 for heterogeneity), and together (RR, 0.43; 95% Cl, 0.32-0.57; P=.20 for heterogeneity). There were no differences in intubation or mortality rates in the analysis of studies comparing the 2 techniques. Conclusions Noninvasive ventilation reduces the need for intubation and mortality in patients with acute cardiogenic pulmonary edema. Although the level of evidence is higher for CPAP, there are no significant differences in clinical outcomes when comparing CPAP vs NIPSV.	Univ Barcelona, ICU Dept, Hosp Dos Maig Consorci Sanitari Integral Barcelon, Barcelona 08025, Spain; Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Iberoamer Cochrane Ctr, E-08193 Barcelona, Spain; Hosp Sabadell, Corp Parc Tauli, Serv Med Intens, Sabadell, Spain	University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Masip, J (corresponding author), Univ Barcelona, ICU Dept, Hosp Dos Maig Consorci Sanitari Integral Barcelon, Dos Maig 301, Barcelona 08025, Spain.	jmasip@ub.edu	Subirana, Mireia/AAD-5377-2019; Fernandez, Rafael/A-9586-2010	Subirana, Mireia/0000-0003-1577-4159; Fernandez, Rafael/0000-0001-5711-5317; Roque i Figuls, Marta/0000-0003-0043-1364				Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellone A, 2005, INTENS CARE MED, V31, P807, DOI 10.1007/s00134-005-2649-6; Bellone A, 2004, CRIT CARE MED, V32, P1860, DOI 10.1097/01.CCM.0000139694.47326.B6; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOLLAERT PE, 2002, AM J RESP CRIT CARE, V165, pA387; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Burns KEA, 2005, CRIT CARE MED, V33, P1477, DOI 10.1097/01.CCM.0000168042.59035.D8; Chadda K, 2002, CRIT CARE MED, V30, P2457, DOI 10.1097/00003246-200211000-00009; Crane SD, 2004, EMERG MED J, V21, P155, DOI 10.1136/emj.2003.005413; Craven RA, 2000, ACAD EMERG MED, V7, P1065, DOI 10.1111/j.1553-2712.2000.tb02102.x; Cross AM, 2003, EMERG MED J, V20, P531, DOI 10.1136/emj.20.6.531; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; [赫朝霞 Hao Chaoxia], 2002, [江西医学院学报, Acta Academiae Medicinae Jiangxi], V42, P48; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kelly CA, 2002, EUR HEART J, V23, P1379, DOI 10.1053/euhj.2001.3156; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; Levitt MA, 2001, J EMERG MED, V21, P363, DOI 10.1016/S0736-4679(01)00385-7; LIESCHING TN, 2003, AM J RESP CRIT CARE, V167, pA864; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; Lin M, 1991, J Formos Med Assoc, V90, P736; Mackay CA, 2000, AM J RESP CRIT CAR S, V161, pA416; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Masip J, 2004, AM J RESP CRIT CARE, V169, P1072, DOI 10.1164/ajrccm.169.9.954; MASIP J, 2005, EUR J HEART FAIL S1, V4, P11; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; Mehta S, 2005, INTENS CARE MED, V31, P757, DOI 10.1007/s00134-005-2650-0; Moritz F, 2003, EUR J EMERG MED, V10, P204, DOI 10.1097/00063110-200309000-00009; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Nieminen MS, 2005, EUR HEART J, V26, P384; Pang D, 1998, CHEST, V114, P1185, DOI 10.1378/chest.114.4.1185; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Park M, 2001, Arq Bras Cardiol, V76, P221; Ram FS., 2004, COCHRANE DB SYST REV, V3, DOI [DOI 10.1002/14651858.CD004104.PUB3, 10.1002/14651858.cd004104.pub3]; RASANEN J, 1985, AM J CARDIOL, V55, P296, DOI 10.1016/0002-9149(85)90364-9; Rusterholtz T, 1999, INTENS CARE MED, V25, P21, DOI 10.1007/s001340050782; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sharon A, 2000, J AM COLL CARDIOL, V36, P832, DOI 10.1016/S0735-1097(00)00785-3; Takeda S, 1997, ANESTH ANALG, V84, P1091, DOI 10.1097/00000539-199705000-00025; Takeda S, 1998, JPN CIRC J, V62, P553, DOI 10.1253/jcj.62.553; VAISANEN IT, 1987, CHEST, V92, P481, DOI 10.1378/chest.92.3.481; Wysocki M, 1999, INTENS CARE MED, V25, P1, DOI 10.1007/s001340050778	42	362	401	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3124	3130		10.1001/jama.294.24.3124	http://dx.doi.org/10.1001/jama.294.24.3124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380593				2022-12-28	WOS:000234274200029
J	[Anonymous]				[Anonymous]			Medical faculty members at different professorial levels	BMJ-BRITISH MEDICAL JOURNAL			English	Article													Hug, Balthasar L./G-1568-2010					Diwakar V, 2002, BMJ-BRIT MED J, V325, P695; Leung WC, 2002, BRIT MED J, V325, P693, DOI 10.1136/bmj.325.7366.693	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1530	1530						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16410240				2022-12-28	WOS:000234351300021
J	Bellouin, N; Boucher, O; Haywood, J; Reddy, MS				Bellouin, N; Boucher, O; Haywood, J; Reddy, MS			Global estimate of aerosol direct radiative forcing from satellite measurements	NATURE			English	Article							OPTICAL-PROPERTIES; PRODUCTS; ALGORITHM	Atmospheric aerosols cause scattering and absorption of incoming solar radiation. Additional anthropogenic aerosols released into the atmosphere thus exert a direct radiative forcing on the climate system(1). The degree of present-day aerosol forcing is estimated from global models that incorporate a representation of the aerosol cycles(1-3). Although the models are compared and validated against observations, these estimates remain uncertain. Previous satellite measurements of the direct effect of aerosols contained limited information about aerosol type, and were confined to oceans only(4,5). Here we use state-of-the-art satellite-based measurements of aerosols(6-8) and surface wind speed(9) to estimate the clear-sky direct radiative forcing for 2002, incorporating measurements over land and ocean. We use a Monte Carlo approach to account for uncertainties in aerosol measurements and in the algorithm used. Probability density functions obtained for the direct radiative forcing at the top of the atmosphere give a clear-sky, global, annual average of -1.9 W m(-2) with standard deviation, +/-0.3 W m(-2). These results suggest that present-day direct radiative forcing is stronger than present model estimates, implying future atmospheric warming greater than is presently predicted, as aerosol emissions continue to decline(10).	Met Off, Exeter EX1 3PB, Devon, England; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	Met Office - UK; National Oceanic Atmospheric Admin (NOAA) - USA	Bellouin, N (corresponding author), Met Off, Exeter EX1 3PB, Devon, England.	nicolas.bellouin@metoffice.gov.uk	Boucher, Olivier/K-7483-2012; Boucher, Olivier/J-5810-2012; Haywood, Jim/GQA-6691-2022	Boucher, Olivier/0000-0003-2328-5769; Boucher, Olivier/0000-0003-2328-5769; Haywood, Jim/0000-0002-2143-6634; Bellouin, Nicolas/0000-0003-2109-9559				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Bellouin N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017121; Christopher SA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014803; Collins WD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001365; COX C, 1954, J MAR RES, V13, P198; Dubovik O, 2002, J ATMOS SCI, V59, P590, DOI 10.1175/1520-0469(2002)059<0590:VOAAOP>2.0.CO;2; Herman JR, 1997, J GEOPHYS RES-ATMOS, V102, P16911, DOI 10.1029/96JD03680; Kaufman YJ, 1997, J GEOPHYS RES-ATMOS, V102, P17051, DOI 10.1029/96JD03988; Keil A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002315; Key JR, 1998, COMPUT GEOSCI, V24, P443, DOI 10.1016/S0098-3004(97)00130-1; Kirkevag A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000886; Osborne SR, 2005, ATMOS RES, V73, P173, DOI 10.1016/j.atmosres.2004.09.002; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; RAMASWARNY V, 2001, CLIMATE CHANGE 2001; Reddy MS, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004757; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Roberts DL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004676; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Smirnov A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003879; Stier P, 2005, ATMOS CHEM PHYS, V5, P1125, DOI 10.5194/acp-5-1125-2005; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; Tanre D, 1997, J GEOPHYS RES-ATMOS, V102, P16971, DOI 10.1029/96JD03437; Wentz FJ, 1997, J GEOPHYS RES-OCEANS, V102, P8703, DOI 10.1029/96JC01751	23	355	374	12	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1138	1141		10.1038/nature04348	http://dx.doi.org/10.1038/nature04348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372005				2022-12-28	WOS:000234111500046
J	Dyson, F				Dyson, F			The death of a star	NATURE			English	Editorial Material									Inst Adv Study, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Dyson, F (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.								0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1086	1086		10.1038/4381086a	http://dx.doi.org/10.1038/4381086a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371988				2022-12-28	WOS:000234111500026
J	Knauth, LP; Burt, DM; Wohletz, KH				Knauth, LP; Burt, DM; Wohletz, KH			Impact origin of sediments at the opportunity landing site on Mars	NATURE			English	Article							MERIDIANI-PLANUM; ACCRETIONARY LAPILLI; CRATER EJECTA; HEMATITE; WATER; GEOCHEMISTRY; ENVIRONMENT; SPHERULES; SUEVITE; BRINES	Mars Exploration Rover Opportunity discovered sediments with layered structures thought to be unique to aqueous deposition and with minerals attributed to evaporation of an acidic salty sea. Remarkable iron-rich spherules were ascribed to later groundwater alteration, and the inferred abundance of water reinforced optimism that Mars was once habitable. The layered structures, however, are not unique to water deposition, and the scenario encounters difficulties in accounting for highly soluble salts admixed with less soluble salts, the lack of clay minerals from acid - rock reactions, high sphericity and near- uniform sizes of the spherules and the absence of a basin boundary. Here we present a simple alternative explanation involving deposition from a ground-hugging turbulent flow of rock fragments, salts, sulphides, brines and ice produced by meteorite impact. Subsequent weathering by intergranular water films can account for all of the features observed without invoking shallow seas, lakes or near- surface aquifers. Layered sequences observed elsewhere on heavily cratered Mars and attributed to wind, water or volcanism may well have formed similarly. If so, the search for past life on Mars should be reassessed accordingly.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Los Alamos National Laboratory	Knauth, LP (corresponding author), Arizona State Univ, Dept Geol Sci, Box 871404, Tempe, AZ 85287 USA.	Knauth@asu.edu						[Anonymous], 1977, EFFECTS NUCL WEAPONS; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BOHOR BF, 1995, METEORITICS, V30, P182, DOI 10.1111/j.1945-5100.1995.tb01113.x; BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1; BRUECKNER J, 2005, LUNAR PLANET SCI, V36; Bullock MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019980; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14169, DOI 10.1029/JB095iB09p14169; Burt DM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001862; CARLSON RH, 1962, PNE217P U CAL LAW RA; Carr M. H., 1977, Journal of Geophysical Research, V82, P4055, DOI 10.1029/JS082i028p04055; Cas R.A.F., 1988, VOLCANIC SUCCESSIONS, P348, DOI DOI 10.1007/978-94-009-3167-1; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Chan MA, 2004, NATURE, V429, P731, DOI 10.1038/nature02600; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dressler BO, 2004, METEORIT PLANET SCI, V39, P857, DOI 10.1111/j.1945-5100.2004.tb00935.x; Dutrizac JE, 2000, REV MINERAL GEOCHEM, V40, P405, DOI 10.2138/rmg.2000.40.8; FISHER RV, 1970, AM J SCI, V268, P157, DOI 10.2475/ajs.268.2.157; FISHER RV, 1984, PYROCLASTIC ROCKS, P249; GARVIN JB, 2002, LUNAR PLANET SCI, V33; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; GOLOMBEK MP, 2005, LUNAR PLANET SCI, V36; GRAUP G, 1981, EARTH PLANET SC LETT, V55, P407, DOI 10.1016/0012-821X(81)90168-0; Hunt C. B., 1966, 494B US GEOL SURV; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Kerr RA, 2004, SCIENCE, V306, P2010, DOI 10.1126/science.306.5704.2010; KIEFFER SW, 1980, REV GEOPHYS, V18, P143, DOI 10.1029/RG018i001p00143; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Knauth LP, 2003, GEOCHIM COSMOCHIM AC, V67, P185, DOI 10.1016/S0016-7037(02)01051-7; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Lowe DR, 2003, ASTROBIOLOGY, V3, P7, DOI 10.1089/153110703321632408; LOWE DR, 1978, J SEDIMENT PETROL, V48, P709; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI [10.1016/0012-821X(73)90162-3, 10.1016/0012-821X(74)90115-0]; MCPHIE J, 1990, B VOLCANOL, V52, P334, DOI 10.1007/BF00302047; Melosh H.L, 1989, IMPACT CRATERING GEO; MELOSH HJ, 2004, METEORIT PLANET SCI, V39; MITCHELL DL, 2002, LUNAR PLANET SCI, V33; OBERBECK VR, 1975, REV GEOPHYS, V13, P337, DOI 10.1029/RG013i002p00337; Osinski GR, 2004, METEORIT PLANET SCI, V39, P1655, DOI 10.1111/j.1945-5100.2004.tb00065.x; SCHULTZ PH, 1979, J GEOPHYS RES, V84, P7669, DOI 10.1029/JB084iB13p07669; SCHUMACHER R, 1995, B VOLCANOL, V56, P626, DOI 10.1007/s004450050069; Sheridan M.F., 1983, MICROBEAM ANAL, P35; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VALENTINE GA, 1989, B VOLCANOL, V51, P395, DOI 10.1007/BF01078808; WOHLETZ KH, 1983, ICARUS, V56, P15, DOI 10.1016/0019-1035(83)90125-2; WOHLETZ KH, 1984, GEOLOGY, V12, P591, DOI 10.1130/0091-7613(1984)12<591:VASDPP>2.0.CO;2; WOHLETZ KH, 1998, DEV VOLCANOLOGY MAGM, P247	50	109	110	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1123	1128		10.1038/nature04383	http://dx.doi.org/10.1038/nature04383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372001				2022-12-28	WOS:000234111500042
J	Amato, I				Amato, I			Nanotechnologists seek biological niches	CELL			English	Editorial Material								Biologists are embracing nanotechnology-the engineering and manipulating of entities in the 1 to 100 nm range-and are exploiting its potential to develop new therapeutics and diagnostics.											0	10	10	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					967	970		10.1016/j.cell.2005.12.001	http://dx.doi.org/10.1016/j.cell.2005.12.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360022	Bronze			2022-12-28	WOS:000234177200001
J	Pitsiladis, YP; Scott, R				Pitsiladis, YP; Scott, R			Essay - The makings of the perfect athlete	LANCET			English	Article									Univ Glasgow, Int Ctr E African Running Sci, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Pitsiladis, YP (corresponding author), Univ Glasgow, Int Ctr E African Running Sci, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	y.pitsiladis@bio.gla.ac.uk		Pitsiladis, Yannis/0000-0001-6210-2449				Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Dennis C, 2005, NATURE, V434, P260, DOI 10.1038/434260a; Rankinen T, 2004, MED SCI SPORT EXER, V36, P1451, DOI 10.1249/01.MSS.0000139902.42385.5F; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311	4	11	11	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S16	S17		10.1016/S0140-6736(05)67828-2	http://dx.doi.org/10.1016/S0140-6736(05)67828-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360732	Bronze			2022-12-28	WOS:000234374400011
J	Robertson, D; Garland, EM; Raj, SR; Demartinis, N				Robertson, D; Garland, EM; Raj, SR; Demartinis, N			Case report - Marathon runner with severe autonomic failure	LANCET			English	Article							DOPAMINE		Vanderbilt Univ, Auton Dysfunct Ctr, Nashville, TN 37232 USA; Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT USA	Vanderbilt University; University of Connecticut	Robertson, D (corresponding author), Vanderbilt Univ, Auton Dysfunct Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA.	david.robertson@vanderbilt.edu		Raj, Satish/0000-0002-5890-3785; DeMartinis, Nicholas/0000-0003-4075-1397	NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR020783, M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071784, P01HL056693] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR020783, M01 RR00095] Funding Source: Medline; NHLBI NIH HHS [R01 HL071784, 5PO1 HL56693] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIAGGIONI I, 1987, LANCET, V2, P1170; INTVELD AJM, 1987, LANCET, V1, P183; RAJ SR, IN PRESS ADV THERAPY; ROBERTSON D, 1986, NEW ENGL J MED, V314, P1494, DOI 10.1056/NEJM198606053142307; ROBERTSON D, 2003, DOPAMINE BETA HYDROX	5	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S13	S13		10.1016/S0140-6736(05)67826-9	http://dx.doi.org/10.1016/S0140-6736(05)67826-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360730	Bronze			2022-12-28	WOS:000234374400009
J	Singh, MAF				Singh, MAF			Essay - Fit for life - a geriatrician's perspective on ageing well	LANCET			English	Article									Univ Sydney, Fac Hlth Sci, Sch Exercise & Sport Sci, Lidcombe, NSW 2141, Australia	University of Sydney	Singh, MAF (corresponding author), Univ Sydney, Fac Hlth Sci, Sch Exercise & Sport Sci, East St, Lidcombe, NSW 2141, Australia.	m.singh@fhs.usyd.edu.au							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S51	S51		10.1016/S0140-6736(05)67849-X	http://dx.doi.org/10.1016/S0140-6736(05)67849-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999FO	16360755				2022-12-28	WOS:000234374400032
J	Watanabe, M; Houten, SM; Mataki, C; Christoffolete, MA; Kim, BW; Sato, H; Messaddeq, N; Harney, JW; Ezaki, O; Kodama, T; Schoonjans, K; Bianco, AC; Auwerx, J				Watanabe, M; Houten, SM; Mataki, C; Christoffolete, MA; Kim, BW; Sato, H; Messaddeq, N; Harney, JW; Ezaki, O; Kodama, T; Schoonjans, K; Bianco, AC; Auwerx, J			Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation	NATURE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; NUCLEAR RECEPTOR; ADAPTIVE THERMOGENESIS; INSULIN-RESISTANCE; BROWN FAT; GENE; FXR; IDENTIFICATION; BIOSYNTHESIS; HEPATOCYTES	While bile acids (BAs) have long been known to be essential in dietary lipid absorption and cholesterol catabolism, in recent years an important role for BAs as signalling molecules has emerged. BAs activate mitogen-activated protein kinase pathways(1,2), are ligands for the G-protein-coupled receptor ( GPCR) TGR5(3,4) and activate nuclear hormone receptors such as farnesoid X receptor alpha ( FXR-alpha; NR1H4)(5-7). FXR-alpha regulates the enterohepatic recycling and biosynthesis of BAs by controlling the expression of genes such as the short heterodimer partner (SHP; NR0B2)(8,9) that inhibits the activity of other nuclear receptors. The FXR-alpha-mediated SHP induction also underlies the downregulation of the hepatic fatty acid and triglyceride biosynthesis and very-low-density lipoprotein production mediated by sterol-regulatory-element-binding protein 1c(10). This indicates that BAs might be able to function beyond the control of BA homeostasis as general metabolic integrators. Here we show that the administration of BAs to mice increases energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This novel metabolic effect of BAs is critically dependent on induction of the cyclic-AMP-dependent thyroid hormone activating enzyme type 2 iodothyronine deiodinase (D2) because it is lost in D2(-/-) mice. Treatment of brown adipocytes and human skeletal myocytes with BA increases D2 activity and oxygen consumption. These effects are independent of FXR-alpha, and instead are mediated by increased cAMP production that stems from the binding of BAs with the G-protein-coupled receptor TGR5. In both rodents and humans, the most thermogenically important tissues are specifically targeted by this mechanism because they coexpress D2 and TGR5. The BA - TGR5 - cAMP - D2 signalling pathway is therefore a crucial mechanism for fine-tuning energy homeostasis that can be targeted to improve metabolic control.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Brigham & Womens Hosp, Dept Med, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Natl Inst Hlth & Nutr, Div Clin Nutr, Shinjuku Ku, Tokyo 1628636, Japan; Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo 1538904, Japan; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institute of Health & Nutrition - Japan; University of Tokyo	Auwerx, J (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021; Bianco, Antonio C/A-4965-2008; Houten, Sander/Y-3599-2019; Bianco, Antonio/AAK-6336-2020	Bianco, Antonio C/0000-0001-7737-6813; Houten, Sander/0000-0002-6167-9147; Bianco, Antonio/0000-0001-7737-6813; Christoffolete, Marcelo/0000-0003-0374-0795; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393				Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Branco M, 1999, AM J PHYSIOL-ENDOC M, V276, pE179, DOI 10.1152/ajpendo.1999.276.1.E179; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Cohen DE, 2003, HEPATOLOGY TXB LIVER, P1713; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; EVERSON GT, 1987, J LIPID RES, V28, P238; FAIN JN, 1967, J BIOL CHEM, V242, P1887; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HINUMA S, 2005, Patent No. 2003380574; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; IKEMOTO S, 1997, AM J PHYSIOL, V273, P37; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025	25	1482	1610	12	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					484	489		10.1038/nature04330	http://dx.doi.org/10.1038/nature04330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16400329				2022-12-28	WOS:000234859200049
J	Gibson, CS; MacLennan, AH; Goldwater, PN; Haan, EA; Priest, K; Dekker, GA				Gibson, CS; MacLennan, AH; Goldwater, PN; Haan, EA; Priest, K; Dekker, GA		S Australian Cerebral Palsy Res Gr	Neurotropic viruses and cerebral palsy: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							POLYMERASE-CHAIN-REACTION; AMNIOTIC-FLUID; PRETERM LABOR; CYTOMEGALOVIRUS-INFECTION; INHERITED THROMBOPHILIAS; INTRAUTERINE INFECTION; BRAIN-BARRIER; BIRTH; VARICELLA; PREGNANCY	Objective To investigate the association between cerebral palsy and direct evidence for perinatal exposure to neurotropic viruses. Design Population based case-control study. Setting Adelaide Women's and Children's Hospital Research Laboratory. Participants and main outcome measures Newborn screening cards of 443 white case patients with cerebral palsy and 883 white controls were tested for viral nucleic acids from enteroviruses and herpes viruses by using polymerase chain reaction. Herpes group A viruses included herpes simplex viruses I and 2 (HSV-1 and HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus 8 (HHV-8); herpes group B viruses included varicella zoster virus (VZV) and human herpes viruses 6 and 7 (HHV-6 and HHV-7). Results The prevalence of viral nucleic acids in the control population was high: 39.8% of controls tested positive, and the prevalence was highest in preterm babies. The detection of herpes group B viral nucleic acids increased the risk of developing cerebral palsy (odds ratio 1.68, 95% confidence interval 1.09 to 2.59). Conclusions Perinatal exposure to neurotropic viruses is associated with preterm delivery and cerebral palsy.	Univ Adelaide, Dept Obstet Gynaecol, Womens Childrens Hosp, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Microbiol & Infect Dis, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; Dept Hlth, Epidemiol Branch, Adelaide, SA 5000, Australia	University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; Womens & Childrens Hospital Australia	Gibson, CS (corresponding author), Univ Adelaide, Dept Obstet Gynaecol, Womens Childrens Hosp, 1st Floor Queen Victoria Bldg,72 King William Rd, Adelaide, SA 5006, Australia.	catherine.s.gibson@adelaide.edu.au						ADINOLFI M, 1985, DEV MED CHILD NEUROL, V27, P532; Brown HL, 1998, SEMIN PERINATOL, V22, P260, DOI 10.1016/S0146-0005(98)80014-1; Corey RP, 2000, ARCH OPHTHALMOL-CHIC, V118, P837, DOI 10.1001/archopht.118.6.837; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; FOROUZAN I, 1992, OBSTET GYNECOL, V80, P535; Friese K, 2003, BJOG-INT J OBSTET GY, V110, P52, DOI 10.1016/S1470-0328(03)00025-9; Gibson CS, 2005, AM J OBSTET GYNECOL, V193, P1437, DOI 10.1016/j.ajog.2005.02.107; Gibson CS, 2005, PATHOLOGY, V37, P160, DOI 10.1080/00313020500058250; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HAMMAD E, 1989, ACTA PAEDIATR SCAND, V78, P963, DOI 10.1111/j.1651-2227.1989.tb11186.x; HUANG YC, 1996, J FORMOS MED ASSOC, V93, P393; Jacobsson B, 2004, EUR J OBSTET GYN R B, V115, P159, DOI 10.1016/j.ejogrb.2003.11.014; Johnson G, 2000, J CLIN MICROBIOL, V38, P3274, DOI 10.1128/JCM.38.9.3274-3279.2000; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; MCLEAN LK, 1995, AM J OBSTET GYNECOL, V173, P1282, DOI 10.1016/0002-9378(95)91371-8; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Mouly F, 1997, AM J OBSTET GYNECOL, V177, P894, DOI 10.1016/S0002-9378(97)70291-6; Nelson KB, 2002, MENT RETARD DEV D R, V8, P1, DOI 10.1002/mrdd.10010; O'Neill J F, 1998, Trans Am Ophthalmol Soc, V96, P813; Palmer AL, 1997, J INFECT DIS, V176, P1437, DOI 10.1086/514139; REMINGTON JS, 1995, INFECT DIS FETUS UNB; Rogers CDG, 2000, BIOTECHNOL APPL BIOC, V31, P219, DOI 10.1042/BA19990113; Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S; Takami T, 2000, J HOSP INFECT, V45, P283, DOI 10.1053/jhin.2000.0788; Vigneswaran Rasiah, 2004, BMC Pregnancy Childbirth, V4, P1, DOI 10.1186/1471-2393-4-1; Wenstrom KD, 1998, OBSTET GYNECOL, V92, P420, DOI 10.1016/S0029-7844(98)00210-5; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yost NP, 2000, CLIN OBSTET GYNECOL, V43, P759, DOI 10.1097/00003081-200012000-00006	28	56	61	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					76	79		10.1136/bmj.38668.616806.3A	http://dx.doi.org/10.1136/bmj.38668.616806.3A			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16399770	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000234777000016
J	Hochstrasser, M				Hochstrasser, M			Lingering mysteries of ubiquitin-chain assembly	CELL			English	Review							CONJUGATING ENZYME; MULTIUBIQUITIN CHAIN; IN-VIVO; U-BOX; DOMAIN; INSIGHTS; COMPLEX; LIGASE; CDC34; DEGRADATION	The small protein ubiquitin is often linked to substrates as a polymer. Such polymers vary in both linkage and length, which has important consequences for their function. Surprisingly, the mechanisms of ubiquitin-chain assembly are still not known. Deciphering them will shed light on why substrates differ in the extent and timing of polyubiquitin modification and how ancillary ubiquitination factors function.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R37GM046904, R01GM053756] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53756, GM46904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; REISS Y, 1989, J BIOL CHEM, V264, P10378; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501	31	204	214	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					27	34		10.1016/j.cell.2005.12.025	http://dx.doi.org/10.1016/j.cell.2005.12.025			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413479	Bronze			2022-12-28	WOS:000234969600007
J	Imre, A; Csaba, G; Ji, L; Orlov, A; Bernstein, GH; Porod, W				Imre, A; Csaba, G; Ji, L; Orlov, A; Bernstein, GH; Porod, W			Majority logic gate for magnetic quantum-dot cellular automata	SCIENCE			English	Article								We describe the operation of, and demonstrate logic functionality in, networks of physically coupled, nanometer-scale magnets designed for digital computation in magnetic quantum-dot cellular automata (MQCA) systems. MQCA offer low power dissipation and high integration density of functional elements and operate at room temperature. The basic MQCA logic gate, that is, the three-input majority logic gate, is demonstrated.	Univ Notre Dame, Dept Elect Engn, Ctr Nano Sci & Technol, Notre Dame, IN 46556 USA; Tech Univ Munich, Inst Nanoelect, D-80333 Munich, Germany	University of Notre Dame; Technical University of Munich	Imre, A (corresponding author), Univ Notre Dame, Dept Elect Engn, Ctr Nano Sci & Technol, Notre Dame, IN 46556 USA.	aimre@nd.edu	Joshi-Imre, Alexandra/A-2912-2010; Csaba, Gyorgy/O-9720-2015	Joshi-Imre, Alexandra/0000-0002-4271-1623; Csaba, Gyorgy/0000-0001-7592-0256; Orlov, Alexei/0000-0003-2506-6287				Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Allwood DA, 2002, SCIENCE, V296, P2003, DOI 10.1126/science.1070595; Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; Bernstein GH, 2005, MICROELECTRON J, V36, P619, DOI 10.1016/j.mejo.2004.12.002; Cowburn RP, 2000, SCIENCE, V287, P1466, DOI 10.1126/science.287.5457.1466; Csaba G, 2002, IEEE T NANOTECHNOL, V1, P209, DOI 10.1109/TNANO.2002.807380; Csaba G, 2003, INT J CIRC THEOR APP, V31, P67, DOI 10.1002/cta.226; Csaba G, 2001, INT J CIRC THEOR APP, V29, P73, DOI 10.1002/1097-007X(200101/02)29:1<73::AID-CTA134>3.0.CO;2-A; Csaba G., 2002, J COMPUT ELECTRON, V1, P87, DOI 10.1023/A:1020771912723; CSABA G, 2003, THESIS U NOTRE DAME; Csurgay AI, 2000, IEEE T CIRCUITS-I, V47, P1212, DOI 10.1109/81.873875; Donahue M., 6376 NISTIR; Gerrits T, 2002, NATURE, V418, P509, DOI 10.1038/nature00905; Haque SA, 2004, J MAGN MAGN MATER, V282, P380, DOI 10.1016/j.jmmm.2004.04.088; Imre A, 2003, SUPERLATTICE MICROST, V34, P513, DOI 10.1016/j.spmi.2004.03.051; Imre A, 2003, 2003 THIRD IEEE CONFERENCE ON NANOTECHNOLOGY, VOLS ONE AND TWO, PROCEEDINGS, P20; Kummamuru RK, 2003, IEEE T ELECTRON DEV, V50, P1906, DOI 10.1109/TED.2003.816522; Lent C. S., 1993, Nanotechnology, V4, P49, DOI 10.1088/0957-4484/4/1/004; Lent CS, 2000, SCIENCE, V288, P1597, DOI 10.1126/science.288.5471.1597; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Orlov AO, 1997, SCIENCE, V277, P928, DOI 10.1126/science.277.5328.928; ORLOV AO, 2004, MESOSCOPIC TUNNELING, P125; Parish MCB, 2003, APPL PHYS LETT, V83, P2046, DOI 10.1063/1.1608492; Ross C, 2001, ANNU REV MATER RES, V31, P203, DOI 10.1146/annurev.matsci.31.1.203; Slaughter JM, 2002, J SUPERCOND, V15, P19, DOI 10.1023/A:1014018925270; Snider GL, 1999, J APPL PHYS, V85, P4283, DOI 10.1063/1.370344; Timler J, 2002, J APPL PHYS, V91, P823, DOI 10.1063/1.1421217	27	712	732	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					205	208		10.1126/science.1120506	http://dx.doi.org/10.1126/science.1120506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410520				2022-12-28	WOS:000234722200035
J	Smith, C				Smith, C			Two geometric solutions to a transporting problem	SCIENCE			English	Editorial Material							COPII VESICLE COAT; ELECTRON CRYOMICROSCOPY; CLATHRIN		Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Smith, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	corinne.smith@warwick.ac.uk	Smith, Corinne J/A-3170-2009	Smith, Corinne J/0000-0003-3364-7946				BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003	15	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					182	183		10.1126/science.1123754	http://dx.doi.org/10.1126/science.1123754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410510				2022-12-28	WOS:000234722200025
J	Kmietowicz, Z				Kmietowicz, Z			Primary care - A century of general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												zosia@blueyonder.co.uk						COLLINGS JS, 1950, LANCET, V258, P555; Department of Health, 2001, SHIFT BAL POW NHS SE; Gibson R., 1981, FAMILY DOCTOR HIS LI; HORNER NG, 1922, GROWTH GEN PRACTITIO; Loudon I., 1998, GEN PRACTICE NATL HL; Secretary of State for Health, 2000, NHS PLAN; TAYLOR S, 1954, GOOD GEN PRACTICE	7	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					39	40		10.1136/bmj.332.7532.39	http://dx.doi.org/10.1136/bmj.332.7532.39			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003LR	16399738	Green Published			2022-12-28	WOS:000234684200022
J	Shevchenko, EV; Talapin, DV; Kotov, NA; O'Brien, S; Murray, CB				Shevchenko, EV; Talapin, DV; Kotov, NA; O'Brien, S; Murray, CB			Structural diversity in binary nanoparticle superlattices	NATURE			English	Article							SEMICONDUCTOR QUANTUM DOTS; 2 DIFFERENT SIZES; NANOCRYSTAL SUPERLATTICES; SPHERES; CRYSTALLINE; ARRANGEMENTS; PARTICLE; PHASE; FILMS	Assembly of small building blocks such as atoms, molecules and nanoparticles into macroscopic structures - that is, 'bottom up' assembly - is a theme that runs through chemistry, biology and material science. Bacteria(1), macromolecules(2) and nanoparticles(3) can self-assemble, generating ordered structures with a precision that challenges current lithographic techniques. The assembly of nanoparticles of two different materials into a binary nanoparticle superlattice (BNSL)(3-7) can provide a general and inexpensive path to a large variety of materials (metamaterials) with precisely controlled chemical composition and tight placement of the components. Maximization of the nanoparticle packing density has been proposed as the driving force for BNSL formation(3,8,9), and only a few BNSL structures have been predicted to be thermodynamically stable. Recently, colloidal crystals with micrometre-scale lattice spacings have been grown from oppositely charged polymethyl methacrylate spheres(10,11). Here we demonstrate formation of more than 15 different BNSL structures, using combinations of semiconducting, metallic and magnetic nanoparticle building blocks. At least ten of these colloidal crystalline structures have not been reported previously. We demonstrate that electrical charges on sterically stabilized nanoparticles determine BNSL stoichiometry; additional contributions from entropic, van der Waals, steric and dipolar forces stabilize the variety of BNSL structures.	IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Heights, NY 10598 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	International Business Machines (IBM); Columbia University; University of Michigan System; University of Michigan	Talapin, DV (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA.	dvtalapin@lbl.gov; cbmurray@us.ibm.com	O'Brien, Stephen/D-7682-2013; OBrien, Stephen/O-8814-2019; Kotov, Nicholas/AAZ-4204-2021; bartelsdoe, ludwig/F-8008-2011	O'Brien, Stephen/0000-0001-7531-8900; OBrien, Stephen/0000-0001-7531-8900; Kotov, Nicholas/0000-0002-6864-5804; 				Bartlett P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128302; Bolhuis PG, 1997, NATURE, V388, P235, DOI 10.1038/40779; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; COTTIN X, 1995, J CHEM PHYS, V102, P3354, DOI 10.1063/1.469209; ELDRIDGE MD, 1993, NATURE, V365, P35, DOI 10.1038/365035a0; Guarini KW, 2002, ADV MATER, V14, P1290, DOI 10.1002/1521-4095(20020916)14:18<1290::AID-ADMA1290>3.0.CO;2-N; HACHISU S, 1980, NATURE, V283, P188, DOI 10.1038/283188a0; Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s; Islam MA, 2002, APPL PHYS LETT, V80, P3823, DOI 10.1063/1.1480878; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Korgel BA, 1998, J PHYS CHEM B, V102, P8379, DOI 10.1021/jp981598o; Krauss TD, 1999, PHYS REV LETT, V83, P4840, DOI 10.1103/PhysRevLett.83.4840; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; MURRAY MJ, 1980, PHILOS MAG A, V42, P721, DOI 10.1080/01418618008239380; OBRIEN RW, 1978, J CHEM SOC FARAD T 2, V74, P1607, DOI 10.1039/f29787401607; OHARA PC, 1995, PHYS REV LETT, V75, P3466, DOI 10.1103/PhysRevLett.75.3466; Prasad BLV, 2002, LANGMUIR, V18, P7515, DOI 10.1021/la020181d; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Rabani E, 2003, NATURE, V426, P271, DOI 10.1038/nature02087; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; SANDERS JV, 1978, NATURE, V275, P201, DOI 10.1038/275201a0; Saunders AE, 2005, CHEMPHYSCHEM, V6, P61, DOI 10.1002/cphc.200400382; Shenton W, 1997, NATURE, V389, P585, DOI 10.1038/39287; Shevchenko EV, 2002, J AM CHEM SOC, V124, P11480, DOI 10.1021/ja025976l; Shevchenko EV, 2005, J AM CHEM SOC, V127, P8741, DOI 10.1021/ja050510z; Shim M, 1999, J CHEM PHYS, V111, P6955, DOI 10.1063/1.479988; Wong S, 2003, J AM CHEM SOC, V125, P15589, DOI 10.1021/ja0379969; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Zhang YW, 2005, J AM CHEM SOC, V127, P3260, DOI 10.1021/ja042801y	30	1738	1766	20	1039	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					55	59		10.1038/nature04414	http://dx.doi.org/10.1038/nature04414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397494	Green Published, Bronze			2022-12-28	WOS:000234378700032
J	Flannery, B; Heffernan, RT; Harrison, LH; Ray, SM; Reingold, AL; Hadler, J; Schaffner, W; Lynfield, R; Thomas, AR; Li, JM; Campsmith, M; Whitney, CG; Schuchat, A				Flannery, B; Heffernan, RT; Harrison, LH; Ray, SM; Reingold, AL; Hadler, J; Schaffner, W; Lynfield, R; Thomas, AR; Li, JM; Campsmith, M; Whitney, CG; Schuchat, A			Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization	ANNALS OF INTERNAL MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SURVEILLANCE; CHILDREN; AIDS	Background: Adults infected with HIV have high rates of invasive pneumococcal disease. Introduction of pneumococcal conjugate vaccine for children could affect disease among HIV-infected adults. Objective: To compare invasive pneumococcal disease among HIV-infected adults before and after the introduction of a pediatric conjugate vaccine. Design: Active laboratory-based surveillance in an adult population of 10.8 million, including 38 314 living with AIDS. Setting: 7 Active Bacterial Core surveillance areas in the United States. Patients: All surveillance-area residents 18 to 64 years of age with Streptococcus pneumoniae isolated from a sterile site between 1998 and 2003. Measurements: Ratio of the number of cases of invasive pneumococcal disease among HIV-infected adults to the estimated number of adults 18 to 64 years of age living with AIDS; serotype-specific subset analyses; and comparison of periods before and after introduction of conjugate vaccine by using exact tests. Results: Of 8582 cases of invasive pneumococcal disease in adults, 2013 (24%) occurred among persons infected with HIV. Between baseline (1998 to 1999) and 2003, the ratio of invasive pneumococcal disease in HIV-infected adults to the number of adults living with AIDS in the surveillance areas decreased from 1127 to 919 cases per 100000 AIDS population, a reduction of 19% (P= 0.002). Among HIV-infected adults, the ratio for disease caused by pneumococcal serotypes included in the conjugate vaccine decreased 62% (P < 0.001), although the ratio for disease caused by nonvaccine serotypes increased 44% (P < 0.001). Limitations: Ratios are proxy measures of incidence rates. The denominator of surveillance-area residents living with HIV infection was not available. Conclusions: Introduction of the pediatric conjugate vaccine was associated with an overall decrease in invasive pneumococcal disease among HIV-infected adults, despite increased disease caused by nonvaccine serotypes.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Flannery, B (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, 1600 Clifton Rd NE,MS C-23, Atlanta, GA 30333 USA.	bflannery@cdc.gov		Ray, Susan/0000-0002-6327-088X				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Breiman RF, 2000, ARCH INTERN MED, V160, P2633, DOI 10.1001/archinte.160.17.2633; *CDCP\, NAT IMM SURV; *CDCP, 2004, HIV AIDS SURV REP 20, V15; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; *NAT COMM CLIN LAB, 2004, METH DIL ANT SUSC TE; National Committee for Clinical Laboratory Standards, 2004, PERF STAND ANT SUS S, V24; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; US Bureau of the Census, POP EST; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 1989, MMWR MORB MORTAL WKL, V38, P73; 1989, MMWR MORB MORTAL WKL, V38, P64	23	122	127	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					1	9		10.7326/0003-4819-144-1-200601030-00004	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389249				2022-12-28	WOS:000234474200001
J	Hiesinger, PR; Hassan, BA				Hiesinger, PR; Hassan, BA			Genetics in the age of systems biology	CELL			English	Article							CAENORHABDITIS-ELEGANS; DROSOPHILA; GENOME		VIB, Dept Human Genet, Neurogenet Lab, B-3000 Louvain, Belgium; Catholic Univ Louvain, Sch Med, B-3000 Louvain, Belgium; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Baylor College of Medicine; Howard Hughes Medical Institute	Hassan, BA (corresponding author), VIB, Dept Human Genet, Neurogenet Lab, B-3000 Louvain, Belgium.	bassem.hassan@med.kuleuven.be	Hassan, Bassem A/D-5221-2012	Hassan, Bassem A/0000-0001-9533-4908				Dawkins R., 1986, BLIND WATCHMAKER; Friedman A, 2004, CURR OPIN GENET DEV, V14, P470, DOI 10.1016/j.gde.2004.07.010; Gregan J, 2005, CURR BIOL, V15, P1663, DOI 10.1016/j.cub.2005.07.059; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; HODGKIN JA, 1977, GENETICS, V86, P275; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Liu ET, 2005, CELL, V121, P505, DOI 10.1016/j.cell.2005.04.021; Nagy A, 2003, NAT GENET, V33, P276, DOI 10.1038/ng1115; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0	10	16	19	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1173	1174		10.1016/j.cell.2005.12.006	http://dx.doi.org/10.1016/j.cell.2005.12.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377554	Bronze			2022-12-28	WOS:000234584500002
J	Laird, DJ; De Tomaso, AW; Weissman, IL				Laird, DJ; De Tomaso, AW; Weissman, IL			Stem cells are units of natural selection in a colonial ascidian	CELL			English	Article							PROTOCHORDATE HISTOCOMPATIBILITY LOCUS; BOTRYLLUS-SCHLOSSERI; BONE-MARROW; ALDEHYDE DEHYDROGENASE; HEMATOPOIETIC-CELLS; TELOMERASE ACTIVITY; BUDDING TUNICATES; PERIPHERAL-BLOOD; EVOLUTION; ALLORECOGNITION	Stem cells are highly conserved biological units of development and regeneration. Here we formally demonstrate that stem cell lineages are also legitimate units of natural selection. In a colonial ascidian, Botryllus schlosseri, vascular fusion between genetically distinct individuals results in cellular parasitism of somatic tissues, gametes, or both. We show that genetic hierarchies of somatic and gametic parasitism following fusion can be replicated by transplanting cells between colonies. We prospectively isolate a population of multipotent, self-renewing stem cells that retain their competitive phenotype upon transplantation. Their single-cell contribution to either somatic or germline fates, but not to both, is consistent with separate lineages of somatic and germline stem cells or pluripotent stem cells that differentiate according to the niche in which they land. Since fusion is restricted to individuals that share a fusion/histocompatibility allele, these data suggest that histocompatibility genes in Botryllus evolved to protect the body from parasitic stem cells usurping asexual or sexual inheritance.	Stanford Univ, Med Ctr, Dept Biol Sci, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Laird, DJ (corresponding author), Stanford Univ, Med Ctr, Dept Biol Sci, Dept Pathol, Stanford, CA 94305 USA.	diana@stanfordalumni.org	Laird, Diana/Y-4387-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054762] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041588] Funding Source: Medline; NIDDK NIH HHS [DK54762, R01 DK054762] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Berrill NJ, 1941, BIOL BULL-US, V80, P169, DOI 10.2307/1537595; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BOYD H, 1986, BIOL B, V170; BUSS LW, 1985, DEV COMP IMMUNOL, V9, P191, DOI 10.1016/0145-305X(85)90110-7; Chadwick-Furman NE, 2003, BIOL BULL-US, V205, P133, DOI 10.2307/1543234; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fallon P, 2003, BRIT J HAEMATOL, V122, P99, DOI 10.1046/j.1365-2141.2003.04357.x; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARA K, 1992, DEV GROWTH DIFFER, V34, P437; HENRY C, 1980, SELECTED METHODS CEL; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hou M, 2001, CLIN CHEM, V47, P519; IZZARD CS, 1973, J MORPHOL, V139, P1, DOI 10.1002/jmor.1051390102; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; KAWAMURA K, 1995, SEMIN CELL BIOL, V6, P117, DOI 10.1006/scel.1995.0017; Laird DJ, 2004, DEV BIOL, V273, P185, DOI 10.1016/j.ydbio.2004.05.029; Laird DJ, 2004, DEV COMP IMMUNOL, V28, P201, DOI 10.1016/j.dci.2003.08.007; LAUZON RJ, 1992, DEV DYNAM, V194, P71, DOI 10.1002/aja.1001940109; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; MUKAI H, 1976, J MORPHOL, V148, P337, DOI 10.1002/jmor.1051480306; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; OKA H, 1959, BIOL BULL, V117, P340, DOI 10.2307/1538913; OKA H, 1959, BIOL BULL, V1112, P225; Paz G, 2002, DEV COMP IMMUNOL, V26, P615, DOI 10.1016/S0145-305X(02)00022-8; RINKEVICH B, 1991, INT IMMUNOL, V3, P1265, DOI 10.1093/intimm/3.12.1265; RINKEVICH B, 1987, J ZOOL, V213, P717, DOI 10.1111/j.1469-7998.1987.tb03736.x; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Stoner DS, 1997, MOL MAR BIOL BIOTECH, V6, P163; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455	52	143	146	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1351	1360		10.1016/j.cell.2005.10.026	http://dx.doi.org/10.1016/j.cell.2005.10.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377573	Bronze			2022-12-28	WOS:000234584500021
J	Li, X; Carthew, RW				Li, X; Carthew, RW			A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye	CELL			English	Article							GENE REGULATORY NETWORKS; TYROSINE KINASE; FEEDBACK LOOP; CELL; ACTIVATION; EXPRESSION; TRANSCRIPTION; TARGETS; PROTEIN; LIN-14	A critical question about signal transduction is how weak or transient activation of signaling pathways achieves a robust and long-term switch in gene expression. We report that a microRNA is part of a mechanism that makes cells sensitive to signals in the Drosophila eye. Expression of miR-7 is activated in cells as they begin differentiating into photoreceptors. This is dependent on EGF receptor (EGFR) signaling that triggers ERK-mediated degradation of the transcription factor Yan. In nonstimulated cells, Yan represses miR-7 transcription, whereas miR-7 RNA represses Yan protein expression in photoreceptors, by binding to sequences within its mRNA 3'UTR. We propose that reciprocal negative feedback between Yan and miR-7 ensures mutually exclusive expression, with Yan in progenitor cells and miR-7 in photoreceptor cells. Expression is switched when EGFR signaling transiently triggers Yan degradation. This two-tiered mechanism explains how signal transduction activity can robustly generate a stable change in gene-expression patterns.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Gabay L, 1996, DEVELOPMENT, V122, P3355; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pichaud F, 2001, CELL, V105, P9, DOI 10.1016/S0092-8674(01)00292-6; Queenan AM, 1997, DEVELOPMENT, V124, P3871; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	45	270	313	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1267	1277		10.1016/j.cell.2005.10.040	http://dx.doi.org/10.1016/j.cell.2005.10.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377567	Bronze			2022-12-28	WOS:000234584500015
J	Amelin, Y				Amelin, Y			Geochemistry - A tale of early Earth told in zircons	SCIENCE			English	Editorial Material							DETRITAL ZIRCONS; CHONDRITES; MANTLE; CRUST; HF		Geol Survey Canada, Ottawa, ON K1A 0E8, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Amelin, Y (corresponding author), Geol Survey Canada, 601 Booth St, Ottawa, ON K1A 0E8, Canada.	yamelin@nrcan.gc.ca						ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Bizzarro M, 2003, NATURE, V421, P931, DOI 10.1038/nature01421; BLACK LP, 1971, EARTH PLANET SC LETT, V12, P245; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; COMPSTON W, 1986, NATURE, V321, P766, DOI 10.1038/321766a0; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; Patchett PJ, 2004, EARTH PLANET SC LETT, V222, P29, DOI 10.1016/j.epsl.2004.02.030; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	10	8	9	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2005	310	5756					1914	1915		10.1126/science.1121536	http://dx.doi.org/10.1126/science.1121536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373565				2022-12-28	WOS:000234275400030
J	Boisvert, CA				Boisvert, CA			The pelvic fin and girdle of Panderichthys and the origin of tetrapod locomotion	NATURE			English	Article								One of the most marked transformations in the vertebrate transition to land was that of fins to limbs. This transformation involved not only the generation of morphological novelties ( digits, sacrum) but also a shift in locomotory dominance from the pectoral to the pelvic appendage(1). Despite its importance, the transformation from pelvic fin to hindlimb is the least studied and least well-documented part of this transformation, which is bracketed by the osteolepiform Eusthenopteron and the early tetrapods Ichthyostega and Acanthostega, but is not directly illuminated by any intermediate form. Panderichthys is the closest tetrapod relative currently represented by complete fossils(2), but its pelvic fin skeleton has not been described. Here, I present the only known articulated pelvic fin endoskeleton and associated partial pelvis of Panderichthys. The pelvic girdle is even less tetrapod-like than that of the osteolepiform Eusthenopteron(3), but the pelvic fin endoskeleton shares derived characteristics with basal tetrapods despite being more primitive than the pectoral fin of Panderichthys(4,5). The evolution of tetrapod locomotion appears to have passed through a stage of body-flexion propulsion, in which the pelvic fins played a relatively minor anchoring part, before the emergence of hindlimb-powered propulsion in the interval between Panderichthys and Acanthostega.	Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden	Uppsala University	Boisvert, CA (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	catherine.boisvert@ebc.uu.se	Boisvert, Catherine A/A-9782-2019	Boisvert, Catherine A/0000-0002-0618-7270				Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; [Anonymous], 1992, FOSSIL FISHES LIVING; Carroll RL, 2005, ZOOL J LINN SOC-LOND, V143, P345, DOI 10.1111/j.1096-3642.2005.00151.x; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Jarvik E., 1980, BASIC STRUCTURE EVOL; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1992, ZH OBSHCH BIOL, V53, P149; Vorobyeva EI, 1998, PALEONTOL ZH, P3; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285	14	73	77	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1145	1147		10.1038/nature04119	http://dx.doi.org/10.1038/nature04119			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372007				2022-12-28	WOS:000234111500048
J	Cassman, M				Cassman, M			Barriers to progress in systems biology	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Entelos, Foster City, CA USA	University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; Entelos Inc.				Katagiri, Fumiaki/0000-0001-6893-3788				CASSMAN M, PROPOSAL SOFTWARE IN; CASSMAN M, IN PRESS ASSESSMENT	2	51	53	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1079	1079		10.1038/4381079a	http://dx.doi.org/10.1038/4381079a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371982	Bronze			2022-12-28	WOS:000234111500021
J	Genel, M; Ljungqvist, A				Genel, M; Ljungqvist, A			Essay - Gender verification of female athletes	LANCET			English	Article									Yale Univ, Child Hlth Res Ctr, New Haven, CT 06520 USA; Swedish Sports Confederat, S-11473 Stockholm, Sweden	Yale University; Swedish Sports Confederation	Genel, M (corresponding author), Yale Univ, Child Hlth Res Ctr, POB 208081, New Haven, CT 06520 USA.	myron.genel@yale.edu						DELACHAPELLE A, 1986, JAMA-J AM MED ASSOC, V256, P1920, DOI 10.1001/jama.256.14.1920; Dickinson BD, 2002, MED SCI SPORT EXER, V34, P1539, DOI 10.1097/00005768-200210000-00001; LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V277, P850; SIMPSON JL, 1993, SPORTS MED, V16, P305, DOI 10.2165/00007256-199316050-00002	4	19	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S41	S41		10.1016/S0140-6736(05)67843-9	http://dx.doi.org/10.1016/S0140-6736(05)67843-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360748				2022-12-28	WOS:000234374400026
J	Rekart, ML				Rekart, ML			Sex-work harm reduction	LANCET			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USERS; CONDOM USE; COMMERCIAL SEX; HIV PREVENTION; FEMALE CONDOM; HUMAN-RIGHTS; COST-EFFECTIVENESS; SUBSTANCE-ABUSE; VIRUS-INFECTION	Sex work is an extremely dangerous profession. The use of harm-reduction principles can help to safeguard sex workers' lives in the same way that drug users have benefited from drug-use harm reduction. Sex workers are exposed to serious harms: drug use, disease, violence, discrimination, debt, criminalisation, and exploitation (child prostitution, trafficking for sex work, and exploitation of migrants). Successful and promising harm-reduction strategies are available: education, empowerment, prevention, care, occupational health and safety, decriminalisation of sex workers, and human-rights-based approaches. Successful interventions include peer education, training in condom-negotiating skills, safety tips for street-based sex workers, male and female condoms, the prevention-care synergy, occupational health and safety guidelines for brothels, self-help organisations, and community-based child protection networks. Straightforward and achievable steps are available to improve the day-to-day lives of sex workers while they continue to work. Conceptualising and debating sex-work harm reduction as a new paradigm can hasten this process.	Univ British Columbia, British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada	University of British Columbia	Rekart, ML (corresponding author), Univ British Columbia, British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada.	michael.rekart@bccdc.ca						Abellanosa I, 1996, SEX TRANSM DIS, V23, P407, DOI 10.1097/00007435-199609000-00011; *ACT WORKC, 1989, ACT SEX IND COD PRAC; Agha S, 2004, CULT HEALTH SEX, V6, P283, DOI 10.1080/13691050410001680474; Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Ainsworth M, 2001, AIDS, V15, pW27; Alexander P, 1998, J Am Med Womens Assoc (1972), V53, P77; ALEXANDER P, 1992, AIDS HLTH PROMOT EXC, V1, P4; Aral SO, 2002, SEX TRANSM DIS, V29, P798, DOI 10.1097/00007435-200212000-00011; Aral SO, 2003, SEX TRANSM DIS, V30, P39, DOI 10.1097/00007435-200301000-00009; Aral SO, 1998, SEX TRANSM DIS, V25, P455, DOI 10.1097/00007435-199810000-00002; Asthana S, 1996, SOC SCI MED, V43, P133, DOI 10.1016/0277-9536(95)00348-7; BANDES A, 2001, HARM REDUCTION COMMU; BANDYOPADHYAY N, 1999, SEX HLTH EXCH, V2, P6; Barnitz L, 2001, CHILD WELFARE, V80, P597; Blanchard JF, 2005, J INFECT DIS, V191, pS139, DOI 10.1086/425273; Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Braitstein P, 2003, SOC SCI MED, V57, P561, DOI 10.1016/S0277-9536(02)00403-3; Bronfman MN, 2002, AIDS, V16, pS42, DOI 10.1097/00002030-200212003-00007; BROWN T, 1998, SEXUALLY TRANSMITTED; Buckingham RW, 2005, AIDS CARE, V17, P640, DOI 10.1080/09540120412331319697; *CHAI PROJ, TRICKS TRAD HLTH SAF; Chan R, 2001, INT J STD AIDS, V12, P159, DOI 10.1258/0956462011916956; Chege M N, 2002, East Afr Med J, V79, P382; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; COHEN E, 1994, J PSYCHOACTIVE DRUGS, V26, P233, DOI 10.1080/02791072.1994.10472436; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V38, P202, DOI 10.1097/00126334-200502010-00012; Cwikel J, 2003, J EPIDEMIOL COMMUN H, V57, P809, DOI 10.1136/jech.57.10.809; DALLABETTA GA, 1995, AIDS, V9, P293, DOI 10.1097/00002030-199509030-00012; Decosas J, 1997, AIDS, V11, pS77; DEGRAAF R, 1995, AIDS CARE, V7, P35, DOI 10.1080/09540129550126948; Dehne KL, 2000, B WORLD HEALTH ORGAN, V78, P628; Delvaux T, 2003, REPROD HEALTH MATTER, V11, P88, DOI 10.1016/S0968-8080(03)02163-3; DENAIUD F, 1997, SANTE, V7, P405; DIMENSTEIN G, 2000, MENINAS DA NOITE; Donovan B, 2004, LANCET, V363, P545, DOI 10.1016/S0140-6736(04)15543-8; Donovan B, 2000, SEX TRANSM INFECT, V76, P88, DOI 10.1136/sti.76.2.88; Duckett M, 2001, MIGRANTS RIGHT HLTH; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Feldblum PJ, 2005, SEX TRANSM INFECT, V81, P166, DOI 10.1136/sti.2004.010074; Finger C, 2003, LANCET, V361, P1196, DOI 10.1016/S0140-6736(03)12976-5; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Fontanet AL, 1998, AIDS, V12, P1851, DOI 10.1097/00002030-199814000-00017; Ford K, 2000, INT J STD AIDS, V11, P731, DOI 10.1258/0956462001915156; Ford N, 1999, B WORLD HEALTH ORGAN, V77, P888; Franssen FME, 2002, CLIN NUTR, V21, P1, DOI 10.1054/clnu.2001.0485; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; GEROFI J, 1995, CONTRACEPTION, V52, P223, DOI 10.1016/0010-7824(95)00183-B; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; GIBNEY L, 1999, PREVENTING HIV DEV C; Gilks CF, 1997, AIDS, V11, P911, DOI 10.1097/00002030-199707000-00011; Goldman L., 2000, CECIL TXB MED; Gollub EL, 2000, AM J PUBLIC HEALTH, V90, P1377, DOI 10.2105/AJPH.90.9.1377; *GOV QUEB, 2004, PROST RUE AV; Grayman JH, 2005, AIDS BEHAV, V9, P41, DOI 10.1007/s10461-005-1680-5; Greenberg J, 1998, J WOMENS HEALTH, V7, P587, DOI 10.1089/jwh.1998.7.587; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Hansen H, 2002, J SEX RES, V39, P292, DOI 10.1080/00224490209552153; Harcourt C, 2001, AUST NZ J PUBL HEAL, V25, P84, DOI 10.1111/j.1467-842X.2001.tb00556.x; HEPBURN M, 1993, BRIT MED J, V307, P1370, DOI 10.1136/bmj.307.6916.1370; HILLIER SL, J ACQUIR IMMUNE DEFI, V39, P1; Hilton B A, 2000, Can J Nurs Res, V32, P17; *HLTH CAN, 2002, POP HLTH APPR DET HL; HOLMES KK, 1994, P NATL ACAD SCI USA, V91, P2448, DOI 10.1073/pnas.91.7.2448; Hook Er., 1999, SEX TRANSM DIS; HUNT CW, 1989, J HEALTH SOC BEHAV, V30, P353, DOI 10.2307/2136985; Hutton G, 2003, INT J HEALTH PLAN M, V18, P117, DOI 10.1002/hpm.700; Jenkins C, 2002, AIDS EDUC PREV, V14, P97, DOI 10.1521/aeap.14.4.97.23882; Kerrigan D, 2003, AIDS, V17, P415, DOI 10.1097/00002030-200302140-00016; Khamboonruang C, 1996, SEX TRANSM DIS, V23, P264, DOI 10.1097/00007435-199607000-00003; Kilmarx PH, 1998, AIDS, V12, P1889, DOI 10.1097/00002030-199814000-00021; LENG BH, 2005, INT J STD AIDS, V16, P170; LEWIS M, 1997, SEX DIS SOC COMP HIS; Liao SS, 2003, AIDS EDUC PREV, V15, P109, DOI 10.1521/aeap.15.3.109.23834; LINGE G, 1997, NO PLACE BORDERS HIV; Lowndes CM, 2003, SEX TRANSM DIS, V30, P46, DOI 10.1097/00007435-200301000-00010; Mak R, 2003, SEX TRANSM INFECT, V79, P157, DOI 10.1136/sti.79.2.157; Mardh PA, 1999, EUR J CONTRACEP REPR, V4, P165, DOI 10.3109/13625189909040811; Marseille E, 2001, SOC SCI MED, V52, P135, DOI 10.1016/S0277-9536(00)00282-3; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; Maticka-Tyndale E, 1999, CAN J PUBLIC HEALTH, V90, P19, DOI 10.1007/BF03404092; Merson MH, 2000, AIDS, V14, pS68; Misra G, 2000, Health Hum Rights, V5, P88; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; Morton AN, 2002, SEX TRANSM INFECT, V78, P309, DOI 10.1136/sti.78.4.309; NELSON KE, 1994, AIDS RES HUM RETROV, V10, pS243; Nemoto T, 2004, AIDS BEHAV, V8, P475, DOI 10.1007/s10461-004-7331-4; Ness RB, 2004, AM J PUBLIC HEALTH, V94, P1327, DOI 10.2105/AJPH.94.8.1327; Nessa K, 2005, SEX TRANSM DIS, V32, P13, DOI 10.1097/01.olq.0000148298.26228.74; *NETW SEX WORK PRO, 1997, MAK SEX WORK SAF; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; Ngugi EN BE, 1999, PREVENTING HIV DEV C, P205; O'Connor CA, 1998, AIDS PATIENT CARE ST, V12, P931, DOI 10.1089/apc.1998.12.931; OConnor CC, 1996, GENITOURIN MED, V72, P47; *OP SOC I, INT HARM RED DEV PRO; OVERS C, 1992, AIDS HLTH PROMOT EXC, V1, P1; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Paris M, 1999, SEX TRANSM DIS, V26, P103, DOI 10.1097/00007435-199902000-00008; Patrick DM, 2001, CAN MED ASSOC J, V165, P889; Pauw I, 2003, CULT HEALTH SEX, V5, P465, DOI 10.1080/136910501185198; Pedersen W, 2003, SOC SCI MED, V56, P135, DOI 10.1016/S0277-9536(02)00015-1; Persaud NE, 2000, SEX TRANSM INFECT, V76, P318, DOI 10.1136/sti.76.4.318; PLUMMER FA, 1991, AIDS, V5, pS169; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Pyett PM, 1997, AIDS CARE, V9, P539, DOI 10.1080/713613193; RAMAN S, 1992, AIDS HLTH PROMOT EXC, V1, P6; Rekart ML, 2002, SEX TRANSM INFECT, V78, pI47, DOI 10.1136/sti.78.suppl_1.i47; RIO LM, 1991, ARCH SEX BEHAV, V20, P205, DOI 10.1007/BF01541945; Rojanapithayakorn W, 1995, J Med Assoc Thai, V78, P350; Romero-Daza Nancy, 2003, Med Anthropol, V22, P233; Rugpao S, 1997, J ACQ IMMUN DEF SYND, V14, P169, DOI 10.1097/00042560-199702010-00011; RUNGANGA A, 1992, SOC SCI MED, V35, P1037, DOI 10.1016/0277-9536(92)90243-J; *SCARL ALL AUSTR F, 1999, GUID BEST PRACT OCC; SEIDLIN M, 1993, AIDS, V7, P1247, DOI 10.1097/00002030-199309000-00015; SILBERT MH, 1982, J PSYCHOACTIVE DRUGS, V14, P193, DOI 10.1080/02791072.1982.10471928; Silliman Jael, 2002, POLICING NATL BODY S; Smith RJ, 2005, AIDS, V19, P413, DOI 10.1097/01.aids.0000161771.44276.92; SNELL JG, 1994, HASTINGS LAW J, V45, P1565; Spina M, 1998, SEX TRANSM DIS, V25, P451, DOI 10.1097/00007435-199810000-00001; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; STERN LS, 1991, TRICKS TRADE; TAN ML, 1994, AIDS, V8, pS207; Tawil O, 1999, AIDS, V13, pS239; Thuy NT, 2000, AIDS BEHAV, V4, P93; TROCKI KF, 1991, J ACQ IMMUN DEF SYND, V4, P981; Tuan NA, 2004, SEX TRANSM DIS, V31, P15, DOI 10.1097/01.OLQ.0000105002.34902.B5; UN, 2000, PROT PREV SUPPR PUN; *UNAIDS, 2001, HIV AIDS HUM RIGHTS; *UNAIDS, 2000, PUBL HLTH APPR STD C; *UNAIDS, 2004, REP GLOB HIV AIDS EP; *UNAIDS, 2003, HIV AIDS HUM RIGHTS; UNAIDS, 2001, POP MOB AIDS UNAIDS; *UNAIDS, 2000, INN APPR HIV PREV UN; *UNAIDS, 1997, REF AIDS UNAIDS BEST; UNAIDS, 2002, SEX WORK HIV AIDS; *UNAIDS, 1998, MICR HIV PREV UNAIDS; UNAIDS, 1999, SUMM BOOKL BEST PRAC; UNAIDS, 2000, FEM SEX WORK HIV PRE; *UNFPA IPPF, 2004, INT HIV VOL COUNS TE; *UNICEF E AS PAC, CHILDR EDG; *UNIFEM, 1998, TRAFF WOM CHILDR MEK; *UNIFEM, 1999, UNIFEMS INT WORK GRO; van Griensven GJP, 1998, SEX TRANSM INFECT, V74, P54, DOI 10.1136/sti.74.1.54; VANBEELEN N, 1998, RES SEX WORK; Vanwesenbeeck I, 2002, ANN REV SEX RES, V12, P242; VANWESENBEECK I, 1994, PATIENT EDUC COUNS, V24, P307, DOI 10.1016/0738-3991(94)90074-4; VISRUTARATNA S, 1995, AIDS, V9, pS69; Walker Karen Elizabeth, 2002, J Child Health Care, V6, P182; Wallman S, 2001, HEALTH RISK SOC, V3, P75; Ward H, 1999, SEX TRANSM INFECT, V75, P340, DOI 10.1136/sti.75.5.340; Wawer MJ, 1996, SOC SCI MED, V42, P453, DOI 10.1016/0277-9536(95)00150-6; Weiner A, 1996, SOC WORK, V41, P97, DOI 10.1093/sw/41.1.97; Wendell DA, 2003, INT J STD AIDS, V14, P334, DOI 10.1258/095646203321605549; *WHO, 2002, WHO ORG; *WHO, 2003, HARM RED APPR INJ DR; *WHO, SEX WORK TOOLK; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1; WILLIAMS C, 2000, P 13 INT C AIDS JUL, V2, P241; Williamson C, 2001, WESTERN J NURS RES, V23, P463, DOI 10.1177/01939450122045311; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; Wolffers I, 2003, LANCET, V362, P2019, DOI 10.1016/S0140-6736(03)15026-X; Wolffers I, 2003, LANCET, V361, P1981, DOI 10.1016/S0140-6736(03)13594-5; Wolffers I, 2002, CULT HEALTH SEX, V4, P459, DOI 10.1080/13691050110143356; Wolffers I, 1999, Cult Health Sex, V1, P39, DOI 10.1080/136910599301157; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P1936, DOI 10.1001/jama.263.14.1936; Wong ML, 2003, SEX TRANSM INFECT, V79, P163, DOI 10.1136/sti.79.2.163; *WORKC NEW S WAL, 2001, HLTH SAF GUID BROTH; World Health Organization (WHO), 2001, SEX WORK AS; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329; Yimin C, 2003, INT J GYNECOL OBSTET, V81, P233, DOI 10.1016/S0020-7292(02)00378-8; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147; [No title captured]; 2001, LANCET, V358, P2095	179	341	343	0	96	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2123	2134		10.1016/S0140-6736(05)67732-X	http://dx.doi.org/10.1016/S0140-6736(05)67732-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996AE	16360791				2022-12-28	WOS:000234146000029
J	Krause, J; Dear, PH; Pollack, JL; Slatkin, M; Spriggs, H; Barnes, I; Lister, AM; Ebersberger, I; Paabo, S; Hofreiter, M				Krause, J; Dear, PH; Pollack, JL; Slatkin, M; Spriggs, H; Barnes, I; Lister, AM; Ebersberger, I; Paabo, S; Hofreiter, M			Multiplex amplification of the mammoth mitochondrial genome and the evolution of Elephantidae	NATURE			English	Article							DNA-SEQUENCES; PHYLOGENETIC INFERENCE; CYTOCHROME-B; ANCIENT DNA; CLOCK	In studying the genomes of extinct species, two principal limitations are typically the small quantities of endogenous ancient DNA and its degraded condition(1), even though products of up to 1,600 base pairs ( bp) have been amplified in rare cases(2). Using small overlapping polymerase chain reaction products, longer stretches of sequences or even whole mitochondrial genomes(3,4) can be reconstructed, but this approach is limited by the number of amplifications that can be performed from rare samples. Thus, even from well-studied Pleistocene species such as mammoths, ground sloths and cave bears, no DNA sequences of more than about 1,000 bp have been reconstructed(5-7). Here we report the complete mitochondrial genome sequence of the Pleistocene woolly mammoth Mammuthus primigenius. We used about 200 mg of bone and a new approach that allows the simultaneous retrieval of multiple sequences from small amounts of degraded DNA. Our phylogenetic analyses show that the mammoth was more closely related to the Asian than to the African elephant. However, the divergence of mammoth, African and Asian elephants occurred over a short time, corresponding to only about 7% of the total length of the phylogenetic tree for the three evolutionary lineages.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; UCL, Dept Biol, London WC1E 6BT, England; Univ Dusseldorf, WE Informat, D-40225 Dusseldorf, Germany	Max Planck Society; MRC Laboratory Molecular Biology; University of California System; University of California Berkeley; University of London; University College London; Heinrich Heine University Dusseldorf	Hofreiter, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.	hofreiter@eva.mpg.de	Barnes, Ian C/B-8081-2008; Krause, Johannes/E-6640-2015; Dear, Paul H/A-1162-2012; Krause, Johannes/AFP-2642-2022; Hofreiter, Michael/A-3996-2017	Barnes, Ian C/0000-0001-8322-6918; Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Hofreiter, Michael/0000-0003-0441-4705; Lister, Adrian/0000-0002-7985-138X	MRC [MC_U105131672] Funding Source: UKRI; Medical Research Council [MC_U105131672] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Debruyne R, 2003, MOL PHYLOGENET EVOL, V26, P421, DOI 10.1016/S1055-7903(02)00292-0; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Felsenstein J., 2004, INFERRING PHYLOGENIE, P196; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Nei M., 1986, Progress in Clinical and Biological Research, V218, P133; Noro M, 1998, J MOL EVOL, V46, P314, DOI 10.1007/PL00006308; Ozawa T, 1997, J MOL EVOL, V44, P406, DOI 10.1007/PL00006160; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; TAJIMA F, 1993, GENETICS, V135, P599; TAJIMA F, 1983, GENETICS, V105, P437; Tassy Pascal, 2003, P331; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Yang H, 1996, P NATL ACAD SCI USA, V93, P1190, DOI 10.1073/pnas.93.3.1190	29	161	185	2	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					724	727		10.1038/nature04432	http://dx.doi.org/10.1038/nature04432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16362058				2022-12-28	WOS:000235193100044
J	Dunlap, JC				Dunlap, JC			Running a clock requires quality time together	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; DROSOPHILA; PERIOD; PHOSPHORYLATION; RHYTHMS		Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Dunlap, JC (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NIGMS NIH HHS [R01 GM034985] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cardone L, 2003, NAT CELL BIOL, V5, P859, DOI 10.1038/ncb1003-859; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; DUNLAP JC, 2004, CHRONOBIOLOGY BIOL T, P210; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Menaker M., 1971, BIOCHRONOMETRY; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 2003, MOL BIOL CIRCADIAN R; Shafer OT, 2002, J NEUROSCI, V22, P5946; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499	17	16	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					184	186		10.1126/science.1122839	http://dx.doi.org/10.1126/science.1122839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410512				2022-12-28	WOS:000234722200027
J	MacRae, IJ; Zhou, KH; Li, F; Repic, A; Brooks, AN; Cande, WZ; Adams, PD; Doudna, JA				MacRae, IJ; Zhou, KH; Li, F; Repic, A; Brooks, AN; Cande, WZ; Adams, PD; Doudna, JA			Structural basis for double-stranded RNA processing by dicer	SCIENCE			English	Article							COLI RIBONUCLEASE-III; CRYSTAL-STRUCTURE; INTERFERENCE; INITIATION; BINDING; MECHANISM; SUBSTRATE; MICRORNA; DOMAIN; IONS	The specialized ribonuclease Dicer initiates RNA interference by cleaving double-stranded RNA (dsRNA) substrates into small fragments about 25 nucleotides in length. In the crystal structure of an intact Dicer enzyme, the PAZ domain, a module that binds the end of dsRNA, is separated from the two catalytic ribonuclease III (RNase III) domains by a flat, positively charged surface. The 65 angstrom distance between the PAZ and RNase III domains matches the length spanned by 25 base pairs of RNA. Thus, Dicer itself is a molecular ruler that recognizes dsRNA and cleaves a specified distance from the helical end.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Adams, Paul David/A-1977-2013; Brooks, Angela/B-6173-2011	Adams, Paul David/0000-0001-9333-8219; Li, Fei/0000-0002-1206-9684				AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Akey DL, 2005, PROTEIN SCI, V14, P2744, DOI 10.1110/ps.051665905; Baulcombe D, 2002, TRENDS MICROBIOL, V10, P306, DOI 10.1016/S0966-842X(02)02387-9; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chang JH, 2003, J VIROL, V77, P11910, DOI 10.1128/JVI.77.22.11910-11917.2003; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MACRAE IJ, UNPUB; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; REPIC A, UNPUB; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Sun W, 2005, NUCLEIC ACIDS RES, V33, P807, DOI 10.1093/nar/gki197; Sun WM, 2001, BIOCHEMISTRY-US, V40, P14976, DOI 10.1021/bi011570u; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Zamore PD, 2001, MOL CELL, V8, P1158, DOI 10.1016/S1097-2765(01)00418-X; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	38	657	732	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					195	198		10.1126/science.1121638	http://dx.doi.org/10.1126/science.1121638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410517				2022-12-28	WOS:000234722200032
J	Meyer, P; Saez, L; Young, MW				Meyer, P; Saez, L; Young, MW			PER-TIM interactions in living Drosophila cells: An interval timer for the circadian clock	SCIENCE			English	Article							TIMELESS PROTEIN; NUCLEAR ENTRY; MELANOGASTER; TRANSCRIPTION; DOUBLETIME; GENETICS; KINASES; LOOP	In contrast to current models, fluorescence resonance energy transfer measurements using a single-cell imaging assay with fluorescent forms of PER and TIM showed that these proteins bind rapidly and persist in the cytoplasm while gradually accumulating in discrete foci. After similar to 6 hours, complexes abruptly dissociated, as PER and TIM independently moved to the nucleus in a narrow time frame. The per(L) mutation delayed nuclear accumulation in vivo and in our cultured cell system, but without affecting rates of PER/TIM assembly or dissociation. This finding points to a previously unrecognized form of temporal regulation that underlies the periodicity of the circadian clock.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIGMS NIH HHS [GM54339] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chang DC, 2003, CURR BIOL, V13, P758, DOI 10.1016/S0960-9822(03)00286-0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 2004, DEV CELL, V6, P160, DOI 10.1016/S1534-5807(04)00030-9; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Hall JC, 2005, METHOD ENZYMOL, V393, P61, DOI 10.1016/S0076-6879(05)93004-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	22	134	139	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					226	229		10.1126/science.1118126	http://dx.doi.org/10.1126/science.1118126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410523				2022-12-28	WOS:000234722200041
J	Szabadics, J; Varga, C; Molnar, G; Olah, S; Barzo, P; Tamas, G				Szabadics, J; Varga, C; Molnar, G; Olah, S; Barzo, P; Tamas, G			Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits	SCIENCE			English	Article							ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; IN-VIVO; CORTEX; GABA; HIPPOCAMPUS; RESPONSES; RAT; INTERNEURONS; INHIBITION	Axons in the cerebral cortex receive synaptic input at the axon initial segment almost exclusively from gamma-aminobutyric acid-releasing (GABAergic) axo-axonic cells (AACs). The axon has the lowest threshold for action potential generation in neurons; thus, AACs are considered to be strategically placed inhibitory neurons controlling neuronal output. However, we found that AACs can depolarize pyramidal cells and can initiate stereotyped series of synaptic events in rat and human cortical networks because of a depolarized reversal potential for axonal relative to perisomatic GABAergic inputs. Excitation and signal propagation initiated by AACs is supported by the absence of the potassium chloride cotransporter 2 in the axon.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Univ Szeged, Dept Neurosurg, H-6726 Szeged, Hungary	Szeged University; Szeged University	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozep Fasor 52, H-6726 Szeged, Hungary.	gtamas@bio.u-szeged.hu	Molnar, Gabor/L-8415-2018; Tamas, Gabor/AAG-9305-2020	Molnar, Gabor/0000-0001-7959-139X; Tamas, Gabor/0000-0002-7905-6001; Szabadics, Janos/0000-0002-4968-2562; Varga, Csaba/0000-0002-9188-1282	PHS HHS [N535915] Funding Source: Medline; Wellcome Trust Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Abeles M., 1991, CORTICONICS; ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; Chavas J, 2003, J NEUROSCI, V23, P2019; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gulacsi A, 2003, J NEUROSCI, V23, P8237; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	28	415	421	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					233	235		10.1126/science.1121325	http://dx.doi.org/10.1126/science.1121325			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410524				2022-12-28	WOS:000234722200043
J	Shatz, CJ				Shatz, CJ			Lawrence C. Katz (1956-2005) - Obituary	NATURE			English	Biographical-Item									Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 25 Shattuck St, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					152	152		10.1038/439152a	http://dx.doi.org/10.1038/439152a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407942	Bronze			2022-12-28	WOS:000234538400028
J	Clark, JM				Clark, JM			Paleontology - A different kind of croc	SCIENCE			English	Editorial Material							CHINA		George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Clark, JM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jclark@gwu.edu						BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Clark JM, 2004, NATURE, V430, P1021, DOI 10.1038/nature02802; Fraas E., 1902, PALAEONTOGRAPHICA, V49, P1; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Langston W. Jr., 1973, P263; WU XC, 1995, NATURE, V376, P678, DOI 10.1038/376678a0	6	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2006	311	5757					43	44		10.1126/science.1122245	http://dx.doi.org/10.1126/science.1122245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400137				2022-12-28	WOS:000234546300024
J	Marris, E				Marris, E			More than just hot air?	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2006	439	7072					17	17		10.1038/439017a	http://dx.doi.org/10.1038/439017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397475	Bronze			2022-12-28	WOS:000234378700011
J	van de Beek, D; de Gans, J; Tunkel, AR; Wijdicks, EFM				van de Beek, D; de Gans, J; Tunkel, AR; Wijdicks, EFM			Current concepts: Community-acquired bacterial meningitis in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESISTANT STREPTOCOCCUS-PNEUMONIAE; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; PNEUMOCOCCAL MENINGITIS; PROGNOSTIC-FACTORS; LUMBAR PUNCTURE; COMPLICATIONS; DEXAMETHASONE; PATHOGENESIS		Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam, NL-1100 DD Amsterdam, Netherlands; Monmouth Med Ctr, Dept Med, Long Branch, NJ USA; Mayo Clin, Coll Med, Div Crit Care Neurol, Dept Neurol, Rochester, MN USA	University of Amsterdam; Academic Medical Center Amsterdam; Mayo Clinic	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol H2, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019; van de beek, diederik/A-2935-2010	van de Beek, Diederik/0000-0002-4571-044X; 				Angstwurm K, 2000, J CEREBR BLOOD F MET, V20, P834, DOI 10.1097/00004647-200005000-00010; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; DILL SR, 1995, CLIN INFECT DIS, V20, P372, DOI 10.1093/clinids/20.2.372; DINUBILE MJ, 1990, J INFECT DIS, V161, P1216, DOI 10.1093/infdis/161.6.1216; DODGE PR, 1965, NEW ENGL J MED, V272, P954, DOI 10.1056/NEJM196505062721806; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Fishman RA., 1992, CEREBROSPINAL FLUID; FRASER A, 2005, COCHRANE DB SYST REV, V1; Gates GA, 2003, NEW ENGL J MED, V349, P421, DOI 10.1056/NEJMp038107; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Hussein AS, 2000, MEDICINE, V79, P360, DOI 10.1097/00005792-200011000-00002; Jiang XN, 2004, EXP NEUROL, V190, P224, DOI 10.1016/j.expneurol.2004.07.010; Kastenbauer S, 2004, EUR J PHARMACOL, V504, P235, DOI 10.1016/j.ejphar.2004.10.001; Kastenbauer S, 2004, EUR J PHARMACOL, V498, P315, DOI 10.1016/j.ejphar.2004.07.081; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; KLUGMAN KP, 1995, ANTIMICROB AGENTS CH, V39, P1988, DOI 10.1128/AAC.39.9.1988; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; Lorenzl S, 1996, CRIT CARE MED, V24, P1874, DOI 10.1097/00003246-199611000-00018; Lutsar I, 2003, J ANTIMICROB CHEMOTH, V52, P651, DOI 10.1093/jac/dkg417; Mitchell WG, 1996, EPILEPSIA, V37, pS74, DOI 10.1111/j.1528-1157.1996.tb06025.x; Moller K, 2000, STROKE, V31, P1116, DOI 10.1161/01.STR.31.5.1116; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; OATESWHITEHEAD RM, 2005, COCHRANE DB SYST REV, V3; Oliver WJ, 2003, PEDIATRICS, V112, pE174, DOI 10.1542/peds.112.3.e174; Paul R, 2000, CRIT CARE MED, V28, P2552, DOI 10.1097/00003246-200007000-00060; PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; RADSTROM P, 1994, J CLIN MICROBIOL, V32, P2738; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Sigurdardottir B, 1997, ARCH INTERN MED, V157, P425, DOI 10.1001/archinte.157.4.425; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Swartz MN, 2004, NEW ENGL J MED, V351, P1826, DOI 10.1056/NEJMp048246; TAUBER MG, 1993, J INFECT DIS, V168, P473, DOI 10.1093/infdis/168.2.473; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; TUNKEL AR, 2001, BACTERIAL MENINGITIS; van Crevel H, 2002, J NEUROL, V249, P129, DOI 10.1007/PL00007855; van de Beek D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub2; van de Beek D, 2005, NEW ENGL J MED, V352, P950; van de Beek D, 2005, NEW ENGL J MED, V352, P514; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2002, J INFECT DIS, V186, P1047, DOI 10.1086/344229; van de Beek D, 2002, J ANTIMICROB CHEMOTH, V49, P661, DOI 10.1093/jac/49.4.661; van de Beek D, 2004, ANN INTERN MED, V141, P327, DOI 10.7326/0003-4819-141-4-200408170-00028; VILADRICH PF, 1991, ANTIMICROB AGENTS CH, V35, P2467, DOI 10.1128/AAC.35.12.2467; Weststrate W, 1996, LANCET, V347, P399, DOI 10.1016/S0140-6736(96)90577-2; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; WIJDICKS EFM, 2003, CLIN PRACTICE CRITIC; Winkler F, 2002, J NEUROL, V249, P1292, DOI 10.1007/s00415-002-0844-8	63	503	516	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					44	53		10.1056/NEJMra052116	http://dx.doi.org/10.1056/NEJMra052116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394301				2022-12-28	WOS:000234358600007
J	Cameron, SM				Cameron, SM			Cinderella revisited	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BALL; CARE	Objective To examine the references to Cinderella in medical literature. Design Analysis of papers published in the past 50 years that mention Cinderella. Results The trend for use of Cinderella as a metaphor in medical publications is increasing exponentially. Five separate themes emerged: neglect, identity, transformation, exhaustion, and the mixed metaphor. Conclusions The medical use of the Cinderella fable is growing in popularity.	Dalhousie Univ, Dept Family Med, Halifax, NS B3H 2E2, Canada	Dalhousie University	Cameron, SM (corresponding author), Dalhousie Univ, Dept Family Med, 5909 Vet Mem Lane, Halifax, NS B3H 2E2, Canada.	Stewart.Cameron@Dal.Ca						BERKOW SG, 1954, OBSTET GYNECOL, V3, P222; BOTTONE EJ, 1977, MT SINAI J MED, V44, P42; Briscoe T, 1990, Nurs Stand, V4, P26; Brown P, 2001, NATURE, V410, P1018, DOI 10.1038/35074279; CARPENTER H, 1984, OXFORD COMPANION CHI, P118; Castledine G, 1993, Br J Nurs, V2, P381; Cirino G, 2003, TRENDS PHARMACOL SCI, V24, P91, DOI 10.1016/S0165-6147(02)00049-4; Crombie IK, 2000, BMJ-BRIT MED J, V320, P392, DOI 10.1136/bmj.320.7232.392; de Gaetano G, 2001, HAEMATOLOGICA, V86, P349; DELOSREYES TM, 2003, REV ENFERM, V26, P54; DIETZ JMB, 2005, ATEN PRIM, V36, P53; Eisen T, 2005, EUR J CANCER, V41, P1106, DOI 10.1016/j.ejca.2005.01.008; Funder JW, 1999, J CLIN ENDOCR METAB, V84, P393, DOI 10.1210/jc.84.2.393; GIORDANO C, 1978, INT J ARTIF ORGANS, V1, P3; GOODWIN J, 1980, AM J PSYCHIAT, V137, P1223; Graziottin A, 2001, Climacteric, V4, P4, DOI 10.1080/713605029; HARLEY JMG, 1992, ULSTER MED J, V61, P75; Hazelton L, 2004, CAN MED ASSOC J, V171, P1495, DOI 10.1503/cmaj.1041466; Jenkins HS, 2005, ANN EMERG MED, V45, P333, DOI 10.1016/j.annemergmed.2004.09.004; Konner K, 1999, NEPHROL DIAL TRANSPL, V14, P2094, DOI 10.1093/ndt/14.9.2094; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Lefurgy S, 2004, CHEM BIOL, V11, P151, DOI 10.1016/j.chembiol.2004.02.005; MASTROFRANCESCO S, 1986, PREV ASSIST DENT, V12, P50; Maurissen JPJ, 1997, NEUROTOXICOLOGY, V18, P41; MILLS A, 1992, TRENDS PHARMACOL SCI, V13, P399, DOI 10.1016/0165-6147(92)90122-M; Norman A, 1983, Nurs Mirror, V156, P16; Pond CM, 2000, POSTGRAD MED J, V76, P671, DOI 10.1136/pmj.76.901.671; PRESAS JMM, 1993, MED CLIN-BARCELONA, V101, P253; Przemeck M, 2005, ANASTH INTENSIV NOTF, V40, P327, DOI 10.1055/s-2005-870111; Saikku P, 2000, Duodecim, V116, P241; Schwartz RA, 2004, INT J DERMATOL, V43, P230, DOI 10.1111/j.1365-4632.2004.02001.x; Scoble JE, 1996, NEPHROL DIAL TRANSPL, V11, P1516; Solaro RJ, 2000, CIRC RES, V87, P173, DOI 10.1161/01.RES.87.3.173; Wilson Joy, 2004, Manag Care, V13, P13; Zennaro D, 2003, J ELECTROMYOGR KINES, V13, P113, DOI 10.1016/S1050-6411(02)00066-4; Zhang SG, 2003, NAT REV GENET, V4, P243, DOI 10.1038/nrg1054	36	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1543	1544C		10.1136/bmj.331.7531.1543	http://dx.doi.org/10.1136/bmj.331.7531.1543			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373746	Green Published, Bronze			2022-12-28	WOS:000234351300027
J	Lim, MSC; Hellard, ME; Aitken, CK				Lim, MSC; Hellard, ME; Aitken, CK			The case of the disappearing teaspoons: longitudinal cohort study of the displacement of teaspoons in an Australian research instittite	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine die overall rate of loss of workplace teaspoons and whether attrition and displacernent are correlated with the relative value of the teaspoons or type of tearoom. Design Longitudinal cohort study. Setting Research institute employing about 140 people. Subjects 70 discreetly numbered teaspoons placed in tearooms around the institute and observed weekly over five months. Main outcome measures Incidence of teaspoon loss per 100 teaspoon years and teaspoon half life. Results 56 (80%) of the 70 teaspoons disappeared during the study The half life of the teaspoons was 81 days. The half life of teaspoons in communal tearooms (42 days) was significantly shorter than for those in rooms associated with particular research groups (77 days). The rate of loss was not influenced by the teaspoons' value. The incidence of teaspoon loss over the period of observation was 360.62 per 100 teaspoon years. At this rate, an estimated 250 teaspoons would need to be purchased annually to maintain a practical institute-wide population of 70 teaspoons. Conclusions The loss of workplace teaspoons was rapid, showing that their availability, and hence office culture in general, is constantly threatened.	Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Epidemiol & Populat Hlth Res, Melbourne, Vic 3001, Australia	Burnet Institute	Aitken, CK (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Epidemiol & Populat Hlth Res, GPO Box 2284, Melbourne, Vic 3001, Australia.	aitken@burnet.edu.au		Aitken, Campbell/0000-0002-0923-4837				ADAMS D, 1979, HITCHHIKERS GUIDE GA, P320; *BLUE WHAL, AM CET SOC FACTSH; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; JENNINGS PE, 1948, NY TIMES MAGAZI 0613, P19; *M TECH NAT CONS T, PREL ASS CONS STAT M	5	10	10	0	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1498	1500		10.1136/bmj.331.7531.1498	http://dx.doi.org/10.1136/bmj.331.7531.1498			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373727	Green Published, Bronze			2022-12-28	WOS:000234351300007
J	Sherman, KJ; Cherkin, DC; Erro, J; Miglioretti, DL; Deyo, RA				Sherman, KJ; Cherkin, DC; Erro, J; Miglioretti, DL; Deyo, RA			Comparing yoga, exercise, and a self-care book for chronic low back pain - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							IMPORTANT DIFFERENCE; NATIONAL-SURVEY; HATHA YOGA; THERAPY; OUTCOMES; DISABILITY; PATTERNS	Background: Chronic low back pain is a common problem that has only modestly effective treatment options. Objective: To determine whether yoga is more effective than conventional therapeutic exercise or a self-care book for patients with chronic low back pain. Design: Randomized, controlled trial. Setting: A nonprofit, integrated health care system. Patients: 101 adults with chronic low back pain. Intervention: 12-week sessions of yoga or conventional therapeutic exercise classes or a self-care book. Measurements: Primary outcomes were back-related functional status (modified 24-point Roland Disability Scale) and "bothersomeness" of pain (11-point numerical scale). The primary time point was 12 weeks. Clinically significant change was considered to be 2.5 points on the functional status scale and 1.5 points on the bothersomeness scale. Secondary outcomes were days of restricted activity, general health status, and medication use. Results: After adjustment for baseline values, back-related function in the yoga group was superior to the book and exercise groups at 12 weeks (yoga vs. book: mean difference, -3.4 [95% CI, -5.1 to - 1.6] [P < 0.001]; yoga vs. exercise: mean difference, -1.8 [CI, -3.5 to - 0.1] [P = 0.034]). No significant differences in symptom bothersomeness were found between any 2 groups at 12 weeks; at 26 weeks, the yoga group was superior to the book group with respect to this measure (mean difference, -2.2 [CI, -3.2 to - 1.2]; P < 0.001). At 26 weeks, back-related function in the yoga group was superior to the book group (mean difference, -3.6 [CI, -5.4 to - 1.8]; P < 0.001). Conclusions: Yoga was more effective than a self-care book for improving function and reducing chronic low back pain, and the benefits persisted for at least several months.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle	Sherman, KJ (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	Sherman.k@ghc.org			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT001215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048093] Funding Source: NIH RePORTER; NCCIH NIH HHS [R21AT 001215] Funding Source: Medline; NIAMS NIH HHS [P60AR48093] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALDWIN MC, 1999, DISS ABSTR INT A, V60, P1031; Barnes Patricia M, 2004, Adv Data, P1; Bogduk N, 2004, MED J AUSTRALIA, V180, P79, DOI 10.5694/j.1326-5377.2004.tb05805.x; Bombardier C, 2001, J RHEUMATOL, V28, P431; Cherkin DC, 1996, SPINE, V21, P2900, DOI 10.1097/00007632-199612150-00023; DEYO RA, 1988, ARCH PHYS MED REHAB, V69, P1044; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Galantino ML, 2004, ALTERN THER HEALTH M, V10, P56; GOLBUS S, 2000, CURRENT HLTH, V2, P30; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Jacobs BP, 2004, ALTERN THER HEALTH M, V10, P80; Kraftsow, 1999, YOGA WELLNESS; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Liddle SD, 2004, PAIN, V107, P176, DOI 10.1016/j.pain.2003.10.017; MOORE JEL, 1999, BACK PAIN HELPBOOK; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; RIESS P, 1986, 861584 PHS; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Sovik R, 2000, PROG BRAIN RES, V122, P491; SPILNER M, 1999, PREVENTION       FEB, P53; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Williams K, 2003, INT J YOGA THER, V13, P55; Williams KA, 2005, PAIN, V115, P107, DOI 10.1016/j.pain.2005.02.016; Wolsko PM, 2003, SPINE, V28, P292, DOI 10.1097/00007632-200302010-00018; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2001, NURSING, V31, P20; 1998, HARV HLTH LETT, V24, P4	32	290	297	3	80	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					849	856		10.7326/0003-4819-143-12-200512200-00003	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995CL	16365466				2022-12-28	WOS:000234077400001
J	Armstrong, N; Welsman, J				Armstrong, N; Welsman, J			Essay - Physiology of the child athlete	LANCET			English	Article									Univ Exeter, Childrens Hlth & Exercise Res Ctr, Exeter EX1 2LU, Devon, England	University of Exeter	Armstrong, N (corresponding author), Univ Exeter, Childrens Hlth & Exercise Res Ctr, Exeter EX1 2LU, Devon, England.	N.Armstrong@exeter.ac.uk						Armstrong N, 2000, PAEDIAT EXERCISE SCI; Armstrong N., 1997, YOUNG PEOPLE PHYS AC; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003	3	11	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S44	S45		10.1016/S0140-6736(05)67845-2	http://dx.doi.org/10.1016/S0140-6736(05)67845-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360750				2022-12-28	WOS:000234374400028
J	van Mechelen, W; Verhagen, E				van Mechelen, W; Verhagen, E			Essay - Injury prevention in young people - time to accept responsibility	LANCET			English	Article									VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Dept Publ & Occupat Hlth, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Mechelen, W (corresponding author), VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	w.vanmechelen@vumc.nl	van Mechelen, Willem/C-8463-2013; Verhagen, Evert/A-1502-2013	Verhagen, Evert/0000-0001-9227-8234; van Mechelen, Willem/0000-0001-7136-6382					0	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S46	S46		10.1016/S0140-6736(05)67846-4	http://dx.doi.org/10.1016/S0140-6736(05)67846-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360751				2022-12-28	WOS:000234374400029
J	Zinsstag, J; Schelling, E; Wyss, K; Mahamat, MB				Zinsstag, J; Schelling, E; Wyss, K; Mahamat, MB			Potential of cooperation between human and animal health to strengthen health systems	LANCET			English	Editorial Material							Q-FEVER; BRUCELLOSIS; LIVESTOCK; INFLUENZA; MEDICINE; DISEASE		Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; Swiss Trop Inst, Swiss Ctr Int Hlth, CH-4002 Basel, Switzerland; Ctr Support Sante Int, NDjamena, Chad	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Zinsstag, J (corresponding author), Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland.	jakob.zinsstag@unibas.ch	Zinsstag, Jakob/A-8317-2008; Schelling, Esther/K-7990-2015	Zinsstag, Jakob/0000-0002-8899-6097; Schelling, Esther/0000-0001-6444-0898; Wyss, Kaspar/0000-0003-0156-5989				*AFR UN INT BUR AF, 2003, COMM BAS AN HLTH WOR; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2004, STRENGTHENING HLTH S; [Anonymous], [No title captured]; Bechir M, 2004, Med Trop (Mars), V64, P497; Bertollini R, 2004, B WORLD HEALTH ORGAN, V82, P322; Braine T, 2005, B WORLD HEALTH ORGAN, V83, P7; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343; DRIESCH A, 2003, GESCH TIERMEDIZIN; Karesh WB, 2005, FOREIGN AFF, V84, P38, DOI 10.2307/20034419; Karesh WB, 2002, CONSERV BIOL, V16, P1432, DOI 10.1046/j.1523-1739.2002.01443.x; Klempner MS, 2004, NEW ENGL J MED, V350, P1171, DOI 10.1056/NEJMp048039; Lebel J., 2002, HLTH ECOSYSTEM APPRO; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; *NAT LIB MED, FIND AID CW SCHWAB P; Osofsky S. A., 2005, CONSERVATION DEV INT; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Ruegg W, 2004, HIST U EUROPE; Saunders LZ, 2000, VET PATHOL, V37, P199, DOI 10.1354/vp.37-3-199; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Schwabe CW., 1984, VET MED HUMAN HLTH, V3rd; SILKIN T, 2005, VET SERVICES HORN AF; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Tan-Torres ET, 2003, MAKING CHOICES HLTH; Tanner M, 2005, B WORLD HEALTH ORGAN, V83, P403; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Weiss M.G., 2001, ANTHROPOL MED, V8, P5, DOI [10.1080/13648470120070980, DOI 10.1080/13648470120070980]; *WHO, MIN SUMM HLTH RES; *WHO REG OFF EUR, EC INF DIS; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017; Zinsstag J, 2001, SCIENCE, V294, P477, DOI 10.1126/science.294.5542.477; 1994, LIVING UNCERTAINTY N; WORLD REPORT KNOWLED	37	170	177	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2142	2145		10.1016/S0140-6736(05)67731-8	http://dx.doi.org/10.1016/S0140-6736(05)67731-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996AE	16360795				2022-12-28	WOS:000234146000033
J	Chipman, A				Chipman, A			All systems go	NATURE			English	News Item																			0	1	1	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					136	137		10.1038/439136a	http://dx.doi.org/10.1038/439136a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407925				2022-12-28	WOS:000234538400015
J	Franks, NR; Richardson, T				Franks, NR; Richardson, T			Teaching in tandem-running ants	NATURE			English	Editorial Material							LEPTOTHORAX; NAVIGATION; EMIGRATION		Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Franks, NR (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	nigel.franks@bristol.ac.uk	Franks, Nigel/AAG-8207-2019; Richardson, Thomas/H-9898-2019	Franks, Nigel/0000-0001-8139-9604; Richardson, Thomas/0000-0002-0220-4897				CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Galef BG, 2005, ANIM BEHAV, V70, P91, DOI 10.1016/j.anbehav.2004.12.004; Holldobler B., 1990, pi; McLeman MA, 2002, INSECT SOC, V49, P203, DOI 10.1007/s00040-002-8302-2; MOGLICH M, 1974, SCIENCE, V186, P1046, DOI 10.1126/science.186.4168.1046; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Moglich M., 1974, Psyche Camb, V81, P219, DOI 10.1155/1974/25763; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2001, ETHOLOGY, V107, P1125, DOI 10.1046/j.1439-0310.2001.00749.x; SHETTLEWORTH SJ, 1998, COGNITION EVOLUTION, P475	10	248	258	5	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					153	153		10.1038/439153a	http://dx.doi.org/10.1038/439153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407943	Bronze			2022-12-28	WOS:000234538400029
J	Phan, TD; Gosling, JT; Davis, MS; Skoug, RM; Oieroset, M; Lin, RP; Lepping, RP; McComas, DJ; Smith, CW; Reme, H; Balogh, A				Phan, TD; Gosling, JT; Davis, MS; Skoug, RM; Oieroset, M; Lin, RP; Lepping, RP; McComas, DJ; Smith, CW; Reme, H; Balogh, A			A magnetic reconnection X-line extending more than 390 Earth radii in the solar wind	NATURE			English	Article							MAGNETOPAUSE; PLASMA	Magnetic reconnection in a current sheet converts magnetic energy into particle energy, a process that is important in many laboratory(1), space(2,3) and astrophysical contexts(4-6). It is not known at present whether reconnection is fundamentally a process that can occur over an extended region in space or whether it is patchy and unpredictable in nature(7). Frequent reports of small-scale flux ropes and flow channels associated with reconnection(8-13) in the Earth's magnetosphere raise the possibility that reconnection is intrinsically patchy, with each reconnection X-line ( the line along which oppositely directed magnetic field lines reconnect) extending at most a few Earth radii (R-E), even though the associated current sheets span many tens or hundreds of R-E. Here we report three-spacecraft observations of accelerated flow associated with reconnection in a current sheet embedded in the solar wind flow, where the reconnection X-line extended at least 390R(E) ( or 2.5 x 10(6) km). Observations of this and 27 similar events imply that reconnection is fundamentally a large-scale process. Patchy reconnection observed in the Earth's magnetosphere is therefore likely to be a geophysical effect associated with fluctuating boundary conditions, rather than a fundamental property of reconnection. Our observations also reveal, surprisingly, that reconnection can operate in a quasi-steady-state manner even when undriven by the external flow.	Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; NASA, Goddard Space Flight Ctr, Lab Solar & Space Phys, Greenbelt, MD 20771 USA; SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78228 USA; Univ New Hampshire, Dept Phys, Durham, NH 03824 USA; Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; Ctr Etud Spatiale Rayonnements, F-31029 Toulouse, France; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BZ, England	University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Southwest Research Institute; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Imperial College London	Phan, TD (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	phan@ssl.berkeley.edu	McComas, David J/H-6202-2011; Balogh, Andre/GZK-2076-2022	McComas, David J/0000-0001-6160-1158; Skoug, Ruth/0000-0003-1991-2643				Cowley S. W. H., 1984, GEOPHYS MONOGR SER, V30, P375, DOI DOI 10.1029/GM030P0375; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Frey HU, 2003, NATURE, V426, P533, DOI 10.1038/nature02084; Fuselier SA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900165; Gosling JT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022406; Gosling JT, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010809; GOSLING JT, 1982, J GEOPHYS RES-SPACE, V87, P2147, DOI 10.1029/JA087iA04p02147; HUDSON PD, 1970, PLANET SPACE SCI, V18, P1611, DOI 10.1016/0032-0633(70)90036-X; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kronberg PP, 2002, PHYS TODAY, V55, P40, DOI 10.1063/1.1537911; Louarn P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020625; Nakamura R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019558; NISHIDA A, 1989, GEOPHYS RES LETT, V16, P227, DOI 10.1029/GL016i003p00227; Owen CJ, 2001, ANN GEOPHYS-GERMANY, V19, P1509, DOI 10.5194/angeo-19-1509-2001; PARE VK, 1984, GEOPHYS MONOGR SER, V30, P341; PASCHMANN G, 1982, J GEOPHYS RES-SPACE, V87, P2159, DOI 10.1029/JA087iA04p02159; PASCHMANN G, 1986, J GEOPHYS RES, V91, P1099, DOI 10.1029/JA091iA10p11099; Petschek H.E., 1964, NASA SPECIAL PUBLICA, VVol. 50, P425; Phan TD, 2004, ANN GEOPHYS-GERMANY, V22, P2355, DOI 10.5194/angeo-22-2355-2004; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pinnock M, 2003, ANN GEOPHYS-GERMANY, V21, P1467, DOI 10.5194/angeo-21-1467-2003; Priest E.R, 1984, GMS, V30, P63; RUSSELL CT, 1978, SPACE SCI REV, V22, P681, DOI 10.1007/BF00212619; SONNERUP BU, 1974, J GEOPHYS RES, V79, P1546, DOI 10.1029/JA079i010p01546; SONNERUP BU, 1967, J GEOPHYS RES, V72, P171, DOI 10.1029/JZ072i001p00171; Sonnerup BUO, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020134	26	231	238	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					175	178		10.1038/nature04393	http://dx.doi.org/10.1038/nature04393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407946				2022-12-28	WOS:000234538400033
J	Bos, JD; de Korte, J				Bos, JD; de Korte, J			Effects of etanercept on quality of life, fatigue, and depression in psoriasis	LANCET			English	Editorial Material									Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1100 DE Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Bos, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1100 DE Amsterdam, Netherlands.	j.d.bos@amc.uva.nl						Boehncke WH, 2005, EXP DERMATOL, V14, P70, DOI 10.1111/j.0906-6705.2005.290b.x; Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; Chren MM, 1997, ARCH DERMATOL, V133, P1433, DOI 10.1001/archderm.133.11.1433; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; de Korte J, 2002, ARCH DERMATOL, V138, P1221, DOI 10.1001/archderm.138.9.1221; Devrimci-Ozguven H, 2000, J EUR ACAD DERMATOL, V14, P267, DOI 10.1046/j.1468-3083.2000.00085.x; Feldman SR, 2005, J AM ACAD DERMATOL, V53, P887, DOI 10.1016/j.jaad.2005.06.053; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; Keller S., 1994, SF36 PHYS MENTAL HLT; Pacan P, 2003, DERMATOLOGIE PSYCHOS, V4, P142; Sterry W, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06070.x; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X	12	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					6	7		10.1016/S0140-6736(05)67818-X	http://dx.doi.org/10.1016/S0140-6736(05)67818-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399133				2022-12-28	WOS:000234443100005
J	Kouyialis, AT; Boviatsis, EJ; Sakas, DE				Kouyialis, AT; Boviatsis, EJ; Sakas, DE			Oral steroids as a cause of diverticulurn perforation	LANCET			English	Editorial Material									Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens 10676, Greece	Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Kouyialis, AT (corresponding author), Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens 10676, Greece.	kouyialis@hotmail.com							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					83	83		10.1016/S0140-6736(06)67929-4	http://dx.doi.org/10.1016/S0140-6736(06)67929-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399158				2022-12-28	WOS:000234443100035
J	Room, R				Room, R			British livers and British alcohol policy	LANCET			English	Editorial Material							CIRRHOSIS MORTALITY		Stockholm Univ, Ctr Social Res Alcohol & Drugs, SE-10691 Stockholm, Sweden	Stockholm University	Room, R (corresponding author), Stockholm Univ, Ctr Social Res Alcohol & Drugs, SE-10691 Stockholm, Sweden.	robin.room@sorad.su.se	Room, Robin/ABF-7460-2021; Room, Robin/ABH-8505-2020	Room, Robin/0000-0002-5618-385X; 				Babor TF, 2003, ALCOHOL NO ORDINARY; BOSELY S, 2005, GUARDIAN        0816; Carmiel-Haggai M, 2003, GASTROENTEROLOGY, V125, P1818, DOI 10.1053/j.gastro.2003.09.019; French SW, 2004, HEPATOL RES, V29, P69, DOI 10.1016/j.hepres.2004.02.006; *HM CUST EXC, 2002, MEAS IND TAX LOSS; Leifman H., 2001, NORDIC STUDIES ALCOH, V18, P54; Leifman H., 2002, CONTEMP DRUG PROBL, V29, P501, DOI DOI 10.1177/009145090202900303; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; *PRIM MIN STRAT UN, 2003, INT AN REP STRAT UN; Ramstedt M, 2001, ADDICTION, V96, pS19; Room R, 2004, ADDICTION, V99, P925, DOI 10.1111/j.1360-0443.2004.00776.x; Stranges S, 2004, ALCOHOL CLIN EXP RES, V28, P949, DOI 10.1097/01.ALC.0000128229.23396.42	12	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					10	11		10.1016/S0140-6736(06)67901-4	http://dx.doi.org/10.1016/S0140-6736(06)67901-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399136				2022-12-28	WOS:000234443100008
J	Roscoe, TJ				Roscoe, TJ			The nursing profession's coming of age - Not as successful as it looks	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Sothall Med Ctr, Sheffield S20 5JX, S Yorkshire, England		Roscoe, TJ (corresponding author), Sothall Med Ctr, Sheffield S20 5JX, S Yorkshire, England.	Trefor@nhs.net						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51-e	http://dx.doi.org/10.1136/bmj.332.7532.51-e			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399746	Green Published			2022-12-28	WOS:000234684200034
J	Yu, HJ; Shu, YL; Hu, SX; Zhang, H; Gao, ZC; Chen, HL; Dong, J; Xu, CL; Zhang, Y; Xiang, NJ; Wang, M; Guo, JY; Cox, N; Lim, W; Li, DX; Wang, Y; Yang, WZ				Yu, HJ; Shu, YL; Hu, SX; Zhang, H; Gao, ZC; Chen, HL; Dong, J; Xu, CL; Zhang, Y; Xiang, NJ; Wang, M; Guo, JY; Cox, N; Lim, W; Li, DX; Wang, Y; Yang, WZ			The first confirmed human case of avian influenza A (H5N1) in Mainland China	LANCET			English	Editorial Material							DISEASE; VIRUS		Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing 100050, Peoples R China; CDC, Natl Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China; Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China; Hunan Prov Ctr Dis Control & Prevent, Changsha 410005, Peoples R China; Chinese Acad Agr Sci, Harbin Vet Res Inst, Harbin 115001, Peoples R China; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Ctr Hlth Protect, Kowloon, Hong Kong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Centers for Disease Control & Prevention - USA	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, 27 Nanwei Rd, Beijing 100050, Peoples R China.	ywz126@vip.sina.com	Yang, Wei/HIA-0360-2022					Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	4	54	77	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					84	84		10.1016/S0140-6736(05)67894-4	http://dx.doi.org/10.1016/S0140-6736(05)67894-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000EG	16399159				2022-12-28	WOS:000234443100036
J	Firestein, GS				Firestein, GS			Inhibiting inflammation in rheumatoid arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Clin Invest Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Firestein, GS (corresponding author), Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA.							Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Nandakumar KS, 2003, AM J PATHOL, V163, P1827, DOI 10.1016/S0002-9440(10)63542-0	5	30	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					80	82		10.1056/NEJMcibr054344	http://dx.doi.org/10.1056/NEJMcibr054344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394307				2022-12-28	WOS:000234358600014
J	Hsu, CY; McCulloch, CE; Iribarren, C; Darbinian, J; Go, AS				Hsu, CY; McCulloch, CE; Iribarren, C; Darbinian, J; Go, AS			Body mass index and risk for end-stage renal disease	ANNALS OF INTERNAL MEDICINE			English	Article							KIDNEY-DISEASE; WEIGHT-LOSS; LIFE-STYLE; OBESITY; OVERWEIGHT; HEMODYNAMICS; PROTEINURIA; PREDICTORS; TRENDS	Background: Although interest in the relationship between obesity and kidney disease is increasing, few epidemiologic studies have examined whether excess weight is an independent risk factor for end-stage renal disease (ESRD). Objective: To determine the association between increased body mass index (BMI) and risk for ESRD. Design: Historical (nonconcurrent) cohort study. Setting: A large integrated health care delivery system in northern California. Participants: 320 252 adult members of Kaiser Permanente who volunteered for screening health checkups between 1964 and 1985 and who had height and weight measured. Measurements: The authors ascertained ESRD cases by matching data with the U.S. Renal Data System registry through 2000. Results: A total of 1471 cases of ESRD occurred during 8 347 955 person-years of follow-up. Higher BMI was a risk factor for ESRD in multivariable models that adjusted for age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level. Compared with persons who had normal weight (BMI, 18.5 to 24.9 kg/m(2)), the adjusted relative risk for ESRD was 1.87 (95% Cl, 1.64 to 2.14) for those who were overweight (BMI, 25.0 to 29.9 kg/m(2)), 3.57 (Cl, 3.05 to 4.18) for those with class I obesity (BMI, 30.0 to 34.9 kg/m(2)), 6.12 (CI, 4.97 to 7.54) for those with class II obesity (BMI, 35.0 to 39.9 kg/m(2)), and 7.07 (Cl, 5.37 to 9.31) for those with extreme obesity (BMI >= 40 kg/m(2)). Higher baseline BMI remained an independent predictor for ESRD after additional adjustments for baseline blood pressure level and presence or absence of diabetes mellitus. Limitations: Primary analyses were based on single measurements of exposures. Conclusions: High BMI is a common, strong, and potentially modifiable risk factor for ESRD.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Oakland, CA USA	University of California System; University of California San Francisco; Kaiser Permanente	Hsu, CY (corresponding author), Univ Calif San Francisco, Div Nephrol, 513 Parnassus Ave,672HSE,Box 0532, San Francisco, CA 94143 USA.	hsuchi@medicine.ucsf.edu	Go, Alan S./AAE-7745-2019	Hsu, Chi-yuan/0000-0001-8182-1238	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK061520] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrass CK, 2004, J AM SOC NEPHROL, V15, P2768, DOI 10.1097/01.ASN.0000141963.04540.3E; Adelman RD, 2002, CURR OPIN NEPHROL HY, V11, P331, DOI 10.1097/00041552-200205000-00010; [Anonymous], 2003, Am J Kidney Dis, V42, P1; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Bosma RJ, 2004, KIDNEY INT, V65, P259, DOI 10.1111/j.1523-1755.2004.00351.x; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; BROCHNERMORTENSEN J, 1980, SCAND J CLIN LAB INV, V40, P695, DOI 10.3109/00365518009095584; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COHEN AH, 1975, AM J PATHOL, V81, P117; Cohen MF, 1978, MULTIPHASIC HLTH TES; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; FISHER LD, 1996, BIOSTATISTICS METHOD; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Iseki K, 1997, KIDNEY INT, pS169; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KASISKE BL, 1986, ARCH INTERN MED, V146, P1105, DOI 10.1001/archinte.146.6.1105; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Ramirez SPB, 2002, J AM SOC NEPHROL, V13, P1907, DOI 10.1097/01.ASN.0000018406.20282.C8; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	40	925	966	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					21	28		10.7326/0003-4819-144-1-200601030-00006	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389251				2022-12-28	WOS:000234474200003
J	Martin, M; Cho, JY; Cesare, AJ; Griffith, JD; Attardi, G				Martin, M; Cho, JY; Cesare, AJ; Griffith, JD; Attardi, G			Termination factor-mediated DNA loop between termination and initiation sites drives mitochondrial rRNA synthesis	CELL			English	Article							TRANSCRIPTION TERMINATION; FACTOR MTERF; IDENTIFICATION; PROTEIN; PURIFICATION; CHROMATIN; MONOMER; STRAND; MTDNA	The human mitochondrial transcription termination factor mTERF plays a central role in the control of heavy-strand rDNA transcription by promoting initiation, besides termination, of this transcription. However, until now, the mechanism underlying this stimulation of transcription by mTERF was not understood. In the present work, addition of mTERF to a HeLa cell mitochondrial lysate-based reaction mixture containing an artificial rDNA template did indeed specifically stimulate rDNA transcription. This stimulation required that mTERF be simultaneously bound to the rDNA transcription termination and initiation sites in the same molecule, thus forming a loop. Most significantly, a double binding of mTERF to the rDNA molecule, with resulting loop formation, was also shown in vivo. These results strongly suggest that, to satisfy the need for high rate of rDNA transcription, human mitochondrial rRNA synthesis involves mTERF-mediated rDNA looping that promotes recycling of the transcription machinery.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Attardi, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	attardi@caltech.edu	Cesare, Anthony/N-7415-2019; Cesare, Anthony J/F-4691-2010; Martin, Miguel Angel/B-6261-2017	Cesare, Anthony/0000-0002-0864-1254; Cesare, Anthony J/0000-0002-0864-1254; Martin, Miguel Angel/0000-0003-4741-772X; Cho, Jae/0000-0002-6534-116X	NIGMS NIH HHS [GM11726, GM31819] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asin-Cayuela J, 2004, J BIOL CHEM, V279, P15670, DOI 10.1074/jbc.M312537200; ATTARDI G, 1983, METHOD ENZYMOL, V97, P435; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Silva P, 1996, Methods Enzymol, V264, P129, DOI 10.1016/S0076-6879(96)64014-2; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Helm M, 2004, J MOL BIOL, V337, P545, DOI 10.1016/j.jmb.2004.01.036; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; KRUSE B, 1995, METHODS MOL BIOL, V37; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Prieto-Martin A, 2004, J BIOCHEM, V136, P825, DOI 10.1093/jb/mvh192; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; VINOGRAD J, 1963, P NATL ACAD SCI USA, V49, P12, DOI 10.1073/pnas.49.1.12	25	137	147	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1227	1240		10.1016/j.cell.2005.09.040	http://dx.doi.org/10.1016/j.cell.2005.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377564	Bronze			2022-12-28	WOS:000234584500012
J	Mitchell, LB; Exner, DV; Wyse, DG; Connolly, CJ; Prystai, GD; Bayes, AJ; Kidd, WT; Kieser, T; Burgess, JJ; Ferland, A; MacAdams, CL; Maitland, A				Mitchell, LB; Exner, DV; Wyse, DG; Connolly, CJ; Prystai, GD; Bayes, AJ; Kidd, WT; Kieser, T; Burgess, JJ; Ferland, A; MacAdams, CL; Maitland, A			Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OPEN-HEART-SURGERY; FIBRILLATION SUPPRESSION TRIAL; CORONARY-ARTERY SURGERY; ATRIAL-FIBRILLATION; INTRAVENOUS AMIODARONE; DOUBLE-BLIND; PLACEBO; THERAPY; RISK; COMPLICATIONS	Context Atrial tachyarrhythmias after cardiac surgery are associated with adverse outcomes and increased costs. Previous trials of amiodarone prophylaxis, while promising, were relatively small and yielded conflicting results. Objective To determine whether a brief perioperative course of oral amiodarone is an effective and safe prophylaxis for atrial tachyarrhythmias after cardiac surgery overall and in important subgroups. Design, Setting, and Patients Double-blind randomized controlled trial of 601 patients listed for nonemergent coronary artery bypass graft (CABG) surgery and/or valve replacement/repair surgery between February 1, 1999, and September 26, 2003, at a tertiary care hospital. The patients were followed up for 1 year. Intervention Oral amiodarone (10 mg/kg daily) or placebo administered 6 days prior to surgery through 6 days after surgery (13 days). Randomization was stratified for subgroups defined by age, type of surgery, and use of preoperative beta-blockers. Main Outcome Measure Incidence of atrial tachyarrhythmias lasting 5 minutes or longer that prompted therapy by the sixth postoperative day. Results Atrial tachyarrhythmias occurred in fewer amiodarone patients (48/299; 16.1 %) than in placebo patients (89/302; 29.5%) overall (hazard ratio [HR], 0.52; 95% confidence interval [CI], 0.34-0.69; P<.001); in patients younger than 65 years (19 [11.2%] vs 36 [21.1%]; HR, 0.51 [95% Cl, 0.28-0-94]; P=.02); in patients aged 65 years or older (28 [21.7%] vs 54 [41.2%]; HR, 0.45 [95% CI, 0.27-0.75]; P<.001); in patients who had CABG surgery only (22 [11.3%] vs 46 [23.6%]; HR, 0.45 [95% Cl, 0.26-0.79]; P=.002); in patients who had valve replacement/repair surgery with or without CABG surgery (25 [23.8%] vs 44 [44.1%]; HR, 0.51 [95% Cl, 0.31-0.84; P=.008); in patients who received preoperative beta-blocker therapy (27 [15.3%] vs 42 [25.0%]; HR, 0.58 [95% Cl, 0.34-0.99]; P=.03); and in patients who did not receive preoperative beta-blocker therapy (20 [16.3%] vs 48 [35.8%]; HR, 0.40 [95% Cl, 0.22-0.71]; P<.001), respectively. Postoperative sustained ventricular tachyarrhythmias occurred less frequently in amiodarone patients (1/299; 0.3%) than in placebo patients (8/302; 2.6%) (P=.04). Dosage reductions of blinded therapy were more common in amiodarone patients (34/299; 11.4%) than in placebo patients (16/302; 5.3%) (P=.008). There were no differences in serious postoperative complications, in-hospital mortality, or readmission to the hospital within 6 months of discharge or in 1-year mortality. Conclusion Oral amiodarone prophylaxis of atrial tachyarrhythmias after cardiac surgery is effective and may be safe overall and in important patient subgroups.	Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; Calgary Hlth Reg, Calgary, AB, Canada; Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Mitchell, LB (corresponding author), Foothills Prov Gen Hosp, Dept Cardiac Sci, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	brent.mitchell@calgaryhealthregion.ca	E, D/AAH-1638-2020					ANDREWS TC, 1991, CIRCULATION, V84, P236; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; BUTLER J, 1993, BRIT HEART J, V70, P56; Connolly SJ, 2003, AM HEART J, V145, P226, DOI 10.1067/mhj.2003.147; COX DR, 1972, J R STAT SOC B, V34, P187; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N; Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E; Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501; Dorge H, 2000, ANN THORAC SURG, V69, P1358, DOI 10.1016/S0003-4975(00)01081-X; ELLIOTT PL, 1983, CIRCULATION, V68, P280; FLAKER GC, 1992, J AM COLL CARDIOL, V20, P527, DOI 10.1016/0735-1097(92)90003-6; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; GALLAGHER JD, 1981, ANESTHESIOLOGY, V55, P186, DOI 10.1097/00000542-198108000-00017; Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9; GOLDSTEIN S, 1987, CONTROL CLIN TRIALS, V8, pS79; Guarnieri T, 1999, J AM COLL CARDIOL, V34, P343, DOI 10.1016/S0735-1097(99)00212-0; Harahsheh BS, 2001, SAUDI MED J, V22, P797; HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P; HOHNLOSER SH, 1994, ANN INTERN MED, V121, P529, DOI 10.7326/0003-4819-121-7-199410010-00009; Hravnak M, 2002, AM J CRIT CARE, V11, P228, DOI 10.4037/ajcc2002.11.3.228; Hravnak M, 2002, CRIT CARE MED, V30, P330, DOI 10.1097/00003246-200202000-00011; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KHAJA F, 1972, ARCH INTERN MED, V129, P433, DOI 10.1001/archinte.129.3.433; LAUER MS, 1989, PROG CARDIOVASC DIS, V31, P367, DOI 10.1016/0033-0620(89)90031-5; Lee SH, 2000, ANN THORAC SURG, V70, P157, DOI 10.1016/S0003-4975(00)01308-4; LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338; LYNN GM, 1992, J THORAC CARDIOV SUR, V104, P1518, DOI 10.1016/S0022-5223(19)33878-4; MACKINNON G, 1983, CAN J SURG, V26, P355; MALOUF JF, 1993, EUR HEART J, V14, P1451, DOI 10.1093/eurheartj/14.11.1451; Maras D, 2001, Am Heart J, V141, pE8, DOI 10.1067/mhj.2001.114201; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; MITCHELL LB, 1989, CIRCULATION, V80, P34, DOI 10.1161/01.CIR.80.1.34; Mitchell LB., 2000, DEV CARDIOVASC MED, P37; NALOS PC, 1987, J THORAC CARDIOV SUR, V93, P904; Redle JD, 1999, AM HEART J, V138, P144, DOI 10.1016/S0002-8703(99)70260-7; ROSENBAUM MB, 1976, AM J CARDIOL, V38, P934, DOI 10.1016/0002-9149(76)90807-9; SHELDON RS, 1988, AM J CARDIOL, V62, P736, DOI 10.1016/0002-9149(88)91213-1; Tokmakoglu H, 2002, EUR J CARDIO-THORAC, V21, P401, DOI 10.1016/S1010-7940(02)00006-4; Treggiari-Venzi MM, 2000, BRIT J ANAESTH, V85, P690, DOI 10.1093/bja/85.5.690; TUZCU EM, 1987, CLEV CLIN J MED, V54, P491, DOI 10.3949/ccjm.54.6.491; White CM, 2003, CIRCULATION, V108, P200, DOI 10.1161/01.cir.0000087445.59819.6f; White CM, 2002, ANN THORAC SURG, V74, P69, DOI 10.1016/S0003-4975(02)03593-2; Yagdi T, 2003, J THORAC CARDIOV SUR, V125, P1420, DOI 10.1016/S0022-5223(02)73292-3; Yazigi A, 2002, J CARDIOTHOR VASC AN, V16, P603, DOI 10.1053/jcan.2002.126956	44	195	206	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3093	3100		10.1001/jama.294.24.3093	http://dx.doi.org/10.1001/jama.294.24.3093			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380589	Bronze			2022-12-28	WOS:000234274200025
J	Moser, HW; Raymond, GV; Dubey, P				Moser, HW; Raymond, GV; Dubey, P			Adrenoleukodystrophy - New approaches to a neurodegenerative disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; ADDISONS-DISEASE; ADRENOMYELONEUROPATHY; MRI; TRANSPLANTATION; SCLEROSIS; VARIANT	X-linked adrenoleukodystrophy (X-ALD), which was first described in 1923, was viewed until 1976 as a rare and inexorably fatal neurodegenerative disorder that affected boys. The genetic defect and biochemical abnormalities have now been defined. Ongoing research has resulted in new findings: (1) there is a wide range of phenotypic expression. At least half of patients with X-ALD are adults with somewhat milder manifestations, and women who are carriers may become symptomatic. X-ALD is often misdiagnosed as attention-deficit/hyperactivity disorder in boys and as multiple sclerosis in men and women, and is not an uncommon cause of Addison disease; (2) the incidence of X-ALD, estimated to be 1:17 000 in all ethnic groups, approximates that of phenylketonuria; (3) noninvasive and presymptomatic diagnosis and prenatal diagnosis are available; family screening and genetic counseling are key to disease prevention; and (4) new therapies, applied early, show promise. Neonatal screening is likely to become available, and a wider awareness of X-ALD and its various modes of presentation permit new pro-active approaches to this distressing disorder.	Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD 21205 USA	Kennedy Krieger Institute	Moser, HW (corresponding author), Kennedy Krieger Inst, Dept Neurogenet, 707 N Broadway, Baltimore, MD 21205 USA.	moser@kennedykrieger.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039276, P01HD010981] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981, HD39276] Funding Source: Medline; PHS HHS [685-008, M0-1-R00052] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; BLAW M, 1970, LEUCODYSTROPHIES POL, P128; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; BUDKA H, 1976, J NEUROL, V213, P237, DOI 10.1007/BF00312873; COX C, IN PRESS ARCH NEUROL; Dubey P, 2005, J PEDIATR-US, V146, P528, DOI 10.1016/j.jpeds.2004.10.067; FANCONI A, 1963, HELV PAEDIATR ACTA, V18, P480; Fatemi A, 2005, NEUROLOGY, V64, P1739, DOI 10.1212/01.WNL.0000164458.02141.06; Fatemi A, 2003, NEUROLOGY, V60, P1301, DOI 10.1212/01.WNL.0000059546.15529.CB; GRIFFIN JW, 1977, NEUROLOGY, V27, P1107, DOI 10.1212/WNL.27.12.1107; Houlden H, 2002, BRAIN, V125, P2681, DOI 10.1093/brain/awf270; IGARASHI M, 1976, J NEUROCHEM, V26, P851, DOI 10.1111/j.1471-4159.1976.tb04462.x; KUMAR AJ, 1987, RADIOLOGY, V165, P497, DOI 10.1148/radiology.165.2.3659373; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Moser AB, 1999, PRENATAL DIAG, V19, P46, DOI 10.1002/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Powers JM, 2000, J NEUROPATH EXP NEUR, V59, P89, DOI 10.1093/jnen/59.2.89; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; Schilder P, 1912, Z GESAMTE NEUROL PSY, V10, P1, DOI 10.1007/BF02901445; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Siemerling E, 1923, ARCH PSYCHIAT NERVEN, V68, P217, DOI 10.1007/BF01835678	25	78	99	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3131	3134		10.1001/jama.294.24.3131	http://dx.doi.org/10.1001/jama.294.24.3131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380594				2022-12-28	WOS:000234274200030
J	Witten, E				Witten, E			Unravelling string theory	NATURE			English	Editorial Material									Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Witten, E (corresponding author), Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA.							Greene B., 1999, ELEGANT UNIVERSE; RAMSEY NF, 1981, PHYS TODAY, V34, P26, DOI 10.1063/1.2914362; Zwiebach B, 2004, 1 COURSE STRING THEO	3	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1085	1085		10.1038/4381085a	http://dx.doi.org/10.1038/4381085a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371987				2022-12-28	WOS:000234111500025
J	Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Sakai, K; Sugimachi, K; Tominaga, T; Uchino, J; Yoshida, M; Haybittle, JL; Davies, C; Harvey, VJ; Holdaway, TM; Kay, RG; Mason, BH; Forbes, JF; Wilcken, N; Gnant, M; Jakesz, R; Ploner, M; Yosef, HMA; Focan, C; Lobelle, JP; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Hupperets, PSGJ; Jackson, S; Ragaz, J; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahra, HT; Portnoj, SM; Baum, M; Cuzick, J; Houghton, J; Riley, D; Mansel, RE; Gordon, NH; Davis, HL; Beatrice, A; Mihura, J; Naja, A; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Lesec'h, JM; Rambert, P; Petruzelka, L; Pribylova, O; Owen, JR; Harbeck, N; Janicke, F; Meisner, G; Meier, P; Howell, A; Ribeiro, GC; Swindell, R; Burrett, J; Clarke, M; Collins, R; Darby, S; Davies, C; Elphinstone, P; Evans, V; Godwin, J; Gray, R; Harwood, C; Hicks, C; Jackson, D; James, S; MacKinnon, E; McGale, P; McHugh, T; Mead, G; Morris, P; Oulds, J; Peto, R; Taylor, C; Wang, Y; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Johansen, H; Mouridsen, HT; Gelman, RS; Harris, JR; Henderson, IC; Shapiro, CL; Christiansen, P; Ejlertsen, B; Mouridsen, HT; Moller, S; Overgaard, M; Carstensen, B; Palshof, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Forrest, P; Jack, W; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Costa, A; Veronesi, U; Bartelink, H; Duchateau, L; Legrand, C; Sylvester, R; Catalano, R; Creech, RH; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Namer, M; Jonat, W; Kaufman, M; Schumacher, M; von Minckwitz, G; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; de Schyrver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Galligioni, E; Boccardo, F; Rubagotti, A; Dent, DM; Gudgeon, CA; Hacking, A; Erazo, A; Medina, JY; Izuo, M; Morishita, Y; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Scheurlen, H; Kaufmann, M; von Fournier, D; Dafni, U; Fountzilas, G; Klefstrom, P; Blomqvist, C; Saarto, T; Magreiter, R; Asselain, B; Salmon, RJ; Vilcoq, JR; Arriagada, R; Hill, C; Laplanche, A; Le, MG; Spielmann, M; Bruzzi, P; Montanaro, E; Rosso, R; Sertoli, MR; Venturini, M; Amadori, D; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Cavalli, F; Coates, A; Collins, J; Forbes, J; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, KN; Rudenstam, CM; Senn, HJ; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Borovik, R; Brufman, G; Hayat, H; Robinson, E; Wigler, N; Bonadonna, G; Camerini, T; De Palo, G; Del Vecchio, M; Formelli, F; Valagussa, P; Martoni, A; Pannuti, F; Cocconi, G; Colozza, A; Camisa, R; Aogi, K; Takashima, S; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bonte, J; Christiaens, R; Paridaens, R; Van den Bogaert, W; Martin, P; Romain, S; Hakes, T; Hudis, CA; Norton, L; Wittes, R; Giokas, G; Kondylis, D; Lissaios, B; de la Huerta, R; Sainz, MG; Altemus, R; Cowan, K; Danforth, D; Lichter, A; Lippman, M; O'Shaughnessy, J; Pierce, LJ; Steinberg, S; Venzon, D; Zujewski, JA; Paradiso, A; De Lena, M; Schittulli, F; Myles, JD; Pater, JL; Pritchard, KI; Whelan, T; Nomura, Y; Anderson, S; Bass, G; Brown, A; Bryant, J; Costantino, J; Dignam, J; Fisher, B; Redmond, C; Wieand, S; Wolmark, N; Baum, M; Jackson, IM; Palmer, MK; Ingle, JN; Suman, VJ; Bengtsson, NO; Jonsson, H; Larsson, LG; Lythgoe, JP; Swindell, R; Kissin, M; Erikstein, B; Hannisdal, E; Jacobsen, AB; Varhaug, JE; Erikstein, B; Gundersen, S; Hauer-Jensen, M; Host, H; Jacobsen, AB; Nissen-Meyer, R; Blamey, RW; Mitchell, AK; Morgan, DAL; Robertson, JFR; Di Palma, M; Mathe, G; Misset, JL; Clark, RM; Levine, M; Pritchard, KI; Whelan, T; Morimoto, K; Sawa, K; Takatsuka, Y; Crossley, E; Harris, A; Talbot, D; Taylor, M; Cocconi, G; di Blasio, B; Ivanov, V; Semiglazov, V; Brockschmidt, J; Cooper, MR; Ueo, H; Falkson, CI; A'Hern, R; Ashley, S; Powles, TJ; Smith, IE; Yarnold, JR; Gazet, JC; Cocoran, N; Deshpande, N; de Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Foster, L; George, WD; Stewart, HJ; Stroner, P; Malmstrom, P; Moller, TR; Ryden, S; Tengrup, I; Tennvall-Nittby, L; Carstenssen, J; Dufmats, M; Hatschek, T; Nordenskjold, B; Soderberg, M; Carpenter, JT; Albain, K; Crowley, J; Green, S; Martino, S; Osborne, CK; Ravdin, PM; Glas, U; Johansson, U; Rutqvist, LE; Singnomklao, T; Wallgren, A; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Brenner, H; Hercbergs, A; Yoshimoto, M; DeBoer, G; Paterson, AHG; Pritchard, KI; Meakin, JW; Panzarella, T; Pritchard, KI; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Bahi, J; Reid, M; Spittle, M; Deutsch, GP; Senanayake, F; Kwong, DLW; Bianco, AR; Carlomagno, C; De Laurentiis, M; De Placido, S; Buzdar, AU; Smith, T; Bergh, J; Holmberg, L; Liljegren, G; Nilsson, J; Seifert, M; Sevelda, P; Zielinsky, CC; Buchanan, RB; Cross, M; Royle, GT; Dunn, JA; Hills, RK; Lee, M; Morrison, JM; Spooner, D; Litton, A; Chlebowski, RT; Caffier, H				Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Sakai, K; Sugimachi, K; Tominaga, T; Uchino, J; Yoshida, M; Haybittle, JL; Davies, C; Harvey, VJ; Holdaway, TM; Kay, RG; Mason, BH; Forbes, JF; Wilcken, N; Gnant, M; Jakesz, R; Ploner, M; Yosef, HMA; Focan, C; Lobelle, JP; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Hupperets, PSGJ; Jackson, S; Ragaz, J; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahra, HT; Portnoj, SM; Baum, M; Cuzick, J; Houghton, J; Riley, D; Mansel, RE; Gordon, NH; Davis, HL; Beatrice, A; Mihura, J; Naja, A; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Lesec'h, JM; Rambert, P; Petruzelka, L; Pribylova, O; Owen, JR; Harbeck, N; Janicke, F; Meisner, G; Meier, P; Howell, A; Ribeiro, GC; Swindell, R; Burrett, J; Clarke, M; Collins, R; Darby, S; Davies, C; Elphinstone, P; Evans, V; Godwin, J; Gray, R; Harwood, C; Hicks, C; Jackson, D; James, S; MacKinnon, E; McGale, P; McHugh, T; Mead, G; Morris, P; Oulds, J; Peto, R; Taylor, C; Wang, Y; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Johansen, H; Mouridsen, HT; Gelman, RS; Harris, JR; Henderson, IC; Shapiro, CL; Christiansen, P; Ejlertsen, B; Mouridsen, HT; Moller, S; Overgaard, M; Carstensen, B; Palshof, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Forrest, P; Jack, W; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Costa, A; Veronesi, U; Bartelink, H; Duchateau, L; Legrand, C; Sylvester, R; Catalano, R; Creech, RH; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Namer, M; Jonat, W; Kaufman, M; Schumacher, M; von Minckwitz, G; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; de Schyrver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Galligioni, E; Boccardo, F; Rubagotti, A; Dent, DM; Gudgeon, CA; Hacking, A; Erazo, A; Medina, JY; Izuo, M; Morishita, Y; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Scheurlen, H; Kaufmann, M; von Fournier, D; Dafni, U; Fountzilas, G; Klefstrom, P; Blomqvist, C; Saarto, T; Magreiter, R; Asselain, B; Salmon, RJ; Vilcoq, JR; Arriagada, R; Hill, C; Laplanche, A; Le, MG; Spielmann, M; Bruzzi, P; Montanaro, E; Rosso, R; Sertoli, MR; Venturini, M; Amadori, D; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Cavalli, F; Coates, A; Collins, J; Forbes, J; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, KN; Rudenstam, CM; Senn, HJ; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Borovik, R; Brufman, G; Hayat, H; Robinson, E; Wigler, N; Bonadonna, G; Camerini, T; De Palo, G; Del Vecchio, M; Formelli, F; Valagussa, P; Martoni, A; Pannuti, F; Cocconi, G; Colozza, A; Camisa, R; Aogi, K; Takashima, S; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bonte, J; Christiaens, R; Paridaens, R; Van den Bogaert, W; Martin, P; Romain, S; Hakes, T; Hudis, CA; Norton, L; Wittes, R; Giokas, G; Kondylis, D; Lissaios, B; de la Huerta, R; Sainz, MG; Altemus, R; Cowan, K; Danforth, D; Lichter, A; Lippman, M; O'Shaughnessy, J; Pierce, LJ; Steinberg, S; Venzon, D; Zujewski, JA; Paradiso, A; De Lena, M; Schittulli, F; Myles, JD; Pater, JL; Pritchard, KI; Whelan, T; Nomura, Y; Anderson, S; Bass, G; Brown, A; Bryant, J; Costantino, J; Dignam, J; Fisher, B; Redmond, C; Wieand, S; Wolmark, N; Baum, M; Jackson, IM; Palmer, MK; Ingle, JN; Suman, VJ; Bengtsson, NO; Jonsson, H; Larsson, LG; Lythgoe, JP; Swindell, R; Kissin, M; Erikstein, B; Hannisdal, E; Jacobsen, AB; Varhaug, JE; Erikstein, B; Gundersen, S; Hauer-Jensen, M; Host, H; Jacobsen, AB; Nissen-Meyer, R; Blamey, RW; Mitchell, AK; Morgan, DAL; Robertson, JFR; Di Palma, M; Mathe, G; Misset, JL; Clark, RM; Levine, M; Pritchard, KI; Whelan, T; Morimoto, K; Sawa, K; Takatsuka, Y; Crossley, E; Harris, A; Talbot, D; Taylor, M; Cocconi, G; di Blasio, B; Ivanov, V; Semiglazov, V; Brockschmidt, J; Cooper, MR; Ueo, H; Falkson, CI; A'Hern, R; Ashley, S; Powles, TJ; Smith, IE; Yarnold, JR; Gazet, JC; Cocoran, N; Deshpande, N; de Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Foster, L; George, WD; Stewart, HJ; Stroner, P; Malmstrom, P; Moller, TR; Ryden, S; Tengrup, I; Tennvall-Nittby, L; Carstenssen, J; Dufmats, M; Hatschek, T; Nordenskjold, B; Soderberg, M; Carpenter, JT; Albain, K; Crowley, J; Green, S; Martino, S; Osborne, CK; Ravdin, PM; Glas, U; Johansson, U; Rutqvist, LE; Singnomklao, T; Wallgren, A; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Brenner, H; Hercbergs, A; Yoshimoto, M; DeBoer, G; Paterson, AHG; Pritchard, KI; Meakin, JW; Panzarella, T; Pritchard, KI; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Bahi, J; Reid, M; Spittle, M; Deutsch, GP; Senanayake, F; Kwong, DLW; Bianco, AR; Carlomagno, C; De Laurentiis, M; De Placido, S; Buzdar, AU; Smith, T; Bergh, J; Holmberg, L; Liljegren, G; Nilsson, J; Seifert, M; Sevelda, P; Zielinsky, CC; Buchanan, RB; Cross, M; Royle, GT; Dunn, JA; Hills, RK; Lee, M; Morrison, JM; Spooner, D; Litton, A; Chlebowski, RT; Caffier, H		EBCTC; Oxford CTSU	Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials	LANCET			English	Article							LOCOREGIONAL RADIATION-THERAPY; SURGICAL ADJUVANT BREAST; CARE PROCESS SURVEY; POSTOPERATIVE RADIOTHERAPY; CONSERVING SURGERY; CONTRALATERAL BREAST; PREMENOPAUSAL WOMEN; TOTAL MASTECTOMY; HEART-DISEASE; STAGE-I	Background in early breast cancer, variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer mortality. To examine this relationship, collaborative meta-analyses were undertaken, based on individual patient data, of the relevant randomised trials that began by 1995. Methods Information was available on 42 000 women in 78 randomised treatment comparisons (radiotherapy vs no radiotherapy, 23 500; more vs less surgery, 9300; more surgery vs radiotherapy, 9300). 24 types of local treatment comparison were identified. To help relate the effect on local (ie, locoregional) recurrence to that on breast cancer mortality, these were grouped according to whether or not the 5-year local recurrence risk exceeded 10% (<10%, 17 000 women; >10%, 25 000 women). Findings About three-quarters of the eventual local recurrence risk occurred during the first 5 years. In the comparisons that involved little (<10%) difference in 5-year local recurrence risk there was little difference in 15-year breast cancer mortality. Among the 25 000 women in the comparisons that involved substantial (>10%) differences, however, 5-year local recurrence risks were 7% active versus 26% control (absolute reduction 19%), and 15-year breast cancer mortality risks were 44.6% versus 49.5% (absolute reduction 5.0%,SE 0.8, 2p<0.00001). These 25 000 women included 7300 with breast-conserving surgery (BCS) in trials of radiotherapy (generally just to the conserved breast), with 5-year local recurrence risks (mainly in the conserved breast, as most had axillary clearance and node-negative disease) 7% versus 26% (reduction 19%), and 15-year breast cancer mortality risks 30.5% versus 35.9% (reduction 5.4%, SE 1.7, 2p=0.0002; overall mortality reduction 5.3%, SE 1.8, 2p=0.005). They also included 8500 with mastectomy, axillary clearance, and node-positive disease in trials of radiotherapy (generally to the chest wall and regional lymph nodes), with similar absolute gains from radiotherapy; 5-year local recurrence risks (mainly at these sites) 6% versus 23% (reduction 17%), and 15-year breast cancer mortality risks 54.7% versus 60.1 % (reduction 5.4%, S E 1.3, 2p=0.0002; overall mortality reduction 4.4%, S E 1.2, 2p=0.0009). Radiotherapy produced similar proportional reductions in local recurrence in all women (irrespective of age or tumour characteristics) and in all major trials of radiotherapy versus not (recent or older; with or without systemic therapy), so large absolute reductions in local recurrence were seen only if the control risk was large. To help assess the life-threatening side-effects of radiotherapy, the trials of radiotherapy versus not were combined with those of radiotherapy versus more surgery. There was, at least with some of the older radiotherapy regimens, a significant excess incidence of contralateral breast cancer (rate ratio 1.18, SE 0 06, 2p=0.002) and a significant excess of non-breast-cancer mortality in irradiated women (rate ratio 1.12, SE 0.04, 2p=0.001). Both were slight during the first 5 years, but continued after year 15. The excess mortality was mainly from heart disease (rate ratio 1.27, SE 0.07, 2p=0.0001) and lung cancer (rate ratio 1.78, SE 0.22, 2p=0.0004). Interpretation In these trials, avoidance of a local recurrence in the conserved breast after BCS and avoidance of a local recurrence elsewhere (eg, the chest wall or regional nodes) after mastectomy were of comparable relevance to 15-year breast cancer mortality. Differences in local treatment that substantially affect local recurrence rates would, in the hypothetical absence of any other causes of death, avoid about one breast cancer death over the next 15 years for every four local recurrences avoided, and should reduce 15-year overall mortality.	Univ Oxford, CTSU, Oxford OX3 7LF, England; ATLAS Trial Collaborat Study Grp, Oxford, England	University of Oxford; University of Oxford	Abe, O (corresponding author), Univ Oxford, CTSU, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	bc.overview@ctsu.ox.ac.uk	Gkiokas, Georgios/AAE-6312-2020; Brenner, Hermann/ABE-6383-2020; Pritchard, Kathleen I/I-2184-2014; Fountzilas, George/ABF-2139-2020; Martoni, Andrea/AAC-1707-2021; Whelan, Timothy/D-3185-2017; Petruzelka, Lubos/A-2750-2017; Hudis, Clifford/AAW-9482-2021; Bruzzi, Paolo/AAU-3363-2021; Gnant, Michael/AAN-7054-2020; Vakaet, Luc/A-6467-2010; De Laurentiis, Michelino/AAC-6321-2022; paradiso, angelo V/J-9457-2018; Jonat, Walter/E-3024-2010; Evans, Diane/F-9258-2017; Fentiman, Ian/AAB-9886-2020; Brenner, Hermann/B-4627-2017; Dafni, Ourania/AAH-4453-2019; Harris, Adrian L/ABA-3343-2020; Boccardo, Francesco Mario/AAF-2654-2019; Fentiman, Ian S/I-7644-2019; van der Hage, Jos/AAG-3541-2021	Brenner, Hermann/0000-0002-6129-1572; Pritchard, Kathleen I/0000-0003-0758-9666; Whelan, Timothy/0000-0001-9844-2023; Petruzelka, Lubos/0000-0002-4397-0635; Hudis, Clifford/0000-0001-7144-8791; Gnant, Michael/0000-0003-1002-2118; De Laurentiis, Michelino/0000-0001-9009-1572; Brenner, Hermann/0000-0002-6129-1572; Dafni, Ourania/0000-0003-4367-4497; Harris, Adrian L/0000-0003-1376-8409; Boccardo, Francesco Mario/0000-0002-5392-4077; Semiglazov, Vladimir/0000-0003-0077-9619; Coombes, Raoul Charles/0000-0002-4811-1100; Norton, Larry/0000-0003-3701-9250; Howell, Anthony/0000-0002-6233-719X; Anderson, Stewart/0000-0001-8948-0650; de Vries, Elisabeth/0000-0002-8949-7425; Blomqvist, Carl/0000-0003-3041-1938; Evans, Vaughan/0000-0002-2366-2301; van der Hage, Jos/0000-0001-9040-1323; , david/0000-0002-4133-9364; Douglas, Pamela/0000-0001-9876-4049; Bergh, Jonas/0000-0001-5526-1847; Morgan, David/0000-0002-2291-1740; Bruzzi, Paolo/0000-0002-7874-2077; Valentini, Miriam/0000-0002-1421-6975; Wang, Xiang/0000-0002-1522-9532; Smith, David/0000-0002-9465-988X; RUBAGOTTI, Alessandra/0000-0002-4009-8829; Portnoj, S/0000-0002-8965-5040; Bliss, Judith/0000-0001-7957-7424; Arriagada, Rodrigo/0000-0002-3134-1735; Hills, Robert/0000-0003-0166-0062				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ABE O, 1995, NEW ENGL J MED, V333, P1444; ARRIAGADA R, 1995, J CLIN ONCOL, V13, P2869, DOI 10.1200/JCO.1995.13.12.2869; Arriagada R, 2003, ANN ONCOL, V14, P1617, DOI 10.1093/annonc/mdg452; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Ceilley E, 2005, INT J RADIAT ONCOL, V61, P365, DOI 10.1016/j.ijrobp.2004.05.069; CUZICK J, 1987, CANCER TREAT REP, V71, P15; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Deutsch M, 2003, CANCER, V98, P1362, DOI 10.1002/cncr.11655; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fisher ER, 2001, CANCER-AM CANCER SOC, V91, P1679, DOI 10.1002/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8; FULLER SA, 1992, RADIOTHER ONCOL, V25, P19, DOI 10.1016/0167-8140(92)90190-6; Kini VR, 1999, AM J CLIN ONCOL-CANC, V22, P429, DOI 10.1097/00000421-199910000-00001; Kinlen L, 2005, NATURE, V438, P41, DOI 10.1038/438041a; Krag D, 2003, NEW ENGL J MED, V349, P603, DOI 10.1056/NEJMe038105; Nattinger AB, 2000, LANCET, V356, P1148, DOI 10.1016/S0140-6736(00)02757-4; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pierce LJ, 2005, INT J RADIAT ONCOL, V62, P183, DOI 10.1016/j.ijrobp.2004.09.019; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Shank B, 2000, INT J RADIAT ONCOL, V48, P1291, DOI 10.1016/S0360-3016(00)00797-5; SOLIN LJ, 1991, INT J RADIAT ONCOL, V20, P105, DOI 10.1016/0360-3016(91)90145-T; STORM HH, 1992, J NATL CANCER I, V84, P1245, DOI 10.1093/jnci/84.16.1245; Taghian A, 2004, INT J RADIAT ONCOL, V60, P706, DOI 10.1016/j.ijrobp.2004.04.027; Vinh-Hung V, 2004, JNCI-J NATL CANCER I, V96, P115, DOI 10.1093/jnci/djh013; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Whelan TJ, 2000, J CLIN ONCOL, V18, P1220, DOI 10.1200/JCO.2000.18.6.1220	33	3871	4041	10	123	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2087	2106						20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360786				2022-12-28	WOS:000234146000024
J	Schroter, S				Schroter, S			Importance of free access to research articles on decision to submit to the BMJ: survey of authors	BRITISH MEDICAL JOURNAL			English	Article								Objectives 16 determine whether free access to research articles on bmj.com is an important factor in authors' decisions on whether to submit to the BMJ, whether the introduction of access controls to part of the BMJ's content has influenced authors' perceptions of the journal, and whether the introduction of further access controls Would influence authors' perceptions. Design Cross sectional electronic survey. Participants Authors of research articles published in the BMJ. Results 211/415 (51%) eligible authors responded. Three quarters (159/211) said the fact that all readers would have free access to their paper on bmj.com was very important. or important to their decision to submit to the BMJ. Over half (111/211) said closure of free access to research articles Would make them slightly less likely to submit research articles to the BMJ in the future, 14% (29/211) said they would be much less likely to submit, and 34% (71/211) said it would not influence their decision. Authors were equally divided in their opinion as to whether the closure of access to parts of the journal since January 2005 had affected their view of the BMJ, 40% (84/211) said it had, 38% (80/211) said it had not. In contrast, 67% (141/211) said their view of the Billy Would change if it closed access to research articles. Authors' comments largely focused on disappointment with such a regressive step in the era of open access publishing, loss of a distinctive feature of the Billy, a perceived reduction in the journal's usefulness as a resource and global influence, restricted readership, less attractive to publish in, and the negative impact on the journal's image. Conclusions Authors value free access to research articles and consider this an important factor in deciding whether to submit to the Billy. Closing access to research articles would have a negative effect on authors' perceptions of the journal and their likeliness to submit.				sschroter@bmj.com	Schroter, Sara/G-3427-2012	Schroter, Sara/0000-0002-8791-8564				Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Delamothe T, 2003, BRIT MED J, V327, P241, DOI 10.1136/bmj.327.7409.241; EISEN M, 2001, NATURE WEBDEBATES; GODLEE F, 2005, BMJ-BRIT MED J, P330, DOI DOI 10.1136/BMJ.330.7494.0-G; HOPKINS C, 2001, NATURE WEBDEBATES	5	9	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 18	2006	332	7538					394	396		10.1136/bmj.38705.490961.55	http://dx.doi.org/10.1136/bmj.38705.490961.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017HZ	16401629	Bronze, Green Published			2022-12-28	WOS:000235686000017
J	Costa, S; Shaw, P				Costa, S; Shaw, P			Chromatin organization and cell fate switch respond to positional information in Arabidopsis	NATURE			English	Article							ROOT EPIDERMIS; DIFFERENTIATION; REGULATOR; HYPOCOTYL; PROTEIN; GLABRA2; GENE	Many types of plant cell retain their developmental plasticity and have the capacity to switch fate when exposed to a new source of positional information. In the root epidermis of Arabidopsis, cells differentiate in alternating files of hair cells and non-hair cells(1,2), in response to positional information and the activity of the homoeodomain transcription factor GLABRA2 (GL2) in future non-hair cells(3-6). Here we show by three-dimensional fluorescence in situ hybridization on intact root epidermal tissue that alternative states of chromatin organization around the GL2 locus are required to control position-dependent cell-type specification. When, as a result of an atypical cell division, a cell is displaced from a hair file into a non-hair file, it switches fate(6). We show that during this event the chromatin state around the GL2 locus is not inherited, but is reorganized in the G1 phase of the cell cycle in response to local positional information. This ability to remodel chromatin organization may provide the basis for the plasticity in plant cell fate changes.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Shaw, P (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	peter.shaw@bbsrc.ac.uk	shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669; Costa, Silvia/0000-0001-9931-3493				Berger F, 1998, CURR BIOL, V8, P421, DOI 10.1016/S0960-9822(98)70176-9; Costa S, 2003, DEVELOPMENT, V130, P2893, DOI 10.1242/dev.00493; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dolan L, 1999, SEMIN CELL DEV BIOL, V10, P149, DOI 10.1006/scdb.1999.0290; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Hung CY, 1998, PLANT PHYSIOL, V117, P73, DOI 10.1104/pp.117.1.73; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lin Y, 2001, DEVELOPMENT, V128, P3697; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Szymkowiak EJ, 1996, ANNU REV PLANT PHYS, V47, P351, DOI 10.1146/annurev.arplant.47.1.351; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Wolpert L, 2003, DEVELOPMENT, V130, P4497, DOI 10.1242/dev.00728	19	117	121	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					493	496		10.1038/nature04269	http://dx.doi.org/10.1038/nature04269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16362059				2022-12-28	WOS:000234859200051
J	Williams, D; Churchill, D				Williams, D; Churchill, D			Lesson of the week - Ulcerative proctitis in men who have sex with men: an emerging outbreak	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Royal Sussex Cty Hosp, Dept Genitourinary Med, Brighton BN2 5BE, E Sussex, England	University of Brighton	Churchill, D (corresponding author), Royal Sussex Cty Hosp, Dept Genitourinary Med, Brighton BN2 5BE, E Sussex, England.	Duncan.Churchill@bsuh.nhs.uk	Churchill, Duncan/AAT-5441-2020					*BRIT ASS SEX HLTH, CLIN EFF GUID; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GOTZ H, 2004, EUROSURVEILLANCE, P8; *HLTH PROT AG, LGV LYMPH VEN; Mabey D, 2002, SEX TRANSM INFECT, V78, P90, DOI 10.1136/sti.78.2.90; SIMMS I, 2004, EUROSURVEILLANCE WEE, P8; 2004, CDR WEEKLY, V14, P3	7	16	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					99	100		10.1136/bmj.332.7533.99	http://dx.doi.org/10.1136/bmj.332.7533.99			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410585	Green Published			2022-12-28	WOS:000234777000024
J	Stagg, SM; Gurkan, C; Fowler, DM; LaPointe, P; Foss, TR; Potter, CS; Carragher, B; Balch, WE				Stagg, SM; Gurkan, C; Fowler, DM; LaPointe, P; Foss, TR; Potter, CS; Carragher, B; Balch, WE			Structure of the Sec13/31 COPII coat cage	NATURE			English	Article							ENDOPLASMIC-RETICULUM; VESICLE FORMATION; ELECTRON CRYOMICROSCOPY; COMPLEX; ER; TRANSPORT; CLATHRIN; PROTEIN; GOLGI; PURIFICATION	Endomembranes of eukaryotic cells are dynamic structures that are in continuous communication through the activity of specialized cellular machineries(1), such as the coat protein complex II ( COPII), which mediates cargo export from the endoplasmic reticulum (ER)(2,3). COPII consists of the Sar1 GTPase, Sec23 and Sec24 (Sec23/24), where Sec23 is a Sar1-specific GTPase-activating protein and Sec24 functions in cargo selection, and Sec13 and Sec31 (Sec13/31), which has a structural role(3). Whereas recent results have shown that Sec23/24 and Sec13/31 can self-assemble to form COPII cage-like particles(4), we now show that Sec13/31 can self-assemble to form minimal cages in the absence of Sec23/24. We present a three-dimensional reconstruction of these Sec13/31 cages at 30 angstrom resolution using cryo-electron microscopy and single particle analysis. These results reveal a novel cuboctahedron geometry with the potential to form a flexible lattice and to generate a diverse range of containers. Our data are consistent with a model for COPII coat complex assembly in which Sec23/24 has a non-structural role as a multivalent ligand localizing the self-assembly of Sec13/31 to form a cage lattice driving ER cargo export.	Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Carragher, B (corresponding author), Scripps Res Inst, Natl Resource Automated Mol Microscopy, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bcarr@scripps.edu; webalch@scripps.edu	Gurkan, Cemal/S-5751-2016	Gurkan, Cemal/0000-0001-7379-4559; LaPointe, Paul/0000-0002-5465-1795; Carragher, Bridget/0000-0002-0624-5020				Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Belden WJ, 2001, METHOD ENZYMOL, V329, P438; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gurkan C, 2005, METHOD ENZYMOL, V404, P58, DOI 10.1016/S0076-6879(05)04006-1; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Shugrue CA, 1999, J CELL SCI, V112, P4547; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597; ZHU Y, 2004, IEEE ISB104 C ARL VI	29	227	239	4	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					234	238		10.1038/nature04339	http://dx.doi.org/10.1038/nature04339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407955				2022-12-28	WOS:000234538400047
J	Black, C				Black, C			Still striving for utopia	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Black, C (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	carolblack@rcplondon.ac.uk						Department of Health, 2004, STAND BETT HLTH; *ROYAL COLL PHYS L, 2005, DOCT SOC MED PROF CH	2	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					47	48		10.1136/bmj.332.7532.47	http://dx.doi.org/10.1136/bmj.332.7532.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399743	Green Published			2022-12-28	WOS:000234684200027
J	Opie, LH; Commerford, PJ; Gersh, BJ				Opie, LH; Commerford, PJ; Gersh, BJ			Controversies in Cardiology 1 - Controversies in stable coronary artery disease	LANCET			English	Review							C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; LONG-ACTING NIFEDIPINE; EURO HEART SURVEY; MYOCARDIAL-INFARCTION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; METABOLIC SYNDROME; CLINICAL-PRACTICE	Coronary heart disease is still highly prevalent worldwide, and stable angina pectoris is one of its more common presentations. Three major controversies are risk factor management, drug therapy, and intervention. As well as the major risk factors stated by the Framingham study and European guidelines, other factors include abdominal obesity, metabolic syndrome, and psychological stress. How should these additional factors be rated? With respect to drug therapy, apart from aspirin, all patients with stable angina should be assessed for statin treatment. Although statins will reduce coronary events by about one third in patients with vascular disease, the absolute benefit depends on the absolute risk. Non-controversially, all patients should be considered for angiotensin-converting-enzyme inhibitors. The concept that beta blockers are protective from future coronary events can be disputed. Percutaneous coronary intervention can relieve symptoms without extending lifespan beyond medical therapy. However, strong mortality data favour coronary-artery bypass grafting in individuals with triple-vessel or even double-vessel disease. Thus, effort angina needs comprehensive assessment, lifestyle changes, and treatment tailored to the individual patient.	Univ Cape Town, Sch Med, Observ, Hatter Inst Heart Res,Cape Heart Ctr, ZA-7925 Cape Town, South Africa; Univ Cape Town, Sch Med, Observ, Dept Med, ZA-7925 Cape Town, South Africa; Groote Schuur Hosp, Cardic Clin, Dept Med, ZA-7925 Cape Town, South Africa; Mayo Clin, Rochester, MN USA	University of Cape Town; University of Cape Town; University of Cape Town; Mayo Clinic	Opie, LH (corresponding author), Univ Cape Town, Sch Med, Observ, Hatter Inst Heart Res,Cape Heart Ctr, ZA-7925 Cape Town, South Africa.	Opie@capeheart.uct.ac.za						Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arroyo-Espliguero R, 2004, EUR HEART J, V25, P401, DOI 10.1016/j.ehj.2003.12.017; Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Barbut D, 1997, ANN THORAC SURG, V63, P998, DOI 10.1016/S0003-4975(96)01254-4; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Boden WE, 2004, J AM COLL CARDIOL, V43, P1752, DOI 10.1016/j.jacc.2004.02.025; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chong PH, 2004, PHARMACOTHERAPY, V24, P1194, DOI 10.1592/phco.24.13.1194.38084; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Curtis JP, 2004, CIRCULATION, V110, P3746, DOI 10.1161/01.CIR.0000150389.35936.4D; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Deckelbaum R. J., 1999, Circulation, V100, P450; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ellis SG, 2002, CIRCULATION, V106, P1205, DOI 10.1161/01.CIR.0000028146.71416.2E; Fisher M, 2004, HEART, V90, P336, DOI 10.1136/hrt.2003.018622; Forrester JS, 2005, CIRCULATION, V111, P1847, DOI 10.1161/01.CIR.0000160860.36911.BD; Fox KM, 2003, LANCET, V362, P782; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Gersh BJ, 2005, NEW ENGL J MED, V352, P2235, DOI 10.1056/NEJMe058053; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Hlatky MA, 1997, CIRCULATION, V96, P11; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Iakovou L, 2005, J AM COLL CARDIOL, V45, P805, DOI 10.1016/j.jacc.2004.12.012; Iestra JA, 2005, CIRCULATION, V112, P924, DOI 10.1161/CIRCULATIONAHA.104.503995; Jabbour S, 2004, AM J CARDIOL, V93, P294, DOI 10.1016/j.amjcard.2003.10.007; Jenkins DJA, 2002, CIRCULATION, V106, P1327, DOI 10.1161/01.CIR.0000028421.91733.20; Jula A, 2002, JAMA-J AM MED ASSOC, V287, P598, DOI 10.1001/jama.287.5.598; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kaski JC, 2004, CIRCULATION, V109, P568, DOI 10.1161/01.CIR.0000116601.58103.62; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koh KK, 2005, HYPERTENSION, V45, P1088, DOI 10.1161/01.HYP.0000166722.91714.ba; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Leaf A, 2002, CIRCULATION, V105, P1874, DOI 10.1161/01.CIR.0000015344.46176.99; Lenzen MJ, 2005, EUR HEART J, V26, P1169, DOI 10.1093/eurheartj/ehi238; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Lubsen J, 2005, J HYPERTENS, V23, P641, DOI 10.1097/01.hjh.0000160223.94220.29; McKhann GM, 2005, NEUROLOGY, V65, P991, DOI 10.1212/01.wnl.0000175220.78475.99; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704; Ndrepepa G, 2005, CIRCULATION, V112, P2102, DOI 10.1161/CIRCULATIONAHA.105.550715; Newman MF, 2004, CIRCULATION, V110, P3402, DOI 10.1161/01.CIR.0000150860.91937.ED; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; OPIE L, 2004, HEART PHYSL; Opie LH, 2005, DRUGS FOR THE HEART; Park SJ, 2005, CIRCULATION, V112, P2226, DOI 10.1161/CIRCULATIONAHA.105.574798; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Prior JO, 2005, CIRCULATION, V111, P2291, DOI 10.1161/01.CIR.0000164232.62768.51; Qiao Q, 2003, DIABETES CARE, V26, P688; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rihal CS, 2003, CIRCULATION, V108, P2439, DOI 10.1161/01.CIR.0000094405.21583.7C; Ros E, 2004, CIRCULATION, V109, P1609, DOI 10.1161/01.CIR.0000124477.91474.FF; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Ruel G, 2005, METABOLISM, V54, P856, DOI 10.1016/j.metabol.2005.01.031; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Scognamiglio R, 2005, CIRCULATION, V112, P179, DOI 10.1161/CIRCULATIONAHA.104.495127; Selnes OA, 2005, ANN NEUROL, V57, P615, DOI 10.1002/ana.20481; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Snow V, 2004, ANN INTERN MED, V141, P562, DOI 10.7326/0003-4819-141-7-200410050-00014; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Stein E, 2004, AM HEART J, V148, P447, DOI 10.1016/j.ahj.2004.03.052; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vasan RS, 2005, ANN INTERN MED, V142, P393, DOI 10.7326/0003-4819-142-6-200503150-00005; Verhoeff BJ, 2005, CIRCULATION, V111, P76, DOI 10.1161/01.CIR.0000151610.98409.2F; Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; White HD, 2003, LANCET, V362, P755, DOI 10.1016/S0140-6736(03)14295-X; Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Yusuf S, 2005, NEW ENGL J MED, V352, P937; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zebrack JS, 2002, J AM COLL CARDIOL, V39, P632, DOI 10.1016/S0735-1097(01)01804-6	114	51	56	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					69	78		10.1016/S0140-6736(06)67927-0	http://dx.doi.org/10.1016/S0140-6736(06)67927-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399156				2022-12-28	WOS:000234443100033
J	Binney, JJ				Binney, JJ			Astronomy - Triangulating the galaxy	SCIENCE			English	Editorial Material									Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England	University of Oxford	Binney, JJ (corresponding author), Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England.	binney@thphys.ox.ac.uk		Binney, James/0000-0002-1926-2436				Bissantz N, 2004, ASTROPHYS J, V601, pL155, DOI 10.1086/382043; Famaey B, 2005, MON NOT R ASTRON SOC, V363, P603, DOI 10.1111/j.1365-2966.2005.09474.x; HUMPHREYS RM, 1978, ASTROPHYS J SUPPL S, V38, P309, DOI 10.1086/190578; RIX HW, 1995, ASTROPHYS J, V447, P82, DOI 10.1086/175858; Xu Y, 2006, SCIENCE, V311, P54, DOI 10.1126/science.1120914	5	5	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					44	45		10.1126/science.1122556	http://dx.doi.org/10.1126/science.1122556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400138				2022-12-28	WOS:000234546300025
J	Dumont, S; Cheng, W; Serebrov, V; Beran, RK; Tinoco, I; Pyle, AM; Bustamante, C				Dumont, S; Cheng, W; Serebrov, V; Beran, RK; Tinoco, I; Pyle, AM; Bustamante, C			RNA translocation and unwinding mechanism of HCVNS3 helicase and its coordination by ATP	NATURE			English	Article							HEPATITIS-C VIRUS; DNA HELICASE; STEP-SIZE; CRYSTAL-STRUCTURE; MOLECULES; PROTEIN; OLIGONUCLEOTIDE; PROCESSIVITY; REVEALS; BINDING	Helicases are a ubiquitous class of enzymes involved in nearly all aspects of DNA and RNA metabolism. Despite recent progress in understanding their mechanism of action, limited resolution has left inaccessible the detailed mechanisms by which these enzymes couple the rearrangement of nucleic acid structures to the binding and hydrolysis of ATP(1,2). Observing individual mechanistic cycles of these motor proteins is central to understanding their cellular functions. Here we follow in real time, at a resolution of two base pairs and 20 ms, the RNA translocation and unwinding cycles of a hepatitis C virus helicase (NS3) monomer. NS3 is a representative superfamily-2 helicase essential for viral replication(3), and therefore a potentially important drug target(4). We show that the cyclic movement of NS3 is coordinated by ATP in discrete steps of 11 +/- 3 base pairs, and that actual unwinding occurs in rapid smaller substeps of 3.6 +/- 1.3 base pairs, also triggered by ATP binding, indicating that NS3 might move like an inchworm(5,6). This ATP-coupling mechanism is likely to be applicable to other non-hexameric helicases involved in many essential cellular functions. The assay developed here should be useful in investigating a broad range of nucleic acid translocation motors.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Yale University; Howard Hughes Medical Institute; Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Serebrov, Victor/0000-0002-5800-3103	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bianco PR, 2004, LANCET, V364, P1385, DOI 10.1016/S0140-6736(04)17238-3; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Frick DN, 2003, DRUG NEWS PERSPECT, V16, P355, DOI 10.1358/dnp.2003.16.6.829307; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	30	287	294	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					105	108		10.1038/nature04331	http://dx.doi.org/10.1038/nature04331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397502	Green Accepted			2022-12-28	WOS:000234378700043
J	Ruiz-Palacios, GM; Perez-Schael, I; Velazquez, FR; Abate, H; Breuer, T; Clemens, SC; Cheuvart, B; Espinoza, F; Gillard, P; Innis, BL; Cervantes, Y; Linhares, AC; Lopez, P; Macias-Parra, M; Ortega-Barria, E; Richardson, V; Rivera-Medina, DM; Rivera, L; Salinas, B; Pavia-Ruz, N; Salmeron, J; Ruttimann, R; Tinoco, JC; Rubio, P; Nunez, E; Guerrero, ML; Yarzabal, JP; Damaso, S; Tornieporth, N; Saez-Llorens, X; Vergara, RF; Vesikari, T; Bouckenooghe, A; Clemens, R; De Vos, B; O'Ryan, M				Ruiz-Palacios, GM; Perez-Schael, I; Velazquez, FR; Abate, H; Breuer, T; Clemens, SC; Cheuvart, B; Espinoza, F; Gillard, P; Innis, BL; Cervantes, Y; Linhares, AC; Lopez, P; Macias-Parra, M; Ortega-Barria, E; Richardson, V; Rivera-Medina, DM; Rivera, L; Salinas, B; Pavia-Ruz, N; Salmeron, J; Ruttimann, R; Tinoco, JC; Rubio, P; Nunez, E; Guerrero, ML; Yarzabal, JP; Damaso, S; Tornieporth, N; Saez-Llorens, X; Vergara, RF; Vesikari, T; Bouckenooghe, A; Clemens, R; De Vos, B; O'Ryan, M		Human Rotavirus Vaccine Study Grp	Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL INTUSSUSCEPTION; INFANTS; CHILDREN; LIVE; SURVEILLANCE; HOSPITALIZATIONS; IMMUNOGENICITY; HOSPITALS; SANTIAGO; AMERICA	BACKGROUND: The safety and efficacy of an attenuated G1P[8] human rotavirus (HRV) vaccine were tested in a randomized, double-blind, phase 3 trial. METHODS: We studied 63,225 healthy infants from 11 Latin American countries and Finland who received two oral doses of either the HRV vaccine (31,673 infants) or placebo (31,552 infants) at approximately two months and four months of age. Severe gastroenteritis episodes were identified by active surveillance. The severity of disease was graded with the use of the 20-point Vesikari scale. Vaccine efficacy was evaluated in a subgroup of 20,169 infants (10,159 vaccinees and 10,010 placebo recipients). RESULTS: The efficacy of the vaccine against severe rotavirus gastroenteritis and against rotavirus-associated hospitalization was 85 percent (P<0.001 for the comparison with placebo) and reached 100 percent against more severe rotavirus gastroenteritis. Hospitalization for diarrhea of any cause was reduced by 42 percent (95 percent confidence interval, 29 to 53 percent; P<0.001). During the 31-day window after each dose, six vaccine recipients and seven placebo recipients had definite intussusception (difference in risk, -0.32 per 10,000 infants; 95 percent confidence interval, -2.91 to 2.18; P=0.78). CONCLUSIONS: Two oral doses of the live attenuated G1P[8] HRV vaccine were highly efficacious in protecting infants against severe rotavirus gastroenteritis, significantly reduced the rate of severe gastroenteritis from any cause, and were not associated with an increased risk of intussusception.	Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; Inst Biomed Fuvesin, Secc Enfermedades Enter, Caracas, Venezuela; Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Ped, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City, DF, Mexico; Hosp Dr Humberto Notti, Mendoza, Argentina; GlaxoSmithKline Biol, Rixensart, Belgium; GlaxoSmithKline Biol, Rio De Janeiro, Brazil; Carlos Chagas Inst, Rio De Janeiro, Brazil; Univ Nacl Autonoma Leon, Leon, Nicaragua; GlaxoSmithKline Inc, King Of Prussia, PA USA; GlaxoSmithKline Inc, Mexico City, DF, Mexico; Minist Hlth, Inst Evandro Chagas, Belem, Para, Brazil; Clin Materno Infantil Farallones, Cali, Colombia; Inst Nacl Pediat, Mexico City, DF, Mexico; Inst Adv Sci Invest & High Technol Serv, Panama City, Panama; Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; Hosp Especialidades Ctr Med La Raza, Inst Hondureno Seguridad Social, Tegucigalpa, Honduras; Hosp Nuestra Senora Altagracia, Santo Domingo, Dominican Rep; Univ Carabobo, Hosp Ninos, Serv Hidratac, Ciudad Hosp Dr Enrique Tejera Insalud, Valencia, Estado Carabobo, Venezuela; Univ Nacl Autonoma Mexico, Dept Expt Med, Mexico City 04510, DF, Mexico; Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; GlaxoSmithKline Inc, Buenos Aires, DF, Argentina; Hosp Gen Durango, Durango, Mexico; GlaxoSmithKline Inc, San Jose, Costa Rica; Univ Concepcion, Concepcion, Chile; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; Hosp Nino, Dept Infect Dis, Panama City, Panama; Univ Valparaiso, Fac Med, Preclin Dept, Valparaiso, Chile; Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile	Universidad de Chile; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Mexicano del Seguro Social; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Instituto Evandro Chagas; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social; GlaxoSmithKline; GlaxoSmithKline; Universidad de Concepcion; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad de Valparaiso; Tampere University; Universidad de Chile	O'Ryan, M (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Independencia 1027, Santiago 7, Chile.	moryan@med.uchile.cl	Ruiz-Palacios, Guillermo/GYQ-5462-2022; O'Ryan, Miguel/H-3478-2013	O'Ryan, Miguel/0000-0002-7926-2163; Innis, Bruce/0000-0002-1753-7248; SAEZ LLORENS, XAVIER/0000-0002-1149-5905; Macias, Mercedes/0000-0002-3538-2550; Yarzabal, Juan Pablo/0000-0002-6490-2084; Costa Clemens, Sue Ann/0000-0001-9576-0878; Clemens, Ralf/0000-0003-4685-4207; Lopez Lopez, Pio/0000-0001-5230-6595; Salmeron, Jorge/0000-0002-5113-299X				ABATE H, 2004, INT C PED CANC MEX A; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P2; Bernstein DI, 2002, J INFECT DIS, V186, P1487, DOI 10.1086/344732; Bernstein DI, 1999, LANCET, V354, P287, DOI 10.1016/S0140-6736(98)12106-2; Bernstein DI, 1998, VACCINE, V16, P381, DOI 10.1016/S0264-410X(97)00210-7; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; De Vos Beatrice, 2004, Pediatr Infect Dis J, V23, pS179, DOI 10.1097/01.inf.0000142370.16514.4a; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Griffin DD, 2000, J CLIN MICROBIOL, V38, P2784, DOI 10.1128/JCM.38.7.2784-2787.2000; Guardado Julio A Armero, 2004, Pediatr Infect Dis J, V23, pS156, DOI 10.1097/01.inf.0000142464.83628.8e; HEATON P, 2005, M ADV COMM IMM PRACT; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; Kane EM, 2004, REV PANAM SALUD PUBL, V16, P371, DOI 10.1590/S1020-49892004001200002; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Linhares A C, 2000, Rev Panam Salud Publica, V8, P305, DOI 10.1590/S1020-49892000001000002; Lucero Y, 2004, REV MED CHILE, V132, P565; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Murphy BR, 2003, J INFECT DIS, V187, P1301, DOI 10.1086/367895; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; O'Ryan M, 2003, PEDIATR INFECT DIS J, V22, P717, DOI 10.1097/01.inf.0000078374.82903.e8; O'Ryan M, 2001, PEDIATR INFECT DIS J, V20, P685, DOI 10.1097/00006454-200107000-00009; Pang XL, 1999, J CLIN VIROL, V13, P9, DOI 10.1016/S1386-6532(98)00013-4; PARASHAR U, 2004, P 6 INT ROT S MEX CI, P6; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Perez-Schael I, 2003, PEDIATR INFECT DIS J, V22, P234, DOI 10.1097/00006454-200303000-00006; PerezSchael I, 1998, NEW ENGL J MED, V338, P1002; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; PEREZSCHAEL I, 2005, 5 INT C ANT AG CHEM; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Saez-Llorens X, 2004, PEDIATR INFECT DIS J, V23, P363, DOI 10.1097/00006454-200404000-00020; Salinas Belen, 2004, Pediatr Infect Dis J, V23, pS161, DOI 10.1097/01.inf.0000142465.25992.c3; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Santosham M, 1997, J PEDIATR-US, V131, P632, DOI 10.1016/S0022-3476(97)70076-3; Simonsen L, 2005, J INFECT DIS, V192, pS36, DOI 10.1086/431512; Tang ML, 2004, STAT MED, V23, P3593, DOI 10.1002/sim.1906; Velazquez F Raul, 2004, Pediatr Infect Dis J, V23, pS149, DOI 10.1097/01.inf.0000142463.72442.91; Velazquez F Raul, 2004, Pediatr Infect Dis J, V23, pS173, DOI 10.1097/01.inf.0000142467.50724.de; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2004, VACCINE, V22, P2836, DOI 10.1016/j.vaccine.2004.01.044; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; Withdrawal of rotavirus vaccine, 1999, MMWR-MORBID MORTAL W, V48, P1007; 1997, WKLY EPIDEMIOL REC, V72, P35	46	1379	1449	3	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					11	22		10.1056/NEJMoa052434	http://dx.doi.org/10.1056/NEJMoa052434			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394298	Bronze			2022-12-28	WOS:000234358600004
J	Garfield, E				Garfield, E			The history and meaning of the journal impact factor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; CITATIONS; ESTROGEN; SCIENCE; ACCESS		Thomson Sci, Philadelphia, PA 19104 USA	Clarivate	Garfield, E (corresponding author), Thomson Sci, 3501 Market St, Philadelphia, PA 19104 USA.	garfield@codex.cis.upenn.edu	Garfield, Eugene/A-1009-2008					Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Antelman K, 2004, COLL RES LIBR, V65, P372, DOI 10.5860/crl.65.5.372; Brodman E, 1944, Bull Med Libr Assoc, V32, P479; Garfield E, 1998, SCIENTIST, V12, P12; Garfield E, 1998, SCIENTIST, V12, P10; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; GARFIELD E, 1986, ANN INTERN MED, V105, P3113; GARFIELD E, 1972, CURR CONTENTS, P5; GARFIELD E, 1963, GENETICS CITATION IN; Hansen HB, 1997, CLIN PHYSIOL, V17, P409, DOI 10.1046/j.1365-2281.1997.04545.x; Hoeffel C, 1998, ALLERGY, V53, P1225, DOI 10.1111/j.1398-9995.1998.tb03848.x; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; Lock S., 1989, CBE VIEWS, V12, P57; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Opthof T, 1999, CARDIOVASC RES, V41, P1; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; Pudovkin AI, 2004, P ASIST ANNU, V41, P507, DOI 10.1002/meet.1450410159; Pudovkin AI, 2002, J AM SOC INF SCI TEC, V53, P1113, DOI 10.1002/asi.10153; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; *THOMS SCI, J PERFORMANCE INDICA; Vaughan L, 2003, J AM SOC INF SCI TEC, V54, P1313, DOI 10.1002/asi.10338; Yu G, 2005, SCIENTOMETRICS, V64, P235, DOI 10.1007/s11192-005-0249-4	25	1522	1597	28	635	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					90	93		10.1001/jama.295.1.90	http://dx.doi.org/10.1001/jama.295.1.90			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999HT	16391221				2022-12-28	WOS:000234381100025
J	Bach, PB; McClellan, MB				Bach, PB; McClellan, MB			A prescription for a modern Medicare program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Medicare & Med Serv, Washington, DC USA	Centers for Medicare & Medicaid Services	Bach, PB (corresponding author), Ctr Medicare & Med Serv, Washington, DC USA.								0	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2733	2735		10.1056/NEJMp058249	http://dx.doi.org/10.1056/NEJMp058249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	997LK	16382056				2022-12-28	WOS:000234246700001
J	Borsani, O; Zhu, JH; Verslues, PE; Sunkar, R; Zhu, JK				Borsani, O; Zhu, JH; Verslues, PE; Sunkar, R; Zhu, JK			Endogenous siRNAs derived from a pair of natural cis-antisense transcripts regulate salt tolerance in Arabidopsis	CELL			English	Article							TRANS-ACTING SIRNAS; DOUBLE-STRANDED-RNA; BINDING-PROTEIN HYL1; DNA METHYLATION; PROLINE CATABOLISM; INTERFERING RNA; PLANTS; MICRORNAS; GENES; BIOGENESIS	In higher eukaryotes, miRNAs and siRNAs guide translational inhibition, mRNA cleavage, or chromatin regulation. We found that the antisense overlapping gene pair of Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH), a stress-related gene, and SRO5, a gene of unknown function, generates two types of siRNAs. When both transcripts are present, a 24-nt siRNA is formed by a biogenesis pathway dependent on DCL2, RDR6, SGS3, and NRPD1 A. Initial cleavage of the P5CDH transcript guided by the 24-nt siRNA establishes a phase for the subsequent generation of 21-nt siRNAs by DCL1 and further cleavage of P5CDH transcripts. The expression of SRO5 is induced by salt, and this induction is required to initiate siRNA formation. Our data suggest that the P5CDH and SRO5 proteins are also functionally related, and that the P5CDHSRO5 gene pair defines a mode of siRNA function and biogenesis that may be applied to other natural cis-antisense gene pairs in eukaryotic genomes.	Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Zhu, Jianhua/F-7127-2013; Sunkar, Ramanjulu/L-2982-2014	Zhu, Jian-Kang/0000-0001-5134-731X; Borsani, Omar/0000-0002-9111-5801	NIGMS NIH HHS [R01GM59138, R01 GM059138, R01GM0707501, R01 GM059138-11] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ayliffe MA, 2002, PLANT PHYSIOL, V129, P169, DOI 10.1104/pp.010940; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Boi S, 2004, CURR GENOMICS, V5, P509, DOI 10.2174/1389202043349020; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hellmann H, 2000, PLANT PHYSIOL, V123, P779, DOI 10.1104/pp.123.2.779; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Iyer S, 1998, PLANT PHYSIOL, V116, P203, DOI 10.1104/pp.116.1.203; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	52	776	871	4	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1279	1291		10.1016/j.cell.2005.11.035	http://dx.doi.org/10.1016/j.cell.2005.11.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377568	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000234584500016
J	Lomas, D				Lomas, D			Painting the history of cardiology	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Sch Arts Hist Cultures, Manchester M13 9PL, Lancs, England	University of Manchester	Lomas, D (corresponding author), Univ Manchester, Sch Arts Hist Cultures, Manchester M13 9PL, Lancs, England.	david.c.lomas@manchester.ac.uk						Chavez Ignacio, 1946, DIEGO RIVERA SUS FRE; IZQUIERDO JJ, 1942, CUANDROS MURALES FAC; Izquierdo Jose Joaquin, 1936, HARVEY INICIADOR MET; Vasconcelos Jose, 1997, COSMIC RACE RAZA COS	4	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1533	1535		10.1136/bmj.331.7531.1533	http://dx.doi.org/10.1136/bmj.331.7531.1533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373742	Green Published, Bronze			2022-12-28	WOS:000234351300023
J	Machida, M; Asai, K; Sano, M; Tanaka, T; Kumagai, T; Terai, G; Kusumoto, KI; Arima, T; Akita, O; Kashiwagi, Y; Abe, K; Gomi, K; Horiuchi, H; Kitamoto, K; Kobayashi, T; Takeuchi, M; Denning, DW; Galagan, JE; Nierman, WC; Yu, JJ; Archer, DB; Bennett, JW; Bhatnagar, D; Cleveland, TE; Fedorova, ND; Gotoh, O; Horikawa, H; Hosoyama, A; Ichinomiya, M; Igarashi, R; Iwashita, K; Juvvadi, PR; Kato, M; Kato, Y; Kin, T; Kokubun, A; Maeda, H; Maeyama, N; Maruyama, J; Nagasaki, H; Nakajima, T; Oda, K; Okada, K; Paulsen, I; Sakamoto, K; Sawano, T; Takahashi, M; Takase, K; Terabayashi, Y; Wortman, JR; Yamada, O; Yamagata, Y; Anazawa, H; Hata, Y; Koide, Y; Komori, T; Koyama, Y; Minetoki, T; Suharnan, S; Tanaka, A; Isono, K; Kuhara, S; Ogasawara, N; Kikuchi, H				Machida, M; Asai, K; Sano, M; Tanaka, T; Kumagai, T; Terai, G; Kusumoto, KI; Arima, T; Akita, O; Kashiwagi, Y; Abe, K; Gomi, K; Horiuchi, H; Kitamoto, K; Kobayashi, T; Takeuchi, M; Denning, DW; Galagan, JE; Nierman, WC; Yu, JJ; Archer, DB; Bennett, JW; Bhatnagar, D; Cleveland, TE; Fedorova, ND; Gotoh, O; Horikawa, H; Hosoyama, A; Ichinomiya, M; Igarashi, R; Iwashita, K; Juvvadi, PR; Kato, M; Kato, Y; Kin, T; Kokubun, A; Maeda, H; Maeyama, N; Maruyama, J; Nagasaki, H; Nakajima, T; Oda, K; Okada, K; Paulsen, I; Sakamoto, K; Sawano, T; Takahashi, M; Takase, K; Terabayashi, Y; Wortman, JR; Yamada, O; Yamagata, Y; Anazawa, H; Hata, Y; Koide, Y; Komori, T; Koyama, Y; Minetoki, T; Suharnan, S; Tanaka, A; Isono, K; Kuhara, S; Ogasawara, N; Kikuchi, H			Genome sequencing and analysis of Aspergillus oryzae	NATURE			English	Article							HIGH-LEVEL EXPRESSION; GENE; EVOLUTION; TRANSFORMATION; PLASMID; PROGRAM; FLAVUS; YEAST; TAGS; DNA	The genome of Aspergillus oryzae, a fungus important for the production of traditional fermented foods and beverages in Japan, has been sequenced. The ability to secrete large amounts of proteins and the development of a transformation system(1) have facilitated the use of A. oryzae in modern biotechnology(2-4). Although both A. oryzae and Aspergillus flavus belong to the section Flavi of the subgenus Circumdati of Aspergillus, A. oryzae, unlike A. flavus, does not produce aflatoxin, and its long history of use in the food industry has proved its safety. Here we show that the 37-megabase (Mb) genome of A. oryzae contains 12,074 genes and is expanded by 7 - 9 Mb in comparison with the genomes of Aspergillus nidulans(5) and Aspergillus fumigatus(6). Comparison of the three aspergilli species revealed the presence of syntenic blocks and A. oryzae-specific blocks ( lacking synteny with A. nidulans and A. fumigatus) in a mosaic manner throughout the genome of A. oryzae. The blocks of A. oryzae-specific sequence are enriched for genes involved in metabolism, particularly those for the synthesis of secondary metabolites. Specific expansion of genes for secretory hydrolytic enzymes, amino acid metabolism and amino acid/sugar uptake transporters supports the idea that A. oryzae is an ideal microorganism for fermentation.	Natl Inst Adv Ind Sci & Technol AIST, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; AIST, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Technol & Evaluat, Shibuya Ku, Tokyo 1510066, Japan; Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; Natl Res Inst Brewing, Hiroshima 7390046, Japan; Tohoku Univ, Aoba Ku, Sendai, Miyagi 9818555, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan; Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Tokyo Univ Agr & Technol, Tokyo 1830054, Japan; Univ Manchester, Manchester M23 9PL, Lancs, England; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Inst Genom Res, Rockville, MD 20850 USA; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; Tulane Univ, New Orleans, LA 70118 USA; Kyowa Hakko Kogyo Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan; Gekkeikan Sake Co Ltd, Res Inst, Fushimi Ku, Kyoto 6128361, Japan; Amano Enzyme Inc, Gifu 5090108, Japan; INTEC Web & Genome Informat Corp, Koto Ku, Tokyo 1368637, Japan; Kikkoman Foods Inc, Chiba 2780037, Japan; Ozeki Co Ltd, Nishinomiya, Hyogo 6638227, Japan; Axiohelix, Koto Ku, Tokyo 1350064, Japan; Higeta Shoyu Ltd, Chiba 2888680, Japan; Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan; Nara Inst Sci & Technol, Nara 6300101, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Tohoku University; University of Tokyo; Nagoya University; Tokyo University of Agriculture & Technology; University of Manchester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; J. Craig Venter Institute; George Washington University; United States Department of Agriculture (USDA); University of Nottingham; Tulane University; Kyowa Kirin Ltd; Kikkoman Corporation; Kyushu University; Nara Institute of Science & Technology	Machida, M (corresponding author), Natl Inst Adv Ind Sci & Technol AIST, Inst Biol Resources & Funct, Higashi 1-1-1, Tsukuba, Ibaraki 3058566, Japan.	m.machida@aist.go.jp	Paulsen, Ian T/K-3832-2012; Denning, David/AAC-6931-2019; Abrams, Natalie/AAM-5468-2021; TAKEUCHI, Michio/H-6592-2013; Yamagata, Youhei/H-6602-2013; Bennett, Joan W./AAT-1267-2021; Kobayashi, Tetsuo/I-6901-2014; Kato, Masashi/AAG-3755-2021; Abrams, Natalie/F-4845-2011; Ogasawara, Naotake/B-7971-2011; Asai, Kiyoshi/AAT-8344-2020; Juvvadi, Praveen/G-9380-2012	Paulsen, Ian T/0000-0001-9015-9418; Denning, David/0000-0001-5626-2251; Abrams, Natalie/0000-0001-9698-2819; Kobayashi, Tetsuo/0000-0002-4008-454X; Kato, Masashi/0000-0002-8951-3640; Abrams, Natalie/0000-0001-9698-2819; Asai, Kiyoshi/0000-0003-0909-4982; Juvvadi, Praveen/0000-0002-5112-7824; Terabayashi, Yasunobu/0000-0002-3372-0907; Galagan, James/0000-0003-0542-3291; Wortman, Jennifer/0000-0002-8713-1227	Biotechnology and Biological Sciences Research Council [CFB17726] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Archer DB, 2004, CURR OPIN MICROBIOL, V7, P499, DOI 10.1016/j.mib.2004.08.003; ASAI K, 1998, PAC S BIOCOMPUT, V3, P228; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Gotoh O, 2000, BIOINFORMATICS, V16, P190, DOI 10.1093/bioinformatics/16.3.190; HATA Y, 1991, GENE, V108, P145, DOI 10.1016/0378-1119(91)90500-B; HORI H, 1987, MOL BIOL EVOL, V4, P445; IIMURA Y, 1987, AGR BIOL CHEM TOKYO, V51, P323, DOI 10.1080/00021369.1987.10868064; KITAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P1467, DOI 10.1271/bbb.58.1467; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; LAWRENCE JG, 1992, GENETICS, V131, P753; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maeda H, 2004, APPL MICROBIOL BIOT, V65, P74, DOI 10.1007/s00253-004-1608-4; Majoros WH, 2003, NUCLEIC ACIDS RES, V31, P3601, DOI 10.1093/nar/gkg527; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; Prade RA, 1997, P NATL ACAD SCI USA, V94, P14564, DOI 10.1073/pnas.94.26.14564; Sakaguchi K, 1992, APPL MOL GENETICS FI, P54; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSUCHIYA K, 1992, APPL MICROBIOL BIOT, V38, P109; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; WARD PP, 1992, BIO-TECHNOL, V10, P784, DOI 10.1038/nbt0792-784; WATSON JC, 1986, METHOD ENZYMOL, V118, P57; Yu JJ, 2004, FEMS MICROBIOL LETT, V237, P333, DOI 10.1016/j.femsle.2004.06.054	28	899	1582	17	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1157	1161		10.1038/nature04300	http://dx.doi.org/10.1038/nature04300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372010	Bronze, Green Published			2022-12-28	WOS:000234111500051
J	Martinez, FD				Martinez, FD			Safety of long-acting beta agonists - An urgent need to clear the air	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRONCHODILATOR TREATMENT; ASTHMA; SALMETEROL		Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ 85721 USA	University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ 85721 USA.							Anderson HR, 2005, BRIT MED J, V330, P117, DOI 10.1136/bmj.38316.729907.8F; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Getahun D, 2005, J ASTHMA, V42, P373, DOI 10.1081/JAS-200062995; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3	4	111	113	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2637	2639		10.1056/NEJMp058299	http://dx.doi.org/10.1056/NEJMp058299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371628				2022-12-28	WOS:000234094400003
J	Pages, F; Berger, A; Camus, M; Sanchez-Cabo, F; Costes, A; Molidor, R; Mlecnik, B; Kirilovsky, A; Nilsson, M; Damotte, D; Meatchi, T; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Galon, J				Pages, F; Berger, A; Camus, M; Sanchez-Cabo, F; Costes, A; Molidor, R; Mlecnik, B; Kirilovsky, A; Nilsson, M; Damotte, D; Meatchi, T; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Galon, J			Effector memory T cells, early metastasis, and survival in colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; CLUSTER-ANALYSIS; COLON-CARCINOMA; INFLAMMATION; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; CROSSROADS; EXPRESSION; DEATH; LINK	Background: The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. Methods: We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). Results: Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor-node-metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-gamma, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7-CD28+CD27+) to effector memory (CD45RO+ CCR7-CD28-CD27-) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival. Conclusions: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.	Univ Paris 06, Assistance Publ Hop Paris, Rene Descartes Fac Med, INSERM,U255, Paris, France; Georges Pompidou European Hosp, Dept Gen & Digest Surg, Paris, France; Georges Pompidou European Hosp, Dept Pathol, Paris, France; Georges Pompidou European Hosp, Immunol Lab, Paris, France; Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Graz University of Technology	Galon, J (corresponding author), Ctr Rech Biomed Cordeliers, INSERM, U255, 15 Rue Ecole Med, F-75006 Paris, France.	jerome.galon@u255.bhdc.jussieu.fr	costes, anne/A-1564-2010; Galon, Jerome/G-9838-2019; Sanchez-Cabo, Fatima/N-5030-2014; mlecnik, bernhard/AAT-7467-2021; Trajanoski, Zlatko/AAT-6703-2021; Sanchez-Cabo, Fatima/AAC-5563-2020; COLENO-COSTES, Anne/K-3176-2015	Galon, Jerome/0000-0001-9635-1339; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Sanchez-Cabo, Fatima/0000-0003-1881-1664; COLENO-COSTES, Anne/0000-0002-1775-682X; fridman, wolf herman/0000-0002-1332-0973				Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Compton CC, 2003, MODERN PATHOL, V16, P376, DOI 10.1097/01.MP.0000062859.46942.93; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalerba P, 2003, CRIT REV ONCOL HEMAT, V46, P33, DOI 10.1016/S1040-8428(02)00159-2; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Moore RJ, 1999, NAT MED, V5, P1087, DOI 10.1038/12532; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Pages F, 1999, INT J CANCER, V84, P326, DOI 10.1002/(SICI)1097-0215(19990621)84:3<326::AID-IJC22>3.0.CO;2-K; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sobin, 2009, UICC TNM CLASSIFICAT; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Xiang R, 1999, J IMMUNOL, V163, P3676; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	30	1528	1603	5	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2654	2666		10.1056/NEJMoa051424	http://dx.doi.org/10.1056/NEJMoa051424			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371631				2022-12-28	WOS:000234094400006
J	McKim, KS				McKim, KS			When size does not matter: Pairing sites during meiosis	CELL			English	Review							CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; MEIOTIC RECOMBINATION; X-CHROMOSOME	Specialized sites along DNA maintain the pairing of homologous chromosomes during meiosis. Three research articles, including two in this issue of Cell, describe proteins from the fruit fly (Thomas et al., 2005) and the worm (MacQueen et al., 2005; Phillips et al., 2005) that bind to these sites and stabilize pairing interactions.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	McKim, KS (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.	mckim@rci.rutgers.edu						Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; COOPER KW, 1964, P NATL ACAD SCI USA, V52, P1248, DOI 10.1073/pnas.52.5.1248; Hawley R.S., 1988, GENETIC RECOMBINATIO, P497; HAWLEY RS, 1980, GENETICS, V94, P625; HERMAN RK, 1989, GENETICS, V121, P723; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MCKEE BD, 1992, GENETICS, V132, P529; MCKIM KS, 1988, GENETICS, V120, P987; MCKIM KS, 1993, GENETICS, V134, P749; Meneely PM, 2002, GENETICS, V162, P1169; Sherizen D, 2005, GENETICS, V169, P767, DOI 10.1534/genetics.104.035824; Thomas SE, 2005, CELL, V123, P555, DOI 10.1016/j.cell.2005.08.043; Tomkiel JE, 2001, GENETICS, V157, P273; Vazquez J, 2002, CURR BIOL, V12, P1473, DOI 10.1016/S0960-9822(02)01090-4; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	16	8	8	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					989	992		10.1016/j.cell.2005.11.031	http://dx.doi.org/10.1016/j.cell.2005.11.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360029	Bronze			2022-12-28	WOS:000234177200008
J	Harland, RW				Harland, RW			Essay - Sport and exercise medicine - a personal perspective	LANCET			English	Article									Queens Univ Belfast, Belfast, Antrim, North Ireland	Queens University Belfast		r.hadand@qub.ac.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S53	S54		10.1016/S0140-6736(05)67852-X	http://dx.doi.org/10.1016/S0140-6736(05)67852-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360757				2022-12-28	WOS:000234374400033
J	Thorp, MA; James, AL				Thorp, MA; James, AL			Prosper Meniere	LANCET			English	Editorial Material							DISEASE; MENIERE,PROSPER		Western Mem Reg Hosp, Corner Brook, NF A2H 6C7, Canada; Southmead Gen Hosp, Dept Otolaryngol, Bristol, Avon, England	Southmead Hospital	Thorp, MA (corresponding author), Western Mem Reg Hosp, Corner Brook, NF A2H 6C7, Canada.	m_cthorp@nf.sympatico.ca		James, Adrian/0000-0002-4125-4053				Alford B; Committee on Hearing and Equilibrium, 1972, T AM ACAD OPHTHALMOL, V76, P1462; Baloh RW, 2001, ARCH NEUROL-CHICAGO, V58, P1151, DOI 10.1001/archneur.58.7.1151; Beasley NJP, 1996, J LARYNGOL OTOL, V110, P1107, DOI 10.1017/S002221510013590X; *COMM HEAR EQ, 1995, OTOLARYNGOL HEAD NEC, V93, P579; Committee on Hearing and Equilibrium, 1985, AAO HNS B, V5, P6; Furstenberg AC, 1941, ARCHIV OTOLARYNGOL, V34, P1083; James AL, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001873; JAMES AL, 2003, CLIN EVID, V9, P565; MCBRIDE P, 1880, EDINBURGH MED J, V25, P702; MCKEE GJ, 1991, CLIN OTOLARYNGOL, V16, P216, DOI 10.1111/j.1365-2273.1991.tb01980.x; Morrison A W, 1997, Ear Nose Throat J, V76, P626; PAPPAS DG, 1993, AM J OTOL, V14, P318; Silverstein Herbert, 2003, Ear Nose Throat J, V82, P185; Thomsen J, 1998, ACTA OTO-LARYNGOL, V118, P769, DOI 10.1080/00016489850182413	14	12	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2137	2139		10.1016/S0140-6736(05)67144-9	http://dx.doi.org/10.1016/S0140-6736(05)67144-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360793				2022-12-28	WOS:000234146000031
J	Saturno, WA; Stuart, D; Beltran, B				Saturno, WA; Stuart, D; Beltran, B			Early Maya writing at San Bartolo, Guatemala	SCIENCE			English	Article							ORIGINS	The ruins of San Bartolo, Guatemala, contain a sample of Maya hieroglyphic writing dating to the Late Preclassic period (400 B.C. to 200 A.D.). The writing appears on preserved painted walls and plaster fragments buried within the pyramidal structure known as "Las Pinturas,'' which was constructed in discrete phases over several centuries. Samples of carbonized wood that are closely associated with the writing have calibrated radiocarbon dates of 200 to 300 B.C. This early Maya writing implies that a developed Maya writing system was in use centuries earlier than previously thought, approximating a time when we see the earliest scripts elsewhere in Mesoamerica.	Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA; Univ Texas, Dept Art & Art Hist, Austin, TX 78712 USA; Univ San Carlos, Escuela Hist, Guatemala City, Guatemala	University System Of New Hampshire; University of New Hampshire; University of Texas System; University of Texas Austin; Universidad de San Carlos de Guatemala	Saturno, WA (corresponding author), Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA.	wsaturno@unh.edu						Cahn Robert, 1993, INDIANA, V13, P39; CAPITAINE FW, 1988, PUBL RES REPORTS ANC, V16; Flannery KV, 2003, P NATL ACAD SCI USA, V100, P11801, DOI 10.1073/pnas.1934526100; HANSEN RD, 1991, EARLY MAYA TEXT MIRA; HOUSTON SD, 2005, 1 WRITING SCRIPT INV, P293; JUSTESON JS, 1993, SCIENCE, V259, P1703, DOI 10.1126/science.259.5102.1703; MARCUS J, 1976, ANNU REV ANTHROPOL, V5, P35, DOI 10.1146/annurev.an.05.100176.000343; MARCUS J, 1992, MESOAMERICAN WRITING, P41; ONEILL T, 2002, NATIL GEOGRAPHIC MAG, V201, P70; Pohl MED, 2002, SCIENCE, V298, P1984, DOI 10.1126/science.1078474; SATURNO W, 2001, REONOCIMIENTO ARQUEO; SATURNO W, 2005, PUBL ANCIENT AM, V7; SATURNO W, 2002, SYMBOLS, P3; Sharer Robert James, 1987, ARCHAEOLOGICAL INVES, P49; Wauchope Robert, 1965, HDB MIDDLE AM INDIAN, V3, P931	15	69	69	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2006	311	5765					1281	1283		10.1126/science.1121745	http://dx.doi.org/10.1126/science.1121745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16400112				2022-12-28	WOS:000235870400040
J	Wilson, CB				Wilson, CB			Surgery - Adoption of new surgical technology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANEURYSMS		Hlth Technol Ctr, San Francisco, CA USA; Inst Future Calif, Menlo Pk, CA USA		Wilson, CB (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	cwilson@charleswilson.org						[Anonymous], 1989, JAMA-J AM MED ASSOC, V262, P953; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Cain M., 2002, DIFFUSION INNOVATION; Chalmers T C, 1972, Ann Thorac Surg, V14, P323; Christensen C. M., 1997, INNOVATORS DILEMMA N; Gladwell M., 2006, TIPPING POINT LITTLE; GUGLIELMI G, 1991, J NEUROSURG, V75, P8, DOI 10.3171/jns.1991.75.1.0008; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; MCKINLAY JB, 1980, MILBANK FUND Q, V58, P217, DOI 10.2307/3349713; MCKINLAY JB, 1981, MILBANK FUND Q, V59, P374, DOI 10.2307/3349685; MITTMAN R, 2004, DIFFUSION NEW TECHNO; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Romodanov AP, 1982, ADV TECHNICAL STANDA, P25; SMITH L, 1964, JAMA-J AM MED ASSOC, V187, P137; YASARGIL MG, 1970, SURGERY, V67, P221	16	132	134	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					112	114		10.1136/bmj.332.7533.112	http://dx.doi.org/10.1136/bmj.332.7533.112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410591	Green Published			2022-12-28	WOS:000234777000028
J	Cowburn, RP				Cowburn, RP			Where have all the transistors gone?	SCIENCE			English	Editorial Material							CELLULAR-AUTOMATA		Univ London Imperial Coll Sci Technol & Med, Blackett Phys Lab, London SW7 2BW, England	Imperial College London	Cowburn, RP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Phys Lab, Prince Consort Rd, London SW7 2BW, England.	r.cowburn@imperial.ac.uk	Cowburn, Russell/D-5820-2015	Cowburn, Russell/0000-0003-0867-8900				Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; Cowburn RP, 2000, SCIENCE, V287, P1466, DOI 10.1126/science.287.5457.1466; Feynman R. P., 2018, FEYNMAN LECT COMPUTA, V1st, DOI [10.1201/9780429500442, DOI 10.1201/9780429500442]; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Schumacher HW, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935765; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	7	21	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					183	184		10.1126/science.1122441	http://dx.doi.org/10.1126/science.1122441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410511				2022-12-28	WOS:000234722200026
J	Iacono, AT; Johnson, BA; Grgurich, WF; Youssef, JG; Corcoran, TE; Seiler, DA; Dauber, JH; Smaldone, GC; Zeevi, A; Yousem, SA; Fung, JJ; Burckart, GJ; McCurry, KR; Griffith, BP				Iacono, AT; Johnson, BA; Grgurich, WF; Youssef, JG; Corcoran, TE; Seiler, DA; Dauber, JH; Smaldone, GC; Zeevi, A; Yousem, SA; Fung, JJ; Burckart, GJ; McCurry, KR; Griffith, BP			A randomized trial of inhaled cyclosporine in lung-transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; AEROSOLIZED CYCLOSPORINE; ALLOGRAFT RECIPIENTS; PULMONARY-FUNCTION; INTERFERON-GAMMA; GENE-EXPRESSION; REJECTION; HEART; MANAGEMENT; SURVIVAL	BACKGROUND: Conventional regimens of immunosuppressive drugs often do not prevent chronic rejection after lung transplantation. Topical delivery of cyclosporine in addition to conventional systemic immunosuppression might help prevent acute and chronic rejection events. METHODS: We conducted a single-center, randomized, double-blind, placebo-controlled trial of inhaled cyclosporine initiated within six weeks after transplantation and given in addition to systemic immunosuppression. A total of 58 patients were randomly assigned to inhale either 300 mg of aerosol cyclosporine (28 patients) or aerosol placebo (30 patients) three days a week for the first two years after transplantation. The primary end point was the rate of histologic acute rejection. RESULTS: The rates of acute rejection of grade 2 or higher were similar in the cyclosporine and placebo groups: 0.44 episode (95 percent confidence interval, 0.31 to 0.62) vs. 0.46 episode (95 percent confidence interval, 0.33 to 0.64) per patient per year, respectively (P=0.87 by Poisson regression). Survival was improved with aerosolized cyclosporine, with 3 deaths among patients receiving cyclosporine and 14 deaths among patients receiving placebo (relative risk of death, 0.20; 95 percent confidence interval, 0.06 to 0.70; P=0.01). Chronic rejection-free survival also improved with cyclosporine, as determined by spirometric analysis (10 events in the cyclosporine group and 20 events in the placebo group; relative risk of chronic rejection, 0.38; 95 percent confidence interval, 0.18 to 0.82; P=0.01) and histologic analysis (6 vs. 19 events, respectively; relative risk, 0.27; 95 percent confidence interval, 0.11 to 0.67; P=0.005). The risks of nephrotoxic effects and opportunistic infection were similar for patients in the cyclosporine group and the placebo group. CONCLUSIONS: Inhaled cyclosporine did not improve the rate of acute rejection, but it did improve survival and extend periods of chronic rejection-free survival.	Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; Univ Pittsburgh, Div Cardiothorac Surg, Pittsburgh, PA USA; SUNY Stony Brook, Div Pulm & Crit Care Med, Stony Brook, NY 11794 USA; Univ So Calif, Dept Pharm, Los Angeles, CA USA; Univ Maryland, Div Cardiothorac Surg, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Southern California; University System of Maryland; University of Maryland Baltimore	Iacono, AT (corresponding author), Univ Maryland, Sch Med, Med Sch Teaching Facil 800, Div Pulm Transplantat & Pulm & Clit Care Med, 10 S Pine St, Baltimore, MD 21201 USA.	aiacono@medicine.umaryland.edu	FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441; Youssef, Jihad/0000-0002-1234-3946; Corcoran, Tim/0000-0003-1069-095X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059490] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL059490 01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; BANDO K, 1995, J THORAC CARDIOV SUR, V110, P4, DOI 10.1016/S0022-5223(05)80003-0; Burckart GJ, 2003, PHARM RES-DORDR, V20, P252, DOI 10.1023/A:1022275222207; Corcoran TE, 2004, EUR RESPIR J, V23, P378, DOI 10.1183/09031936.04.00059204; Date H, 1998, J HEART LUNG TRANSPL, V17, P869; DIPADOVA FE, 1989, PHARMACOL REV, V41, P373; DOWLING RD, 1990, SURGERY, V108, P198; Duncan SR, 1996, J CLIN INVEST, V97, P2642, DOI 10.1172/JCI118714; Duncan SR, 2002, AM J RESP CRIT CARE, V165, P1439, DOI 10.1164/rccm.2107009; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Garcia JEL, 1998, RESP MED, V92, P722, DOI 10.1016/S0954-6111(98)90002-6; Hosenpud JD, 1998, J HEART LUNG TRANSPL, V17, P656; Iacono A, 1997, TRANSPLANTATION, V64, P263, DOI 10.1097/00007890-199707270-00015; Iacono AT, 2005, J HEART LUNG TRANSPL, V24, pS82, DOI 10.1016/j.healun.2004.11.146; Iacono AT, 1996, AM J RESP CRIT CARE, V153, P1451, DOI 10.1164/ajrccm.153.4.8616581; Iacono AT, 2004, EUR RESPIR J, V23, P384, DOI 10.1183/09031936.04.00058504; Iacono AT, 1997, AM J RESP CRIT CARE, V155, P1690, DOI 10.1164/ajrccm.155.5.9154878; Iacono AT, 2003, CURR OPIN ORGAN TRAN, V8, P327; KEENAN RJ, 1995, SURGERY, V118, P385, DOI 10.1016/S0039-6060(05)80349-6; KEENAN RJ, 1992, TRANSPLANTATION, V53, P20, DOI 10.1097/00007890-199201000-00003; Keenan RJ, 1997, J THORAC CARDIOV SUR, V113, P335, DOI 10.1016/S0022-5223(97)70331-3; KESTEN S, 1995, AM J RESP CRIT CARE, V152, P1321, DOI 10.1164/ajrccm.152.4.7551389; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; Mitruka SN, 2000, J HEART LUNG TRANSPL, V19, P969, DOI 10.1016/S1053-2498(00)00176-5; MORRIS JF, 1976, WESTERN J MED, V125, P110; Muggenburg BA., 1990, J AEROSOL MED, V3, P1, DOI [10.1089/jam.1990.3.1, DOI 10.1089/JAM.1990.3.1]; ORIORDAN TG, 1995, AM J RESP CRIT CARE, V151, P516, DOI 10.1164/ajrccm.151.2.7842214; PARADIS I, 1993, CLIN CHEST MED, V14, P751; Sharples LD, 1996, TRANSPLANTATION, V61, P560, DOI 10.1097/00007890-199602270-00008; Tikkanen JM, 2002, AM J RESP CRIT CARE, V165, P724, DOI 10.1164/ajrccm.165.5.2107084; TRULOCK EP, 1993, CHEST, V103, P1566, DOI 10.1378/chest.103.5.1566; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; YOUSEM SA, 1992, AM J SURG PATHOL, V16, P877, DOI 10.1097/00000478-199209000-00006; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; YOUSEM SA, 1993, AM J SURG PATHOL, V17, P491, DOI 10.1097/00000478-199305000-00008	36	165	174	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					141	150		10.1056/NEJMoa043204	http://dx.doi.org/10.1056/NEJMoa043204			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407509				2022-12-28	WOS:000234528600006
J	Connolly, SJ; Dorian, P; Roberts, RS; Gent, M; Bailin, S; Fain, ES; Thorpe, K; Champagne, J; Talajic, M; Coutu, B; Gronefeld, GC; Hohnloser, SH				Connolly, SJ; Dorian, P; Roberts, RS; Gent, M; Bailin, S; Fain, ES; Thorpe, K; Champagne, J; Talajic, M; Coutu, B; Gronefeld, GC; Hohnloser, SH		OPTIC Investigators	Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators - The optic study. A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; METAANALYSIS; THERAPY; CAMIAT; CIDS	Context Implantable cardioverterdefibrillator (ICD) therapy is effective but is associated with high-voltage shocks that are painful. Objective To determine whether amiodarone plus beta-blocker or sotalol are better than beta-blocker alone for prevention of ICD shocks. Design, Setting, and Patients A randomized controlled trial with blinded adjudication of events of 412 patients from 39 outpatient ICD clinical centers located in Canada, Germany, United States, England, Sweden, and Austria, conducted from January 13, 2001, to September 28, 2004. Patients were eligible if they had received an ICD within 21 days for inducible or spontaneously occurring ventricular tachycardia or fibrillation. Intervention Patients were randomized to treatment for 1 year with amiodarone plus beta-blocker, sotalol alone, or beta-blocker alone. Main Outcome Measure Primary outcome was ICD shock for any reason., Results Shocks occurred in 41 patients (38.5%) assigned to beta-blocker alone, 26 (24.3%) assigned to sotalol, and 12 (10.3%) assigned to amiodarone plus beta-blocker. A reduction in the risk of shock was observed with use of either amiodarone plus beta-blocker or sotalol vs beta-blockeralone (hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.28-0.68; P<.001). Amiodarone plus beta-blocker significantly reduced the risk of shock compared with beta-blocker alone (HR, 0.27; 95% Cl, 0.14-0.52; P<.001) and sotalol (HR, 0.43; 95% Cl, 0.22-0.85; P=.02). There was a trend for sotalol to reduce shocks compared with beta-blocker alone (HR, 0.61; 95% C1, 0.37-1.01; P=.055). The rates of study drug discontinuation at 1 year were 18.2% for amiodarone, 23.5% for sotalol, and 5.3% for beta-blocker alone. Adverse pulmonary and thyroid events and symptomatic bradycardia were more common among patients randomized to amiodarone. Conclusions Despite use of advanced ICD technology and treatment with a beta-blocker, shocks occur commonly in the first year after ICD implant. Amiodarone plus beta-blocker is effective for preventing these shocks and is more effective than sotalol but has an increased risk of drug-related adverse effects.	McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8L 2X2, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Iowa Heart Ctr, Des Moines, IA USA; St Jude Med Cardiac Rhythm Management Div, Sylmar, CA USA; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Frankfurt, Frankfurt, Germany	McMaster University; McMaster University; University of Toronto; Laval University; Universite de Montreal; Universite de Montreal; Goethe University Frankfurt	Connolly, SJ (corresponding author), McMaster Univ, Dept Med, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	connostu@hhsc.ca		Talajic, Mario/0000-0001-8469-4748; Bailin, Steven/0000-0001-9237-5448; Thorpe, Kevin/0000-0002-7586-3893				Boutitie F, 1999, CIRCULATION, V99, P2268, DOI 10.1161/01.CIR.99.17.2268; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Connolly SJ, 1997, LANCET, V350, P1417; Connolly SJ, 1999, CIRCULATION, V100, P2025, DOI 10.1161/01.CIR.100.19.2025; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; HOHNLOSER SH, 1994, NEW ENGL J MED, V331, P31; Irvine J, 2002, AM HEART J, V144, P282, DOI 10.1067/mhj.2002.124049; Kamphuis HCM, 2003, EUROPACE, V5, P381, DOI 10.1016/S1099-5129(03)00078-3; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330; Seidl K, 1998, AM J CARDIOL, V82, P744, DOI 10.1016/S0002-9149(98)00478-0; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4	13	455	484	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					165	171		10.1001/jama.295.2.165	http://dx.doi.org/10.1001/jama.295.2.165			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403928	Bronze			2022-12-28	WOS:000234544300023
J	Bennett, S; Boerma, JT; Brugha, R				Bennett, S; Boerma, JT; Brugha, R			Scaling up HIV/AIDS evaluation	LANCET			English	Editorial Material							HIV; PREVENTION; HEALTH; LESSONS		ABT Associates Inc, Bethesda, MD 20814 USA; WHO, CH-1211 Geneva, Switzerland; Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth, Dublin 2, Ireland	ABT Associates; World Health Organization; Royal College of Surgeons - Ireland	Bennett, S (corresponding author), ABT Associates Inc, 4800 Montgomery Lane,Suite 600, Bethesda, MD 20814 USA.	sara_bennett@abtassoc.com	Brugha, Ruairi/C-8420-2012	Brugha, Ruairi/0000-0003-0729-0197; bennett, sara/0000-0001-8094-8798				[Anonymous], 2001, MACR HLTH INV HLTH E; Aral SO, 2005, J INFECT DIS, V191, pS1, DOI 10.1086/425290; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brugha R, 2004, LANCET, V364, P95, DOI 10.1016/S0140-6736(04)16595-1; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Feachem RGA, 2004, TROP MED INT HEALTH, V9, P1139, DOI 10.1111/j.1365-3156.2004.01343.x; *GLOB FUND, INV FUT GLOB FUND 3; Global Forum for Health Research, 2004, MON FIN FLOWS HLTH R; Global Forum for Health Research & World Health Organization, 2004, 1090 GLOB FOR HLTH R; Hogan DR, 2005, B WORLD HEALTH ORGAN, V83, P135; Joint Learning Initiative, HUM RES HLTH OV CRIS; Kaul I, 2001, B WORLD HEALTH ORGAN, V79, P869; LEWIS M, 2005, 5 CTR GLOB DEV; Moatti JP, 2003, AIDS, V17, pS69, DOI 10.1097/00002030-200317003-00010; *NAT AC SCI, COMM PRES EM PLAN AI; *OECD, INT DEV STAT ONL; ROUX AD, 2002, OXFORD TXB PUBLIC HL, P504; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Singh S, 2004, REPROD HEALTH MATTER, V12, P129, DOI 10.1016/S0968-8080(04)23118-4; *SWEF RES NETW, COMM RES PROT MON EV; UN Millennium Project, 2005, INV DEV PRACT PLAN A; UNAIDS/WHO, 2004, AIDS EP UPD 2004; *UNAIDS WHO UNICEF, MEAS EV USAID NAT AI; World Bank, 2005, COMM RES IMPR EFF HI; World Health Organization, 2004, WORLD REP KNOWL BETT	28	40	40	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					79	82		10.1016/S0140-6736(06)67928-2	http://dx.doi.org/10.1016/S0140-6736(06)67928-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000EG	16399157				2022-12-28	WOS:000234443100034
J	Bauch, T; Lindstrom, T; Tafuri, F; Rotoli, G; Delsing, P; Claeson, T; Lombardi, F				Bauch, T; Lindstrom, T; Tafuri, F; Rotoli, G; Delsing, P; Claeson, T; Lombardi, F			Quantum dynamics of a d-wave Josephson junction	SCIENCE			English	Article							PHASE DIFFERENCE; STATE	Here we present the direct observation of macroscopic quantum properties in an all high-critical-temperature superconductor d-wave Josephson junction. Although dissipation caused by low-energy excitations is expected to strongly suppress macroscopic quantum effects, we demonstrate energy level quantization in our d-wave Josephson junction. The result indicates that the role of dissipation mechanisms in high-temperature superconductors has to be revised, and it may also have consequences for the class of solid-state "quiet" quantum bits with superior coherence time.	Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, S-41296 Gothenburg, Sweden; Univ Naples 2, Dipartimento Ingn Informaz, Ist Nazl Fis Mat, Aversa, CE, Italy; Univ Aquila, Dipartimento Ingn Meccan Energet & Gest, Laquila, Italy	Chalmers University of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Universita della Campania Vanvitelli; University of L'Aquila	Lombardi, F (corresponding author), Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, S-41296 Gothenburg, Sweden.	floriana.lombardi@mc2.chalmers.se	Rotoli, Giacomo/E-4718-2011; Tafuri, Francesco/D-8246-2018; Bauch, Thilo/B-5756-2016; Delsing, Per/F-7288-2010	Rotoli, Giacomo/0000-0002-2331-8949; Tafuri, Francesco/0000-0003-0784-1454; Bauch, Thilo/0000-0002-8918-4293; Lombardi, Floriana/0000-0002-3478-3766; Claeson, Tord/0000-0002-6390-5160; Delsing, Per/0000-0002-1222-3506				Amin MHS, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.064516; Amin MHS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017001; Bauch T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087003; Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Blais A, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042308; Blatter G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.174511; Burkard G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134504; CALDEIRA AO, 1981, PHYS REV LETT, V46, P211, DOI 10.1103/PhysRevLett.46.211; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; CLARKE J, 1988, SCIENCE, V239, P992, DOI 10.1126/science.239.4843.992; DEVORET MH, 1992, QUANTUM TUNNELING CO, pCH6; Duty T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.140503; Fominov YV, 2003, JETP LETT+, V77, P587, DOI 10.1134/1.1595702; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; FULTON TA, 1974, PHYS REV B, V9, P4760, DOI 10.1103/PhysRevB.9.4760; Granozio FM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevD.67.184506; Homes CC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.184515; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; Kawabata S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052506; Lombardi F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.207001; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; NEVILLE RC, 1972, J APPL PHYS, V43, P2124, DOI 10.1063/1.1661463; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.037003; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	30	97	99	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					57	60		10.1126/science.1120793	http://dx.doi.org/10.1126/science.1120793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400142				2022-12-28	WOS:000234546300030
J	Currie, CR; Poulsen, M; Mendenhall, J; Boomsma, JJ; Billen, J				Currie, CR; Poulsen, M; Mendenhall, J; Boomsma, JJ; Billen, J			Coevolved crypts and exocrine glands support mutualistic bacteria in fungus-growing ants	SCIENCE			English	Article							PHYLOGENETIC ANALYSIS; TRIPARTITE MUTUALISM; SYMBIOSIS; PARASITES; GARDENS	Attine ants engage in a quadripartite symbiosis with fungi they cultivate for food, specialized garden parasites, and parasite-inhibiting bacteria. Molecular phylogenetic evidence supports an ancient host-pathogen association between the ant-cultivar mutualism and the garden parasite. Here we show that ants rear the antibiotic-producing bacteria in elaborate cuticular crypts, supported by unique exocrine glands, and that these structures have been highly modified across the ants' evolutionary history. This specialized structural evolution, together with the absence of these bacteria and modifications in other ant genera that do not grow fungus, indicate that the bacteria have an ancient and coevolved association with the ants, their fungal cultivar, and the garden parasite.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Copenhagen, Inst Biol, Dept Populat Biol, DK-2100 Copenhagen, Denmark; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Catholic Univ Louvain, Inst Zool, B-3000 Louvain, Belgium	University of Wisconsin System; University of Wisconsin Madison; University of Kansas; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Copenhagen; University of Texas System; University of Texas Austin; Universite Catholique Louvain	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu	Poulsen, Michael/C-6276-2012; Boomsma, Jacobus J/M-2785-2014	Poulsen, Michael/0000-0002-2839-1715; Boomsma, Jacobus J/0000-0002-3598-1609; Billen, Johan/0000-0002-2392-7293				Billen J., 1998, PHEROMONE COMMUNICAT; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Goodfellow M., 1984, BIOL ACTINOMYCETES; Margulis L., 1991, SYMBIOSISOURCE EVO; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; SMITH MR, 1947, AM MIDL NAT, V37, P521, DOI 10.2307/2421469; Weber N. A., 1972, GARDENING ANTS ATTIN; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466	20	241	251	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					81	83		10.1126/science.1119744	http://dx.doi.org/10.1126/science.1119744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400148				2022-12-28	WOS:000234546300037
J	Milne, AC; Avenell, A; Potter, J				Milne, AC; Avenell, A; Potter, J			Meta-analysis: Protein and energy supplementation in older people	ANNALS OF INTERNAL MEDICINE			English	Review							ORAL NUTRITIONAL SUPPLEMENTATION; OBSTRUCTIVE PULMONARY-DISEASE; DIETARY SUPPLEMENTATION; ELDERLY-PATIENTS; FUNCTIONAL STATUS; BODY-COMPOSITION; GERIATRIC-PATIENTS; ACUTE EXACERBATION; SUPPORT; MUSCLE	Background: Protein and energy undernutrition is common in older people, and further deterioration may occur during illness. Purpose: To assess whether oral protein and energy supplementation improves clinical and nutritional outcomes for older people in the hospital, in an institution, or in the community. Data Sources: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, HealthStar, CINAHL, BIOSIS, and CAB abstracts. The authors included English- and non-English-language studies and hand-searched journals, contacted manufacturers, and sought information from trialists. The date of the most recent search of CENTRAL and MEDLINE is June 2005. Study Selection: Randomized and quasi-randomized controlled trials of oral protein and energy supplementation compared with placebo or control treatment in older people. Data Extraction: Two reviewers independently assessed trials for inclusion, extracted data, and assessed trial quality. Differences were resolved by consensus. Data Synthesis: Fifty-five trials were included (n = 9187 randomly assigned participants). For patients in short-term care hospitals who were given oral supplements, evidence suggested fewer complications (Peto odds ratio, 0.72 [95% Cl, 0.53 to 0.97]) and reduced mortality (Peto odds ratio, 0.66 [Cl, 0.49 to 0.90]) for those undernourished at baseline. Few studies reported evidence that suggested any change in mortality, morbidity, or function for those given supplements at home. Ten trials reported gastrointestinal disturbances, such as nausea, vomiting, and diarrhea, with oral supplements. Limitations: The quality of most studies, as reported, was poor, particularly for concealment of allocation and blinding of outcome assessors. Many studies were too small or the follow-up time was too short to detect a statistically significant change in clinical outcome. The clinical results are dominated by 1 very large recent trial in patients with stroke. Although this was a high-quality trial, few participants were undernourished at baseline. Conclusions: Oral nutritional supplements can improve nutritional status and seem to reduce mortality and complications for undernourished elderly patients in the hospital. Current evidence does not support routine supplementation for older people at home or for well-nourished older patients in any setting.	Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Wollongong Hosp, Sydney, NSW, Australia	University of Aberdeen; Wollongong Hospital	Milne, AC (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland.	a.c.milne@.abdn.ac.uk			Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office		*AG HEALTHC RES QU, HCUPNET TOOL ID TRAC; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Avenell A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001880.pub3; BANERJEE A K, 1978, Age and Ageing, V7, P237, DOI 10.1093/ageing/7.4.237; Barr SI, 2000, J AM DIET ASSOC, V100, P810, DOI 10.1016/S0002-8223(00)00236-4; Benati G, 2001, ARCH GERONTOL GERIAT, P43, DOI 10.1016/S0167-4943(01)00120-0; Bonnefoy M, 2003, BRIT J NUTR, V89, P731, DOI 10.1079/BJN2003836; Bourdel-Marchasson I, 2000, NUTRITION, V16, P1, DOI 10.1016/S0899-9007(99)00227-0; BROQVIST M, 1994, EUR HEART J, V15, P1641, DOI 10.1093/oxfordjournals.eurheartj.a060447; Brown Katrina M., 1992, Proceedings of the Nutrition Society, V51, p132A; Bruce D, 2003, CLIN NUTR, V22, P497, DOI 10.1016/S0261-5614(03)00050-5; Carver AD, 1995, J HUM NUTR DIET, V8, P389, DOI 10.1111/j.1365-277X.1995.tb00334.x; Collins CE, 2005, NUTRITION, V21, P147, DOI 10.1016/j.nut.2004.10.006; *CRG BON JOINT MUS, 2005, COCHR LIB; Daniels LA, 2003, CLIN NUTR S, V22, pS86; DEEKS JJ, 1998, 6 COCHR C BALTM MAR; DELETTER MC, 1991, THESIS U KENTUCKY LE; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; Edington J, 2004, CLIN NUTR, V23, P195, DOI 10.1016/S0261-5614(03)00107-9; Eneroth M, 2004, J Wound Care, V13, P230; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gariballa SE, 1998, JPEN-PARENTER ENTER, V22, P315, DOI 10.1177/0148607198022005315; Gazzotti C, 2003, AGE AGEING, V32, P321, DOI 10.1093/ageing/32.3.321; Gegerle P, 1986, Schweiz Rundsch Med Prax, V75, P933; GRAYDONALD K, 1995, J NUTR, V125, P2965; GURNEY JM, 1973, AM J CLIN NUTR, V26, P912, DOI 10.1093/ajcn/26.9.912; Hampson G, 2003, OSTEOPOROSIS INT, V14, P750, DOI 10.1007/s00198-003-1440-1; HANKEY CR, 1993, J HUM NUTR DIET, V6, P317, DOI 10.1111/j.1365-277X.1993.tb00377.x; HANKINS C, 1996, THESIS SYDNEY U SYDN; Hickson M, 2004, CLIN NUTR, V23, P69, DOI 10.1016/S0261-5614(03)00090-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hubsch S., 1992, CLIN NUTR, V11, P97; Jensen MB, 1997, NUTRITION, V13, P422, DOI 10.1016/S0899-9007(97)91280-6; KNOWLES JB, 1988, CHEST, V93, P977, DOI 10.1378/chest.93.5.977; Krondl M, 1999, J AM DIET ASSOC, V99, P1542, DOI 10.1016/S0002-8223(99)00378-8; Kwok T, 2001, J Nutr Health Aging, V5, P17; LARSSON J, 1990, CLIN NUTR, V9, P179, DOI 10.1016/0261-5614(90)90017-M; Lauque S, 2004, J AM GERIATR SOC, V52, P1702, DOI 10.1111/j.1532-5415.2004.52464.x; Lauque S, 2000, AGE AGEING, V29, P51, DOI 10.1093/ageing/29.1.51; Liu LJ, 2002, J GERONTOL A-BIOL, V57, pM741, DOI 10.1093/gerona/57.11.M741; MacFie J, 2000, NUTRITION, V16, P723, DOI 10.1016/S0899-9007(00)00377-4; MADIGAN C, 1994, THESIS SYDNEY U SYDN; MCEVOY AW, 1982, HUM NUTR-APPL NUTR, V36, P374; McWhirter JP, 1996, NUTRITION, V12, P502, DOI 10.1016/S0899-9007(96)91727-X; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; MEREDITH CN, 1992, J AM GERIATR SOC, V40, P155, DOI 10.1111/j.1532-5415.1992.tb01937.x; Milne AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub2; OVESEN L, 1992, CLIN NUTR, V11, P154, DOI 10.1016/0261-5614(92)90076-3; Payette H, 2002, J AM DIET ASSOC, V102, P1088, DOI 10.1016/S0002-8223(02)90245-2; Payette H, 2002, AM J CLIN NUTR, V75, p340S; Potter J, 1998, BRIT MED J, V317, P495, DOI 10.1136/bmj.317.7157.495; Potter JM, 2001, CURR OPIN CLIN NUTR, V4, P21, DOI 10.1097/00075197-200101000-00005; Potter JM, 2001, JPEN-PARENTER ENTER, V25, P323, DOI 10.1177/0148607101025006323; Price R, 2005, GERONTOLOGY, V51, P179, DOI 10.1159/000083991; Royal College of Physicians, 2003, NUTR PAT DOCT RESP; SaudnyUnterberger H, 1997, AM J RESP CRIT CARE, V156, P794, DOI 10.1164/ajrccm.156.3.9612102; SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381; SCORER HJ, 1990, EFFECT NUTR SUPPLEME; STABLEFORTH PG, 1986, BRIT J SURG, V73, P651, DOI 10.1002/bjs.1800730826; Steiner MC, 2003, THORAX, V58, P745, DOI 10.1136/thorax.58.9.745; Stratton RJ, 2003, DIS RELATED MALNUTRI; Sullivan DH, 2004, J GERONTOL A-BIOL, V59, P633; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Sullivan DH, 2002, J GEN INTERN MED, V17, P923, DOI 10.1046/j.1525-1497.2002.10930.x; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tidermark J, 2004, CLIN NUTR, V23, P587, DOI 10.1016/j.clnu.2003.10.006; Vermeeren MAP, 2004, CLIN NUTR, V23, P1184, DOI 10.1016/j.clnu.2004.03.008; Vlaming S, 2001, CLIN NUTR, V20, P517, DOI 10.1054/clnu.2001.0486; Volkert D, 1996, AGING-CLIN EXP RES, V8, P386, DOI 10.1007/BF03339600; Weekes E., 1999, Proceedings of the Nutrition Society, V58, p126A; WOO J, 1994, AGE AGEING, V23, P40, DOI 10.1093/ageing/23.1.40; Wouters-Wesseling W, 2003, CLIN NUTR, V22, P371, DOI 10.1016/S0261-5614(03)00034-7; Wouters-Wesseling W, 2002, EUR J CLIN NUTR, V56, P245, DOI 10.1038/sj.ejcn.1601319; Yamaguchi L. Y., 1998, Nutrition Today, V33, P37, DOI 10.1097/00017285-199801000-00007; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	76	215	223	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					37	48		10.7326/0003-4819-144-1-200601030-00008	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389253				2022-12-28	WOS:000234474200005
J	Ohtsubo, K; Takamatsu, S; Minowa, MT; Yoshida, A; Takeuchi, M; Marth, JD				Ohtsubo, K; Takamatsu, S; Minowa, MT; Yoshida, A; Takeuchi, M; Marth, JD			Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes	CELL			English	Article							PANCREATIC BETA-CELLS; UDP-N-ACETYLGLUCOSAMINE; HIGH-FAT DIET; GLUCOSE-TRANSPORTER; C57BL/6J MICE; CDNA CLONING; EXPRESSION; GLUT-2; FAMILY; HYPERGLYCEMIA	Pancreatic beta cell-surface expression of glucose transporter 2 (Glut-2) is essential for glucose-stimulated insulin secretion, thereby controlling blood glucose homeostasis in response to dietary intake. We show that the murine GlcNAcT-IVa glycosyltransferase is required for Glut-2 residency on the 0 cell surface by constructing a cell-type and glycoprotein-specific N-glycan ligand for pancreatic lectin receptors. Loss of GlcNAcT-IVa, or the addition of glycan ligand mimetics, attenuates Glut-2 cell surface half-life, provoking endocytosis with redistribution into endosomes and lysosomes. The ensuing impairment of glucose-stimulated insulin secretion leads to metabolic dysfunction diagnostic of type 2 diabetes. Remarkably, the induction of diabetes by chronic ingestion of a high-fat diet is associated with reduced GlcNAcT-IV expression and attenuated Glut-2 glycosylation coincident with Glut-2 endocytosis. We infer that beta cell glucose-transporter glycosylation mediates a link between diet and insulin production that typically suppresses the pathogenesis of type 2 diabetes.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Kirin Brewery Company Limited; University of Fukui	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jmarth@ucsd.edu			NIDDK NIH HHS [DK48247] Funding Source: Medline; NIGMS NIH HHS [GM62116] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Ing BL, 1996, BIOCHEM BIOPH RES CO, V218, P76, DOI 10.1006/bbrc.1996.0015; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Lipkowitz MS, 2002, GLYCOCONJUGATE J, V19, P491, DOI 10.1023/B:GLYC.0000014078.65610.2f; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; ORCI L, 1990, J CLIN INVEST, V86, P1615, DOI 10.1172/JCI114883; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; THORENS B, 1993, J CELL BIOL, V123, P1687, DOI 10.1083/jcb.123.6.1687; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Tokugawa K, 1996, GLYCOCONJUGATE J, V13, P53, DOI 10.1007/BF01049679; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; VALERA A, 1994, J BIOL CHEM, V269, P28543; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; Varki A, 1999, ESSENTIALS GLYCOBIOL, P455; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshida A, 1998, GLYCOCONJUGATE J, V15, P1115, DOI 10.1023/A:1006951519522	37	310	326	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1307	1321		10.1016/j.cell.2005.09.041	http://dx.doi.org/10.1016/j.cell.2005.09.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377570	Bronze			2022-12-28	WOS:000234584500018
J	Thurlimann, B; Keshaviah, A; Coates, AS; Mouridsen, H; Mauriac, L; Forbes, JF; Paridaens, R; Castiglione-Gertsch, M; Gelber, RD; Rabaglio, M; Smith, I; Wardly, A; Price, KN; Goldhirsch, A				Thurlimann, B; Keshaviah, A; Coates, AS; Mouridsen, H; Mauriac, L; Forbes, JF; Paridaens, R; Castiglione-Gertsch, M; Gelber, RD; Rabaglio, M; Smith, I; Wardly, A; Price, KN; Goldhirsch, A		BIG 1-98 Collaborative Grp	A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AROMATASE INHIBITORS; RANDOMIZED-TRIAL; PHASE-III; ADJUVANT TAMOXIFEN; DRUG-THERAPY; AROMATIZATION; ANASTROZOLE; COMBINATION; EXEMESTANE; MORBIDITY	Background The aromatase inhibitor letrozole is a more effective treatment for metastatic breast cancer and more effective in the neoadjuvant setting than tamoxifen. We compared letrozole with tamoxifen as adjuvant treatment for steroid-hormone-receptor-positive breast cancer in postmenopausal women. Methods The Breast International Group (BIG) 1-98 study is a randomized, phase 3, double-blind trial that compared five years of treatment with various adjuvant endocrine therapy regimens in postmenopausal women with hormone-receptor-positive breast cancer: letrozole, letrozole followed by tamoxifen, tamoxifen, and tamoxifen followed by letrozole. This analysis compares the two groups assigned to receive letrozole initially with the two groups assigned to receive tamoxifen initially; events and follow-up in the sequential-treatment groups were included up to the time that treatments were switched. Results A total of 8010 women with data that could be assessed were enrolled, 4003 in the letrozole group and 4007 in the tamoxifen group. After a median follow-up of 25.8 months, 351 events had occurred in the letrozole group and 428 events in the tamoxifen group, with five-year disease-free survival estimates of 84.0 percent and 81.4 percent, respectively. As compared with tamoxifen, letrozole significantly reduced the risk of an event ending a period of disease-free survival (hazard ratio, 0.81; 95 percent confidence interval, 0.70 to 0.93; P=0.003), especially the risk of distant recurrence (hazard ratio, 0.73; 95 percent confidence interval, 0.60 to 0.88; P=0.001). Thromboembolism, endometrial cancer, and vaginal bleeding were more common in the tamoxifen group. Women given letrozole had a higher incidence of skeletal and cardiac events and of hypercholesterolemia. Conclusions In postmenopausal women with endocrine-responsive breast cancer, adjuvant treatment with letrozole, as compared with tamoxifen, reduced the risk of recurrent disease, especially at distant sites.	Int Breast Canc Study Grp Coordinating Ctr, CH-3088 Bern, Switzerland; Kantonsspital, Senol Ctr Eastern Switzerland, St Gallen, Switzerland; Swiss Grp Clin Canc Res, Bern, Switzerland; Dana Farber Canc Inst, IBCSG Stat Ctr, Boston, MA 02115 USA; Univ Sydney, Sydney, NSW 2006, Australia; Canc Council Australia, Sydney, NSW, Australia; Vejle Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark; Federat Natl Ctr Lutte Canc, Inst Bergonie, Bordeaux, France; Univ Newcastle, Newcastle Mater Hosp, Australian New Zealand Breast Canc Trials Grp, Newcastle, NSW 2308, Australia; Catholic Univ Louvain, Univ Hosp Gasthuisberg, Dept Med Oncol, B-3000 Louvain, Belgium; Inselspital Bern, CH-3010 Bern, Switzerland; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; Royal Marsden Hosp, London SW3 6JJ, England; Royal Marsden Natl Hlth Serv Trust, Surrey, England; Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England; Manchester Univ Hosp Trust, Manchester, Lancs, England; European Inst Oncol, Milan, Italy; Oncol Inst So Switzerland, Bellinzona, Switzerland	International Breast Cancer Study Group; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Swiss Group for Clinical Cancer Research (SAKK); Harvard University; Dana-Farber Cancer Institute; University of Sydney; Cancer Council New South Wales; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; UNICANCER; Institut Bergonie; Calvary Mater Newcastle Hospital; University of Newcastle; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Christie NHS Foundation Trust; Christie Hospital; IRCCS European Institute of Oncology (IEO); Institute of Oncology Research (IOR)	Thurlimann, B (corresponding author), Int Breast Canc Study Grp Coordinating Ctr, Effingerstr 56, CH-3088 Bern, Switzerland.	ibcsg.big198@ibcsg.org	Wardley, Andrew/N-8135-2015; Wardley, Andrew Michael/GLU-5636-2022; Morabito, A./J-4814-2018	Wardley, Andrew/0000-0002-9639-0888; Wardley, Andrew Michael/0000-0002-9639-0888; Morabito, A./0000-0002-1319-9608; Keshaviah, Aparna/0000-0002-4324-6807				AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Baum M, 2002, LANCET, V359, P2131; BAUM M, 2003, CANCER, V98, P1902; Baum M, 2002, LANCET, V360, P1520; Bradbury BD, 2005, CANCER-AM CANCER SOC, V103, P1114, DOI 10.1002/cncr.20900; Braithwaite RS, 2003, J GEN INTERN MED, V18, P937, DOI 10.1046/j.1525-1497.2003.20724.x; Chang J, 1996, ANN ONCOL, V7, P671; Clarke M, 1998, LANCET, V351, P1451; Coombes RC, 2004, NEW ENGL J MED, V351, P2461; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Dowsett M, 1995, CLIN CANCER RES, V1, P1511; Dowsett M, 2005, J CLIN ONCOL, V23, P7512, DOI 10.1200/JCO.2005.01.4829; Elisaf MS, 2001, EUR J CANCER, V37, P1510, DOI 10.1016/S0959-8049(01)00155-1; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Geisler J, 1998, CLIN CANCER RES, V4, P2089; Geisler J, 1996, BRIT J CANCER, V74, P1286, DOI 10.1038/bjc.1996.531; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Herrington DM, 2001, WOMEN HEALTH ISS, V11, P95, DOI 10.1016/S1049-3867(01)00075-5; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lonning PE, 2004, ENDOCR-RELAT CANCER, V11, P179, DOI 10.1677/erc.0.0110179; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MCDONALD CC, 1995, BRIT MED J, V311, P977; Mouridsen, 2001, J CLIN ONCOL, V19, P3302; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Reis SE, 2001, J NATL CANCER I, V93, P16, DOI 10.1093/jnci/93.1.16; RUTQVIST LE, 1993, J NATL CANCER I, V85, P1398, DOI 10.1093/jnci/85.17.1398; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Wasan KM, 2005, ANN ONCOL, V16, P707, DOI 10.1093/annonc/mdi158; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	38	1244	1284	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2747	2757						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382061				2022-12-28	WOS:000234246700006
J	Kurien, BT; Gross, T; Scofield, RH				Kurien, BT; Gross, T; Scofield, RH			Barbering in mice: a model for trichotillomania	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSESSIVE-COMPULSIVE DISORDER; SPECTRUM DISORDERS; GROOMING BEHAVIOR; IMMUNIZATION; PEPTIDES; RO; HOXB8; MOUSE		Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kurien, BT (corresponding author), Oklahoma Med Res Fdn, Arthrit & Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	biji-kurien@omrf.ouhsc.edu	Scofield, Robert Hal/AEJ-8314-2022; Kurien, Biji T/C-2392-2008	Kurien, Biji T/0000-0002-7877-6859	NIAMS NIH HHS [ARO1844] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K11AR001844] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alsafwah S, 2000, GASTROINTEST ENDOSC, V52, P784, DOI 10.1067/mge.2000.108927; Bouwer C, 1998, PSYCHOSOM MED, V60, P658, DOI 10.1097/00006842-199809000-00025; BRESNAHAN JF, 1983, LAB ANIM SCI, V33, P290; du Toit PL, 2001, COMPR PSYCHIAT, V42, P247, DOI 10.1053/comp.2001.23134; Garner JP, 2004, COMPARATIVE MED, V54, P216; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Lochner C, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-2; O'Sullivan RL, 2000, PSYCHIAT CLIN N AM, V23, P587, DOI 10.1016/S0193-953X(05)70182-9; ORDNICK PS, 1994, J BEHAV THER EXP PSY, V25, P189; Reilly CE, 2002, J NEUROL, V249, P499; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Scofield RH, 2002, SCAND J IMMUNOL, V56, P477, DOI 10.1046/j.1365-3083.2002.01159.x; Scofield RH, 1996, J IMMUNOL, V156, P4059; Scofield RH, 1999, ARTHRITIS RHEUM, V42, P1017, DOI 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7; Simeon D, 1997, J NERV MENT DIS, V185, P117, DOI 10.1097/00005053-199702000-00009; STEIN DJ, 1995, J CLIN PSYCHIAT, V56, P28; STROZIK E, 1981, LAB ANIM, V15, P309, DOI 10.1258/002367781780953040; SWEDO SE, 1992, PSYCHIAT CLIN N AM, V15, P767; VANDENBROEK FAR, 1993, LAB ANIM, V27, P270, DOI 10.1258/002367793780745462; Wright HH, 2003, PSYCHOL REP, V92, P228, DOI 10.2466/PR0.92.1.228-230; 1994, DIAGNOSTIC STAT MANU, P618	21	22	23	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1503	1505		10.1136/bmj.331.7531.1503	http://dx.doi.org/10.1136/bmj.331.7531.1503			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373730	Bronze, Green Published			2022-12-28	WOS:000234351300010
J	Flanagan, JF; Mi, LZ; Chruszcz, M; Cymborowski, M; Clines, KL; Kim, YC; Minor, W; Rastinejad, F; Khorasanizadeh, S				Flanagan, JF; Mi, LZ; Chruszcz, M; Cymborowski, M; Clines, KL; Kim, YC; Minor, W; Rastinejad, F; Khorasanizadeh, S			Double chromodomains cooperate to recognize the methylated histone H3 tail	NATURE			English	Article							DNA-BINDING; CHROMATIN; NUCLEOSOME; CHD1; PROTEINS; COMPLEX; GENES	Chromodomains are modules implicated in the recognition of lysine-methylated histone tails and nucleic acids(1,2). CHD ( for chromo-ATPase/helicase-DNA-binding) proteins regulate ATP-dependent nucleosome assembly and mobilization through their conserved double chromodomains and SWI2/SNF2 helicase/ ATPase domain(3-5). The Drosophila CHD1 localizes to the interbands and puffs of the polytene chromosomes, which are classic sites of transcriptional activity(6). Other CHD isoforms (CHD3/4 or Mi-2) are important for nucleosome remodelling in histone deacetylase complexes(7,8). Deletion of chromodomains impairs nucleosome binding and remodelling by CHD proteins(4). Here we describe the structure of the tandem arrangement of the human CHD1 chromodomains, and its interactions with histone tails. Unlike HP1 and Polycomb proteins that use single chromodomains to bind to their respective methylated histone H3 tails, the two chromodomains of CHD1 cooperate to interact with one methylated H3 tail. We show that the human CHD1 double chromodomains target the lysine 4-methylated histone H3 tail (H3K4me), a hallmark of active chromatin(9). Methylammonium recognition involves two aromatic residues, not the three-residue aromatic cage used by chromodomains of HP1 and Polycomb proteins(10-13). Furthermore, unique inserts within chromodomain 1 of CHD1 block the expected site of H3 tail binding seen in HP1 and Polycomb, instead directing H3 binding to a groove at the inter-chromodomain junction.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	University of Virginia; University of Virginia; University of Virginia; United States Department of Energy (DOE); Argonne National Laboratory	Khorasanizadeh, S (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	fr9c@virginia.edu; khorasan@virginia.edu	Mi, Li-Zhi/B-1371-2016; Minor, Wladek/F-3096-2014; Chruszcz, Maksymilian/E-6407-2011	Mi, Li-Zhi/0000-0001-9907-5245; Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Kim, Youngchang/0000-0002-1610-4889				Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Delano W. L., 2004, PYMOL USERS GUIDE; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Tajul-Arifin K, 2003, GENOME RES, V13, P1416, DOI 10.1101/gr.1015703; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	402	413	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1181	1185		10.1038/nature04290	http://dx.doi.org/10.1038/nature04290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372014				2022-12-28	WOS:000234111500056
J	Greenwood, DR; Comeskey, D; Hunt, MB; Rasmussen, LEL				Greenwood, DR; Comeskey, D; Hunt, MB; Rasmussen, LEL			Chemical communication - Chirality in elephant pheromones	NATURE			English	Editorial Material							ASIAN ELEPHANTS; MUSTH; IDENTIFICATION; SEMIOCHEMICALS; DENDROCTONUS; BEETLE		Mt Albert Res Ctr, Auckland, New Zealand; Palmerston N Res Ctr, Palmerston North, New Zealand; Oregon Hlth Sci Univ, Dept Environm & Biomol Syst, OGI Sch Sci & Engn, Beaverton, OR 97006 USA	New Zealand Institute for Plant & Food Research Ltd; Oregon Health & Science University	Greenwood, DR (corresponding author), Mt Albert Res Ctr, Private Bag 92-169, Auckland, New Zealand.	betsr@ebs.ogi.edu	Greenwood, David R/D-2375-2016	Greenwood, David R/0000-0001-5280-042X; Hunt, Martin/0000-0002-3040-0545				FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; KINZER GW, 1969, NATURE, V221, P477, DOI 10.1038/221477a0; Mori K, 1998, CHIRALITY, V10, P578, DOI 10.1002/(SICI)1520-636X(1998)10:7<578::AID-CHIR5>3.0.CO;2-Z; Paine TD, 1999, J CHEM ECOL, V25, P433, DOI 10.1023/A:1020989417318; PERRIN TE, 1996, J CHEM ECOL, V21, P207; Rasmussen LEL, 1999, PHYSIOL BEHAV, V67, P539, DOI 10.1016/S0031-9384(99)00114-6; Rasmussen LEL, 2005, BEHAVIOUR, V142, P351, DOI 10.1163/1568539053778300; Rasmussen LEL, 2003, CHEM SENSES, V28, P433, DOI 10.1093/chemse/28.5.433; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; RASUSSEN LEL, 2004, J ELEPHANT MAN ASS, V15, P30; SILVERSTEIN RM, 1988, J CHEM ECOL, V14, P1981, DOI 10.1007/BF01014245; STEWART TE, 1977, J CHEM ECOL, V3, P27, DOI 10.1007/BF00988131	12	70	71	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1097	1098		10.1038/4381097a	http://dx.doi.org/10.1038/4381097a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371998				2022-12-28	WOS:000234111500035
J	Golan, Y; Wolf, MP; Pauker, SG; Wong, JB; Hadley, S				Golan, Y; Wolf, MP; Pauker, SG; Wong, JB; Hadley, S			Empirical anti-Candida therapy among sdected patients in the intensive care unit: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	31st Critical Care Congress of the Society-of-Critical-Care-Medicine	JAN 26-30, 2002	SAN DIEGO, CA	Soc Crit Care Med			LIPOSOMAL AMPHOTERICIN-B; BLOOD CULTURE-SYSTEMS; INVASIVE FUNGAL-INFECTIONS; PLACEBO-CONTROLLED TRIAL; CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; QUALITY-OF-LIFE; ANTIMICROBIAL SURVEILLANCE PROGRAM; HOSPITAL-ACQUIRED CANDIDEMIA; NON-NEUTROPENIC PATIENTS	Background: mortality from invasive candidiasis is high. Low culture sensitivity and treatment delay contribute to increased mortality, but nonselective early therapy may result in excess costs and drug resistance. Objective: To determine the cost-effectiveness of anti-Candida strategies for high-risk patients in the intensive care unit (ICU). Design: Cost-effectiveness decision model. Data Sources: Published data to 10 May 2005, identified from MEDLINE and Cochrane Library searches, ICU databases, expert estimates, and actual hospital costs. Target Population: Patients in the ICU with suspected infection who have not responded to antibacterial therapy. Time Horizon: Lifetime. Perspective: Societal. Interventions: Fluconazole, caspofungin, amphotericin 13, or lipid formulation of amphotericin B given as either empirical or culture-based therapy and no anti-Candida therapy. Outcome Measures: incremental life expectancy and incremental cost per discounted life-year (DLY) saved. Results of Base-Case Analysis: Ten percent of the target population will have invasive candidiasis. Empirical caspofungin therapy is the most effective strategy but is expensive ($295 115 per DLY saved). Empirical fluconazole therapy is the most reasonable strategy ($12 593 per DLY saved) and decreases mortality from 44.0% to 30.4% in patients with invasive candidiasis and from 22.4% to 21.0% in the overall target cohort. Results of Sensitivity Analysis: Empirical fluconazole therapy is reasonable for likelihoods of invasive candidiasis greater than 2.5% or fluconazole resistance less than 24.0%. For higher resistance levels, empirical caspofungin therapy is preferred. For low prevalences of invasive candidiasis, culture-based fluconazole is reasonable. For prevalences exceeding 60%, empirical caspofungin therapy is reasonable. For caspofungin to be reasonable at a prevalence of 10%, its cost must be reduced by 58%. Limitations: Less severe illness and limited use of broad-spectrum antimicrobial agents, typical of smaller hospitals, could result in a lower risk for invasive candidiasis. Conclusions: In patients in the ICU with suspected infection who have not responded to antibiotic treatment, empirical fluconazole should reduce mortality at an acceptable cost. The use of empirical strategies in low-risk patients is not justified.	Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Golan, Y (corresponding author), Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, 750 Washington St,Box 041, Boston, MA 02111 USA.	ygolan@tufts-nemc.org		Wong, John/0000-0003-4203-9010	NLM NIH HHS [T15 LM07092-11] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		AbeleHorn M, 1996, INFECTION, V24, P426, DOI 10.1007/BF01713042; AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ables AZ, 2000, INFECT DIS CLIN PRAC, V9, P169, DOI 10.1097/00019048-200009040-00006; Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Anaissie E, 1995, 35 INT C ANT AG CHEM; Anaissie EJ, 1998, AM J MED, V104, P238, DOI 10.1016/S0002-9343(98)00030-8; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bates DW, 2001, KIDNEY INT, V60, P1452, DOI 10.1046/j.1523-1755.2001.00948.x; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Blot S, 2001, J HOSP INFECT, V47, P308, DOI 10.1053/jhin.2000.0918; Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811; Borst Annemarie, 2002, Clin Lab, V48, P487; Borzotta AP, 1999, ARCH SURG-CHICAGO, V134, P657, DOI 10.1001/archsurg.134.6.657; Brandt G, 1976, MMW Munch Med Wochenschr, V118, P1453; BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4; Cagnoni PJ, 2000, J CLIN ONCOL, V18, P2476, DOI 10.1200/JCO.2000.18.12.2476; Calandra T, 2002, INTENS CARE MED, V28, P1698, DOI 10.1007/s00134-002-1539-4; Cannon JP, 2001, PHARMACOTHERAPY, V21, P1107, DOI 10.1592/phco.21.13.1107.34613; CHANDRASEKAR PH, 1995, BONE MARROW TRANSPL, V16, P675; Chen YC, 2003, J ANTIMICROB CHEMOTH, V52, P71, DOI 10.1093/jac/dkg275; Clark AD, 1998, BRIT J HAEMATOL, V103, P198; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; DeLaurenzi A, 1996, INFECTION, V24, P361, DOI 10.1007/BF01716080; Duran MT, 2003, ENFERM INFEC MICR CL, V21, P488, DOI 10.1157/13052332; DURANDZALESKI I, 1994, MED DECIS MAKING, V14, P98, DOI 10.1177/0272989X9401400112; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Edgeworth JD, 1999, CRIT CARE MED, V27, P1421, DOI 10.1097/00003246-199908000-00002; EGDAHI RH, 1983, JAMA-J AM MED ASSOC, V250, P76, DOI 10.1001/jama.250.1.76; Eggimann P, 1999, CRIT CARE MED, V27, P1066, DOI 10.1097/00003246-199906000-00019; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Fleming RV, 2001, LEUKEMIA LYMPHOMA, V40, P511, DOI 10.3109/10428190109097650; FLETCHER A, 1992, J HUM HYPERTENS, V6, P437; FRASER VJ, 1992, CLIN INFECT DIS, V15, P414, DOI 10.1093/clind/15.3.414; Garbino J, 2002, INTENS CARE MED, V28, P1708, DOI 10.1007/s00134-002-1540-y; Garbino J, 2002, MEDICINE, V81, P425, DOI 10.1097/00005792-200211000-00003; GEARHART MO, 1994, ANN PHARMACOTHER, V28, P1177, DOI 10.1177/106002809402801009; Gleason TG, 1997, ARCH SURG-CHICAGO, V132, P1197, DOI 10.1001/archsurg.1997.01430350047008; GLEASON TG, 1997, ARCH SURG-CHICAGO, V132, P1202; Gold MR, 1996, COST EFFECTIVENESS H; Gottlieb J E, 1981, Med Decis Making, V1, P74; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Harbarth S, 2002, CLIN INFECT DIS, V35, pE120, DOI 10.1086/344468; Horvath LL, 2003, J CLIN MICROBIOL, V41, P4714, DOI 10.1128/JCM.41.10.4714-4717.2003; ITO JL, 1998, CLEAR STEERING COMM; JONES JM, 1990, CLIN MICROBIOL REV, V3, P32, DOI 10.1128/CMR.3.1.32-45.1990; Kami M, 2002, BRIT J HAEMATOL, V117, P40, DOI 10.1046/j.1365-2141.2002.03414.x; Kao AS, 1999, CLIN INFECT DIS, V29, P1164, DOI 10.1086/313450; Kirby L, 2001, INT J TECHNOL ASSESS, V17, P181, DOI 10.1017/S0266462300105045; KOMSHIAN SV, 1989, REV INFECT DIS, V11, P379; Kontoyiannis DP, 2001, MYCOSES, V44, P125, DOI 10.1046/j.1439-0507.2001.00649.x; Kuti JL, 2004, PHARMACOECONOMICS, V22, P301, DOI 10.2165/00019053-200422050-00004; Kvale R, 2002, INTENS CARE MED, V28, P1110, DOI 10.1007/s00134-002-1378-3; Liebowitz LD, 2001, DIAGN MICR INFEC DIS, V40, P27, DOI 10.1016/S0732-8893(01)00243-7; Lipsett PA, 2004, CLIN INFECT DIS, V39, pS193, DOI 10.1086/421956; Lizana FG, 2003, INTENS CARE MED, V29, P1286, DOI 10.1007/s00134-003-1875-z; LYON R, 1995, AM J CLIN PATHOL, V103, P660; MacCallum DA, 2004, ANTIMICROB AGENTS CH, V48, P4911, DOI 10.1128/AAC.48.12.4911-4914.2004; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; *MAN DEEP CAND INF, 1994, INTENSICE CARE MED, V20, P522; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Marco F, 2003, DIAGN MICR INFEC DIS, V46, P259, DOI 10.1016/S0732-8893(03)00086-5; MCTAGGART B, 2003, 43 INT S C ANT AG CH; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Murray PR, 1998, J CLIN MICROBIOL, V36, P1601, DOI 10.1128/JCM.36.6.1601-1603.1998; Niskanen M, 1996, CRIT CARE MED, V24, P1962, DOI 10.1097/00003246-199612000-00006; NollaSalas J, 1997, INTENS CARE MED, V23, P23, DOI 10.1007/s001340050286; Olaechea PM, 2004, EUR J CLIN MICROBIOL, V23, P323, DOI 10.1007/s10096-004-1104-x; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pelz RK, 2001, ANN SURG, V233, P542, DOI 10.1097/00000658-200104000-00010; Petri MG, 1997, INTENS CARE MED, V23, P317, DOI 10.1007/s001340050334; Petti CA, 1996, J CLIN MICROBIOL, V34, P1877, DOI 10.1128/JCM.34.8.1877-1879.1996; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3142, DOI 10.1128/JCM.42.7.3142-3146.2004; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3117, DOI 10.1128/JCM.42.7.3117-3119.2004; Pfaller MA, 1999, DIAGN MICR INFEC DIS, V33, P217, DOI 10.1016/S0732-8893(98)00160-6; Pfaller MA, 2003, J CLIN MICROBIOL, V41, P1440, DOI 10.1128/JCM.41.4.1440-1446.2003; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002; Pfaller MA, 2004, CLIN MICROBIOL INFEC, V10, P11, DOI 10.1111/j.1470-9465.2004.t01-1-00844.x; Phillips P, 1997, EUR J CLIN MICROBIOL, V16, P337, DOI 10.1007/BF01726360; PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008; RANTALA A, 1989, SCAND J INFECT DIS, V21, P557, DOI 10.3109/00365548909037885; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Rex JH, 2001, CLIN INFECT DIS, V32, P1191, DOI 10.1086/319763; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Safran DB, 1997, ARCH SURG-CHICAGO, V132, P1184, DOI 10.1001/archsurg.1997.01430350034006; SAVINO JA, 1994, J TRAUMA, V36, P20, DOI 10.1097/00005373-199401000-00004; Schelonka RL, 2003, J PEDIATR-US, V142, P564, DOI 10.1067/mpd.2003.188; Simmons RL, 1997, ARCH SURG-CHICAGO, V132, P1188; Sobel JD, 2001, CLIN INFECT DIS, V33, P187, DOI 10.1086/321812; SOBEL JD, 1988, CRIT CARE CLIN, V4, P325; St-Germain G, 2001, J CLIN MICROBIOL, V39, P949, DOI 10.1128/JCM.39.3.949-953.2001; TELENTI A, 1989, EUR J CLIN MICROBIOL, V8, P825, DOI 10.1007/BF02185855; Testore GP, 2001, DIAGN MICR INFEC DIS, V41, P23; Tirodker Urmila H, 2003, J Perinatol, V23, P117, DOI 10.1038/sj.jp.7210868; Ullmann AJ, 2003, CURR MED RES OPIN, V19, P263, DOI 10.1185/030079903125001884; ULLMANN AJ, 2004, 13 INT S INF IMM HOS; Villanueva A, 2002, AM J MED, V113, P294, DOI 10.1016/S0002-9343(02)01191-9; Villanueva A, 2001, CLIN INFECT DIS, V33, P1529, DOI 10.1086/323401; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 1998, INTENS CARE MED, V24, P206, DOI 10.1007/s001340050552; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Voss A, 1997, INFECTION, V25, P8, DOI 10.1007/BF02113499; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Weigelt JA, 1999, ARCH SURG-CHICAGO, V134, P664; Weinstein MC, 1999, ANN INTERN MED, V130, P857, DOI 10.7326/0003-4819-130-10-199905180-00021; Weinstein MC, 1980, CLIN DECISION ANAL; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; WEY SB, 1989, ARCH INTERN MED, V149, P2349, DOI 10.1001/archinte.149.10.2349; Wilson ML, 1999, J CLIN MICROBIOL, V37, P1709, DOI 10.1128/JCM.37.6.1709-1713.1999; WILSON ML, 1993, J CLIN MICROBIOL, V31, P865, DOI 10.1128/JCM.31.4.865-871.1993; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451; WINGARD JR, 1993, ANTIMICROB AGENTS CH, V37, P1847, DOI 10.1128/AAC.37.9.1847; WINGARD JR, 1991, NEW ENGL J MED, V325, P1274, DOI 10.1056/NEJM199110313251803; Wong J B, 1999, Am J Med, V107, p74S	119	70	71	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					857	869		10.7326/0003-4819-143-12-200512200-00004	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	995CL	16365467				2022-12-28	WOS:000234077400002
J	Wu, ZH; Mabb, A; Miyamoto, S				Wu, ZH; Mabb, A; Miyamoto, S			PIDD: A switch hitter	CELL			English	Editorial Material							NF-KAPPA-B; GENOTOXIC STRESS; ACTIVATION; PROTEIN	In response to genotoxic stress, the PIDD protein promotes apoptosis downstream of the tumor-suppressor protein p53. In this issue of Cell, Janssens et al. (2005) demonstrate that, in response to such stress, PIDD forms a nuclear complex that enhances sumoylation of NEMO. This modification is important for the activation of the antiapoptotic transcription factor NF-kappa B.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wu, ZH (corresponding author), Univ Wisconsin, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	smiyamot@wisc.edu		Mabb, Angela/0000-0002-3000-8690				Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432	9	28	30	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					980	982		10.1016/j.cell.2005.11.025	http://dx.doi.org/10.1016/j.cell.2005.11.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360026	Bronze			2022-12-28	WOS:000234177200005
J	Womelsdorf, T; Fries, P; Mitra, PP; Desimone, R				Womelsdorf, T; Fries, P; Mitra, PP; Desimone, R			Gamma-band synchronization in visual cortex predicts speed of change detection	NATURE			English	Article							NEURONAL-ACTIVITY; AREA V4; NEURAL MECHANISMS; SPATIAL ATTENTION; PARIETAL CORTEX; CORTICAL AREAS; MODULATION; OSCILLATIONS; RESPONSES; MT	Our capacity to process and respond behaviourally to multiple incoming stimuli is very limited. To optimize the use of this limited capacity, attentional mechanisms give priority to behaviourally relevant stimuli at the expense of irrelevant distractors. In visual areas, attended stimuli induce enhanced responses and an improved synchronization of rhythmic neuronal activity in the gamma frequency band (40 - 70 Hz)(1-11). Both effects probably improve the neuronal signalling of attended stimuli within and among brain areas(1,12-16). Attention also results in improved behavioural performance and shortened reaction times. However, it is not known how reaction times are related to either response strength or gamma-band synchronization in visual areas. Here we show that behavioural response times to a stimulus change can be predicted specifically by the degree of gamma-band synchronization among those neurons in monkey visual area V4 that are activated by the behaviourally relevant stimulus. When there are two visual stimuli and monkeys have to detect a change in one stimulus while ignoring the other, their reactions are fastest when the relevant stimulus induces strong gamma-band synchronization before and after the change in stimulus. This enhanced gamma-band synchronization is also followed by shorter neuronal response latencies on the fast trials. Conversely, the monkeys' reactions are slowest when gamma-band synchronization is high in response to the irrelevant distractor. Thus, enhanced neuronal gamma-band synchronization and shortened neuronal response latencies to an attended stimulus seem to have direct effects on visually triggered behaviour, reflecting an early neuronal correlate of efficient visuo-motor integration.	Radboud Univ, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Radboud University Nijmegen; Radboud University Nijmegen; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT)	Womelsdorf, T (corresponding author), Radboud Univ, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands.	t.womelsdorf@fcdonders.ru.nl	Fries, Pascal/E-3196-2010; Desimone, Robert/G-1121-2018; Womelsdorf, Thilo/C-3096-2015	Fries, Pascal/0000-0002-4270-1468; Womelsdorf, Thilo/0000-0001-6921-4187; Desimone, Robert/0000-0002-5938-4227; Mitra, Partha/0000-0001-8818-6804	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Lee D, 2003, J NEUROSCI, V23, P6798; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0	27	543	553	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2006	439	7077					733	736		10.1038/nature04258	http://dx.doi.org/10.1038/nature04258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16372022				2022-12-28	WOS:000235193100046
J	Nurse, P				Nurse, P			US biomedical research under siege	CELL			English	Editorial Material								The stagnation of biomedical research funding in the US is placing great pressure on the research enterprise. It is time to consider some radical solutions.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Nurse, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	nurse@rockefeller.edu							0	14	14	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					9	12		10.1016/j.cell.2005.12.029	http://dx.doi.org/10.1016/j.cell.2005.12.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413473	Bronze			2022-12-28	WOS:000234969600001
J	Zou, PJ; Pinotsis, N; Lange, S; Song, YH; Popov, A; Mavridis, I; Mayans, OM; Gautel, M; Wilmanns, M				Zou, PJ; Pinotsis, N; Lange, S; Song, YH; Popov, A; Mavridis, I; Mayans, OM; Gautel, M; Wilmanns, M			Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk	NATURE			English	Article							CROSS-LINKING; T-CAP; TELETHONIN; DOMAINS; ULTRASTRUCTURE; ANTIBODIES; MUTATIONS; INTERACTS; SUGGESTS; COMPLEX	The Z-disk of striated and cardiac muscle sarcomeres is one of the most densely packed cellular structures in eukaryotic cells(1). It provides the architectural framework for assembling and anchoring the largest known muscle filament systems by an extensive network of protein - protein interactions, requiring an extraordinary level of mechanical stability. Here we show, using X-ray crystallography, how the amino terminus of the longest filament component, the giant muscle protein titin, is assembled into an antiparallel ( 2: 1) sandwich complex by the Z-disk ligand telethonin. The pseudosymmetric structure of telethonin mediates a unique palindromic arrangement of two titin filaments, a type of molecular assembly previously found only in protein DNA-complexes. We have confirmed its unique architecture in vivo by protein complementation assays, and in vitro by experiments using fluorescence resonance energy transfer. The model proposed may provide a molecular paradigm of how major sarcomeric filaments are crosslinked, anchored and aligned within complex cytoskeletal networks.	DESY, EMBL Hamburg, D-22603 Hamburg, Germany; Demokritos Natl Ctr Sci Res, Inst Phys Chem, GR-15310 Athens, Greece; Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; Kings Coll London, Div Cardiovasc, London SE1 1UL, England; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); National Centre of Scientific Research "Demokritos"; University of London; King's College London; University of London; King's College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Wilmanns, M (corresponding author), DESY, EMBL Hamburg, Notleststr 85, D-22603 Hamburg, Germany.	wilmanns@embl-hamburg.de	Pinotsis, Nikos/AAD-4013-2019; Lange, Stephan/A-1422-2010; Pinotsis, Nikolaos/G-3853-2011; Gautel, Mathias/AAB-9860-2019; Popov, Alexander/A-8827-2008	Pinotsis, Nikos/0000-0002-5096-257X; Lange, Stephan/0000-0001-9361-6602; Wilmanns, Matthias/0000-0002-4643-5435; Popov, Alexander/0000-0002-3058-8912; Gautel, Mathias/0000-0003-4027-9803; Mayans, Olga/0000-0001-6876-8532	Medical Research Council [G0200496] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; GUDDAT LW, 1995, FASEB J, V9, P101, DOI 10.1096/fasebj.9.1.7821748; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Luther PK, 2002, J MOL BIOL, V319, P1157, DOI 10.1016/S0022-2836(02)00372-8; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Ramsland PA, 2002, J MOL RECOGNIT, V15, P248, DOI 10.1002/jmr.585; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Schroder R, 2001, J MUSCLE RES CELL M, V22, P259, DOI 10.1023/A:1012242011109; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	30	134	141	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					229	233		10.1038/nature04343	http://dx.doi.org/10.1038/nature04343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407954	Green Published			2022-12-28	WOS:000234538400046
J	Horton, R				Horton, R			The coming decade for global action on child health	LANCET			English	Editorial Material							SURVIVAL		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2005, STAT WORLDS CHILDR 2; Belli PC, 2005, B WORLD HEALTH ORGAN, V83, P777; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Horton R, 2005, LANCET, V365, P821, DOI 10.1016/S0140-6736(05)71015-1; Horton R, 2004, LANCET, V364, P2071, DOI 10.1016/S0140-6736(04)17560-0; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee JW, 2003, LANCET, V362, P262, DOI 10.1016/S0140-6736(03)14006-8; Paraje G, 2005, SCIENCE, V308, P959, DOI 10.1126/science.1108705; Sall M, 2005, LANCET, V366, P1988, DOI 10.1016/S0140-6736(05)67796-3; World Bank, 2006, REP NUTR CENTR DEV S; World Health Organization, 2005, WORLD HLTH REP 2005	17	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					3	5		10.1016/S0140-6736(06)67899-9	http://dx.doi.org/10.1016/S0140-6736(06)67899-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000EG	16399132				2022-12-28	WOS:000234443100004
J	Javaid, MK; Crozier, SR; Harvey, NC; Gale, CR; Dennison, EM; Boucher, BJ; Arden, NK; Godfrey, KM; Cooper, C				Javaid, MK; Crozier, SR; Harvey, NC; Gale, CR; Dennison, EM; Boucher, BJ; Arden, NK; Godfrey, KM; Cooper, C		Princess Anne Hosp Study Grp	Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study	LANCET			English	Article							BIRTH-WEIGHT; MINERAL DENSITY; D DEFICIENCY; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; HIP FRACTURE; CALCIUM; GROWTH; ABSORPTIOMETRY; INFANTS	Background Vitamin D insufficiency is common in women of childbearing age and increasing evidence suggests that the risk of osteoporotic fracture in adulthood could be determined partly by environmental factors during intrauterine and early postnatal life. We investigated the effect of maternal vitamin D status during pregnancy on childhood skeletal growth. Methods In a longitudinal study, we studied 198 children born in 1991-92 in a hospital in Southampton, UK; the body build, nutrition, and vitamin D status of their mothers had been characterised during pregnancy. The children were followed up at age 9 years to relate these maternal characteristics to their body size and bone mass. Findings 49 (31%) mothers had insufficient and 28 (18%) had deficient circulating concentrations of 25(OH)-vitamin D during late pregnancy. Reduced concentration of 25(OH)-vitamin D in mothers during late pregnancy was associated with reduced whole-body (r=0.21, p=0.0088) and lumbar-spine (r=0.17, p=0.03) bone-mineral content in children at age 9 years. Both the estimated exposure to ultraviolet B radiation during late pregnancy and the maternal use of vitamin D supplements predicted maternal 25(OH)-vitamin D concentration (p<0.0001 and p=0.0110, respectively) and childhood bone mass (p=0.0267). Reduced concentration of umbilical-venous calcium also predicted reduced childhood bone mass (p=0.0286). Interpretation Maternal vitamin D insufficiency is common during pregnancy and is associated with reduced bone-mineral accrual in the offspring during childhood; this association is mediated partly through the concentration of umbilical venous calcium. Vitamin D supplementation of pregnant women, especially during winter months, could lead to longlasting reductions in the risk of osteoporotic fracture in their offspring.	Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England; Royal London Hosp, London E1 1BB, England	University of Southampton; Barts Health NHS Trust; Royal London Hospital	Cooper, C (corresponding author), Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	Gale, Catharine R/B-1653-2012	Boucher, Barbara J/0000-0003-1206-7555; Harvey, Nicholas/0000-0002-8194-2512; Gale, Catharine/0000-0002-3361-8638; Dennison, Elaine/0000-0002-3048-4961; Cooper, Cyrus/0000-0003-3510-0709; Javaid, Muhammad/0000-0001-7985-0048; Crozier, Sarah/0000-0002-9524-1127; Godfrey, Keith/0000-0002-4643-0618	Medical Research Council [G0400491, MC_UP_A620_1014] Funding Source: Medline; Medical Research Council [U1475000002, U1475000001] Funding Source: researchfish; MRC [G0400491] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bettica P, 1999, OSTEOPOROSIS INT, V9, P226, DOI 10.1007/s001980050141; Bolotin HH, 2001, J BONE MINER RES, V16, P417, DOI 10.1359/jbmr.2001.16.2.417; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; COOPER C, 1995, J BONE MINER RES, V10, P940; Cooper C, 2001, OSTEOPOROSIS INT, V12, P623, DOI 10.1007/s001980170061; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Diamond T, 1998, MED J AUSTRALIA, V169, P138, DOI 10.5694/j.1326-5377.1998.tb116014.x; Fewtrell MS, 2000, J PEDIATR-US, V137, P668, DOI 10.1067/mpd.2000.108953; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Godfrey KM, 1997, BRIT J OBSTET GYNAEC, V104, P663, DOI 10.1111/j.1471-0528.1997.tb11975.x; Hosking DJ, 1996, CLIN ENDOCRINOL, V45, P1; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; KOO WWK, 1995, J BONE MINER RES, V10, P1998; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001/jama.281.16.1505; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Mehta G, 2002, CALCIFIED TISSUE INT, V71, P493, DOI 10.1007/s00223-001-2104-9; MELTON LJ, 1988, OSTEOPOROSIS ETIOLOG, P111; MURPHY S, 1994, BRIT MED J, V308, P939, DOI 10.1136/bmj.308.6934.939; NELSON N, 1987, SCAND J CLIN LAB INV, V47, P111; Oreffo ROC, 2003, BONE, V33, P100, DOI 10.1016/S8756-3282(03)00166-2; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Sowers MF, 2000, BEST PRACT RES CL EN, V14, P317, DOI 10.1053/beem.2000.0076; Specker B, 2004, AM J CLIN NUTR, V80, p1740S, DOI 10.1093/ajcn/80.6.1740S; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Tobias JH, 2004, J BONE MINER RES, V19, P177, DOI 10.1359/JBMR.0301235; Widdowson E M, 1974, Adv Exp Med Biol, V49, P165; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541	34	574	602	2	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					36	43		10.1016/S0140-6736(06)67922-1	http://dx.doi.org/10.1016/S0140-6736(06)67922-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399151				2022-12-28	WOS:000234443100028
J	Smith, IE; Chua, S				Smith, IE; Chua, S			ABC of breast diseases - Medical treatment of early breast cancer. I: adjuvant treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WOMEN		Royal Marsden Hosp, London, England	Royal Marsden NHS Foundation Trust	Smith, IE (corresponding author), Royal Marsden Hosp, London, England.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	4	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					34	37		10.1136/bmj.332.7532.34	http://dx.doi.org/10.1136/bmj.332.7532.34			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399737	Green Published			2022-12-28	WOS:000234684200021
J	Drayna, D				Drayna, D			Is our behavior written in our genes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIDCD, Sect Syst Biol Commun Disorders, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Drayna, D (corresponding author), NIDCD, Sect Syst Biol Commun Disorders, Rockville, MD USA.							Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Mustanski BS, 2002, ANN REV SEX RES, V13, P89	3	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					7	9		10.1056/NEJMp058215	http://dx.doi.org/10.1056/NEJMp058215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998ZO	16394297				2022-12-28	WOS:000234358600003
J	Bartlett, JG				Bartlett, JG			Update in infectious diseases	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEPATITIS-B; HAEMOPHILUS-INFLUENZAE; BLOOD-TRANSFUSION; ELDERLY-PATIENTS; PNEUMONIA; OUTCOMES; EXACERBATIONS; TRANSMISSION; LAMIVUDINE		Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Med,Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Med,Div Infect Dis, 600 N Wolfe St, Baltimore, MD 21205 USA.	jb@jhmi.edu						Bach PB, 2001, ANN INTERN MED, V134, P600, DOI 10.7326/0003-4819-134-7-200104030-00016; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fritsche TR, 2004, DIAGN MICR INFEC DIS, V49, P201, DOI 10.1016/j.diagmicrobio.2004.03.002; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Harvey RF, 2004, BMJ-BRIT MED J, V328, P1417, DOI 10.1136/bmj.38082.626725.EE; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Human death associated with bat rabies-California, 2003, MMWR MORB MORTAL WKL, V53, P33; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Sethi S, 2004, AM J RESP CRIT CARE, V169, P448, DOI 10.1164/rccm.200308-1181OC; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; *US FOOD DRUG ADM, 2005, FDA TALK PAP FDA UPD; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382; 2004, MMWR MORB MORTAL WKL, V53, P1171; 2004, MMWR MORB MORTAL WKL, V53, P586	23	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					49	56		10.7326/0003-4819-144-1-200601030-00009	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389254				2022-12-28	WOS:000234474200006
J	Brockes, JP; Kumar, A				Brockes, JP; Kumar, A			Appendage regeneration in adult vertebrates and implications for regenerative medicine	SCIENCE			English	Review							AMPHIBIAN LIMB REGENERATION; RETINOIC ACID; LENS REGENERATION; PATTERN-FORMATION; CELL-CYCLE; NOTOPHTHALMUS-VIRIDESCENS; RETINOBLASTOMA PROTEIN; MUSCLE REGENERATION; AMBYSTOMA-MEXICANUM; AXOLOTL LIMBS	The regeneration of complex structures in adult salamanders depends on mechanisms that offer pointers for regenerative medicine. These include the plasticity of differentiated cells and the retention in regenerative cells of local cues such as positional identity. Limb regeneration proceeds by the local formation of a blastema, a growth zone of mesenchymal stem cells on the stump. The blastema can regenerate autonomously as a self-organizing system over variable linear dimensions. Here we consider the prospects for limb regeneration in mammals from this viewpoint.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London	Brockes, JP (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	j.brockes@ucl.ac.uk		Brockes, Jeremy/0000-0002-3395-5159				Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; BADER D, 1979, J EXP ZOOL, V208, P177, DOI 10.1002/jez.1402080206; Bettencourt-Dias M, 2003, J CELL SCI, V116, P4001, DOI 10.1242/jcs.00698; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BROCKES JP, 1984, SCIENCE, V225, P1280, DOI 10.1126/science.6474177; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Brockes JP, 2001, J ANAT, V199, P3; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; BRYANT SV, 1992, DEV BIOL, V152, P1, DOI 10.1016/0012-1606(92)90152-7; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Del Rio-Tsonis K, 2003, DEV DYNAM, V226, P211, DOI 10.1002/dvdy.10224; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; EGUCHI G, 1971, DEV GROWTH DIFFER, V13, P337; Eguchi G, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P207; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084952102000903; GARDINER DM, 1986, DEV BIOL, V118, P488, DOI 10.1016/0012-1606(86)90020-5; GHOSH S, 1994, INT J DEV BIOL, V38, P479; GOSS RJ, 1980, CLIN ORTHOP RELAT R, P270; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Guyenot E., 1948, Revue Suisse de Zoologie, V55, P1; Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67; Hall SM, 2005, PERIPHERAL NEUROPATH, P1403; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239; Heber-Katz E, 2004, CURR TOP MICROBIOL, V280, P165; Imokawa Y, 2004, PHILOS T R SOC B, V359, P765, DOI 10.1098/rstb.2004.1467; Imokawa Y, 2003, CURR BIOL, V13, P877, DOI 10.1016/S0960-9822(03)00294-X; Khan PA, 1999, DEV GENES EVOL, V209, P323, DOI 10.1007/s004270050260; KIM WS, 1986, ROUX ARCH DEV BIOL, V195, P455, DOI 10.1007/BF00375749; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x; Lopez MLSS, 2004, DEV CELL, V6, P719; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; MESCHER AL, 1976, J EXP ZOOL, V195, P117, DOI 10.1002/jez.1401950111; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Murray EW, 1998, J BIOL CHEM, V273, P25279, DOI 10.1074/jbc.273.39.25279; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Okada T.S, 1991, TRANSDIFFERENTIATION; OLIVER G, 1988, CELL, V55, P1017, DOI 10.1016/0092-8674(88)90246-2; OSTEEN WK, 1962, ANAT REC, V142, P179, DOI 10.1002/ar.1091420210; Pecorino LT, 1996, CURR BIOL, V6, P563, DOI 10.1016/S0960-9822(02)00542-0; PESCITELLI MJ, 1980, DEV BIOL, V79, P255, DOI 10.1016/0012-1606(80)90115-3; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; PIETSCH P, 1965, ANAT REC, V152, P439, DOI 10.1002/ar.1091520403; Powell MB, 1997, J IMMUNOL, V158, P1692; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; REYER RW, 1973, DEV BIOL, V32, P258, DOI 10.1016/0012-1606(73)90240-6; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; Roy S, 2000, DEV BIOL, V218, P199, DOI 10.1006/dbio.1999.9556; Roy S, 2002, J EXP ZOOL, V293, P186, DOI 10.1002/jez.10110; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; SAVARD P, 1988, EMBO J, V7, P4275, DOI 10.1002/j.1460-2075.1988.tb03325.x; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Stocum DL, 2004, ADV ANAT EMBRYOL CEL, V176, P1; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; STOCUM DL, 1968, DEV BIOL, V18, P457, DOI 10.1016/0012-1606(68)90052-3; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Tanaka EM, 1999, CURR BIOL, V9, P792, DOI 10.1016/S0960-9822(99)80362-5; TANK PW, 1976, J MORPHOL, V150, P117, DOI 10.1002/jmor.1051500106; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thitoff AR, 2003, ANAT REC PART A, V271A, P185, DOI 10.1002/ar.a.10023; Thornton CS, 1938, J MORPHOL, V62, P219, DOI 10.1002/jmor.1050620204; Velloso CP, 2001, CURR BIOL, V11, P855, DOI 10.1016/S0960-9822(01)00234-2; Velloso CP, 2000, DIFFERENTIATION, V66, P239, DOI 10.1046/j.1432-0436.2000.660410.x; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	88	277	292	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1919	1923		10.1126/science.1115200	http://dx.doi.org/10.1126/science.1115200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373567	Green Submitted			2022-12-28	WOS:000234275400032
J	Sun, ZD; Takagi, K; Matsushima, F				Sun, ZD; Takagi, K; Matsushima, F			Separation and conversion dynamics of four nuclear spin isomers of ethylene	SCIENCE			English	Article							FORMALDEHYDE; WATER	Molecules with three or more nuclei of nonzero spin exist as discrete spin isomers whose interconversion in the gas phase is generally considered improbable. We have studied the interconversion process in ethylene by creating a sample depleted in the B-w nuclear spin isomer. The separation was achieved through spatial drift of this isomer induced by resonant absorption of narrow-band infrared light. Evolution of the depleted sample revealed conversion between B-2u and B-3u isomers at a rate linearly proportional to pressure, with a rate constant of 5.5 (+/- 0.8) x 10(-4) s(-1) torr(-1). However, almost no change was observed in the A(g) isomer populations. The results suggest a spin conversion mechanism in C2H4 via quantum relaxation within the same inversion symmetry.	Toyama Univ, Dept Phys, Toyama 9308555, Japan	University of Toyama	Sun, ZD (corresponding author), Toyama Univ, Dept Phys, Toyama 9308555, Japan.	zdsun@unbsj.ca						BUNKER PR, 1998, MOL SYMMETRY SPECTRO, P407; CAUUET I, 1990, J MOL SPECTROSC, V139, P191, DOI 10.1016/0022-2852(90)90251-K; Chapovskii P. L., 1990, Soviet Physics - JETP, V70, P895; Chapovsky PL, 2000, CHEM PHYS LETT, V322, P424, DOI 10.1016/S0009-2614(00)00445-0; CHAPOVSKY PL, 1991, PHYS REV A, V43, P3624, DOI 10.1103/PhysRevA.43.3624; CURL RF, 1967, J CHEM PHYS, V46, P3220, DOI 10.1063/1.1841193; Dello Russo N, 2005, ASTROPHYS J, V621, P537, DOI 10.1086/427473; Dickins JE, 1999, ASTROPHYS J, V518, P733, DOI 10.1086/307317; Farkas A., 1935, ORTHOHYDROGEN PARAHY; GELMUKHANOV FK, 1979, JETP LETT+, V29, P711; Herzberg G., 1945, INFRARED RAMAN SPECT, V2; Kawakita H, 2001, SCIENCE, V294, P1089, DOI 10.1126/science.1064339; Lifshitz, 1981, QUANTUM MECH; Nagels B, 1996, PHYS REV A, V54, P2050, DOI 10.1103/PhysRevA.54.2050; OKA T, 1973, J MOL SPECTROSC, V48, P503, DOI 10.1016/0022-2852(73)90113-6; Peters G, 1999, CHEM PHYS LETT, V302, P181, DOI 10.1016/S0009-2614(99)00042-1; Sun ZD, 2000, J OPT SOC AM B, V17, P2068, DOI 10.1364/JOSAB.17.002068; Tikhonov VI, 2002, SCIENCE, V296, P2363, DOI 10.1126/science.1069513	18	65	67	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2005	310	5756					1938	1941		10.1126/science.1120037	http://dx.doi.org/10.1126/science.1120037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373570				2022-12-28	WOS:000234275400037
J	Vabulas, RM; Hartl, FU				Vabulas, RM; Hartl, FU			Protein synthesis upon acute nutrient restriction relies on proteasome function	SCIENCE			English	Article							DEGRADATION; STARVATION; INHIBITORS; UBIQUITIN; ACIDIFICATION; AUTOPHAGY	The mechanisms that protect mammalian cells against amino acid deprivation are only partially understood. We found that during an acute decrease. in external amino acid supply, before up-regulation of the autophagosomal-lysosomai pathway, efficient translation was ensured by proteasomal protein degradation. Amino acids for the synthesis of new proteins were supplied by the degradation of preexisting proteins, whereas nascent and newly formed polypeptides remained largely protected from proteolysis. Proteasome inhibition during nutrient deprivation caused rapid amino acid depletion and marked impairment of translation. Thus, the proteasome plays a crucial rote in cell survival after acute disruption of amino acid supply.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Vabulas, RM (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	vabulas@biochem.mpg.de; uhartl@biochem.mpg.de	Vabulas, R. Martin/D-3506-2011; Hartl, F. Ulrich/Y-8206-2019					BOTBOL V, 1989, J BIOL CHEM, V264, P13504; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEGLEN PO, 1986, BIOMED BIOCHIM ACTA, V45, P1647; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekine K, 2001, INT J CANCER, V94, P485, DOI 10.1002/ijc.1492; Tietz NW, 1995, CLIN GUIDE LAB TESTS, V3rd; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; WEK SA, 1995, MOL CELL BIOL, V15, P4497; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	24	254	257	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1960	1963		10.1126/science.1121925	http://dx.doi.org/10.1126/science.1121925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373576				2022-12-28	WOS:000234275400044
J	Megraud, F				Megraud, F			A humble bacterium sweeps this year's Nobel Prize	CELL			English	Editorial Material							UNIDENTIFIED CURVED BACILLI	Earlier this month, the Nobel Prize in Physiology or Medicine was awarded to the Australians Barry Marshall and Robin Warren for their discovery of the bacterium Helicobacter pylori and its role in peptic ulcer disease and gastric cancer It is the first time since 1928 that the Nobel Prize has been awarded for the discovery of a bacterium, and H. pylori is the first bacterium to be associated with cancer.	Univ Victor Segalen Bordeaux 2, INSERM ERI 10, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Megraud, F (corresponding author), Univ Victor Segalen Bordeaux 2, INSERM ERI 10, Bordeaux, France.	francis.megraud@chu-bordeaux.fr						Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; IARC, 1994, IARC MON EV CARC RIS, V61, P177; MARSHALL BJ, 1984, LANCET, V1, P1311; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WARREN JR, 1983, LANCET, V1, P1273; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	11	38	39	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					975	976		10.1016/j.cell.2005.11.032	http://dx.doi.org/10.1016/j.cell.2005.11.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360024	Bronze			2022-12-28	WOS:000234177200003
J	Butcher, J				Butcher, J			Profile - Lewis Gordon Pugh - Polar swimmer	LANCET			English	Biographical-Item												james.butcher@lancet.com						PUGH LG, PUBLICATION LIST	1	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S23	S24		10.1016/S0140-6736(05)67833-6	http://dx.doi.org/10.1016/S0140-6736(05)67833-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360737				2022-12-28	WOS:000234374400016
J	Simpson				Simpson			Personal account - Sports injury of a guide-dog	LANCET			English	Article												simpywimpy@hotmail.com							0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S65	S65		10.1016/S0140-6736(05)67859-2	http://dx.doi.org/10.1016/S0140-6736(05)67859-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360763				2022-12-28	WOS:000234374400039
J	Dodwell, D; Crellin, A				Dodwell, D; Crellin, A			Cancer care - Waiting for radiotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOCAL-CONTROL; TIMES; DELAY; SURVIVAL; HEAD		Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England	Cookridge Hospital	Dodwell, D (corresponding author), Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England.	david.dodwell@leedsth.nhs.uk						Ash D, 2004, CLIN ONCOL-UK, V16, P387, DOI 10.1016/j.clon.2004.06.006; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Choan E, 2005, INT J RADIAT ONCOL, V61, P1071; Fortin A, 2002, INT J RADIAT ONCOL, V52, P929, DOI 10.1016/S0360-3016(01)02606-2; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Jones B, 2005, BRIT MED J, V330, P979, DOI 10.1136/bmj.330.7498.979; Leon X, 2003, RADIOTHER ONCOL, V66, P277, DOI 10.1016/S0167-8140(03)00022-7; Mikeljevic JS, 2004, BRIT J CANCER, V90, P1343, DOI 10.1038/sj.bjc.6601693; O'Rourke N, 2000, CLIN ONCOL-UK, V12, P141, DOI 10.1053/clon.2000.9139; Probst H, 2003, J RADIOTHER PRACT, V3, P113; *ROYAL COLL RAD, 2003, EQ WORKL STAFF RAD U; *ROYAL COLL RAD, 2000, PROV REPL RAD EQ; Schwartz DL, 2002, INT J RADIAT ONCOL, V52, P1352, DOI 10.1016/S0360-3016(01)02807-3; Waaijer A, 2003, RADIOTHER ONCOL, V66, P271, DOI 10.1016/S0167-8140(03)00036-7	14	25	25	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					107	109		10.1136/bmj.332.7533.107	http://dx.doi.org/10.1136/bmj.332.7533.107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410589	Green Published			2022-12-28	WOS:000234777000026
J	Holstege, FCP; Clevers, H				Holstege, FCP; Clevers, H			Transcription factor target practice	CELL			English	Editorial Material							ENHANCERS	In this issue of Cell, Hallikas et al. (2006) and Wei et al. (2006) describe different ways of identifying direct targets of transcription factors and their corresponding regulatory sequences in the genome. Although still under development, these studies provide an efficient way to decipher regulatory networks.	Univ Utrecht, Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Holstege, FCP (corresponding author), Univ Utrecht, Med Ctr, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@med.uu.nl	Holstege, Frank/AAM-9944-2021					Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; WEI CL, 2006, CELL; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2	9	14	14	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					21	23		10.1016/j.cell.2005.12.026	http://dx.doi.org/10.1016/j.cell.2005.12.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413477	Bronze			2022-12-28	WOS:000234969600005
J	Li, T; Chen, XJ; Garbutt, KC; Zhou, PB; Zheng, N				Li, T; Chen, XJ; Garbutt, KC; Zhou, PB; Zheng, N			Structure of DDB1 in complex with a paramyxovirus V protein: Viral hijack of a propeller cluster in ubiquitin ligase	CELL			English	Article							CRYSTAL-STRUCTURE; TOMATO HOMOLOG; GENOME STABILITY; BETA-PROPELLERS; BINDING-PROTEIN; SOCS-BOX; IN-VIVO; SV5 V; STAT1; SIMIAN-VIRUS-5	The DDB1-CuI4A ubiquitin ligase complex promotes protein ubiquitination in diverse cellular functions and is reprogrammed by the V proteins of paramyxoviruses to degrade STATs and block interferon signaling. Here we report the crystal structures of DDB1 alone and in complex with the simian virus 5 V protein. The DDB1 structure reveals an intertwined three-propeller cluster, which contains two tightly coupled P propellers with a large pocket in between and a third 0 propeller flexibly attached on the side. The rigid double-propeller fold of DDB1 is targeted by the viral V protein, which inserts an entire helix into the double-propeller pocket, whereas the third propeller domain docks DDB1 to the N terminus of the CuI4A scaffold. Together, these results not only provide structural insights into how the virus hijacks the DDB1-CuI4A ubiquitin ligase but also establish a structural framework for understanding the multiple functions of DDB1 in the uniquely assembled cullin-RING E3 machinery.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA	University of Washington; University of Washington Seattle; Cornell University	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu			NATIONAL CANCER INSTITUTE [R01CA107134, R01CA098210, R56CA098210] Funding Source: NIH RePORTER; NCI NIH HHS [CA098210, CA107134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; DeLano WL, 2002, PYMOL USERS MANUAL; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Levin I, 2003, THEOR APPL GENET, V106, P454, DOI 10.1007/s00122-002-1080-4; Lieberman M, 2004, THEOR APPL GENET, V108, P1574, DOI 10.1007/s00122-004-1584-1; Lin GY, 1997, VIROLOGY, V238, P460, DOI 10.1006/viro.1997.8866; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu W, 2000, J BIOL CHEM, V275, P21429, DOI 10.1074/jbc.M000961200; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Mustilli AC, 1999, PLANT CELL, V11, P145, DOI 10.1105/tpc.11.2.145; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Parisien JP, 2002, J VIROL, V76, P6435, DOI 10.1128/JVI.76.13.6435-6441.2002; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Randall RE, 1996, VIROLOGY, V224, P121, DOI 10.1006/viro.1996.0513; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMAS SM, 1988, CELL, V54, P891, DOI 10.1016/S0092-8674(88)91285-8; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Young DF, 2001, J VIROL, V75, P3363, DOI 10.1128/JVI.75.7.3363-3370.2001; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	65	204	211	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					105	117		10.1016/j.cell.2005.10.033	http://dx.doi.org/10.1016/j.cell.2005.10.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413485	Bronze			2022-12-28	WOS:000234969600013
J	Jarosz, DF; Godoy, VG; Delaney, JC; Essigmann, JM; Walker, GC				Jarosz, DF; Godoy, VG; Delaney, JC; Essigmann, JM; Walker, GC			A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates	NATURE			English	Article							ESCHERICHIA-COLI; LESION-BYPASS; ERROR-PRONE; POL-IV; MUTAGENESIS; RIBONUCLEOTIDES; MUTATIONS; ADDUCTS; ROLES; GENE	Translesion synthesis (TLS) by Y-family DNA polymerases is a chief mechanism of DNA damage tolerance(1). Such TLS can be accurate or error-prone, as it is for bypass of a cyclobutane pyrimidine dimer by DNA polymerase h (XP-V or Rad30) or bypass of a (6-4) TT photoproduct by DNA polymerase V (UmuD'C-2), respectively(2,3). Although DinB is the only Y-family DNA polymerase conserved among all domains of life, the biological rationale for this striking conservation has remained enigmatic(4). Here we report that the Escherichia coli dinB gene is required for resistance to some DNA-damaging agents that form adducts at the N-2-position of deoxyguanosine (dG). We show that DinB (DNA polymerase IV) catalyses accurate TLS over one such N-2-dG adduct (N-2-furfuryl-dG), and that DinB and its mammalian orthologue, DNA polymerase kappa, insert deoxycytidine (dC) opposite N-2-furfuryl-dG with 10-15-fold greater catalytic proficiency than opposite undamaged dG. We also show that mutating a single amino acid, the 'steric gate' residue of DinB (Phe13 --> Val) and that of its archaeal homologue Dbh (Phe12 --> Ala), separates the abilities of these enzymes to perform TLS over N-2-dG adducts from their abilities to replicate an undamaged template. We propose that DinB and its orthologues are specialized to catalyse relatively accurate TLS over some N-2-dG adducts that are ubiquitous in nature, that lesion bypass occurs more efficiently than synthesis on undamaged DNA, and that this specificity may be achieved at least in part through a lesion-induced conformational change.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261; Jarosz, Daniel/0000-0003-3497-5888				Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BROTCORNELANNOYE A, 1986, P NATL ACAD SCI USA, V83, P3904, DOI 10.1073/pnas.83.11.3904; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; DeCorte BL, 1996, CHEM RES TOXICOL, V9, P630, DOI 10.1021/tx9501795; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen X, 2002, J BIOL CHEM, V277, P5265, DOI 10.1074/jbc.M109575200; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; WATANABE M, 1994, MUTAT RES, V314, P39, DOI 10.1016/0921-8777(94)90059-0; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Yasui M, 2004, BIOCHEMISTRY-US, V43, P15005, DOI 10.1021/bi048279+; Zewail-Foote M, 2001, CHEM BIOL, V8, P1033, DOI 10.1016/S1074-5521(01)00071-0	28	198	201	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					225	228		10.1038/nature04318	http://dx.doi.org/10.1038/nature04318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407906				2022-12-28	WOS:000234538400045
J	Spathis, MGS				Spathis, MGS			The nursing profession's coming of age - Plus ca change	BRITISH MEDICAL JOURNAL			English	Letter									St Helier Hosp, Carshalton SM5 1AA, Surrey, England	St Helier Hospital	Spathis, MGS (corresponding author), St Helier Hosp, Carshalton SM5 1AA, Surrey, England.	spathis@doctors.org.uk						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					51	51		10.1136/bmj.332.7532.51-c	http://dx.doi.org/10.1136/bmj.332.7532.51-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399748	Green Published			2022-12-28	WOS:000234684200032
J	Sobolski, GK; Barton, JH; Emanuel, EJ				Sobolski, GK; Barton, JH; Emanuel, EJ			Technology licensing - Lessons from the US experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTELLECTUAL PROPERTY; UNIVERSITY		NHGRI, Dept Clin Bioeth, NIH, Bethesda, MD 20892 USA; NHGRI, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Law, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University	Emanuel, EJ (corresponding author), NHGRI, Dept Clin Bioeth, NIH, Bldg 10,Room 1c118,10 Ctr Dr, Bethesda, MD 20892 USA.	eemanuel@nih.gov						*ASS U TECHN MAN, 2001, AUTM LIC SURV; Benkler Y, 2004, SCIENCE, V305, P1110, DOI 10.1126/science.1100526; Campbell EG, 2004, HEALTH AFFAIR, V23, P64, DOI 10.1377/hlthaff.23.1.64; Colyvas J, 2002, MANAGE SCI, V48, P61, DOI 10.1287/mnsc.48.1.61.14272; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; Feldman MP, 2004, MINERVA, V42, P105, DOI 10.1023/B:MINE.0000030019.99709.a0; Garduno E., 2004, S AFRICAN U TECHNOLO; Graff G, 2002, CALIF MANAGE REV, V45, P88, DOI 10.2307/41166155; Nelson R. R, 2001, J TECHNOLOGY TRANSFE, V26, P13, DOI DOI 10.1023/A:1007875910066; Organisation for Economic Co-operation and Development, 2003, TURN SCI BUS PAT LIC; RADOVESIC S, 1999, INT TECHNOLOGY TRANS; ROMAN V, 2004, SCI DEV NET NEW 0517; *STAT INT PROP OFF, ANN REP 2000; Thursby JG, 2003, SCIENCE, V301, P1052, DOI 10.1126/science.1087473; UK Commission on Intellectual Property Rights, 2002, INT INT PROP RIGHTS; *US COLL U UT PAT, 2002, CAL YEARS 1996 2000	16	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3137	3140		10.1001/jama.294.24.3137	http://dx.doi.org/10.1001/jama.294.24.3137			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380596				2022-12-28	WOS:000234274200032
J	Handysides, J; Handysides, S				Handysides, J; Handysides, S			Stains on the carpet	BRITISH MEDICAL JOURNAL			English	Article							BEETROOT; BEETURIA		Orchard Surg, Buntingford SG9 9DL, England; N Essex Mental Hlth Partnership NHS Trust, Child & Family Consultat Serv, Harlow CM20 1QR, Essex, England		Handysides, S (corresponding author), Orchard Surg, Buntingford SG9 9DL, England.	stuart_handysides@hotmail.com						EASTWOOD MA, 1995, QJM-INT J MED, V88, P711; FINCH AM, 1981, CLIN SCI, V60, P411, DOI 10.1042/cs0600411; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P539; Tesoriere L, 2004, AM J CLIN NUTR, V80, P941, DOI 10.1093/ajcn/80.4.941; WATTS AR, 1993, PHARMACOGENETICS, V3, P302, DOI 10.1097/00008571-199312000-00004	5	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1501	1501		10.1136/bmj.331.7531.1501	http://dx.doi.org/10.1136/bmj.331.7531.1501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373728	Green Published, Bronze			2022-12-28	WOS:000234351300008
J	Griffiths, MJD; Evans, TW				Griffiths, MJD; Evans, TW			Drug therapy - Inhaled nitric oxide therapy in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY VASCULAR-RESISTANCE; ACUTE LUNG INJURY; SICKLE-CELL-DISEASE; AEROSOLIZED PROSTACYCLIN; DOSE-RESPONSE; BIOLOGICAL-ACTIVITY; REPERFUSION INJURY; RANDOMIZED-TRIAL; GAS-EXCHANGE		Univ London Imperial Coll Sci Technol & Med, London, England; Royal Brompton Hosp, Adult Intens Care Unit, London SW3 6LY, England; Royal Brompton Hosp, Intens Care Serv, London SW3 6LY, England	Imperial College London; Royal Brompton Hospital; Royal Brompton Hospital	Evans, TW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Crit Care Unit, Sydney St, London SW3 6NP, England.	t.evans@rbh.nthames.nhs.uk		Griffiths, Mark/0000-0002-1615-1896				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; ADATIA I, 1994, ANN THORAC SURG, V57, P1311, DOI 10.1016/0003-4975(94)91382-X; Adrie C, 1998, J APPL PHYSIOL, V84, P435, DOI 10.1152/jappl.1998.84.2.435; Adrie C, 2000, ANESTHESIOLOGY, V93, P422, DOI 10.1097/00000542-200008000-00021; Ardehali A, 2001, TRANSPLANTATION, V72, P112, DOI 10.1097/00007890-200107150-00022; Atz AM, 1996, ANN THORAC SURG, V62, P1759, DOI 10.1016/S0003-4975(96)00542-5; Atz AM, 2002, J THORAC CARDIOV SUR, V124, P628, DOI 10.1067/mtc.2002.125265; Bacha EA, 1997, TRANSPLANTATION, V63, P1380, DOI 10.1097/00007890-199705270-00002; Barbera JA, 1996, LANCET, V347, P436, DOI 10.1016/S0140-6736(96)90011-2; BENZING A, 1994, ACTA ANAESTH SCAND, V38, P640, DOI 10.1111/j.1399-6576.1994.tb03970.x; BENZING A, 1995, ANESTHESIOLOGY, V83, P1153, DOI 10.1097/00000542-199512000-00004; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brett SJ, 1998, CHEST, V114, P1397, DOI 10.1378/chest.114.5.1397; Brett SJ, 1998, CLIN SCI, V95, P621, DOI 10.1042/cs0950621; Brower RG, 2004, NEW ENGL J MED, V351, P327; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Capellier G, 1997, INTENS CARE MED, V23, P1089, DOI 10.1007/s001340050461; Chen L, 2001, AM J PHYSIOL-HEART C, V281, pH124, DOI 10.1152/ajpheart.2001.281.1.H124; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Cuthbertson BH, 1997, INTENS CARE MED, V23, P1212, DOI 10.1007/s001340050488; Date H, 1996, J THORAC CARDIOV SUR, V111, P913, DOI 10.1016/S0022-5223(96)70364-1; Della Rocca G, 2001, J CARDIOTHOR VASC AN, V15, P224, DOI 10.1053/jcan.2001.21974; Dellinger RP, 1998, CRIT CARE MED, V26, P15, DOI 10.1097/00003246-199801000-00011; DUPUY PM, 1992, J CLIN INVEST, V90, P421, DOI 10.1172/JCI115877; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Eichelbronner O, 1996, INTENS CARE MED, V22, P880; *EX HS, 1996, OCC EXP LIM 1996; Fox-Robichaud A, 1998, J CLIN INVEST, V101, P2497, DOI 10.1172/JCI2736; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; FROSTELL C, 1991, CIRCULATION, V84, P2212; FROSTELL CG, 1993, ANESTHESIOLOGY, V78, P427, DOI 10.1097/00000542-199303000-00005; Gallart L, 1998, AM J RESP CRIT CARE, V158, P1770, DOI 10.1164/ajrccm.158.6.9804066; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gerlach H, 2003, AM J RESP CRIT CARE, V167, P1008, DOI 10.1164/rccm.2108121; GERLACH H, 1993, EUR J CLIN INVEST, V23, P499, DOI 10.1111/j.1365-2362.1993.tb00797.x; Gessler P, 1996, INTENS CARE MED, V22, P252, DOI 10.1007/BF01712246; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; GREENBAUM R, 1967, BRIT J ANAESTH, V39, P393, DOI 10.1093/bja/39.5.393; Gries A, 1997, ANESTHESIOLOGY, V86, P387, DOI 10.1097/00000542-199702000-00013; Hampl V, 2000, PHYSIOL REV, V80, P1337, DOI 10.1152/physrev.2000.80.4.1337; Haraldsson A, 1998, CHEST, V114, P780, DOI 10.1378/chest.114.3.780; Haraldsson A, 2000, INTENS CARE MED, V26, P188, DOI 10.1007/s001340050044; HEISS LN, 1994, P NATL ACAD SCI USA, V91, P267, DOI 10.1073/pnas.91.1.267; HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474; Holzmann A, 1996, AM J PHYSIOL-LUNG C, V271, pL981, DOI 10.1152/ajplung.1996.271.6.L981; HUGOD C, 1979, INT ARCH OCC ENV HEA, V42, P159, DOI 10.1007/BF00377770; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lamb NJ, 1999, AM J RESP CRIT CARE, V160, P1031, DOI 10.1164/ajrccm.160.3.9810048; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Liu MY, 2000, AM J PHYSIOL-LUNG C, V278, pL1071, DOI 10.1152/ajplung.2000.278.5.L1071; LOH E, 1994, CIRCULATION, V90, P2780, DOI 10.1161/01.CIR.90.6.2780; Lorch SA, 2004, PEDIATR RES, V56, P345, DOI 10.1203/01.PDR.0000134256.30519.9B; Lowson SM, 2004, BRIT MED BULL, V70, P119, DOI 10.1093/bmb/ldh028; Lundin S, 1999, INTENS CARE MED, V25, P911, DOI 10.1007/s001340050982; Macdonald PS, 1998, J HEART LUNG TRANSPL, V17, P312; Manktelow C, 1997, ANESTHESIOLOGY, V87, P297, DOI 10.1097/00000542-199708000-00017; Matalon S, 1996, AM J PHYSIOL-LUNG C, V270, pL273, DOI 10.1152/ajplung.1996.270.2.L273; Matsumoto A, 1997, LANCET, V350, P818; Matsumoto A, 1997, LANCET, V349, P999, DOI 10.1016/S0140-6736(05)62897-8; McCleverty JA, 2004, CHEM REV, V104, P403, DOI 10.1021/cr020623q; Meade MO, 2003, AM J RESP CRIT CARE, V167, P1483, DOI 10.1164/rccm.2203034; Michael JR, 1998, AM J RESP CRIT CARE, V157, P1372, DOI 10.1164/ajrccm.157.5.96-10089; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Mourgeon E, 1997, AM J RESP CRIT CARE, V156, P1692, DOI 10.1164/ajrccm.156.5.96-12012; Neviere R, 2000, CRIT CARE MED, V28, P1072, DOI 10.1097/00003246-200004000-00027; NORMAN V, 1965, NATURE, V205, P915, DOI 10.1038/205915b0; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PAYEN D, 1999, INTENS CARE MED S, V25, pS166; Pepke-Zaba J, 2003, THORAX, V58, P283, DOI 10.1136/thorax.58.4.283; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; POSS WB, 1995, J APPL PHYSIOL, V79, P886, DOI 10.1152/jappl.1995.79.3.886; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Putensen C, 1998, AM J RESP CRIT CARE, V157, P1743, DOI 10.1164/ajrccm.157.6.9609017; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; RICH GF, 1993, ANESTHESIOLOGY, V78, P1028, DOI 10.1097/00000542-199306000-00004; RIMAR S, 1993, CIRCULATION, V88, P2884, DOI 10.1161/01.CIR.88.6.2884; Roger N, 1997, AM J RESP CRIT CARE, V156, P800, DOI 10.1164/ajrccm.156.3.9611051; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; ROSSAINT R, 1995, CHEST, V107, P1107, DOI 10.1378/chest.107.4.1107; Sato Y, 1999, AM J RESP CRIT CARE, V159, P1469, DOI 10.1164/ajrccm.159.5.9808063; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265; SITBON O, 1995, AM J RESP CRIT CARE, V151, P384, DOI 10.1164/ajrccm.151.2.7842196; SNOW DJ, 1994, BRIT J ANAESTH, V72, P185, DOI 10.1093/bja/72.2.185; Sokol J, 2003, ANESTH ANALG, V97, P989, DOI [10.1213/01.ANE.0000078819.48523.26, 10.1213/01.ANE.0000078819.45523.26]; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CIRCULATION, V89, P2035, DOI 10.1161/01.CIR.89.5.2035; Steudel W, 1999, ANESTHESIOLOGY, V91, P1090, DOI 10.1097/00000542-199910000-00030; Stuart RB, 2003, AM J PHYSIOL-LUNG C, V285, pL628, DOI 10.1152/ajplung.00264.2002; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; Takahashi Y, 1998, AM J PHYSIOL-HEART C, V274, pH349, DOI 10.1152/ajpheart.1998.274.1.H349; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Troncy E, 1998, AM J RESP CRIT CARE, V157, P1483, DOI 10.1164/ajrccm.157.5.9707090; Uchida T, 1998, CHEST, V113, P1658, DOI 10.1378/chest.113.6.1658; Vonbank K, 2003, THORAX, V58, P289, DOI 10.1136/thorax.58.4.289; Walmrath D, 1996, AM J RESP CRIT CARE, V153, P991, DOI 10.1164/ajrccm.153.3.8630585; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Wedgwood S, 2001, CIRC RES, V89, P357, DOI 10.1161/hh1601.094983; Weinberger B, 2001, TOXICOL SCI, V59, P5, DOI 10.1093/toxsci/59.1.5; WEITZENBLUM E, 1981, THORAX, V36, P752, DOI 10.1136/thx.36.10.752; Westfelt UN, 1997, ACTA ANAESTH SCAND, V41, P266, DOI 10.1111/j.1399-6576.1997.tb04678.x; Young JD, 1996, BRIT J ANAESTH, V76, P652, DOI 10.1093/bja/76.5.652; YOUNG JD, 1994, INTENS CARE MED, V20, P581, DOI 10.1007/BF01705726; Yurtseven N, 2003, ANESTHESIOLOGY, V99, P855, DOI 10.1097/00000542-200310000-00017; ZAPOL WM, 1977, NEW ENGL J MED, V296, P476, DOI 10.1056/NEJM197703032960903; Zhu S, 2001, AM J RESP CRIT CARE, V163, P166, DOI 10.1164/ajrccm.163.1.2005068; Zwissler B, 1996, AM J RESP CRIT CARE, V154, P1671, DOI 10.1164/ajrccm.154.6.8970353	121	239	247	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2683	2695		10.1056/NEJMra051884	http://dx.doi.org/10.1056/NEJMra051884			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371634				2022-12-28	WOS:000234094400009
J	Parrish, JA				Parrish, JA			Immunosuppression, skin cancer, and ultraviolet A radiation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUVA		Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Parrish, JA (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.							Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Marcil I, 2001, LANCET, V358, P1042, DOI 10.1016/S0140-6736(01)06179-7; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805	5	37	41	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2712	2713		10.1056/NEJMcibr054224	http://dx.doi.org/10.1056/NEJMcibr054224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371639				2022-12-28	WOS:000234094400015
J	Ferri, CP; Prince, M; Brayne, C; Brodaty, H; Fratiglioni, L; Ganguli, M; Hall, K; Hasegawa, K; Hendrie, H; Huang, YQ; Jorm, A; Mathers, C; Menezes, PR; Rimmer, E; Scazufca, M				Ferri, CP; Prince, M; Brayne, C; Brodaty, H; Fratiglioni, L; Ganguli, M; Hall, K; Hasegawa, K; Hendrie, H; Huang, YQ; Jorm, A; Mathers, C; Menezes, PR; Rimmer, E; Scazufca, M		Alzheimers Dis Intl	Global prevalence of dementia: a Delphi consensus study	LANCET			English	Article							ALZHEIMERS-DISEASE; DEVELOPING-COUNTRIES; DETERMINISTIC APPROACH; AFRICAN-AMERICANS; RURAL-COMMUNITY; INDO-US; PEOPLE; MORTALITY; HEALTH; IMPACT	Background 100 years after the first description, Alzheimer's disease is one of the most disabling and burdensome health conditions worldwide. We used the Delphi consensus method to determine dementia prevalence for each world region. Methods 12 international experts were provided with a systematic review of published studies on dementia and were asked to provide prevalence estimates for every WHO world region, for men and women combined, in 5-year age bands from 60 to 84 years, and for those aged 85 years and older. UN population estimates and projections were used to estimate numbers of people with dementia in 2001, 2020, and 2040. We estimated incidence rates from prevalence, remission, and mortality. Findings Evidence from well-planned, representative epidemiological surveys is scarce in many regions. We estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia every year (one new case every 7 seconds). The number of people affected will double every 20 years to 81.1 million by 2040. Most people with dementia live in developing countries (60% in 2001, rising to 71% by 2040). Rates of increase are not uniform; numbers in developed countries are forecast to increase by 100% between 2001 and 2040, but by more than 300% in India, China, and their south Asian and western Pacific neighbours. Interpretation We believe that the detailed estimates in this paper constitute the best currently available basis for policymaking, planning, and allocation of health and welfare resources.	Kings Coll London, Inst Psychiat, Epidemiol Sect, London SE5 8AF, England; Alzheimers Dis Int, London, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; Univ New S Wales, Sydney, NSW, Australia; Karolinska Inst, NEUROTEC, S-10401 Stockholm, Sweden; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Indiana Univ, Sch Med, Ctr Aging Res, Bloomington, IN 47405 USA; St Marianna Univ, Sch Med, Kanagawa, Japan; Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; WHO, Measurement & Hlth Informat, Evidence & Informat Policy, Geneva, Switzerland; Univ Sao Paulo, Dept Prevent Med, BR-05508 Sao Paulo, Brazil; Univ Sao Paulo, Dept Psychiat, BR-05508 Sao Paulo, Brazil	University of London; King's College London; University of Cambridge; University of New South Wales Sydney; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; Saint Marianna University; Peking University; University of Melbourne; World Health Organization; Universidade de Sao Paulo; Universidade de Sao Paulo	Ferri, CP (corresponding author), Kings Coll London, Inst Psychiat, Epidemiol Sect, POB 060,de Crespigny Pk, London SE5 8AF, England.	c.ferri@iop.kcl.ac.uk	Scazufca, Marcia/K-7418-2012; Menezes, Paulo/AAM-3529-2021; MORAN, CATHERINE L/C-9539-2015; Ferri, Cleusa Pinheiro/B-2922-2010; Ganguli, Mary/A-3638-2013; Robles-Sardin, Alma E/M-7714-2015; Jorm, Anthony F/B-5555-2009; Menezes, Paulo R/C-9985-2010; Prince, Martin J/A-9170-2010; Brodaty, Henry/E-2753-2010; Brayne, Carol/AAA-4285-2020	Menezes, Paulo/0000-0001-6330-3314; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Robles-Sardin, Alma E/0000-0003-2044-7793; Jorm, Anthony F/0000-0002-1424-4116; Menezes, Paulo R/0000-0001-6330-3314; Prince, Martin J/0000-0003-1379-7146; Brodaty, Henry/0000-0001-9487-6617; Brayne, Carol/0000-0001-5307-663X; Scazufca, Marcia/0000-0002-4545-006X; Mathers, Colin/0000-0002-0617-6731	NIA NIH HHS [R01 AG009956-14S1, R01 AG009956] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009956] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Beaglehole R., 2003, WORLD HLTH REPORT 20; Breteler MMB, 1998, HAEMOSTASIS, V28, P167; Chandra V, 1998, NEUROLOGY, V51, P1000, DOI 10.1212/WNL.51.4.1000; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; COMASHERRA A, 1728, 2005 PSSRU; Ferri CP, 2004, INT PSYCHOGERIATR, V16, P441, DOI 10.1017/S1041610204000833; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jagger C, 2000, NEUROLOGY, V54, pS16; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KALACHE A, 1991, INT J GERIATR PSYCH, V6, P617, DOI 10.1002/gps.930060902; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; McGee MA, 1998, INT J EPIDEMIOL, V27, P87, DOI 10.1093/ije/27.1.87; McGee MA, 2001, NEUROEPIDEMIOLOGY, V20, P221, DOI 10.1159/000054793; Murphy MK, 1988, HEALTH TECHNOL ASSES, V2, p[i, 1]; Pandav RS, 2004, AM J GERIAT PSYCHIAT, V12, P523, DOI 10.1176/appi.ajgp.12.5.523; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2000, INT J GERIATR PSYCH, V15, P21, DOI 10.1002/(SICI)1099-1166(200001)15:1<21::AID-GPS71>3.0.CO;2-5; Prince M, 1997, TROP MED INT HEALTH, V2, P993, DOI 10.1046/j.1365-3156.1997.d01-156.x; Rajkumar S, 1997, INT J GERIATR PSYCH, V12, P702, DOI 10.1002/(SICI)1099-1166(199707)12:7<702::AID-GPS489>3.0.CO;2-H; Schneider J, 1999, INT J GERIATR PSYCH, V14, P651, DOI 10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.3.CO;2-2; Shaji KS, 2003, INT J GERIATR PSYCH, V18, P1, DOI 10.1002/gps.649; Shaji S, 1996, BRIT J PSYCHIAT, V168, P745, DOI 10.1192/bjp.168.6.745; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447	27	3668	3878	21	662	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2112	2117		10.1016/S0140-6736(05)67889-0	http://dx.doi.org/10.1016/S0140-6736(05)67889-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360788	Green Accepted			2022-12-28	WOS:000234146000026
J	McCarvill, S				McCarvill, S			Essay - Prosthetics for athletes	LANCET			English	Article									Otto Bock Hlth Care, Salt Lake City, UT 84120 USA		McCarvill, S (corresponding author), Otto Bock Hlth Care, 3820 W Great Lakes Dr, Salt Lake City, UT 84120 USA.	Sarah.McCarvill@ottobock.com							0	1	1	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S10	S10		10.1016/S0140-6736(05)67824-5	http://dx.doi.org/10.1016/S0140-6736(05)67824-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360728				2022-12-28	WOS:000234374400007
J	Lamoreux, JF; Morrison, JC; Ricketts, TH; Olson, DM; Dinerstein, E; McKnight, MW; Shugart, HH				Lamoreux, JF; Morrison, JC; Ricketts, TH; Olson, DM; Dinerstein, E; McKnight, MW; Shugart, HH			Global tests of biodiversity concordance and the importance of endemism	NATURE			English	Article							INDICATOR GROUPS; CONSERVATION; HOTSPOTS; ECOLOGY	Understanding patterns of biodiversity distribution is essential to conservation strategies(1), but severe data constraints make surrogate measures necessary(2-4). For this reason, many studies have tested the performance of terrestrial vertebrates as surrogates for overall species diversity, but these tests have typically been limited to a single taxon or region(3-10). Here we show that global patterns of richness are highly correlated among amphibians, reptiles, birds and mammals, as are endemism patterns. Furthermore, we demonstrate that although the correlation between global richness and endemism is low, aggregate regions selected for high levels of endemism capture significantly more species than expected by chance. Although areas high in endemism have long been targeted for the protection of narrow-ranging species(11,12), our findings provide evidence that endemism is also a useful surrogate for the conservation of all terrestrial vertebrates.	Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; World Wildlife Fund US, Washington, DC 20037 USA; Wildlife Conservat Soc S Pacific, Suva, Fiji; Univ N Carolina, Curriculum Ecol, Chapel Hill, NC 27599 USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Lamoreux, JF (corresponding author), Univ Virginia, Dept Environm Sci, 291 McCormick Rd, Charlottesville, VA 22904 USA.	lamoreux@virginia.edu	Shugart, Herman/C-5156-2009	Shugart, Herman/0000-0002-1766-8379				Aron A., 1999, STAT PSYCHOL; Balmford A, 1998, TRENDS ECOL EVOL, V13, P409, DOI 10.1016/S0169-5347(98)01415-3; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 1998, NATURE, V394, P229, DOI 10.1038/28288; Groves C.R., 2003, DRAFTING CONSERVATIO; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Manly BFJ, 1997, RANDOMIZATION BOOTST; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; Pimm SL, 1999, NATURE, V402, P853, DOI 10.1038/47183; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Ricketts T. H., 2001, Animal Biodiversity and Conservation, V24, P91; Ricketts TH, 1999, BIOSCIENCE, V49, P369, DOI 10.2307/1313630; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; WILLIAMS PH, 1998, CONSERVATION CHANGIN, P211	30	357	382	4	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					212	214		10.1038/nature04291	http://dx.doi.org/10.1038/nature04291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16382239	Bronze			2022-12-28	WOS:000235839500046
J	Singh, SK; Hora, R; Belrhali, H; Chitnis, CE; Sharma, A				Singh, SK; Hora, R; Belrhali, H; Chitnis, CE; Sharma, A			Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain	NATURE			English	Article							RED-CELL INVASION; PLASMODIUM-VIVAX; ERYTHROCYTE INVASION; CRYSTAL-STRUCTURES; PROTEIN; FALCIPARUM; RESIDUES; KNOWLESI; ASSOCIATION; PATHWAY	Molecular processes that govern pathogenic features of erythrocyte invasion and cytoadherence in malaria are reliant on Plasmodium-specific Duffy-binding-like domains (DBLs)(1). These cysteine-rich modules recognize diverse host cell-surface receptors during pathogenesis. DBLs of parasite erythrocyte-binding proteins mediate invasion, and those from the antigenically variant P. falciparum erythrocyte membrane protein 1 ( PfEMP1) have been implicated in cytoadherence. The simian and human malarial parasites, P. knowlesi and P. vivax, invade human erythrocytes exclusively through the host DARC receptor ( Duffy antigen receptor for chemokines)(2,3). Here we present the crystal structure of the P. knowlesi DBL domain (Pk alpha-DBL), which binds to DARC during invasion of human erythrocytes. Pk alpha-DBL retains the overall fold observed in DBLs from P. falciparum erythrocyte-binding antigen (EBA)- 175 (ref. 4). Mapping the residues that have previously been implicated in binding(5-7) highlights a fairly flat but exposed site for DARC recognition in subdomain 2 of Pk alpha-DBL; this is in sharp contrast to receptor recognition by EBA- 175 ( ref. 4). In Pk alpha-DBL, the residues that contact DARC and the clusters of residues under immune pressure map to opposite surfaces of the DBL, and suggest a possible mechanism for immune evasion by P. vivax. Our comparative structural analysis of Pk alpha-DBL and P. falciparum EBA- 175 provides a framework for the understanding of malaria parasite DBLs, and may affect the development of new prophylactic and therapeutic strategies.	ICGEB, Struct & Computat Biol Grp, New Delhi 110067, India; ICGEB, Malaria Res Grp, New Delhi 110067, India; European Mol Biol Lab, F-38042 Grenoble 9, France	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; European Molecular Biology Laboratory (EMBL)	Sharma, A (corresponding author), ICGEB, Struct & Computat Biol Grp, Aruna Asaf Marg, New Delhi 110067, India.	asharma@icgeb.res.in		Hora, Rachna/0000-0002-6085-8389; Chitnis, Chetan/0000-0002-8773-9865				ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P112; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Singh SK, 2003, BIOCHEM J, V374, P193, DOI 10.1042/BJ20030622; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; VanBuskirk KM, 2004, P NATL ACAD SCI USA, V101, P15754, DOI 10.1073/pnas.0405421101; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	31	191	197	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					741	744		10.1038/nature04443	http://dx.doi.org/10.1038/nature04443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16372020				2022-12-28	WOS:000235193100048
J	Yamaguchi, KE; Ohmoto, H				Yamaguchi, KE; Ohmoto, H			Comment on "Iron isotope constraints on the archean and paleoproterozoic ocean redox state"	SCIENCE			English	Editorial Material							ROCKS	Rouxel et al. (Reports, 18 February 2005, p. 1088) argued that changes in the iron isotopic composition of sedimentary sulfides reflect changes in the oxidation state of the atmosphere-ocean system between 2.3 and 1.8 million years ago. We show that misinterpretations of the origins of these minerals undermine their conclusions.	JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; NASA, Astrobiol Inst, Washington, DC 20546 USA; Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yamaguchi, KE (corresponding author), JAMSTEC, IFREE, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	kosei@jamstec.go.jp	Yamaguchi, Kosei E/B-2882-2008	Yamaguchi, Kosei E/0000-0001-8728-6918				Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; *GEOL SURV W AUSTR, 1990, MEMOIR W AUSTR GEOLO, V3; Haruna M, 2003, RESOUR GEOL, V53, P75, DOI 10.1111/j.1751-3928.2003.tb00160.x; Kakegawa T, 1998, GEOCHIM COSMOCHIM AC, V62, P3205, DOI 10.1016/S0016-7037(98)00229-4; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; *SACS, 1980, GEOL SOC S AFR HDB, V9; SEVERMANN S, 2003, EOS S, V84; SEVERMANN S, 2004, EOS S, V85; Yamaguchi KE, 2005, CHEM GEOL, V218, P135, DOI 10.1016/j.chemgeo.2005.01.020	9	11	11	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758								10.1126/science.1118221	http://dx.doi.org/10.1126/science.1118221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410508				2022-12-28	WOS:000234722200016
J	Pounds, JA; Bustamante, MR; Coloma, LA; Consuegra, JA; Fogden, MPL; Foster, PN; La Marca, E; Masters, KL; Merino-Viteri, A; Puschendorf, R; Ron, SR; Sanchez-Azofeifa, GA; Still, CJ; Young, BE				Pounds, JA; Bustamante, MR; Coloma, LA; Consuegra, JA; Fogden, MPL; Foster, PN; La Marca, E; Masters, KL; Merino-Viteri, A; Puschendorf, R; Ron, SR; Sanchez-Azofeifa, GA; Still, CJ; Young, BE			Widespread amphibian extinctions from epidemic disease driven by global warming	NATURE			English	Article							CLIMATE-CHANGE; POPULATION DECLINES; BATRACHOCHYTRIUM-DENDROBATIDIS; TROPICAL MOUNTAIN; WATER-VAPOR; COSTA-RICA; ECOLOGY; TRENDS; CHYTRIDIOMYCOSIS; TEMPERATURE	As the Earth warms, many species are likely to disappear, often because of changing disease dynamics. Here we show that a recent mass extinction associated with pathogen outbreaks is tied to global warming. Seventeen years ago, in the mountains of Costa Rica, the Monteverde harlequin frog ( Atelopus sp.) vanished along with the golden toad ( Bufo periglenes). An estimated 67% of the 110 or so species of Atelopus, which are endemic to the American tropics, have met the same fate, and a pathogenic chytrid fungus (Batrachochytrium dendrobatidis) is implicated. Analysing the timing of losses in relation to changes in sea surface and air temperatures, we conclude with 'very high confidence' (>99%, following the Intergovernmental Panel on Climate Change, IPCC) that large-scale warming is a key factor in the disappearances. We propose that temperatures at many highland localities are shifting towards the growth optimum of Batrachochytrium, thus encouraging outbreaks. With climate change promoting infectious disease and eroding biodiversity, the urgency of reducing greenhouse-gas concentrations is now undeniable.	Monteverde Cloud Forest Preserve & Trop Sci Ctr, Golden Toad Lab Conservat, Santa Elena 565573, Puntarenas, Costa Rica; Pontificia Univ Catolica Ecuador, Escuela Biol, Ctr Biodiversidad & Ambiente, Museo Zool, Quito, Ecuador; Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA; Univ Tokyo, Ctr Climat Studies Res, Meguro Ku, Tokyo 1538904, Japan; Univ Los Andes, Fac Ciencias Forestales & Ambientales, Escuela Geog, Lab Biogeog, Merida, Venezuela; Council Int Educ Exchange, Monteverde 565526, Puntarenas, Costa Rica; Univ Costa Rica, Escuela Biol, San Pedro, Costa Rica; Univ Texas, Texas Mem Museum, Austin, TX 78712 USA; Univ Texas, Dept Integrat Biol, Austin, TX 78712 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; NatureServ, Monteverde 565575, Puntarenas, Costa Rica	Pontificia Universidad Catolica del Ecuador; Columbia University; University of Tokyo; University of Los Andes Venezuela; Universidad Costa Rica; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Alberta; University of California System; University of California Santa Barbara	Pounds, JA (corresponding author), Monteverde Cloud Forest Preserve & Trop Sci Ctr, Golden Toad Lab Conservat, Santa Elena 565573, Puntarenas, Costa Rica.	goldtoad@racsa.co.cr	Coloma, Luis/AAO-3956-2020; Merino-Viteri, Andrés/AHB-0977-2022; Puschendorf, Robert/B-6280-2011; Ron, Santiago/J-4203-2019; Foster, Pru/K-5476-2012; Sanchez-Azofeifa, Arturo/F-4700-2014	Coloma, Luis/0000-0003-0158-2455; Merino-Viteri, Andrés/0000-0003-1039-2645; Puschendorf, Robert/0000-0002-8105-171X; Ron, Santiago/0000-0001-6300-9350; Foster, Pru/0000-0003-4735-1521; Still, Christopher/0000-0002-8295-4494; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600				Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; CACERES L, 1998, CONSECUENCIAS CLIMAT; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Dai A, 1999, J CLIMATE, V12, P2451, DOI [10.1175/1520-0442(1999)012<2451:EOCSMP>2.0.CO;2, 10.1175/1520-0442(1999)012&lt;2451:EOCSMP&gt;2.0.CO;2]; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gomez I., 1996, TOP METEOR OCEANOGR, V3, P27; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lawton RO, 2001, SCIENCE, V294, P584; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Merino-Viteri A, 2005, STUDIES ANDEAN FROGS, P9; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penner JE, 2004, NATURE, V432, P962, DOI 10.1038/432962a; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds J. Alan, 2000, P149; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Quintana-Gomez RA, 1999, J CLIMATE, V12, P2104, DOI 10.1175/1520-0442(1999)012<2104:TOMAMT>2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Ron SR, 2003, J HERPETOL, V37, P116, DOI 10.1670/0022-1511(2003)037[0116:PDOTJT]2.0.CO;2; ROOT TL, 1995, SCIENCE, V269, P334, DOI 10.1126/science.269.5222.334; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ross RJ, 2001, J CLIMATE, V14, P1602, DOI 10.1175/1520-0442(2001)014<1602:RBNHTW>2.0.CO;2; Sanchez-Azofeifa G, 2001, BIOTROPICA, V33, P378, DOI 10.1111/j.1744-7429.2001.tb00192.x; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wentz FJ, 2000, NATURE, V403, P414, DOI 10.1038/35000184	50	1201	1342	14	1355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					161	167		10.1038/nature04246	http://dx.doi.org/10.1038/nature04246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407945				2022-12-28	WOS:000234538400031
J	Achard, P; Cheng, H; De Grauwe, L; Decat, J; Schoutteten, H; Moritz, T; Van Der Straeten, D; Peng, JR; Harberd, NP				Achard, P; Cheng, H; De Grauwe, L; Decat, J; Schoutteten, H; Moritz, T; Van Der Straeten, D; Peng, JR; Harberd, NP			Integration of plant responses to environmentally activated phytohormonal signals	SCIENCE			English	Article							GIBBERELLIN RESPONSE; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; FLORAL DEVELOPMENT; GENE-EXPRESSION; PROTEIN; GROWTH; TRANSDUCTION; OVEREXPRESSION; MODULATION	Plants live in fixed locations and survive adversity by integrating growth responses to diverse environmental signals. Here, we show that the nuclear-localized growth-repressing DELLA proteins of Arabidopsis integrate responses to independent hormonal and environmental signals of adverse conditions. The growth restraint conferred by DELLA proteins is beneficial and promotes survival. We propose that DELLAs permit flexible and appropriate modulation of plant growth in response to changes in natural environments.	John Innes Ctr, Norwich NR4 7UJ, Norfolk, England; Inst Mol & Cell Biol, Singapore 138673, Singapore; Univ Ghent, Dept Mol Genet, Unit Plant Hormones Signaling & Bioimaging, B-9000 Ghent, Belgium; Swedish Univ Agr Sci, Dept Forest & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Ghent University; Swedish University of Agricultural Sciences; Umea University	Van Der Straeten, D (corresponding author), John Innes Ctr, Norwich NR4 7UJ, Norfolk, England.	dominique.vanderstraeten@ugent.be; pengjr@imcb.a-star.edu.sg; nicholas.harberd@bbsrc.ac.uk	Van Der Straeten, Dominique/E-7385-2016; Achard, Patrick/A-5406-2010	Van Der Straeten, Dominique/0000-0002-7755-1420; Peng, Jinrong/0000-0002-0793-4848; Moritz, Thomas/0000-0002-4258-3190	Biotechnology and Biological Sciences Research Council [P19972, BBS/E/J/00000583] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Harberd NP, 2003, SCIENCE, V299, P1853, DOI 10.1126/science.1083217; King KE, 2001, GENETICS, V159, P767; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Vriezen WH, 2004, PLANT J, V37, P505, DOI 10.1046/j.1365-313X.2003.01975.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	28	991	1087	21	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					91	94		10.1126/science.1118642	http://dx.doi.org/10.1126/science.1118642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400150				2022-12-28	WOS:000234546300040
J	Sicardy, B; Bellucci, A; Gendron, E; Lacombe, F; Lacour, S; Lecacheux, J; Lellouch, E; Renner, S; Pau, S; Roques, F; Widemann, T; Colas, F; Vachier, F; Martins, RV; Ageorges, N; Hainaut, O; Marco, O; Beisker, W; Hummel, E; Feinstein, C; Levato, H; Maury, A; Frappa, E; Gaillard, B; Lavayssiere, M; Di Sora, M; Mallia, F; Masi, G; Behrend, R; Carrier, F; Mousis, O; Rousselot, P; Alvarez-Candal, A; Lazzaro, D; Veiga, C; Andrei, AH; Assafin, M; Neto, DND; Jacques, C; Pimentel, E; Weaver, D; Lecampion, JF; Doncel, F; Momiyama, T; Tancredi, G				Sicardy, B; Bellucci, A; Gendron, E; Lacombe, F; Lacour, S; Lecacheux, J; Lellouch, E; Renner, S; Pau, S; Roques, F; Widemann, T; Colas, F; Vachier, F; Martins, RV; Ageorges, N; Hainaut, O; Marco, O; Beisker, W; Hummel, E; Feinstein, C; Levato, H; Maury, A; Frappa, E; Gaillard, B; Lavayssiere, M; Di Sora, M; Mallia, F; Masi, G; Behrend, R; Carrier, F; Mousis, O; Rousselot, P; Alvarez-Candal, A; Lazzaro, D; Veiga, C; Andrei, AH; Assafin, M; Neto, DND; Jacques, C; Pimentel, E; Weaver, D; Lecampion, JF; Doncel, F; Momiyama, T; Tancredi, G			Charon's size and an upper limit on its atmosphere from a stellar occultation	NATURE			English	Article							PLUTO-CHARON; CCD OBSERVATIONS; MASS-RATIO; TELESCOPE; PARAMETERS; SYSTEM	Pluto and its satellite, Charon ( discovered in 1978; ref. 1), appear to form a double planet, rather than a hierarchical planet/satellite couple. Charon is about half Pluto's size and about one-eighth its mass. The precise radii of Pluto and Charon have remained uncertain, leading to large uncertainties on their densities(2). Although stellar occultations by Charon are in principle a powerful way of measuring its size, they are rare, as the satellite subtends less than 0.3 microradians (0.06 arcsec) on the sky. One occultation ( in 1980) yielded a lower limit of 600 km for the satellite's radius(3), which was later refined to 601.5 km ( ref. 4). Here we report observations from a multi-station stellar occultation by Charon, which we use to derive a radius, R-C = 603.6 +/- 1.4 km (1 sigma), and a density of rho = 1.71 +/- 0.08 g cm(-3). This occultation also provides upper limits of 110 and 15 (3 sigma) nanobar for an atmosphere around Charon, assuming respectively a pure nitrogen or pure methane atmosphere.	Observ Paris, LESIA, F-92195 Meudon, France; Univ Paris 06, F-75252 Paris 5, France; Observ Paris, IMCCE, F-75014 Paris, France; European So Observ, Santiago 19, Chile; Int Occultat Timing Assoc, European Sect, D-30459 Hannover, Germany; Astron Observ, Fac Ciencias Astron & Geofis, RA-1900 La Plata, Argentina; Consejo Nacl Invest Cient & Tecn, Inst Astrofis La Plata, RA-1900 La Plata, Argentina; Complejo Astron, RA-5402 San Juan, Argentina; Gene Shoemaker Observ, San Pedro De Atacama, Chile; Plantearium St Etienne, F-42100 St Etienne, France; Care Of Colas F, Assoc Utilisateurs Detecteurs Elect, F-75014 Paris, France; Campo Catino Austral Observ, San Pedro De Atacama, Chile; Univ Roma Tor Vergata, I-00133 Rome, Italy; Observ Geneva, CH-1290 Sauverny, Switzerland; Observ Besancon, F-25010 Besancon, France; Observ Nacl, BR-20921400 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Observ Valongo, BR-20080090 Rio de Janeiro, Brazil; Observ CEAMIG REA, BR-31545120 Belo Horizonte, MG, Brazil; Univ Fortaleza, Observ Astron Christus, BR-60140140 Fortaleza, Ceara, Brazil; Observ Aquitain Sci Univers, F-33270 Floirac, France; Univ Nacl Asunc, Astron Observ, Asuncion 2169, Paraguay; Observ Astron Molinos, Fac Ciencias, Montevideo 11400, Uruguay	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; European Southern Observatory; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Rome Tor Vergata; University of Geneva; Universidade Federal do Rio de Janeiro; Universidade Fortaleza; Universidad Nacional de Asuncion; Universidad de la Republica, Uruguay	Sicardy, B (corresponding author), Observ Paris, LESIA, F-92195 Meudon, France.	bruno.sicardy@obspm.fr	Assafin, Marcelo/C-3188-2013; Hainaut, Olivier R./AAY-7006-2021; Bellucci, Andrea/L-6374-2014; Alvarez-Candal, Alvaro/M-4834-2013; Lazzaro, Daniela/I-3509-2012; Andrei, Alexandre H/M-4597-2017; Mousis, Olivier/X-2712-2019	Bellucci, Andrea/0000-0003-4035-5271; Alvarez-Candal, Alvaro/0000-0002-5045-9675; Lazzaro, Daniela/0000-0002-4470-6043; Andrei, Alexandre H/0000-0001-8154-7646; Frappa, Eric/0000-0001-5327-7781; Lacour, Sylvestre/0000-0002-6948-0263; Marco, Olivier/0000-0002-2967-6368; Vachier, Frederic/0000-0002-4289-4466; Assafin, Marcelo/0000-0002-8211-0777				BURATTI BJ, 1995, ASTRON J, V110, P1405, DOI 10.1086/117614; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; CHRISTY JW, 1978, ASTRON J, V83, P1005, DOI 10.1086/112284; Dumas C, 2001, ASTRON J, V121, P1163, DOI 10.1086/318747; ELLIOT JL, 1991, ICARUS, V89, P244, DOI 10.1016/0019-1035(91)90176-T; GURWELL MA, 2005, B AM ASTRON SOC, V37, P743; McKinnon W. B., 1997, PLUTO CHARON, P295; Null GW, 1996, ASTRON J, V111, P1368, DOI 10.1086/117883; Olkin CB, 2003, ICARUS, V164, P254, DOI 10.1016/S0019-1035(03)00136-2; REINSCH K, 1994, ICARUS, V108, P209, DOI 10.1006/icar.1994.1055; STANSBERRY JA, 1994, ICARUS, V111, P503, DOI 10.1006/icar.1994.1160; STERN SA, 1992, ANNU REV ASTRON ASTR, V30, P185, DOI 10.1146/annurev.aa.30.090192.001153; Tholen DJ, 1997, ICARUS, V125, P245, DOI 10.1006/icar.1996.5494; THOLEN DJ, 1997, PLUTO CHARON, P193; THOLEN DJ, 1990, B AM ASTRON SOC, V22, P1129; Walker A. R, 1980, MNRAS, V192, P47; Yelle R.V., 1997, PLUTO CHARON PART 4, P347; YOUNG EF, 1994, ICARUS, V108, P219, DOI 10.1006/icar.1994.1056	18	62	63	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					52	54		10.1038/nature04351	http://dx.doi.org/10.1038/nature04351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397493				2022-12-28	WOS:000234378700031
J	Sedlak, TW; Snyder, SH				Sedlak, TW; Snyder, SH			Messenger molecules and cell death - Therapeutic implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NITRIC-OXIDE SYNTHASE; CULTURED CEREBELLAR NEURONS; HEME OXYGENASE-1 DEFICIENCY; IRON REGULATORY PROTEINS; PARKINSONS-DISEASE; SERUM BILIRUBIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; POLY(ADP-RIBOSE) POLYMERASE; MUTANT HUNTINGTIN; APOPTOTIC PATHWAYS	Programmed cell death, also called apoptosis, participates not only in normal physiologic processes such as development of the immune system, but also in many diseases. A loss of normal cell death may occur in cancer, and excessive cell death is found in a variety of neurodegenerative conditions. We describe 3 distinct pathways that regulate cell death. First, bilirubin, often thought to be a toxic end product of heme metabolism, serves as a physiologic cytoprotectant that may attenuate multiple forms of morbidity. In a second pathway, the glycolytic enzyme glyceraldehyde-3-phosphatedehydrogenase (GAPDH) mediates a novel cell death cascade. Cytotoxic stimuli, via nitric oxide generation, lead to the binding of GAPDH to the protein Siah1, translocation of GAPDH-Siah1 to the nucleus, and ultimately cell death. Third, cytochrome c, released from mitochondria early in apoptosis, synergizes with inositol-1,4,5-triphosphate (IP3) to elicit massive cellular calcium release, resulting in cell death. These pathways may regulate cell survival in a variety of pathologic states and represent fertile targets for novel therapies.	Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Snyder, SH (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Wood Basic Sci Bldg 813,725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu			NIDA NIH HHS [DA-00074, DA-00266] Funding Source: Medline; NIMH NIH HHS [MH68830] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Amersi F, 1999, J CLIN INVEST, V104, P1631, DOI 10.1172/JCI7903; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x; Andringa G., 2000, Journal of Neural Transmission Supplement, V60, P215; BAE BI, 2004, SOC NEUR 34 ANN M OC; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BOYNTON BR, 1989, NEW ENGL J MED, V321, P193; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chang EF, 2003, J NEUROSCI, V23, P3689; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeJonge MH, 1999, J PEDIATR-US, V135, P102, DOI 10.1016/S0022-3476(99)70336-7; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; DENNERY PA, 1995, FREE RADICAL BIO MED, V19, P395, DOI 10.1016/0891-5849(95)00032-S; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; FAUCHERE JC, 1994, EUR J PEDIATR, V153, P358, DOI 10.1007/s004310050153; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GATON DD, 1991, BRIT J OPHTHALMOL, V75, P532, DOI 10.1136/bjo.75.9.532; GOEHNING D, 2005, P NATL ACAD SCI USA, V102, P1466; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gulesserian T, 2005, CLIN CHEM, V51, P1661, DOI 10.1373/clinchem.2005.051581; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hammerman C, 2002, J PEDIATR GASTR NUTR, V35, P344, DOI 10.1097/00005176-200209000-00020; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARA MR, 2005, SOC NEUR 35 ANN M NO; HELLER B, 1995, J BIOL CHEM, V270, P11176, DOI 10.1074/jbc.270.19.11176; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HEYMAN E, 1989, NEW ENGL J MED, V320, P256; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horn S, 2004, NEUROLOGY, V63, pS7, DOI 10.1212/WNL.63.7_suppl_2.S7; Hosono S, 2002, J PEDIAT OPHTH STRAB, V39, P151, DOI 10.3928/0191-3913-20020501-06; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Ishizaka N, 2001, STROKE, V32, P581, DOI 10.1161/01.STR.32.2.580-b; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jenner P, 2004, NEUROLOGY, V63, pS13, DOI 10.1212/WNL.63.7_suppl_2.S13; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kaplan M, 2003, PEDIATRICS, V111, P886, DOI 10.1542/peds.111.4.886; Kato Y, 2003, HEPATOLOGY, V38, P364, DOI 10.1053/jhep.2003.50300; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LeWitt PA, 2004, NEUROLOGY, V63, pS23, DOI 10.1212/WNL.63.7_suppl_2.S23; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7; Matarredona ER, 2003, RESTOR NEUROL NEUROS, V21, P29; Milner Joshua D, 2003, J Perinatol, V23, P208, DOI 10.1038/sj.jp.7210887; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ohta K, 2000, AM J KIDNEY DIS, V35, P863, DOI 10.1016/S0272-6386(00)70256-3; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; RYTER SW, 2004, SCI STKE, V230, pRE6; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; SEDLAK TW, 2004, SOC NEUR 34 ANN M OC; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stocchi F, 2003, ANN NEUROL, V53, pS87, DOI 10.1002/ana.10488; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Vitek L, 2005, PEDIATRICS, V115, P1411, DOI 10.1542/peds.2004-1796; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Waldmeier PC, 2000, N-S ARCH PHARMACOL, V362, P526, DOI 10.1007/s002100000300; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yeo KL, 1998, PEDIATRICS, V102, P1426, DOI 10.1542/peds.102.6.1426; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youdim MBH, 2004, NEUROLOGY, V63, pS32, DOI 10.1212/WNL.63.7_suppl_2.S32; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	112	38	39	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					81	89		10.1001/jama.295.1.81	http://dx.doi.org/10.1001/jama.295.1.81			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391220				2022-12-28	WOS:000234381100024
J	Wansink, B; van Ittersum, K				Wansink, B; van Ittersum, K			Shape of glass and amount of alcohol poured: comparative study of effect of practice and concentration	BRITISH MEDICAL JOURNAL			English	Article							STANDARD DRINK; VOLUME; CONSUMPTION; SIZE	Objective To determine whether people pour different amounts into short, wide glasses than into tall, slender ones. Design College students practised pouring alcohol into a standard glass before pouring into larger glasses; bartenders poured alcohol for four mixed drinks either with no instructions or after being told to take their time. Setting University town and large city, United States. Participants 198 college Students and 86 bartenders. Main outcome measures Volume of alcohol poured into short, wide and tall, slender glasses. Results Aiming to pour a "shot" of alcohol (1.5 ounces, 44.3 ml), both students and bartenders Poured more into short, wide glasses than into tall slender glasses (46.1 ml v 44.7 ml and 54.6 ml v 46.4 ml, respectively). Practice reduced the tendency to overpour, but not for short, wide glasses. Despite an average of six years of experience, bartenders poured 20.5% more into short, wide glasses than tall, slender ones; paying careful attention reduced but did not eliminate the effect. Conclusions To avoid overpouring, use tall, narrow glasses or ones on which the alcohol level is premarked. To avoid underestimating die amount Of alcohol consumed, studies using self reports of standard drinks should ask about the shape of the glass.	Cornell Univ, Ithaca, NY 14853 USA; Georgia Inst Technol, Coll Management, Atlanta, GA 30332 USA	Cornell University; University System of Georgia; Georgia Institute of Technology	Wansink, B (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	wansink@cornell.edu	Van Ittersum, Koert/G-7433-2011; Wansink, Brian/G-4284-2010; Wansink, Brian/G-1219-2011					Carruthers S J, 1992, Drug Alcohol Rev, V11, P363, DOI 10.1080/09595239200185491; LEMMENS P, 1992, J STUD ALCOHOL, V53, P476, DOI 10.15288/jsa.1992.53.476; LEMMENS PH, 1994, ADDICTION, V89, P593, DOI 10.1111/j.1360-0443.1994.tb03336.x; MILLER WR, 1991, BRIT J ADDICT, V86, P43; Piaget J., 1969, MECHS PERCEPTION; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; STOCKWELL T, 1991, AUST J PUBLIC HEALTH, V15, P56; STOCKWELL T, 1989, BRIT MED J, V298, P571, DOI 10.1136/bmj.298.6673.571-a; TURNER C, 1990, BRIT J ADDICT, V85, P1171; Wansink B, 1996, J MARKETING, V60, P1, DOI 10.2307/1251838; Wansink B, 2005, JAMA-J AM MED ASSOC, V293, P1727, DOI 10.1001/jama.293.14.1727; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621	12	73	73	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1512	1514		10.1136/bmj.331.7531.1512	http://dx.doi.org/10.1136/bmj.331.7531.1512			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373735	Bronze, Green Published			2022-12-28	WOS:000234351300015
J	Landisman, CE; Connors, BW				Landisman, CE; Connors, BW			Long-term modulation of electrical synapses in the mammalian thalamus	SCIENCE			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; LATERAL GENICULATE-NUCLEUS; DOPAMINERGIC MODULATION; RETICULAR NUCLEUS; MIXED SYNAPSES; NEURONS; TRANSMISSION; BRAIN; CELLS; INTERNEURONS	Electrical synapses are common between inhibitory neurons in the mammalian thalamus and neocortex. Synaptic modulation, which allows flexibility of communication between neurons, has been studied extensively at chemical synapses, but modulation of electrical synapses in the mammalian brain has barely been examined. We found that the activation of metabotropic glutamate receptors, via endogenous neurotransmitter or by agonist, causes long-term reduction of electrical synapse strength between the inhibitory neurons of the rat thalamic reticular nucleus.	Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Brown University; Harvard University; Harvard Medical School	Landisman, CE (corresponding author), Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA.	Carole_Landisman@hms.harvard.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157	NINDS NIH HHS [NS40528, NS25983, NS050434] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983, R21NS040528, R01NS050434] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BENNETT MVL, 1966, ANN NY ACAD SCI, V137, P509, DOI 10.1111/j.1749-6632.1966.tb50178.x; COBBETT P, 1984, J NEUROSCI, V4, P3034; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2005, PROG BRAIN RES, V149, P41, DOI 10.1016/S0079-6123(05)49004-4; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LASATER EM, 1985, P NATL ACAD SCI USA, V82, P3025, DOI 10.1073/pnas.82.9.3025; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; ODONNELL P, 1993, J NEUROSCI, V13, P3456; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; PEREDA A, 1992, P NATL ACAD SCI USA, V89, P12088, DOI 10.1073/pnas.89.24.12088; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; RORIG B, 1995, J NEUROSCI, V15, P7386; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0	29	120	124	3	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1809	1813		10.1126/science.1114655	http://dx.doi.org/10.1126/science.1114655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357260				2022-12-28	WOS:000234093600045
J	Martinez, JJ; Seveau, S; Veiga, E; Matsuyama, S; Cossart, P				Martinez, JJ; Seveau, S; Veiga, E; Matsuyama, S; Cossart, P			Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii	CELL			English	Article							OUTER-MEMBRANE PROTEIN; LISTERIA-MONOCYTOGENES; DOWN-REGULATION; SPOTTED-FEVER; LIPID RAFTS; E-CADHERIN; COMPLEX; ENTRY; INVASION; ADHESION	Rickettsia conorii, a strictly intracellular and category C priority bacterial pathogen (NIAID), invades different mammalian cells. Although some signaling events involved in bacterial entry have been documented, the bacterial and host proteins mediating entry were not known. We report the identification of the Ku70 subunit of DNA-dependent protein kinase (DNA-PK) as a receptor involved in R. conorii internalization. Ku70 is recruited to R. conorii entry sites, and inhibition of Ku70 expression impairs R. conorii internalization. Bacterial invasion is dependent on the presence of cholesterol-enriched microdomains containing Ku70. R. conorii infection stimulates the ubiquitination of Ku70. In addition, the ubiquitin ligase c-Cbl is recruited to R. conorii entry foci, and downregulation of endogenous c-Cbl blocks bacterial invasion and Ku70 ubiquitination. An affinity chromatography approach identified the rickettsial protein rOmpB as a ligand for Ku70. This is the first report of a receptor-ligand interaction involved in the internalization of any rickettsial species.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; INSERM, U604, F-75015 Paris, France; INRA, USC2020, F-75015 Paris, France; Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Case Western Reserve University; Case Western Reserve University	Martinez, JJ (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr	veiga, esteban/C-2129-2011; Seveau, Stephanie/E-4060-2011	veiga, esteban/0000-0002-7333-2466; 				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; CARL M, 1990, P NATL ACAD SCI USA, V87, P8237, DOI 10.1073/pnas.87.21.8237; CHAN JYC, 1989, J BIOL CHEM, V264, P3651; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Feng HM, 2004, INFECT IMMUN, V72, P3524, DOI 10.1128/IAI.72.6.3524-3530.2004; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HAND WL, 1970, ARCH INTERN MED, V125, P879, DOI 10.1001/archinte.125.5.879; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Joshi SG, 2003, INFECT IMMUN, V71, P4127, DOI 10.1128/IAI.71.7.4127-4136.2003; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Koike M, 2002, J RADIAT RES, V43, P223, DOI 10.1269/jrr.43.223; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Monferran S, 2004, J MOL BIOL, V337, P503, DOI 10.1016/j.jmb.2004.01.057; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; RAMM LE, 1976, INFECT IMMUN, V13, P120, DOI 10.1128/IAI.13.1.120-126.1976; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; VEIGA E, 2005, IN PRESS NAT CELL BI; VISHWANATH S, 1991, FEMS MICROBIOL LETT, V81, P341, DOI 10.1111/j.1574-6968.1991.tb04783.x; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7; WALKER DH, 1985, AM J TROP MED HYG, V34, P361, DOI 10.4269/ajtmh.1985.34.361; WALKER DH, 1983, INFECT IMMUN, V40, P840, DOI 10.1128/IAI.40.2.840-842.1983; YAGUPSKY P, 1993, CLIN INFECT DIS, V17, P850, DOI 10.1093/clinids/17.5.850; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	54	130	143	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1013	1023		10.1016/j.cell.2005.08.046	http://dx.doi.org/10.1016/j.cell.2005.08.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360032	Bronze			2022-12-28	WOS:000234177200011
J	Petroski, MD; Deshaies, RJ				Petroski, MD; Deshaies, RJ			Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE; CDC34; RECOGNITION; DEGRADATION; SUBUNIT; SIC1; PHOSPHORYLATION; PROTEASOME; RBX1	Ubiquitin chains linked via lysine 48 (K48) of ubiquitin mediate recognition of ubiquitinated proteins by the proteasome. However, the mechanisms underlying polymerization of this targeting signal on a substrate are unknown. Here we dissect this process using the cyclin-dependent kinase inhibitor Sic1 and its ubiquitination by the cullin-RING ubiquitin ligase SCFCdC4 and the ubiquitin-conjugating enzyme Cdc34. We show that Sic1 ubiquitination can be separated into two steps: attachment of the first ubiquitin, which is rate limiting, followed by rapid elongation of a K48-linked ubiquitin chain. Mutation of an acidic loop conserved among Cdc34 orthologs has no effect on attachment of the first ubiquitin onto Sic1 but compromises the processivity and linkage specificity of ubiquitin-chain synthesis. We propose that the acidic loop favorably positions K48 of a substrate-linked ubiquitin to attack SCF bound Cdc34-ubiquitin thioester and thereby enables processive synthesis of K48-linked ubiquitin chains by SCF-Cdc34.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Petroski, MD (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, 156-29 Calif Inst Technol,1200 E Calif Blvd, Pasadena, CA 91125 USA.	mpetroski@rigel.com; deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354				Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; HAAS AL, 1988, UBIQUITIN, P173; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; LIU Y, 1995, MOL CELL BIOL, V15, P5635; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	31	210	213	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					1107	1120		10.1016/j.cell.2005.09.033	http://dx.doi.org/10.1016/j.cell.2005.09.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360039	Bronze			2022-12-28	WOS:000234177200018
J	Garrick, J; Requa, R				Garrick, J; Requa, R			Essay - Long-term complications of exercise	LANCET			English	Article									St Francis Mem Hosp, Ctr Sports Med, San Francisco, CA 94109 USA		Garrick, J (corresponding author), St Francis Mem Hosp, Ctr Sports Med, 900 Hyde St, San Francisco, CA 94109 USA.	jgarrick@chw.edu							0	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S58	S59		10.1016/S0140-6736(05)67854-3	http://dx.doi.org/10.1016/S0140-6736(05)67854-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360759	Bronze			2022-12-28	WOS:000234374400035
J	Hambrecht, R; Gielen, S				Hambrecht, R; Gielen, S			Essay - Hunter-gatherer to sedentary lifestyle	LANCET			English	Article							CORONARY-ARTERY-DISEASE; EXERCISE		Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hambrecht, R (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany.	hamr@medizin.uni-leipzig.de						Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238	5	7	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S60	S61		10.1016/S0140-6736(05)67856-7	http://dx.doi.org/10.1016/S0140-6736(05)67856-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360760				2022-12-28	WOS:000234374400036
J	Stafford, N				Stafford, N			Profile - Klaus Mees - A hungry man	LANCET			English	Biographical-Item												ns@europefn.de							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S35	S35		10.1016/S0140-6736(05)67839-7	http://dx.doi.org/10.1016/S0140-6736(05)67839-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360744				2022-12-28	WOS:000234374400022
J	Hessels, JWT; Ransom, SM; Stairs, IH; Freire, PCC; Kaspi, VM; Camilo, F				Hessels, JWT; Ransom, SM; Stairs, IH; Freire, PCC; Kaspi, VM; Camilo, F			A radio pulsar spinning at 716 Hz	SCIENCE			English	Article							ECLIPSING MILLISECOND PULSAR; NEUTRON-STARS	We have discovered a 716-hertz eclipsing binary radio pulsar in the globular cluster Terzan 5 using the Green Bank Telescope. It is the fastest spinning neutron star found to date, breaking the 24-year record held by the 642-hertz pulsar B1937+21. The difficulty in detecting this pulsar, because of its very low flux density and high eclipse fraction (similar to 40% of the orbit), suggests that even faster spinning neutron stars exist. If the pulsar has a mass less than twice the mass of the Sun, then its radius must be constrained by the spin rate to be <16 kilometers. The short period of this pulsar also constrains models that suggest that gravitational radiation, through an r-mode (Rossby wave) instability, limits the maximum spin frequency of neutron stars.	McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; Natl Radio Astron Observ, Charlottesville, VA 22903 USA; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; Arecibo Observ, Natl Astron & Ionosphere Ctr, Arecibo, PR 00612 USA; Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA	McGill University; National Radio Astronomy Observatory (NRAO); University of British Columbia; National Aeronautics & Space Administration (NASA); Columbia University	Hessels, JWT (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	hessels@physics.mcgill.ca	Hessels, Jason/GTO-3261-2022; Freire, Paulo/ABE-8926-2021	Hessels, Jason/0000-0003-2317-1446; Freire, Paulo/0000-0003-1307-9435; Ransom, Scott/0000-0001-5799-9714				ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Andersson N, 1998, ASTROPHYS J, V502, P708, DOI 10.1086/305919; Andersson N, 1999, ASTROPHYS J, V510, P846, DOI 10.1086/306625; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Bildsten L, 1998, ASTROPHYS J, V501, pL89, DOI 10.1086/311440; Chakrabarty D, 2003, NATURE, V424, P42, DOI 10.1038/nature01732; Chakrabarty D, 2005, ASP C SER, V328, P279; Cutler C, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.084025; D'Amico N, 2001, ASTROPHYS J, V561, pL89, DOI 10.1086/324562; DEMOREST P, 2004, AM ASTR SOC M ABSTR, V205; FERDMAN RD, 2004, AM ASTR SOC M ABSTR, V205; Ferraro FR, 2003, ASTROPHYS J, V584, pL13, DOI 10.1086/368279; Friedman JL, 1998, ASTROPHYS J, V502, P714, DOI 10.1086/305920; JOHNSTON HM, 1991, ASTROPHYS J, V368, P504, DOI 10.1086/169715; Kaplan DL, 2005, PUBL ASTRON SOC PAC, V117, P643, DOI 10.1086/430368; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Levin Y, 2001, MON NOT R ASTRON SOC, V324, P917, DOI 10.1046/j.1365-8711.2001.04323.x; LI B, 2005, NUCL THEOR; LYNE AG, 1990, NATURE, V347, P650, DOI 10.1038/347650a0; Lyne AG, 2000, MON NOT R ASTRON SOC, V316, P491, DOI 10.1046/j.1365-8711.2000.03517.x; Meylan G, 1997, ASTRON ASTROPHYS REV, V8, P1, DOI 10.1007/s001590050008; RADHAKRISHNAN V, 1982, CURR SCI INDIA, V51, P1096; Ransom S.M., 2001, THESIS HARVARD U; Ransom SM, 2005, SCIENCE, V307, P892, DOI 10.1126/science.1108632; Ransom SM, 2004, ASTROPHYS J, V604, P328, DOI 10.1086/381730; Ransom SM, 2002, ASTRON J, V124, P1788, DOI 10.1086/342285; TAVANI M, 1991, ASTROPHYS J, V379, pL69, DOI 10.1086/186156	27	499	512	4	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1901	1904		10.1126/science.1123430	http://dx.doi.org/10.1126/science.1123430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16410486	Green Submitted			2022-12-28	WOS:000236387800038
J	Xu, YD; Chun, MM				Xu, YD; Chun, MM			Dissociable neural mechanisms supporting visual short-term memory for objects	NATURE			English	Article							WORKING-MEMORY; ACTIVATION; CAPACITY; ATTENTION; DYNAMICS; STORAGE; CORTEX; AREAS	Using visual information to guide behaviour requires storage in a temporary buffer, known as visual short-term memory (VSTM)(1), that sustains attended information across saccades and other visual interruptions. There is growing debate on whether VSTM capacity is limited to a fixed number of objects(2,3) or whether it is variable(4,5). Here we report four experiments using functional magnetic resonance imaging that resolve this controversy by dissociating the representation capacities of the parietal and occipital cortices. Whereas representations in the inferior intraparietal sulcus (IPS) are fixed to about four objects at different spatial locations regardless of object complexity, those in the superior IPS and the lateral occipital complex are variable, tracking the number of objects held in VSTM, and representing fewer than four objects as their complexity increases. These neural response patterns were observed during both VSTM encoding and maintenance. Thus, multiple systems act together to support VSTM: whereas the inferior IPS maintains spatial attention over a fixed number of objects at different spatial locations, the superior IPS and the lateral occipital complex encode and maintain a variable subset of the attended objects, depending on their complexity. VSTM capacity is therefore determined both by a fixed number of objects and by object complexity.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Xu, YD (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	yaoda.xu@yale.edu		Chun, Marvin/0000-0003-1070-7993				Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; FUSTER JM, 1982, J NEUROSCI, V2, P361; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Miller EK, 1996, J NEUROSCI, V16, P5154; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; TALAIRACH J, 1988, COPLANAR STEREOAXIS; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770	30	708	730	5	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					91	95		10.1038/nature04262	http://dx.doi.org/10.1038/nature04262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16382240				2022-12-28	WOS:000235685700046
J	Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK				Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK			NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia	NATURE			English	Article							WHITE-MATTER; GLIAL-CELLS; GLUTAMATE; EXCITOTOXICITY; OLIGODENDROCYTES; MECHANISMS; DISORDERS; GLYCINE; INJURY	Central nervous system myelin is a specialized structure produced by oligodendrocytes that ensheaths axons, allowing rapid and efficient saltatory conduction of action potentials(1). Many disorders promote damage to and eventual loss of the myelin sheath, which often results in significant neurological morbidity. However, little is known about the fundamental mechanisms that initiate myelin damage, with the assumption being that its fate follows that of the parent oligodendrocyte. Here we show that NMDA (N-methyl-D-aspartate) glutamate receptors mediate Ca2+ accumulation in central myelin in response to chemical ischaemia in vitro. Using two-photon microscopy, we imaged fluorescence of the Ca2+ indicator X-rhod-1 loaded into oligodendrocytes and the cytoplasmic compartment of the myelin sheath in adult rat optic nerves. The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptor antagonist NBQX(2) completely blocked the ischaemic Ca2+ increase in oligodendroglial cell bodies, but only modestly reduced the Ca2+ increase in myelin. In contrast, the Ca2+ increase in myelin was abolished by broad-spectrum NMDA receptor antagonists (MK-801, 7-chlorokynurenic acid, D-AP5(3,4)), but not by more selective blockers of NR2A and NR2B subunit-containing receptors (NVP-AAM077(5) and ifenprodil(2,4)). In vitro ischaemia causes ultrastructural damage to both axon cylinders and myelin(6). NMDA receptor antagonism greatly reduced the damage to myelin. NR1, NR2 and NR3 subunits were detected in myelin by immunohistochemistry and immunoprecipitation, indicating that all necessary subunits are present for the formation of functional NMDA receptors. Our data show that the mature myelin sheath can respond independently to injurious stimuli. Given that axons are known to release glutamate(7-9), our finding that the Ca2+ increase was mediated in large part by activation of myelinic NMDA receptors suggests a new mechanism of axo-myelinic signalling. Such a mechanism may represent a potentially important therapeutic target in disorders in which demyelination is a prominent feature, such as multiple sclerosis, neurotrauma, infections (for example, HIV encephalomyelopathy) and aspects of ischaemic brain injury.	Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4K9, Canada; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA; Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Cleveland Clinic Foundation; University of Calgary	Stys, PK (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada.	pstys@ohri.ca	Micu, Ileana/M-9468-2016	Micu, Ileana/0000-0001-7112-0075; Zamponi, Gerald W./0000-0002-0644-9066				Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dingledine R, 1999, PHARMACOL REV, V51, P7; Hinman JD, 2004, J NEUROCHEM, V89, P430, DOI 10.1046/j.1471-4159.2004.02348.x; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; Li S, 1999, J Neurosci, V19, pRC16; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MRSULJA BJ, 1985, BRAIN RES, V343, P154, DOI 10.1016/0006-8993(85)91170-9; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; QUARLES RH, IN PRESS BASIC NEURO, P51; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Wallstrom E, 1996, J NEUROL SCI, V137, P89, DOI 10.1016/0022-510X(95)00339-4; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; Waxman SG, 1995, AXON STRUCTURE FUNCT; Ziak D, 1998, PHYSIOL RES, V47, P365	30	382	398	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					988	992		10.1038/nature04474	http://dx.doi.org/10.1038/nature04474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16372019				2022-12-28	WOS:000235486100050
J	Donato, DC; Fontaine, JB; Campbell, JL; Robinson, WD; Kauffman, JB; Law, BE				Donato, DC; Fontaine, JB; Campbell, JL; Robinson, WD; Kauffman, JB; Law, BE			Post-wildfire logging hinders regeneration and increases fire risk	SCIENCE			English	Article									Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; Forest Serv, Inst Pacific Isl Forestry, USDA, Pacific SW Res Stn, Hilo, HI 96720 USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Donato, DC (corresponding author), Oregon State Univ, Dept Forest Sci, Peavy Hall 154, Corvallis, OR 97331 USA.	dan.donato@oregonstate.edu	Fontaine, Joseph/O-2758-2019; Law, Beverly Elizabeth/G-3882-2010; Fontaine, Joseph B/M-9186-2013	Fontaine, Joseph/0000-0002-6515-7864; Law, Beverly Elizabeth/0000-0002-1605-1203; Fontaine, Joseph B/0000-0002-6515-7864				Agee, 1993, FIRE ECOLOGY PACIFIC; GORTE RW, 1996, C RES SERVICE PUBLIC; Lindenmayer DB, 2004, SCIENCE, V303, P1303, DOI 10.1126/science.1093438; Sessions J, 2004, J FOREST, V102, P38; Tesch S. D., 1989, Western Journal of Applied Forestry, V4, P89	5	226	235	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2006	311	5759					352	352		10.1126/science.1122855	http://dx.doi.org/10.1126/science.1122855			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16400111	Green Submitted			2022-12-28	WOS:000234938500035
J	McDonnell, A; Wilson, R; Goodacre, S				McDonnell, A; Wilson, R; Goodacre, S			Health policy - Evaluating and implementing new services	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE PAIN TEAMS; POSTOPERATIVE PAIN; NHS DIRECT; CARE; MANAGEMENT; PROVIDERS; IMPACT		Univ Sheffield, Sch Nursing & Midwifery, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	McDonnell, A (corresponding author), Univ Sheffield, Sch Nursing & Midwifery, Sheffield S1 4DA, S Yorkshire, England.	a.mcdonnell@sheffield.ac.uk		Goodacre, Steve/0000-0003-0803-8444				CALMAN K, 1997, DEV EMERGENCY COMMUN; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chalder M, 2003, BRIT MED J, V326, P532, DOI 10.1136/bmj.326.7388.532; *COMPTR AUD GEN, 2002, NHS DIR ENGL; Dash P, 2004, BMJ-BRIT MED J, V328, P340, DOI 10.1136/bmj.328.7435.340; *DEP HLTH NHS MOD, 2003, NAT OUTR REP; Gladwell M., 2001, TIPPING POINT LITTLE; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Guest D., 2004, EVALUATION IMPACT NU; Langhorne P., 1998, STROKE UNITS EVIDENC; Leaman AM, 2003, EMERG MED J, V20, P118, DOI 10.1136/emj.20.2.118; McDonnell A, 2003, J CLIN NURS, V12, P387, DOI 10.1046/j.1365-2702.2003.00748.x; McDonnell A, 2003, J ADV NURS, V41, P261, DOI 10.1046/j.1365-2648.2003.02527.x; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; O'Cathain A, 2000, BRIT MED J, V320, P1035, DOI 10.1136/bmj.320.7241.1035; PROPPER C, 2003, CTR MARKET PUBLIC OR; READ S, 2004, EVALUATION MODERN MA; *ROYAL COLL SURG E, 1990, COMM PROV SURG SERV; Salisbury C, 2004, BRIT J GEN PRACT, V54, P330; Sinha S, 2000, QJM-INT J MED, V93, P633, DOI 10.1093/qjmed/93.9.633; Stroke Unit Trailists' Collaboration, 2007, COCHRANE DB SYST REV; Wood D, 2001, BMJ-BRIT MED J, V323, P586, DOI 10.1136/bmj.323.7313.586; [No title captured]	24	29	29	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					109	112		10.1136/bmj.332.7533.109	http://dx.doi.org/10.1136/bmj.332.7533.109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	004UE	16410590	Green Published			2022-12-28	WOS:000234777000027
J	Albanese, V; Yam, AYW; Baughman, J; Parnot, C; Frydman, J				Albanese, V; Yam, AYW; Baughman, J; Parnot, C; Frydman, J			Systems analyses reveal two chaperone networks with distinct functions in eukaryotic cells	CELL			English	Article							HEAT-SHOCK RESPONSE; RIBOSOME-ASSOCIATED CHAPERONE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MOLECULAR CHAPERONES; TRIGGER FACTOR; POLYPEPTIDE FLUX; BINDING PROTEIN; CYTOSOLIC HSP70; NASCENT CHAINS	Molecular chaperones assist the folding of newly translated and stress-denatured proteins. In prokaryotes, overlapping sets of chaperones mediate both processes. In contrast, we find that eukaryotes evolved distinct chaperone networks to carry out these functions. Genomic and functional analyses indicate that in addition to stress-inducible chaperones that protect the cellular proteome from stress, eukaryotes contain a stress-repressed chaperone network that is dedicated to protein biogenesis. These stress-repressed chaperones are transcriptionally, functionally, and physically linked to the translational apparatus and associate with nascent polypeptides emerging from the ribosome. Consistent with a function in de novo protein folding, impairment of the translation-linked chaperone network renders cells sensitive to misfolding in the context of protein synthesis but not in the context of environmental stress. The emergence of a translation-linked chaperone network likely underlies the elaborate cotranslational folding process necessary for the evolution of larger multidomain proteins characteristic of eukaryotic cells.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, BioX Program, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Gimenez, Luis E Diaz/D-9291-2011	Parnot, Charles/0000-0002-7346-5883; , judith/0000-0003-2302-6943; Albanese, Veronique/0000-0002-5947-7415	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56433] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ashburner M, 2001, GENOME RES, V11, P1425; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bukau B, 1996, TRENDS CELL BIOL, V6, P480, DOI 10.1016/0962-8924(96)84946-4; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; HALLADAY JT, 1995, MOL CELL BIOL, V15, P4890; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu Xiao-Dong, 1996, Genes and Development, V10, P592, DOI 10.1101/gad.10.5.592; Lopez N, 1999, J BACTERIOL, V181, P3136, DOI 10.1128/JB.181.10.3136-3143.1999; MAGER WH, 1991, MOL CELL BIOCHEM, V104, P181; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; MIKLOS D, 1994, P NATL ACAD SCI USA, V91, P2743, DOI 10.1073/pnas.91.7.2743; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200	58	190	195	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					75	88		10.1016/j.cell.2005.11.039	http://dx.doi.org/10.1016/j.cell.2005.11.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413483	Bronze			2022-12-28	WOS:000234969600011
J	Panja, AS				Panja, AS			The nursing profession's coming of age - A difference in cultures	BRITISH MEDICAL JOURNAL			English	Letter									Greens Med Practice, London N4 1TL, England		Panja, AS (corresponding author), Greens Med Practice, 96 Umfreville Rd, London N4 1TL, England.	ayanpanja@hotmail.com						Young G, 2005, BRIT MED J, V331, P1415, DOI 10.1136/bmj.331.7529.1415	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					52	52		10.1136/bmj.332.7532.52	http://dx.doi.org/10.1136/bmj.332.7532.52			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16399757	Green Published			2022-12-28	WOS:000234684200036
J	Scarpa, T				Scarpa, T			Research funding - Peer review at NIH	SCIENCE			English	Editorial Material									NIH, Ctr Sci Review, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA	Scarpa, T (corresponding author), NIH, Ctr Sci Review, Bethesda, MD 20814 USA.	scarpat@csr.nih.gov						Kotchen TA, 2004, JAMA-J AM MED ASSOC, V291, P836, DOI 10.1001/jama.291.7.836; Mandel Richard, 1996, HALF CENTURY PEER RE; *NIH, 2005, NOTOD06013 NIH OFF E	3	15	15	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2006	311	5757					41	41		10.1126/science.1122796	http://dx.doi.org/10.1126/science.1122796			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001ON	16400135				2022-12-28	WOS:000234546300022
J	Krawitt, EL				Krawitt, EL			Medical progress: Autoimmune hepatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PRIMARY BILIARY-CIRRHOSIS; CHRONIC ACTIVE HEPATITIS; PRIMARY SCLEROSING CHOLANGITIS; SUPPRESSOR-CELL ACTIVITY; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; SOLUBLE LIVER ANTIGEN; TERM-FOLLOW-UP; OVERLAP SYNDROME; CORTICOSTEROID-THERAPY; URSODEOXYCHOLIC ACID		Univ Vermont, Dept Med, Burlington, VT 05405 USA; Dartmouth Coll, Dept Med, Hanover, NH 03755 USA	University of Vermont; Dartmouth College	Krawitt, EL (corresponding author), Univ Vermont, Dept Med, Given C-246, Burlington, VT 05405 USA.	edward.krawitt@uvm.edu	Hug, Balthasar L./G-1568-2010					Abdo AA, 2002, HEPATOLOGY, V36, P1393, DOI 10.1053/jhep.2002.37200; Abdo A, 2004, CLIN GASTROENTEROL H, V2, P107, DOI 10.1016/S1542-3565(03)00313-6; Agarwal K, 2000, HEPATOLOGY, V31, P49, DOI 10.1002/hep.510310110; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Alvarez F, 1999, J HEPATOL, V30, P222, DOI 10.1016/S0168-8278(99)80065-8; Batts KP, 1998, AUTOIMMUNE LIVER DIS, P115; Bittencourt PL, 2003, AM J GASTROENTEROL, V98, P1616, DOI 10.1016/S0002-9270(03)00307-1; Bittencourt PL, 2001, J HEPATOL, V35, P24, DOI 10.1016/S0168-8278(01)00072-1; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; Bridoux-Henno L, 2004, CLIN GASTROENTEROL H, V2, P825, DOI 10.1016/S1542-3565(04)00354-4; Buchel E, 2002, AM J GASTROENTEROL, V97, P3160; Burak KW, 1998, J HEPATOL, V29, P990, DOI 10.1016/S0168-8278(98)80128-1; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Cotler SJ, 2001, J CLIN GASTROENTEROL, V32, P428, DOI 10.1097/00004836-200105000-00014; Czaja AJ, 1996, HEPATOLOGY, V24, P1068; Czaja AJ, 2005, HEPATOLOGY, V41, P207, DOI 10.1002/hep.20539; Czaja AJ, 2004, J HEPATOL, V40, P646, DOI 10.1016/j.jhep.2004.01.009; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 1999, GASTROENTEROLOGY, V117, P645, DOI 10.1016/S0016-5085(99)70458-0; Czaja AJ, 2002, J HEPATOL, V37, P302, DOI 10.1016/S0168-8278(02)00182-4; Czaja AJ, 1999, HEPATOLOGY, V30, P1381, DOI 10.1002/hep.510300603; CZAJA AJ, 1990, HEPATOLOGY, V11, P1044, DOI 10.1002/hep.1840110621; Czaja AJ, 2000, GASTROENTEROLOGY, V119, P1312, DOI 10.1053/gast.2000.0010000001; DAVIS PA, 1992, HEPATOLOGY, V16, P1128, DOI 10.1016/0270-9139(92)90004-S; Djilali-Saiah I, 2004, J HEPATOL, V40, P904, DOI 10.1016/j.jhep.2004.02.023; Donaldson PT, 2002, SEMIN LIVER DIS, V22, P353, DOI 10.1055/s-2002-35705; DONALDSON PT, 1998, AUTOIMMUNE LIVER DIS, P141; Duchini A, 2000, AM J GASTROENTEROL, V95, P3238; Duclos-Vallee JC, 2003, GUT, V52, P893, DOI 10.1136/gut.52.6.893; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; Feldstein AE, 2003, HEPATOLOGY, V38, P210, DOI 10.1053/jhep.2003.50289; Fernandes NF, 1999, AM J GASTROENTEROL, V94, P241; Fukagawa NK, 2001, DIGEST DIS SCI, V46, P2080, DOI 10.1023/A:1011930008011; Gohlke F, 1996, J HEPATOL, V24, P699, DOI 10.1016/S0168-8278(96)80266-2; Gonzalez-Koch A, 2001, LIVER TRANSPLANT, V7, P302, DOI 10.1053/jlts.2001.21449; GOODMAN ZD, 1995, DIGEST DIS SCI, V40, P1232, DOI 10.1007/BF02065530; Gough A, 1996, BRIT MED J, V312, P169; Graziadei IW, 2003, LUPUS, V12, P409, DOI 10.1191/0961203303lu313cr; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Heneghan MA, 2001, HEPATOLOGY, V34, P464, DOI 10.1053/jhep.2001.26756; Heneghan MA, 2001, GUT, V48, P97, DOI 10.1136/gut.48.1.97; Hennes EM, 2005, HEPATOLOGY, V42, p295A; Herkel J, 2002, HEPATOLOGY, V35, P403, DOI 10.1053/jhep.2002.30699; HODGSON HJF, 1978, P NATL ACAD SCI USA, V75, P1549, DOI 10.1073/pnas.75.3.1549; HUPPERTZ HI, 1995, J HEPATOL, V23, P204, DOI 10.1016/0168-8278(95)80336-X; Hurlburt KJ, 2002, AM J GASTROENTEROL, V97, P2402, DOI 10.1111/j.1572-0241.2002.06019.x; Inui A, 2005, LIVER TRANSPLANT, V11, P504, DOI 10.1002/lt.20404; JOHNSON PJ, 1995, NEW ENGL J MED, V333, P958, DOI 10.1056/NEJM199510123331502; Joshi S, 2002, HEPATOLOGY, V35, P409, DOI 10.1053/jhep.2002.30902; Kanzler S, 1997, Z GASTROENTEROL, V35, P571; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kerkar N, 1998, LANCET, V351, P409, DOI 10.1016/S0140-6736(97)06478-7; Kerkar N, 2003, J IMMUNOL, V170, P1481, DOI 10.4049/jimmunol.170.3.1481; Kessler WR, 2004, CLIN GASTROENTEROL H, V2, P625, DOI 10.1016/S1542-3565(04)00246-0; Kosar Y, 2002, J CLIN GASTROENTEROL, V35, P185, DOI 10.1097/00004836-200208000-00012; Krawitt EL, 1999, ANN INTERN MED, V131, P796, DOI 10.7326/0003-4819-131-10-199911160-00032; KRAWITT EL, 1988, CLIN IMMUNOL IMMUNOP, V46, P249, DOI 10.1016/0090-1229(88)90187-0; KRAWITT EL, 2005, UPTODATE VERSION 13; Langley PG, 2002, J HEPATOL, V37, P441, DOI 10.1016/S0168-8278(02)00214-3; Lapierre P, 1999, GASTROENTEROLOGY, V116, P643, DOI 10.1016/S0016-5085(99)70186-1; LEWIS JH, 1998, AUTOIMMUNE LIVER DIS, P627; Lim KN, 2001, AM J GASTROENTEROL, V96, P3390, DOI 10.1111/j.1572-0241.2001.05272.x; Lohse AW, 1999, HEPATOLOGY, V29, P1078, DOI 10.1002/hep.510290409; LOHSE AW, 1995, HEPATOLOGY, V22, P381, DOI 10.1016/0270-9139(95)90554-5; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Ma Y, 2002, HEPATOLOGY, V35, P658, DOI 10.1053/jhep.2002.32092; MACKAY IR, 1965, ANN NY ACAD SCI, V124, P767, DOI 10.1111/j.1749-6632.1965.tb19000.x; McNair ANB, 1998, AM J GASTROENTEROL, V93, P777; Mieli-Vergani G, 2004, J HEPATOL, V40, P3, DOI 10.1016/j.jhep.2003.10.022; Nietsch HH, 2000, AM J GASTROENTEROL, V95, P2993, DOI 10.1016/S0002-9270(00)02015-3; Nishioka M., 1998, AUTOIMMUNE LIVER DIS, P413; NOURIARIA KT, 1982, NEW ENGL J MED, V307, P1301, DOI 10.1056/NEJM198211183072102; Obermayer-Straub P, 2001, GASTROENTEROLOGY, V121, P668, DOI 10.1053/gast.2001.27103; Pando M, 1999, HEPATOLOGY, V30, P1374, DOI 10.1002/hep.510300611; Pratt DS, 1996, GASTROENTEROLOGY, V110, P271, DOI 10.1053/gast.1996.v110.pm8536867; Pratt DS, 1997, GASTROENTEROLOGY, V113, P664, DOI 10.1053/gast.1997.v113.pm9247489; Ratziu V, 1999, J HEPATOL, V30, P131, DOI 10.1016/S0168-8278(99)80017-8; Reich DJ, 2000, HEPATOLOGY, V32, P693, DOI 10.1053/jhep.2000.16666; Reuben A, 2003, HEPATOLOGY, V38, P1596, DOI 10.1002/hep.510380643; Richardson PD, 2000, J HEPATOL, V33, P371, DOI 10.1016/S0168-8278(00)80271-8; Roberts SK, 1996, GASTROENTEROLOGY, V110, P848, DOI 10.1053/gast.1996.v110.pm8608895; Romero-Gomez M, 2004, AM J GASTROENTEROL, V99, P2150, DOI 10.1111/j.1572-0241.2004.40416.x; Roozendaal C, 2000, J HEPATOL, V32, P734, DOI 10.1016/S0168-8278(00)80241-X; Rumbo C, 2002, J PEDIATR GASTR NUTR, V35, P391, DOI 10.1097/00005176-200209000-00032; Salcedo M, 2002, HEPATOLOGY, V35, P349, DOI 10.1053/jhep.2002.31167; Samuel D, 2004, CLIN GASTROENTEROL H, V2, P622, DOI 10.1016/S1542-3565(04)00245-9; SANCHEZURDAZPAL L, 1992, HEPATOLOGY, V15, P215, DOI 10.1002/hep.1840150208; Schramm C, 2001, AM J GASTROENTEROL, V96, P1587; Skoog SM, 2002, AM J GASTROENTEROL, V97, P1568, DOI 10.1016/S0002-9270(02)04107-2; Sterling MJ, 1996, AM J GASTROENTEROL, V91, P2233; Terjung B, 2000, GASTROENTEROLOGY, V119, P310, DOI 10.1053/gast.2000.9366; Toda G, 1997, J HEPATOL, V26, P1207, DOI 10.1016/S0168-8278(97)80453-9; van Buuren HR, 2000, J HEPATOL, V33, P543, DOI 10.1034/j.1600-0641.2000.033004543.x; VANTHIEL DH, 1995, AM J GASTROENTEROL, V90, P771; Venkataramani A, 2001, AM J GASTROENTEROL, V96, P3432; Vento S, 1997, LANCET, V350, P1298, DOI 10.1016/S0140-6736(05)62476-2; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019	100	581	642	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					54	66		10.1056/NEJMra050408	http://dx.doi.org/10.1056/NEJMra050408			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394302				2022-12-28	WOS:000234358600008
J	Niedernhofer, LJ; Lalai, AS; Hoeijmakers, JHJ				Niedernhofer, LJ; Lalai, AS; Hoeijmakers, JHJ			Fanconi anemia (cross)linked to DNA repair	CELL			English	Review							CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; MAMMALIAN-CELLS; HELICASE BRIP1; PATHWAY; PROTEIN; BRCA1; DEFICIENT; BACH1		Erasmus Med Ctr, Dept Cell Biol & Genet, Ctr Biomed Genet, Ctr Genet Med, NL-3000 DR Rotterdam, Netherlands; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Inst Canc, Pittsburgh, PA 15213 USA	Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoeijmakers, JHJ (corresponding author), Erasmus Med Ctr, Dept Cell Biol & Genet, Ctr Biomed Genet, Ctr Genet Med, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.hoeijmakers@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021		NCI NIH HHS [K22-CA111525, K22 CA111525] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA111525] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; ALTER BP, 1991, BLOOD, V78, P602; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; Auerbach AD, 2001, METABOLIC MOL BASIS, V1, P753; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Kook H, 2005, HEMATOLOGY, V10, P108, DOI 10.1080/10245330512331390096; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Sala-Trepat M, 2000, EXP CELL RES, V260, P208, DOI 10.1006/excr.2000.4994; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740	37	241	245	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1191	1198		10.1016/j.cell.2005.12.009	http://dx.doi.org/10.1016/j.cell.2005.12.009			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377561	Bronze			2022-12-28	WOS:000234584500009
J	Platt, OS				Platt, OS			Preventing stroke in sickle cell anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ULTRASONOGRAPHY		Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, William B Castle Soc, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Platt, OS (corresponding author), Childrens Hosp, Dept Lab Med, 300 Longwood Ave, Boston, MA 02115 USA.							ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; HAM THOMAS H., 1940, TRANS ASSOC AMER PHYSICIANS, V55, P127; JANDL JH, 1996, BIOGRAPHICAL MEMOIRS, V67, P14	4	32	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2005	353	26					2743	2745		10.1056/NEJMp058274	http://dx.doi.org/10.1056/NEJMp058274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997LK	16382060				2022-12-28	WOS:000234246700005
J	Zhai, WG; Jeong, H; Cui, LB; Krainc, D; Tjian, R				Zhai, WG; Jeong, H; Cui, LB; Krainc, D; Tjian, R			In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets	CELL			English	Article							INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE DISEASE; GENE-EXPRESSION; CAG REPEAT; PROTEIN; SP1; ACTIVATION; BRAIN; TFIIF; DYSREGULATION	Transcriptional dysregulation has emerged as a potentially important pathogenic mechanism in Huntington's disease, a neurodegenerative disorder associated with polyglutamine expansion in the huntingtin (htt) protein. Here, we report the development of a biochemically defined in vitro transcription assay that is responsive to mutant htt. We demonstrate that both gene-specific activator protein Sp1 and selective components of the core transcription apparatus, including TRID and TFIIF, are direct targets inhibited by mutant htt in a polyglutamine-dependent manner. The RAP30 subunit of TRIF specifically interacts with mutant htt both in vitro and in vivo to interfere with formation of the RAP30-RAP74 native complex. Importantly, overexpression of RAP30 in cultured primary striatal cells protects neurons from mutant htt-induced cellular toxicity and alleviates the transcriptional inhibition of the dopamine D2 receptor gene by mutant htt. Our results suggest a mutant htt-directed repression mechanism involving multiple specific components of the basal transcription apparatus.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodenerat Dis, Charlestown, MA 02129 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodenerat Dis, 114 16th St, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu; jmlim@uclink4.berkeley.edu			NCI NIH HHS [CA025417] Funding Source: Medline; NINDS NIH HHS [P01NS045242, R01NS050352] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA025417, R37CA025417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045242, R01NS050352] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Frejtag W, 2001, J BIOL CHEM, V276, P14685, DOI 10.1074/jbc.M009224200; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GARRETT KP, 1992, J BIOL CHEM, V267, P23942; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Hoshino M, 2004, BIOCHEM BIOPH RES CO, V313, P110, DOI 10.1016/j.bbrc.2003.11.086; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Okazawa H, 2003, CELL MOL LIFE SCI, V60, P1427, DOI 10.1007/s00018-003-3013-z; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sipione S, 2001, MOL NEUROBIOL, V23, P21; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212	34	139	140	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1241	1253		10.1016/j.cell.2005.10.030	http://dx.doi.org/10.1016/j.cell.2005.10.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377565	Bronze			2022-12-28	WOS:000234584500013
J	Gal, AA; Cagle, PT				Gal, AA; Cagle, PT			The 100-year anniversary of the description of the frozen section procedure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGICAL PATHOLOGY; BIOPSY; ORIGINS		Arch Pathol & Lab Med, Northfield, IL USA		Gal, AA (corresponding author), Emory Univ Hosp, Dept Pathol & Lab Med, Room H171,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	agal@emory.edu						Bloodgood JC., 1927, J AM MED ASS, V88, P1022, DOI [10.1001/jama.1927.02680390050028, DOI 10.1001/JAMA.1927.02680390050028]; BLOODGOOD JC, 1927, SOUTH MED J, V20, P18; CARTER D, 1997, GUIDING SURG HAND HI, P23; CLAPESATTLE H, 1941, DOCTORS MAYO, P442; CULLEN TS, 1895, J HOPKINS HOSP B, V6, P67; DAHLIN DC, 1980, MAYO CLIN PROC, V55, P721; FECHNER RE, 1977, GUIDING SURGEON HAND, P7; Gal AA, 2005, ARCH PATHOL LAB MED, V129, P1532; Gal AA, 2001, ADV ANAT PATHOL, V8, P1, DOI 10.1097/00125480-200101000-00001; Gutmann EJ, 1998, MODERN PATHOL, V11, P686; Gutmann EJ, 2003, MODERN PATHOL, V16, P515, DOI 10.1097/01.MP.0000068260.01286.AC; Hellwig CA, 1932, ARCH PATHOL, V13, P607; JACYNA LS, 1988, B HIST MED, V62, P384; Lechago J, 2005, ARCH PATHOL LAB MED, V129, P1529; ROBINSON J, 1949, T CULLEN BALTIMORE, P120; Rosai, 1997, GUIDING SURG HAND HI, P145; ROSAI J, 1997, GUIDING SURG HAND HI, P1; ROSEN G, 1977, AM J SURG PATHOL, V1, P361, DOI 10.1097/00000478-197712000-00010; Unni, 1996, INT PATHOL, V37, P1; Wilson LB, 1905, JAMA-J AM MED ASSOC, V45, P1737, DOI DOI 10.1001/JAMA.1905.52510230037003C; WRIGHT JR, 1985, B HIST MED, V59, P295	21	48	49	6	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3135	3137		10.1001/jama.294.24.3135	http://dx.doi.org/10.1001/jama.294.24.3135			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380595				2022-12-28	WOS:000234274200031
J	Jackson, T				Jackson, T			The emergence of ringing vertigo	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Jackson, T (corresponding author), BMJ, London WC1H 9JR, England.	tjackson@bmj.com						BENNETT R, 2005, RINGING WORLD   0701, P618; Bunyan John, 1998, GRACE ABOUNDING CHIE; CAMP J, 2005, RINGING WORLD   0520, P473; MAJOR H, 2005, RINGING WORLD   1202, P1162; MAYOU R, 2005, RINGING WORLD   0715, P666; MORRIS M, 2005, GUARDIAN        0704; MOTTERSHEAD J, 2005, RINGING WORLD   0506, P426; SHERLAWJOHNSON R, 2005, RINGING WORLD   0610, P548; WILD J, 2005, RINGING WORLD   0729, P717	9	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1502	1503		10.1136/bmj.331.7531.1502	http://dx.doi.org/10.1136/bmj.331.7531.1502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373729	Green Published, Bronze			2022-12-28	WOS:000234351300009
J	Schoener, TW; Losos, JB; Spiller, DA				Schoener, TW; Losos, JB; Spiller, DA			Island biogeography of populations: An introduced species transforms survival patterns	SCIENCE			English	Article							PREDATION; BEHAVIOR; HABITAT; BIRDS; RISK	Population phenomena; which provide much of the underlying basis for the theoretical structure of island biogeography, have received little direct study. We determined a key population trait-survival-in the Bahamian lizard Anolis sagrei on islands with an experimentally introduced predatory lizard and on neighboring unmanipulated islands. On unmanipulated islands, survival declined with several variables, most notably vegetation height: The island with the shortest vegetation had nearly the highest survival recorded for any lizard. On islands with, the introduced predator, which forages mostly on the ground, A. sagrei shifted to taller vegetation; unlike on unmanipulated islands, its survival was very low on islands with the shortest vegetation but was higher on the others. Thus, species introduction radically changed a resident species' relation of survival to a key island-biogeogriphical variable.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Davis; Washington University (WUSTL)	Schoener, TW (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	twschoener@ucdavis.edu						BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Castilla AM, 1998, ACTA OECOL, V19, P107, DOI 10.1016/S1146-609X(98)80014-3; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P262, DOI 10.1073/pnas.73.1.262; HOLT RD, 1966, FOOD WEBS INTEGRATIO, P313; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lomolino M. V., 2005, BIOGEOGRAPHY; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; MAC ARTHUR ROBERT H., 1967; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Peterson AT, 2003, ECOL LETT, V6, P774, DOI 10.1046/j.1461-0248.2003.00502.x; Philippi Thomas E., 1993, P183; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schoener A., 1988, P483; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; SCHOENER TW, 1983, J ANIM ECOL, V52, P237, DOI 10.2307/4598; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stephens D.W., 1986, pi	23	31	32	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1807	1809		10.1126/science.1120165	http://dx.doi.org/10.1126/science.1120165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357259				2022-12-28	WOS:000234093600044
J	Mason, BR; Portus, M				Mason, BR; Portus, M			Essay - Biomechanical support in sport	LANCET			English	Article									Australian Inst Sport, Biomech Dept, Belconnen, ACT 2616, Australia	Australian Institute of Sport	Mason, BR (corresponding author), Australian Inst Sport, Biomech Dept, POB 176, Belconnen, ACT 2616, Australia.	bmason@ausport.gov.au							0	3	3	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S25	S26		10.1016/S0140-6736(05)67834-8	http://dx.doi.org/10.1016/S0140-6736(05)67834-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360738				2022-12-28	WOS:000234374400017
